<?xml version="1.0" encoding="UTF-8"?><xml><records><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Nickol, Michaela E.</author><author>Ciric, Justine</author><author>Falcinelli, Shane D.</author><author>Chertow, Daniel S.</author><author>Kindrachuk, Jason</author></authors></contributors><titles><title>Characterization of Host and Bacterial Contributions to Lung Barrier Dysfunction Following Co-infection with 2009 Pandemic Influenza and Methicillin Resistant Staphylococcus aureus</title><secondary-title>Viruses</secondary-title></titles><periodical><full-title>Viruses</full-title></periodical><pages>1-18</pages><volume>11</volume><issue>2</issue><keywords><keyword>2009 pandemic</keyword><keyword>Staphylococcus aureus</keyword><keyword>alveolar epithelial cells</keyword><keyword>barrier function</keyword><keyword>co-infection</keyword><keyword>influenza</keyword><keyword>kinome</keyword><keyword>virulence factors</keyword></keywords><dates><year>2019</year></dates><electronic-resource-num>10.3390/v11020116</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Characterization of Host and Bacterial Contributions.pdf</url></pdf-urls></urls><abstract>Influenza viruses are a threat to global public health resulting in ~500,000 deaths each year. Despite an intensive vaccination program, influenza infections remain a recurrent, yet unsolved public health problem. Secondary bacterial infections frequently complicate influenza infections during seasonal outbreaks and pandemics, resulting in increased morbidity and mortality. Staphylococcus aureus, including methicillin-resistant S. aureus (MRSA), is frequently associated with these co-infections, including the 2009 influenza pandemic. Damage to alveolar epithelium is a major contributor to severe influenza-bacterial co-infections and can result in gas exchange abnormalities, fluid leakage, and respiratory insufficiency. These deleterious manifestations likely involve both pathogen- and host-mediated mechanisms. However, there is a paucity of information regarding the mechanisms (pathogen- and/or host-mediated) underlying influenza-bacterial co-infection pathogenesis. To address this, we characterized the contributions of viral-, bacterial-, and host-mediated factors to the altered structure and function of alveolar epithelial cells during co-infection with a focus on the 2009 pandemic influenza (pdm2009) and MRSA. Here, we characterized pdm2009 and MRSA replication kinetics, temporal host kinome responses, modulation of MRSA virulence factors, and disruption of alveolar barrier integrity in response to pdm2009-MRSA co-infection. Our results suggest that alveolar barrier disruption during co-infection is mediated primarily through host response dysregulation, resulting in loss of alveolar barrier integrity.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tang, Juan</author><author>Lu, Xiangjun</author><author>Chen, Bin</author><author>Cai, Enqi</author><author>Liu, Wenli</author><author>Jiang, Jinxiao</author><author>Chen, Feifei</author></authors></contributors><titles><title>Mechanisms of silver nanoparticles-induced cytotoxicity and apoptosis in rat tracheal epithelial cells</title></titles><periodical/><pages>155-165</pages><volume>44</volume><issue>3</issue><keywords><keyword>apoptosis</keyword><keyword>cytotoxicity</keyword><keyword>oxidative stress</keyword><keyword>rat tracheal epithelial cells</keyword><keyword>silver nanoparticles</keyword></keywords><dates><year>2019</year></dates><urls><pdf-urls><url>internal-pdf://Tang et al. - 2019 - Mechanisms of silver nanoparticles-induced cytotoxicity and apoptosis in rat tracheal epithelial cells.pdf</url></pdf-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Anchan, Akshata</author><author>Kalogirou-baldwin, Panagiota</author><author>Johnson, Rebecca</author><author>Kho, Dan T</author><author>Joseph, Wayne</author><author>Hucklesby, James</author><author>Finlay, Graeme J</author><author>Carroll, Simon J O</author><author>Angel, Catherine E</author><author>Graham, E Scott</author></authors></contributors><titles><title>Real-Time Measurement of Melanoma Cell-Mediated Human Brain Endothelial Barrier Disruption Using Sensing Technology</title><secondary-title>Biosensors</secondary-title></titles><periodical><full-title>Biosensors</full-title></periodical><volume>9</volume><issue>56</issue><keywords><keyword>barrier function</keyword><keyword>blood</keyword><keyword>brain barrier</keyword><keyword>ecis</keyword><keyword>endothelium</keyword><keyword>impedance</keyword></keywords><dates><year>2019</year></dates><isbn>6409923694</isbn><urls><pdf-urls><url>internal-pdf://Real-Time Measurement of Melanoma Cell-Mediated Human Brain Endothelial Barrier Disruption Using Electric Cell-Substrate Impedance Sensing Technology.pdf</url></pdf-urls></urls><label>Barrier Function</label><abstract>Electric cell-substrate impedance sensing (ECIS) is an impedance-based method for monitoring changes in cell behaviour in real-time. In this paper, we highlight the importance of ECIS in measuring the kinetics of human melanoma cell invasion across human brain endothelium. ECIS data can be mathematically modelled to assess which component of the endothelial paracellular and basolateral barriers is being affected and when. Our results reveal that a range of humanmelanoma cells can mediate disruption of human brain endothelium, primarily involving the paracellular route, as demonstrated by ECIS. The sensitivity of ECIS also reveals that the paracellular barrier weakens within 30–60 min of the melanoma cells being added to the apical face of the endothelial cells. Imaging reveals pronounced localisation of the melanoma cells at the paracellular junctions consistent with paracellular migration. Time-lapse imaging further reveals junctional opening and disruption of the endothelial monolayer by the invasive melanoma cells all within several hours. We suggest that the ability of ECIS to resolve changes to barrier integrity in real time, and to determine the route of migration, provides a powerful tool for future studies investigating the key molecules involved in the invasive process of cancer cells</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pronk, Manon C</author><author>Majolee, Jisca</author><author>Loregger, Anke</author><author>van Bezu, Jan S.M.</author><author>Zelcer, Noam</author><author>Hordijk, Peter L.</author><author>Kovacevic, Igor</author></authors></contributors><titles><title>FBXW7 regulates endothelial barrier function by suppression of the cholesterol synthesis pathway and prenylation of RhoB Manon</title><secondary-title>Molecular biology of the cell</secondary-title></titles><periodical><full-title>Molecular biology of the cell</full-title></periodical><volume>30</volume><issue>5</issue><keywords/><dates><year>2019</year></dates><urls><pdf-urls><url>internal-pdf://FBXW7 regulates endothelial barrier function by suppression of the cholesterol.pdf</url></pdf-urls></urls><abstract>Rho GTPases control both the actin cytoskeleton and adherens junction stability and are recognized as essential regulators of endothelial barrier function. They act as molecular switches and are primarily regulated by the exchange of GDP and GTP. However, posttranslational modifications such as phosphorylation, prenylation, and ubiquitination can additionally alter their localization, stability, and activity. F-box proteins are involved in the recognition of substrate proteins predestined for ubiquitination and subsequent degradation. Given the importance of ubiquitination, we studied the effect of the loss of 62 members of the F-box protein family on endothelial barrier function in human umbilical vein endothelial cells. Endothelial barrier function was quantified by electrical cell impedance sensing and macromolecule passage assay. Our RNA interference–based screen identified FBXW7 as a key regulator of endothelial barrier function. Mechanistically, loss of FBXW7 induced the accumulation of the RhoB GTPase in endothelial cells, resulting in their increased contractility and permeability. FBXW7 knockdown induced activation of the cholesterol biosynthesis pathway and changed the prenylation of RhoB. This effect was reversed by farnesyl transferase inhibitors and by the addition of geranylgeranyl pyrophosphate. In summary, this study identifies FBXW7 as a novel regulator of endothelial barrier function in vitro. Loss of FBXW7 indirectly modulates RhoB activity via alteration of the cholesterol biosynthesis pathway and, consequently, of the prenylation status and activity of RhoB, resulting in increased contractility and disruption of the endothelial barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dennhardt, Sophie</author><author>Finke, Karl R.</author><author>Huwiler, Andrea</author><author>Coldewey, Sina M.</author></authors></contributors><titles><title>Sphingosine-1-phosphate promotes barrier-stabilizing effects in human microvascular endothelial cells via AMPK-dependent mechanisms</title><secondary-title>Biochimica et Biophysica Acta - Molecular Basis of Disease</secondary-title></titles><periodical><full-title>Biochimica et Biophysica Acta - Molecular Basis of Disease</full-title></periodical><pages>0-1</pages><issue>December 2018</issue><keywords><keyword>AMP-dependent kinase</keyword><keyword>Barrier breakdown</keyword><keyword>ECIS</keyword><keyword>Endothelial barrier</keyword><keyword>Inflammation</keyword><keyword>Sphingosine-1-phosphate</keyword></keywords><dates><year>2019</year></dates><publisher>Elsevier</publisher><electronic-resource-num>10.1016/j.bbadis.2018.12.022</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Sphingosine-1-phosphate promotes barrier-stabilizing eﬀects in human microvascular endothelial cells via AMPK-dependent mechanisms.pdf</url></pdf-urls><web-urls><url>https://doi.org/10.1016/j.bbadis.2018.12.022</url></web-urls></urls><abstract>Breakdown of the endothelial barrier is a critical step in the development of organ failure in severe inflammatory conditions such as sepsis. Endothelial cells from different tissues show phenotypic variations which are often neglected in endothelial research. Sphingosine-1-phosphate (S1P) and AMP-dependent kinase (AMPK) have been shown to protect the endothelium and phosphorylation of AMPK by S1P was shown in several cell types. However, the role of the S1P-AMPK interrelationship for endothelial barrier stabilization has not been investigated. To assess the role of the S1P-AMPK signalling axis in this context, we established an in vitro model allowing real-time monitoring of endothelial barrier function in human microvascular endothelial cells (HMEC-1) and murine glomerular endothelial cells (GENCs) with the electric cell-substrate impedance sensing (ECIS™) system. Following the disruption of the cell barrier by co-administration of LPS, TNF-α IL-1ß IFN-γ and IL–6, we demonstrated self-recovery of the disrupted barrier in HMEC-1, while the barrier remained compromised in GENCs. Under physiological conditions we observed a rapid phosphorylation of AMPK in HMEC-1 stimulated with S1P, but not in GENCs. Consistently, S1P enhanced the basal endothelial barrier in HMEC-1 exclusively. siRNA-mediated knockdown of AMPK in HMEC-1 led to a less pronounced barrier enhancement. Thus we present evidence for a functional role of AMPK in S1P-mediated barrier stabilization in HMEC-1 and we provide insight into cell-type specific differences of the S1P-AMPK-interrelationship, which might influence the development of interventional strategies targeting endothelial barrier dysfunction.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Alwhaibi, Abdulrahman</author><author>Somanath, Payaningal R.</author><author>Hafez, Sherif</author><author>Gao, Fei</author><author>Ergul, Adviye</author><author>Verma, Arti</author><author>Sabbineni, Harika</author><author>Artham, Sandeep</author></authors></contributors><titles><title>Endothelial stromelysin1 regulation by the forkhead box-O transcription factors is crucial in the exudative phase of acute lung injury</title><secondary-title>Pharmacological Research</secondary-title></titles><periodical><full-title>Pharmacological Research</full-title></periodical><pages>249-263</pages><volume>141</volume><issue>January</issue><keywords><keyword>ARDS</keyword><keyword>Akt1</keyword><keyword>Claudin5</keyword><keyword>FoxO</keyword><keyword>Lung injury</keyword><keyword>MMP3</keyword><keyword>Stromelysin1</keyword></keywords><dates><year>2019</year></dates><publisher>Elsevier</publisher><electronic-resource-num>10.1016/j.phrs.2019.01.006</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Endothelial stromelysin1 regulation by the forkhead box-O transcription.pdf</url></pdf-urls><web-urls><url>https://doi.org/10.1016/j.phrs.2019.01.006</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Morgan, Katie</author><author>Martucci, Nicole</author><author>Kozlowska, Ada</author><author>Gamal, Wesam</author><author>Brzeszczynki, Fillip</author><author>Treskes, Philipp</author><author>Samuel, Kay</author><author>Hayes, Peter</author><author>Nelson, Lenny</author><author>Bagnaninchi, Pierre</author><author>Brzeszczynska, Joanna</author><author>Plevris, John</author></authors></contributors><titles><title>Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line</title><secondary-title>Biomedicine and Pharmacotherapy</secondary-title></titles><periodical><full-title>Biomedicine and Pharmacotherapy</full-title></periodical><pages>1408-1416</pages><volume>111</volume><issue>January</issue><keywords><keyword>Adaptive response</keyword><keyword>Cell membrane</keyword><keyword>Chlorpromazine</keyword><keyword>ECIS</keyword><keyword>HepaRG</keyword><keyword>Impedance sensing</keyword><keyword>Pro-inflammatory</keyword><keyword>Tight junctions</keyword></keywords><dates><year>2019</year></dates><publisher>Elsevier</publisher><electronic-resource-num>10.1016/j.biopha.2019.01.020</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Chlorpromazine toxicity is associated with disruption of cell membrane integrity and initiation of a pro-inflammatory response in the HepaRG hepatic cell line.pdf</url></pdf-urls><web-urls><url>https://doi.org/10.1016/j.biopha.2019.01.020</url></web-urls></urls><abstract>Chlorpromazine (CPZ) is a neuroleptic drug and prototype compound used to study intrahepatic cholestasis. The exact mechanisms of CPZ induced cholestasis remain unclear. Rat hepatocytes, or a sandwich culture of rat and human hepatocytes, have been the most commonly used models for studying CPZ toxicity in vitro. However, to better predict outcomes in pre-clinical trials where cholestasis may be an unwanted consequence, a human in vitro model, based on human HepaRG cells, capable of real-time, non-invasive and label free monitoring, alongside molecular investigations would be beneficial. To address this we used the human hepatic HepaRG cell line, and established concentrations of CPZ ranging from sub-toxic, 25 μM and 50 μM, to toxic 100 μM and compared them with untreated control. To assess the effect of this range of CPZ concentrations we employed electrical cell-substrate impedance sensing (ECIS) to measure viability and cell membrane interactions alongside traditional viability assays, immunocytostaining and qRT-PCR to assess genes of interest within adaptive and inflammatory pathways. Using these methods, we show a concentration dependant response to CPZ involving pro-inflammatory pathway, loss of tight junctions and membrane integrity, and an adaptive response mediated by Cytochrome P450 (CYP) enzyme activation and up-regulation of membrane phospholipid and xenobiotic transporters. In conclusion, structural changes within the membrane caused by sub-toxic and toxic concentrations of CPZ negatively impact the function of the cellular membrane. Damage to efflux transport proteins caused by CPZ induce cholestasis alongside downstream inflammation, which activates compensatory responses for cell survival. Lay summary: Chlorpromazine is a drug used to treat patients with schizophrenia, which has a known association with liver damage. Here we show that it causes inflammation and alters the cell membranes in liver and bile duct cells similar to what is seen within a human population. The initiation of the inflammatory response and changes to cellular structure may provide insight into the damage and disease process and inform medical treatment.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lai, Yi-Ting</author><author>Chu, Yeh-Shiu</author><author>Lo, Jun-Chih</author><author>Hung, Yu-Han</author><author>Lo, Chun-Min</author></authors></contributors><titles><title>Effects of electrode diameter on the detection sensitivity and frequency characteristics of electric cell-substrate impedance sensing</title><secondary-title>Sensors and Actuators B: Chemical</secondary-title></titles><periodical><full-title>Sensors and Actuators B: Chemical</full-title></periodical><pages>707-715</pages><volume>288</volume><issue>February</issue><keywords><keyword>Electric cell-substrate impedance sensing (ECIS)</keyword><keyword>Electrochemical impedance spectroscopy (EIS)</keyword><keyword>Electrode size</keyword><keyword>MDA-MB-231</keyword><keyword>Sensitivity</keyword><keyword>Transforming growth factor-beta 1 (TGF-β1)</keyword><keyword>eis</keyword><keyword>electric cell-substrate impedance sensing</keyword><keyword>electrochemical impedance spectroscopy</keyword></keywords><dates><year>2019</year></dates><publisher>Elsevier</publisher><electronic-resource-num>10.1016/J.SNB.2019.02.098</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Eﬀects of electrode diameter on the detection sensitivity and frequency characteristics of electric cell-substrate impedance sensing .pdf</url></pdf-urls><web-urls><url>https://www.sciencedirect.com/science/article/pii/S0925400519303223?via%3Dihub</url></web-urls></urls><abstract>Cell-based electrochemical impedance spectroscopy (EIS) has emerged as a label-free approach to monitor whole cellular behavior in response to the environmental stimuli in real time. The measured impedance is strongly dependent on the attached cells, the sensing electrode size, and the constriction resistance between the sensing electrode and its counter electrode. However, determining the optimal electrode size for sensitive detection of impedance characteristics of the attached cells remains a challenge. In this study, four different cell lines (MDCK, MCF-7, HUVEC, and MDA-MB-231 cells) were cultured on the sensing electrodes with four different diameters, 250, 100, 50, and 25 μm, and impedance measurements were performed at frequencies ranging from 25 Hz to 64 kHz using electric cell-substrate impedance sensing (ECIS) method. As the diameter of sensing electrode decreases, the peak value (optimal detection sensitivity) of the normalized resistance spectrum decreases and the peak position (optimal detection frequency) shifts to the high-frequency region. These criteria were applied to sensitively measure impedance changes of MDA-MB-231 cells in response to TGF-β1 treatment. The transient increase of measured impedance after TGF-β1 treatment coincided with the augmented formation of the peripheral paxillin-rich sites and the increased cell migration rate, while little difference in cell spreading area was observed. Our results suggest that 250 μm is approximately the optimal electrode diameter for EIS measurement if sensitively monitoring the morphological changes of adherent cells is required.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mouton, Alan J.</author><author>Ma, Yonggang</author><author>Rivera Gonzalez, Osvaldo J.</author><author>Daseke, Michael J.</author><author>Flynn, Elizabeth R.</author><author>Freeman, Tom C.</author><author>Garrett, Michael R.</author><author>DeLeon-Pennell, Kristine Y.</author><author>Lindsey, Merry L.</author></authors></contributors><titles><title>Fibroblast polarization over the myocardial infarction time continuum shifts roles from inflammation to angiogenesis</title><secondary-title>Basic Research in Cardiology</secondary-title></titles><periodical><full-title>Basic Research in Cardiology</full-title></periodical><pages>1-16</pages><volume>114</volume><issue>2</issue><keywords><keyword>Angiogenesis</keyword><keyword>Cardiac remodeling</keyword><keyword>Extracellular matrix</keyword><keyword>Fibroblast</keyword><keyword>Myocardial infarction</keyword><keyword>Transcriptome</keyword></keywords><dates><year>2019</year></dates><publisher>Springer Berlin Heidelberg</publisher><isbn>0123456789</isbn><electronic-resource-num>10.1007/s00395-019-0715-4</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Fibroblast polarization over the myocardial infarction time continuum.pdf</url></pdf-urls><web-urls><url>https://doi.org/10.1007/s00395-019-0715-4</url></web-urls></urls><abstract>Cardiac fibroblasts are the major producers of extracellular matrix (ECM) to form infarct scar. We hypothesized that fibro- blasts undergo a spectrum of phenotype states over the course of myocardial infarction (MI) from early onset to scar forma- tion. Fibroblasts were isolated from the infarct region of C57BL/6J male mice (3–6 months old, n = 60) at days 0 (no MI control) and 1, 3, or 7 after MI. Whole transcriptome analysis was performed by RNA-sequencing. Of the genes sequenced, 3371 were differentially expressed after MI. Enrichment analysis revealed that MI day 1 fibroblasts displayed pro-inflam- matory, leukocyte-recruiting, pro-survival, and anti-migratory phenotype through Tnfrsf9 and CD137 signaling. MI day 3 fibroblasts had a proliferative, pro-fibrotic, and pro-angiogenic profile with elevated Il4ra signaling. MI day 7 fibroblasts showed an anti-angiogenic homeostatic-like myofibroblast profile and with a step-wise increase in Acta2 expression. MI day 7 fibroblasts relied on Pik3r3 signaling to mediate Tgfb1 effects and Fgfr2 to regulate PI3K signaling. In vitro, the day 3 MI fibroblast secretome stimulated angiogenesis, while day 7 MI fibroblast secretome repressed angiogenesis through Thbs1 signaling. Our results reveal novel mechanisms for fibroblasts in expressing pro-inflammatory molecules and regulating angiogenesis following MI.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gong, Haoli</author><author>Derbigny, Wilbert A.</author><author>Seye, Cheikh I.</author><author>Kumar, Ramesh</author><author>Liu, Luyao</author><author>Ramos-Solis, Nicole</author></authors></contributors><titles><title>TLR3 deficiency exacerbates the loss of epithelial barrier function during genital tract Chlamydia muridarum infection</title><secondary-title>Plos One</secondary-title></titles><periodical><full-title>Plos One</full-title></periodical><pages>e0207422</pages><volume>14</volume><issue>1</issue><keywords/><dates><year>2019</year></dates><isbn>1111111111</isbn><electronic-resource-num>10.1371/journal.pone.0207422</electronic-resource-num><urls><pdf-urls><url>internal-pdf://TLR3 deficiency exacerbates the loss of epithelial barrier function during genital tract Chlamydia muridarum infection.pdf</url></pdf-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Valle, Maria L.</author><author>Dworshak, Janine</author><author>Sharma, Ashok</author><author>Ibrahim, Ahmed S.</author><author>Al-Shabrawey, Mohamed</author><author>Sharma, Shruti</author></authors></contributors><titles><title>Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells</title><secondary-title>Experimental Eye Research</secondary-title></titles><periodical><full-title>Experimental Eye Research</full-title></periodical><pages>27-36</pages><volume>178</volume><issue>September 2018</issue><keywords><keyword>Endothelial cells</keyword><keyword>Inflammation</keyword><keyword>Interleukin-6</keyword><keyword>Trans-signaling</keyword><keyword>sgp130</keyword></keywords><dates><year>2019</year></dates><publisher>Elsevier</publisher><electronic-resource-num>10.1016/j.exer.2018.09.009</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells.pdf</url></pdf-urls><web-urls><url>https://doi.org/10.1016/j.exer.2018.09.009</url></web-urls></urls><abstract>Vascular inflammation plays a critical role in the pathogenesis of diabetic retinopathy. Recently, Interleukin-6 (IL-6) trans-signaling via soluble IL-6 receptor (sIL-6R) has emerged as a prominent regulator of inflammation in endothelial cells. This study was designed to test the hypothesis that selective inhibition of the IL-6 trans-signaling pathway will attenuate inflammation and subsequent barrier disruption in retinal endothelial cells. Human retinal endothelial cells (HRECs) were exposed to IL-6 and sIL-6R to induce IL-6 trans-signaling and the commercially available compound sgp130Fc (soluble gp-130 fused chimera) was used to selectively inhibit IL-6 trans-signaling. IL-6 trans-signaling activation caused a significant increase in STAT3 phosphorylation, expression of adhesion molecules, ROS production and apoptosis in HRECs whereas a significant decrease in mitochondrial membrane potential and NO production was observed in IL-6 trans-signaling activated cells. These changes were not observed in cells pre-treated with sgp130Fc. IL-6 trans-signaling activation was sufficient to cause barrier disruption in endothelial monolayers and pre-treatment of HRECs with sgp130Fc, maintained endothelial barrier function similar to that of untreated cells. Thus, in conclusion, these results indicate that IL-6 trans-signaling is an important mediator of inflammation, apoptosis and barrier disruptive effects in the retinal endothelial cells and inhibition of the IL-6 trans-signaling pathway using sgp130-Fc attenuates vascular inflammation and endothelial barrier disruption.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rath, Anca</author><author>Eichhorn, Michael</author><author>Träger, Katharina</author><author>Paulsen, Friedrich</author><author>Hampel, Ulrike</author></authors></contributors><titles><title>In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells</title><secondary-title>Annals of Anatomy</secondary-title></titles><periodical><full-title>Annals of Anatomy</full-title></periodical><pages>129-138</pages><volume>222</volume><keywords><keyword>Benzalkonium chloride</keyword><keyword>Meibomian gland</keyword><keyword>Prostaglandins</keyword></keywords><dates><year>2019</year></dates><publisher>Elsevier GmbH.</publisher><electronic-resource-num>10.1016/j.aanat.2018.12.003</electronic-resource-num><urls><pdf-urls><url>internal-pdf://In vitro effects of benzalkonium chloride and prostaglandins on human meibomian gland epithelial cells.pdf</url></pdf-urls><web-urls><url>https://doi.org/10.1016/j.aanat.2018.12.003</url></web-urls></urls><abstract>Purpose: Benzalkonium chloride is the most widely used preservative in ophthalmic topical solutions. The aim of this study was to investigate the influence of BAC as a single substance or as a component of several commercially available ophthalmic solutions on meibomian gland epithelial cells in vitro. Materials and methods: An immortalized human meibomian gland epithelial cell line (HMGEC) was used and cells were cultured in the absence or presence of fetal bovine serum to assess cell morphology, cell proliferation, cell viability (MTS assay) and impedance sensing (ECIS) after stimulation with BAC. Further, the viability of HMGECs stimulated with BAC-containing and BAC-free bimatoprost, travoprost and latanoprost was evaluated using the MTS assay. Real-time PCR analysis for hyperkeratinization associated genes (cornulin, involucrin) was performed. Results: In the absence of serum, the proliferation rate of HMGECs decreased starting with 0.1 μg/ml BAC. At concentrations of 50 μg/ml BAC and higher, cell viability was reduced after 10 min exposure with a corresponding change in cell morphology. Toxicity of BAC-containing ophthalmic solutions was greater than that of BAC alone, whereas BAC-free alternative products did not significantly influence cell viability. Confluence, cell-cell contacts and serum-containing medium appeared to facilitate HMGECs survival. Expression rate of involucrin and cornulin declined after exposure to preserved bimatoprost and BAC. Conclusions: BAC showed cytotoxic effects on HMGECs starting with a concentration of 0.1 μg/ml. The combination of BAC and prostaglandin-analogs might have a synergistic effect which results in higher toxicity than BAC alone. Unpreserved eye drops and eye drops preserved with Polyquaternium-1 are less damaging to HMGECs.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Glioblastoma, U- M G</author></authors></contributors><titles><title>Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Effects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis</title><secondary-title>Sensors</secondary-title></titles><periodical><full-title>Sensors</full-title></periodical><volume>19</volume><issue>2275</issue><keywords><keyword>andrographolide</keyword><keyword>ecis</keyword><keyword>glioblastoma</keyword><keyword>suberoylanilide hydroxamic acid</keyword><keyword>temozolomide</keyword></keywords><dates><year>2019</year></dates><urls><pdf-urls><url>internal-pdf://Application of Electric Cell-Substrate Impedance Sensing to Investigate the Cytotoxic Eﬀects of Andrographolide on U-87 MG Glioblastoma Cell Migration and Apoptosis.pdf</url></pdf-urls></urls><label>barrier function</label><abstract>Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor in adults. In recent studies, the efficacy of suberoylanilide hydroxamic acid (SAHA) has been investigated for GBM.We explored the effects of two exploratory compounds, the histone deacetylase SAHA and the natural product andrographolide, on Uppsala 87 Malignant Glioma (U-87 MG) cell migration and viability in comparison with the clinically used therapeutic agent temozolomide (TMZ). We used the electric cell–substrate impedance sensing (ECIS) system to monitor the migration of U-87 MG cells after treatment with various concentrations of these compounds. Moreover, we used the Alamar blue assay and western blotting to observe the concentration-dependent changes in the viability and apoptosis of U-87 MG cells. Our results demonstrated that both SAHA and andrographolide (10–300 µM) significantly inhibited GBM cell migration in a concentration-dependent manner, and 10 µM SAHA and 56 µM andrographolide demonstrated remarkable inhibitory effects on U-87 MG migration. Western blotting indicated that compared with TMZ, both SAHA and andrographolide induced higher expression levels of apoptosis-related proteins, such as caspase-3, BAX, and PARP in U-87 MG cells. Furthermore, all three drugs downregulated the expression of the antiapoptotic protein Bcl-2. In conclusion, SAHA and andrographolide showed exceptional results in inhibiting cell migration and motility. The ECIS wound healing assay is a powerful technique to identify and screen potential therapeutic agents that can inhibit cancer cell migration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Derada Troletti, Claudio</author><author>Fontijn, Ruud D.</author><author>Gowing, Elizabeth</author><author>Charabati, Marc</author><author>van Het Hof, Bert</author><author>Didouh, Imad</author><author>van der Pol, Susanne M.A.</author><author>Geerts, Dirk</author><author>Prat, Alexandre</author><author>van Horssen, Jack</author><author>Kooij, Gijs</author><author>de Vries, Helga E.</author></authors></contributors><titles><title>Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial cell dysfunction and occurs during multiple sclerosis pathophysiology</title><secondary-title>Cell Death and Disease</secondary-title></titles><periodical><full-title>Cell Death and Disease</full-title></periodical><volume>10</volume><issue>2</issue><keywords/><dates><year>2019</year></dates><publisher>Springer US</publisher><electronic-resource-num>10.1038/s41419-018-1294-2</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Inflammation-induced endothelial to mesenchymal transition promotes brain endothelial dysfunction and occurs during multiple sclerosis pathophysiology.pdf</url></pdf-urls><web-urls><url>http://dx.doi.org/10.1038/s41419-018-1294-2</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lenin, Raji</author><author>Nagy, Peter G</author><author>Alli, Shanta</author><author>Rao, Vidhya R</author><author>Clauss, Matthias A</author><author>Kompella, Uday B</author><author>Gangaraju, Rajashekhar</author></authors></contributors><titles><title>Critical role of endoplasmic reticulum stress in chronic endothelial activation− induced visual deficits in tie2‐tumor necrosis factor mice</title><secondary-title>Journal of cellular biochemistry</secondary-title></titles><periodical><full-title>Journal of cellular biochemistry</full-title></periodical><keywords/><dates><year>2018</year></dates><publisher>Wiley Online Library</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Robilliard, Laverne</author><author>Kho, Dan</author><author>Johnson, Rebecca</author><author>Anchan, Akshata</author><author>O’Carroll, Simon</author><author>Graham, Euan</author></authors></contributors><titles><title>The Importance of Multifrequency Impedance Sensing of Endothelial Barrier Formation Using ECIS Technology for the Generation of a Strong and Durable Paracellular Barrier</title><secondary-title>Biosensors</secondary-title></titles><periodical><full-title>Biosensors</full-title></periodical><pages>64</pages><volume>8</volume><issue>3</issue><keywords/><dates><year>2018</year></dates><publisher>Multidisciplinary Digital Publishing Institute</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Slater, Sadie C</author><author>Jover, Eva</author><author>Martello, Andrea</author><author>Mitić, Tijana</author><author>Rodriguez-Arabaolaza, Iker</author><author>Vono, Rosa</author><author>Alvino, Valeria V</author><author>Satchell, Simon C</author><author>Spinetti, Gaia</author><author>Caporali, Andrea</author></authors></contributors><titles><title>MicroRNA-532-5p regulates pericyte function through targeting the transcription regulator BACH1 and Angiopoietin-1</title><secondary-title>Molecular Therapy</secondary-title></titles><periodical><full-title>Molecular Therapy</full-title></periodical><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sun, Xu</author><author>Ma, Xueman</author><author>Li, Qiwei</author><author>Yang, Yong</author><author>Xu, Xiaolong</author><author>Sun, Jiaqi</author><author>Yu, Mingwei</author><author>Cao, Kexin</author><author>Yang, Lin</author><author>Yang, Guowang</author></authors></contributors><titles><title>Anti‑cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies</title><secondary-title>International journal of molecular medicine</secondary-title></titles><periodical><full-title>International journal of molecular medicine</full-title></periodical><pages>811-820</pages><volume>42</volume><issue>2</issue><keywords/><dates><year>2018</year></dates><publisher>Spandidos Publications</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Leligdowicz, Aleksandra</author><author>Chun, Lauren F</author><author>Jauregui, Alejandra</author><author>Vessel, Kathryn</author><author>Liu, Kathleen D</author><author>Calfee, Carolyn S</author><author>Matthay, Michael A</author></authors></contributors><titles><title>Human pulmonary endothelial cell permeability after exposure to LPS-stimulated leukocyte supernatants derived from patients with early sepsis</title><secondary-title>American Journal of Physiology-Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology-Lung Cellular and Molecular Physiology</full-title></periodical><keywords/><dates><year>2018</year></dates><publisher>American Physiological Society Bethesda, MD</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Szulcek, Robert</author><author>Bollensdorff, Christian</author><author>Hordijk, Peter</author><author>Gabriel, Matthias</author></authors></contributors><titles><title>The covalently immobilized antimicrobial peptide LL37 acts as a VEGF mimic and stimulates endothelial cell proliferation</title><secondary-title>Biochemical and biophysical research communications</secondary-title></titles><periodical><full-title>Biochemical and biophysical research communications</full-title></periodical><pages>887-890</pages><volume>496</volume><issue>3</issue><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Meegan, Jamie E</author><author>Yang, Xiaoyuan</author><author>Beard Jr, Richard S</author><author>Jannaway, Melanie</author><author>Chatterjee, Victor</author><author>Taylor-Clark, Thomas E</author><author>Yuan, Sarah Y</author></authors></contributors><titles><title>Citrullinated histone 3 causes endothelial barrier dysfunction</title><secondary-title>Biochemical and biophysical research communications</secondary-title></titles><periodical><full-title>Biochemical and biophysical research communications</full-title></periodical><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kiewiet, Mensiena B G</author><author>Rodríguez, Martín I González</author><author>Dekkers, Renske</author><author>Gros, Marjan</author><author>Ulfman, Laurien H</author><author>Groeneveld, Andre</author><author>de Vos, Paul</author><author>Faas, Marijke M</author></authors></contributors><titles><title>The epithelial barrier-protecting properties of a soy hydrolysate</title><secondary-title>Food &amp; function</secondary-title></titles><periodical><full-title>Food &amp; function</full-title></periodical><pages>4164-4172</pages><volume>9</volume><issue>8</issue><keywords/><dates><year>2018</year></dates><publisher>Royal Society of Chemistry</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zou, Qing‐yun</author><author>Zhao, Ying‐jie</author><author>Li, Hua</author><author>Wang, Xiang‐zhen</author><author>Liu, Ai‐xia</author><author>Zhong, Xin‐qi</author><author>Yan, Qin</author><author>Li, Yan</author><author>Zhou, Chi</author><author>Zheng, Jing</author></authors></contributors><titles><title>GNA11 differentially mediates fibroblast growth factor 2‐and vascular endothelial growth factor A‐induced cellular responses in human fetoplacental endothelial cells</title><secondary-title>The Journal of physiology</secondary-title></titles><periodical><full-title>The Journal of physiology</full-title></periodical><keywords/><dates><year>2018</year></dates><publisher>Wiley Online Library</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Curtis, Theresa M.</author><author>Hannett, Joseph M.</author><author>Harman, Rebecca M.</author><author>Puoplo, Nicholas A.</author><author>Van de Walle, Gerlinde R.</author></authors></contributors><titles><title>The secretome of adipose-derived mesenchymal stem cells protects SH-SY5Y cells from arsenic-induced toxicity, independent of a neuron-like differentiation mechanism</title><secondary-title>NeuroToxicology</secondary-title></titles><periodical><full-title>NeuroToxicology</full-title></periodical><pages>54-64</pages><volume>67</volume><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1016/j.neuro.2018.04.009</electronic-resource-num><urls><web-urls><url>https://linkinghub.elsevier.com/retrieve/pii/S0161813X18301207</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ghavampour, Sharang</author><author>Kleefeldt, Florian</author><author>Bömmel, Heike</author><author>Volland, Julian</author><author>Paus, Alexander</author><author>Horst, Andrea</author><author>Pfeiffer, Verena</author><author>Hübner, Stefan</author><author>Wagner, Nicole</author><author>Rueckschloss, Uwe</author><author>Ergün, Süleyman</author></authors></contributors><titles><title>Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling</title><secondary-title>The FASEB Journal</secondary-title></titles><periodical><full-title>The FASEB Journal</full-title></periodical><pages>fj.201800331R</pages><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1096/fj.201800331R</electronic-resource-num><urls><web-urls><url>http://www.fasebj.org/doi/10.1096/fj.201800331R</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van der Vlugt, Luciën E P M</author><author>Eger, Katrien</author><author>Müller, Christoph</author><author>Ninaber, Dennis K</author><author>Zarcone, Maria C</author><author>Amatngalim, Gimano D</author><author>Bracher, Franz</author><author>von Mutius, Erika</author><author>Smits, Hermelijn H</author><author>Hiemstra, Pieter S</author></authors></contributors><titles><title>Farm dust reduces viral load in human bronchial epithelial cells by increasing barrier function and antiviral responses</title><secondary-title>Journal of Allergy and Clinical Immunology</secondary-title></titles><periodical><full-title>Journal of Allergy and Clinical Immunology</full-title></periodical><pages>1949-1952</pages><volume>141</volume><issue>5</issue><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pannekoek, Willem-Jan</author><author>Vliem, Marjolein J</author><author>Bos, Johannes L</author></authors></contributors><titles><title>Multiple Rap1 effectors control Epac1-mediated tightening of endothelial junctions</title><secondary-title>Small GTPases</secondary-title></titles><periodical><full-title>Small GTPases</full-title></periodical><pages>1-8</pages><keywords/><dates><year>2018</year></dates><publisher>Taylor &amp; Francis</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cavallini, F</author><author>Tarantola, M</author></authors></contributors><titles><title>ECIS based wounding and reorganization of cardiomyocytes and fibroblasts in co-cultures</title><secondary-title>Progress in Biophysics and Molecular Biology</secondary-title></titles><periodical><full-title>Progress in Biophysics and Molecular Biology</full-title></periodical><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><electronic-resource-num>10.1016/j.pbiomolbio.2018.06.010</electronic-resource-num><urls><web-urls><url>https://linkinghub.elsevier.com/retrieve/pii/S0079610718300658</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Vila Cuenca, Marc</author><author>van Bezu, Jan</author><author>Beelen, Rob H J</author><author>Vervloet, Marc G</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>Stabilization of cell–cell junctions by active vitamin D ameliorates uraemia-induced loss of human endothelial barrier function</title><secondary-title>Nephrology Dialysis Transplantation</secondary-title></titles><periodical><full-title>Nephrology Dialysis Transplantation</full-title></periodical><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1093/ndt/gfy111</electronic-resource-num><urls><web-urls><url>https://academic.oup.com/ndt/advance-article/doi/10.1093/ndt/gfy111/4990530</url></web-urls></urls><abstract>A B S T R A C T Background. Uraemia induces endothelial cell (EC) injury and impaired repair capacity, for which the underlying mechanism remains unclear. Active vitamin D (VD) may promote endothe-lial repair, however, the mechanism that mediates the effects of VD in chronic kidney disease are poorly understood. Thus, we investigated uraemia-induced endothelial damage and the pro-tection against such damage by active VD. Methods. We applied electric cell-substrate impedance sensing (ECIS) to study real-time responses of human ECs exposed to pooled uraemic and non-uraemic plasma with or without the addition of active VD. The effects of indoxyl sulphate and p-cre-sol were tested in non-uraemic plasma. Structural changes for vascular endothelial (VE)-cadherin and F-actin were assessed by immunostaining and quantified. Results. The exposure of ECs to uraemic media significantly de-creased endothelial barrier function after 24 h. Cell migration after electrical wounding and recovery of the barrier after thrombin-induced loss of integrity were significantly impaired in uraemic-medium stimulated cells and cells exposed to indoxyl sulphate and p-cresol. This effect on ECIS was dependent on loss of cell–cell interaction. Mechanistically, we found that EC, ex-posed to uraemic media, displayed disrupted VE-cadherin inter-actions and F-actin reorganization. VD supplementation rescued both endothelial barrier function and cell–cell interactions in ECs exposed to uraemic media. These events were associated with an increment of VE-cadherin at intercellular junctions. Conclusions. Our data demonstrate a potentially clinically rele-vant mechanism for uraemia-induced endothelial damage. Furthermore, active VD rescued the uraemic medium-induced loss of cell–cell adhesion, revealing a novel role of active VD in preservation of endothelial integrity during uraemia.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wu, Li</author><author>Ye, Zeming</author><author>Pan, Ying</author><author>Li, Xianliang</author><author>Fu, Xian</author><author>Zhang, Bo</author><author>Li, Youfu</author><author>Lin, Wanrong</author><author>Li, Xuelong</author><author>Gao, Qingchun</author></authors></contributors><titles><title>Vascular endothelial growth factor aggravates cerebral ischemia and reperfusion-induced blood-brain-barrier disruption through regulating LOC102640519/HOXC13/ZO-1 signaling</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pati, Shibani</author><author>Peng, Zhanglong</author><author>Wataha, Katherine</author><author>Miyazawa, Byron</author><author>Potter, Daniel R</author><author>Kozar, Rosemary A</author></authors></contributors><titles><title>Lyophilized plasma attenuates vascular permeability, inflammation and lung injury in hemorrhagic shock</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e0192363</pages><volume>13</volume><issue>2</issue><keywords/><dates><year>2018</year></dates><publisher>Public Library of Science</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mertens, Koen</author><author>Meijer, Alexander B.</author><author>van den Eshof, Bart L.</author><author>van den Biggelaar, Maartje</author><author>Hoogendijk, Arie J.</author><author>Béguin, Eelke P.</author><author>Nota, Benjamin</author></authors></contributors><titles><title>Integrated proteomic analysis of tumor necrosis factor α and interleukin 1β-induced endothelial inflammation</title><secondary-title>Journal of Proteomics</secondary-title></titles><periodical><full-title>Journal of Proteomics</full-title></periodical><pages>89-101</pages><volume>192</volume><issue>June 2018</issue><keywords><keyword>Cell surface proteomics</keyword><keyword>Endothelium</keyword><keyword>IL-1β</keyword><keyword>Inflammation</keyword><keyword>Phosphoproteomics</keyword><keyword>Proteomics</keyword><keyword>TNFα</keyword></keywords><dates><year>2018</year></dates><publisher>Elsevier</publisher><electronic-resource-num>10.1016/j.jprot.2018.08.011</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Integrated proteomic analysis of tumor necrosis factorαand interleukin 1βinduced endothelial inﬂammation .pdf</url></pdf-urls><web-urls><url>https://doi.org/10.1016/j.jprot.2018.08.011</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Alma, L.J.</author><author>De Groot, C.J.M.</author><author>De Menezes, R.X.</author><author>Hermes, W.</author><author>Hordijk, P.L.</author><author>Kovačević, I.</author></authors></contributors><titles><title>Endothelial dysfunction as a long-term effect of late onset hypertensive pregnancy disorders: High BMI is key</title><secondary-title>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</secondary-title></titles><periodical><full-title>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</full-title></periodical><pages>62-69</pages><volume>225</volume><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1016/j.ejogrb.2018.04.003</electronic-resource-num><urls><web-urls><url>https://linkinghub.elsevier.com/retrieve/pii/S0301211518301611</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Shaver, Ciara M.</author><author>Wickersham, Nancy</author><author>McNeil, J. Brennan</author><author>Nagata, Hiromasa</author><author>Miller, Adam</author><author>Landstreet, Stuart R.</author><author>Kuck, Jamie L.</author><author>Diamond, Joshua M.</author><author>Lederer, David J.</author><author>Kawut, Steven M.</author><author>Palmer, Scott M.</author><author>Wille, Keith M.</author><author>Weinacker, Ann</author><author>Lama, Vibha N.</author><author>Crespo, Maria M.</author><author>Orens, Jonathan B.</author><author>Shah, Pali D.</author><author>Hage, Chadi A.</author><author>Cantu, Edward</author><author>Porteous, Mary K.</author><author>Dhillon, Gundeep</author><author>McDyer, John</author><author>Bastarache, Julie A.</author><author>Christie, Jason D.</author><author>Ware, Lorraine B.</author></authors></contributors><titles><title>Cell-free hemoglobin promotes primary graft dysfunction through oxidative lung endothelial injury</title><secondary-title>JCI Insight</secondary-title></titles><periodical><full-title>JCI Insight</full-title></periodical><volume>3</volume><issue>2</issue><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1172/jci.insight.98546</electronic-resource-num><urls><web-urls><url>https://insight.jci.org/articles/view/98546</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Liao, Danying</author><author>Mei, Heng</author><author>Hu, Yu</author><author>Newman, Debra K</author><author>Newman, Peter J</author></authors></contributors><titles><title>CRISPR-mediated deletion of the PECAM-1 cytoplasmic domain increases receptor lateral mobility and strengthens endothelial cell junctional integrity</title><secondary-title>Life sciences</secondary-title></titles><periodical><full-title>Life sciences</full-title></periodical><pages>186-193</pages><volume>193</volume><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chiang, Nan</author><author>Riley, Ian R.</author><author>Dalli, Jesmond</author><author>Rodriguez, Ana R.</author><author>Spur, Bernd W.</author><author>Serhan, Charles N.</author></authors></contributors><titles><title>New maresin conjugates in tissue regeneration pathway counters leukotriene D 4 –stimulated vascular responses</title><secondary-title>The FASEB Journal</secondary-title></titles><periodical><full-title>The FASEB Journal</full-title></periodical><pages>4043-4052</pages><volume>32</volume><issue>7</issue><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1096/fj.201701493R</electronic-resource-num><urls><web-urls><url>https://www.fasebj.org/doi/10.1096/fj.201701493R</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pérez, Pablo</author><author>Huertas, Gloria</author><author>Olmo, Alberto</author><author>Maldonado-Jacobi, Andrés</author><author>Serrano, Juan</author><author>Martín, María</author><author>Daza, Paula</author><author>Yúfera, Alberto</author></authors></contributors><titles><title>Remote Cell Growth Sensing Using Self-Sustained Bio-Oscillations</title><secondary-title>Sensors</secondary-title></titles><periodical><full-title>Sensors</full-title></periodical><pages>2550</pages><volume>18</volume><issue>8</issue><keywords/><dates><year>2018</year></dates><publisher>Multidisciplinary Digital Publishing Institute</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chandra, Deepak</author><author>Poole, Jill A.</author><author>Bailey, Kristina L.</author><author>Staab, Elizabeth</author><author>Sweeter, Jenea M.</author><author>DeVasure, Jane M.</author><author>Romberger, Debra J.</author><author>Wyatt, Todd A.</author></authors></contributors><titles><title>Dimethylarginine dimethylaminohydrolase (DDAH) overexpression enhances wound repair in airway epithelial cells exposed to agricultural organic dust</title><secondary-title>Inhalation Toxicology</secondary-title></titles><periodical><full-title>Inhalation Toxicology</full-title></periodical><pages>133-139</pages><volume>30</volume><issue>3</issue><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1080/08958378.2018.1474976</electronic-resource-num><urls><web-urls><url>https://www.tandfonline.com/doi/full/10.1080/08958378.2018.1474976</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Troletti, Claudio Derada</author><author>Pinheiro, Melissa A Lopes</author><author>Charabati, Marc</author><author>Gowing, Elizabeth</author><author>van het Hof, Bert</author><author>van der Pol, Susanne M A</author><author>Geerts, Dirk</author><author>Prat, Alexandre</author><author>Fontijn, Ruud D</author><author>Unger, Wendy W</author></authors></contributors><titles><title>Notch signaling is impaired during inflammation in a Lunatic Fringe-dependent manner</title><secondary-title>Brain, behavior, and immunity</secondary-title></titles><periodical><full-title>Brain, behavior, and immunity</full-title></periodical><pages>48-56</pages><volume>69</volume><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bhargavan, Biju</author><author>Kanmogne, Georgette D.</author></authors></contributors><titles><title>Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis</title><secondary-title>Molecular Neurobiology</secondary-title></titles><periodical><full-title>Molecular Neurobiology</full-title></periodical><pages>1352-1363</pages><volume>55</volume><issue>2</issue><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1007/s12035-017-0382-0</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s12035-017-0382-0</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Conference Proceedings">3</ref-type><contributors><authors><author>Park, Sang-Oh</author><author>Kim, Jong-Dae</author><author>Park, Chan-Young</author><author>Kim, Yu-Seop</author><author>Shin, Soo-Yong</author><author>Jeon, Sung-Ho</author><author>Kim, Jong-Won</author><author>Song, Hye-Jeong</author></authors></contributors><titles><title>Electrical cell-substrate impedance spectroscopy system using cloud based database</title><secondary-title>2018 IEEE International Conference on Applied System Invention (ICASI)</secondary-title></titles><periodical><full-title>2018 IEEE International Conference on Applied System Invention (ICASI)</full-title></periodical><pages>267-270</pages><keywords/><dates><year>2018</year></dates><publisher>IEEE</publisher><isbn>1538643421</isbn><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Fallacara, Arianna</author><author>Busato, Laura</author><author>Pozzoli, Michele</author><author>Ghadiri, Maliheh</author><author>Ong, Hui Xin</author><author>Young, Paul M</author><author>Manfredini, Stefano</author><author>Traini, Daniela</author></authors></contributors><titles><title>Combination of urea-crosslinked hyaluronic acid and sodium ascorbyl phosphate for the treatment of inflammatory lung diseases: An in vitro study</title><secondary-title>European Journal of Pharmaceutical Sciences</secondary-title></titles><periodical><full-title>European Journal of Pharmaceutical Sciences</full-title></periodical><pages>96-106</pages><volume>120</volume><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiao, Bo</author><author>Chen, Qiubing</author><author>Zhang, Zhan</author><author>Wang, Lixin</author><author>Denning, Timothy</author><author>Kang, Yuejun</author><author>Merlin, Didier</author></authors></contributors><titles><title>TNFα gene silencing mediated by orally targeted nanoparticles combined with interleukin-22 for synergistic combination therapy of ulcerative colitis</title><secondary-title>Journal of Controlled Release</secondary-title></titles><periodical><full-title>Journal of Controlled Release</full-title></periodical><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1016/j.jconrel.2018.08.021</electronic-resource-num><urls><web-urls><url>https://linkinghub.elsevier.com/retrieve/pii/S0168365918304875</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Amado-Azevedo, Joana</author><author>de Menezes, Renee X</author><author>van Nieuw Amerongen, Geerten P</author><author>van Hinsbergh, Victor W M</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>A functional siRNA screen identifies RhoGTPase-associated genes involved in thrombin-induced endothelial permeability</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e0201231</pages><volume>13</volume><issue>7</issue><keywords/><dates><year>2018</year></dates><publisher>Public Library of Science</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kovačević, Igor</author><author>Sakaue, Tomohisa</author><author>Majoleé, Jisca</author><author>Pronk, Manon C</author><author>Maekawa, Masashi</author><author>Geerts, Dirk</author><author>Fernandez-Borja, Mar</author><author>Higashiyama, Shigeki</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>The Cullin-3–Rbx1–KCTD10 complex controls endothelial barrier function via K63 ubiquitination of RhoB</title><secondary-title>J Cell Biol</secondary-title></titles><periodical><full-title>J Cell Biol</full-title></periodical><pages>jcb-201606055</pages><keywords/><dates><year>2018</year></dates><publisher>Rockefeller University Press</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kovacs‐Kasa, Anita</author><author>Kim, Kyung Mi</author><author>Cherian‐Shaw, Mary</author><author>Black, Stephen M</author><author>Fulton, David J</author><author>Verin, Alexander D</author></authors></contributors><titles><title>Extracellular adenosine‐induced Rac1 activation in pulmonary endothelium: Molecular mechanisms and barrier‐protective role</title><secondary-title>Journal of cellular physiology</secondary-title></titles><periodical><full-title>Journal of cellular physiology</full-title></periodical><pages>5736-5746</pages><volume>233</volume><issue>8</issue><keywords/><dates><year>2018</year></dates><publisher>Wiley Online Library</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hilfenhaus, Georg</author><author>Nguyen, Dai Phuong</author><author>Freshman, Jonathan</author><author>Prajapati, Divya</author><author>Ma, Feiyang</author><author>Song, Dana</author><author>Ziyad, Safiyyah</author><author>Cuadrado, Myriam</author><author>Pellegrini, Matteo</author><author>Bustelo, Xosé R</author></authors></contributors><titles><title>Vav3-induced cytoskeletal dynamics contribute to heterotypic properties of endothelial barriers</title><secondary-title>J Cell Biol</secondary-title></titles><periodical><full-title>J Cell Biol</full-title></periodical><pages>jcb-201706041</pages><keywords/><dates><year>2018</year></dates><publisher>Rockefeller University Press</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ghadiri, Maliheh</author><author>Canney, Finbarr</author><author>Pacciana, Cristina</author><author>Colombo, Gaia</author><author>Young, Paul M.</author><author>Traini, Daniela</author></authors></contributors><titles><title>The use of fatty acids as absorption enhancer for pulmonary drug delivery</title><secondary-title>International Journal of Pharmaceutics</secondary-title></titles><periodical><full-title>International Journal of Pharmaceutics</full-title></periodical><pages>93-100</pages><volume>541</volume><issue>1-2</issue><keywords/><dates><year>2018</year></dates><electronic-resource-num>10.1016/j.ijpharm.2018.02.027</electronic-resource-num><urls><web-urls><url>https://linkinghub.elsevier.com/retrieve/pii/S037851731830108X</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cvitic, Silvija</author><author>Novakovic, Boris</author><author>Gordon, Lavinia</author><author>Ulz, Christine M</author><author>Mühlberger, Magdalena</author><author>Diaz-Perez, Francisca I</author><author>Joo, Jihoon E</author><author>Svendova, Vendula</author><author>Schimek, Michael G</author><author>Trajanoski, Slave</author></authors></contributors><titles><title>Human fetoplacental arterial and venous endothelial cells are differentially programmed by gestational diabetes mellitus, resulting in cell-specific barrier function changes</title><secondary-title>Diabetologia</secondary-title></titles><periodical><full-title>Diabetologia</full-title></periodical><pages>1-14</pages><keywords/><dates><year>2018</year></dates><publisher>Springer</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Amado-Azevedo, J</author><author>Reinhard, N R</author><author>van Bezu, J</author><author>van Nieuw Amerongen, G P</author><author>van Hinsbergh, V W M</author><author>Hordijk, P L</author></authors></contributors><titles><title>The minor histocompatibility antigen 1 (HMHA1)/ArhGAP45 is a RacGAP and a novel regulator of endothelial integrity</title><secondary-title>Vascular pharmacology</secondary-title></titles><periodical><full-title>Vascular pharmacology</full-title></periodical><pages>38-47</pages><volume>101</volume><keywords/><dates><year>2018</year></dates><publisher>Elsevier</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mleynek, Tara</author><author>Li, Dean</author><author>Rosenblatt, Jody</author><author>Redd, Michael Jarman</author><author>Chan, Aubrey</author><author>Gu, Yapeng</author></authors></contributors><titles><title>Endothelia extrude apoptotic cells to maintain a constant barrier</title><secondary-title>bioRxiv</secondary-title></titles><periodical><full-title>bioRxiv</full-title></periodical><pages>268946</pages><keywords/><dates><year>2018</year></dates><publisher>Cold Spring Harbor Laboratory</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Baumer, Yvonne</author><author>McCurdy, Sara</author><author>Weatherby, Tina M.</author><author>Mehta, Nehal N.</author><author>Halbherr, Stefan</author><author>Halbherr, Pascal</author><author>Yamazaki, Noboru</author><author>Boisvert, William A.</author></authors></contributors><titles><title>Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis</title><secondary-title>Nature Communications</secondary-title></titles><periodical><full-title>Nature Communications</full-title></periodical><pages>1129</pages><volume>8</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/s41467-017-01186-z</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/s41467-017-01186-z</url></web-urls></urls><label>ECIS Attachment;ECIS Barrier Function;Wound Healing</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Samra, Yara A.</author><author>Saleh, Heba M.</author><author>Hussein, Khaled A.</author><author>Elsherbiny, Nehal M.</author><author>Ibrahim, Ahmed S.</author><author>Elmasry, Khaled</author><author>Fulzele, Sadanand</author><author>El-Shishtawy, Mamdouh M.</author><author>Eissa, Laila A.</author><author>Al-Shabrawey, Mohamed</author><author>Liou, Gregory I.</author></authors></contributors><titles><title>Adenosine Deaminase-2–Induced Hyperpermeability in Human Retinal Vascular Endothelial Cells Is Suppressed by MicroRNA-146b-3p</title><secondary-title>Investigative Opthalmology &amp; Visual Science</secondary-title></titles><periodical><full-title>Investigative Opthalmology &amp; Visual Science</full-title></periodical><pages>933</pages><volume>58</volume><issue>2</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1167/iovs.16-19782</electronic-resource-num><urls><web-urls><url>http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.16-19782</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tramontini Gomes de Sousa Cardozo, Francielle</author><author>Baimukanova, Gyulnar</author><author>Lanteri, Marion Christine</author><author>Keating, Sheila Marie</author><author>Moraes Ferreira, Frederico</author><author>Heitman, John</author><author>Pannuti, Cláudio Sérgio</author><author>Pati, Shibani</author><author>Romano, Camila Malta</author><author>Cerdeira Sabino, Ester</author></authors><secondary-authors><author>Jin, Dong-Yan</author></secondary-authors></contributors><titles><title>Serum from dengue virus-infected patients with and without plasma leakage differentially affects endothelial cells barrier function in vitro</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0178820</pages><volume>12</volume><issue>6</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1371/journal.pone.0178820</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0178820</url></web-urls></urls><label>ECIS Barrier Function</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jung, Mira</author><author>Ma, Yonggang</author><author>Iyer, Rugmani Padmanabhan</author><author>DeLeon-Pennell, Kristine Y.</author><author>Yabluchanskiy, Andriy</author><author>Garrett, Michael R.</author><author>Lindsey, Merry L.</author></authors></contributors><titles><title>IL-10 improves cardiac remodeling after myocardial infarction by stimulating M2 macrophage polarization and fibroblast activation</title><secondary-title>Basic Research in Cardiology</secondary-title></titles><periodical><full-title>Basic Research in Cardiology</full-title></periodical><pages>33</pages><volume>112</volume><issue>3</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1007/s00395-017-0622-5</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s00395-017-0622-5</url></web-urls></urls><label>Wound Healing</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mehta, Nehal N.</author><author>Teague, Heather L.</author><author>Swindell, William R.</author><author>Baumer, Yvonne</author><author>Ward, Nicole L.</author><author>Xing, Xianying</author><author>Baugous, Brooke</author><author>Johnston, Andrew</author><author>Joshi, Aditya A.</author><author>Silverman, Joanna</author><author>Barnes, Drew H.</author><author>Wolterink, Liza</author><author>Nair, Rajan P.</author><author>Stuart, Philip E.</author><author>Playford, Martin</author><author>Voorhees, John J.</author><author>Sarkar, Mrinal K.</author><author>Elder, James T.</author><author>Gallagher, Katherine</author><author>Ganesh, Santhi K.</author><author>Gudjonsson, Johann E.</author></authors></contributors><titles><title>IFN-γ and TNF-α synergism may provide a link between psoriasis and inflammatory atherogenesis</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>13831</pages><volume>7</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/s41598-017-14365-1</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/s41598-017-14365-1</url></web-urls></urls><label>ECIS Barrier Function</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kispert, Shannon E.</author><author>Marentette, John</author><author>Campian, E. Cristian</author><author>Isbell, T. Scott</author><author>Kuenzel, Hannah</author><author>McHowat, Jane</author></authors></contributors><titles><title>Cigarette smoke‐induced urothelial cell damage: potential role of platelet‐activating factor</title><secondary-title>Physiological Reports</secondary-title></titles><periodical><full-title>Physiological Reports</full-title></periodical><pages>e13177</pages><volume>5</volume><issue>5</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.14814/phy2.13177</electronic-resource-num><urls><web-urls><url>http://physreports.physiology.org/lookup/doi/10.14814/phy2.13177</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tóth, Gábor</author><author>Szöllősi, János</author><author>Vereb, György</author></authors></contributors><titles><title>Quantitating ADCC against adherent cells: Impedance-based detection is superior to release, membrane permeability, or caspase activation assays in resolving antibody dose response</title><secondary-title>Cytometry Part A</secondary-title></titles><periodical><full-title>Cytometry Part A</full-title></periodical><pages>1021-1029</pages><volume>91</volume><issue>10</issue><keywords><keyword>Antibody Dependent Cellular Cytotoxicity</keyword><keyword>PI/CFSE</keyword><keyword>PanToxiLux</keyword><keyword>adherent cell</keyword><keyword>cytometric ADCC assay</keyword><keyword>impedance-based cell analyzer</keyword><keyword>nonradioactive ADCC assay</keyword></keywords><dates><year>2017</year></dates><electronic-resource-num>10.1002/cyto.a.23247</electronic-resource-num><urls><pdf-urls><url>internal-pdf://Quantitating ADCC Against Adherent Cells Impedance-Based Detection is Superior to Release, Membrane Permeability, or Caspase Activation Assays in Resolving Antibody Dose Response.pdf</url></pdf-urls></urls><abstract>© 2017 International Society for Advancement of Cytometry. Monoclonal antibody-based immunotherapeutics will dominate Pharma's next generation of blockbuster drugs, and Fc-associated functions, including antibody dependent cellular cytotoxicity (ADCC) are among the highly desired activities mediated by these antibodies. Therefore, quantitative evaluation of ADCC is required during drug development. Our objective was to find the most suitable and reliable nonradioactive method for quantitative analysis of in vitro ADCC against adherent cells, which often serve as models for solid tumors. The test system was comprised the HER2 positive JIMT-1 cells targeted by the specific therapeutic antibodies trastuzumab (Herceptin®) and pertuzumab (Perjeta ® ). These cells are resistant to the direct biological effects of these antibodies, and, therefore, allow the isolated assessment of ADCC. We compared fluorescein diacetate (FDA) and carboxyfluorescein diacetate succinimidyl ester (CFSE) release as a fluorescent alternative to 51 Cr release; propidium iodide (PI) uptake revealing increased membrane permeability; the PanToxiLux assay measuring ADCC induced pro-apoptotic protease activity in flow cytometry; and an impedance-based real time cell adhesion test. We found that release assays are compromised by high spontaneous release of the label. PI uptake could not differentiate well between spontaneous NK activity and specific ADCC. The PanToxiLux assay, besides allowing for shorter assay times, offers improvement over the previous approaches in distinguishing spontaneous and antibody mediated NK action, but, probably owed to the prolonged detached state of adherent target cells, only at highly saturating antibody concentrations. In the case of adherent target cells, impedance-based cell analysis attains functional information exclusively on the target cells without having to label them for distinguishing from effectors or assay readout. It also allows continuous monitoring for days, and specifically detects target cell detachment, as the final functional consequence of ADCC. The sensitivity of this method even allows for quantitating the additivity and saturability of ADCC as a function of antibody concentration. We conclude that impedance-based assays are the most sensitive for quantitatively assessing in vitro ADCC on adherent target cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wagner, Alixandra</author><author>Eldawud, Reem</author><author>White, Andrew</author><author>Agarwal, Sushant</author><author>Stueckle, Todd A.</author><author>Sierros, Konstantinos A.</author><author>Rojanasakul, Yon</author><author>Gupta, Rakesh K.</author><author>Dinu, Cerasela Zoica</author></authors></contributors><titles><title>Toxicity evaluations of nanoclays and thermally degraded byproducts through spectroscopical and microscopical approaches</title><secondary-title>Biochimica et Biophysica Acta (BBA) - General Subjects</secondary-title></titles><periodical><full-title>Biochimica et Biophysica Acta (BBA) - General Subjects</full-title></periodical><pages>3406-3415</pages><volume>1861</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1016/j.bbagen.2016.09.003</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0304416516303257</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Nanes, Benjamin A.</author><author>Grimsley-Myers, Cynthia M.</author><author>Cadwell, Chantel M.</author><author>Robinson, Brian S.</author><author>Lowery, Anthony M.</author><author>Vincent, Peter A.</author><author>Mosunjac, Marina</author><author>Früh, Klaus</author><author>Kowalczyk, Andrew P.</author></authors><secondary-authors><author>Hardin, Jeffrey D.</author></secondary-authors></contributors><titles><title>p120-catenin regulates VE-cadherin endocytosis and degradation induced by the Kaposi sarcoma–associated ubiquitin ligase K5</title><secondary-title>Molecular Biology of the Cell</secondary-title></titles><periodical><full-title>Molecular Biology of the Cell</full-title></periodical><pages>30-40</pages><volume>28</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1091/mbc.E16-06-0459</electronic-resource-num><urls><web-urls><url>http://www.molbiolcell.org/lookup/doi/10.1091/mbc.E16-06-0459</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gong, Haixia</author><author>Liu, Menglin</author><author>Klomp, Jeff</author><author>Merrill, Bradley J.</author><author>Rehman, Jalees</author><author>Malik, Asrar B.</author></authors></contributors><titles><title>Method for Dual Viral Vector Mediated CRISPR-Cas9 Gene Disruption in Primary Human Endothelial Cells</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>42127</pages><volume>7</volume><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/srep42127</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep42127</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cui, Yu-Xin</author><author>Bradbury, Robyn</author><author>Flamini, Valentina</author><author>Wu, Bo</author><author>Jordan, Nicola</author><author>Jiang, Wen G</author></authors></contributors><titles><title>MicroRNA-7 suppresses the homing and migration potential of human endothelial cells to highly metastatic human breast cancer cells</title><secondary-title>British Journal of Cancer</secondary-title></titles><periodical><full-title>British Journal of Cancer</full-title></periodical><pages>89-101</pages><volume>117</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/bjc.2017.156</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/bjc.2017.156</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Elfick, Alistair</author><author>Rischitor, Grigore</author><author>Mouras, Rabah</author><author>Azfer, Asim</author><author>Lungaro, Lisa</author><author>Uhlarz, Marc</author><author>Herrmannsdörfer, Thomas</author><author>Lucocq, John</author><author>Gamal, Wesam</author><author>Bagnaninchi, Pierre</author><author>Semple, Scott</author><author>Salter, Donald M</author></authors></contributors><titles><title>Biosynthesis of magnetic nanoparticles by human mesenchymal stem cells following transfection with the magnetotactic bacterial gene mms6</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>39755</pages><volume>7</volume><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/srep39755</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep39755</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hong, Jian</author><author>Chu, Ming</author><author>Qian, Lijun</author><author>Wang, Junhong</author><author>Guo, Yan</author><author>Xu, Di</author></authors></contributors><titles><title>Fibrillar Type I Collagen Enhances the Differentiation and Proliferation of Myofibroblasts by Lowering α 2 β 1 Integrin Expression in Cardiac Fibrosis</title><secondary-title>BioMed Research International</secondary-title></titles><periodical><full-title>BioMed Research International</full-title></periodical><pages>1-11</pages><volume>2017</volume><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1155/2017/1790808</electronic-resource-num><urls><web-urls><url>https://www.hindawi.com/journals/bmri/2017/1790808/</url></web-urls></urls><abstract>Many studies have shown that α 2 β 1 integrin plays an important role in the development of cardiac fibrosis. However, the mechanism of how α 2 β 1 integrin regulates the differentiation and proliferation of myofibroblasts in cardiac fibrosis through fibrillar collagen (FC) remains uncertain. We established that FC mimicked the 3-dimensional extracellular matrix (ECM) of fibroblasts from post-myocardial infarction (MI) patients in vivo. This allowed us to explore the differentiation and proliferation of cardiac fibroblasts on FC. Here, we report that low expression of α 2 β 1 integrin increased protein kinase B (AKT) activation and α -smooth muscle actin ( α -SMA) expression. This occurred due to the instability of phosphatase and tensin homolog (PTEN) in myofibroblasts on FC. We also demonstrated that FC reduced protein phosphatase type 2A (PP2A) activity of myofibroblasts, which was coincident with low α 2 β 1 integrin expression and activation of AKT, but not mitogen-activated protein kinase (ERK). In addition, knock-down of both β 1 integrin and PP2A in fibroblasts promoted differentiation and proliferation via AKT activation and increased α -SMA expression. In summary, our study demonstrated that low α 2 β 1 integrin expression regulated its downstream targets PTEN and AKT via crosstalk with PP2A, a critical cell signaling pathway that permits aberrant differentiation and proliferation of myofibroblasts on FC.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ungewiß, Hanna</author><author>Vielmuth, Franziska</author><author>Suzuki, Shintaro T.</author><author>Maiser, Andreas</author><author>Harz, Hartmann</author><author>Leonhardt, Heinrich</author><author>Kugelmann, Daniela</author><author>Schlegel, Nicolas</author><author>Waschke, Jens</author></authors></contributors><titles><title>Desmoglein 2 regulates the intestinal epithelial barrier via p38 mitogen-activated protein kinase</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>6329</pages><volume>7</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/s41598-017-06713-y</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/s41598-017-06713-y</url></web-urls></urls><label>ECIS Barrier Function</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kho, Dan Ting</author><author>Johnson, Rebecca</author><author>Robilliard, Laverne</author><author>du Mez, Elyce</author><author>McIntosh, Julie</author><author>O’Carroll, Simon J.</author><author>Angel, Catherine E.</author><author>Graham, E. Scott</author></authors><secondary-authors><author>Liebner, Stefan</author></secondary-authors></contributors><titles><title>ECIS technology reveals that monocytes isolated by CD14+ve selection mediate greater loss of BBB integrity than untouched monocytes, which occurs to a greater extent with IL-1β activated endothelium in comparison to TNFα</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0180267</pages><volume>12</volume><issue>7</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1371/journal.pone.0180267</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0180267</url></web-urls></urls><label>ECIS Barrier Function;Inflammation</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kathiriya, Jaymin J</author><author>Nakra, Niyati</author><author>Nixon, Jenna</author><author>Patel, Puja S</author><author>Vaghasiya, Vijay</author><author>Alhassani, Ahmed</author><author>Tian, Zhi</author><author>Allen-Gipson, Diane</author><author>Davé, Vrushank</author></authors></contributors><titles><title>Galectin-1 inhibition attenuates profibrotic signaling in hypoxia-induced pulmonary fibrosis</title><secondary-title>Cell Death Discovery</secondary-title></titles><periodical><full-title>Cell Death Discovery</full-title></periodical><pages>17010</pages><volume>3</volume><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/cddiscovery.2017.10</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/cddiscovery201710</url></web-urls></urls><label>ECIS Growth;ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mohamed, Riyaz</author><author>Sharma, Isha</author><author>Ibrahim, Ahmed S.</author><author>Saleh, Heba</author><author>Elsherbiny, Nehal M.</author><author>Fulzele, Sadanand</author><author>Elmasry, Khaled</author><author>Smith, Sylvia B.</author><author>Al-Shabrawey, Mohamed</author><author>Tawfik, Amany</author></authors></contributors><titles><title>Hyperhomocysteinemia Alters Retinal Endothelial Cells Barrier Function and Angiogenic Potential via Activation of Oxidative Stress</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>11952</pages><volume>7</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/s41598-017-09731-y</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/s41598-017-09731-y</url></web-urls></urls><label>ECIS Barrier Function</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hung, Chi-Feng</author><author>Hsiao, Chien-Yu</author><author>Hsieh, Wen-Hao</author><author>Li, Hsin-Ju</author><author>Tsai, Yi-Ju</author><author>Lin, Chun-Nan</author><author>Chang, Hsun-Hsien</author><author>Wu, Nan-Lin</author></authors><secondary-authors><author>Andrade, Paula B.</author></secondary-authors></contributors><titles><title>18ß-glycyrrhetinic acid derivative promotes proliferation, migration and aquaporin-3 expression in human dermal fibroblasts</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0182981</pages><volume>12</volume><issue>8</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1371/journal.pone.0182981</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0182981</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Garrett, Joshua P.</author><author>Lowery, Anthony M.</author><author>Adam, Alejandro P.</author><author>Kowalczyk, Andrew P.</author><author>Vincent, Peter A.</author></authors><secondary-authors><author>Yap, Alpha</author></secondary-authors></contributors><titles><title>Regulation of endothelial barrier function by p120-catenin∙VE-cadherin interaction</title><secondary-title>Molecular Biology of the Cell</secondary-title></titles><periodical><full-title>Molecular Biology of the Cell</full-title></periodical><pages>85-97</pages><volume>28</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1091/mbc.E16-08-0616</electronic-resource-num><urls><web-urls><url>http://www.molbiolcell.org/lookup/doi/10.1091/mbc.E16-08-0616</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Retzlaff, Jennifer</author><author>Thamm, Kristina</author><author>Ghosh, Chandra C.</author><author>Ziegler, Wolfgang</author><author>Haller, Hermann</author><author>Parikh, Samir M.</author><author>David, Sascha</author></authors></contributors><titles><title>Flunarizine suppresses endothelial Angiopoietin-2 in a calcium - dependent fashion in sepsis</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>44113</pages><volume>7</volume><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/srep44113</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep44113</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Doggett, Travis M.</author><author>Alves, Natascha G.</author><author>Yuan, Sarah Y.</author><author>Breslin, Jerome W.</author></authors></contributors><titles><title>Sphingosine-1-Phosphate Treatment Can Ameliorate Microvascular Leakage Caused by Combined Alcohol Intoxication and Hemorrhagic Shock</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>4078</pages><volume>7</volume><issue>1</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1038/s41598-017-04157-y</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/s41598-017-04157-y</url></web-urls></urls><label>ECIS Barrier Function</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Singla, Sunit</author><author>Sysol, Justin R.</author><author>Dille, Benjamin</author><author>Jones, Nicole</author><author>Chen, Jiwang</author><author>Machado, Roberto F.</author></authors></contributors><titles><title>Hemin Causes Lung Microvascular Endothelial Barrier Dysfunction by Necroptotic Cell Death</title><secondary-title>American Journal of Respiratory Cell and Molecular Biology</secondary-title></titles><periodical><full-title>American Journal of Respiratory Cell and Molecular Biology</full-title></periodical><pages>307-314</pages><volume>57</volume><issue>3</issue><keywords/><dates><year>2017</year></dates><electronic-resource-num>10.1165/rcmb.2016-0287OC</electronic-resource-num><urls><web-urls><url>http://www.atsjournals.org/doi/10.1165/rcmb.2016-0287OC</url></web-urls></urls><label>Signal Transduction</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Grade, Patient-derived High</author><author>Ovarian, Serous</author><author>Negative, Triple</author><author>Cancer, Breast</author></authors></contributors><titles><title>International Journal of Chronic Diseases &amp; Therapy ( IJCDT ) Patient-Derived High Grade Serous Ovarian Cancer and Triple Negative Breast Cancer Cells</title></titles><periodical/><pages>31-38</pages><volume>2</volume><keywords><keyword>brca1</keyword><keyword>brca1a</keyword><keyword>interaction</keyword><keyword>migration</keyword><keyword>proliferation</keyword><keyword>protein-protein</keyword><keyword>serous epithelial ovarian cancers</keyword><keyword>triple negative breast cancers</keyword><keyword>ubc9</keyword></keywords><dates><year>2016</year></dates><urls><pdf-urls><url>internal-pdf://</url></pdf-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tasev, Dimitar</author><author>Konijnenberg, Lara S. F.</author><author>Amado-Azevedo, Joana</author><author>van Wijhe, Michiel H.</author><author>Koolwijk, Pieter</author><author>van Hinsbergh, Victor W. M.</author></authors></contributors><titles><title>CD34 expression modulates tube-forming capacity and barrier properties of peripheral blood-derived endothelial colony-forming cells (ECFCs)</title><secondary-title>Angiogenesis</secondary-title></titles><periodical><full-title>Angiogenesis</full-title></periodical><pages>325-338</pages><volume>19</volume><issue>3</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1007/s10456-016-9506-9</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s10456-016-9506-9</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ryman, Valerie E.</author><author>Packiriswamy, Nandakumar</author><author>Sordillo, Lorraine M.</author></authors></contributors><titles><title>Apoptosis of Endothelial Cells by 13-HPODE Contributes to Impairment of Endothelial Barrier Integrity</title><secondary-title>Mediators of Inflammation</secondary-title></titles><periodical><full-title>Mediators of Inflammation</full-title></periodical><pages>1-13</pages><volume>2016</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1155/2016/9867138</electronic-resource-num><urls><web-urls><url>https://www.hindawi.com/journals/mi/2016/9867138/</url></web-urls></urls><abstract>Inflammation is an essential host response during bacterial infections such as bovine mastitis. Endothelial cells are critical for an appropriate inflammatory response and loss of vascular barrier integrity is implicated in the pathogenesis of Streptococcus uberis -induced mastitis. Previous studies suggested that accumulation of linoleic acid (LA) oxygenation products derived from 15-lipoxygenase-1 (15-LOX-1) metabolism could regulate vascular functions. The initial LA derivative from the 15-LOX-1 pathway, 13-hydroperoxyoctadecadienoic acid (HPODE), can induce endothelial death, whereas the reduced hydroxyl product, 13-hydroxyoctadecadienoic acid (HODE), is abundantly produced during vascular activation. However, the relative contribution of specific LA-derived metabolites on impairment of mammary endothelial integrity is unknown. Our hypothesis was that S. uberis -induced LA-derived 15-LOX-1 oxygenation products impair mammary endothelial barrier integrity by apoptosis. Exposure of bovine mammary endothelial cells (BMEC) to S. uberis did not increase 15-LOX-1 LA metabolism. However, S. uberis challenge of bovine monocytes demonstrated that monocytes may be a significant source of both 13-HPODE and 13-HODE during mastitis. Exposure of BMEC to 13-HPODE, but not 13-HODE, significantly reduced endothelial barrier integrity and increased apoptosis. Changing oxidant status by coexposure to an antioxidant during 13-HPODE treatment prevented adverse effects of 13-HPODE, including amelioration of apoptosis. A better understanding of how the oxidant status of the vascular microenvironment impacts endothelial barrier properties could lead to more efficacious treatments for S. uberis mastitis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Santhanam, Sruthi</author><author>Liang, Jue</author><author>Struckhoff, Jessica</author><author>Hamilton, Paul D.</author><author>Ravi, Nathan</author></authors></contributors><titles><title>Biomimetic hydrogel with tunable mechanical properties for vitreous substitutes</title><secondary-title>Acta Biomaterialia</secondary-title></titles><periodical><full-title>Acta Biomaterialia</full-title></periodical><pages>327-337</pages><volume>43</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.actbio.2016.07.051</electronic-resource-num><urls/><abstract>The vitreous humor of the eye is a biological hydrogel principally composed of collagen fibers interspersed with hyaluronic acid. Certain pathological conditions necessitate its removal and replacement. Current substitutes, like silicone oils and perfluorocarbons, are not biomimetic and have known complications. In this study, we have developed an in situ forming two-component biomimetic hydrogel with tunable mechanical and osmotic properties. The components are gellan, an analogue of collagen, and poly(methacrylamide-co-methacrylate), an analogue of hyaluronic acid; both endowed with thiol side groups. We used response surface methodology to consider seventeen possible hydrogels to determine how each component affects the optical, mechanical, sol-gel transition temperature and swelling properties. The optical and physical properties of the hydrogels were similar to vitreous. The shear storage moduli ranged from 3 to 358Pa at 1Hz and sol-gel transition temperatures from 35.5 to 43°C. The hydrogel had the ability to remain swollen without degradation for four weeks in vitro. Three hydrogels were tested for biocompatibility on primary porcine retinal pigment epithelial cells, human retinal pigment epithelial cells, and fibroblast (3T3/NIH) cells, by electric cell-substrate impedance sensing system. The two-component hydrogels allowed for the tuning and optimizing of mechanical, swelling, and transition temperature to obtain three biocompatible hydrogels with properties similar to the vitreous. Future studies include testing of the optimized hydrogels in animal models for use as a long-term substitute, whose preliminary results are mentioned. 

STATEMENT OF SIGNIFICANCE
Although hydrogels are researched as long-term vitreous substitute, none have advanced sufficiently to reach clinical application. Our work focuses on the development of a novel two component in situ forming hydrogel that bio-mimic the natural vitreous. Our thiol-containing copolymers can be injected as an aqueous solution into the vitreous cavity wherein, at physiological temperature, the rigid component will instantaneously form a physical gel imbedding the random coil copolymer. Upon subsequent oxidation, the two components will form disulfide cross-links and a stable reversible hydrogel capable of providing osmotic pressure to reattach the retina. It may be left in the eye permanently or easily removed by injection of a simple reducing agent to cleave the disulfide bonds, rather than surgery. This contribution is significant because it is expected to provide patients with a much better quality of life by improving surgical outcomes, creating much less post-operative burden, and reducing the need for secondary surgeries.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van Vliet, Erwin A</author><author>Otte, Willem M</author><author>Wadman, Wytse J</author><author>Aronica, Eleonora</author><author>Kooij, Gijs</author><author>de Vries, Helga E</author><author>Dijkhuizen, Rick M</author><author>Gorter, Jan A</author></authors></contributors><titles><title>Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats II: Potential mechanisms</title><secondary-title>Epilepsia</secondary-title></titles><periodical><full-title>Epilepsia</full-title></periodical><pages>70-78</pages><volume>57</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1111/epi.13245</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1111/epi.13245</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xie, Lishi</author><author>Chiang, Eddie T.</author><author>Wu, Xiaomin</author><author>Kelly, Gabriel T.</author><author>Kanteti, Prasad</author><author>Singleton, Patrick A.</author><author>Camp, Sara M.</author><author>Zhou, Tingting</author><author>Dudek, Steven M.</author><author>Natarajan, Viswanathan</author><author>Wang, Ting</author><author>Black, Steven M.</author><author>Garcia, Joe G. N.</author><author>Jacobson, Jeffrey R.</author></authors><secondary-authors><author>Birukova, Anna A</author></secondary-authors></contributors><titles><title>Regulation of Thrombin-Induced Lung Endothelial Cell Barrier Disruption by Protein Kinase C Delta</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0158865</pages><volume>11</volume><issue>7</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1371/journal.pone.0158865</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0158865</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gallego-Delgado, Julio</author><author>Basu-Roy, Upal</author><author>Ty, Maureen</author><author>Alique, Matilde</author><author>Fernandez-Arias, Cristina</author><author>Movila, Alexandru</author><author>Gomes, Pollyanna</author><author>Weinstock, Ada</author><author>Xu, Wenyue</author><author>Edagha, Innocent</author><author>Wassmer, Samuel C</author><author>Walther, Thomas</author><author>Ruiz-Ortega, Marta</author><author>Rodriguez, Ana</author></authors></contributors><titles><title>Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria.</title><secondary-title>The Journal of clinical investigation</secondary-title></titles><periodical><full-title>The Journal of clinical investigation</full-title></periodical><volume>126</volume><issue>10</issue><keywords/><dates><year>2016</year></dates><publisher>American Society for Clinical Investigation</publisher><accession-num>27643439</accession-num><electronic-resource-num>10.1172/JCI87306</electronic-resource-num><language>en</language><urls><pdf-urls><url>internal-pdf://</url></pdf-urls><web-urls><url>http://www.jci.org/articles/view/87306#.V-rXQESrWK4.mendeley</url></web-urls></urls><abstract>Cerebral malaria is characterized by cytoadhesion of Plasmodium falciparum-infected red blood cells (Pf-iRBCs) to endothelial cells in the brain, disruption of the blood-brain barrier, and cerebral microhemorrhages. No available antimalarial drugs specifically target the endothelial disruptions underlying this complication, which is responsible for the majority of malaria-associated deaths. Here, we have demonstrated that ruptured Pf-iRBCs induce activation of β-catenin, leading to disruption of inter-endothelial cell junctions in human brain microvascular endothelial cells (HBMECs). Inhibition of β-catenin-induced TCF/LEF transcription in the nucleus of HBMECs prevented the disruption of endothelial junctions, confirming that β-catenin is a key mediator of P. falciparum adverse effects on endothelial integrity. Blockade of the angiotensin II type 1 receptor (AT1) or stimulation of the type 2 receptor (AT2) abrogated Pf-iRBC-induced activation of β-catenin and prevented the disruption of HBMEC monolayers. In a mouse model of cerebral malaria, modulation of angiotensin II receptors produced similar effects, leading to protection against cerebral malaria, reduced cerebral hemorrhages, and increased survival. In contrast, AT2-deficient mice were more susceptible to cerebral malaria. The interrelation of the β-catenin and the angiotensin II signaling pathways opens immediate host-targeted therapeutic possibilities for cerebral malaria and other diseases in which brain endothelial integrity is compromised.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chatterjee, Ishita</author><author>Baruah, Jugajyoti</author><author>Lurie, Erin E.</author><author>Wary, Kishore K.</author></authors></contributors><titles><title>Endothelial lipid phosphate phosphatase-3 deficiency that disrupts the endothelial barrier function is a modifier of cardiovascular development</title><secondary-title>Cardiovascular Research</secondary-title></titles><periodical><full-title>Cardiovascular Research</full-title></periodical><pages>105-118</pages><volume>111</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1093/cvr/cvw090</electronic-resource-num><urls><web-urls><url>http://cardiovascres.oxfordjournals.org/lookup/doi/10.1093/cvr/cvw090</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Faura Tellez, Grissel</author><author>Willemse, Brigitte W. M.</author><author>Brouwer, Uilke</author><author>Nijboer-Brinksma, Susan</author><author>Vandepoele, Karl</author><author>Noordhoek, Jacobien A.</author><author>Heijink, Irene</author><author>de Vries, Maaike</author><author>Smithers, Natalie P.</author><author>Postma, Dirkje S.</author><author>Timens, Wim</author><author>Wiffen, Laura</author><author>van Roy, Frans</author><author>Holloway, John W.</author><author>Lackie, Peter M.</author><author>Nawijn, Martijn C.</author><author>Koppelman, Gerard H.</author></authors><secondary-authors><author>Koval, Michael</author></secondary-authors></contributors><titles><title>Protocadherin-1 Localization and Cell-Adhesion Function in Airway Epithelial Cells in Asthma</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0163967</pages><volume>11</volume><issue>10</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1371/journal.pone.0163967</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0163967</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Monickaraj, F.</author><author>McGuire, P. G.</author><author>Nitta, C. F.</author><author>Ghosh, K.</author><author>Das, A.</author></authors></contributors><titles><title>Cathepsin D: an M -derived factor mediating increased endothelial cell permeability with implications for alteration of the blood-retinal barrier in diabetic retinopathy</title><secondary-title>The FASEB Journal</secondary-title></titles><periodical><full-title>The FASEB Journal</full-title></periodical><pages>1670-1682</pages><volume>30</volume><issue>4</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1096/fj.15-279802</electronic-resource-num><urls><web-urls><url>http://www.fasebj.org/cgi/doi/10.1096/fj.15-279802</url></web-urls></urls><label>ECIS TEER;Inflammation;Signal Transduction</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cha, Byong-Ki</author><author>Kim, Young-Suk</author><author>Hwang, Ki-Eun</author><author>Cho, Kyung-Hwa</author><author>Kim, Byoung-Ryun</author><author>Jun, Hong-Young</author><author>Yoon, Kwon-Ha</author><author>Jeong, Eun-Taik</author><author>Kim, Hak-Ryul</author></authors></contributors><titles><title>Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1</title><secondary-title>Oncotarget</secondary-title></titles><periodical><full-title>Oncotarget</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.18632/oncotarget.11127</electronic-resource-num><urls><web-urls><url>http://www.oncotarget.com/abstract/11127</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Adam, Alejandro P</author><author>Lowery, Anthony M</author><author>Martino, Nina</author><author>Alsaffar, Hiba</author><author>Vincent, Peter A</author></authors></contributors><titles><title>Src Family Kinases Modulate the Loss of Endothelial Barrier Function in Response to TNF-α: Crosstalk with p38 Signaling.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e0161975</pages><volume>11</volume><issue>9</issue><keywords/><dates><year>2016</year></dates><publisher>Public Library of Science</publisher><accession-num>27603666</accession-num><electronic-resource-num>10.1371/journal.pone.0161975</electronic-resource-num><urls><pdf-urls><url>internal-pdf://</url></pdf-urls><web-urls><url>http://dx.doi.org/10.1371/journal.pone.0161975</url></web-urls></urls><label>ECIS Attachment;Signal Transduction</label><abstract>Activation of Src Family Kinase (SFK) signaling is required for the increase in endothelial permeability induced by a variety of cytokines and growth factors. However, we previously demonstrated that activation of endogenous SFKs by expression of dominant negative C-terminal Src Kinase (DN-Csk) is not sufficient to decrease endothelial adherens junction integrity. Basal SFK activity has been observed in normal venular endothelia and was not associated with increased basal permeability. The basal SFK activity however was found to contribute to increased sensitivity of the venular endothelium to inflammatory mediator-induced leakage. How SFK activation achieves this is still not well understood. Here, we show that SFK activation renders human dermal microvascular endothelial cells susceptible to low doses of TNF-α. Treatment of DN-Csk-expressing cells with 50 pg/ml TNF-α induced a loss of TEER as well as drastic changes in the actin cytoskeleton and focal adhesion proteins. This synergistic effect was independent of ROCK or NF-κB activity. TNF-α-induced p38 signaling was required for the synergistic effect on barrier function, and activation of the p38 MAPK alone was also able to induce changes in permeability only in monolayers with active SFKs. These results suggest that the activation of endogenous levels of SFK renders the endothelial barrier more susceptible to low, physiologic doses of TNF-α through activation of p38 which leads to a loss of endothelial tight junctions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Poroyko, Valeriy A.</author><author>Carreras, Alba</author><author>Khalyfa, Abdelnaby</author><author>Khalyfa, Ahamed A.</author><author>Leone, Vanessa</author><author>Peris, Eduard</author><author>Almendros, Isaac</author><author>Gileles-Hillel, Alex</author><author>Qiao, Zhuanhong</author><author>Hubert, Nathaniel</author><author>Farré, Ramon</author><author>Chang, Eugene B.</author><author>Gozal, David</author></authors></contributors><titles><title>Chronic Sleep Disruption Alters Gut Microbiota, Induces Systemic and Adipose Tissue Inflammation and Insulin Resistance in Mice</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>35405</pages><volume>6</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/srep35405</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep35405</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yang, Jen Ming</author><author>Chen, Szi-Wen</author><author>Yang, Jhe-Hao</author><author>Hsu, Chih-Chin</author><author>Wang, Jong-Shyan</author></authors></contributors><titles><title>A quantitative cell modeling and wound-healing analysis based on the Electric Cell-substrate Impedance Sensing (ECIS) method</title><secondary-title>Computers in Biology and Medicine</secondary-title></titles><periodical><full-title>Computers in Biology and Medicine</full-title></periodical><pages>134-143</pages><volume>69</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.compbiomed.2015.12.022</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0010482515004151</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Owen, Sioned</author><author>Zhao, Huishan</author><author>Dart, Alwyn</author><author>Wang, Yamei</author><author>Ruge, Fiona</author><author>Gao, Yong</author><author>Wei, Cong</author><author>Wu, Yiling</author><author>Jiang, Wen</author></authors></contributors><titles><title>Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells</title><secondary-title>International Journal of Oncology</secondary-title></titles><periodical><full-title>International Journal of Oncology</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.3892/ijo.2016.3685</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/10.3892/ijo.2016.3685</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Vogt, Leonie M</author><author>Sahasrabudhe, Neha M</author><author>Ramasamy, Uttara</author><author>Meyer, Diederick</author><author>Pullens, Gerdie</author><author>Faas, Marijke M</author><author>Venema, Koen</author><author>Schols, Henk A</author><author>de Vos, Paul</author></authors></contributors><titles><title>The impact of lemon pectin characteristics on TLR activation and T84 intestinal epithelial cell barrier function</title><secondary-title>Journal of Functional Foods</secondary-title></titles><periodical><full-title>Journal of Functional Foods</full-title></periodical><pages>398-407</pages><volume>22</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.jff.2016.02.002</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S1756464616000566</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Koning, N J</author><author>Overmars, M A H</author><author>van den Brom, C E</author><author>van Bezu, J</author><author>Simon, L E</author><author>Vonk, A B A</author><author>Girbes, A R J</author><author>van Nieuw Amerongen, G P</author><author>Boer, C</author></authors><secondary-authors><author>Absalom, A R</author></secondary-authors></contributors><titles><title>Endothelial hyperpermeability after cardiac surgery with cardiopulmonary bypass as assessed using an in vitro bioassay for endothelial barrier function</title><secondary-title>British Journal of Anaesthesia</secondary-title></titles><periodical><full-title>British Journal of Anaesthesia</full-title></periodical><pages>223-232</pages><volume>116</volume><issue>2</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1093/bja/aev411</electronic-resource-num><urls><web-urls><url>http://bja.oxfordjournals.org/lookup/doi/10.1093/bja/aev411</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Epshtein, Y</author><author>Wang, H</author><author>Jacobson, J R</author><author>Malik, A B</author></authors></contributors><titles><title>ID: 125: ROLE OF TRPM2 IN SPHINGOLIPID-MEDIATED RADIATION-INDUCED LUNG INJURY</title><secondary-title>Journal of Investigative Medicine</secondary-title></titles><periodical><full-title>Journal of Investigative Medicine</full-title></periodical><pages>972</pages><volume>64</volume><issue>4</issue><keywords/><dates><year>2016</year></dates><urls><web-urls><url>http://jim.bmj.com/content/64/4/972.1.abstract</url></web-urls></urls><abstract>Rationale We previously reported sphingolipid signaling is an important mediator of radiation-induced lung injury (RILI) although the mechanisms underlying these effects have not been fully defined. A potential molecule of interest in this regard in TRPM2 (transient receptor potential (melastatin) 2), an oxidant sensitive, non-selective cation channel expressed in the lung endothelium that is known to regulate endothelial cell (EC) permeability and cellular responses to radiation injury. Thus, we hypothesized that TRPM2 is an important regulator of RILI-mediated by sphingolipids.Methods To assess the role of TRPM2 on endothelial cell barrier regulation, human pulmonary artery EC were grown to confluence overlying gold-plated microelectrodes for real-time measurements of transendothelial electrical resistance (TER) reflective of barrier integrity via an Electrical Cell-sensing Impedance System (ECIS, Applied Biophysics, Troy, NY). Cells were transfected with TRPM2 siRNA (100 mM, 3 d) or non-specific siRNA prior to treatment with sphingosine 1-phosphate (1 mM), known to induce barrier enhancement. In separate experiments, prior to S1P stimulation EC were treated with either DPQ or 3-AB, both inhibitors of poly-ADP-ribose polymerase (PARP), an enzyme that mediates TRPM2 channel opening. Subsequently, to assess the role of TRPM2 to RILI in a previously characterized in vivo model, female TRPM2-/- mice were subjected to 20 Gy single dose thoracic radiation with body weights measured every 2 weeks and bronchalveolar lavage fluid collected for measurement of protein levels at 6 wks.Results TRPM2-silenced EC demonstrated a significant attenuation of S1P-induced barrier enhancement as measured by TER. In addition, barrier enhancement by S1P was also significantly attenuated in cells treated with either DPQ or 3-AB. In our murine RILI model, body weights increased at 2 weeks in wildtype radiated mice while weights were decreased in TRPM2−/− mice consistent with an increased injury response in these animals. Similarly, at 6 weeks TRPM2−/− mice were found to have a significant increase in BAL protein levels compared to TRPM2−/− control animals (1.54 fold change, p&amp;lt;0.022) while there was not a significant increase noted in RILI-challenged wildtype mice.Conclusion Our data confirm TRPM2 as an important mediator of EC barrier regulation of S1P. Moreover, we found TRPM2−/− mice were more susceptible to RILI, a model of inflammatory lung injury mediated by sphingolipid signaling. Our findings suggest that modulation of TRPM2 effecting downstream sphingolipid signaling may represent a novel therapeutic strategy for some patients with inflammatory lung diseases including RILI.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Deuel, J W</author><author>Schaer, C A</author><author>Boretti, F S</author><author>Opitz, L</author><author>Garcia-Rubio, I</author><author>Baek, J H</author><author>Spahn, D R</author><author>Buehler, P W</author><author>Schaer, D J</author></authors></contributors><titles><title>Hemoglobinuria-related acute kidney injury is driven by intrarenal oxidative reactions triggering a heme toxicity response</title><secondary-title>Cell Death and Disease</secondary-title></titles><periodical><full-title>Cell Death and Disease</full-title></periodical><pages>e2064</pages><volume>7</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/cddis.2015.392</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/cddis.2015.392</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Haasdijk, Remco A.</author><author>Den Dekker, Wijnand K.</author><author>Cheng, Caroline</author><author>Tempel, Dennie</author><author>Szulcek, Robert</author><author>Bos, Frank L.</author><author>Hermkens, Dorien M.A.</author><author>Chrifi, Ihsan</author><author>Brandt, Maarten M.</author><author>Van Dijk, Chris</author><author>Xu, Yan Juan</author><author>Van De Kamp, Esther H.M.</author><author>Blonden, Lau A.J.</author><author>Van Bezu, Jan</author><author>Sluimer, Judith C.</author><author>Biessen, Erik A.L.</author><author>Van Nieuw Amerongen, Geerten P.</author><author>Duckers, Henricus J.</author></authors></contributors><titles><title>THSD1 preserves vascular integrity and protects against intraplaque haemorrhaging in ApoE −/− mice</title><secondary-title>Cardiovascular Research</secondary-title></titles><periodical><full-title>Cardiovascular Research</full-title></periodical><pages>129-139</pages><volume>110</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1093/cvr/cvw015</electronic-resource-num><urls><web-urls><url>http://cardiovascres.oxfordjournals.org/lookup/doi/10.1093/cvr/cvw015</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Marcos-Ramiro, Beatriz</author><author>García-Weber, Diego</author><author>Barroso, Susana</author><author>Feito, Jorge</author><author>Ortega, María C.</author><author>Cernuda-Morollón, Eva</author><author>Reglero-Real, Natalia</author><author>Fernández-Martín, Laura</author><author>Durán, Maria C.</author><author>Alonso, Miguel A.</author><author>Correas, Isabel</author><author>Cox, Susan</author><author>Ridley, Anne J.</author><author>Millán, Jaime</author></authors></contributors><titles><title>RhoB controls endothelial barrier recovery by inhibiting Rac1 trafficking to the cell border</title><secondary-title>The Journal of Cell Biology</secondary-title></titles><periodical><full-title>The Journal of Cell Biology</full-title></periodical><pages>385-402</pages><volume>213</volume><issue>3</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1083/jcb.201504038</electronic-resource-num><urls><web-urls><url>http://www.jcb.org/lookup/doi/10.1083/jcb.201504038</url></web-urls></urls><abstract>Endothelial barrier dysfunction underlies chronic inflammatory diseases. In searching for new proteins essential to the human endothelial inflammatory response, we have found that the endosomal GTPase RhoB is up-regulated in response to inflammatory cytokines and expressed in the endothelium of some chronically inflamed tissues. We show that although RhoB and the related RhoA and RhoC play additive and redundant roles in various aspects of endothelial barrier function, RhoB specifically inhibits barrier restoration after acute cell contraction by preventing plasma membrane extension. During barrier restoration, RhoB trafficking is induced between vesicles containing RhoB nanoclusters and plasma membrane protrusions. The Rho GTPase Rac1 controls membrane spreading and stabilizes endothelial barriers. We show that RhoB colocalizes with Rac1 in endosomes and inhibits Rac1 activity and trafficking to the cell border during barrier recovery. Inhibition of endosomal trafficking impairs barrier reformation, whereas induction of Rac1 translocation to the plasma membrane accelerates it. Therefore, RhoB-specific regulation of Rac1 trafficking controls endothelial barrier integrity during inflammation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Li, Jin</author><author>Ye, Lin</author><author>Shi, Xiaoshun</author><author>Chen, Jingyi</author><author>Feng, Fenglan</author><author>Chen, Yaoqi</author><author>Xiao, Yiren</author><author>Shen, Jianfei</author><author>Li, Peng</author><author>Jiang, Wen G.</author><author>He, Jianxing</author></authors></contributors><titles><title>Repulsive guidance molecule B inhibits metastasis and is associated with decreased mortality in non-small cell lung cancer</title><secondary-title>Oncotarget</secondary-title></titles><periodical><full-title>Oncotarget</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.18632/oncotarget.7463</electronic-resource-num><urls><web-urls><url>http://www.oncotarget.com/abstract/7463</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Thompson, Leslie C</author><author>Holland, Nathan A</author><author>Snyder, Ryan J</author><author>Luo, Bin</author><author>Becak, Daniel P</author><author>Odom, Jillian T</author><author>Harrison, Benjamin S</author><author>Brown, Jared M</author><author>Gowdy, Kymberly M</author><author>Wingard, Christopher J</author></authors></contributors><titles><title>Pulmonary instillation of MWCNT increases lung permeability, decreases gp130 expression in the lungs, and initiates cardiovascular IL-6 transsignaling</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>L142-L154</pages><volume>310</volume><issue>2</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1152/ajplung.00384.2014</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00384.2014</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gillrie, Mark R.</author><author>Renaux, Bernard</author><author>Russell-Goldman, Eleanor</author><author>Avril, Marion</author><author>Brazier, Andrew J.</author><author>Mihara, Koichiro</author><author>Di Cera, Enrico</author><author>Milner, Danny A.</author><author>Hollenberg, Morley D.</author><author>Smith, Joseph D.</author><author>Ho, May</author></authors></contributors><titles><title>Thrombin Cleavage of Plasmodium falciparum Erythrocyte Membrane Protein 1 Inhibits Cytoadherence</title><secondary-title>mBio</secondary-title></titles><periodical><full-title>mBio</full-title></periodical><pages>e01120-16</pages><volume>7</volume><issue>5</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1128/mBio.01120-16</electronic-resource-num><urls><web-urls><url>http://mbio.asm.org/lookup/doi/10.1128/mBio.01120-16</url></web-urls></urls><abstract>Plasmodium falciparum malaria remains one of the most deadly infections worldwide. The pathogenesis of the infection results from the sequestration of infected erythrocytes (IRBC) in vital organs, including the brain, with resulting impairment of blood flow, hypoxia, and lactic acidosis. Sequestration occurs through the adhesion of IRBC to host receptors on microvascular endothelium by Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1), a large family of variant surface antigens, each with up to seven extracellular domains that can bind to multiple host receptors. Consequently, antiadhesive therapies directed at single endothelial adhesion molecules may not be effective. In this study, we demonstrated that the serine protease thrombin, which is pivotal in the activation of the coagulation cascade, cleaved the major parasite adhesin on the surface of IRBC. As a result, adhesion under flow was dramatically reduced, and already adherent IRBC were detached. Thrombin cleavage sites were mapped to the Duffy binding-like δ1 (DBLδ1) domain and interdomains 1 and 2 in the PfEMP1 of the parasite line IT4var19. Furthermore, we observed an inverse correlation between the presence of thrombin and IRBC in cerebral malaria autopsies of children. We investigated a modified (R67A) thrombin and thrombin inhibitor, hirugen, both of which inhibit the binding of substrates to exosite I, thereby reducing its proinflammatory properties. Both approaches reduced the barrier dysfunction induced by thrombin without affecting its proteolytic activity on PfEMP1, raising the possibility that thrombin cleavage of variant PfEMP1 may be exploited as a broadly inhibitory antiadhesive therapy.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Montorsi, Lucia</author><author>Guizzetti, Filippo</author><author>Alecci, Claudia</author><author>Caporali, Andrea</author><author>Martello, Andrea</author><author>Giacinto Atene, Claudio</author><author>Parenti, Sandra</author><author>Pizzini, Silvia</author><author>Zanovello, Paola</author><author>Bortoluzzi, Stefania</author><author>Ferrari, Sergio</author><author>Grande, Alexis</author><author>Zanocco-Marani, Tommaso</author></authors></contributors><titles><title>Loss of zfp36 expression in colorectal cancer correlates to wnt/ ß-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1</title><secondary-title>Oncotarget</secondary-title></titles><periodical><full-title>Oncotarget</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.18632/oncotarget.10828</electronic-resource-num><urls><web-urls><url>http://www.oncotarget.com/abstract/10828</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pennington, Matthew R.</author><author>Curtis, Theresa M.</author><author>Divers, Thomas J.</author><author>Wagner, Bettina</author><author>Ness, SallyAnne L.</author><author>Tennant, Bud C.</author><author>Van de Walle, Gerlinde R.</author></authors></contributors><titles><title>Equine Mesenchymal Stromal Cells from Different Sources Efficiently Differentiate into Hepatocyte-Like Cells</title><secondary-title>Tissue Engineering Part C: Methods</secondary-title></titles><periodical><full-title>Tissue Engineering Part C: Methods</full-title></periodical><pages>596-607</pages><volume>22</volume><issue>6</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1089/ten.tec.2015.0403</electronic-resource-num><urls><web-urls><url>http://online.liebertpub.com/doi/10.1089/ten.tec.2015.0403</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wu, Limin</author><author>Ramirez, Servio H</author><author>Andrews, Allison M</author><author>Leung, Wendy</author><author>Itoh, Kanako</author><author>Wu, Jiang</author><author>Arai, Ken</author><author>Lo, Eng H</author><author>Lok, Josephine</author></authors></contributors><titles><title>Neuregulin1-β decreases interleukin-1β-induced RhoA activation, myosin light chain phosphorylation, and endothelial hyperpermeability</title><secondary-title>Journal of Neurochemistry</secondary-title></titles><periodical><full-title>Journal of Neurochemistry</full-title></periodical><pages>250-257</pages><volume>136</volume><issue>2</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1111/jnc.13374</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1111/jnc.13374</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Klei, Linda R.</author><author>Hu, Dong</author><author>Panek, Robert</author><author>Alfano, Danielle N.</author><author>Bridwell, Rachel E.</author><author>Bailey, Kelly M.</author><author>Oravecz-Wilson, Katherine I.</author><author>Concel, Vincent J.</author><author>Hess, Emily M.</author><author>Van Beek, Matthew</author><author>Delekta, Phillip C.</author><author>Gu, Shufang</author><author>Watkins, Simon C.</author><author>Ting, Adrian T.</author><author>Gough, Peter J.</author><author>Foley, Kevin P.</author><author>Bertin, John</author><author>McAllister-Lucas, Linda M.</author><author>Lucas, Peter C.</author></authors></contributors><titles><title>MALT1 Protease Activation Triggers Acute Disruption of Endothelial Barrier Integrity via CYLD Cleavage</title><secondary-title>Cell Reports</secondary-title></titles><periodical><full-title>Cell Reports</full-title></periodical><pages>221-232</pages><volume>17</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.celrep.2016.08.080</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S2211124716311767</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Book Section">7</ref-type><contributors><authors><author>Kataoka, Noriyuki</author></authors></contributors><titles><title>Mechanobiology of Endothelial Cells Related to the Formation of Arterial Disease</title><secondary-title>Vascular Engineering</secondary-title></titles><periodical><full-title>Vascular Engineering</full-title></periodical><pages>141-157</pages><keywords/><dates><year>2016</year></dates><pub-location>Tokyo</pub-location><publisher>Springer Japan</publisher><electronic-resource-num>10.1007/978-4-431-54801-0_8</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/978-4-431-54801-0_8</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Letsiou, E.</author><author>Sammani, S.</author><author>Wang, H.</author><author>Belvitch, P.</author><author>Dudek, S.M.</author></authors></contributors><titles><title>Parkin regulates LPS-induced pro-inflammatory responses in acute lung injury</title><secondary-title>Translational Research</secondary-title></titles><periodical><full-title>Translational Research</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.trsl.2016.09.002</electronic-resource-num><urls/><abstract>The Acute Respiratory Distress Syndrome (ARDS) is a serious condition resulting from direct or indirect lung injury that is associated with high mortality and morbidity. A key biological event in the pathogenesis of the acute lung injury (ALI) that causes ARDS is activation of the lung endothelium (EC), which is triggered by a variety of inflammatory insults leading to barrier disruption and excessive adhesion/activation of neutrophils. Recently, we demonstrated that imatinib protects against LPS-induced EC activation by inhibiting c-Abl kinase. In the present study, we explored the role of parkin, a novel c-Abl substrate, in ALI. Parkin is an E3 ubiquitin ligase originally characterized in the pathogenesis of Parkinson’s disease; however its potential role in acute inflammatory processes and lung EC function remain largely unknown. Using parkin deficient (PARK2-/-) mice, we now demonstrate a crucial role for parkin in mediating LPS-induced ALI. After LPS, PARK2-/- mice have reduced total protein and cell levels in bronchoalveolar lavage (BAL) compared to wild type (WT). Moreover, in LPS-treated PARK2-/- lungs, the sequestration/activation of neutrophils and release of inflammatory cytokines (IL-6, TNF-ɑ) are significantly reduced. The BAL levels of soluble VCAM-1 and ICAM-1 are also decreased in LPS-treated PARK2-/- mice compared to WT. In cultured human lung endothelial cells, down-regulation of parkin by siRNA decreases LPS-induced VCAM-1 expression, IL-8 and IL-6 secretion, and NF-kB phosphorylation. These results suggest a previously unidentified role of parkin in mediating endotoxin-induced endothelial pro-inflammatory signaling, and indicate that it may play a critical role in acute inflammation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Arnardottir, Hildur H.</author><author>Dalli, Jesmond</author><author>Norling, Lucy V.</author><author>Colas, Romain A.</author><author>Perretti, Mauro</author><author>Serhan, Charles N.</author></authors></contributors><titles><title>Resolvin D3 Is Dysregulated in Arthritis and Reduces Arthritic Inflammation</title><secondary-title>The Journal of Immunology</secondary-title></titles><periodical><full-title>The Journal of Immunology</full-title></periodical><pages>2362-2368</pages><volume>197</volume><issue>6</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.4049/jimmunol.1502268</electronic-resource-num><urls><web-urls><url>http://www.jimmunol.org/lookup/doi/10.4049/jimmunol.1502268</url></web-urls></urls><label>Signal Transduction</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lee, Hung-Yen</author><author>Mohammed, Kamal A</author><author>Goldberg, Eugene P</author><author>Kaye, Frederic</author><author>Najmunnisa, Nasreen</author></authors></contributors><titles><title>Silencing Receptor EphA2 Enhanced Sensitivity to Lipoplatin™ in Lung Tumor and MPM Cells.</title><secondary-title>Cancer investigation</secondary-title></titles><periodical><full-title>Cancer investigation</full-title></periodical><pages>293-304</pages><volume>34</volume><issue>7</issue><keywords><keyword>EphA2 receptor</keyword><keyword>Lipoplatin</keyword><keyword>combination therapy</keyword><keyword>liposomal nanoparticles</keyword><keyword>malignant pleural mesothelioma</keyword><keyword>non-small cell lung cancer</keyword></keywords><dates><year>2016</year></dates><publisher>Taylor &amp; Francis</publisher><accession-num>27438907</accession-num><electronic-resource-num>10.1080/07357907.2016.1201678</electronic-resource-num><language>en</language><urls><web-urls><url>http://www.tandfonline.com/doi/abs/10.1080/07357907.2016.1201678#.V-rZdmwYzMw.mendeley</url></web-urls></urls><abstract>Receptor EphA2 is overexpressed in lung cancer and malignant pleural mesothelioma (MPM) which promote tumorogenesis. Lipoplatin™, a new liposomal cisplatin formulation, is used against resistant tumors. Use of cisplatin-based drugs leads to unacceptable toxicities. To improve the effectiveness of Lipoplatin, enhancing the cellular sensitivity of lung tumor and MPM cells is critical. Therefore, we targeted receptor EphA2 by silencing interference RNA (siRNA) and treated tumor cells with Lipoplatin. The combined effects of siRNA-EphA2 and Lipoplatin were determined. We report that silencing EphA2 significantly enhanced the cellular sensitivity of lung tumor and MPM cells to Lipoplatin and maybe a potential therapy for lung cancer.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tóth, Gábor</author><author>Szöőr, Árpád</author><author>Simon, László</author><author>Yarden, Yosef</author><author>Szöllősi, János</author><author>Vereb, György</author></authors></contributors><titles><title>The combination of trastuzumab and pertuzumab administered at approved doses may delay development of trastuzumab resistance by additively enhancing antibody-dependent cell-mediated cytotoxicity</title><secondary-title>mAbs</secondary-title></titles><periodical><full-title>mAbs</full-title></periodical><pages>1361-1370</pages><volume>8</volume><issue>7</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1080/19420862.2016.1204503</electronic-resource-num><urls><web-urls><url>https://www.tandfonline.com/doi/full/10.1080/19420862.2016.1204503</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Broekman, W.</author><author>Roelofs, H.</author><author>Zarcone, M. C.</author><author>Taube, C.</author><author>Stolk, J.</author><author>Hiemstra, P. S.</author></authors></contributors><titles><title>Functional characterisation of bone marrow-derived mesenchymal stromal cells from COPD patients</title><secondary-title>ERJ Open Research</secondary-title></titles><periodical><full-title>ERJ Open Research</full-title></periodical><pages>00045-2015-45-2015</pages><volume>2</volume><issue>2</issue><keywords/><dates><year>2016</year></dates><publisher>European Respiratory Society Journals</publisher><isbn>10.1183/23120541.00045-2015</isbn><electronic-resource-num>10.1183/23120541.00045-2015</electronic-resource-num><language>en</language><urls><pdf-urls><url>internal-pdf://</url></pdf-urls><web-urls><url>http://openres.ersjournals.com/content/2/2/00045-2015.abstract</url></web-urls></urls><abstract>Autologous bone marrow-derived mesenchymal stromal cells (BM-MSCs) are evaluated for clinical use in chronic obstructive pulmonary disease (COPD) patients, but it is unclear whether COPD affects BM-MSCs.

To investigate this, BM-MSCs from nine COPD patients and nine non-COPD age-matched controls were compared with regard to immunophenotype, growth and differentiation potential, and migration capacity. Other functional assays included the response to pro-inflammatory stimuli and inducers of the nuclear factor (erythroid derived 2)-like 2 antioxidant response element (Nrf2-ARE) pathway, and effects on NCI-H292 airway epithelial cells.

No significant differences were observed in terms of morphology, proliferation and migration, except for increased adipocyte differentiation potential in the COPD group. Both groups were comparable regarding mRNA expression of growth factors and inflammatory mediators, and in their potential to induce mRNA expression of epidermal growth factor receptor ligands in NCI-H292 airway epithelial cells. MSCs from COPD patients secreted more interleukin-6 in response to pro-inflammatory stimuli. Activation of the Nrf2-ARE pathway resulted in a comparable induction of mRNA expression of four target genes, but the expression of the NAD(P)H:quinone oxidoreductase 1 gene NQO1 was lower in MSCs from COPD patients.

The observation that MSCs from COPD patients are phenotypically and functionally comparable to those from non-COPD controls implies that autologous MSCs can be considered for use in the setting of clinical trials as a treatment for COPD.

Phenotype and functional analysis of BM-MSCs from COPD patients supports their use in autologous MSC treatment &lt;http://ow.ly/TRtX3008t6c&gt;</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, Yi</author><author>Huang, Yan</author><author>Cantalupo, Anna</author><author>Azevedo, Paula S.</author><author>Siragusa, Mauro</author><author>Bielawski, Jacek</author><author>Giordano, Frank J.</author><author>Di Lorenzo, Annarita</author></authors></contributors><titles><title>Endothelial Nogo-B regulates sphingolipid biosynthesis to promote pathological cardiac hypertrophy during chronic pressure overload</title><secondary-title>JCI Insight</secondary-title></titles><periodical><full-title>JCI Insight</full-title></periodical><volume>1</volume><issue>5</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1172/jci.insight.85484</electronic-resource-num><urls><web-urls><url>https://insight.jci.org/articles/view/85484</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yang, Lu</author><author>Chen, Xufeng</author><author>Simet, Samantha M</author><author>Hu, Guoku</author><author>Cai, Yu</author><author>Niu, Fang</author><author>Kook, Yeonhee</author><author>Buch, Shilpa J</author></authors></contributors><titles><title>ROS/HIF-1α/PDGF-BB Autocrine Loop Contributes to Cocaine-mediated Alveolar Epithelial Barrier Damage</title><secondary-title>American Journal of Respiratory Cell and Molecular Biology</secondary-title></titles><periodical><full-title>American Journal of Respiratory Cell and Molecular Biology</full-title></periodical><pages>rcmb.2016-0096OC</pages><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1165/rcmb.2016-0096OC</electronic-resource-num><urls><web-urls><url>http://www.atsjournals.org/doi/10.1165/rcmb.2016-0096OC</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kovacs-Kasa, Anita</author><author>Gorshkov, Boris A.</author><author>Kim, Kyung-Mi</author><author>Kumar, Sanjiv</author><author>Black, Stephen M.</author><author>Fulton, David J.</author><author>Dimitropoulou, Christiana</author><author>Catravas, John D.</author><author>Verin, Alexander D.</author></authors></contributors><titles><title>The protective role of MLCP-mediated ERM dephosphorylation in endotoxin-induced lung injury in vitro and in vivo</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>39018</pages><volume>6</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/srep39018</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep39018</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tauseef, M</author><author>Farazuddin, M</author><author>Sukriti, S</author><author>Rajput, C</author><author>Meyer, J O</author><author>Ramasamy, S K</author><author>Mehta, D</author></authors></contributors><titles><title>Transient receptor potential channel 1 maintains adherens junction plasticity by suppressing sphingosine kinase 1 expression to induce endothelial hyperpermeability</title><secondary-title>The FASEB Journal</secondary-title></titles><periodical><full-title>The FASEB Journal</full-title></periodical><pages>102-110</pages><volume>30</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1096/fj.15-275891</electronic-resource-num><urls><web-urls><url>http://www.fasebj.org/cgi/doi/10.1096/fj.15-275891</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ochoa-Callejero, Laura</author><author>Pozo-Rodrigálvarez, Andrea</author><author>Martínez-Murillo, Ricardo</author><author>Martínez, Alfredo</author></authors></contributors><titles><title>Lack of adrenomedullin in mouse endothelial cells results in defective angiogenesis, enhanced vascular permeability, less metastasis, and more brain damage</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>33495</pages><volume>6</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/srep33495</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep33495</url></web-urls></urls><label>ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Heijink, I H</author><author>Jonker, M R</author><author>de Vries, M</author><author>van Oosterhout, A J M</author><author>Telenga, E</author><author>ten Hacken, N H T</author><author>Postma, D S</author><author>van den Berge, M</author></authors></contributors><titles><title>Budesonide and fluticasone propionate differentially affect the airway epithelial barrier</title><secondary-title>Respiratory Research</secondary-title></titles><periodical><full-title>Respiratory Research</full-title></periodical><pages>2</pages><volume>17</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1186/s12931-015-0318-z</electronic-resource-num><urls><web-urls><url>http://respiratory-research.com/content/17/1/2</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Stolwijk, Judith A</author><author>Zhang, Xuexin</author><author>Gueguinou, Maxime</author><author>Zhang, Wei</author><author>Matrougui, Khalid</author><author>Renken, Christian</author><author>Trebak, Mohamed</author></authors></contributors><titles><title>Calcium Signaling is Dispensable for Receptor-Regulation of Endothelial Barrier Function</title><secondary-title>Journal of Biological Chemistry</secondary-title></titles><periodical><full-title>Journal of Biological Chemistry</full-title></periodical><pages>jbc.M116.756114</pages><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1074/jbc.M116.756114</electronic-resource-num><urls><web-urls><url>http://www.jbc.org/lookup/doi/10.1074/jbc.M116.756114</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Maeda, T.</author><author>Inagaki, M.</author><author>Fujita, Y.</author><author>Kimoto, T.</author><author>Tanabe-Fujimura, C.</author><author>Zou, K.</author><author>Liu, J.</author><author>Liu, S.</author><author>Komano, H.</author></authors></contributors><titles><title>ATP increases the migration of microglia across the brain endothelial cell monolayer</title><secondary-title>Bioscience Reports</secondary-title></titles><periodical><full-title>Bioscience Reports</full-title></periodical><pages>e00318-e00318</pages><volume>36</volume><issue>2</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1042/BSR20160054</electronic-resource-num><urls><web-urls><url>http://bioscirep.org/cgi/doi/10.1042/BSR20160054</url></web-urls></urls><label>ECIS Barrier Function;ECIS Modeling</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bolinger, Mark T.</author><author>Ramshekar, Aniket</author><author>Waldschmidt, Helen V.</author><author>Larsen, Scott D.</author><author>Bewley, Maria C.</author><author>Flanagan, John M.</author><author>Antonetti, David A.</author></authors></contributors><titles><title>Occludin S471 Phosphorylation Contributes to Epithelial Monolayer Maturation</title><secondary-title>Molecular and Cellular Biology</secondary-title></titles><periodical><full-title>Molecular and Cellular Biology</full-title></periodical><pages>2051-2066</pages><volume>36</volume><issue>15</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1128/MCB.00053-16</electronic-resource-num><urls><web-urls><url>http://mcb.asm.org/lookup/doi/10.1128/MCB.00053-16</url></web-urls></urls><abstract>Multiple organ systems require epithelial barriers for normal function, and barrier loss is a hallmark of diseases ranging from inflammation to epithelial cancers. However, the molecular processes regulating epithelial barrier maturation are not fully elucidated. After contact, epithelial cells undergo size-reductive proliferation and differentiate, creating a dense, highly ordered monolayer with high resistance barriers. We provide evidence that the tight junction protein occludin contributes to the regulation of epithelial cell maturation upon phosphorylation of S471 in its coiled-coil domain. Overexpression of a phosphoinhibitory occludin S471A mutant prevents size-reductive proliferation and subsequent tight junction maturation in a dominant manner. Inhibition of cell proliferation in cell-contacted but immature monolayers recapitulated this phenotype. A kinase screen identified G-protein-coupled receptor kinases (GRKs) targeting S471, and GRK inhibitors delayed epithelial packing and junction maturation. We conclude that occludin contributes to the regulation of size-reductive proliferation and epithelial cell maturation in a phosphorylation-dependent manner.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jian, Ming-Yuan</author><author>Liu, Yanping</author><author>Li, Qian</author><author>Wolkowicz, Paul</author><author>Alexeyev, Mikhail</author><author>Zmijewski, Jaroslaw</author><author>Creighton, Judy</author></authors></contributors><titles><title>N-cadherin coordinates AMP kinase-mediated lung vascular repair</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>L71-L85</pages><volume>310</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1152/ajplung.00227.2015</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00227.2015</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kostadinova, Elena</author><author>Chaput, Catherine</author><author>Gutbier, Birgitt</author><author>Lippmann, Juliane</author><author>Sander, Leif E.</author><author>Mitchell, Timothy J.</author><author>Suttorp, Norbert</author><author>Witzenrath, Martin</author><author>Opitz, Bastian</author></authors></contributors><titles><title>NLRP3 protects alveolar barrier integrity by an inflammasome-independent increase of epithelial cell adherence</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>30943</pages><volume>6</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/srep30943</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep30943</url></web-urls></urls><label>ECIS Barrier Function</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bartlett, Annie</author><author>Sanders, Andrew</author><author>Ruge, Fiona</author><author>Harding, Keith</author><author>Jiang, Wen</author></authors></contributors><titles><title>Potential implications of interleukin-7 in chronic wound healing</title><secondary-title>Experimental and Therapeutic Medicine</secondary-title></titles><periodical><full-title>Experimental and Therapeutic Medicine</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.3892/etm.2016.3263</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/10.3892/etm.2016.3263</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bass, Heather M</author><author>Beard, Richard S</author><author>Cha, Byeong J</author><author>Yuan, Sarah Y</author><author>Nelson, Peter R</author></authors></contributors><titles><title>Thrombomodulin Induces a Quiescent Phenotype and Inhibits Migration in Vascular Smooth Muscle Cells In Vitro</title><secondary-title>Annals of Vascular Surgery</secondary-title></titles><periodical><full-title>Annals of Vascular Surgery</full-title></periodical><pages>149-156</pages><volume>30</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.avsg.2015.10.002</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0890509615007761</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ghadiri, Maliheh</author><author>Mamlouk, Mariam</author><author>Spicer, Patrick</author><author>Jarolimek, Wolfgang</author><author>Grau, Georges E.R.</author><author>Young, Paul M.</author><author>Traini, Daniela</author></authors></contributors><titles><title>Effect of polyunsaturated fatty acids (PUFAs) on airway epithelial cells' tight junction</title><secondary-title>Pulmonary Pharmacology &amp; Therapeutics</secondary-title></titles><periodical><full-title>Pulmonary Pharmacology &amp; Therapeutics</full-title></periodical><pages>30-38</pages><volume>40</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.pupt.2016.07.004</electronic-resource-num><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jones, A.</author><author>Griffiths, J.</author><author>Sanders, A.</author><author>Owen, S.</author><author>Ruge, F.</author><author>Harding, K.</author><author>Jiang, W.</author></authors></contributors><titles><title>The clinical significance and impact of interleukin?15 on keratinocyte cell growth and migration</title><secondary-title>International Journal of Molecular Medicine</secondary-title></titles><periodical><full-title>International Journal of Molecular Medicine</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.3892/ijmm.2016.2687</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/10.3892/ijmm.2016.2687</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Huang, Ching-Hui</author><author>Hsu, Chih-Chin</author><author>Chen, Carl Pai-Chu</author><author>Chow, Shu-Er</author><author>Wang, Jong-Shyan</author><author>Shyu, Yu-Chiau</author><author>Lu, Mu-Jie</author></authors></contributors><titles><title>Negative pressure induces p120-catenin–dependent adherens junction disassembly in keratinocytes during wound healing</title><secondary-title>Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</secondary-title></titles><periodical><full-title>Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</full-title></periodical><pages>2212-2220</pages><volume>1863</volume><issue>9</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.bbamcr.2016.05.017</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0167488916301616</url></web-urls></urls><abstract>A negative-pressure of 125mmHg (NP) has been widely used to treat chronic wounds in modern medicine. Keratinocytes under NP treatment have shown accelerated cell movement and decreased E-cadherin expression. However, the molecular mechanism of E-cadherin regulation under NP remains incompletely understood. Therefore, we investigated the E-cadherin regulation in keratinocytes (HaCaT cells) under NP. HaCaT cells were treated at ambient pressure (AP) and NP for 12h. Cell movement was measured by traditional and electric wound healing assays at the 2 different pressures. Mutants with overexpression of p120-catenin (p120ctn) were used to observe the effect of NP on p120ctn and E-cadherin expression during wound healing. Cell fractionation and immunoblotting data showed that NP increased Y228-phosphorylated p120ctn level and resulted in the translocation of p120ctn from the plasma membrane to cytoplasm. Immunofluorescence images revealed that NP decreased the co-localization of p120ctn and E-cadherin on the plasma membrane. Knockdown of p120ctn reduced E-cadherin expression and accelerated cell movement under AP. Overexpression of the Y228-phosphorylation-mimic p120ctn decreased E-cadherin membrane expression under both AP and NP. Phosphorylation-deficient mutants conferred restored adherens junctions (AJs) under NP. The Src inhibitor blocked the phosphorylation of p120ctn and impeded cell migration under NP. In conclusion, Src-dependent phosphorylation of p120ctn can respond rapidly to NP and contribute to E-cadherin downregulation. The NP-induced disassembly of the AJ further accelerates wound healing.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kargl, J</author><author>Andersen, L</author><author>Hasenöhrl, C</author><author>Feuersinger, D</author><author>Stančić, A</author><author>Fauland, A</author><author>Magnes, C</author><author>El-Heliebi, A</author><author>Lax, S</author><author>Uranitsch, S</author><author>Haybaeck, J</author><author>Heinemann, A</author><author>Schicho, R</author></authors></contributors><titles><title>GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis</title><secondary-title>British Journal of Pharmacology</secondary-title></titles><periodical><full-title>British Journal of Pharmacology</full-title></periodical><pages>142-154</pages><volume>173</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1111/bph.13345</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1111/bph.13345</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Canning, Paul</author><author>Kenny, Bridget-Ann</author><author>Prise, Vivien</author><author>Glenn, Josephine</author><author>Sarker, Mosharraf H</author><author>Hudson, Natalie</author><author>Brandt, Martin</author><author>Lopez, Francisco J</author><author>Gale, David</author><author>Luthert, Philip J</author><author>Adamson, Peter</author><author>Turowski, Patric</author><author>Stitt, Alan W</author></authors></contributors><titles><title>Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>7213-8</pages><volume>113</volume><issue>26</issue><keywords/><dates><year>2016</year></dates><accession-num>27298369</accession-num><electronic-resource-num>10.1073/pnas.1514213113</electronic-resource-num><urls><pdf-urls><url>internal-pdf://</url></pdf-urls><web-urls><url>http://www.pnas.org/cgi/content/long/113/26/7213</url></web-urls></urls><abstract>Lipoprotein-associated phospholipase A2 (Lp-PLA2) hydrolyses oxidized low-density lipoproteins into proinflammatory products, which can have detrimental effects on vascular function. As a specific inhibitor of Lp-PLA2, darapladib has been shown to be protective against atherogenesis and vascular leakage in diabetic and hypercholesterolemic animal models. This study has investigated whether Lp-PLA2 and its major enzymatic product, lysophosphatidylcholine (LPC), are involved in blood-retinal barrier (BRB) damage during diabetic retinopathy. We assessed BRB protection in diabetic rats through use of species-specific analogs of darapladib. Systemic Lp-PLA2 inhibition using SB-435495 at 10 mg/kg (i.p.) effectively suppressed BRB breakdown in streptozotocin-diabetic Brown Norway rats. This inhibitory effect was comparable to intravitreal VEGF neutralization, and the protection against BRB dysfunction was additive when both targets were inhibited simultaneously. Mechanistic studies in primary brain and retinal microvascular endothelial cells, as well as occluded rat pial microvessels, showed that luminal but not abluminal LPC potently induced permeability, and that this required signaling by the VEGF receptor 2 (VEGFR2). Taken together, this study demonstrates that Lp-PLA2 inhibition can effectively prevent diabetes-mediated BRB dysfunction and that LPC impacts on the retinal vascular endothelium to induce vasopermeability via VEGFR2. Thus, Lp-PLA2 may be a useful therapeutic target for patients with diabetic macular edema (DME), perhaps in combination with currently administered anti-VEGF agents.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tian, Xinyong</author><author>Ohmura, Tomomi</author><author>Shah, Alok S.</author><author>Son, Sophia</author><author>Tian, Yufeng</author><author>Birukova, Anna A.</author></authors></contributors><titles><title>Role of End Binding Protein-1 in endothelial permeability response to barrier-disruptive and barrier-enhancing agonists</title><secondary-title>Cellular Signalling</secondary-title></titles><periodical><full-title>Cellular Signalling</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.cellsig.2016.09.005</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0898656816302315</url></web-urls></urls><abstract>Rapid changes in microtubule (MT) polymerization dynamics affect regional activity of small GTPases RhoA and Rac1, which play a key role in the regulation of actin cytoskeleton and endothelial cell (EC) permeability. This study tested the role of End Binding Protein-1 (EB1) in the mechanisms of increased and decreased EC permeability caused by thrombin and hepatocyte growth factor (HGF) and mediated by RhoA and Rac1 GTPases, respectively. Stimulation of human lung EC with thrombin inhibited peripheral MT growth, which was monitored by morphological and biochemical evaluation of peripheral MT and the levels of stabilized MT. In contrast, stimulation of EC with HGF promoted peripheral MT growth and protrusion of EB1-positive MT plus ends to the EC peripheral submembrane area. EB1 knockdown by small interfering RNA did not affect partial MT depolymerization, activation of Rho signaling, and permeability response to thrombin, but suppressed the HGF-induced endothelial barrier enhancement. EB1 knockdown suppressed HGF-induced activation of Rac1 and Rac1 cytoskeletal effectors cortactin and PAK1, impaired HGF-induced assembly of cortical cytoskeleton regulatory complex (WAVE-p21Arc-IQGAP1), and blocked HGF-induced enhancement of peripheral actin cytoskeleton and VE-cadherin-positive adherens junctions. Altogether, these data demonstrate a role for EB1 in coordination of MT-dependent barrier enhancement response to HGF, but show no involvement of EB1 in acute increase of EC permeability caused by the barrier disruptive agonist. The results suggest that increased peripheral EB1 distribution is a critical component of the Rac1-mediated pathway and peripheral cytoskeletal remodeling essential for agonist-induced EC barrier enhancement.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wu, Zhiyong</author><author>Wang, Zhiwei</author><author>Dai, Feifeng</author><author>Liu, Huagang</author><author>Ren, Wei</author><author>Chang, Jinxing</author><author>Li, Bowen</author></authors></contributors><titles><title>Dephosphorylation of Y685-VE-Cadherin Involved in Pulmonary Microvascular Endothelial Barrier Injury Induced by Angiotensin II</title><secondary-title>Mediators of Inflammation</secondary-title></titles><periodical><full-title>Mediators of Inflammation</full-title></periodical><pages>1-10</pages><volume>2016</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1155/2016/8696481</electronic-resource-num><urls><web-urls><url>https://www.hindawi.com/journals/mi/2016/8696481/</url></web-urls></urls><abstract>Angiotensin II (AngII) caused pulmonary microvascular endothelial barrier injury, which induced acute aortic dissection (AAD) combined with acute lung injury (ALI). However, the exact mechanism is unclear. We investigated the role of dephosphorylation of Y685-VE-cadherin in the AngII induced pulmonary microvascular endothelial barrier injury. Mice or pulmonary microvascular endothelial cells (PMVECs) were divided into control group, AngII group, AngII+PP2 (Src kinase inhibitor) group, and PP2 group. PP2 was used to inhibit the phosphorylation of Y685-VE-cadherin. Pathological changes, infiltration of macrophages and neutrophils, and pulmonary microvascular permeability were used to determine the pulmonary microvascular endothelial barrier function. Flow cytometry was used to determine the apoptosis of PMVECs, and immunofluorescence was used to determine the skeletal arrangement. Transendothelial resistance was used to detect the permeability of endothelial barrier. Phosphorylation of Y685-VE-cadherin was significantly reduced after AngII stimulation ( P &lt; 0.05 ), together with skeletal rearrangement, and elevation of endothelial permeability which finally induced endothelial barrier injury. After PP2 interference, the phosphorylation of Y685-VE-cadherin was further reduced and the endothelial permeability was further elevated. These data indicated that AngII could induce pulmonary injury by triggering endothelial barrier injury, and such process may be related to the dephosphorylation of Y685-VE-cadherin and the endothelial skeletal rearrangement.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Veréb, Zoltán</author><author>Póliska, Szilárd</author><author>Albert, Réka</author><author>Olstad, Ole Kristoffer</author><author>Boratkó, Anita</author><author>Csortos, Csilla</author><author>Moe, Morten C.</author><author>Facskó, Andrea</author><author>Petrovski, Goran</author></authors></contributors><titles><title>Role of Human Corneal Stroma-Derived Mesenchymal-Like Stem Cells in Corneal Immunity and Wound Healing</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>26227</pages><volume>6</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/srep26227</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep26227</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Skaria, Tom</author><author>Burgener, Julia</author><author>Bachli, Esther</author><author>Schoedon, Gabriele</author></authors><secondary-authors><author>Tharakan, Binu</author></secondary-authors></contributors><titles><title>IL-4 Causes Hyperpermeability of Vascular Endothelial Cells through Wnt5A Signaling</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0156002</pages><volume>11</volume><issue>5</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1371/journal.pone.0156002</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0156002</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Miloudi, Khalil</author><author>Binet, François</author><author>Wilson, Ariel</author><author>Cerani, Agustin</author><author>Oubaha, Malika</author><author>Menard, Catherine</author><author>Henriques, Sullivan</author><author>Mawambo, Gaelle</author><author>Dejda, Agnieszka</author><author>Nguyen, Phuong Trang</author><author>Rezende, Flavio A.</author><author>Bourgault, Steve</author><author>Kennedy, Timothy E.</author><author>Sapieha, Przemyslaw</author></authors></contributors><titles><title>Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy</title><secondary-title>Journal of Clinical Investigation</secondary-title></titles><periodical><full-title>Journal of Clinical Investigation</full-title></periodical><pages>3006-3022</pages><volume>126</volume><issue>8</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1172/JCI84767</electronic-resource-num><urls><web-urls><url>https://www.jci.org/articles/view/84767</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sorrell, Tania C</author><author>Juillard, Pierre-Georges</author><author>Djordjevic, Julianne T</author><author>Kaufman-Francis, Keren</author><author>Dietmann, Anelia</author><author>Milonig, Alban</author><author>Combes, Valery</author><author>Grau, Georges E R</author></authors></contributors><titles><title>Cryptococcal transmigration across a model brain blood-barrier: evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. grubii strain H99 and Cryptococcus gattii strain R265</title><secondary-title>Microbes and Infection</secondary-title></titles><periodical><full-title>Microbes and Infection</full-title></periodical><pages>57-67</pages><volume>18</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.micinf.2015.08.017</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S1286457915001896</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Shaver, Ciara M</author><author>Upchurch, Cameron P</author><author>Janz, David R</author><author>Grove, Brandon S</author><author>Putz, Nathan D</author><author>Wickersham, Nancy E</author><author>Dikalov, Sergey I</author><author>Ware, Lorraine B</author><author>Bastarache, Julie A</author></authors></contributors><titles><title>Cell-free hemoglobin: a novel mediator of acute lung injury</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>L532-L541</pages><volume>310</volume><issue>6</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1152/ajplung.00155.2015</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00155.2015</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Haines, Ricci J.</author><author>Beard, Richard S.</author><author>Eitner, Rebecca A.</author><author>Chen, Liwei</author><author>Wu, Mack H.</author></authors><secondary-authors><author>Karhausen, Jörn</author></secondary-authors></contributors><titles><title>TNFα/IFNγ Mediated Intestinal Epithelial Barrier Dysfunction Is Attenuated by MicroRNA-93 Downregulation of PTK6 in Mouse Colonic Epithelial Cells</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0154351</pages><volume>11</volume><issue>4</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1371/journal.pone.0154351</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0154351</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jensen, Maria Risager</author><author>Bajic, Goran</author><author>Zhang, Xianwei</author><author>Laustsen, Anne Kjær</author><author>Koldsø, Heidi</author><author>Skeby, Katrine Kirkeby</author><author>Schiøtt, Birgit</author><author>Andersen, Gregers R.</author><author>Vorup-Jensen, Thomas</author></authors></contributors><titles><title>Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3</title><secondary-title>Journal of Biological Chemistry</secondary-title></titles><periodical><full-title>Journal of Biological Chemistry</full-title></periodical><pages>16963-16976</pages><volume>291</volume><issue>33</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1074/jbc.M116.732222</electronic-resource-num><urls><web-urls><url>http://www.jbc.org/lookup/doi/10.1074/jbc.M116.732222</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Harman, Rebecca M.</author><author>Curtis, Theresa M.</author><author>Argyle, David J.</author><author>Coonrod, Scott A.</author><author>Van de Walle, Gerlinde R.</author></authors></contributors><titles><title>A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species</title><secondary-title>Journal of Mammary Gland Biology and Neoplasia</secondary-title></titles><periodical><full-title>Journal of Mammary Gland Biology and Neoplasia</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1007/s10911-016-9350-y</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s10911-016-9350-y</url></web-urls></urls><label>ECIS Growth;ECIS Invasion</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, Xun E.</author><author>Adderley, Shaquria P.</author><author>Breslin, Jerome W.</author></authors><secondary-authors><author>Tharakan, Binu</author></secondary-authors></contributors><titles><title>Activation of RhoA, but Not Rac1, Mediates Early Stages of S1P-Induced Endothelial Barrier Enhancement</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0155490</pages><volume>11</volume><issue>5</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1371/journal.pone.0155490</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0155490</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Reinhard, Nathalie R.</author><author>van Helden, Suzanne F.</author><author>Anthony, Eloise C.</author><author>Yin, Taofei</author><author>Wu, Yi I.</author><author>Goedhart, Joachim</author><author>Gadella, Theodorus W. J.</author><author>Hordijk, Peter L.</author></authors></contributors><titles><title>Spatiotemporal analysis of RhoA/B/C activation in primary human endothelial cells</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>25502</pages><volume>6</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/srep25502</electronic-resource-num><urls><web-urls><url>http://www.nature.com/articles/srep25502</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kumar VR, S.</author><author>Darisipudi, M. N.</author><author>Steiger, S.</author><author>Devarapu, S. K.</author><author>Tato, M.</author><author>Kukarni, O. P.</author><author>Mulay, S. R.</author><author>Thomasova, D.</author><author>Popper, B.</author><author>Demleitner, J.</author><author>Zuchtriegel, G.</author><author>Reichel, C.</author><author>Cohen, C. D.</author><author>Lindenmeyer, M. T.</author><author>Liapis, H.</author><author>Moll, S.</author><author>Reid, E.</author><author>Stitt, A. W.</author><author>Schott, B.</author><author>Gruner, S.</author><author>Haap, W.</author><author>Ebeling, M.</author><author>Hartmann, G.</author><author>Anders, H.-J.</author></authors></contributors><titles><title>Cathepsin S Cleavage of Protease-Activated Receptor-2 on Endothelial Cells Promotes Microvascular Diabetes Complications</title><secondary-title>Journal of the American Society of Nephrology</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology</full-title></periodical><pages>1635-1649</pages><volume>27</volume><issue>6</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1681/ASN.2015020208</electronic-resource-num><urls><web-urls><url>http://www.jasn.org/cgi/doi/10.1681/ASN.2015020208</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Theiler, Anna</author><author>Konya, Viktoria</author><author>Pasterk, Lisa</author><author>Maric, Jovana</author><author>Bärnthaler, Thomas</author><author>Lanz, Ilse</author><author>Platzer, Wolfgang</author><author>Schuligoi, Rufina</author><author>Heinemann, Akos</author></authors></contributors><titles><title>The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation</title><secondary-title>Vascular Pharmacology</secondary-title></titles><periodical><full-title>Vascular Pharmacology</full-title></periodical><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1016/j.vph.2016.09.008</electronic-resource-num><urls><pdf-urls><url>internal-pdf://</url></pdf-urls></urls><abstract>Endothelial dysfunction is a hallmark of inflammatory conditions. We recently demonstrated that prostaglandin (PG)E2 enhances the resistance of pulmonary endothelium in vitro and counteracts lipopolysaccharide (LPS)-induced pulmonary inflammation in vivo via EP4 receptors. The aim of this study was to investigate the role of the EP1/EP3 receptor agonist 17-phenyl-trinor-(pt)-PGE2 on acute lung inflammation in a mouse model. In LPS-induced pulmonary inflammation in mice, 17-pt-PGE2 reduced neutrophil infiltration and inhibited vascular leakage. These effects were unaltered by an EP1 antagonist, but reversed by EP4 receptor antagonists. 17-pt-PGE2 increased the resistance of pulmonary microvascular endothelial cells and prevented thrombin-induced disruption of endothelial junctions. Again, these effects were not mediated via EP1 or EP3 but through activation of the EP4 receptor, as demonstrated by the lack of effect of more selective EP1 and EP3 receptor agonists, prevention of these effects by EP4 antagonists and EP4 receptor knock-down by siRNA. In contrast, the aggregation enhancing effect of 17-pt-PGE2 in human platelets was mediated via EP3 receptors. Our results demonstrate that 17-pt-PGE2 enhances the endothelial barrier in vitro on pulmonary microvascular endothelial cells, and accordingly ameliorates the recruitment of neutrophils, via EP4 receptors in vivo. This suggests a beneficial effect of 17-pt-PGE2 on pulmonary inflammatory diseases.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wang, Haibo</author><author>Han, Xiaokun</author><author>Bretz, Colin A</author><author>Becker, Silke</author><author>Gambhir, Deeksha</author><author>Smith, George W</author><author>Samulski, R Jude</author><author>Wittchen, Erika S</author><author>Quilliam, Lawrence A</author><author>Chrzanowska-Wodnicka, Magdalena</author><author>Hartnett, M Elizabeth</author></authors></contributors><titles><title>Retinal pigment epithelial cell expression of active Rap 1a by scAAV2 inhibits choroidal neovascularization</title><secondary-title>Molecular Therapy - Methods &amp; Clinical Development</secondary-title></titles><periodical><full-title>Molecular Therapy - Methods &amp; Clinical Development</full-title></periodical><pages>16056</pages><volume>3</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/mtm.2016.56</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S2329050117300281</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rom, Slava</author><author>Zuluaga-Ramirez, Viviana</author><author>Reichenbach, Nancy L.</author><author>Dykstra, Holly</author><author>Gajghate, Sachin</author><author>Pacher, Pal</author><author>Persidsky, Yuri</author></authors></contributors><titles><title>PARP inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood-brain barrier</title><secondary-title>Journal of Neuroinflammation</secondary-title></titles><periodical><full-title>Journal of Neuroinflammation</full-title></periodical><pages>254</pages><volume>13</volume><issue>1</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1186/s12974-016-0729-x</electronic-resource-num><urls><web-urls><url>http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0729-x</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yao, Ting</author><author>Zhang, Chen-guang</author><author>Gong, Ming-tao</author><author>Zhang, Min</author><author>Wang, Lei</author><author>Ding, Wei</author></authors></contributors><titles><title>Decorin-mediated inhibition of the migration of U87MG glioma cells involves activation of autophagy and suppression of TGF-β signaling</title><secondary-title>FEBS Open Bio</secondary-title></titles><periodical><full-title>FEBS Open Bio</full-title></periodical><pages>707-719</pages><volume>6</volume><issue>7</issue><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1002/2211-5463.12076</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1002/2211-5463.12076</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dorland, Yvonne L.</author><author>Malinova, Tsveta S.</author><author>van Stalborch, Anne-Marieke D.</author><author>Grieve, Adam G.</author><author>van Geemen, Daphne</author><author>Jansen, Nicolette S.</author><author>de Kreuk, Bart-Jan</author><author>Nawaz, Kalim</author><author>Kole, Jeroen</author><author>Geerts, Dirk</author><author>Musters, René J. P.</author><author>de Rooij, Johan</author><author>Hordijk, Peter L.</author><author>Huveneers, Stephan</author></authors></contributors><titles><title>The F-BAR protein pacsin2 inhibits asymmetric VE-cadherin internalization from tensile adherens junctions</title><secondary-title>Nature Communications</secondary-title></titles><periodical><full-title>Nature Communications</full-title></periodical><pages>12210</pages><volume>7</volume><keywords/><dates><year>2016</year></dates><electronic-resource-num>10.1038/ncomms12210</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/ncomms12210</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bellotti, Mariela I</author><author>Giana, Fabián E</author><author>Bonetto, Fabián J</author></authors></contributors><titles><title>Impedance spectroscopy applied to the fast wounding dynamics of an electrical wound-healing assay in mammalian cells</title><secondary-title>Measurement Science and Technology</secondary-title></titles><periodical><full-title>Measurement Science and Technology</full-title></periodical><pages>85701</pages><volume>26</volume><issue>8</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1088/0957-0233/26/8/085701</electronic-resource-num><urls><web-urls><url>http://stacks.iop.org/0957-0233/26/i=8/a=085701?key=crossref.bdb0f572213319a9f721841b39e99bb3</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhou, Xiaolei</author><author>Zheng, Ke</author><author>Li, Rui</author><author>Chen, Zhuo</author><author>Yuan, Cai</author><author>Hu, Ping</author><author>Chen, Jincan</author><author>Xue, Jinping</author><author>Huang, Mingdong</author></authors></contributors><titles><title>A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging</title><secondary-title>Acta Biomaterialia</secondary-title></titles><periodical><full-title>Acta Biomaterialia</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.actbio.2015.05.017</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S174270611500241X</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van ‘t Wout, Emily F A</author><author>van Schadewijk, Annemarie</author><author>van Boxtel, Ria</author><author>Dalton, Lucy E</author><author>Clarke, Hanna J</author><author>Tommassen, Jan</author><author>Marciniak, Stefan J</author><author>Hiemstra, Pieter S</author></authors><secondary-authors><author>Parsek, Matthew R</author></secondary-authors></contributors><titles><title>Virulence Factors of Pseudomonas aeruginosa Induce Both the Unfolded Protein and Integrated Stress Responses in Airway Epithelial Cells</title><secondary-title>PLOS Pathogens</secondary-title></titles><periodical><full-title>PLOS Pathogens</full-title></periodical><pages>e1004946</pages><volume>11</volume><issue>6</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1371/journal.ppat.1004946</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.ppat.1004946</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bussche, Leen</author><author>Harman, Rebecca M</author><author>Syracuse, Bethany A</author><author>Plante, Eric L</author><author>Lu, Yen-Chun</author><author>Curtis, Theresa M</author><author>Ma, Minglin</author><author>Van de Walle, Gerlinde R</author></authors></contributors><titles><title>Microencapsulated equine mesenchymal stromal cells promote cutaneous wound healing in vitro</title><secondary-title>Stem Cell Research &amp; Therapy</secondary-title></titles><periodical><full-title>Stem Cell Research &amp; Therapy</full-title></periodical><pages>66</pages><volume>6</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1186/s13287-015-0037-x</electronic-resource-num><urls><web-urls><url>http://stemcellres.com/content/6/1/66</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kondrikov, Dmitry</author><author>Fulton, David</author><author>Dong, Zheng</author><author>Su, Yunchao</author></authors><secondary-authors><author>Zhao, You-Yang</author></secondary-authors></contributors><titles><title>Heat Shock Protein 70 Prevents Hyperoxia-Induced Disruption of Lung Endothelial Barrier via Caspase-Dependent and AIF-Dependent Pathways</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0129343</pages><volume>10</volume><issue>6</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1371/journal.pone.0129343</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0129343</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hampel, Ulrike</author><author>Krüger, Magret</author><author>Kunnen, Carolina</author><author>Garreis, Fabian</author><author>Willcox, Mark</author><author>Paulsen, Friedrich</author></authors></contributors><titles><title>In vitro effects of docosahexaenoic and eicosapentaenoic acid on human meibomian gland epithelial cells</title><secondary-title>Experimental Eye Research</secondary-title></titles><periodical><full-title>Experimental Eye Research</full-title></periodical><pages>139-148</pages><volume>140</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.exer.2015.08.024</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0014483515300208</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Breslin, Jerome W</author><author>Zhang, Xun E</author><author>Worthylake, Rebecca A</author><author>Souza-Smith, Flavia M</author></authors><secondary-authors><author>Komarova, Yulia</author></secondary-authors></contributors><titles><title>Involvement of Local Lamellipodia in Endothelial Barrier Function</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0117970</pages><volume>10</volume><issue>2</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1371/journal.pone.0117970</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0117970</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Balasubramaniam, Sona Lakshme</author><author>Gopalakrishnapillai, Anilkumar</author><author>Gangadharan, Vimal</author><author>Duncan, Randall L</author><author>Barwe, Sonali P</author></authors></contributors><titles><title>Sodium-Calcium Exchanger 1 Regulates Epithelial Cell Migration via Calcium-dependent Extracellular Signal-regulated Kinase Signaling</title><secondary-title>Journal of Biological Chemistry</secondary-title></titles><periodical><full-title>Journal of Biological Chemistry</full-title></periodical><pages>12463-12473</pages><volume>290</volume><issue>20</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1074/jbc.M114.629519</electronic-resource-num><urls><web-urls><url>http://www.jbc.org/lookup/doi/10.1074/jbc.M114.629519</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mao, P Pu</author><author>Wu, Songling</author><author>Li, Jianchun</author><author>Fu, Wei</author><author>He, Weiqun</author><author>Liu, Xiaoqing</author><author>Slutsky, Arthur S</author><author>Zhang, Haibo</author><author>Li, Yimin</author></authors></contributors><titles><title>Human alveolar epithelial type II cells in primary culture</title><secondary-title>Physiological Reports</secondary-title></titles><periodical><full-title>Physiological Reports</full-title></periodical><pages>e12288-e12288</pages><volume>3</volume><issue>2</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.14814/phy2.12288</electronic-resource-num><urls><web-urls><url>http://physreports.physiology.org/content/3/2/e12288.abstract</url><url>http://physreports.physiology.org/cgi/doi/10.14814/phy2.12288</url></web-urls></urls><abstract>Pu Mao, Songling Wu, Jianchun Li, Wei Fu, Weiqun He, Xiaoqing Liu, Arthur S. Slutsky, Haibo Zhang and Yimin Li1State Key Laboratory of Respiratory Diseases and Guangzhou Institute of Respiratory Diseases, GuangzhouGuangdong, China2The First Affiliated Hospital of Guangzhou Medical University, GuangzhouGuangdong, China3Keenan Research Centre for Biomedical Science of St. Michael&amp;#039;s Hospital, Toronto, Ontario, Canada4Department of Medicine, University of Toronto, Toronto, Ontario, Canada5Department of Anesthesia, University of Toronto, Toronto, Ontario, Canada6Department of Physiology, University of Toronto, Toronto, Ontario, CanadaCorrespondenceHaibo Zhang, 619 LKSKI, 30 Bond Street, Toronto, ON, M5B 1W8, Canada.Tel: 416‐864‐6060 ext. 77654Fax: 416‐864‐5277E‐mail: zhangh{at}smh.caandYimin Li, 151 Yanjiang Street West, Guangzhou, Guangdong 510120, China. Tel: 0086‐020‐83062905 Fax: 0086‐020‐83062905 E‐mail: dryiminli{at}vip.163.com. AbstractAlveolar epithelial type II (AEII) cells are a key structure and defender in the lung but also are the targets in many lung diseases, including acute respiratory distress syndrome, ventilator‐induced lung injury, and pulmonary fibrosis. We sought to establish an optimized method for high yielding and long maintenance of characteristics of primary human AEII cells to facilitate the investigation of the mechanisms of lung diseases at the cellular and molecular levels. Adult human peripheral normal lung tissues of oncologic patients undergoing lung resection were collected. The AEII cells were isolated and identified by the expression of pro‐surfactant protein (SP)C, epithelial sodium channel (αENaC) and cytokeratin (CK)‐8, the lamellar bodies specific for AEII cells, and confirmed by the histology using electron microscopy. The phenotype of AEII cells was characterized by the expression of surfactant proteins (SP‐A, SP‐B, SP‐C, SP‐D), CK‐8, KL‐6, αENaC, and aquaporin (AQP)‐3, which was maintained over 20 days. The biological activity of the primary human AEII cells producing SP‐C, cytokines, and intercellular adhesion molecule‐1 was vigorous in response to stimulation with tumor necrosis factor‐α. We have modified previous methods and optimized a method for isolation of high purity and long maintenance of the human AEII cell phenotype in primary culture. This method provides an important tool for studies aiming at elucidating the molecular mechanisms of lung diseases exclusively in AEII cells. Human lunglamellar bodiessurfactant proteinsFootnotes  Funding Information  This work was supported by grants from the Natural Science Foundation of China (NSFC) (No. 81270125) to YL and HZ, and the Canadian Institutes of Health Research (CIHR) to HZ. These authors are contributed equally to this work. © 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Shao, Min</author><author>Tang, Song‑Tao</author><author>Liu, Bao</author><author>Zhu, Hua‑Qing</author></authors></contributors><titles><title>Rac1 mediates HMGB1‑induced hyperpermeability in pulmonary microvascular endothelial cells via MAPK signal transduction</title><secondary-title>Molecular Medicine Reports</secondary-title></titles><periodical><full-title>Molecular Medicine Reports</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3892/mmr.2015.4521</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/10.3892/mmr.2015.4521</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Konya, V</author><author>Maric, J</author><author>Jandl, K</author><author>Luschnig, P</author><author>Aringer, I</author><author>Lanz, I</author><author>Platzer, W</author><author>Theiler, A</author><author>Bärnthaler, T</author><author>Frei, R</author><author>Marsche, G</author><author>Marsh, L M</author><author>Olschewski, A</author><author>Th Lippe, I</author><author>Heinemann, A</author><author>Schuligoi, R</author></authors></contributors><titles><title>EP 4 receptor prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function</title><secondary-title>British Journal of Pharmacology</secondary-title></titles><periodical><full-title>British Journal of Pharmacology</full-title></periodical><pages>n/a-n/a</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1111/bph.13229</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1111/bph.13229</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tian, Yufeng</author><author>Mambetsariev, Isa</author><author>Sarich, Nicolene</author><author>Meng, Fanyong</author><author>Birukova, Anna A</author></authors></contributors><titles><title>Role of microtubules in attenuation of PepG-induced vascular endothelial dysfunction by atrial natriuretic peptide</title><secondary-title>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</secondary-title></titles><periodical><full-title>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</full-title></periodical><pages>104-119</pages><volume>1852</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.bbadis.2014.10.012</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0925443914003184</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Banerjee, Santanu</author><author>Ninkovic, Jana</author><author>Meng, Jingjing</author><author>Sharma, Umakant</author><author>Ma, Jing</author><author>Charboneau, Richard</author><author>Roy, Sabita</author></authors></contributors><titles><title>Morphine compromises bronchial epithelial TLR2/IL17R signaling crosstalk, necessary for lung IL17 homeostasis</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>11384</pages><volume>5</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/srep11384</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/srep11384</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Barabutis, Nektarios</author><author>Dimitropoulou, Christiana</author><author>Birmpas, Charalampos</author><author>Joshi, Atul</author><author>Thangjam, Gagan</author><author>Catravas, John D</author></authors></contributors><titles><title>p53 protects against LPS-Induced Lung Endothelial Barrier Dysfunction</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>ajplung.00334.2014</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajplung.00334.2014</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00334.2014</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rom, Slava</author><author>Dykstra, Holly</author><author>Zuluaga-Ramirez, Viviana</author><author>Reichenbach, Nancy L</author><author>Persidsky, Yuri</author></authors></contributors><titles><title>miR-98 and let-7g* protect the blood–brain barrier under neuroinflammatory conditions</title><secondary-title>Journal of Cerebral Blood Flow &amp; Metabolism</secondary-title></titles><periodical><full-title>Journal of Cerebral Blood Flow &amp; Metabolism</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/jcbfm.2015.154</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/jcbfm.2015.154</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bondu, Virginie</author><author>Schrader, Ron</author><author>Gawinowicz, Mary Ann</author><author>McGuire, Paul</author><author>Lawrence, Daniel A</author><author>Hjelle, Brian</author><author>Buranda, Tione</author></authors></contributors><titles><title>Elevated Cytokines, Thrombin and PAI-1 in Severe HCPS Patients Due to Sin Nombre Virus</title><secondary-title>Viruses</secondary-title></titles><periodical><full-title>Viruses</full-title></periodical><pages>559-589</pages><volume>7</volume><issue>2</issue><keywords/><dates><year>2015</year></dates><accession-num>25674766</accession-num><electronic-resource-num>10.3390/v7020559</electronic-resource-num><urls><web-urls><url>http://www.mdpi.com/1999-4915/7/2/559/</url><url>http://www.ncbi.nlm.nih.gov/pubmed/25674766</url></web-urls></urls><label>ECIS Barrier Function;ECIS TEER</label><abstract>Sin Nombre Hantavirus (SNV, Bunyaviridae Hantavirus) is a Category A pathogen that causes Hantavirus Cardiopulmonary Syndrome (HCPS) with case fatality ratios generally ranging from 30% to 50%. HCPS is characterized by vascular leakage due to dysregulation of the endothelial barrier function. The loss of vascular integrity results in non-cardiogenic pulmonary edema, shock, multi-organ failure and death. Using Electric Cell-substrate Impedance Sensing (ECIS) measurements, we found that plasma samples drawn from University of New Mexico Hospital patients with serologically-confirmed HCPS, induce loss of cell-cell adhesion in confluent epithelial and endothelial cell monolayers grown in ECIS cultureware. We show that the loss of cell-cell adhesion is sensitive to both thrombin and plasmin inhibitors in mild cases, and to thrombin only inhibition in severe cases, suggesting an increasing prothrombotic state with disease severity. A proteomic profile (2D gel electrophoresis and mass spectrometry) of HCPS plasma samples in our cohort revealed robust antifibrinolytic activity among terminal case patients. The prothrombotic activity is highlighted by acute ≥30 to &gt;100 fold increases in active plasminogen activator inhibitor (PAI-1) which, preceded death of the subjects within 48 h. Taken together, this suggests that PAI-1 might be a response to the severe pathology as it is expected to reduce plasmin activity and possibly thrombin activity in the terminal patients.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Good, Robert B</author><author>Gilbane, Adrian J</author><author>Trinder, Sarah L</author><author>Denton, Christopher P</author><author>Coghlan, Gerry</author><author>Abraham, David J</author><author>Holmes, Alan M</author></authors></contributors><titles><title>Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension</title><secondary-title>The American Journal of Pathology</secondary-title></titles><periodical><full-title>The American Journal of Pathology</full-title></periodical><pages>1850-1858</pages><volume>185</volume><issue>7</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.ajpath.2015.03.019</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0002944015002102</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, Xudong</author><author>Li, Fang</author><author>Nordin, Anis Nurashikin</author><author>Tarbell, John</author><author>Voiculescu, Ioana</author></authors></contributors><titles><title>Toxicity studies using mammalian cells and impedance spectroscopy method</title><secondary-title>Sensing and Bio-Sensing Research</secondary-title></titles><periodical><full-title>Sensing and Bio-Sensing Research</full-title></periodical><pages>112-121</pages><volume>3</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.sbsr.2015.01.002</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S2214180415000045</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gibson, C C</author><author>Zhu, W</author><author>Davis, C T</author><author>Bowman-Kirigin, J A</author><author>Chan, A C</author><author>Ling, J</author><author>Walker, A E</author><author>Goitre, L</author><author>Delle Monache, S</author><author>Retta, S F</author><author>Shiu, Y.-T. E</author><author>Grossmann, A H</author><author>Thomas, K R</author><author>Donato, A J</author><author>Lesniewski, L A</author><author>Whitehead, K J</author><author>Li, D Y</author></authors></contributors><titles><title>Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>289-299</pages><volume>131</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1161/CIRCULATIONAHA.114.010403</electronic-resource-num><urls><web-urls><url>http://circ.ahajournals.org/cgi/doi/10.1161/CIRCULATIONAHA.114.010403</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Flemming, S</author><author>Burkard, N</author><author>Renschler, M</author><author>Vielmuth, F</author><author>Meir, M</author><author>Schick, M A</author><author>Wunder, C</author><author>Germer, C.-T.</author><author>Spindler, V</author><author>Waschke, J</author><author>Schlegel, N</author></authors></contributors><titles><title>Soluble VE-cadherin is involved in endothelial barrier breakdown in systemic inflammation and sepsis</title><secondary-title>Cardiovascular Research</secondary-title></titles><periodical><full-title>Cardiovascular Research</full-title></periodical><pages>32-44</pages><volume>107</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1093/cvr/cvv144</electronic-resource-num><urls><web-urls><url>http://cardiovascres.oxfordjournals.org/cgi/doi/10.1093/cvr/cvv144</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Liu, Ju</author><author>Li, Yan</author><author>Dong, Fengyun</author><author>Li, Liqun</author><author>Masuda, Takahiro</author><author>Allen, Thaddeus D</author><author>Lobe, Corrinne G</author></authors></contributors><titles><title>Trichostatin A suppresses lung adenocarcinoma development in Grg1 overexpressing transgenic mice</title><secondary-title>Biochemical and Biophysical Research Communications</secondary-title></titles><periodical><full-title>Biochemical and Biophysical Research Communications</full-title></periodical><pages>1230-1236</pages><volume>463</volume><issue>4</issue><keywords/><dates><year>2015</year></dates><publisher>Elsevier Ltd</publisher><electronic-resource-num>10.1016/j.bbrc.2015.06.090</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0006291X15301431</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Richardson, D D</author><author>Tol, S</author><author>Valle-Encinas, E</author><author>Pleguezuelos, C</author><author>Bierings, R</author><author>Geerts, D</author><author>Fernandez-Borja, M</author></authors></contributors><titles><title>The prion protein inhibits monocytic cell migration by stimulating 1 integrin adhesion and uropod formation</title><secondary-title>Journal of Cell Science</secondary-title></titles><periodical><full-title>Journal of Cell Science</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1242/jcs.165365</electronic-resource-num><urls><web-urls><url>http://jcs.biologists.org/cgi/doi/10.1242/jcs.165365</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukova, Anna A</author><author>Meng, Fanyong</author><author>Tian, Yufeng</author><author>Meliton, Angelo</author><author>Sarich, Nicolene</author><author>Quilliam, Lawrence A</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Prostacyclin post-treatment improves LPS-induced acute lung injury and endothelial barrier recovery via Rap1</title><secondary-title>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</secondary-title></titles><periodical><full-title>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</full-title></periodical><pages>778-791</pages><volume>1852</volume><issue>5</issue><keywords><keyword>Cytoskeleton</keyword><keyword>Endothelium</keyword><keyword>Inflammation</keyword><keyword>Lung</keyword><keyword>Permeability</keyword></keywords><dates><year>2015</year></dates><publisher>Elsevier B.V.</publisher><isbn>0925-4439</isbn><electronic-resource-num>10.1016/j.bbadis.2014.12.016</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0925443914004104</url></web-urls></urls><label>ECIS Barrier Function;Inflammation</label><abstract>Protective effects of prostacyclin (PC) or its stable analog beraprost against agonist-induced lung vascular inflammation have been associated with elevation of intracellular cAMP and Rac GTPase signaling which inhibited the RhoA GTPase-dependent pathway of endothelial barrier dysfunction. This study investigated a distinct mechanism of PC-stimulated lung vascular endothelial (EC) barrier recovery and resolution of LPS-induced inflammation mediated by small GTPase Rap1. Efficient barrier recovery was observed in LPS-challenged pulmonary EC after prostacyclin administration even after 15 h of initial inflammatory insult and was accompanied by the significant attenuation of p38 MAP kinase and NFκB signaling and decreased production of IL-8 and soluble ICAM1. These effects were reproduced in cells post-treated with 8CPT, a small molecule activator of Rap1-specific nucleotide exchange factor Epac. By contrast, pharmacologic Epac inhibitor, Rap1 knockdown, or knockdown of cell junction-associated Rap1 effector afadin attenuated EC recovery caused by PC or 8CPT post-treatment. The key role of Rap1 in lung barrier restoration was further confirmed in the murine model of LPS-induced acute lung injury. Lung injury was monitored by measurements of bronchoalveolar lavage protein content, cell count, and Evans blue extravasation and live imaging of vascular leak over 6 days using a fluorescent tracer. The data showed significant acceleration of lung recovery by PC and 8CPT post-treatment, which was abrogated in Rap1a−/− mice. These results suggest that post-treatment with PC triggers the Epac/Rap1/afadin-dependent mechanism of endothelial barrier restoration and downregulation of p38MAPK and NFκB inflammatory cascades, altogether leading to accelerated lung recovery.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Haines, R J J</author><author>Beard, R S S</author><author>Wu, M H H</author></authors></contributors><titles><title>Protein tyrosine kinase 6 mediates TNFα-induced endothelial barrier dysfunction</title><secondary-title>Biochemical and biophysical research communications</secondary-title></titles><periodical><full-title>Biochemical and biophysical research communications</full-title></periodical><pages>190-196</pages><volume>456</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><accession-num>25446122</accession-num><electronic-resource-num>10.1016/j.bbrc.2014.11.057</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0006291X14020877</url><url>http://www.ncbi.nlm.nih.gov/pubmed/25446122</url></web-urls></urls><abstract>A key event in the progression of systemic inflammation resulting from severe trauma or shock involves microvascular hyperpermeability, which leads to excessive plasma fluid and proteins accumulating in extravascular space resulting in tissue edema. The precise molecular mechanism of the hyperpermeability response is not completely understood. Protein tyrosine kinase 6 (PTK6, also known as breast tumor kinase BRK) is a non-receptor tyrosine kinase related to Src-family proteins. Although it has also been shown that PTK6 participates in regulating epithelial barrier function, the role of PTK6 in endothelial barrier function has not been reported. In this study, we hypothesized that PTK6 is (1) expressed in vascular endothelial cells, and (2) contributes to vascular endothelial hyperpermeability in response to TNFα. Results showed that PTK6 was detected in mouse endothelial cells at the level of protein and mRNA. In addition, PTK6 knockdown attenuated TNFα induced decrease in endothelial barrier function as measured by electric cell-substrate impedance sensing (ECIS) and in vitro transwell albumin-flux assays. Furthermore, we showed that TNFα treatment of endothelial cells increased active PTK6 association with p120-catenin at endothelial cell-cell junctions. Further analysis using immunocytochemistry and immunoprecipitation demonstrated that PTK6 knockdown attenuated TNFα induced VE-cadherin internalization as well as promoting its association with p120-catenin. Our study demonstrates a novel role of PTK6 in mediating endothelial barrier dysfunction.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chignalia, Andreia Z</author><author>Vogel, Stephen M</author><author>Reynolds, Albert B</author><author>Mehta, Dolly</author><author>Dull, Randal O</author><author>Minshall, Richard D</author><author>Malik, Asrar B</author><author>Liu, Yuru</author></authors></contributors><titles><title>p120-Catenin Expressed in Alveolar Type II Cells Is Essential for the Regulation of Lung Innate Immune Response</title><secondary-title>The American Journal of Pathology</secondary-title></titles><periodical><full-title>The American Journal of Pathology</full-title></periodical><pages>1251-1263</pages><volume>185</volume><issue>5</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.ajpath.2015.01.022</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0002944015000917</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hobson, Adrian D</author><author>Harris, Christopher M</author><author>van der Kam, Elizabeth L</author><author>Turner, Sean C</author><author>Abibi, Ayome</author><author>Aguirre, Ana L</author><author>Bousquet, Peter</author><author>Kebede, Tegest</author><author>Konopacki, Donald B</author><author>Gintant, Gary</author><author>Kim, Youngjae</author><author>Larson, Kelly</author><author>Maull, John W</author><author>Moore, Nigel S</author><author>Shi, Dan</author><author>Shrestha, Anurupa</author><author>Tang, Xiubo</author><author>Zhang, Peng</author><author>Sarris, Kathy K</author></authors></contributors><titles><title>Discovery of A-971432, An Orally Bioavailable Selective Sphingosine-1-Phosphate Receptor 5 (S1P 5 ) Agonist for the Potential Treatment of Neurodegenerative Disorders</title><secondary-title>Journal of Medicinal Chemistry</secondary-title></titles><periodical><full-title>Journal of Medicinal Chemistry</full-title></periodical><pages>9154-9170</pages><volume>58</volume><issue>23</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1021/acs.jmedchem.5b00928</electronic-resource-num><urls><web-urls><url>http://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00928</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schweitzer, Kelly S</author><author>Chen, Steven X</author><author>Law, Sarah</author><author>Van Demark, Mary</author><author>Poirier, Christophe</author><author>Justice, Matthew J</author><author>Hubbard, Walter C</author><author>Kim, Elena S</author><author>Lai, Xianyin</author><author>Wang, Mu</author><author>Kranz, William D</author><author>Carroll, Clinton J</author><author>Ray, Bruce D</author><author>Bittman, Robert</author><author>Goodpaster, John</author><author>Petrache, Irina</author></authors></contributors><titles><title>Endothelial disruptive proinflammatory effects of nicotine and e-cigarette vapor exposures</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>L175-L187</pages><volume>309</volume><issue>2</issue><keywords/><dates><year>2015</year></dates><publisher>Am Physiological Soc</publisher><electronic-resource-num>10.1152/ajplung.00411.2014</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00411.2014</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hampel, Ulrike</author><author>Schröder, Antje</author><author>Mitchell, Todd</author><author>Brown, Simon</author><author>Snikeris, Peta</author><author>Garreis, Fabian</author><author>Kunnen, Carolina</author><author>Willcox, Mark</author><author>Paulsen, Friedrich</author></authors><secondary-authors><author>Desseyn, Jean-Luc</author></secondary-authors></contributors><titles><title>Serum-Induced Keratinization Processes in an Immortalized Human Meibomian Gland Epithelial Cell Line</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0128096</pages><volume>10</volume><issue>6</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1371/journal.pone.0128096</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0128096</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Boratkó, Anita</author><author>Péter, Margit</author><author>Thalwieser, Zsófia</author><author>Kovács, Előd</author><author>Csortos, Csilla</author></authors></contributors><titles><title>Elongation factor-1A1 is a novel substrate of the protein phosphatase 1-TIMAP complex</title><secondary-title>The International Journal of Biochemistry &amp; Cell Biology</secondary-title></titles><periodical><full-title>The International Journal of Biochemistry &amp; Cell Biology</full-title></periodical><pages>105-113</pages><volume>69</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.biocel.2015.10.021</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S1357272515300467</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>de Vallière, Cheryl</author><author>Vidal, Solange</author><author>Clay, Ieuan</author><author>Jurisic, Giorgia</author><author>Tcymbarevich, Irina</author><author>Lang, Silvia</author><author>Ludwig, Marie-Gabrielle</author><author>Okoniewski, Michal</author><author>Eloranta, Jyrki J</author><author>Kullak-Ublick, Gerd A</author><author>Wagner, Carsten A</author><author>Rogler, Gerhard</author><author>Seuwen, Klaus</author></authors></contributors><titles><title>The pH-sensing receptor OGR1 improves barrier function of epithelial cells and inhibits migration in an acidic environment</title><secondary-title>American Journal of Physiology - Gastrointestinal and Liver Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Gastrointestinal and Liver Physiology</full-title></periodical><pages>G475-G490</pages><volume>309</volume><issue>6</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajpgi.00408.2014</electronic-resource-num><urls><web-urls><url>http://ajpgi.physiology.org/lookup/doi/10.1152/ajpgi.00408.2014</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Piegeler, T</author><author>Schläpfer, M</author><author>Dull, R O</author><author>Schwartz, D E</author><author>Borgeat, A</author><author>Minshall, R D</author><author>Beck-Schimmer, B</author></authors><secondary-authors><author>Galley, H F</author></secondary-authors></contributors><titles><title>Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase</title><secondary-title>British Journal of Anaesthesia</secondary-title></titles><periodical><full-title>British Journal of Anaesthesia</full-title></periodical><pages>784-791</pages><volume>115</volume><issue>5</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1093/bja/aev341</electronic-resource-num><urls><web-urls><url>http://bja.oxfordjournals.org/lookup/doi/10.1093/bja/aev341</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Spindler, Volker</author><author>Meir, Michael</author><author>Vigh, Balázs</author><author>Flemming, Sven</author><author>Hütz, Katharina</author><author>Germer, Christoph-Thomas</author><author>Waschke, Jens</author><author>Schlegel, Nicolas</author></authors></contributors><titles><title>Loss of Desmoglein 2 Contributes to the Pathogenesis of Crohnʼs Disease</title><secondary-title>Inflammatory Bowel Diseases</secondary-title></titles><periodical><full-title>Inflammatory Bowel Diseases</full-title></periodical><pages>1</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1097/MIB.0000000000000486</electronic-resource-num><urls><web-urls><url>http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&amp;an=00054725-900000000-99117</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zahlten, Janine</author><author>Herta, Toni</author><author>Kabus, Christin</author><author>Steinfeldt, Magdalena</author><author>Kershaw, Olivia</author><author>García, Pedro</author><author>Hocke, Andreas C</author><author>Gruber, Achim D</author><author>Hübner, Ralf-Harto</author><author>Steinicke, Robert</author><author>Doehn, Jan-Moritz</author><author>Suttorp, Norbert</author><author>Hippenstiel, Stefan</author></authors></contributors><titles><title>Pneumococci LytA-dependent KLF4 Expression Terminates IL-8 Secretion in Lung Epithelium</title><secondary-title>American Journal of Respiratory Cell and Molecular Biology</secondary-title></titles><periodical><full-title>American Journal of Respiratory Cell and Molecular Biology</full-title></periodical><pages>150310141351001</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1165/rcmb.2014-0024OC</electronic-resource-num><urls><web-urls><url>http://www.atsjournals.org/doi/10.1165/rcmb.2014-0024OC</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Landgraf, Lisa</author><author>Müller, Ines</author><author>Ernst, Peter</author><author>Schäfer, Miriam</author><author>Rosman, Christina</author><author>Schick, Isabel</author><author>Köhler, Oskar</author><author>Oehring, Hartmut</author><author>Breus, Vladimir V</author><author>Basché, Thomas</author><author>Sönnichsen, Carsten</author><author>Tremel, Wolfgang</author><author>Hilger, Ingrid</author></authors></contributors><titles><title>Comparative evaluation of the impact on endothelial cells induced by different nanoparticle structures and functionalization</title><secondary-title>Beilstein Journal of Nanotechnology</secondary-title></titles><periodical><full-title>Beilstein Journal of Nanotechnology</full-title></periodical><pages>300-312</pages><volume>6</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3762/bjnano.6.28</electronic-resource-num><urls><web-urls><url>http://www.beilstein-journals.org/bjnano/content/6/1/28</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Peitzman, Elizabeth R</author><author>Zaidman, Nathan A</author><author>Maniak, Peter J</author><author>O'Grady, Scott M</author></authors></contributors><titles><title>Agonist binding to β-adrenergic receptors on human airway epithelial cells inhibits migration and wound repair</title><secondary-title>American Journal of Physiology - Cell Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Cell Physiology</full-title></periodical><pages>C847-C855</pages><volume>309</volume><issue>12</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajpcell.00159.2015</electronic-resource-num><urls><web-urls><url>http://ajpcell.physiology.org/lookup/doi/10.1152/ajpcell.00159.2015</url></web-urls></urls><label>ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Nickols, Jordan</author><author>Obiako, Boniface</author><author>Ramila, K C</author><author>Putinta, Kevin</author><author>Schilling, Sarah</author><author>Sayner, Sarah L</author></authors></contributors><titles><title>Lipopolysaccharide-induced pulmonary endothelial barrier disruption and lung edema: critical role for bicarbonate stimulation of AC10</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>L1430-L1437</pages><volume>309</volume><issue>12</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajplung.00067.2015</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00067.2015</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Meir, Michael</author><author>Flemming, Sven</author><author>Burkard, Natalie</author><author>Bergauer, Lisa</author><author>Metzger, Marco</author><author>Germer, Christoph-Thomas</author><author>Schlegel, Nicolas</author></authors></contributors><titles><title>Glial cell line-derived neurotrophic factor promotes barrier maturation and wound healing in intestinal epithelial cells in vitro</title><secondary-title>American Journal of Physiology - Gastrointestinal and Liver Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Gastrointestinal and Liver Physiology</full-title></periodical><pages>G613-G624</pages><volume>309</volume><issue>8</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajpgi.00357.2014</electronic-resource-num><urls><web-urls><url>http://ajpgi.physiology.org/lookup/doi/10.1152/ajpgi.00357.2014</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wang, Lichun</author><author>Bittman, Robert</author><author>Garcia, Joe G N</author><author>Dudek, Steven M</author></authors></contributors><titles><title>Junctional complex and focal adhesion rearrangement mediates pulmonary endothelial barrier enhancement by FTY720 S-phosphonate</title><secondary-title>Microvascular Research</secondary-title></titles><periodical><full-title>Microvascular Research</full-title></periodical><pages>102-109</pages><volume>99</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.mvr.2015.03.007</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0026286215000345</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kourtidis, Antonis</author><author>Ngok, Siu P</author><author>Pulimeno, Pamela</author><author>Feathers, Ryan W</author><author>Carpio, Lomeli R</author><author>Baker, Tiffany R</author><author>Carr, Jennifer M</author><author>Yan, Irene K</author><author>Borges, Sahra</author><author>Perez, Edith A</author><author>Storz, Peter</author><author>Copland, John A</author><author>Patel, Tushar</author><author>Thompson, E Aubrey</author><author>Citi, Sandra</author><author>Anastasiadis, Panos Z</author></authors></contributors><titles><title>Distinct E-cadherin-based complexes regulate cell behaviour through miRNA processing or Src and p120 catenin activity</title><secondary-title>Nature Cell Biology</secondary-title></titles><periodical><full-title>Nature Cell Biology</full-title></periodical><pages>1145-1157</pages><volume>17</volume><issue>9</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/ncb3227</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/ncb3227</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chiang, Nan</author><author>Dalli, Jesmond</author><author>Colas, Romain A</author><author>Serhan, Charles N</author></authors></contributors><titles><title>Identification of resolvin D2 receptor mediating resolution of infections and organ protection</title><secondary-title>The Journal of Experimental Medicine</secondary-title></titles><periodical><full-title>The Journal of Experimental Medicine</full-title></periodical><pages>1203-1217</pages><volume>212</volume><issue>8</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1084/jem.20150225</electronic-resource-num><urls><web-urls><url>http://www.jem.org/lookup/doi/10.1084/jem.20150225</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Das, Lopamudra</author><author>Das, Soumen</author><author>Chatterjee, Jyotirmoy</author></authors></contributors><titles><title>Electrical Bioimpedance Analysis: A New Method in Cervical Cancer Screening</title><secondary-title>Journal of Medical Engineering</secondary-title></titles><periodical><full-title>Journal of Medical Engineering</full-title></periodical><pages>1-5</pages><volume>2015</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1155/2015/636075</electronic-resource-num><urls><web-urls><url>http://www.hindawi.com/journals/jme/2015/636075/</url></web-urls></urls><abstract>Cervical cancer is the second most common female cancer worldwide and a disease of concern due to its high rate of incidence of about 500,000 women annually and is responsible for about 280,000 deaths in a year. The mortality and morbidity of cervical cancer are reduced through mass screening via Pap smear, but this technique suffers from very high false negativity of around 30% to 40% and hence the sensitivity of this technique is not more than 60%. Electrical bioimpedance study employing cytosensors over a frequency range offers instantaneous and quantitative means to monitor cellular events and is an upcoming technique in real time to classify cells as normal and abnormal ones. This technology is exploited for label-free detection of diseases by identifying and measuring nonbiological parameters of the cell which may carry the disease signature.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Watters, Andrea K</author><author>Rom, Slava</author><author>Hill, Jeremy D</author><author>Dematatis, Marie K</author><author>Zhou, Yu</author><author>Merkel, Steven F</author><author>Andrews, Allison M</author><author>Cena, Jonathan</author><author>Potula, Raghava</author><author>Skuba, Andrew</author><author>Son, Young-Jin</author><author>Persidsky, Yuri</author><author>Ramirez, Servio H</author></authors></contributors><titles><title>Identification and Dynamic Regulation of Tight Junction Protein Expression in Human Neural Stem Cells</title><secondary-title>Stem Cells and Development</secondary-title></titles><periodical><full-title>Stem Cells and Development</full-title></periodical><pages>1377-1389</pages><volume>24</volume><issue>12</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1089/scd.2014.0497</electronic-resource-num><urls><web-urls><url>http://online.liebertpub.com/doi/10.1089/scd.2014.0497</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Podjaski, C</author><author>Alvarez, J I</author><author>Bourbonniere, L</author><author>Larouche, S</author><author>Terouz, S</author><author>Bin, J M</author><author>Lecuyer, M.-A.</author><author>Saint-Laurent, O</author><author>Larochelle, C</author><author>Darlington, P J</author><author>Arbour, N</author><author>Antel, J P</author><author>Kennedy, T E</author><author>Prat, A</author></authors></contributors><titles><title>Netrin 1 regulates blood-brain barrier function and neuroinflammation</title><secondary-title>Brain</secondary-title></titles><periodical><full-title>Brain</full-title></periodical><pages>1598-1612</pages><volume>138</volume><issue>6</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1093/brain/awv092</electronic-resource-num><urls><web-urls><url>http://www.brain.oxfordjournals.org/cgi/doi/10.1093/brain/awv092</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rom, Slava</author><author>Zuluaga-Ramirez, Viviana</author><author>Dykstra, Holly</author><author>Reichenbach, Nancy L</author><author>Ramirez, Servio H</author><author>Persidsky, Yuri</author></authors></contributors><titles><title>Poly(ADP-ribose) polymerase-1 inhibition in brain endothelium protects the blood–brain barrier under physiologic and neuroinflammatory conditions</title><secondary-title>Journal of Cerebral Blood Flow &amp; Metabolism</secondary-title></titles><periodical><full-title>Journal of Cerebral Blood Flow &amp; Metabolism</full-title></periodical><pages>28-36</pages><volume>35</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/jcbfm.2014.167</electronic-resource-num><urls><web-urls><url>http://jcb.sagepub.com/lookup/doi/10.1038/jcbfm.2014.167</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Borgas, Diana</author><author>Chambers, Eboni</author><author>Newton, Julie</author><author>Ko, Junsuk</author><author>Rivera, Stephanie</author><author>Rounds, Sharon</author><author>Lu, Qing</author></authors></contributors><titles><title>Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6</title><secondary-title>American Journal of Respiratory Cell and Molecular Biology</secondary-title></titles><periodical><full-title>American Journal of Respiratory Cell and Molecular Biology</full-title></periodical><pages>rcmb.2015-0149OC</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1165/rcmb.2015-0149OC</electronic-resource-num><urls><web-urls><url>http://www.atsjournals.org/doi/10.1165/rcmb.2015-0149OC</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sugiyama, Michael G</author><author>Armstrong, Susan M</author><author>Wang, Changsen</author><author>Hwang, David</author><author>Leong-Poi, Howard</author><author>Advani, Andrew</author><author>Advani, Suzanne</author><author>Zhang, Haibo</author><author>Szaszi, Katalin</author><author>Tabuchi, Arata</author><author>Kuebler, Wolfgang M</author><author>Van Slyke, Paul</author><author>Dumont, Dan J</author><author>Lee, Warren L</author></authors></contributors><titles><title>The Tie2-agonist Vasculotide rescues mice from influenza virus infection</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>11030</pages><volume>5</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/srep11030</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/srep11030</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Liu, Fuhong</author><author>Wang, Bei</author><author>Li, Liqun</author><author>Dong, Fengyun</author><author>Chen, Xiaocui</author><author>Li, Yan</author><author>Dong, Xiuzhen</author><author>Wada, Youichiro</author><author>Kapron, Carolyn</author><author>Liu, Ju</author></authors></contributors><titles><title>Low-Dose Cadmium Upregulates VEGF Expression in Lung Adenocarcinoma Cells</title><secondary-title>International Journal of Environmental Research and Public Health</secondary-title></titles><periodical><full-title>International Journal of Environmental Research and Public Health</full-title></periodical><pages>10508-10521</pages><volume>12</volume><issue>9</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3390/ijerph120910508</electronic-resource-num><urls><web-urls><url>http://www.mdpi.com/1660-4601/12/9/10508/</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>de Vries, Maaike</author><author>Hesse, Laura</author><author>Jonker, Marnix R</author><author>van den Berge, Maarten</author><author>van Oosterhout, Antoon J M</author><author>Heijink, Irene H</author><author>Nawijn, Martijn C</author></authors></contributors><titles><title>Pim1 kinase activity preserves airway epithelial integrity upon house dust mite exposure</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>ajplung.00043.2015</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajplung.00043.2015</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00043.2015</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Letsiou, E</author><author>Rizzo, A N</author><author>Sammani, S</author><author>Naureckas, P</author><author>Jacobson, J R</author><author>Garcia, J G N</author><author>Dudek, S M</author></authors></contributors><titles><title>Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>L259-L269</pages><volume>308</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajplung.00323.2014</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00323.2014</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sleire, L</author><author>Skeie, B S</author><author>Netland, I A</author><author>Førde, H E</author><author>Dodoo, E</author><author>Selheim, F</author><author>Leiss, L</author><author>Heggdal, J I</author><author>Pedersen, P-H</author><author>Wang, J</author><author>Enger, P Ø</author></authors></contributors><titles><title>Drug repurposing: sulfasalazine sensitizes gliomas to gamma knife radiosurgery by blocking cystine uptake through system Xc−, leading to glutathione depletion</title><secondary-title>Oncogene</secondary-title></titles><periodical><full-title>Oncogene</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/onc.2015.60</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/onc.2015.60</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cavet, Megan E</author><author>Vollmer, Thomas R</author><author>Harrington, Karen L</author><author>VanDerMeid, Karl</author><author>Richardson, Mary E</author></authors></contributors><titles><title>Regulation of Endothelin-1–Induced Trabecular Meshwork Cell Contractility by Latanoprostene Bunod</title><secondary-title>Investigative Opthalmology &amp; Visual Science</secondary-title></titles><periodical><full-title>Investigative Opthalmology &amp; Visual Science</full-title></periodical><pages>4108</pages><volume>56</volume><issue>6</issue><keywords><keyword>-donating</keyword><keyword>atanoprostene bunod</keyword><keyword>contractility</keyword><keyword>for its ability to</keyword><keyword>fp</keyword><keyword>glaucoma</keyword><keyword>in</keyword><keyword>iop</keyword><keyword>is a nitric oxide</keyword><keyword>lbn</keyword><keyword>nitric oxide</keyword><keyword>no</keyword><keyword>prostaglandin</keyword><keyword>prostaglandin f2 a</keyword><keyword>receptor agonist under investigation</keyword><keyword>reduce elevated intraocular pressure</keyword><keyword>trabecular meshwork</keyword></keywords><dates><year>2015</year></dates><accession-num>26114488</accession-num><electronic-resource-num>10.1167/iovs.14-16015</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/26114488</url><url>http://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.14-16015</url></web-urls></urls><label>ECIS Barrier Function</label><abstract>PURPOSE: Previous in vivo studies demonstrated that latanoprostene bunod (LBN), a nitric oxide (NO)-donating prostaglandin F2α receptor agonist, results in greater intraocular pressure (IOP) lowering than latanoprost. The present series of investigations compared the effects of LBN and latanoprost on primary human trabecular meshwork cell (HTMC) contractility and underlying signaling pathways to determine whether LBN might mediate this additional IOP lowering via the conventional outflow pathway.\n\nMETHODS: The effect of LBN (1-100 μM) on HTMC cGMP levels was determined by ELISA with or without the soluble guanylate cyclase (sGC) inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ). Endothelin-1 (ET-1) was used to induce HTMC contractility. To determine the effect of LBN on myosin light chain-2 (MLC-2) phosphorylation, HTMCs were pretreated with 10 to 60 μM LBN for 1 hour and then ET-1 for 5 minutes. MLC-2 phosphorylation was determined by Western blotting. Effects of LBN (30 and 45 μM) on ET-1-induced filamentous (F)-actin cytoskeletal stress fibers and the focal adhesion associated protein vinculin were determined by confocal microscopy. ET-1-induced HTMC monolayer resistance in the presence of LBN (45 μM) was determined by electrical cell substrate impedance sensing, as an indicator of cell contractility. Latanoprost and SE 175 (an NO donor which releases NO on reductive transformation within the cells) were used as comparators in all studies.\n\nRESULTS: LBN (1-100 μM) significantly increased cGMP levels in a dose-dependent manner, with a half maximal effective concentration (EC50) of 1.5 ± 1.3 μM, and with maximal effect similar to that of 100 μM SE 175. In contrast, latanoprost caused a minimal increase in cGMP levels at 100 μM only. The cGMP elevation induced by LBN or SE 175 was abolished by ODQ and was therefore sGC-dependent. The two NO donors SE 175 and LBN elicited a reduction in ET-1-induced MLC-2 phosphorylation that was significantly greater than that mediated by latanoprost in HTMCs. SE 175 (100 μM) and LBN (30 or 45 μM) caused a dramatic reduction in ET-1-induced actin stress fibers and vinculin localization at focal adhesions, whereas 45 μM latanoprost was without observable effect. SE 175 reduced ET-1-induced increases in HTMC resistance in a dose-dependent manner. A synergistic effect on reduction of HTMC resistance was observed when latanoprost and SE 175 doses were given together. LBN significantly reduced ET-1-induced HTMC monolayer resistance increases to a greater extent than latanoprost, indicating a greater reduction in cell contractility with LBN.\n\nCONCLUSIONS: LBN, SE 175, and latanoprost caused relaxation of ET-1-contracted HTMCs. The effect on HTMC relaxation observed with LBN was significantly greater in magnitude than that observed with latanoprost or SE 175. Data indicate that the NO-donating moiety of LBN mediates HTMC relaxation through activation of the cGMP signaling pathway and a subsequent reduction in MLC-2 phosphorylation. These findings suggest that increased conventional outflow facility may mediate the additional IOP-lowering effects of LBN over that of latanoprost observed in in vivo studies.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kozyulina, P Y</author><author>Loskutov, Y V</author><author>Kozyreva, V K</author><author>Rajulapati, a.</author><author>Ice, R J</author><author>Jones, B C</author><author>Pugacheva, E N</author></authors></contributors><titles><title>Prometastatic NEDD9 Regulates Individual Cell Migration via Caveolin-1-Dependent Trafficking of Integrins</title><secondary-title>Molecular Cancer Research</secondary-title></titles><periodical><full-title>Molecular Cancer Research</full-title></periodical><pages>423-438</pages><volume>13</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><isbn>3042934667</isbn><accession-num>25319010</accession-num><electronic-resource-num>10.1158/1541-7786.MCR-14-0353</electronic-resource-num><urls><web-urls><url>http://mcr.aacrjournals.org/cgi/doi/10.1158/1541-7786.MCR-14-0353</url></web-urls></urls><abstract>UNLABELLED: The dissemination of tumor cells relies on efficient cell adhesion and migration, which in turn depends upon endocytic trafficking of integrins. In the current work, it was found that depletion of the prometastatic protein, NEDD9, in breast cancer cells results in a significant decrease in individual cell migration due to impaired trafficking of ligand-bound integrins. NEDD9 deficiency does not affect the expression or internalization of integrins but heightens caveolae-dependent trafficking of ligand-bound integrins to early endosomes. Increase in mobility of ligand-bound integrins is concomitant with an increase in tyrosine phosphorylation of caveolin-1 (CAV1) and volume of CAV1-vesicles. NEDD9 directly binds to CAV1 and colocalizes within CAV1 vesicles. In the absence of NEDD9, the trafficking of ligand-bound integrins from early to late endosomes is impaired, resulting in a significant decrease in degradation of ligand-integrin complexes and an increase in recycling of ligand-bound integrins from early endosomes back to the plasma membrane without ligand disengagement, thus leading to low adhesion and migration. Reexpression of NEDD9 or decrease in the amount of active, tyrosine 14 phosphorylated (Tyr14) CAV1 in NEDD9-depleted cells rescues the integrin trafficking deficiency and restores cellular adhesion and migration capacity. Collectively, these findings indicate that NEDD9 orchestrates trafficking of ligand-bound integrins through the attenuation of CAV1 activity.\n\nIMPLICATIONS: This study provides valuable new insight into the potential therapeutic benefit of NEDD9 depletion to reduce dissemination of tumor cells and discovers a new regulatory role of NEDD9 in promoting migration through modulation of CAV1-dependent trafficking of integrins.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Buchholz, Scott</author><author>Sieverding, Shelby</author><author>Provost, Joseph</author><author>Wallert, Mark</author></authors></contributors><titles><title>The Impact of Calcineurin B Homologous Protein Isoform 2 Expression on Non-small Cell Lung Cancer Cell Function under Hypoxic Conditions</title><secondary-title>FASEB J</secondary-title></titles><periodical><full-title>FASEB J</full-title></periodical><pages>725.8-</pages><volume>29</volume><issue>1_Supplement</issue><keywords/><dates><year>2015</year></dates><urls><web-urls><url>http://www.fasebj.org/content/29/1_Supplement/725.8.short</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kim, Gab Seok</author><author>Yang, Li</author><author>Zhang, Guoqi</author><author>Zhao, Honggang</author><author>Selim, Magdy</author><author>McCullough, Louise D</author><author>Kluk, Michael J</author><author>Sanchez, Teresa</author></authors></contributors><titles><title>Critical role of sphingosine-1-phosphate receptor-2 in the disruption of cerebrovascular integrity in experimental stroke</title><secondary-title>Nature Communications</secondary-title></titles><periodical><full-title>Nature Communications</full-title></periodical><pages>7893</pages><volume>6</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/ncomms8893</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/ncomms8893</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rother, J</author><author>Richter, C</author><author>Turco, L</author><author>Knoch, F</author><author>Mey, I</author><author>Luther, S</author><author>Janshoff, a.</author><author>Bodenschatz, E</author><author>Tarantola, M</author></authors></contributors><titles><title>Crosstalk of cardiomyocytes and fibroblasts in co-cultures</title><secondary-title>Open Biology</secondary-title></titles><periodical><full-title>Open Biology</full-title></periodical><pages>150038</pages><volume>5</volume><issue>6</issue><keywords><keyword>cardiomyocytes</keyword><keyword>contractile function</keyword><keyword>electric cell-substrate</keyword><keyword>fibroblasts</keyword><keyword>fibrosis</keyword><keyword>impedance sensing</keyword><keyword>impedance spectroscopy</keyword></keywords><dates><year>2015</year></dates><electronic-resource-num>10.1098/rsob.150038</electronic-resource-num><urls><web-urls><url>http://rsob.royalsocietypublishing.org/lookup/doi/10.1098/rsob.150038</url><url>http://rsob.royalsocietypublishing.org/cgi/doi/10.1098/rsob.150038</url><url>http://rsob.royalsocietypublishing.org/lookup/doi/10.1098/rsob.150038%5Cnhttp://rsob.royalsocietypublishing.org/cgi/doi/</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Conference Proceedings">3</ref-type><contributors><authors><author>Reiss, Bjoern</author><author>Wegener, Joachim</author></authors></contributors><titles><title>Impedance analysis of different cell monolayers grown on gold-film electrodes</title><secondary-title>2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)</secondary-title></titles><periodical><full-title>2015 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC)</full-title></periodical><pages>7079-7082</pages><keywords/><dates><year>2015</year></dates><publisher>IEEE</publisher><isbn>978-1-4244-9271-8</isbn><electronic-resource-num>10.1109/EMBC.2015.7320023</electronic-resource-num><urls><web-urls><url>http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=7320023</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ji, Jiafu</author><author>Jia, Shuqin</author><author>Jia, Yongning</author><author>Ji, Ke</author><author>Hargest, Rachel</author><author>Jiang, Wen G</author></authors></contributors><titles><title>WISP-2 in human gastric cancer and its potential metastatic suppressor role in gastric cancer cells mediated by JNK and PLC-γ pathways</title><secondary-title>British Journal of Cancer</secondary-title></titles><periodical><full-title>British Journal of Cancer</full-title></periodical><pages>921-933</pages><volume>113</volume><issue>6</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/bjc.2015.285</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/bjc.2015.285</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Moughon, D L</author><author>He, H</author><author>Schokrpur, S</author><author>Jiang, Z K</author><author>Yaqoob, M</author><author>David, J</author><author>Lin, C</author><author>Iruela-Arispe, M L</author><author>Dorigo, O</author><author>Wu, L</author></authors></contributors><titles><title>Macrophage Blockade Using CSF1R Inhibitors Reverses the Vascular Leakage Underlying Malignant Ascites in Late-Stage Epithelial Ovarian Cancer</title><secondary-title>Cancer Research</secondary-title></titles><periodical><full-title>Cancer Research</full-title></periodical><pages>4742-4752</pages><volume>75</volume><issue>22</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1158/0008-5472.CAN-14-3373</electronic-resource-num><urls><web-urls><url>http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.CAN-14-3373</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Book Section">7</ref-type><contributors><authors><author>Lai, C -I.</author><author>Chen, W -T.</author><author>Lai, Y -T.</author><author>Lo, C -M.</author></authors></contributors><titles><title>Electrically Assessing the Effect of TGF-β1 on MDA-MB-231 Cells</title></titles><periodical/><pages>188-191</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1007/978-3-319-12262-5_52</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/978-3-319-12262-5_52</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sambale, Franziska</author><author>Stahl, Frank</author><author>Rüdinger, Ferdinand</author><author>Seliktar, Dror</author><author>Kasper, Cornelia</author><author>Bahnemann, Detlef</author><author>Scheper, Thomas</author></authors></contributors><titles><title>Iterative Cellular Screening System for Nanoparticle Safety Testing</title><secondary-title>Journal of Nanomaterials</secondary-title></titles><periodical><full-title>Journal of Nanomaterials</full-title></periodical><pages>1-16</pages><volume>2015</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1155/2015/691069</electronic-resource-num><urls><web-urls><url>http://www.hindawi.com/journals/jnm/2015/691069/</url></web-urls></urls><abstract>Nanoparticles have the potential to exhibit risks to human beings and to the environment; due to the wide applications of nanoproducts, extensive risk management must not be neglected. Therefore, we have constructed a cell-based, iterative screening system to examine a variety of nanoproducts concerning their toxicity during development. The sensitivity and application of various cell-based methods were discussed and proven by applying the screening to two different nanoparticles: zinc oxide and titanium dioxide nanoparticles. They were used as benchmarks to set up our methods and to examine their effects on mammalian cell lines. Different biological processes such as cell viability, gene expression of interleukin-8 and heat shock protein 70, as well as morphology changes were investigated. Within our screening system, both nanoparticle suspensions and coatings can be tested. Electric cell impedance measurements revealed to be a good method for online monitoring of cellular behavior. The implementation of three-dimensional cell culture is essential to better mimic in vivo conditions. In conclusion, our screening system is highly efficient, cost minimizing, and reduces the need for animal studies.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gamal, W</author><author>Borooah, S</author><author>Smith, S</author><author>Underwood, I</author><author>Srsen, V</author><author>Chandran, S</author><author>Bagnaninchi, P O</author><author>Dhillon, B</author></authors></contributors><titles><title>Real-time quantitative monitoring of hiPSC-based model of macular degeneration on Electric Cell-substrate Impedance Sensing microelectrodes</title><secondary-title>Biosensors and Bioelectronics</secondary-title></titles><periodical><full-title>Biosensors and Bioelectronics</full-title></periodical><pages>445-455</pages><volume>71</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.bios.2015.04.079</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0956566315300804</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kheirandish-Gozal, L</author><author>Alonso-Alvarez, M</author><author>Teran-Santos, J</author><author>Gozal, D</author><author>Khalyfa, A</author></authors></contributors><titles><title>Plasma-Derived Exosomes Alter Endothelial Tight Junction In Obese Children With Obstructive Sleep Apnea: Effect Of Adenotonsillectomy (t&amp;a)</title><secondary-title>Am J Respir Crit Care Med</secondary-title></titles><periodical><full-title>Am J Respir Crit Care Med</full-title></periodical><pages>A2596</pages><volume>191</volume><keywords/><dates><year>2015</year></dates><publisher>Am Thoracic Soc</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Fairaq, Arwa</author><author>Goc, Anna</author><author>Artham, Sandeep</author><author>Sabbineni, Harika</author><author>Somanath, Payaningal R</author></authors></contributors><titles><title>TNFα induces inflammatory stress response in microvascular endothelial cells via Akt- and P38 MAP kinase-mediated thrombospondin-1 expression</title><secondary-title>Molecular and Cellular Biochemistry</secondary-title></titles><periodical><full-title>Molecular and Cellular Biochemistry</full-title></periodical><pages>227-236</pages><volume>406</volume><issue>1-2</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1007/s11010-015-2440-0</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s11010-015-2440-0</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Eldawud, Reem</author><author>Wagner, Alixandra</author><author>Dong, Chenbo</author><author>Rojansakul, Yon</author><author>Zoica Dinu, Cerasela</author></authors></contributors><titles><title>Electronic platform for real-time multi-parametric analysis of cellular behavior post-exposure to single-walled carbon nanotubes</title><secondary-title>Biosensors and Bioelectronics</secondary-title></titles><periodical><full-title>Biosensors and Bioelectronics</full-title></periodical><pages>269-277</pages><volume>71</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.bios.2015.04.044</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0956566315300464</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wakaskar, Rajesh R</author><author>Bathena, Sai Praneeth R</author><author>Tallapaka, Shailendra B</author><author>Ambardekar, Vishakha V</author><author>Gautam, Nagsen</author><author>Thakare, Rhishikesh</author><author>Simet, Samantha M</author><author>Curran, Stephen M</author><author>Singh, Rakesh K</author><author>Dong, Yuxiang</author><author>Vetro, Joseph A</author></authors></contributors><titles><title>Peripherally Cross-Linking the Shell of Core-Shell Polymer Micelles Decreases Premature Release of Physically Loaded Combretastatin A4 in Whole Blood and Increases its Mean Residence Time and Subsequent Potency Against Primary Murine Breast Tumors After I</title><secondary-title>Pharmaceutical Research</secondary-title></titles><periodical><full-title>Pharmaceutical Research</full-title></periodical><pages>1028-1044</pages><volume>32</volume><issue>3</issue><keywords><keyword>drug delivery</keyword><keyword>peripheral shell cross-linking</keyword><keyword>pluronic f127</keyword><keyword>poloxamer 407</keyword><keyword>polymer nanocarriers</keyword></keywords><dates><year>2015</year></dates><electronic-resource-num>10.1007/s11095-014-1515-z</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s11095-014-1515-z</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Post, A</author><author>Pannekoek, W J</author><author>Ponsioen, B</author><author>Vliem, M J</author><author>Bos, J L</author></authors></contributors><titles><title>Rap1 Spatially Controls ArhGAP29 To Inhibit Rho Signaling during Endothelial Barrier Regulation</title><secondary-title>Molecular and Cellular Biology</secondary-title></titles><periodical><full-title>Molecular and Cellular Biology</full-title></periodical><pages>2495-2502</pages><volume>35</volume><issue>14</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1128/MCB.01453-14</electronic-resource-num><urls><web-urls><url>http://mcb.asm.org/lookup/doi/10.1128/MCB.01453-14</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Meng, Jingjing</author><author>Banerjee, Santanu</author><author>Li, Dan</author><author>Sindberg, Gregory M</author><author>Wang, Fuyuan</author><author>Ma, Jing</author><author>Roy, Sabita</author></authors></contributors><titles><title>Opioid Exacerbation of Gram-positive sepsis, induced by Gut Microbial Modulation, is Rescued by IL-17A Neutralization</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>10918</pages><volume>5</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/srep10918</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/srep10918</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dong, Fengyun</author><author>Tian, Hu</author><author>Yan, Suhua</author><author>Li, Liqun</author><author>Dong, Xiaofeng</author><author>Wang, Fuhai</author><author>Li, Jie</author><author>Li, Changsheng</author><author>Cao, Zhiqun</author><author>Liu, Xiaochun</author><author>Liu, Ju</author></authors></contributors><titles><title>Dihydroartemisinin inhibits endothelial cell proliferation through the suppression of the ERK signaling pathway</title><secondary-title>International Journal of Molecular Medicine</secondary-title></titles><periodical><full-title>International Journal of Molecular Medicine</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3892/ijmm.2015.2140</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/10.3892/ijmm.2015.2140</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Üllen, Andreas</author><author>Nusshold, Christoph</author><author>Glasnov, Toma</author><author>Saf, Robert</author><author>Cantillo, David</author><author>Eibinger, Gerald</author><author>Reicher, Helga</author><author>Fauler, Günter</author><author>Bernhart, Eva</author><author>Hallstrom, Seth</author><author>Kogelnik, Nora</author><author>Zangger, Klaus</author><author>Oliver Kappe, C</author><author>Malle, Ernst</author><author>Sattler, Wolfgang</author></authors></contributors><titles><title>Covalent adduct formation between the plasmalogen-derived modification product 2-chlorohexadecanal and phloretin</title><secondary-title>Biochemical Pharmacology</secondary-title></titles><periodical><full-title>Biochemical Pharmacology</full-title></periodical><pages>470-481</pages><volume>93</volume><issue>4</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.bcp.2014.12.017</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S000629521400731X</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Breus, Vladimir V</author><author>Pietuch, Anna</author><author>Tarantola, Marco</author><author>Basché, Thomas</author><author>Janshoff, Andreas</author></authors></contributors><titles><title>The effect of surface charge on nonspecific uptake and cytotoxicity of CdSe/ZnS core/shell quantum dots</title><secondary-title>Beilstein Journal of Nanotechnology</secondary-title></titles><periodical><full-title>Beilstein Journal of Nanotechnology</full-title></periodical><pages>281-292</pages><volume>6</volume><keywords/><dates><year>2015</year></dates><accession-num>25821666</accession-num><electronic-resource-num>10.3762/bjnano.6.26</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4362492&amp;tool=pmcentrez&amp;rendertype=abstract</url><url>http://www.beilstein-journals.org/bjnano/content/6/1/26</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>In this work, cytotoxicity and cellular impedance response was compared for CdSe/ZnS core/shell quantum dots (QDs) with positively charged cysteamine-QDs, negatively charged dihydrolipoic acid-QDs and zwitterionic D-penicillamine-QDs exposed to canine kidney MDCKII cells. Pretreatment of cells with pharmacological inhibitors suggested that the uptake of nanoparticles was largely due to receptor-independent pathways or spontaneous entry for carboxylated and zwitterionic QDs, while for amine-functionalized particles involvement of cholesterol-enriched membrane domains is conceivable. Cysteamine-QDs were found to be the least cytotoxic, while D-penicillamine-QDs reduced the mitochondrial activity of MDCKII by 20-25%. Although the cell vitality appeared unaffected (assessed from the changes in mitochondrial activity using a classical MTS assay after 24 h of exposure), the binding of QDs to the cellular interior and their movement across cytoskeletal filaments (captured and characterized by single-particle tracking), was shown to compromise the integrity of the cytoskeletal and plasma membrane dynamics, as evidenced by electric cell-substrate impedance sensing.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Li, Liqun</author><author>Dong, Fengyun</author><author>Xu, Dongmei</author><author>Du, Linna</author><author>Yan, Suhua</author><author>Hu, Hesheng</author><author>Lobe, Corrinne G</author><author>Yi, Fan</author><author>Kapron, Carolyn M</author><author>Liu, Ju</author></authors></contributors><titles><title>Short-term, low-dose cadmium exposure induces hyperpermeability in human renal glomerular endothelial cells</title><secondary-title>Journal of Applied Toxicology</secondary-title></titles><periodical><full-title>Journal of Applied Toxicology</full-title></periodical><pages>n/a-n/a</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1002/jat.3168</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1002/jat.3168</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Clark, Paul R</author><author>Kim, Richard K</author><author>Pober, Jordan S</author><author>Kluger, Martin S</author></authors><secondary-authors><author>Koval, Michael</author></secondary-authors></contributors><titles><title>Tumor Necrosis Factor Disrupts Claudin-5 Endothelial Tight Junction Barriers in Two Distinct NF-κB-Dependent Phases</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0120075</pages><volume>10</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><accession-num>25816133</accession-num><electronic-resource-num>10.1371/journal.pone.0120075</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0120075</url><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4376850&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Barrier Function;ECIS TEER</label><abstract>Capillary leak in severe sepsis involves disruption of endothelial cell tight junctions. We modeled this process by TNF treatment of cultured human dermal microvascular endothelial cell (HDMEC) monolayers, which unlike human umbilical vein endothelial cells form claudin-5-dependent tight junctions and a high-resistance permeability barrier. Continuous monitoring with electrical cell-substrate impedance sensing revealed that TNF disrupts tight junction-dependent HDMEC barriers in discrete steps: an ~5% increase in transendothelial electrical resistance over 40 minutes; a decrease to ~10% below basal levels over 2 hours (phase 1 leak); an interphase plateau of 1 hour; and a major fall in transendothelial electrical resistance to &lt; 70% of basal levels by 8-10 hours (phase 2 leak), with EC50 values of TNF for phase 1 and 2 leak of ~30 and ~150 pg/ml, respectively. TNF leak is reversible and independent of cell death. Leak correlates with disruption of continuous claudin-5 immunofluorescence staining, myosin light chain phosphorylation and loss of claudin-5 co-localization with cortical actin. All these responses require NF-κB signaling, shown by inhibition with Bay 11 or overexpression of IκB super-repressor, and are blocked by H-1152 or Y-27632, selective inhibitors of Rho-associated kinase that do not block other NF-κB-dependent responses. siRNA combined knockdown of Rho-associated kinase-1 and -2 also prevents myosin light chain phosphorylation, loss of claudin-5/actin co-localization, claudin-5 reorganization and reduces phase 1 leak. However, unlike H-1152 and Y-27632, combined Rho-associated kinase-1/2 siRNA knockdown does not reduce the magnitude of phase 2 leak, suggesting that H-1152 and Y-27632 have targets beyond Rho-associated kinases that regulate endothelial barrier function. We conclude that TNF disrupts TJs in HDMECs in two distinct NF-κB-dependent steps, the first involving Rho-associated kinase and the second likely to involve an as yet unidentified but structurally related protein kinase(s).</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ghosh, Chandra C</author><author>Mukherjee, Aditi</author><author>David, Sascha</author><author>Milam, Katelyn E</author><author>Hunter, Jon T</author><author>Parikh, Samir M</author></authors><secondary-authors><author>Ushio-Fukai, Masuko</author></secondary-authors></contributors><titles><title>Angiopoietin-1 Requires Oxidant Signaling through p47phox to Promote Endothelial Barrier Defense</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0119577</pages><volume>10</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1371/journal.pone.0119577</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0119577</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiao, Bo</author><author>Han, Moon Kwon</author><author>Viennois, Emilie</author><author>Wang, Lixin</author><author>Zhang, Mingzhen</author><author>Si, Xiaoying</author><author>Merlin, Didier</author></authors></contributors><titles><title>Hyaluronic acid-functionalized polymeric nanoparticles for colon cancer-targeted combination chemotherapy</title><secondary-title>Nanoscale</secondary-title></titles><periodical><full-title>Nanoscale</full-title></periodical><pages>17745-17755</pages><volume>7</volume><issue>42</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1039/C5NR04831A</electronic-resource-num><urls><web-urls><url>http://xlink.rsc.org/?DOI=C5NR04831A</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zheng, Jiamao</author><author>Almendros, Isaac</author><author>Wang, Yang</author><author>Zhang, Shelley X</author><author>Carreras, Alba</author><author>Qiao, Zhuanhong</author><author>Gozal, David</author></authors></contributors><titles><title>Reduced NADPH oxidase type 2 activity mediates sleep fragmentation-induced effects on TC1 tumors in mice</title><secondary-title>OncoImmunology</secondary-title></titles><periodical><full-title>OncoImmunology</full-title></periodical><pages>e976057</pages><volume>4</volume><issue>2</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.4161/2162402X.2014.976057</electronic-resource-num><urls><web-urls><url>http://www.tandfonline.com/doi/abs/10.4161/2162402X.2014.976057</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jiang, Wen G</author><author>Ye, Lin</author><author>Ruge, Fiona</author><author>Sun, Ping-Hui</author><author>Sanders, Andrew J</author><author>Ji, Ki</author><author>Lane, Jane</author><author>Zhang, Lijian</author><author>Satherley, Lucy</author><author>Weeks, Hoi P</author></authors></contributors><titles><title>Expression of Sonic Hedgehog (SHH) in Human Lung Cancer and the Impact of YangZheng XiaoJi on SHH-mediated Biological Function of Lung Cancer Cells and Tumor Growth</title><secondary-title>Anticancer research</secondary-title></titles><periodical><full-title>Anticancer research</full-title></periodical><pages>1321-1331</pages><volume>35</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><publisher>International Institute of Anticancer Research</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Potter, Daniel R</author><author>Baimukanova, Gail</author><author>Keating, Sheila M</author><author>Deng, Xutao</author><author>Chu, Jeffrey A</author><author>Gibb, Stuart L</author><author>Peng, Zhanglong</author><author>Muench, Marcus O</author><author>Fomin, Marina E</author><author>Spinella, Philip C</author><author>Kozar, Rosemary</author><author>Pati, Shibani</author></authors></contributors><titles><title>Fresh frozen plasma and spray-dried plasma mitigate pulmonary vascular permeability and inflammation in hemorrhagic shock</title><secondary-title>Journal of Trauma and Acute Care Surgery</secondary-title></titles><periodical><full-title>Journal of Trauma and Acute Care Surgery</full-title></periodical><pages>S7-S17</pages><volume>78</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1097/TA.0000000000000630</electronic-resource-num><urls><web-urls><url>http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&amp;an=01586154-201506001-00003</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Suresh, Karthik</author><author>Servinsky, Laura</author><author>Reyes, Jose</author><author>Baksh, Syeda</author><author>Undem, Clark</author><author>Caterina, Michael</author><author>Pearse, David B</author><author>Shimoda, Larissa A</author></authors></contributors><titles><title>Hydrogen peroxide-induced calcium influx in lung microvascular endothelial cells involves TRPV4</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>L1467-L1477</pages><volume>309</volume><issue>12</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajplung.00275.2015</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00275.2015</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rahbar, Elaheh</author><author>Cardenas, Jessica C</author><author>Baimukanova, Gyulnar</author><author>Usadi, Benjamin</author><author>Bruhn, Roberta</author><author>Pati, Shibani</author><author>Ostrowski, Sisse R</author><author>Johansson, Pär I</author><author>Holcomb, John B</author><author>Wade, Charles E</author></authors></contributors><titles><title>Endothelial glycocalyx shedding and vascular permeability in severely injured trauma patients</title><secondary-title>Journal of Translational Medicine</secondary-title></titles><periodical><full-title>Journal of Translational Medicine</full-title></periodical><pages>117</pages><volume>13</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1186/s12967-015-0481-5</electronic-resource-num><urls><web-urls><url>http://www.translational-medicine.com/content/13/1/117</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kispert, Shannon</author><author>Marentette, John</author><author>McHowat, Jane</author></authors></contributors><titles><title>Cigarette smoke induces cell motility via platelet-activating factor accumulation in breast cancer cells: a potential mechanism for metastatic disease</title><secondary-title>Physiological Reports</secondary-title></titles><periodical><full-title>Physiological Reports</full-title></periodical><pages>e12318-e12318</pages><volume>3</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><publisher>Physiological Reports</publisher><accession-num>25802360</accession-num><electronic-resource-num>10.14814/phy2.12318</electronic-resource-num><language>en</language><urls><web-urls><url>http://physreports.physiology.org/content/3/3/e12318.abstract</url><url>http://physreports.physiology.org/cgi/doi/10.14814/phy2.12318</url></web-urls></urls><abstract>Most cancer deaths are a result of metastasis rather than the primary tumor. Although cigarette smoking has been determined as a risk factor for several cancers, its role in metastasis has not been studied in detail. We propose that cigarette smoking contributes to metastatic disease via inhibition of breast cancer cell platelet-activating factor acetylhydrolase (PAF-AH), resulting in PAF accumulation and a subsequent increase in cell motility. We studied several breast cell lines, including immortalized mammary epithelial cells (MCF-10A), luminal A hormone positive MCF-7, basal-like triple negative MDA-MB-468, and claudin-low triple-negative highly metastatic MDA-MB-231 breast tumor cells. We exposed cells to cigarette smoke extract (CSE) for up to 48 h. CSE inhibited PAF-AH activity, increased PAF accumulation, and increased cell motility in MDA-MB-231 metastatic triple negative breast cancer cells. The calcium-independent phospholipase A2 (iPLA2) inhibitor, (S) bromoenol lactone ((S)-BEL) was used to prevent the accumulation of PAF and further prevented the increase in cell motility seen previously when cells were exposed to CSE. Thus, iPLA2 or PAF may represent a therapeutic target to manage metastatic disease, particularly in triple-negative breast cancer patients who smoke.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hyun Jo, Dong</author><author>Lee, Rimi</author><author>Hyoung Kim, Jin</author><author>Oh Jun, Hyoung</author><author>Geol Lee, Tae</author><author>Hun Kim, Jeong</author></authors></contributors><titles><title>Real-time estimation of paracellular permeability of cerebral endothelial cells by capacitance sensor array</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>11014</pages><volume>5</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1038/srep11014</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/srep11014</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ibrahim, Ahmed S</author><author>Elshafey, Sally</author><author>Sellak, Hassan</author><author>Hussein, Khaled A</author><author>El-Sherbiny, Mohamed</author><author>Abdelsaid, Mohammed</author><author>Rizk, Nasser</author><author>Beasley, Selina</author><author>Tawfik, Amany M</author><author>Smith, Sylvia B</author><author>Al-Shabrawey, Mohamed</author></authors></contributors><titles><title>A lipidomic screen of hyperglycemia-treated HRECs links 12/15-Lipoxygenase to microvascular dysfunction during diabetic retinopathy via NADPH oxidase</title><secondary-title>Journal of Lipid Research</secondary-title></titles><periodical><full-title>Journal of Lipid Research</full-title></periodical><pages>599-611</pages><volume>56</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1194/jlr.M056069</electronic-resource-num><urls><web-urls><url>http://www.jlr.org/lookup/doi/10.1194/jlr.M056069</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Du, Linna</author><author>Dong, Fengyun</author><author>Guo, Ling</author><author>Hou, Yinglong</author><author>Yi, Fan</author><author>Liu, Ju</author><author>Xu, Dongmei</author></authors></contributors><titles><title>Interleukin‑1β increases permeability and upregulates the expression of vascular endothelial‑cadherin in human renal glomerular endothelial cells</title><secondary-title>Molecular Medicine Reports</secondary-title></titles><periodical><full-title>Molecular Medicine Reports</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3892/mmr.2015.3172</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/10.3892/mmr.2015.3172</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lu, Hongyan</author><author>Poirier, Christophe</author><author>Cook, Todd</author><author>Traktuev, Dmitry O</author><author>Merfeld-Clauss, Stephanie</author><author>Lease, Benjamin</author><author>Petrache, Irina</author><author>March, Keith L</author><author>Bogatcheva, Natalia V</author></authors></contributors><titles><title>Conditioned media from adipose stromal cells limit lipopolysaccharide-induced lung injury, endothelial hyperpermeability and apoptosis</title><secondary-title>Journal of Translational Medicine</secondary-title></titles><periodical><full-title>Journal of Translational Medicine</full-title></periodical><pages>67</pages><volume>13</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1186/s12967-015-0422-3</electronic-resource-num><urls><web-urls><url>http://www.translational-medicine.com/content/13/1/67</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sabbineni, Harika</author><author>Alwhaibi, Abdulrahman</author><author>Goc, Anna</author><author>Gao, Fei</author><author>Pruitt, Alanna</author><author>Somanath, Payaningal R</author></authors></contributors><titles><title>Genetic deletion and pharmacological inhibition of Akt1 isoform attenuates bladder cancer cell proliferation, motility and invasion</title><secondary-title>European Journal of Pharmacology</secondary-title></titles><periodical><full-title>European Journal of Pharmacology</full-title></periodical><pages>208-214</pages><volume>764</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.ejphar.2015.06.059</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0014299915301242</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Adderley, Shaquria P</author><author>Zhang, Xun E</author><author>Breslin, Jerome W</author></authors></contributors><titles><title>Involvement of the H1 Histamine Receptor, p38 MAP Kinase, Myosin Light Chains Kinase, and Rho/ROCK in Histamine-Induced Endothelial Barrier Dysfunction</title><secondary-title>Microcirculation</secondary-title></titles><periodical><full-title>Microcirculation</full-title></periodical><pages>237-248</pages><volume>22</volume><issue>4</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1111/micc.12189</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1111/micc.12189</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Adderley, Shaquria P</author><author>Lawrence, Curtis</author><author>Madonia, Eyong</author><author>Olubadewo, Joseph O</author><author>Breslin, Jerome W</author></authors></contributors><titles><title>Histamine activates p38 MAP kinase and alters local lamellipodia dynamics, reducing endothelial barrier integrity and eliciting central movement of actin fibers</title><secondary-title>American Journal of Physiology - Cell Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Cell Physiology</full-title></periodical><pages>C51-C59</pages><volume>309</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajpcell.00096.2015</electronic-resource-num><urls><web-urls><url>http://ajpcell.physiology.org/lookup/doi/10.1152/ajpcell.00096.2015</url></web-urls></urls><label>ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wazir, Umar</author><author>Sanders, Andrew</author><author>Wazir, Ahmad</author><author>Ye, Lin</author><author>Jiang, Wen</author><author>Ster, Irina</author><author>Sharma, Anup</author><author>Mokbel, Kefah</author></authors></contributors><titles><title>Effects of the knockdown of death-associated proteinï¿½3 expression on cell adhesion, growth and migration in breast cancer cells</title><secondary-title>Oncology Reports</secondary-title></titles><periodical><full-title>Oncology Reports</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3892/or.2015.3825</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/10.3892/or.2015.3825</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lindsey, Merry L</author><author>Zouein, Fouad A</author><author>Tian, Yuan</author><author>Padmanabhan Iyer, Rugmani</author><author>de Castro Brás, Lisandra E</author></authors></contributors><titles><title>Osteopontin is proteolytically processed by matrix metalloproteinase 9 1</title><secondary-title>Canadian Journal of Physiology and Pharmacology</secondary-title></titles><periodical><full-title>Canadian Journal of Physiology and Pharmacology</full-title></periodical><pages>1-8</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1139/cjpp-2015-0019</electronic-resource-num><urls><web-urls><url>http://www.nrcresearchpress.com/doi/10.1139/cjpp-2015-0019</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiao, Bo</author><author>Zhang, Mingzhen</author><author>Viennois, Emilie</author><author>Zhang, Yuchen</author><author>Wei, Na</author><author>Baker, Mark T</author><author>Jung, Yunjin</author><author>Merlin, Didier</author></authors></contributors><titles><title>Inhibition of MDR1 gene expression and enhancing cellular uptake for effective colon cancer treatment using dual-surface-functionalized nanoparticles</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>147-160</pages><volume>48</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.biomaterials.2015.01.014</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0142961215000319</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Majzner, K</author><author>Wojcik, T</author><author>Szafraniec, E</author><author>Lukawska, M</author><author>Oszczapowicz, I</author><author>Chlopicki, S</author><author>Baranska, M</author></authors></contributors><titles><title>Nuclear accumulation of anthracyclines in the endothelium studied by bimodal imaging: fluorescence and Raman microscopy.</title><secondary-title>The Analyst</secondary-title></titles><periodical><full-title>The Analyst</full-title></periodical><keywords/><dates><year>2015</year></dates><accession-num>25599102</accession-num><electronic-resource-num>10.1039/c4an01882f</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/25599102</url></web-urls></urls><abstract>Anthracycline antibiotics display genotoxic activity towards cancer cells but their clinical utility is limited by their cardiac and vascular toxicity. The aim of this study was to develop a Raman-based methodology to study the nuclear accumulation of anthracyclines in the endothelium. For this purpose bimodal confocal Raman and fluorescence imaging was used to monitor cellular composition changes as a result of anthracycline exposure on endothelial cells (EA.hy926), and nuclear drug accumulation, respectively. Simultaneously effects of anthracyclines on endothelium viability were investigated by caspases-3 and -7 and MTT assays. We demonstrated that nuclear accumulation of DOX and EDOX was similar; however, EDNR accumulated in endothelial nuclei at concentrations 10 times higher than DNR. In turn, epimers of DOX or DNR were both consistently less toxic on the endothelium as compared to their congeners as evidenced by MTT and caspase assays. In summary, bimodal Raman and fluorescence-based nucleus profiling proves to be a valuable tool to study structure-activity relationship of nuclear accumulation and toxicity of anthracyclines in endothelium.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Toman, Petr</author><author>Lien, Chun-Fu</author><author>Ahmad, Zeeshan</author><author>Dietrich, Susanne</author><author>Smith, James R</author><author>An, Qian</author><author>Molnár, Éva</author><author>Pilkington, Geoffrey J</author><author>Górecki, Darek C</author><author>Tsibouklis, John</author><author>Barbu, Eugen</author></authors></contributors><titles><title>Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation</title><secondary-title>Acta Biomaterialia</secondary-title></titles><periodical><full-title>Acta Biomaterialia</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.actbio.2015.05.009</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S1742706115002263</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dhawan, S</author><author>Hiemstra, I H</author><author>Verseijden, C</author><author>Hilbers, F W</author><author>te Velde, A A</author><author>Willemsen, L E M</author><author>Stap, J</author><author>den Haan, J M</author><author>de Jonge, W J</author></authors></contributors><titles><title>Cholinergic receptor activation on epithelia protects against cytokine-induced barrier dysfunction</title><secondary-title>Acta Physiologica</secondary-title></titles><periodical><full-title>Acta Physiologica</full-title></periodical><pages>846-859</pages><volume>213</volume><issue>4</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1111/apha.12469</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1111/apha.12469</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, Xianming</author><author>Brovkovych, Viktor</author><author>Zhang, Yongkang</author><author>Tan, Fulong</author><author>Skidgel, Randal A</author></authors></contributors><titles><title>Downregulation of kinin B1 receptor function by B2 receptor heterodimerization and signaling</title><secondary-title>Cellular Signalling</secondary-title></titles><periodical><full-title>Cellular Signalling</full-title></periodical><pages>90-103</pages><volume>27</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.cellsig.2014.09.019</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0898656814003234</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sambale, F</author><author>Wagner, S</author><author>Stahl, F</author><author>Khaydarov, R R</author><author>Scheper, T</author><author>Bahnemann, D</author></authors></contributors><titles><title>Investigations of the Toxic Effect of Silver Nanoparticles on Mammalian Cell Lines</title><secondary-title>Journal of Nanomaterials</secondary-title></titles><periodical><full-title>Journal of Nanomaterials</full-title></periodical><pages>1-9</pages><volume>2015</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1155/2015/136765</electronic-resource-num><urls><web-urls><url>http://www.hindawi.com/journals/jnm/2015/136765/</url></web-urls></urls><abstract>Silver nanoparticles are widely used for many applications. In this study silver nanoparticles have been tested for their toxic effect on fibroblasts (NIH-3T3), on a human lung adenocarcinoma epithelial cell line (A-549), on PC-12-cells, a rat adrenal pheochromocytoma cell line, and on HEP-G2-cells, a human hepatocellular carcinoma cell line. The viability of the cells cultivated with different concentrations of silver was determined by the MTT assay, a photometric method to determine cell metabolism. Dose-response curves were extrapolated and IC 50 , total lethal concentration (TLC), and no observable adverse effect concentration (NOAEC) values were calculated for each cell line. As another approach, ECIS (electric-cell-substrate-impedance-sensing) an automated method to monitor cellular behavior in real-time was applied to observe cells cultivated with silver nanoparticles. To identify the type of cell death the membrane integrity was analyzed by measurements of the lactate dehydrogenase releases and by determination of the caspase 3/7 activity. To ensure that the cytotoxic effect of silver nanoparticles is not traced back to the presence of Ag + ions in the suspension, an Ag + salt (AgNO 3 ) has been examined at the same concentration of Ag + present in the silver nanoparticle suspension that is assuming that the Ag particles are completely available as Ag + ions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chichger, H</author><author>Duong, H</author><author>Braza, J</author><author>Harrington, E O</author></authors></contributors><titles><title>p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin</title><secondary-title>The FASEB Journal</secondary-title></titles><periodical><full-title>The FASEB Journal</full-title></periodical><pages>868-881</pages><volume>29</volume><issue>3</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1096/fj.14-257212</electronic-resource-num><urls><web-urls><url>http://www.fasebj.org/cgi/doi/10.1096/fj.14-257212</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rutten, Michael J</author><author>Laraway, Bryan</author><author>Gregory, Cynthia R</author><author>Xie, Hua</author><author>Renken, Christian</author><author>Keese, Charles</author><author>Gregory, Kenton W</author></authors></contributors><titles><title>Rapid assay of stem cell functionality and potency using electric cell-substrate impedance sensing</title><secondary-title>Stem Cell Research &amp; Therapy</secondary-title></titles><periodical><full-title>Stem Cell Research &amp; Therapy</full-title></periodical><pages>1-11</pages><volume>6</volume><issue>192</issue><keywords/><dates><year>2015</year></dates><publisher>Stem Cell Research &amp; Therapy</publisher><electronic-resource-num>10.1186/s13287-015-0182-2</electronic-resource-num><urls><web-urls><url>http://dx.doi.org/10.1186/s13287-015-0182-2</url></web-urls></urls><label>ECIS Chemotaxis;ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kugelmann, Daniela</author><author>Waschke, Jens</author><author>Radeva, Mariya Y</author></authors><secondary-authors><author>Deli, Mária A</author></secondary-authors></contributors><titles><title>Adducin Is Involved in Endothelial Barrier Stabilization</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0126213</pages><volume>10</volume><issue>5</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1371/journal.pone.0126213</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0126213</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gao, Fei</author><author>Al-Azayzih, Ahmad</author><author>Somanath, Payaningal R</author></authors></contributors><titles><title>Discrete functions of GSK3α and GSK3β isoforms in prostate tumor growth and micrometastasis</title><secondary-title>Oncotarget</secondary-title></titles><periodical><full-title>Oncotarget</full-title></periodical><pages>5947-5962</pages><volume>6</volume><issue>8</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.18632/oncotarget.3335</electronic-resource-num><urls><web-urls><url>http://oncotarget.com/abstract/3335</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Timmerman, I</author><author>Heemskerk, N</author><author>Kroon, J</author><author>Schaefer, A</author><author>van Rijssel, J</author><author>Hoogenboezem, M</author><author>van Unen, J</author><author>Goedhart, J</author><author>Gadella, T W J</author><author>Yin, T</author><author>Wu, Y</author><author>Huveneers, S</author><author>van Buul, J D</author></authors></contributors><titles><title>A local VE-cadherin/Trio-based signaling complex stabilizes endothelial junctions through Rac1</title><secondary-title>Journal of Cell Science</secondary-title></titles><periodical><full-title>Journal of Cell Science</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1242/jcs.168674</electronic-resource-num><urls><web-urls><url>http://jcs.biologists.org/cgi/doi/10.1242/jcs.168674</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Vogt, Leonie M</author><author>Boekschoten, Mark V</author><author>de Groot, Philip J</author><author>Faas, Marijke M</author><author>de Vos, Paul</author></authors></contributors><titles><title>Cellulose alters the expression of nuclear factor kappa B-related genes and Toll-like receptor-related genes in human peripheral blood mononuclear cells</title><secondary-title>Journal of Functional Foods</secondary-title></titles><periodical><full-title>Journal of Functional Foods</full-title></periodical><pages>520-531</pages><volume>18</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.jff.2015.08.011</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S1756464615003953</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ramuz, M</author><author>Hama, A</author><author>Rivnay, J</author><author>Leleux, P</author><author>Owens, R M</author></authors></contributors><titles><title>Monitoring of cell layer coverage and differentiation with the organic electrochemical transistor</title><secondary-title>J. Mater. Chem. B</secondary-title></titles><periodical><full-title>J. Mater. Chem. B</full-title></periodical><pages>5971-5977</pages><volume>3</volume><issue>29</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1039/C5TB00922G</electronic-resource-num><urls><web-urls><url>http://xlink.rsc.org/?DOI=C5TB00922G</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sambale, Franziska</author><author>Stahl, Frank</author><author>Bahnemann, Detlef</author><author>Scheper, Thomas</author></authors></contributors><titles><title>In vitro toxicological nanoparticle studies under flow exposure</title><secondary-title>Journal of Nanoparticle Research</secondary-title></titles><periodical><full-title>Journal of Nanoparticle Research</full-title></periodical><pages>298</pages><volume>17</volume><issue>7</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1007/s11051-015-3106-2</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s11051-015-3106-2</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cahoon, Judd M</author><author>Rai, Ruju R</author><author>Carroll, Lara S</author><author>Uehara, Hironori</author><author>Zhang, Xiaohui</author><author>O’Neil, Christina L</author><author>Medina, Reinhold J</author><author>Das, Subtrata K</author><author>Muddana, Santosh K</author><author>Olson, Paul R</author><author>Nielson, Spencer</author><author>Walker, Kortnie</author><author>Flood, Maggie M</author><author>Messenger, Wyatt B</author><author>Archer, Bonnie J</author><author>Barabas, Peter</author><author>Krizaj, David</author><author>Gibson, Christopher C</author><author>Li, Dean Y</author><author>Koh, Gou Y</author><author>Gao, Guangping</author><author>Stitt, Alan W</author><author>Ambati, Balamurali K</author></authors></contributors><titles><title>Intravitreal AAV2.COMP-Ang1 Prevents Neurovascular Degeneration in a Murine Model of Diabetic Retinopathy</title><secondary-title>Diabetes</secondary-title></titles><periodical><full-title>Diabetes</full-title></periodical><pages>4247-4259</pages><volume>64</volume><issue>12</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.2337/db14-1030</electronic-resource-num><urls><web-urls><url>http://diabetes.diabetesjournals.org/lookup/doi/10.2337/db14-1030</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Persidsky, Yuri</author><author>Fan, Shongshan</author><author>Dykstra, Holly</author><author>Reichenbach, Nancy L</author><author>Rom, Slava</author><author>Ramirez, Servio H</author></authors></contributors><titles><title>Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium</title><secondary-title>Journal of Neuroimmune Pharmacology</secondary-title></titles><periodical><full-title>Journal of Neuroimmune Pharmacology</full-title></periodical><pages>302-308</pages><volume>10</volume><issue>2</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1007/s11481-015-9591-3</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s11481-015-9591-3</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Persidsky, Yuri</author><author>Hill, Jeremy</author><author>Zhang, Ming</author><author>Dykstra, Holly</author><author>Winfield, Malika</author><author>Reichenbach, Nancy L</author><author>Potula, Raghava</author><author>Mukherjee, Abir</author><author>Ramirez, Servio H</author><author>Rom, Slava</author></authors></contributors><titles><title>Dysfunction of brain pericytes in chronic neuroinflammation</title><secondary-title>Journal of Cerebral Blood Flow &amp; Metabolism</secondary-title></titles><periodical><full-title>Journal of Cerebral Blood Flow &amp; Metabolism</full-title></periodical><pages>0271678X15606149</pages><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1177/0271678X15606149</electronic-resource-num><urls><web-urls><url>http://jcb.sagepub.com/lookup/doi/10.1177/0271678X15606149</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Li, Fu Jun</author><author>Duggal, Ryan N</author><author>Oliva, Octavio M</author><author>Karki, Suman</author><author>Surolia, Ranu</author><author>Wang, Zheng</author><author>Watson, R Douglas</author><author>Thannickal, Victor J</author><author>Powell, Mickie</author><author>Watts, Stephen</author><author>Kulkarni, Tejaswini</author><author>Batra, Hitesh</author><author>Bolisetty, Subhashini</author><author>Agarwal, Anupam</author><author>Antony, Veena B</author></authors><secondary-authors><author>Gallyas, Ferenc</author></secondary-authors></contributors><titles><title>Heme Oxygenase-1 Protects Corexit 9500A-Induced Respiratory Epithelial Injury across Species</title><secondary-title>PLOS ONE</secondary-title></titles><periodical><full-title>PLOS ONE</full-title></periodical><pages>e0122275</pages><volume>10</volume><issue>4</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1371/journal.pone.0122275</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0122275</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yang, F</author><author>Zhou, L</author><author>Wang, D</author><author>Wang, Z</author><author>Huang, Q.-Y.</author></authors></contributors><titles><title>Minocycline ameliorates hypoxia-induced blood–brain barrier damage by inhibition of HIF-1α through SIRT-3/PHD-2 degradation pathway</title><secondary-title>Neuroscience</secondary-title></titles><periodical><full-title>Neuroscience</full-title></periodical><pages>250-259</pages><volume>304</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1016/j.neuroscience.2015.07.051</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S030645221500665X</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mirzapoiazova, Tamara</author><author>Lennon, Frances E</author><author>Mambetsariev, Bolot</author><author>Allen, Michael</author><author>Riehm, Jacob</author><author>Poroyko, Valeriy a</author><author>Singleton, Patrick a</author></authors></contributors><titles><title>Extracellular Vesicles from Caveolin-Enriched Microdomains Regulate Hyaluronan-Mediated Sustained Vascular Integrity</title><secondary-title>International Journal of Cell Biology</secondary-title></titles><periodical><full-title>International Journal of Cell Biology</full-title></periodical><pages>1-11</pages><volume>2015</volume><keywords><keyword>10</keyword><keyword>11 pages</keyword><keyword>1155</keyword><keyword>2015</keyword><keyword>481493</keyword><keyword>article id 481493</keyword><keyword>biology</keyword><keyword>dawi publishing corporation</keyword><keyword>doi</keyword><keyword>dx</keyword><keyword>http</keyword><keyword>international journal of cell</keyword><keyword>org</keyword><keyword>volume 2015</keyword></keywords><dates><year>2015</year></dates><electronic-resource-num>10.1155/2015/481493</electronic-resource-num><urls><web-urls><url>http://www.hindawi.com/journals/ijcb/2015/481493/</url></web-urls></urls><label>ECIS Barrier Function</label><abstract>Defects in vascular integrity are an initiating factor in several disease processes. We have previously reported that high molecular weight hyaluronan (HMW-HA), a major glycosaminoglycan in the body, promotes rapid signal transduction in human pulmonary microvascular endothelial cells (HPMVEC) leading to barrier enhancement. In contrast, low molecular weight hyaluronan (LMW-HA), produced in disease states by hyaluronidases and reactive oxygen species (ROS), induces HPMVEC barrier disruption. However, the mechanism(s) of sustained barrier regulation by HA are poorly defined. Our results indicate that long-term (6–24 hours) exposure of HMW-HA induced release of a novel type of extracellular vesicle from HLMVEC called enlargeosomes (characterized by AHNAK expression) while LMW-HA long-term exposure promoted release of exosomes (characterized by CD9, CD63, and CD81 expression). These effects were blocked by inhibiting caveolin-enriched microdomain (CEM) formation. Further, inhibiting enlargeosome release by annexin II siRNA attenuated the sustained barrier enhancing effects of HMW-HA. Finally, exposure of isolated enlargeosomes to HPMVEC monolayers generated barrier enhancement while exosomes led to barrier disruption. Taken together, these results suggest that differential release of extracellular vesicles from CEM modulate the sustained HPMVEC barrier regulation by HMW-HA and LMW-HA. HMW-HA-induced specialized enlargeosomes can be a potential therapeutic strategy for diseases involving impaired vascular integrity.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Men, Wenjin</author><author>Martin, Tracey A</author><author>Ruge, Fiona</author><author>Zhang, Ning</author><author>Du, Peng</author><author>Yang, Yong</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Expression of Claudins in Human Clear Cell Renal Cell Carcinoma</title><secondary-title>Cancer Genomics-Proteomics</secondary-title></titles><periodical><full-title>Cancer Genomics-Proteomics</full-title></periodical><pages>1-8</pages><volume>12</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><publisher>International Institute of Anticancer Research</publisher><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lukic, Sonja</author><author>Wegener, Joachim</author></authors></contributors><titles><title>Impedimetric Monitoring of Cell-Based Assays</title><secondary-title>eLS</secondary-title></titles><periodical><full-title>eLS</full-title></periodical><pages>1-8</pages><keywords/><dates><year>2015</year></dates><isbn>9780470015902</isbn><electronic-resource-num>10.1002/9780470015902.a0025710</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1002/9780470015902.a0025710</url></web-urls></urls><label>ECIS Review</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Orr, Sarah K</author><author>Colas, Romain A</author><author>Dalli, Jesmond</author><author>Chiang, Nan</author><author>Serhan, Charles N</author></authors></contributors><titles><title>Proresolving actions of a new resolvin D1 analog mimetic qualifies as an immunoresolvent</title><secondary-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</secondary-title></titles><periodical><full-title>American Journal of Physiology - Lung Cellular and Molecular Physiology</full-title></periodical><pages>L904-L911</pages><volume>308</volume><issue>9</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1152/ajplung.00370.2014</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/lookup/doi/10.1152/ajplung.00370.2014</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Glasbey, James</author><author>Sanders, Andrew</author><author>Bosanquet, David</author><author>Ruge, Fiona</author><author>Harding, Keith</author><author>Jiang, Wen</author></authors></contributors><titles><title>Expression of Hepatocyte Growth Factor-Like Protein in Human Wound Tissue and Its Biological Functionality in Human Keratinocytes</title><secondary-title>Biomedicines</secondary-title></titles><periodical><full-title>Biomedicines</full-title></periodical><pages>110-123</pages><volume>3</volume><issue>1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3390/biomedicines3010110</electronic-resource-num><urls><web-urls><url>http://www.mdpi.com/2227-9059/3/1/110/</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mayer, Chad L</author><author>Parello, Caitlin S L</author><author>Lee, Benjamin C</author><author>Itagaki, Kiyoshi</author><author>Kurosawa, Shinichiro</author><author>Stearns-Kurosawa, Deborah J</author></authors></contributors><titles><title>Pro-Coagulant Endothelial Dysfunction Results from EHEC Shiga Toxins and Host Damage-Associated Molecular Patterns</title><secondary-title>Frontiers in Immunology</secondary-title></titles><periodical><full-title>Frontiers in Immunology</full-title></periodical><volume>6</volume><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3389/fimmu.2015.00155</electronic-resource-num><urls><web-urls><url>http://journal.frontiersin.org/article/10.3389/fimmu.2015.00155/abstract</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, Caiqing</author><author>Liu, Qingfa</author><author>Dong, Fengyun</author><author>Li, Liqun</author><author>Du, Juan</author><author>Xie, Qi</author><author>Hu, Hesheng</author><author>Yan, Suhua</author><author>Zhou, Xia</author><author>Li, Changsheng</author><author>Lobe, Corrinne</author><author>Liu, Ju</author></authors></contributors><titles><title>Catalpol downregulates vascular endothelial‑cadherin expression and induces vascular hyperpermeability</title><secondary-title>Molecular Medicine Reports</secondary-title></titles><periodical><full-title>Molecular Medicine Reports</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.3892/mmr.2015.4522</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/10.3892/mmr.2015.4522</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xie, Xinwu</author><author>Liu, Ran</author><author>Xu, Youchun</author><author>Wang, Lei</author><author>Lan, Ziyang</author><author>Chen, Weixing</author><author>Liu, Haoran</author><author>Lu, Ying</author><author>Cheng, Jing</author></authors></contributors><titles><title>In-vitro Hyperthermia Studied in a Continuous Manner Using Electric Impedance Sensing</title><secondary-title>RSC Adv.</secondary-title></titles><periodical><full-title>RSC Adv.</full-title></periodical><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1039/C5RA04743A</electronic-resource-num><urls><web-urls><url>http://pubs.rsc.org/en/Content/ArticleLanding/2015/RA/C5RA04743A</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Broux, B</author><author>Mizee, M R</author><author>Vanheusden, M</author><author>van der Pol, S</author><author>van Horssen, J</author><author>Van Wijmeersch, B</author><author>Somers, V</author><author>de Vries, H E</author><author>Stinissen, P</author><author>Hellings, N</author></authors></contributors><titles><title>IL-15 Amplifies the Pathogenic Properties of CD4+CD28- T Cells in Multiple Sclerosis</title><secondary-title>The Journal of Immunology</secondary-title></titles><periodical><full-title>The Journal of Immunology</full-title></periodical><pages>2099-2109</pages><volume>194</volume><issue>5</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.4049/jimmunol.1401547</electronic-resource-num><urls><web-urls><url>http://www.jimmunol.org/cgi/doi/10.4049/jimmunol.1401547</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Konig, U</author><author>Heitzmann, M</author><author>Beckmann, D</author><author>Hillen, J</author><author>Hansen, U</author><author>Saunders, U</author><author>Hartmann, C</author><author>Korb-Pap, A</author><author>Pap, T</author></authors></contributors><titles><title>A6.7 The junctional adhesion molecule JAM-3 regulates the motility of fibroblast-like synoviocytes</title><secondary-title>Annals of the Rheumatic Diseases</secondary-title></titles><periodical><full-title>Annals of the Rheumatic Diseases</full-title></periodical><pages>A58-A58</pages><volume>74</volume><issue>Suppl 1</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1136/annrheumdis-2015-207259.133</electronic-resource-num><urls><web-urls><url>http://ard.bmj.com/cgi/doi/10.1136/annrheumdis-2015-207259.133</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gong, Haixia</author><author>Rehman, Jalees</author><author>Tang, Haiyang</author><author>Wary, Kishore</author><author>Mittal, Manish</author><author>Chatturvedi, Pallavi</author><author>Zhao, Youyang</author><author>Komorova, Yulia A</author><author>Vogel, Stephen M</author><author>Malik, Asrar B</author></authors></contributors><titles><title>HIF2α signaling inhibits adherens junctional disruption in acute lung injury</title><secondary-title>Journal of Clinical Investigation</secondary-title></titles><periodical><full-title>Journal of Clinical Investigation</full-title></periodical><pages>652-664</pages><volume>125</volume><issue>2</issue><keywords/><dates><year>2015</year></dates><electronic-resource-num>10.1172/JCI77701</electronic-resource-num><urls><web-urls><url>http://www.jci.org/articles/view/77701</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Horimoto, Naoya</author><author>Kitamura, Shinji</author><author>Tsuji, Kenji</author><author>Makino, Hirofumi</author></authors></contributors><titles><title>Mizoribine inhibits the proliferation of renal stem/progenitor cells by G1/S arrest during renal regeneration.</title><secondary-title>Acta medica Okayama</secondary-title></titles><periodical><full-title>Acta medica Okayama</full-title></periodical><pages>7-15</pages><volume>68</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Cell Cycle Checkpoints</keyword><keyword>Cell Cycle Checkpoints: drug effects</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Female</keyword><keyword>G1 Phase</keyword><keyword>Immunosuppressive Agents</keyword><keyword>Immunosuppressive Agents: pharmacology</keyword><keyword>Kidney</keyword><keyword>Kidney: cytology</keyword><keyword>Kidney: drug effects</keyword><keyword>Kidney: physiology</keyword><keyword>Rats</keyword><keyword>Regeneration</keyword><keyword>Regeneration: drug effects</keyword><keyword>Ribonucleosides</keyword><keyword>Ribonucleosides: pharmacology</keyword><keyword>S Phase</keyword><keyword>Sprague-Dawley</keyword><keyword>Stem Cells</keyword><keyword>Stem Cells: drug effects</keyword></keywords><dates><year>2014</year></dates><accession-num>24553483</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24553483</url></web-urls></urls><abstract>Immunosuppressive agents are generally administered to treat kidney diseases. However, it is unclear whether renal stem/progenitor cells are directly affected by the immunosuppressive agents. We used normal rat kidney cells, ureteric bud cells and rat kidney stem/progenitor cells in this study. Mizoribine (MZR), cyclophosphamide (CPA) and cyclosporine (CyA) were added to the culture media of these cells. We evaluated the effects of these immunosuppressive agents on cell proliferation using an electrical cell-substrate impedance sensing system (ECIS) and their effects on the process of renal regeneration using the ischemia-reperfusion (I/R) injury rat model. The ECIS data showed that proliferation of each of the 3 types of cells was significantly suppressed by MZR. MZR treatment enhanced renal tubular injury in ischemia-reperfusion (I/R) injured rats, and significantly decreased levels of M-phase cells and Nestin-positive cells. These results suggested that MZR inhibits the cell cycle of renal stem/progenitor cells;thus, physicians should take note that MZR might affect not only inflammation but also renal regeneration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Joshi, Atul D</author><author>Dimitropoulou, Christiana</author><author>Thangjam, Gagan</author><author>Snead, Connie</author><author>Feldman, Sara</author><author>Barabutis, Nektarios</author><author>Fulton, David</author><author>Hou, Yali</author><author>Kumar, Sanjiv</author><author>Patel, Vijay</author><author>Gorshkov, Boris</author><author>Verin, Alexander D</author><author>Black, Stephen M</author><author>Catravas, John D</author></authors></contributors><titles><title>Heat shock protein 90 inhibitors prevent LPS-induced endothelial barrier dysfunction by disrupting RhoA signaling.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>170-179</pages><volume>50</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Benzoquinones</keyword><keyword>Benzoquinones: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelium</keyword><keyword>HSP90 Heat-Shock Proteins</keyword><keyword>HSP90 Heat-Shock Proteins: antagonists &amp; inhibitor</keyword><keyword>HSP90 Heat-Shock Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Lactams</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: adverse effects</keyword><keyword>Macrocyclic</keyword><keyword>Macrocyclic: pharmacology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword><keyword>src-Family Kinases</keyword><keyword>src-Family Kinases: metabolism</keyword></keywords><dates><year>2014</year></dates><accession-num>23972231</accession-num><electronic-resource-num>10.1165/rcmb.2012-0496OC</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23972231</url></web-urls></urls><label>Signal Transduction</label><abstract>Permeability of the endothelial monolayer is increased when exposed to the bacterial endotoxin LPS. Our previous studies have shown that heat shock protein (Hsp) 90 inhibitors protect and restore LPS-mediated hyperpermeability in bovine pulmonary arterial endothelial cells. In this study, we assessed the effect of Hsp90 inhibition against LPS-mediated hyperpermeability in cultured human lung microvascular endothelial cells (HLMVECs) and delineated the underlying molecular mechanisms. We demonstrate that Hsp90 inhibition is critical in the early phase, to prevent LPS-mediated hyperpermeability, and also in the later phase, to restore LPS-mediated hyperpermeability in HLMVECs. Because RhoA is a well known mediator of endothelial hyperpermeability, we investigated the effect of Hsp90 inhibition on LPS-mediated RhoA signaling. RhoA nitration and activity were increased by LPS in HLMVECs and suppressed when pretreated with the Hsp90 inhibitor, 17-allylamino-17 demethoxy-geldanamycin (17-AAG). In addition, inhibition of Rho kinase, a downstream effector of RhoA, protected HLMVECs from LPS-mediated hyperpermeability and abolished LPS-induced myosin light chain (MLC) phosphorylation, a target of Rho kinase. In agreement with these findings, 17-AAG or dominant-negative RhoA attenuated LPS-induced MLC phosphorylation. MLC phosphorylation induced by constitutively active RhoA was also suppressed by 17-AAG, suggesting a role for Hsp90 downstream of RhoA. Inhibition of Src family kinases also suppressed RhoA activity and MLC phosphorylation. Together, these data indicate that Hsp90 inhibition prevents and repairs LPS-induced lung endothelial barrier dysfunction by suppressing Src-mediated RhoA activity and signaling.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gong, Haixia</author><author>Gao, Xiaopei</author><author>Feng, Shaoting</author><author>Siddiqui, M Rizwan</author><author>Garcia, Alexander</author><author>Bonini, Marcelo G</author><author>Komarova, Yulia</author><author>Vogel, Stephen M</author><author>Mehta, Dolly</author><author>Malik, Asrar B</author></authors></contributors><titles><title>Evidence of a common mechanism of disassembly of adherens junctions through Gα13 targeting of VE-cadherin.</title><secondary-title>The Journal of experimental medicine</secondary-title></titles><periodical><full-title>The Journal of experimental medicine</full-title></periodical><pages>579-591</pages><volume>211</volume><issue>3</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Biotinylation</keyword><keyword>Blotting</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endocytosis</keyword><keyword>Endocytosis: physiology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Evans Blue</keyword><keyword>G12-G13</keyword><keyword>G12-G13: deficiency</keyword><keyword>G12-G13: metabolism</keyword><keyword>GTP-Binding Protein alpha Subunits</keyword><keyword>Genes</keyword><keyword>Hydrogen Peroxide</keyword><keyword>Hydrogen Peroxide: metabolism</keyword><keyword>Immunoprecipitation</keyword><keyword>Inflammation</keyword><keyword>Inflammation: metabolism</keyword><keyword>Knockout</keyword><keyword>Mice</keyword><keyword>Permeability</keyword><keyword>Phosphorylation</keyword><keyword>RNA Interference</keyword><keyword>Western</keyword><keyword>src</keyword><keyword>src: genetics</keyword></keywords><dates><year>2014</year></dates><accession-num>24590762</accession-num><electronic-resource-num>10.1084/jem.20131190</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3949568&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Inflammation</label><abstract>The heterotrimeric G protein Gα13 transduces signals from G protein-coupled receptors (GPCRs) to induce cell spreading, differentiation, migration, and cell polarity. Here, we describe a novel GPCR-independent function of Gα13 in regulating the stability of endothelial cell adherens junctions (AJs). We observed that the oxidant H2O2, which is released in response to multiple proinflammatory mediators, induced the interaction of Gα13 with VE-cadherin. Gα13 binding to VE-cadherin in turn induced Src activation and VE-cadherin phosphorylation at Tyr 658, the p120-catenin binding site thought to be responsible for VE-cadherin internalization. Inhibition of Gα13-VE-cadherin interaction using an interfering peptide derived from the Gα13 binding motif on VE-cadherin abrogated the disruption of AJs in response to inflammatory mediators. These studies identify a unique role of Gα13 binding to VE-cadherin in mediating VE-cadherin internalization and endothelial barrier disruption and inflammation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Widder, Mark W</author><author>Brennan, Linda M</author><author>Hanft, Elizabeth A</author><author>Schrock, Mary E</author><author>James, Ryan R</author><author>van der Schalie, William H</author></authors></contributors><titles><title>Evaluation and refinement of a field-portable drinking water toxicity sensor utilizing electric cell-substrate impedance sensing and a fluidic biochip.</title><secondary-title>Journal of applied toxicology : JAT</secondary-title></titles><periodical><full-title>Journal of applied toxicology : JAT</full-title></periodical><pages>701-708</pages><issue>January 2014</issue><keywords><keyword>10.1002/jat.3017 and impedance</keyword><keyword>ECIS</keyword><keyword>RTgill-W1</keyword><keyword>cells</keyword><keyword>ecis</keyword><keyword>fl uidic biochip</keyword><keyword>fluidic biochip</keyword><keyword>impedance</keyword><keyword>in vitro toxicology</keyword><keyword>rainbow trout gill epithelial</keyword><keyword>rainbow trout gill epithelial cells</keyword><keyword>rtgill-w1</keyword><keyword>toxicity sensor</keyword><keyword>water toxicity</keyword></keywords><dates><year>2014</year></dates><accession-num>25231170</accession-num><electronic-resource-num>10.1002/jat.3017</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/25231170</url></web-urls></urls><abstract>The US Army's need for a reliable and field-portable drinking water toxicity sensor was the catalyst for the development and evaluation of an electric cell-substrate impedance sensing (ECIS) device. Water testing technologies currently available to soldiers in the field are analyte-specific and have limited capabilities to detect broad-based water toxicity. The ECIS sensor described here uses rainbow trout gill epithelial cells seeded on fluidic biochips to measure changes in impedance for the detection of possible chemical contamination of drinking water supplies. Chemicals selected for testing were chosen as representatives of a broad spectrum of toxic industrial compounds. Results of a US Environmental Protection Agency (USEPA)-sponsored evaluation of the field portable device were similar to previously published US Army testing results of a laboratory-based version of the same technology. Twelve of the 18 chemicals tested following USEPA Technology Testing and Evaluation Program procedures were detected by the ECIS sensor within 1 h at USEPA-derived human lethal concentrations. To simplify field-testing methods further, elimination of a procedural step that acclimated cells to serum-free media streamlined the test process with only a slight loss of chemical sensitivity. For field use, the ECIS sensor will be used in conjunction with an enzyme-based sensor that is responsive to carbamate and organophosphorus pesticides. Copyright © 2014 John Wiley &amp; Sons, Ltd.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Goncharova, Elena A</author><author>Goncharov, Dmitry A</author><author>James, Melane L</author><author>Atochina-Vasserman, Elena N</author><author>Stepanova, Victoria</author><author>Hong, Seung-Beom</author><author>Li, Hua</author><author>Gonzales, Linda</author><author>Baba, Masaya</author><author>Linehan, W Marston</author><author>Gow, Andrew J</author><author>Margulies, Susan</author><author>Guttentag, Susan</author><author>Schmidt, Laura S</author><author>Krymskaya, Vera P</author></authors></contributors><titles><title>Folliculin controls lung alveolar enlargement and epithelial cell survival through E-cadherin, LKB1, and AMPK.</title><secondary-title>Cell reports</secondary-title></titles><periodical><full-title>Cell reports</full-title></periodical><pages>412-423</pages><volume>7</volume><issue>2</issue><keywords/><dates><year>2014</year></dates><accession-num>24726356</accession-num><electronic-resource-num>10.1016/j.celrep.2014.03.025</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4034569&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Spontaneous pneumothoraces due to lung cyst rupture afflict patients with the rare disease Birt-Hogg-Dubé (BHD) syndrome, which is caused by mutations of the tumor suppressor gene folliculin (FLCN). The underlying mechanism of the lung manifestations in BHD is unclear. We show that BHD lungs exhibit increased alveolar epithelial cell apoptosis and that Flcn deletion in mouse lung epithelium leads to cell apoptosis, alveolar enlargement, and an impairment of both epithelial barrier and overall lung function. We find that Flcn-null epithelial cell apoptosis is the result of impaired AMPK activation and increased cleaved caspase-3. AMPK activator LKB1 and E-cadherin are downregulated by Flcn loss and restored by its expression. Correspondingly, Flcn-null cell survival is rescued by the AMPK activator AICAR or constitutively active AMPK. AICAR also improves lung condition of Flcn(f/f):SP-C-Cre mice. Our data suggest that lung cysts in BHD may result from an underlying defect in alveolar epithelial cell survival, attributable to FLCN regulation of the E-cadherin-LKB1-AMPK axis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wazir, Umar</author><author>Sanders, Andrew J</author><author>Wazir, Ali</author><author>Baig, Ruqia Mehmood</author><author>Jiang, Wen G</author><author>Ster, Irina C</author><author>Sharma, Anup K</author><author>Mokbel, Kefah</author></authors></contributors><titles><title>Effect of the knockdown of death-associated protein 1 expression on cell adhesion, growth and migration in breast cancer cells.</title><secondary-title>Oncology reports</secondary-title></titles><periodical><full-title>Oncology reports</full-title></periodical><keywords/><dates><year>2014</year></dates><accession-num>25530065</accession-num><electronic-resource-num>10.3892/or.2014.3686</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/25530065</url></web-urls></urls><abstract>Death-associated protein 1 (DAP1) is a highly conserved phosphoprotein involved in the regulation of autophagy. A previous clinical study by our group suggested an association between low DAP1 expression and clinicopathological parameters of human breast cancer. In the present study, we aimed to determine the role of DAP1 in cancer cell behaviour in the context of human breast cancer. We developed knockdown sublines of MCF7 and MDA-MB‑231, and performed growth, adhesion and invasion assays and electric cell-substrate impedance sensing (ECIS) studies of the post-wound migration of cells. In addition, we studied the mRNA expression of caspase 8 and 9, DELE, IPS1, cyclin D1 and p21 in the control and knockdown sublines. Knockdown was associated with increased adhesion and migration, significantly so in the MDA-MB-231DAP1kd cell subline (p=0.029 and p=0.001, respectively). Growth in MCF7 cells showed a significant suppression on day 3 (p=0.029), followed by an increase in growth matching the controls on day 5. While no change in the apoptotic response to serum starvation could be attributed to DAP1 knockdown, the expression of known components of the apoptosis pathway (caspase 8) and cell cycle (p21) was significantly reduced in the MCF7DAP1kd cell subline (p≤0.05), while in MDA-MB-231DAP1kd the expression of a pro-apoptotic molecule, IPS1, was suppressed (p≤0.05). DAP1 may have an important role in cell adhesion, migration and growth in the context of breast cancer and has significant associations with the apoptosis pathway. Furthermore, we believe that delayed increase in growth observed in the MCF7DAP1kd cell subline may indicate activation of a strongly pro-oncogenic pathway downstream of DAP1.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhuge, Yan</author><author>Yuan, Yang</author><author>van Breemen, Richard</author><author>Degrand, Michael</author><author>Holian, Oksana</author><author>Yoder, Mark</author><author>Lum, Hazel</author></authors></contributors><titles><title>Stimulated bronchial epithelial cells release bioactive lysophosphatidylcholine 16:0, 18:0, and 18:1.</title><secondary-title>Allergy, asthma &amp; immunology research</secondary-title></titles><periodical><full-title>Allergy, asthma &amp; immunology research</full-title></periodical><pages>66-74</pages><volume>6</volume><issue>1</issue><keywords/><dates><year>2014</year></dates><accession-num>24404396</accession-num><electronic-resource-num>10.4168/aair.2014.6.1.66</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3881404&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>PURPOSE: In human subjects and animal models with acute and chronic lung injury, the bioactive lysophosphatidylcholine (LPC) is elevated in lung lining fluids. The increased LPC can promote an inflammatory microenvironment resulting in lung injury. Furthermore, pathological lung conditions are associated with upregulated phospholipase A2 (PLA2), the predominant enzyme producing LPC in tissues by hydrolysis of phosphatidylcholine. However, the lung cell populations responsible for increases of LPC have yet to be systematically characterized. The goal was to investigate the LPC generation by bronchial epithelial cells in response to pathological mediators and determine the major LPC species produced. METHODS: Primary human bronchial epithelial cells (NHBE) were challenged by vascular endothelial growth factor (VEGF) for 1 or 6 h, and condition medium and cells collected for quantification of predominant LPC species by high performance liquid chromatography-tandem mass spectrometry (LC-MS-MS). The cells were analyzed by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR) for PLA2. The direct effects of LPC in inducing inflammatory activities on NHBE were assessed by transepithelial resistance as well as expression of interleukin-8 (IL-8) and matrix metalloproteinase-1 (MMP-1). RESULTS: VEGF stimulation of NHBE for 1 or 6 h, significantly increased concentrations of LPC16:0, LPC18:0, and LPC18:1 in condition medium compared to control. The sPLA2-selective inhibitor (oleyloxyethyl phosphorylcholine) inhibited the VEGF-induced release of LPC16:0 and LPC18:1 and PLA2 activity. In contrast, NHBE stimulated with TNF did not induce LPC release. VEGF did not increase mRNA of PLA2 subtypes sPLA2-X, sPLA2-XIIa, cPLA2-IVa, and iPLA2-VI. Exogenous LPC treatment increased expression of IL-8 and MMP-1, and reduced the transepithelial resistance in NHBE. CONCLUSIONS: Our findings indicate that VEGF-stimulated bronchial epithelial cells are a key source of extracellular LPCs, which can function as an autocrine mediator with potential to induce airway epithelial inflammatory injury.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Itokazu, Yutaka</author><author>Pagano, Richard E</author><author>Schroeder, Andreas S</author><author>O'Grady, Scott M</author><author>Limper, Andrew H</author><author>Marks, David L</author></authors></contributors><titles><title>Reduced GM1 ganglioside in CFTR-deficient human airway cells results in decreased β1-integrin signaling and delayed wound repair.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C819-30</pages><volume>306</volume><issue>9</issue><keywords><keyword>Antigens</keyword><keyword>CD29</keyword><keyword>CD29: metabolism</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Crk-Associated Substrate Protein</keyword><keyword>Crk-Associated Substrate Protein: metabolism</keyword><keyword>Cystic Fibrosis</keyword><keyword>Cystic Fibrosis Transmembrane Conductance Regulato</keyword><keyword>Cystic Fibrosis: genetics</keyword><keyword>Cystic Fibrosis: metabolism</keyword><keyword>Cystic Fibrosis: pathology</keyword><keyword>Down-Regulation</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Epithelial Cells: pathology</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Kinase 1: metabolism</keyword><keyword>G(M1) Ganglioside</keyword><keyword>G(M1) Ganglioside: metabolism</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: metabolism</keyword><keyword>Lung: pathology</keyword><keyword>Phosphorylation</keyword><keyword>RNA Interference</keyword><keyword>Time Factors</keyword><keyword>Transfection</keyword><keyword>Tyrosine</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2014</year></dates><accession-num>24500283</accession-num><electronic-resource-num>10.1152/ajpcell.00168.2013</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24500283</url></web-urls></urls><label>Wound Healing</label><abstract>Loss of cystic fibrosis transmembrane conductance regulator (CFTR) function reduces chloride secretion and increases sodium uptake, but it is not clear why CFTR mutation also results in progressive lung inflammation and infection. We previously demonstrated that CFTR-silenced airway cells migrate more slowly during wound repair than CFTR-expressing controls. In addition, CFTR-deficient cells and mouse models have been reported to have altered sphingolipid levels. Here, we investigated the hypothesis that reduced migration in CFTR-deficient airway epithelial cells results from altered sphingolipid composition. We used cell lines derived from a human airway epithelial cell line (Calu-3) stably transfected with CFTR short hairpin RNA (CFTR-silenced) or nontargeting short hairpin RNA (controls). Cell migration was measured by electric cell substrate impedance sensing (ECIS). Lipid analyses, addition of exogenous glycosphingolipids, and immunoblotting were performed. We found that levels of the glycosphingolipid, GM1 ganglioside, were ~60% lower in CFTR-silenced cells than in controls. CFTR-silenced cells exhibited reduced levels of activated β1-integrin, phosphorylated tyrosine 576 of focal adhesion kinase (pFAK), and phosphorylation of Crk-associated substrate (pCAS). Addition of GM1 (but not GM3) ganglioside to CFTR-silenced cells restored activated β1-integrin, pFAK, and pCAS to near control levels and partially restored (~40%) cell migration. Our results suggest that decreased GM1 in CFTR-silenced cells depresses β1-integrin signaling, which contributes to the delayed wound repair observed in these cells. These findings have implications for the pathology of cystic fibrosis, where altered sphingolipid levels in airway epithelial cells could result in a diminished capacity for wound repair after injury.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Das, Debanjan</author><author>Kamil, Farhan Ahmad</author><author>Agrawal, Snehil</author><author>Biswas, Karabi</author><author>Das, Soumen</author></authors></contributors><titles><title>Fragmental Frequency Analysis Method to Estimate Electrical Cell Parameters From Bioimpedance Study</title><secondary-title>IEEE Transactions on Instrumentation and Measurement</secondary-title></titles><periodical><full-title>IEEE Transactions on Instrumentation and Measurement</full-title></periodical><pages>1991-2000</pages><volume>63</volume><issue>8</issue><keywords/><dates><year>2014</year></dates><electronic-resource-num>10.1109/TIM.2014.2303553</electronic-resource-num><urls><web-urls><url>http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=6739131</url></web-urls></urls><abstract>This paper introduces an alternate approach utilizing the fragmental frequency analysis method for analyzing bioimpedance data to estimate electrical cell parameters. Impedance of cervical cancer cells (HeLa) in phosphate buffer saline media is measured using an electric cell-substrate impedance sensing (ECIS) device and impedance analyzer. The measured impedance data were visualized by modeling an equivalent electrical circuit of the system considering the dominancy of individual parameters of the ECIS system and analyzed in different frequency zones. The present approach eliminates the convergence inaccuracy in fitting the experimental impedance data with fitting software arising due to invalid initial conditions, and a large number of data points. This method provides high-frequency characterization, modeling of ECIS system, knowledge of effect of ECIS model parameters with frequency, and an alternate way to calculate model parameters.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hussein, Khaled A</author><author>Choksi, Karishma</author><author>Akeel, Sara</author><author>Ahmad, Saif</author><author>Megyerdi, Sylvia</author><author>El-Sherbiny, Mohamed</author><author>Nawaz, Mohamed</author><author>Abu El-Asrar, Ahmed</author><author>Al-Shabrawey, Mohamed</author></authors></contributors><titles><title>Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy.</title><secondary-title>Experimental eye research</secondary-title></titles><periodical><full-title>Experimental eye research</full-title></periodical><pages>79-88</pages><volume>125</volume><keywords><keyword>Analysis of Variance</keyword><keyword>Animals</keyword><keyword>Bone Morphogenetic Protein 2</keyword><keyword>Bone Morphogenetic Protein 2: metabolism</keyword><keyword>Bone Morphogenetic Protein 2: physiology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytokines</keyword><keyword>Cytokines: metabolism</keyword><keyword>Diabetes Mellitus</keyword><keyword>Diabetic Retinopathy</keyword><keyword>Diabetic Retinopathy: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Ependymoglial Cells</keyword><keyword>Ependymoglial Cells: drug effects</keyword><keyword>Ependymoglial Cells: metabolism</keyword><keyword>Experimental</keyword><keyword>Experimental: etiology</keyword><keyword>Experimental: metabolism</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Rats</keyword><keyword>Retina</keyword><keyword>Retina: cytology</keyword><keyword>Retina: metabolism</keyword><keyword>Up-Regulation</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: metabolism</keyword><keyword>Vitreous Body</keyword><keyword>Vitreous Body: metabolism</keyword></keywords><dates><year>2014</year></dates><accession-num>24910902</accession-num><electronic-resource-num>10.1016/j.exer.2014.05.012</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24910902</url></web-urls></urls><abstract>Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus. Vision loss in DR principally occurs due to breakdown of the blood-retinal barrier (BRB), leading to macular edema, retinal detachment and inner retinal and vitreous hemorrhage. Several growth factors have been shown to play crucial role in the development of these vascular changes; however, the cellular and molecular mechanisms of DR are not yet fully revealed. In the current study we investigated the role of bone morphogenetic protein-2 (BMP2) in DR. We examined the changes in the protein levels of BMP2 in human vitreous and retina in addition to the mouse retina of streptozotocin-induced diabetes. To detect the source of BMP2 during diabetes, human retinal endothelial cells (hRECs) were subjected to high glucose (HG) for 5 days and levels of BMP2 protein were analyzed in conditioned media of these cells relative to control. We also evaluated the effect of BMP2 on the levels of VEGF in cultured rat Müller cells (rMC1). In addition, we tested the pro-inflammatory effects of BMP2 by examining its effect on leukocyte adhesion to cultured hRECs, and levels of adhesion molecules and cytokines production. Finally, the effect of different concentrations of BMP2 on permeability of confluent monolayer of hRECs was evaluated using FITC-Dextran flux permeability assay and by measuring Transcellular Electrical Resistance (TER) using Electric Cell-substrate Impedance Sensing (ECIS). Our results show, for the first time, the up-regulation of BMP2 in diabetic human and mouse retinas in addition to its detection in vitreous of patients with proliferative DR (72 ± 7 pg/ml). In vitro, hRECs showed upregulation of BMP2 in HG conditions suggesting that these cells are a potential source of BMP2 in diabetic conditions. Furthermore, BMP2 induced VEGF secretion by Müller cells in-vitro; and showed a dose response in increasing permeability of cultured hRECs. Meanwhile, BMP2 pro-inflammatory effects were recognized by its ability to induce leukocyte adhesion to the hRECs, intercellular adhesion molecule-1 (ICAM-1) and upregulation of interleukin-6 and 8 (IL-6 and IL-8). These results show that BMP2 could be a contributing growth factor to the development of microvascular dysfunction during DR via enhancing both pro-angiogenic and inflammatory pathways. Our findings suggest BMP2 as a potential therapeutic target to prevent/treat DR.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ma, J</author><author>Wan, J</author><author>Meng, J</author><author>Banerjee, S</author><author>Ramakrishnan, S</author><author>Roy, S</author></authors></contributors><titles><title>Methamphetamine induces autophagy as a pro-survival response against apoptotic endothelial cell death through the Kappa opioid receptor.</title><secondary-title>Cell death &amp; disease</secondary-title></titles><periodical><full-title>Cell death &amp; disease</full-title></periodical><pages>e1099</pages><volume>5</volume><keywords><keyword>abbreviations</keyword><keyword>autophagy</keyword><keyword>bbb</keyword><keyword>blood</keyword><keyword>brain barrier</keyword><keyword>cell death</keyword><keyword>central nervous system</keyword><keyword>chain 3</keyword><keyword>cns</keyword><keyword>kappa opioid receptor</keyword><keyword>lc3</keyword><keyword>lc3-ii</keyword><keyword>methamphetamine</keyword><keyword>microtubule-associated protein 1</keyword><keyword>microtubule-associated protein 1 light</keyword></keywords><dates><year>2014</year></dates><accession-num>24603327</accession-num><electronic-resource-num>10.1038/cddis.2014.64</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3973232&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier</label><abstract>Methamphetamine (METH) is a psychostimulant with high abuse potential and severe neurotoxicity. Recent studies in animal models have indicated that METH can impair the blood-brain barrier (BBB), suggesting that some of the neurotoxic effects resulting from METH abuse could be due to barrier disruption. We report here that while chronic exposure to METH disrupts barrier function of primary human brain microvascular endothelial cells (HBMECs) and human umbilical vein endothelial cells (HUVECs), an early pro-survival response is observed following acute exposure by induction of autophagic mechanisms. Acute METH exposure induces an early increase in Beclin1 and LC3 recruitment. This is mediated through inactivation of the protein kinase B (Akt)/mammalian target of rapamycin (mTOR)/p70S6K pathway, and upregulation of the ERK1/2. Blockade of Kappa opioid receptor (KOR), and treatment with autophagic inhibitors accelerated METH-induced apoptosis, suggesting that the early autophagic response is a survival mechanism for endothelial cells and is mediated through the kappa opioid receptor. Our studies indicate that kappa opioid receptor can be therapeutically exploited for attenuating METH-induced BBB dysfunction.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Susloparova, A</author><author>Koppenhöfer, D</author><author>Law, J K Y</author><author>Vu, X T</author><author>Ingebrandt, S</author></authors></contributors><titles><title>Electrical cell-substrate impedance sensing with field-effect transistors is able to unravel cellular adhesion and detachment processes on a single cell level.</title><secondary-title>Lab on a chip</secondary-title></titles><periodical><full-title>Lab on a chip</full-title></periodical><keywords/><dates><year>2014</year></dates><accession-num>25412224</accession-num><electronic-resource-num>10.1039/c4lc00593g</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/25412224</url></web-urls></urls><abstract>We introduce a novel technique of impedimetric sensing of cellular adhesion, which might have the potential to supplement the well-known technique of Electrical Cell-substrate Impedance Sensing (ECIS) in cell culture assays. In contrast to the already commercialized ECIS method, we are using ion-sensitive field-effect transistor (ISFET) devices. The standard gold microelectrode size in ECIS is in the range of 100-250 μm in diameter. Reason for this limitation is that when downscaling the sensing electrodes, their effective impedance governed by the metal-liquid interface impedance is becoming very large and hence the currents to be measured are becoming very small reaching the limit of standard instrumentation. This is the main reason why typical assays with ECIS are focusing on applications like cell-cell junctions in confluent cultures. Single cell resolution is barely reachable with these systems. Here we use impedance spectroscopy with ISFET devices having gate dimensions of only 16 × 2 μm(2), which is enabling a real single cell resolution. We introduce an electrically equivalent circuit model, explain the measured effects upon single cell detachment, and present different cellular detachment scenarios. Our approach might supplement the field of ECIS with an alternative tool opening up a route for novel cell-substrate impedance sensing assays with so far unreachable lateral resolution.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hamers, Anouk A J</author><author>Uleman, Sven</author><author>van Tiel, Claudia M</author><author>Kruijswijk, Daniëlle</author><author>van Stalborch, Anne-Marieke</author><author>Huveneers, Stephan</author><author>de Vries, Carlie J M</author><author>van 't Veer, Cornelis</author></authors></contributors><titles><title>Limited role of nuclear receptor Nur77 in Escherichia coli-induced peritonitis.</title><secondary-title>Infection and immunity</secondary-title></titles><periodical><full-title>Infection and immunity</full-title></periodical><pages>253-264</pages><volume>82</volume><issue>1</issue><keywords><keyword>Animal</keyword><keyword>Animals</keyword><keyword>Bacterial Load</keyword><keyword>Cytokines</keyword><keyword>Cytokines: metabolism</keyword><keyword>Disease Models</keyword><keyword>Escherichia coli Infections</keyword><keyword>Escherichia coli Infections: metabolism</keyword><keyword>Escherichia coli Infections: pathology</keyword><keyword>Group A</keyword><keyword>Inbred C57BL</keyword><keyword>Liver</keyword><keyword>Liver: cytology</keyword><keyword>Liver: microbiology</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Lung: microbiology</keyword><keyword>Macrophages</keyword><keyword>Macrophages: cytology</keyword><keyword>Member 1</keyword><keyword>Member 1: deficiency</keyword><keyword>Member 1: physiology</keyword><keyword>Mice</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: cytology</keyword><keyword>Nuclear Receptor Subfamily 4</keyword><keyword>Periodontitis</keyword><keyword>Periodontitis: metabolism</keyword><keyword>Periodontitis: microbiology</keyword><keyword>Periodontitis: pathology</keyword><keyword>Peritoneal Cavity</keyword><keyword>Peritoneal Cavity: microbiology</keyword><keyword>Transgenic</keyword></keywords><dates><year>2014</year></dates><accession-num>24166953</accession-num><electronic-resource-num>10.1128/IAI.00721-13</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3911847&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Nuclear receptor Nur77 (NR4A1, TR3, or NGFI-B) has been shown to play an anti-inflammatory role in macrophages, which have a crucial function in defense against peritonitis. The function of Nur77 in Escherichia coli-induced peritoneal sepsis has not yet been investigated. Wild-type and Nur77-knockout mice were inoculated with E. coli, and bacterial outgrowth, cell recruitment, cytokine profiles, and tissue damage were investigated. We found only a minor transient decrease in bacterial loads in lung and liver of Nur77-knockout compared to wild-type mice at 14 h postinfection, yet no changes were found in the peritoneal lavage fluid or blood. No differences in inflammatory cytokine levels or neutrophil/macrophage numbers were observed, and bacterial loads were equal in wild-type and Nur77-knockout mice at 20 h postinfection in all body compartments tested. Also, isolated peritoneal macrophages did not show any differences in cytokine expression patterns in response to E. coli. In endothelial cells, Nur77 strongly downregulated both protein and mRNA expression of claudin-5, VE-cadherin, occludin, ZO-1, and β-catenin, and accordingly, these genes were upregulated in lungs of Nur77-deficient mice. Functional permeability tests pointed toward a strong role for Nur77 in endothelial barrier function. Indeed, tissue damage in E. coli-induced peritonitis was notably modulated by Nur77; liver necrosis and plasma aspartate aminotransferase (ASAT)/alanine aminotransferase (ALAT) levels were lower in Nur77-knockout mice. These data suggest that Nur77 does not play a role in the host response to E. coli in the peritoneal and blood compartments. However, Nur77 does modulate bacterial influx into the organs via increased vascular permeability, thereby aggravating distant organ damage.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hudson, Natalie</author><author>Powner, Michael B</author><author>Sarker, Mosharraf H</author><author>Burgoyne, Thomas</author><author>Campbell, Matthew</author><author>Ockrim, Zoe K</author><author>Martinelli, Roberta</author><author>Futter, Clare E</author><author>Grant, Maria B</author><author>Fraser, Paul A</author><author>Shima, David T</author><author>Greenwood, John</author><author>Turowski, Patric</author></authors></contributors><titles><title>Differential apicobasal VEGF signaling at vascular blood-neural barriers.</title><secondary-title>Developmental cell</secondary-title></titles><periodical><full-title>Developmental cell</full-title></periodical><pages>541-552</pages><volume>30</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: physiology</keyword><keyword>Endothelium</keyword><keyword>Inbred C57BL</keyword><keyword>Inbred Lew</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Microcirculation</keyword><keyword>Neurons</keyword><keyword>Neurons: metabolism</keyword><keyword>Permeability</keyword><keyword>Rats</keyword><keyword>Signal Transduction</keyword><keyword>Vascular</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: metabolism</keyword><keyword>Vascular Endothelial Growth Factor Receptor-1</keyword><keyword>Vascular Endothelial Growth Factor Receptor-1: met</keyword><keyword>Vascular Endothelial Growth Factor Receptor-2</keyword><keyword>Vascular Endothelial Growth Factor Receptor-2: met</keyword><keyword>Vascular: metabolism</keyword><keyword>Wistar</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>p38 Mitogen-Activated Protein Kinases: metabolism</keyword></keywords><dates><year>2014</year></dates><accession-num>25175707</accession-num><electronic-resource-num>10.1016/j.devcel.2014.06.027</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4160345&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier;Signal Transduction</label><abstract>The vascular endothelium operates in a highly polarized environment, but to date there has been little exploration of apicobasal polarization of its signaling. We show that VEGF-A, histamine, IGFBP3, and LPA trigger unequal endothelial responses when acting from the circulation or the parenchymal side at blood-neural barriers. For VEGF-A, highly polarized receptor distribution contributed to distinct signaling patterns: VEGFR2, which was found to be predominantly abluminal, mediated increased permeability via p38; in contrast, luminal VEGFR1 led to Akt activation and facilitated cytoprotection. Importantly, such differential apicobasal signaling and VEGFR distribution were found in the microvasculature of brain and retina but not lung, indicating that endothelial cells at blood-neural barriers possess specialized signaling compartments that assign different functions depending on whether an agonist is tissue or blood borne.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sasi, Walid</author><author>Ye, Lin</author><author>Jiang, Wen G</author><author>Sharma, Anup K</author><author>Mokbel, Kefah</author></authors></contributors><titles><title>In vitro and in vivo effects of suppressor of cytokine signalling 7 knockdown in breast cancer: the influence on cellular response to hepatocyte growth factor.</title><secondary-title>BioMed research international</secondary-title></titles><periodical><full-title>BioMed research international</full-title></periodical><pages>648040</pages><volume>2014</volume><keywords/><dates><year>2014</year></dates><accession-num>25162020</accession-num><electronic-resource-num>10.1155/2014/648040</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4137630&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>PURPOSE: Suppressor of cytokine signaling 7 (SOCS7) is a member of the SOCS family and is known to interact with phospholipase Cγ-1 (PLCγ-1), a key downstream mediator of the hepatocyte growth factor (HGF)/C-MET axis. Here, we report our observations of the effect of knocking down SOCS7 gene on the behaviour of breast cancer cells both in vitro and in vivo and to elucidate whether this involves HGF/C-MET pathway using the PLCγ-1 blocker U73122. METHODS: MCF7 and MDA-MB-231 breast cancer cells were transfected with anti-SOCS7 ribozymal transgene, to create sublines with SOCS7 knockdown. The in vitro growth and migration of the cells were evaluated in basic conditions and with HGF and U73122 treatment using growth assays, scratch-wound, and electrical cell impedance sensing (ECIS) migration assays. MCF7 and MDA-MB-231 in vivo tumour xenograft growth were also studied. RESULTS: Basal in vitro growth and migration of both cellular lines and the in vivo MCF7 xenograft growth were significantly enhanced with SOCS7 knockdown. In vitro HGF treatment has further influenced the growth and migration when SOCS7 gene was knocked-down in both cellular lines (P &lt; 0.05). PLCγ-1 pharmacological inhibition of the HGF/C-MET cascade during their in vitro growth and migration seemed to only occur when SOCS7 gene was knocked down. CONCLUSIONS: We report a unique regulatory role for SOCS7 in controlling the malignant behaviour of breast cancer lines MCF7 and MDA-MB-231 in vitro and the MCF7 tumour xenografts in vivo. We also report a regulatory role for SOCS7 during the in vitro HGF-induced growth and migration in these cells as HGF treatment and SOCS7 loss have synergistically enhanced these functions. This SOCS7 knockdown-attributed effect could be due to a precise anti-PLCγ-1 role.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Conference Proceedings">3</ref-type><contributors><authors><author>Lai, Yi-Ting</author><author>Lo, Chun-Min</author></authors></contributors><titles><title>Assessing in vitro cytotoxicity of cell micromotion by Hilbert-Huang Transform</title><secondary-title>2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society</secondary-title></titles><periodical><full-title>2014 36th Annual International Conference of the IEEE Engineering in Medicine and Biology Society</full-title></periodical><pages>3200-3203</pages><keywords/><dates><year>2014</year></dates><publisher>IEEE</publisher><isbn>978-1-4244-7929-0</isbn><electronic-resource-num>10.1109/EMBC.2014.6944303</electronic-resource-num><urls><web-urls><url>http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=6944303</url></web-urls></urls><abstract>Electric cell-substrate impedance sensing (ECIS) is a powerful instrument for quantifying cell behavior in tissue culture. As cells attach and spread on the sensing electrode, they restrict the current flow and hence cause the increase of electrical impedance. Furthermore, cell motion may reveal itself as electrical fluctuations, which are always associated with living cells and continue even when the cells become fully confluent. The impedance fluctuation is attributed to incessant changes in the size of the cell-substrate space as cells persistently rearrange their cell-substrate adhesion sites. The magnitude of this sort of vertical motion detected by ECIS is of the order of nanometers and referred to as micromotion. In this study, Hilbert-Huang Transform was used as a micromotion analysis tool to distinguish the in vitro cytotoxicity of human umbilical vein endothelial cells (HUVECs) exposed to low levels of cytochalasin B. Hilbert-Huang Transform consists of two procedures: the empirical mode decomposition (EMD) and the Hilbert Transform. The measured impedance fluctuations due to cell micromotion were decomposed into several intrinsic mode functions (IMFs) by EMD, and then these IMFs were transferred to instantaneous frequencies by Hilbert Transform. Both amplitude and phase of instantaneous frequencies were expressed as a time-frequency spectrum, called Hilbert spectrum, which displayed different distribution pattern in response to different cytochalasin B concentration. The total instantaneous energy (IE) of each IMF was also calculated to quantify the spectral difference. In addition to the observation of a dose-dependent relationship, the IE value of the first IMF at 0.1 μM decreased to about 48% of the control value and significantly distinguished the cytotoxic effect of 0.1 μM of cytochalasin B (P&lt;;0.05).</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sumpio, Brandon Bauer Brandon Bauer</author><author>Chitragari, Gautham</author><author>Moriguchi, Takeshi</author><author>Shalaby, Sherif</author><author>Pappas-Brown, Valeria</author><author>Khan, Asif</author><author>Sekaran, Shamala</author><author>Sumpio, Brandon Bauer Brandon Bauer</author><author>Grab, Dennis</author></authors></contributors><titles><title>African Trypanosome-Induced Blood–Brain Barrier Dysfunction under Shear Stress May Not Require ERK Activation</title><secondary-title>International Journal of Angiology</secondary-title></titles><periodical><full-title>International Journal of Angiology</full-title></periodical><keywords><keyword>African trypanosomes - blood–brain barrier - brain</keyword></keywords><dates><year>2014</year></dates><electronic-resource-num>10.1055/s-0034-1370890</electronic-resource-num><urls><web-urls><url>http://www.thieme-connect.de/DOI/DOI?10.1055/s-0034-1370890</url></web-urls></urls><abstract>African trypanosomes are tsetse fly transmitted protozoan parasites responsible for human African trypanosomiasis, a disease characterized by a plethora of neurological symptoms and death. How the parasites under microvascular shear stress (SS) flow conditions in the brain cross the blood–brain barrier (BBB) is not known. In vitro studies using static models comprised of human brain microvascular endothelial cells (BMEC) show that BBB activation and crossing by trypanosomes requires the orchestration of parasite cysteine proteases and host calcium-mediated cell signaling. Here, we examine BMEC barrier function and the activation of extracellular signal-regulated kinase (ERK)1/2 and ERK5, mitogen-activated protein kinase family regulators of microvascular permeability, under static and laminar SS flow and in the context of trypanosome infection. Confluent human BMEC were cultured in electric cell-substrate impedance sensing (ECIS) and parallel-plate glass slide chambers. The human BMEC were exposed to 2 or 14 dyn/cm2 SS in the presence or absence of trypanosomes. Real-time changes in transendothelial electrical resistance (TEER) were monitored and phosphorylation of ERK1/2 and ERK5 analyzed by immunoblot assay. After reaching confluence under static conditions human BMEC TEER was found to rapidly increase when exposed to 2 dyn/cm2 SS, a condition that mimics SS in brain postcapillary venules. Addition of African trypanosomes caused a rapid drop in human BMEC TEER. Increasing SS to 14 dyn/cm2, a condition mimicking SS in brain capillaries, led to a transient increase in TEER in both control and infected human BMEC. However, no differences in ERK1/2 and ERK5 activation were found under any condition tested. African trypanosomiasis alters BBB permeability under low shear conditions through an ERK1/2 and ERK5 independent pathway.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Banki, Eszter</author><author>Sosnowska, Danuta</author><author>Tucsek, Zsuzsanna</author><author>Gautam, Tripti</author><author>Toth, Peter</author><author>Tarantini, Stefano</author><author>Tamas, Andrea</author><author>Helyes, Zsuzsanna</author><author>Reglodi, Dora</author><author>Sonntag, William E</author><author>Csiszar, Anna</author><author>Ungvari, Zoltan</author></authors></contributors><titles><title>Age-Related Decline of Autocrine Pituitary Adenylate Cyclase-Activating Polypeptide Impairs Angiogenic Capacity of Rat Cerebromicrovascular Endothelial Cells.</title><secondary-title>The journals of gerontology. Series A, Biological sciences and medical sciences</secondary-title></titles><periodical><full-title>The journals of gerontology. Series A, Biological sciences and medical sciences</full-title></periodical><pages>665-674</pages><volume>70</volume><issue>6</issue><keywords/><dates><year>2014</year></dates><accession-num>25136000</accession-num><electronic-resource-num>10.1093/gerona/glu116</electronic-resource-num><urls><web-urls><url>http://biomedgerontology.oxfordjournals.org/lookup/doi/10.1093/gerona/glu116</url><url>http://www.ncbi.nlm.nih.gov/pubmed/25136000</url></web-urls></urls><abstract>Aging impairs angiogenic capacity of cerebromicrovascular endothelial cells (CMVECs) promoting microvascular rarefaction, but the underlying mechanisms remain elusive. PACAP is an evolutionarily conserved neuropeptide secreted by endothelial cells and neurons, which confers important antiaging effects. To test the hypothesis that age-related changes in autocrine PACAP signaling contributes to dysregulation of endothelial angiogenic capacity, primary CMVECs were isolated from 3-month-old (young) and 24-month-old (aged) Fischer 344 x Brown Norway rats. In aged CMVECs, expression of PACAP was decreased, which was associated with impaired capacity to form capillary-like structures, impaired adhesiveness to collagen (assessed using electric cell-substrate impedance sensing [ECIS] technology), and increased apoptosis (caspase3 activity) when compared with young cells. Overexpression of PACAP in aged CMVECs resulted in increased formation of capillary-like structures, whereas it did not affect cell adhesion. Treatment with recombinant PACAP also significantly increased endothelial tube formation and inhibited apoptosis in aged CMVECs. In young CMVECs shRNA knockdown of autocrine PACAP expression significantly impaired tube formation capacity, mimicking the aging phenotype. Cellular and mitochondrial reactive oxygen species production (dihydroethidium and MitoSox fluorescence, respectively) were increased in aged CMVECs and were unaffected by PACAP. Collectively, PACAP exerts proangiogenic effects and age-related dysregulation of autocrine PACAP signaling may contribute to impaired angiogenic capacity of CMVECs in aging.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wang, Haibo</author><author>Jiang, Yanchao</author><author>Shi, Dallas</author><author>Quilliam, Lawrence A</author><author>Chrzanowska-Wodnicka, Magdalena</author><author>Wittchen, Erika S</author><author>Li, Dean Y</author><author>Hartnett, M Elizabeth</author></authors></contributors><titles><title>Activation of Rap1 inhibits NADPH oxidase-dependent ROS generation in retinal pigment epithelium and reduces choroidal neovascularization.</title><secondary-title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</secondary-title></titles><periodical><full-title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</full-title></periodical><pages>265-274</pages><volume>28</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Choroidal Neovascularization</keyword><keyword>Choroidal Neovascularization: metabolism</keyword><keyword>Knockout</keyword><keyword>Mice</keyword><keyword>NADPH Oxidase</keyword><keyword>NADPH Oxidase: metabolism</keyword><keyword>Oxidation-Reduction</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reactive Oxygen Species: metabolism</keyword><keyword>Retinal Pigment Epithelium</keyword><keyword>Retinal Pigment Epithelium: metabolism</keyword><keyword>rap1 GTP-Binding Proteins</keyword><keyword>rap1 GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2014</year></dates><accession-num>24043260</accession-num><electronic-resource-num>10.1096/fj.13-240028</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24043260</url></web-urls></urls><abstract>Activation of Rap1 GTPase can improve the integrity of the barrier of the retina pigment epithelium (RPE) and reduce choroidal neovascularization (CNV). Inhibition of NADPH oxidase activation also reduces CNV. We hypothesize that Rap1 inhibits NADPH oxidase-generated ROS and thereby reduces CNV formation. Using a murine model of laser-induced CNV, we determined that reduced Rap1 activity in RPE/choroid occurred with CNV formation and that activation of Rap1 by 2'-O-Me-cAMP (8CPT)-reduced laser-induced CNV via inhibiting NADPH oxidase-generated ROS. In RPE, inhibition of Rap1 by Rap1 GTPase-activating protein (Rap1GAP) increased ROS generation, whereas activation of Rap1 by 8CPT reduced ROS by interfering with the assembly of NADPH oxidase membrane subunit p22phox with NOX4 or cytoplasmic subunit p47phox. Activation of NADPH oxidase with Rap1GAP reduced RPE barrier integrity via cadherin phosphorylation and facilitated choroidal EC migration across the RPE monolayer. Rap1GAP-induced ROS generation was inhibited by active Rap1a, but not Rap1b, and activation of Rap1a by 8CPT in Rap1b(-/-) mice reduced laser-induced CNV, in correlation with decreased ROS generation in RPE/choroid. These findings provide evidence that active Rap1 reduces CNV by interfering with the assembly of NADPH oxidase subunits and increasing the integrity of the RPE barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Goc, Anna</author><author>Al-Husein, Belal</author><author>Katsanevas, Katerina</author><author>Steinbach, Alison</author><author>Lou, Uvette</author><author>Sabbineni, Harika</author><author>Deremer, David L</author><author>Somanath, Payaningal R</author></authors></contributors><titles><title>Targeting Src-mediated Tyr216 phosphorylation and activation of GSK-3 in prostate cancer cells inhibit prostate cancer progression in vitro and in vivo</title><secondary-title>Oncotarget</secondary-title></titles><periodical><full-title>Oncotarget</full-title></periodical><volume>5</volume><issue>3</issue><keywords><keyword>GSK-3</keyword><keyword>Src</keyword><keyword>Tyr-216</keyword><keyword>dasatinib</keyword><keyword>prostate cancer</keyword></keywords><dates><year>2014</year></dates><urls><web-urls><url>www.impactjournals.com/oncotarget%5Cnwww.impactjournals.com/oncotarget/</url></web-urls></urls><label>ECIS Invasion</label><abstract>Recent studies suggest a positive correlation between glycogen synthase kinase-3 (GSK-3) activation and tumor growth. Currently, it is unclear how both Akt that inhibits GSK-3 and active GSK-3 are maintained concurrently in tumor cells. We investigated the role of GSK-3 and the existence of an Akt-resistant pathway for GSK-3 activation in prostate cancer cells. Our data show that Src, a non-receptor tyrosine kinase is responsible for Y216 GSK-3 phosphorylation leading to its activation even when Akt is active. Experiments involving mouse embryonic fibroblasts lacking cSrc, Yes and Fyn, as well as Src activity modulation in prostate cancer cells with constitutively active (CA-Src) and dominant negative Src (DN-Src) plasmids demonstrated the integral role of Src in Y216 GSK-3 phosphorylation and activity modulation. Inhibition of GSK-3 with SB415286 in PC3 cells resulted in impaired motility, proliferation and colony formation. Treatment of PC3 cells with the Src inhibitor dasatinib reduced Y216 GSK-3 phosphorylation and inhibited proliferation, invasion and micrometastasis in vitro. Dasatinib treatment of athymic nude mice resulted in impaired growth of PC3 cell tumor xenograft. Together, we provide novel insight into the Src-mediated Y216 GSK-3 phosphorylation and activation in prostate cancer cells and reveal the potential benefits of targeting Src-GSK-3 axis using drugs such as dasatinib.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kosaraju, K</author><author>Tarannum, M</author><author>Crawford, S</author><author>Garde, K</author><author>Aravamudhan, S</author></authors></contributors><titles><title>Examining the Cellular Uptake and Toxicity of Engineered Nanomaterials</title><secondary-title>ECS Transactions</secondary-title></titles><periodical><full-title>ECS Transactions</full-title></periodical><pages>15-21</pages><volume>61</volume><issue>36</issue><keywords/><dates><year>2014</year></dates><electronic-resource-num>10.1149/06136.0015ecst</electronic-resource-num><urls><web-urls><url>http://ecst.ecsdl.org/cgi/doi/10.1149/06136.0015ecst</url></web-urls></urls><abstract>Engineered Nanomaterials (ENs) such as silica, ceria and alumina nanoparticles have been extensively used in health care, energy and electronics. However, their toxicity and cellular uptake, which are strongly dependent on their physiochemical properties and on cell interaction, are largely unknown. The objective of this work is to study and quantify the cellular uptake of silica, ceria and alumina ENs. First, comprehensive characterization using DLS, zeta potential, BET, XRD, FTIR, Raman, SEM and TEM was done. Then, cell exposure studies were carried out on A549 lung epithetical cells to study cell viability and membrane integrity. Lastly, cellular uptake of ENs was studied by using techniques such as Confocal Raman Spectroscopy and ICP-OES and Electrochemical Cell-substrate Impedance Sensing (ECIS). ICP-OES analysis showed uptake of silica, ceria and alumina, while Confocal Raman indicated the uptake of Ceria ENs. Time-course effects of EN on A549 cells were studied using ECIS measurements.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ameri, Hossein</author><author>Liu, Hua</author><author>Liu, Rong</author><author>Ha, Yonju</author><author>Paulucci-Holthauzen, Adriana A</author><author>Hu, Shuqun</author><author>Motamedi, Massoud</author><author>Godley, Bernard F</author><author>Tilton, Ronald G</author><author>Zhang, Wenbo</author></authors></contributors><titles><title>TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.</title><secondary-title>Investigative ophthalmology &amp; visual science</secondary-title></titles><periodical><full-title>Investigative ophthalmology &amp; visual science</full-title></periodical><pages>801-813</pages><volume>55</volume><issue>2</issue><keywords><keyword>Animal</keyword><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Blotting</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Disease Models</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: physiology</keyword><keyword>Humans</keyword><keyword>Hypoxia-Inducible Factor 1</keyword><keyword>Inbred C57BL</keyword><keyword>Indirect</keyword><keyword>Messenger</keyword><keyword>Messenger: metabolism</keyword><keyword>Mice</keyword><keyword>Nucleic Acid</keyword><keyword>RNA</keyword><keyword>Real-Time Polymerase Chain Reaction</keyword><keyword>Receptors</keyword><keyword>Regulatory Sequences</keyword><keyword>Retinal Neovascularization</keyword><keyword>Retinal Neovascularization: genetics</keyword><keyword>Retinal Neovascularization: metabolism</keyword><keyword>Retinal Neovascularization: pathology</keyword><keyword>Retinal Neovascularization: prevention &amp; control</keyword><keyword>Retinal Vessels</keyword><keyword>Retinal Vessels: pathology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Transfection</keyword><keyword>Tumor Necrosis Factor</keyword><keyword>Tumor Necrosis Factor: antagonists &amp; inhibitors</keyword><keyword>Tumor Necrosis Factor: genetics</keyword><keyword>Tumor Necrosis Factors</keyword><keyword>Tumor Necrosis Factors: antagonists &amp; inhibitors</keyword><keyword>Tumor Necrosis Factors: genetics</keyword><keyword>Western</keyword><keyword>alpha Subunit</keyword><keyword>alpha Subunit: genetics</keyword></keywords><dates><year>2014</year></dates><accession-num>24408972</accession-num><electronic-resource-num>10.1167/iovs.13-12812</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3920863&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Apoptosis;Signal Transduction</label><abstract>PURPOSE: Retinal neovascularization (NV) is a major cause of vision loss in ischemia-induced retinopathy. Tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) and its receptor, fibroblast growth factor inducible-14 (Fn14), have been implicated in angiogenesis, but their role in retinal diseases is unknown. The goal of this study was to investigate the role of TWEAK/Fn14 pathway in retinal NV. METHODS: Studies were performed in a mouse model of oxygen-induced retinopathy (OIR) and in primary human retinal microvascular endothelial cells (HRMECs). Hyperoxia treatment was initiated on postnatal day (P)14. Immunohistochemistry and quantitative PCR (qPCR) were used to assess retinal vascular changes in relation to expression of Fn14 and TWEAK. RESULTS: Fibroblast growth factor-inducible 14 mRNA was prominently increased from P13 to P17 in OIR retinas, whereas TWEAK level was slightly decreased. These alterations were normalized by hyperoxia treatment and were more striking in isolated retinal vessels. There was a discernible shift in the immunoreactivity of Fn14 and TWEAK from the neuronal layers in the healthy retina to the neovascular tufts in that of OIR. Blockade of TWEAK/Fn14 significantly prevented retinal NV while slightly accelerated revascularization. In contrast, activation of Fn14 positively regulated survival pathways in the B-cell lymphoma-2 (Bcl2) family and robustly enhanced HRMEC survival. Furthermore, gene analysis revealed the regulatory region of Fn14 gene contains several conserved hypoxia inducible factor (HIF)-1α binding sites. Overexpression of HIF-1α prominently induced Fn14 expression in HRMECs. CONCLUSIONS: We found that the TNF-like weak inducer of apoptosis (TWEAK)/fibroblast growth factor inducible-14 (Fn14) pathway is involved in the development of pathologic retinal neovascularization. Hypoxia inducible factor-1α is likely implicated in the upregulation of Fn14.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Watson, James E</author><author>Patel, Niketa A</author><author>Carter, Gay</author><author>Moor, Andrea</author><author>Patel, Rekha</author><author>Ghansah, Tomar</author><author>Mathur, Abhishek</author><author>Murr, Michel M</author><author>Bickford, Paula</author><author>Gould, Lisa J</author><author>Cooper, Denise R</author></authors></contributors><titles><title>Comparison of Markers and Functional Attributes of Human Adipose-Derived Stem Cells and Dedifferentiated Adipocyte Cells from Subcutaneous Fat of an Obese Diabetic Donor.</title><secondary-title>Advances in wound care</secondary-title></titles><periodical><full-title>Advances in wound care</full-title></periodical><pages>219-228</pages><volume>3</volume><issue>3</issue><keywords/><dates><year>2014</year></dates><accession-num>24669358</accession-num><electronic-resource-num>10.1089/wound.2013.0452</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3955970&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Objective: Adipose tissue is a robust source of adipose-derived stem cells (ADSCs) that may be able to provide secreted factors that promote the ability of wounded tissue to heal. However, adipocytes also have the potential to dedifferentiate in culture to cells with stem cell-like properties that may improve their behavior and functionality for certain applications. Approach: ADSCs are adult mesenchymal stem cells that are cultured from the stromal vascular fraction of adipose tissue. However, adipocytes are capable of dedifferentiating into cells with stem cell properties. In this case study, we compare ADSC and dedifferentiated fat (DFAT) cells from the same patient and fat depot for mesenchymal cell markers, embryonic stem cell markers, ability to differentiate to adipocytes and osteoblasts, senescence and telomerase levels, and ability of conditioned media (CM) to stimulate migration of human dermal fibroblasts (HDFs). Innovation and Conclusions: ADSCs and DFAT cells displayed identical levels of CD90, CD44, CD105, and were CD34- and CD45-negative. They also expressed similar levels of Oct4, BMI1, KLF4, and SALL4. DFAT cells, however, showed higher efficiency in adipogenic and osteogenic capacity. Telomerase levels of DFAT cells were double those of ADSCs, and senescence declined in DFAT cells. CM from both cell types altered the migration of fibroblasts. Despite reports of ADSCs from a number of human depots, there have been no comparisons of the ability of dedifferentiated DFAT cells from the same donor and depot to differentiate or modulate migration of HDFs. Since ADSCs were from an obese diabetic donor, reprogramming of DFAT cells may help improve a patient's cells for regenerative medicine applications.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dong, Fengyun</author><author>Zhou, Xia</author><author>Li, Changsheng</author><author>Yan, Suhua</author><author>Deng, Xianming</author><author>Cao, Zhiqun</author><author>Li, Liqun</author><author>Tang, Bo</author><author>Allen, Thaddeus D</author><author>Liu, Ju</author></authors></contributors><titles><title>Dihydroartemisinin targets VEGFR2 via the NF-κB pathway in endothelial cells to inhibit angiogenesis</title><secondary-title>Cancer Biology &amp; Therapy</secondary-title></titles><periodical><full-title>Cancer Biology &amp; Therapy</full-title></periodical><pages>1479-1488</pages><volume>15</volume><issue>11</issue><keywords/><dates><year>2014</year></dates><electronic-resource-num>10.4161/15384047.2014.955728</electronic-resource-num><urls><web-urls><url>http://www.tandfonline.com/doi/full/10.4161/15384047.2014.955728</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schorch, Björn</author><author>Song, Shuo</author><author>van Diemen, Ferdy R</author><author>Bock, Hans H</author><author>May, Petra</author><author>Herz, Joachim</author><author>Brummelkamp, Thijn R</author><author>Papatheodorou, Panagiotis</author><author>Aktories, Klaus</author></authors></contributors><titles><title>LRP1 is a receptor for Clostridium perfringens TpeL toxin indicating a two-receptor model of clostridial glycosylating toxins.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>6431-6436</pages><volume>111</volume><issue>17</issue><keywords><keyword>Animals</keyword><keyword>Bacterial Toxins</keyword><keyword>Bacterial Toxins: chemistry</keyword><keyword>Bacterial Toxins: metabolism</keyword><keyword>Biological</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Clostridium perfringens</keyword><keyword>Clostridium perfringens: metabolism</keyword><keyword>Embryo</keyword><keyword>Endocytosis</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: metabolism</keyword><keyword>Genetic Testing</keyword><keyword>Glycosylation</keyword><keyword>Haploidy</keyword><keyword>HeLa Cells</keyword><keyword>Humans</keyword><keyword>Low Density Lipoprotein Receptor-Related Protein-1</keyword><keyword>Mammalian</keyword><keyword>Mammalian: cytology</keyword><keyword>Mice</keyword><keyword>Models</keyword><keyword>Protein Binding</keyword><keyword>Protein Structure</keyword><keyword>Tertiary</keyword></keywords><dates><year>2014</year></dates><accession-num>24737893</accession-num><electronic-resource-num>10.1073/pnas.1323790111</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4035940&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Large glycosylating toxins are major virulence factors of various species of pathogenic Clostridia. Prototypes are Clostridium difficile toxins A and B, which cause antibiotics-associated diarrhea and pseudomembranous colitis. The current model of the toxins' action suggests that receptor binding is mediated by a C-terminal domain of combined repetitive oligopeptides (CROP). This model is challenged by the glycosylating Clostridium perfringens large cytotoxin (TpeL toxin) that is devoid of the CROP domain but still intoxicates cells. Using a haploid genetic screen, we identified LDL receptor-related protein 1 (LRP1) as a host cell receptor for the TpeL toxin. LRP1-deficient cells are not able to take up TpeL and are not intoxicated. Expression of cluster IV of LRP1 is sufficient to rescue toxin uptake in these cells. By plasmon resonance spectroscopy, a KD value of 23 nM was determined for binding of TpeL to LRP1 cluster IV. The C terminus of TpeL (residues 1335-1779) represents the receptor-binding domain (RBD) of the toxin. RBD-like regions are conserved in all other clostridial glycosylating toxins preceding their CROP domain. CROP-deficient C. difficile toxin B is toxic to cells, depending on the RBD-like region (residues 1349-1811) but does not interact with LRP1. Our data indicate the presence of a second, CROP-independent receptor-binding domain in clostridial glycosylating toxins and suggest a two-receptor model for the cellular uptake of clostridial glycosylating toxins.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Brown, Mary Beth</author><author>Hunt, William R</author><author>Noe, Julie E</author><author>Rush, Natalia I</author><author>Schweitzer, Kelly S</author><author>Leece, Thomas C</author><author>Moldobaeva, Aigul</author><author>Wagner, Elizabeth M</author><author>Dudek, Steven M</author><author>Poirier, Christophe</author><author>Presson, Robert G</author><author>Gulbins, Erich</author><author>Petrache, Irina</author></authors></contributors><titles><title>Loss of cystic fibrosis transmembrane conductance regulator impairs lung endothelial cell barrier function and increases susceptibility to microvascular damage from cigarette smoke.</title><secondary-title>Pulmonary circulation</secondary-title></titles><periodical><full-title>Pulmonary circulation</full-title></periodical><pages>260-268</pages><volume>4</volume><issue>2</issue><keywords/><dates><year>2014</year></dates><accession-num>25006445</accession-num><electronic-resource-num>10.1086/675989</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4070785&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Abnormal lung microvascular endothelial vascular barrier function may contribute to pulmonary inflammation, such as that occurring during inhalation of cigarette smoke (CS). Cystic fibrosis transmembrane conductance regulator (CFTR), an anion channel expressed in both epithelial and endothelial cells, regulates the organization of tight junctions between epithelial cells and has also been implicated in the transport of sphingosine-1 phosphate (S1P), a vascular barrier-enhancing sphingolipid. Because CS has been shown to affect CFTR function, we hypothesized that CFTR function contributes to lung endothelial cell barrier and that CFTR dysfunction worsens CS-induced injury. CFTR inhibitors GlyH-101 or CFTRinh172 caused a dose-dependent increase in pulmonary or bronchial endothelial monolayer permeability, which peaked after 4 hours. CFTR inhibition was associated with both intercellular gaps and actin stress fiber formation compared with vehicle-treated cells. Increasing endothelial S1P, either by exogenous treatment or by inhibition of its degradation, significantly improved the barrier function in CFTR-inhibited monolayers. Both cultured lung endothelia and the lung microcirculation visualized in vivo with intravital two-photon imaging of transgenic mice deficient in CFTR showed that CFTR dysfunction increased susceptibility to CS-induced permeability. These results suggested that CFTR function might be required for lung endothelial barrier, including adherence junction stability. Loss of CFTR function, especially concomitant to CS exposure, might promote lung inflammation by increasing endothelial cell permeability, which could be ameliorated by S1P.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Amsellem, Valerie</author><author>Dryden, Nicola H</author><author>Martinelli, Roberta</author><author>Gavins, Felicity</author><author>Almagro, Lourdes Osuna</author><author>Birdsey, Graeme M</author><author>Haskard, Dorian O</author><author>Mason, Justin C</author><author>Turowski, Patric</author><author>Randi, Anna M</author></authors></contributors><titles><title>ICAM-2 regulates vascular permeability and N-cadherin localization through ezrin-radixin-moesin (ERM) proteins and Rac-1 signalling.</title><secondary-title>Cell communication and signaling : CCS</secondary-title></titles><periodical><full-title>Cell communication and signaling : CCS</full-title></periodical><pages>12</pages><volume>12</volume><issue>1</issue><keywords><keyword>Cell adhesion</keyword><keyword>Cell-cell junctions</keyword><keyword>ERM</keyword><keyword>Endothelial</keyword><keyword>ICAM-2</keyword><keyword>N-Cadherin</keyword><keyword>Permeability</keyword><keyword>Rac-1</keyword><keyword>cell adhesion</keyword><keyword>cell-cell junctions</keyword><keyword>endothelial</keyword><keyword>erm</keyword><keyword>icam-2</keyword><keyword>n-cadherin</keyword><keyword>permeability</keyword><keyword>rac-1</keyword></keywords><dates><year>2014</year></dates><publisher>Cell Communication and Signaling</publisher><accession-num>24593809</accession-num><electronic-resource-num>10.1186/1478-811X-12-12</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4015342&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>BACKGROUND: Endothelial junctions control functions such as permeability, angiogenesis and contact inhibition. VE-Cadherin (VECad) is essential for the maintenance of intercellular contacts. In confluent endothelial monolayers, N-Cadherin (NCad) is mostly expressed on the apical and basal membrane, but in the absence of VECad it localizes at junctions. Both cadherins are required for vascular development. The intercellular adhesion molecule (ICAM)-2, also localized at endothelial junctions, is involved in leukocyte recruitment and angiogenesis. RESULTS: In human umbilical vein endothelial cells (HUVEC), both VECad and NCad were found at nascent cell contacts of sub-confluent monolayers, but only VECad localized at the mature junctions of confluent monolayers. Inhibition of ICAM-2 expression by siRNA caused the appearance of small gaps at the junctions and a decrease in NCad junctional staining in sub-confluent monolayers. Endothelioma lines derived from WT or ICAM-2-deficient mice (IC2neg) lacked VECad and failed to form junctions, with loss of contact inhibition. Re-expression of full-length ICAM-2 (IC2 FL) in IC2neg cells restored contact inhibition through recruitment of NCad at the junctions. Mutant ICAM-2 lacking the binding site for ERM proteins (IC2 ΔERM) or the cytoplasmic tail (IC2 ΔTAIL) failed to restore junctions. ICAM-2-dependent Rac-1 activation was also decreased in these mutant cell lines. Barrier function, measured in vitro via transendothelial electrical resistance, was decreased in IC2neg cells, both in resting conditions and after thrombin stimulation. This was dependent on ICAM-2 signalling to the small GTPase Rac-1, since transendothelial electrical resistance of IC2neg cells was restored by constitutively active Rac-1. In vivo, thrombin-induced extravasation of FITC-labeled albumin measured by intravital fluorescence microscopy in the mouse cremaster muscle showed that permeability was increased in ICAM-2-deficient mice compared to controls. CONCLUSIONS: These results indicate that ICAM-2 regulates endothelial barrier function and permeability through a pathway involving N-Cadherin, ERMs and Rac-1.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Astanina, Ksenia</author><author>Simon, Yvette</author><author>Cavelius, Christian</author><author>Petry, Sandra</author><author>Kraegeloh, Annette</author><author>Kiemer, Alexandra K</author></authors></contributors><titles><title>Superparamagnetic iron oxide nanoparticles impair endothelial integrity and inhibit nitric oxide production.</title><secondary-title>Acta biomaterialia</secondary-title></titles><periodical><full-title>Acta biomaterialia</full-title></periodical><pages>4896-4911</pages><volume>10</volume><issue>11</issue><keywords/><dates><year>2014</year></dates><accession-num>25123083</accession-num><electronic-resource-num>10.1016/j.actbio.2014.07.027</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/25123083</url></web-urls></urls><abstract>Superparamagnetic iron oxide nanoparticles (SPION) are widely used both clinically and experimentally for diverse in vivo applications, such as contrast enhancement in magnetic resonance imaging, hyperthermia and drug delivery. Biomedical applications require particles to have defined physical and chemical properties, and to be stable in biological media. Despite a suggested low cytotoxic action, adverse reactions of SPION in concentrations relevant for biomedical use have not yet been studied in sufficient detail. In the present work we employed Endorem®, dextran-stabilized SPION approved as an intravenous contrast agent, and compared its action to a set of other nanoparticles with potential for magnetic resonance imaging applications. SPION in concentrations relevant for in vivo applications were rapidly taken up by endothelial cells and exhibited no direct cytotoxicity. Electric cell impedance sensing measurements demonstrated that SPION, but not BaSO4/Gd nanoparticles, impaired endothelial integrity, as was confirmed by increased intercellular gap formation in endothelial monolayers. These structural changes induced the subcellular translocation and inhibition of the cytoprotective and anti-atherosclerotic enzyme endothelial NO-synthase and reduced NO production. Lipopolysaccharide-induced inflammatory NO production of macrophages was not affected by SPION. In conclusion, our data suggest that SPION might substantially alter endothelial integrity and function at therapeutically relevant doses, which are not cytotoxic.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Piegeler, Tobias</author><author>Votta-Velis, E Gina</author><author>Bakhshi, Farnaz R</author><author>Mao, Mao</author><author>Carnegie, Graeme</author><author>Bonini, Marcelo G</author><author>Schwartz, David E</author><author>Borgeat, Alain</author><author>Beck-Schimmer, Beatrice</author><author>Minshall, Richard D</author></authors></contributors><titles><title>Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation.</title><secondary-title>Anesthesiology</secondary-title></titles><periodical><full-title>Anesthesiology</full-title></periodical><pages>1414-1428</pages><volume>120</volume><issue>6</issue><keywords><keyword>Amides</keyword><keyword>Amides: pharmacology</keyword><keyword>Anesthetics</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Enzyme Activation: physiology</keyword><keyword>Humans</keyword><keyword>Lidocaine</keyword><keyword>Lidocaine: pharmacology</keyword><keyword>Local</keyword><keyword>Local: pharmacology</keyword><keyword>Lung</keyword><keyword>Lung: drug effects</keyword><keyword>Lung: enzymology</keyword><keyword>Microcirculation</keyword><keyword>Microcirculation: drug effects</keyword><keyword>Microcirculation: physiology</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: administration &amp; dosa</keyword><keyword>Tumor Necrosis Factor-alpha: antagonists &amp; inhibit</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: enzymology</keyword><keyword>src-Family Kinases</keyword><keyword>src-Family Kinases: metabolism</keyword><keyword>src-Family Kinases: physiology</keyword></keywords><dates><year>2014</year></dates><accession-num>24525631</accession-num><electronic-resource-num>10.1097/ALN.0000000000000174</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24525631</url></web-urls></urls><abstract>BACKGROUND: Pulmonary endothelial barrier dysfunction mediated in part by Src-kinase activation plays a crucial role in acute inflammatory disease. Proinflammatory cytokines, such as tumor necrosis factor-α (TNFα), activate Src via phosphatidylinositide 3-kinase/Akt-dependent nitric oxide generation, a process initiated by recruitment of phosphatidylinositide 3-kinase regulatory subunit p85 to TNF-receptor-1. Because amide-linked local anesthetics have well-established anti-inflammatory effects, the authors hypothesized that ropivacaine and lidocaine attenuate inflammatory Src signaling by disrupting the phosphatidylinositide 3-kinase-Akt-nitric oxide pathway, thus blocking Src-dependent neutrophil adhesion and endothelial hyperpermeability. METHODS: Human lung microvascular endothelial cells, incubated with TNFα in the absence or presence of clinically relevant concentrations of ropivacaine and lidocaine, were analyzed by Western blot, probing for phosphorylated/activated Src, endothelial nitric oxide synthase, Akt, intercellular adhesion molecule-1, and caveolin-1. The effect of ropivacaine on TNFα-induced nitric oxide generation, co-immunoprecipitation of TNF-receptor-1 with p85, neutrophil adhesion, and endothelial barrier disruption were assessed. RESULTS: Ropivacaine and lidocaine attenuated TNFα-induced Src activation (half-maximal inhibitory concentration [IC50] = 8.611 × 10 M for ropivacaine; IC50 = 5.864 × 10 M for lidocaine) and endothelial nitric oxide synthase phosphorylation (IC50 = 7.572 × 10 M for ropivacaine; IC50 = 6.377 × 10 M for lidocaine). Akt activation (n = 7; P = 0.006) and stimulus-dependent binding of TNF-receptor-1 and p85 (n = 6; P = 0.043) were blocked by 1 nM of ropivacaine. TNFα-induced neutrophil adhesion and disruption of endothelial monolayers via Src-dependent intercellular adhesion molecule-1- and caveolin-1-phosphorylation, respectively, were also attenuated. CONCLUSIONS: Ropivacaine and lidocaine effectively blocked inflammatory TNFα signaling in endothelial cells by attenuating p85 recruitment to TNF-receptor-1. The resultant decrease in Akt, endothelial nitric oxide synthase, and Src phosphorylation reduced neutrophil adhesion and endothelial hyperpermeability. This novel anti-inflammatory &quot;side-effect&quot; of ropivacaine and lidocaine may provide therapeutic benefit in acute inflammatory disease.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Laroui, Hamed</author><author>Geem, Duke</author><author>Xiao, Bo</author><author>Viennois, Emilie</author><author>Rakhya, Poonam</author><author>Denning, Timothy</author><author>Merlin, Didier</author></authors></contributors><titles><title>Targeting intestinal inflammation with CD98 siRNA/PEI-loaded nanoparticles.</title><secondary-title>Molecular therapy : the journal of the American Society of Gene Therapy</secondary-title></titles><periodical><full-title>Molecular therapy : the journal of the American Society of Gene Therapy</full-title></periodical><pages>69-80</pages><volume>22</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>CD98</keyword><keyword>CD98: chemistry</keyword><keyword>CD98: genetics</keyword><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Colon</keyword><keyword>Colon: drug effects</keyword><keyword>Colon: metabolism</keyword><keyword>Colon: pathology</keyword><keyword>Dendritic Cells</keyword><keyword>Dendritic Cells: metabolism</keyword><keyword>Dextran Sulfate</keyword><keyword>Dextran Sulfate: adverse effects</keyword><keyword>Gene Transfer Techniques</keyword><keyword>Inflammation</keyword><keyword>Inflammation: chemically induced</keyword><keyword>Inflammation: genetics</keyword><keyword>Inflammation: metabolism</keyword><keyword>Inflammation: pathology</keyword><keyword>Inflammatory Bowel Diseases</keyword><keyword>Inflammatory Bowel Diseases: genetics</keyword><keyword>Inflammatory Bowel Diseases: metabolism</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: drug effects</keyword><keyword>Intestinal Mucosa: metabolism</keyword><keyword>Intestinal Mucosa: pathology</keyword><keyword>Intestines</keyword><keyword>Intestines: drug effects</keyword><keyword>Intestines: metabolism</keyword><keyword>Intestines: pathology</keyword><keyword>Macrophages</keyword><keyword>Macrophages: metabolism</keyword><keyword>Mice</keyword><keyword>Nanoparticles</keyword><keyword>Nanoparticles: administration &amp; dosage</keyword><keyword>Nanoparticles: chemistry</keyword><keyword>Nanoparticles: ultrastructure</keyword><keyword>Polyethyleneimine</keyword><keyword>Polyethyleneimine: chemistry</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: chemistry</keyword><keyword>Small Interfering: genetics</keyword></keywords><dates><year>2014</year></dates><accession-num>24025751</accession-num><electronic-resource-num>10.1038/mt.2013.214</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24025751</url></web-urls></urls><label>Inflammation</label><abstract>Intestinal CD98 expression plays a crucial role in controlling homeostatic and innate immune responses in the gut. Modulation of CD98 expression in intestinal cells therefore represents a promising therapeutic strategy for the treatment and prevention of inflammatory intestinal diseases, such as inflammatory bowel disease. Here, the advantages of nanoparticles (NPs) are used, including their ability to easily pass through physiological barriers and evade phagocytosis, high loading concentration, rapid kinetics of mixing and resistance to degradation. Using physical chemistry characterizations techniques, CD98 siRNA/polyethyleneimine (PEI)-loaded NPs was characterized (diameter of ~480 nm and a zeta potential of -5.26 mV). Interestingly, CD98 siRNA can be electrostatically complexed by PEI and thus protected from RNase. In addition, CD98 siRNA/PEI-loaded NPs are nontoxic and biocompatible with intestinal cells. Oral administration of CD98/PEI-loaded NPs encapsulated in a hydrogel reduced CD98 expression in mouse colonic tissues and decreased dextran sodium sulfate-induced colitis in a mouse model. Finally, flow cytometry showed that CD98 was effectively downregulated in the intestinal epithelial cells and intestinal macrophages of treated mice. Finally, the results collectively demonstrated the therapeutic effect of &quot;hierarchical nano-micro particles&quot; with colon-homing capabilities and the ability to directly release &quot;molecularly specific&quot; CD98 siRNA in colonic cells, thereby decreasing colitis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ding, Lixiang</author><author>Ye, Lin</author><author>Xu, Jianli</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Impact of fibroblast activation protein on osteosarcoma cell lines in vitro.</title><secondary-title>Oncology letters</secondary-title></titles><periodical><full-title>Oncology letters</full-title></periodical><pages>699-704</pages><volume>7</volume><issue>3</issue><keywords/><dates><year>2014</year></dates><accession-num>24520291</accession-num><electronic-resource-num>10.3892/ol.2014.1788</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3919928&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Fibroblast activation protein (FAP) or seprase, which belongs to the group type II integral serine proteases, is an integral membrane serine peptidase. Previous studies have demonstrated that FAP has an effect on tumor growth, proliferation and invasion. However, the cellular functional role that FAP plays in osteosarcoma (OS) remains unknown. The aim of the present study was to investigate the activities of FAP in OS cell lines. The gene expression of FAP was knocked down through a hammerhead ribozyme transgene, and the various functions between the knockdown cells and their control cells were tested using a series of functional assays in vitro. The results indicated that knockdown of FAP markedly reduced the ability of cellular growth, matrix adhesion, migration and invasion in MG-63 and HOS cell lines compared with the control cells (P&lt;0.05). In conclusion, FAP influences OS cells and may play a role in OS tumor progression and metastasis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wen, Beryl</author><author>Combes, Valery</author><author>Bonhoure, Amandine</author><author>Weksler, Babette B</author><author>Couraud, Pierre-Olivier</author><author>Grau, Georges E R</author></authors></contributors><titles><title>Endotoxin-induced monocytic microparticles have contrasting effects on endothelial inflammatory responses.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e91597</pages><volume>9</volume><issue>3</issue><keywords/><dates><year>2014</year></dates><accession-num>24646764</accession-num><electronic-resource-num>10.1371/journal.pone.0091597</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3960107&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Septic shock is a severe disease state characterised by the body's life threatening response to infection. Complex interactions between endothelial cells and circulating monocytes are responsible for microvasculature dysfunction contributing to the pathogenesis of this syndrome. Here, we intended to determine whether microparticles derived from activated monocytes contribute towards inflammatory processes and notably vascular permeability. We found that endotoxin stimulation of human monocytes enhances the release of microparticles of varying phenotypes and mRNA contents. Elevated numbers of LPS-induced monocytic microparticles (mMP) expressed CD54 and contained higher levels of transcripts for pro-inflammatory cytokines such as TNF, IL-6 and IL-8. Using a prothrombin time assay, a greater reduction in plasma coagulation time was observed with LPS-induced mMP than with non-stimulated mMP. Co-incubation of mMP with the human brain endothelial cell line hCMEC/D3 triggered their time-dependent uptake and significantly enhanced endothelial microparticle release. Unexpectedly, mMP also modified signalling pathways by diminishing pSrc (tyr416) expression and promoted endothelial monolayer tightness, as demonstrated by endothelial impedance and permeability assays. Altogether, these data strongly suggest that LPS-induced mMP have contrasting effects on the intercellular communication network and display a dual potential: enhanced pro-inflammatory and procoagulant properties, together with protective function of the endothelium.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Huertas, G</author><author>Maldonado, A</author><author>Yufera, A</author><author>Rueda, A</author><author>Huertas, J L</author></authors></contributors><titles><title>A Circuit for Cell-Culture Assays</title><secondary-title>IEEE Transactions on Circuits and Systems II: Express Briefs</secondary-title></titles><periodical><full-title>IEEE Transactions on Circuits and Systems II: Express Briefs</full-title></periodical><pages>1</pages><volume>PP</volume><issue>99</issue><keywords/><dates><year>2014</year></dates><electronic-resource-num>10.1109/TCSII.2014.2386233</electronic-resource-num><urls><web-urls><url>http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=6998822</url></web-urls></urls><abstract>A system for cell-culture real-time monitoring using an Oscillation-Based (OB) approach is proposed. The system transforms a Cell-Culture Under Test (CCUT) into a suitable “biological” oscillator, without needing complex circuitry for excitation and measurement. The obtained oscillation parameters are directly related to biological test, owed to an empirically extracted cell-electrode electrical model. A discrete prototype is proposed and experimental results with living cell culture are presented, achieving the expected performances.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dong, Fengyun</author><author>Guo, Fang</author><author>Li, Liqun</author><author>Guo, Ling</author><author>Hou, Yinglong</author><author>Hao, Enkui</author><author>Yan, Suhua</author><author>Allen, Thaddeus D.</author><author>Liu, Ju</author></authors></contributors><titles><title>Cadmium induces vascular permeability via activation of the p38 MAPK pathway</title><secondary-title>Biochemical and Biophysical Research Communications</secondary-title></titles><periodical><full-title>Biochemical and Biophysical Research Communications</full-title></periodical><pages>447-452</pages><volume>450</volume><issue>1</issue><keywords/><dates><year>2014</year></dates><electronic-resource-num>10.1016/j.bbrc.2014.05.140</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0006291X14010456</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Vogt, Leonie M</author><author>Meyer, Diederick</author><author>Pullens, Gerdie</author><author>Faas, Marijke M</author><author>Venema, Koen</author><author>Ramasamy, Uttara</author><author>Schols, Henk A</author><author>de Vos, Paul</author></authors></contributors><titles><title>Toll-like receptor 2 activation by β2→1-fructans protects barrier function of T84 human intestinal epithelial cells in a chain length-dependent manner.</title><secondary-title>The Journal of nutrition</secondary-title></titles><periodical><full-title>The Journal of nutrition</full-title></periodical><pages>1002-1008</pages><volume>144</volume><issue>7</issue><keywords><keyword>Anti-Inflammatory Agents</keyword><keyword>Antibodies</keyword><keyword>Blocking</keyword><keyword>Blocking: pharmacology</keyword><keyword>Cell Line</keyword><keyword>Colon</keyword><keyword>Colon: drug effects</keyword><keyword>Colon: immunology</keyword><keyword>Colon: metabolism</keyword><keyword>Diglycerides</keyword><keyword>Diglycerides: pharmacology</keyword><keyword>Fructans</keyword><keyword>Fructans: antagonists &amp; inhibitors</keyword><keyword>Fructans: chemistry</keyword><keyword>Fructans: metabolism</keyword><keyword>Gastrointestinal Agents</keyword><keyword>Gastrointestinal Agents: antagonists &amp; inhibitors</keyword><keyword>Gastrointestinal Agents: chemistry</keyword><keyword>Gastrointestinal Agents: metabolism</keyword><keyword>Humans</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: drug effects</keyword><keyword>Intestinal Mucosa: immunology</keyword><keyword>Intestinal Mucosa: metabolism</keyword><keyword>Kidney</keyword><keyword>Kidney: drug effects</keyword><keyword>Kidney: immunology</keyword><keyword>Kidney: metabolism</keyword><keyword>Ligands</keyword><keyword>Membrane Transport Modulators</keyword><keyword>Membrane Transport Modulators: antagonists &amp; inhib</keyword><keyword>Membrane Transport Modulators: toxicity</keyword><keyword>Molecular Structure</keyword><keyword>NF-kappa B</keyword><keyword>NF-kappa B: agonists</keyword><keyword>NF-kappa B: metabolism</keyword><keyword>Non-Steroidal</keyword><keyword>Non-Steroidal: antagonists &amp; inhibitors</keyword><keyword>Non-Steroidal: chemistry</keyword><keyword>Non-Steroidal: metabolism</keyword><keyword>Oligopeptides</keyword><keyword>Oligopeptides: pharmacology</keyword><keyword>Prebiotics</keyword><keyword>Prebiotics: analysis</keyword><keyword>Protective Agents</keyword><keyword>Protective Agents: chemistry</keyword><keyword>Protective Agents: metabolism</keyword><keyword>Recombinant Proteins</keyword><keyword>Recombinant Proteins: chemistry</keyword><keyword>Recombinant Proteins: metabolism</keyword><keyword>Tetradecanoylphorbol Acetate</keyword><keyword>Tetradecanoylphorbol Acetate: analogs &amp; derivative</keyword><keyword>Tetradecanoylphorbol Acetate: antagonists &amp; inhibi</keyword><keyword>Tetradecanoylphorbol Acetate: toxicity</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: drug effects</keyword><keyword>Tight Junctions: immunology</keyword><keyword>Tight Junctions: metabolism</keyword><keyword>Toll-Like Receptor 2</keyword><keyword>Toll-Like Receptor 2: agonists</keyword><keyword>Toll-Like Receptor 2: antagonists &amp; inhibitors</keyword><keyword>Toll-Like Receptor 2: genetics</keyword><keyword>Toll-Like Receptor 2: metabolism</keyword><keyword>Transcription Factor AP-1</keyword><keyword>Transcription Factor AP-1: agonists</keyword><keyword>Transcription Factor AP-1: metabolism</keyword></keywords><dates><year>2014</year></dates><accession-num>24790027</accession-num><electronic-resource-num>10.3945/jn.114.191643</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24790027</url></web-urls></urls><abstract>Dietary fiber intake is associated with lower incidence and mortality from disease, but the underlying mechanisms of these protective effects are unclear. We hypothesized that β2→1-fructan dietary fibers confer protection on intestinal epithelial cell barrier function via Toll-like receptor 2 (TLR2), and we studied whether β2→1-fructan chain-length differences affect this process. T84 human intestinal epithelial cell monolayers were incubated with 4 β2→1-fructan formulations of different chain-length compositions and were stimulated with the proinflammatory phorbol 12-myristate 13-acetate (PMA). Transepithelial electrical resistance (TEER) was analyzed by electric cell substrate impedance sensing (ECIS) as a measure for tight junction-mediated barrier function. To confirm TLR2 involvement in barrier modulation by β2→1-fructans, ECIS experiments were repeated using TLR2 blocking antibody. After preincubation of T84 cells with short-chain β2→1-fructans, the decrease in TEER as induced by PMA (62.3 ± 5.2%, P &lt; 0.001) was strongly attenuated (15.2 ± 8.8%, P &lt; 0.01). However, when PMA was applied first, no effect on recovery was observed during addition of the fructans. By blocking TLR2 on the T84 cells, the protective effect of short-chain β2→1-fructans was substantially inhibited. Stimulation of human embryonic kidney human TLR2 reporter cells with β2→1-fructans induced activation of nuclear factor kappa-light-chain-enhancer of activated B cells, confirming that β2→1-fructans are specific ligands for TLR2. To conclude, β2→1-fructans exert time-dependent and chain length-dependent protective effects on the T84 intestinal epithelial cell barrier mediated via TLR2. These results suggest that TLR2 located on intestinal epithelial cells could be a target of β2→1-fructan-mediated health effects.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kalwa, Hermann</author><author>Sartoretto, Juliano L</author><author>Martinelli, Roberta</author><author>Romero, Natalia</author><author>Steinhorn, Benjamin S</author><author>Tao, Ming</author><author>Ozaki, C Keith</author><author>Carman, Christopher V</author><author>Michel, Thomas</author></authors></contributors><titles><title>Central role for hydrogen peroxide in P2Y1 ADP receptor-mediated cellular responses in vascular endothelium.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>3383-3388</pages><volume>111</volume><issue>9</issue><keywords><keyword>Adenosine Diphosphate</keyword><keyword>Adenosine Diphosphate: metabolism</keyword><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>Cell Line</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: genetics</keyword><keyword>Enzyme Activation: physiology</keyword><keyword>Fluorescence</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Humans</keyword><keyword>Hydrogen Peroxide</keyword><keyword>Hydrogen Peroxide: metabolism</keyword><keyword>Immunoblotting</keyword><keyword>Microscopy</keyword><keyword>Purinergic P2Y1</keyword><keyword>Purinergic P2Y1: metabolism</keyword><keyword>Receptors</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>fms-Like Tyrosine Kinase 3</keyword><keyword>fms-Like Tyrosine Kinase 3: metabolism</keyword></keywords><dates><year>2014</year></dates><accession-num>24550450</accession-num><electronic-resource-num>10.1073/pnas.1320854111</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3948230&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>ADP activates a family of cell surface receptors that modulate signaling pathways in a broad range of cells. ADP receptor antagonists are widely used to treat cardiovascular disease states. These studies identify a critical role for the stable reactive oxygen species hydrogen peroxide (H2O2) in mediating cellular responses activated by the G protein-coupled P2Y1 receptor for ADP. We found that ADP-dependent phosphorylation of key endothelial signaling proteins--including endothelial nitric oxide synthase, AMP-activated protein kinase, and the actin-binding MARCKS protein--was blocked by preincubation with PEG-catalase, which degrades H2O2. ADP treatment promoted the H2O2-dependent phosphorylation of c-Abl, a nonreceptor tyrosine kinase that modulates the actin cytoskeleton. Cellular imaging experiments using fluorescence resonance energy transfer-based biosensors revealed that ADP-stimulated activation of the cytoskeleton-associated small GTPase Rac1 was independent of H2O2. However, Rac1-dependent activation of AMP-activated protein kinase, the signaling phospholipid phosphatidylinositol-(4, 5)-bisphosphate, and the c-Abl-interacting protein CrkII are mediated by H2O2. We transfected endothelial cells with differentially targeted HyPer2 H2O2 biosensors and found that ADP promoted a marked increase in H2O2 levels in the cytosol and caveolae, and a smaller increase in mitochondria. We performed a screen for P2Y1 receptor-mediated receptor tyrosine kinase transactivation and discovered that ADP transactivates Fms-like tyrosine kinase 3 (Flt3), a receptor tyrosine kinase expressed in these cells. Our observation that P2Y1 receptor-mediated responses involve Flt3 transactivation may identify a unique mechanism whereby cancer chemotherapy with receptor tyrosine kinase inhibitors promotes vascular dysfunction. Taken together, these findings establish a critical role for endogenous H2O2 in control of ADP-mediated signaling responses in the vascular wall.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bowe, Rachael A</author><author>Cox, Orla T</author><author>Ayllón, Verónica</author><author>Tresse, Emilie</author><author>Healy, Nollaig C</author><author>Edmunds, Shelley J</author><author>Huigsloot, Merei</author><author>O'Connor, Rosemary</author></authors></contributors><titles><title>PDLIM2 regulates transcription factor activity in epithelial-to-mesenchymal transition via the COP9 signalosome.</title><secondary-title>Molecular biology of the cell</secondary-title></titles><periodical><full-title>Molecular biology of the cell</full-title></periodical><pages>184-195</pages><volume>25</volume><issue>1</issue><keywords><keyword>Cell Differentiation</keyword><keyword>Cell Movement</keyword><keyword>Cell Polarity</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Epithelial-Mesenchymal Transition</keyword><keyword>Humans</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Intracellular Signaling Peptides and Proteins: met</keyword><keyword>LIM Domain Proteins</keyword><keyword>LIM Domain Proteins: physiology</keyword><keyword>MCF-7 Cells</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: physiology</keyword><keyword>Multiprotein Complexes</keyword><keyword>Multiprotein Complexes: metabolism</keyword><keyword>NF-kappa B</keyword><keyword>NF-kappa B: metabolism</keyword><keyword>Peptide Hydrolases</keyword><keyword>Peptide Hydrolases: metabolism</keyword><keyword>Protein Transport</keyword><keyword>beta Catenin</keyword></keywords><dates><year>2014</year></dates><accession-num>24196835</accession-num><electronic-resource-num>10.1091/mbc.E13-06-0306</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3873889&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Epithelial cell differentiation and polarized migration associated with epithelial-to-mesenchymal transition (EMT) in cancer requires integration of gene expression with cytoskeletal dynamics. Here we show that the PDZ-LIM domain protein PDLIM2 (Mystique/SLIM), a known cytoskeletal protein and promoter of nuclear nuclear factor κB (NFκB) and signal transducer and activator of transcription (STAT) degradation, regulates transcription factor activity and gene expression through the COP9 signalosome (CSN). Although repressed in certain cancers, PDLIM2 is highly expressed in invasive cancer cells. Here we show that PDLIM2 suppression causes loss of directional migration, inability to polarize the cytoskeleton, and reversal of the EMT phenotype. This is accompanied by altered activity of several transcription factor families, including β-catenin, Ap-1, NFκB, interferon regulatory factors, STATs, JUN, and p53. We also show that PDLIM2 associates with CSN5, and cells with suppressed PDLIM2 exhibit reduced nuclear accumulation and deneddylation activity of the CSN toward the cullin 1 and cullin 3 subunits of cullin-RING ubiquitin ligases. Thus PDLIM2 integrates cytoskeleton signaling with gene expression in epithelial differentiation by controlling the stability of key transcription factors and CSN activity.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wegener, Joachim</author><author>Seebach, Jochen</author></authors></contributors><titles><title>Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches.</title><secondary-title>Cell and tissue research</secondary-title></titles><periodical><full-title>Cell and tissue research</full-title></periodical><pages>485-514</pages><volume>355</volume><issue>3</issue><keywords/><dates><year>2014</year></dates><accession-num>24585359</accession-num><electronic-resource-num>10.1007/s00441-014-1810-3</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24585359</url></web-urls></urls><abstract>Endothelial cells line the inner surface of all blood vessels and constitute a selective barrier between blood and tissue. Permeation of solutes across the endothelial cell monolayer occurs either paracellularly through specialized endothelial cell-cell junctions or transcellularly via special transport mechanisms including transcytosis, via the formation of transcellular channels, or by cell membrane transport proteins. Several in vitro assays have been developed in the past few decades to analyze the molecular mechanisms of transendothelial permeability. Measurement of the electrical resistance of the cell monolayer has proven to be particularly suitable for analyzing paracellular barrier function with high-time resolution over long time periods. We review the various permeability assays and focus on the electrical impedance analysis of endothelial cell monolayers. We also address current progress in the development of techniques used to investigate endothelial permeability with high-lateral resolution and under mechanical loads.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Banerjee, Sulagna</author><author>Nomura, Alice</author><author>Sangwan, Veena</author><author>Chugh, Rohit</author><author>Dudeja, Vikas</author><author>Vickers, Selwyn M</author><author>Saluja, Ashok</author></authors></contributors><titles><title>CD133+ Tumor Initiating Cells in a Syngenic Murine Model of Pancreatic Cancer Respond to Minnelide</title><secondary-title>Clinical Cancer Research</secondary-title></titles><periodical><full-title>Clinical Cancer Research</full-title></periodical><pages>2388-2399</pages><volume>20</volume><issue>9</issue><keywords/><dates><year>2014</year></dates><publisher>AACR</publisher><electronic-resource-num>10.1158/1078-0432.CCR-13-2947</electronic-resource-num><urls><web-urls><url>http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0432.CCR-13-2947</url></web-urls></urls><label>ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van Hooren, Kathinka W E M</author><author>Spijkers, Léon J A</author><author>van Breevoort, Dorothee</author><author>Fernandez-Borja, Mar</author><author>Bierings, Ruben</author><author>van Buul, Jaap D</author><author>Alewijnse, Astrid E</author><author>Peters, Stephan L M</author><author>Voorberg, Jan</author></authors></contributors><titles><title>Sphingosine-1-phosphate receptor 3 mediates sphingosine-1-phosphate induced release of weibel-palade bodies from endothelial cells.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e91346</pages><volume>9</volume><issue>3</issue><keywords/><dates><year>2014</year></dates><accession-num>24632890</accession-num><electronic-resource-num>10.1371/journal.pone.0091346</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3954688&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Sphingosine-1-phosphate (S1P) is an agonist for five distinct G-protein coupled receptors, that is released by platelets, mast cells, erythrocytes and endothelial cells. S1P promotes endothelial cell barrier function and induces release of endothelial cell-specific storage-organelles designated Weibel-Palade bodies (WPBs). S1P-mediated enhancement of endothelial cell barrier function is dependent on S1P receptor 1 (S1PR1) mediated signaling events that result in the activation of the small GTPase Rac1. Recently, we have reported that Rac1 regulates epinephrine-induced WPB exocytosis following its activation by phosphatidylinositol-3,4,5-triphosphate-dependent Rac exchange factor 1 (PREX1). S1P has also been described to induce WPB exocytosis. Here, we confirm that S1P induces release of WPBs using von Willebrand factor (VWF) as a marker. Using siRNA mediated knockdown of gene expression we show that S1PR1 is not involved in S1P-mediated release of WPBs. In contrast depletion of the S1PR3 greatly reduced S1P-induced release of VWF. S1P-mediated enhancement of endothelial barrier function was not affected by S1PR3-depletion whereas it was greatly impaired in cells lacking S1PR1. The Rho kinase inhibitor Y27632 completely abrogated S1P-mediated release of VWF. Also, the calcium chelator BAPTA-AM significantly reduced S1P-induced release of VWF. Our findings indicate that S1P-induced release of haemostatic, inflammatory and angiogenic components stored within WPBs depends on the S1PR3.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kling, Beata</author><author>Bücherl, Daniel</author><author>Palatzky, Peter</author><author>Matysik, Frank-Michael</author><author>Decker, Michael</author><author>Wegener, Joachim</author><author>Heilmann, Jörg</author></authors></contributors><titles><title>Flavonoids, flavonoid metabolites, and phenolic acids inhibit oxidative stress in the neuronal cell line HT-22 monitored by ECIS and MTT assay: a comparative study.</title><secondary-title>Journal of natural products</secondary-title></titles><periodical><full-title>Journal of natural products</full-title></periodical><pages>446-454</pages><volume>77</volume><issue>3</issue><keywords><keyword>Animals</keyword><keyword>Biomolecular</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cultured: drug effects</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Flavonoids</keyword><keyword>Flavonoids: chemistry</keyword><keyword>Flavonoids: pharmacology</keyword><keyword>Hippocampus</keyword><keyword>Hippocampus: cytology</keyword><keyword>Hydroxybenzoates</keyword><keyword>Hydroxybenzoates: chemistry</keyword><keyword>Hydroxybenzoates: pharmacology</keyword><keyword>Mice</keyword><keyword>Molecular Structure</keyword><keyword>Nuclear Magnetic Resonance</keyword><keyword>Oxidative Stress</keyword><keyword>Oxidative Stress: drug effects</keyword><keyword>Quercetin</keyword><keyword>Quercetin: pharmacology</keyword></keywords><dates><year>2014</year></dates><accession-num>24245939</accession-num><electronic-resource-num>10.1021/np400518k</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24245939</url></web-urls></urls><abstract>A real-time and label-free in vitro assay based on electric cell-substrate impedance sensing (ECIS) was established, validated, and compared to an end-point MTT assay within an experimental trial addressing the cytoprotective effects of 19 different flavonoids, flavonoid metabolites, and phenolic acids and their methyl esters on the HT-22 neuronal cell line, after induction of oxidative stress with tert-butyl hydroperoxide. Among the flavonoids under study, only those with a catechol unit and an additional 4-keto group provided cytoprotection. The presence of a 2,3-double bond was not a structural prerequisite for a neuroprotective effect. In the case of the phenolics, catechol substitution was the only structural requirement for activity. The flavonoids and other phenolics with a ferulic acid substitution or a single hydroxy group showed no activity. Electrochemical characterization of all compounds via square-wave voltammetry provided a rather specific correlation between cytoprotective activity and redox potential for the active flavonoids, but not for the active phenolics with a low molecular weight. Moreover this study was used to compare label-free ECIS recordings with results of the established MTT assay. Whereas the former provides time-resolved and thus entirely unbiased information on changes of cell morphology that are unequivocally associated with cell death, the latter requires predefined exposure times and a strict causality between metabolic activity and cell death. However, MTT assays are based on standard lab equipment and provide a more economic way to higher throughput.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Beasley, Selina</author><author>El-Sherbiny, Mohamed</author><author>Megyerdi, Sylvia</author><author>El-Shafey, Sally</author><author>Choksi, Karishma</author><author>Kaddour-Djebbar, Ismail</author><author>Sheibani, Nader</author><author>Hsu, Stephen</author><author>Al-Shabrawey, Mohamed</author></authors></contributors><titles><title>Caspase-14 expression impairs retinal pigment epithelium barrier function: potential role in diabetic macular edema.</title><secondary-title>BioMed research international</secondary-title></titles><periodical><full-title>BioMed research international</full-title></periodical><pages>417986</pages><volume>2014</volume><keywords/><dates><year>2014</year></dates><accession-num>25121097</accession-num><electronic-resource-num>10.1155/2014/417986</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4119899&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>We recently showed that caspase-14 is a novel molecule in retina with potential role in accelerated vascular cell death during diabetic retinopathy (DR). Here, we evaluated whether caspase-14 is implicated in retinal pigment epithelial cells (RPE) dysfunction under hyperglycemia. The impact of high glucose (HG, 30 mM D-glucose) on caspase-14 expression in human RPE (ARPE-19) cells was tested, which showed significant increase in caspase-14 expression compared with normal glucose (5 mM D-glucose + 25 mM L-glucose). We also evaluated the impact of modulating caspase-14 expression on RPE cells barrier function, phagocytosis, and activation of other caspases using ARPE-19 cells transfected with caspase-14 plasmid or caspase-14 siRNA. We used FITC-dextran flux assay and electric cell substrate impedance sensing (ECIS) to test the changes in RPE cell barrier function. Similar to HG, caspase-14 expression in ARPE-19 cells increased FITC-dextran leakage through the confluent monolayer and decreased the transcellular electrical resistance (TER). These effects of HG were prevented by caspase-14 knockdown. Furthermore, caspase-14 knockdown prevented the HG-induced activation of caspase-1 and caspase-9, the only activated caspases by HG. Phagocytic activity was unaffected by caspase-14 expression. Our results suggest that caspase-14 contributes to RPE cell barrier disruption under hyperglycemic conditions and thus plays a role in the development of diabetic macular edema.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sung, J Y</author><author>Park, S-Y</author><author>Kim, J H</author><author>Kang, H G</author><author>Yoon, J H</author><author>Na, Y S</author><author>Kim, Y-N</author><author>Park, B-K</author></authors></contributors><titles><title>Interferon consensus sequence-binding protein (ICSBP) promotes epithelial-to-mesenchymal transition (EMT)-like phenomena, cell-motility, and invasion via TGF-β signaling in U2OS cells.</title><secondary-title>Cell death &amp; disease</secondary-title></titles><periodical><full-title>Cell death &amp; disease</full-title></periodical><pages>e1224</pages><volume>5</volume><keywords><keyword>Bone Neoplasms</keyword><keyword>Bone Neoplasms: genetics</keyword><keyword>Bone Neoplasms: metabolism</keyword><keyword>Bone Neoplasms: pathology</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Shape</keyword><keyword>Coculture Techniques</keyword><keyword>Epithelial-Mesenchymal Transition</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: metabolism</keyword><keyword>Genetic</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Interferon Regulatory Factors</keyword><keyword>Interferon Regulatory Factors: genetics</keyword><keyword>Interferon Regulatory Factors: metabolism</keyword><keyword>Interferon-gamma</keyword><keyword>Interferon-gamma: metabolism</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Osteosarcoma</keyword><keyword>Osteosarcoma: genetics</keyword><keyword>Osteosarcoma: metabolism</keyword><keyword>Osteosarcoma: pathology</keyword><keyword>Promoter Regions</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: genetics</keyword><keyword>Protein-Serine-Threonine Kinases: metabolism</keyword><keyword>RNA Interference</keyword><keyword>Receptors</keyword><keyword>Signal Transduction</keyword><keyword>Time Factors</keyword><keyword>Transcription Factors</keyword><keyword>Transcription Factors: genetics</keyword><keyword>Transcription Factors: metabolism</keyword><keyword>Transfection</keyword><keyword>Transforming Growth Factor beta</keyword><keyword>Transforming Growth Factor beta: genetics</keyword><keyword>Transforming Growth Factor beta: metabolism</keyword><keyword>Tumor</keyword><keyword>Vimentin</keyword><keyword>Vimentin: metabolism</keyword></keywords><dates><year>2014</year></dates><accession-num>24832596</accession-num><electronic-resource-num>10.1038/cddis.2014.189</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4047854&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Interferon consensus sequence-binding protein (ICSBP) is a transcription factor induced by interferon gamma (IFN-γ) and a member of the interferon regulatory factor (IRF) family. ICSBP is predominantly expressed in hematopoietic cells and regulates the immune response and cell growth and differentiation. However, little is known about its function in non-hematopoietic cells. Here we show a novel function for ICSBP in epithelial-to-mesenchymal transition (EMT)-like phenomena (ELP), cell motility, and invasion in human osteosarcoma cell lines, including U2OS cells. IFN-γ treatment induced ICSBP expression and EMT-like morphological change in U2OS cells, which were suppressed by ICSBP knockdown. To further investigate the role of ICSBP in ELP, we established a stable U2OS cell line that overexpresses ICSBP. ICSBP expression caused U2OS cells to have a more elongated shape and an increased vimentin and fibronectin expression. ICSBP expression also promoted adhesiveness, motility, and invasiveness of U2OS cells. ICSBP upregulated transforming growth factor (TGF)-β receptors and activated TGF-β signaling cascades, which were responsible for ELP as well as increased cell motility and invasion. In addition, ICSBP-induced TGF-β receptor activation resulted in the upregulation of Snail. Knockdown of Snail attenuated the ICSBP-induced augmentation of cell motility and invasion. Upregulation of Snail, ELP, and increased invasion by ICSBP expression were also observed in other osteosarcoma cell lines, such as Saos-2 and 143B. Furthermore, ICSBP and TGF-β receptor I were expressed in 45/54 (84%) and 47/54 (87%) of human osteosarcoma tissues, respectively, and showed significant correlation (r=0.47, P=0.0007) with respect to their expression levels. Taken altogether, these data demonstrate a novel function for ICSBP in ELP, cell motility, and invasion through the TGF-β and Snail signaling pathways.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Guo, Ling</author><author>Dong, Fengyun</author><author>Hou, Yinglong</author><author>Cai, Weidong</author><author>Zhou, Xia</author><author>Huang, Ai-Ling</author><author>Yang, Min</author><author>Allen, Thaddeus D</author><author>Liu, Ju</author></authors></contributors><titles><title>Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway.</title><secondary-title>Experimental and therapeutic medicine</secondary-title></titles><periodical><full-title>Experimental and therapeutic medicine</full-title></periodical><pages>1707-1712</pages><volume>8</volume><issue>6</issue><keywords/><dates><year>2014</year></dates><accession-num>25371719</accession-num><electronic-resource-num>10.3892/etm.2014.1997</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4217775&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Dihydroartemisinin (DHA), a semi-synthetic derivative of artemisinin, has been demonstrated to possess a strong antiangiogenic activity. However, the molecular mechanisms underlying this effect remain unclear. Endothelial cell (EC) migration is an essential component of angiogenesis, and the p38 mitogen-activated protein kinase (MAPK) signaling pathway plays a key role in the regulation of migration induced by vascular endothelial growth factor (VEGF). The aim of the present study was to investigate the effects of DHA on EC migration and the p38 MAPK signaling pathway. Human umbilical vein ECs (HUVECs) were treated with DHA and VEGF-induced migration was analyzed. The activation of p38 MAPK was detected by western blot analysis, and the migration assays were performed with a p38-specific inhibitor, SB203850. It was revealed that 20 μM DHA significantly reduced EC migration in the transwell migration assay, wound healing assay and electrical cell-substrate impedance sensing real-time analysis. However, DHA did not affect p38 MAPK phosphorylation or expression. In the absence or presence of SB203850, DHA induced a similar proportional reduction of EC migration in the three migration assays. Therefore, the present study demonstrated that DHA inhibits VEGF-induced EC migration via a p38 MAPK-independent pathway.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Stolwijk, Judith a.</author><author>Matrougui, Khalid</author><author>Renken, Christian W</author><author>Trebak, Mohamed</author></authors></contributors><titles><title>Impedance analysis of GPCR-mediated changes in endothelial barrier function: overview and fundamental considerations for stable and reproducible measurements.</title><secondary-title>Pflugers Archiv : European journal of physiology</secondary-title></titles><periodical><full-title>Pflugers Archiv : European journal of physiology</full-title></periodical><pages>2193-2218</pages><volume>467</volume><issue>10</issue><keywords><keyword>barrier function</keyword><keyword>ecis</keyword><keyword>endothelial cells</keyword><keyword>impedance</keyword><keyword>resistance</keyword><keyword>teer</keyword></keywords><dates><year>2014</year></dates><accession-num>25537398</accession-num><electronic-resource-num>10.1007/s00424-014-1674-0</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/25537398</url><url>http://link.springer.com/10.1007/s00424-014-1674-0</url></web-urls></urls><abstract>The past 20 years has seen significant growth in using impedance-based assays to understand the molecular underpinning of endothelial and epithelial barrier function in response to physiological agonists and pharmacological and toxicological compounds. Most studies on barrier function use G protein-coupled receptor (GPCR) agonists which couple to fast and transient changes in barrier properties. The power of impedance-based techniques such as electric cell-substrate impedance sensing (ECIS) resides in its ability to detect minute changes in cell layer integrity label-free and in real-time ranging from seconds to days. We provide a comprehensive overview of the biophysical principles, applications, and recent developments in impedance-based methodologies. Despite extensive application of impedance analysis in endothelial barrier research, little attention has been paid to data analysis and critical experimental variables, which are both essential for signal stability and reproducibility. We describe the rationale behind common ECIS data presentation and interpretation and illustrate practical guidelines to improve signal intensity by adapting technical parameters such as electrode layout, monitoring frequency, or parameter (resistance versus impedance magnitude). Moreover, we discuss the impact of experimental parameters, including cell source, liquid handling, and agonist preparation on signal intensity and kinetics. Our discussions are supported by experimental data obtained from human microvascular endothelial cells challenged with three GPCR agonists, thrombin, histamine, and sphingosine-1-phosphate.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lee, Monica Y</author><author>Skoura, Athanasia</author><author>Park, Eonjoo</author><author>Landskroner-Eiger, Shira</author><author>Jozsef, Levente</author><author>Luciano, Amelia K</author><author>Murata, Takahisa</author><author>Pasula, Satish</author><author>Dong, Yunzhou</author><author>Bouaouina, Mohamed</author><author>Calderwood, David a</author><author>Ferguson, Shawn M</author><author>De Camilli, Pietro</author><author>Sessa, William C</author></authors></contributors><titles><title>Dynamin 2 regulation of integrin endocytosis, but not VEGF signaling, is crucial for developmental angiogenesis.</title><secondary-title>Development (Cambridge, England)</secondary-title></titles><periodical><full-title>Development (Cambridge, England)</full-title></periodical><pages>1-8</pages><issue>October 2013</issue><keywords><keyword>2012</keyword><keyword>angiogenesis</keyword><keyword>cells</keyword><keyword>dnm</keyword><keyword>dnm1</keyword><keyword>dnm2</keyword><keyword>dynamin</keyword><keyword>endocytosis</keyword><keyword>endothelium</keyword><keyword>ferguson and de camilli</keyword><keyword>for membrane fission leading</keyword><keyword>is a gtpase essential</keyword><keyword>mouse</keyword><keyword>of dnm in mammalian</keyword><keyword>there are three isoforms</keyword><keyword>to clathrin-mediated endocytosis</keyword></keywords><dates><year>2014</year></dates><accession-num>24598168</accession-num><electronic-resource-num>10.1242/dev.104539</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24598168</url></web-urls></urls><label>ECIS Attachment</label><abstract>Here we show that dynamin 2 (Dnm2) is essential for angiogenesis in vitro and in vivo. In cultured endothelial cells lacking Dnm2, vascular endothelial growth factor (VEGF) signaling and receptor levels are augmented whereas cell migration and morphogenesis are impaired. Mechanistically, the loss of Dnm2 increases focal adhesion size and the surface levels of multiple integrins and reduces the activation state of β1 integrin. In vivo, the constitutive or inducible loss of Dnm2 in endothelium impairs branching morphogenesis and promotes the accumulation of β1 integrin at sites of failed angiogenic sprouting. Collectively, our data show that Dnm2 uncouples VEGF signaling from function and coordinates the endocytic turnover of integrins in a manner that is crucially important for angiogenesis in vitro and in vivo.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Allen-Gipson, Diane S</author><author>Zimmerman, Matthew C</author><author>Zhang, Hui</author><author>Castellanos, Glenda</author><author>O'Malley, Jennifer K</author><author>Alvarez-Ramirez, Horacio</author><author>Kharbanda, Kusum</author><author>Sisson, Joseph H</author><author>Wyatt, Todd A</author></authors></contributors><titles><title>Smoke extract impairs adenosine wound healing: implications of smoke-generated reactive oxygen species.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>665-673</pages><volume>48</volume><issue>5</issue><keywords><keyword>Acetylcysteine</keyword><keyword>Acetylcysteine: pharmacology</keyword><keyword>Adenosine</keyword><keyword>Adenosine A2A</keyword><keyword>Adenosine A2A: genetics</keyword><keyword>Adenosine A2A: metabolism</keyword><keyword>Adenosine: metabolism</keyword><keyword>Adenosine: physiology</keyword><keyword>Animals</keyword><keyword>Bronchi</keyword><keyword>Bronchi: pathology</keyword><keyword>Catalase</keyword><keyword>Catalase: physiology</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: metabolism</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Enzyme Activation</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Free Radical Scavengers</keyword><keyword>Free Radical Scavengers: pharmacology</keyword><keyword>Gene Expression</keyword><keyword>Gene Expression: drug effects</keyword><keyword>Glutathione</keyword><keyword>Glutathione: metabolism</keyword><keyword>Humans</keyword><keyword>Hydrogen Peroxide</keyword><keyword>Hydrogen Peroxide: metabolism</keyword><keyword>Primary Cell Culture</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C: metabolism</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reactive Oxygen Species: metabolism</keyword><keyword>Receptor</keyword><keyword>Second Messenger Systems</keyword><keyword>Smoke</keyword><keyword>Tobacco</keyword><keyword>Tobacco: chemistry</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2013</year></dates><accession-num>23371060</accession-num><electronic-resource-num>10.1165/rcmb.2011-0273OC</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23371060</url></web-urls></urls><label>Wound Healing</label><abstract>Adenosine concentrations are elevated in the lungs of patients with asthma and chronic obstructive pulmonary disease, where it balances between tissue repair and excessive airway remodeling. We previously demonstrated that the activation of the adenosine A2A receptor promotes epithelial wound closure. However, the mechanism by which adenosine-mediated wound healing occurs after cigarette smoke exposure has not been investigated. The present study investigates whether cigarette smoke exposure alters adenosine-mediated reparative properties via its ability to induce a shift in the oxidant/antioxidant balance. Using an in vitro wounding model, bronchial epithelial cells were exposed to 5% cigarette smoke extract, were wounded, and were then stimulated with either 10 μM adenosine or the specific A2A receptor agonist, 5'-(N-cyclopropyl)-carboxamido-adenosine (CPCA; 10 μM), and assessed for wound closure. In a subset of experiments, bronchial epithelial cells were infected with adenovirus vectors encoding human superoxide dismutase and/or catalase or control vector. In the presence of 5% smoke extract, significant delay was evident in both adenosine-mediated and CPCA-mediated wound closure. However, cells pretreated with N-acetylcysteine (NAC), a nonspecific antioxidant, reversed smoke extract-mediated inhibition. We found that cells overexpressing mitochondrial catalase repealed the smoke extract inhibition of CPCA-stimulated wound closure, whereas superoxide dismutase overexpression exerted no effect. Kinase experiments revealed that smoke extract significantly reduced the A2A-mediated activation of cyclic adenosine monophosphate-dependent protein kinase. However, pretreatment with NAC reversed this effect. In conclusion, our data suggest that cigarette smoke exposure impairs A2A-stimulated wound repair via a reactive oxygen species-dependent mechanism, thereby providing a better understanding of adenosine signaling that may direct the development of pharmacological tools for the treatment of chronic inflammatory lung disorders.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>George, Margaret D</author><author>Wine, Robert N</author><author>Lackford, Brad</author><author>Kissling, Grace E</author><author>Akiyama, Steven K</author><author>Olden, Kenneth</author><author>Roberts, John D</author></authors></contributors><titles><title>p38 mitogen-activated protein kinase interacts with vinculin at focal adhesions during fatty acid-stimulated cell adhesion.</title><secondary-title>Biochemistry and cell biology = Biochimie et biologie cellulaire</secondary-title></titles><periodical><full-title>Biochemistry and cell biology = Biochimie et biologie cellulaire</full-title></periodical><pages>404-418</pages><volume>91</volume><issue>6</issue><keywords><keyword>Antigens</keyword><keyword>Arachidonic Acid</keyword><keyword>Arachidonic Acid: pharmacology</keyword><keyword>Binding Sites</keyword><keyword>CD29</keyword><keyword>CD29: genetics</keyword><keyword>CD29: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Line</keyword><keyword>Collagen Type IV</keyword><keyword>Collagen Type IV: genetics</keyword><keyword>Collagen Type IV: metabolism</keyword><keyword>Confocal</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: drug effects</keyword><keyword>Cytoskeleton: genetics</keyword><keyword>Cytoskeleton: ultrastructure</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Microscopy</keyword><keyword>Neoplastic</keyword><keyword>Neoplastic: drug effects</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: genetics</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Structure</keyword><keyword>Pseudopodia</keyword><keyword>Pseudopodia: drug effects</keyword><keyword>Pseudopodia: genetics</keyword><keyword>Pseudopodia: ultrastructure</keyword><keyword>Recombinant Fusion Proteins</keyword><keyword>Recombinant Fusion Proteins: genetics</keyword><keyword>Recombinant Fusion Proteins: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Tertiary</keyword><keyword>Tumor</keyword><keyword>Vinculin</keyword><keyword>Vinculin: genetics</keyword><keyword>Vinculin: metabolism</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>p38 Mitogen-Activated Protein Kinases: genetics</keyword><keyword>p38 Mitogen-Activated Protein Kinases: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>24219282</accession-num><electronic-resource-num>10.1139/bcb-2013-0013</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3935246&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Arachidonic acid stimulates cell adhesion by activating α2β1 integrins in a process that depends on protein kinases, including p38 mitogen activated protein kinase. Here, we describe the interaction of cytoskeletal components with key signaling molecules that contribute to the spreading of, and morphological changes in, arachidonic acid-treated MDA-MB-435 human breast carcinoma cells. Arachidonic acid-treated cells showed increased attachment and spreading on collagen type IV, as measured by electric cell-substrate impedance sensing. Fatty acid-treated cells displayed short cortical actin filaments associated with an increased number of β1 integrin-containing pseudopodia, whereas untreated cells displayed elongated stress fibers and fewer clusters of β1 integrins. Confocal microscopy of arachidonic acid-treated cells showed that vinculin and phospho-p38 both appeared enriched in pseudopodia and at the tips of actin filaments, and fluorescence ratio imaging indicated the increase was specific for the phospho-(active) form of p38. Immunoprecipitates of phospho-p38 from extracts of arachidonic acid-treated cells contained vinculin, and GST-vinculin fusion proteins carrying the central region of vinculin bound phospho-p38, whereas fusion proteins expressing the terminal portions of vinculin did not. These data suggest that phospho-p38 associates with particular domains on critical focal adhesion proteins that are involved in tumor cell adhesion and spreading, and that this association can be regulated by factors in the tumor microenvironment.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dewitt, Sharon</author><author>Francis, Robert J</author><author>Hallett, Maurice B</author></authors></contributors><titles><title>Ca²⁺ and calpain control membrane expansion during the rapid cell spreading of neutrophils.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>4627-4635</pages><volume>126</volume><issue>Pt 20</issue><keywords><keyword>4</keyword><keyword>5-Trisphosphate</keyword><keyword>5-Trisphosphate: metabolism</keyword><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Calcium</keyword><keyword>Calcium: metabolism</keyword><keyword>Calpain</keyword><keyword>Calpain: metabolism</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: enzymology</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Cell Shape</keyword><keyword>Cell Shape: physiology</keyword><keyword>Confocal</keyword><keyword>Humans</keyword><keyword>Inositol 1</keyword><keyword>Microscopy</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: cytology</keyword><keyword>Neutrophils: enzymology</keyword><keyword>Neutrophils: metabolism</keyword><keyword>Phagocytosis</keyword></keywords><dates><year>2013</year></dates><accession-num>23943875</accession-num><electronic-resource-num>10.1242/jcs.124917</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3795336&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Following adherence of neutrophils to the endothelium, neutrophils undergo a major morphological change that is a necessary prelude to their extravasation. We show here that this shape change is triggered by an elevation of cytosolic inositol (1,4,5)-trisphosphate (IP3), to provoke physiological Ca(2+) influx through a store-operated mechanism. This transition from a spherical to 'flattened' neutrophil morphology is rapid (∼100 seconds) and is accompanied by an apparent rapid expansion of the area of the plasma membrane. However, no new membrane is added into the plasma membrane. Pharmacological inhibition of calpain-activation, which is triggered by Ca(2+) influx during neutrophil spreading, prevents normal cell flattening. In calpain-suppressed cells, an aberrant form of cell spreading can occur where an uncoordinated and localised expansion of the plasma membrane is evident. These data show that rapid neutrophil spreading is triggered by Ca(2+) influx, which causes activation of calpain and release of furled plasma membrane to allow its apparent 'expansion'.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Moshnikova, Anna</author><author>Moshnikova, Valentina</author><author>Andreev, Oleg A</author><author>Reshetnyak, Yana K</author></authors></contributors><titles><title>Antiproliferative effect of pHLIP-amanitin</title><secondary-title>Biochemistry</secondary-title></titles><periodical><full-title>Biochemistry</full-title></periodical><pages>1171-1178</pages><volume>52</volume><issue>7</issue><keywords/><dates><year>2013</year></dates><isbn>1520-4995 (Electronic)\r0006-2960 (Linking)</isbn><accession-num>23360641</accession-num><electronic-resource-num>10.1021/bi301647y</electronic-resource-num><urls/><abstract>Toxins could be effective anticancer drugs, if their selective delivery into cancer cells could be achieved. We have shown that the energy of membrane-associated folding of water-soluble membrane peptides of the pHLIP (pH low insertion peptide) family could be used to move cell-impermeable cargo across the lipid bilayer into the cytoplasm of cancer cells. Here we present the results of a study of pHLIP-mediated cellular delivery of a polar cell-impermeable toxin, α-amanitin, an inhibitor of RNA polymerase II. We show that pHLIP can deliver α-amanitin into cells in a pH-dependent fashion and induce cell death within 48 h. Translocation capability could be tuned by conjugating amanitin to the C-terminus of pHLIP via linkers of different hydrophobicities that could be cleaved in the cytoplasm. pHLIP-SPDP-amanitin, which exhibits 4-5 times higher antiproliferative ability at pH 6 than at pH 7.4, was selected as the best construct. The major mechanism of amanitin delivery is direct translocation (flip) across a membrane by pHLIP and cleavage of the S-S bond in the cytoplasm. The antiproliferative effect was monitored on four different human cancer cell lines. pHLIP-mediated cytoplasmic delivery of amanitin could create great opportunities to use the toxin as a potent pH-selective anticancer agent, which predominantly targets highly proliferative cancer cells at low extracellular pH values.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Obiako, Boniface</author><author>Calchary, Wendy</author><author>Xu, Ningyong</author><author>Kunstadt, Ryan</author><author>Richardson, Bianca</author><author>Nix, Jessica</author><author>Sayner, Sarah L</author></authors></contributors><titles><title>Bicarbonate disruption of the pulmonary endothelial barrier via activation of endogenous soluble adenylyl cyclase, isoform 10.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L185-92</pages><volume>305</volume><issue>2</issue><keywords><keyword>Acidosis</keyword><keyword>Acidosis: enzymology</keyword><keyword>Adenylate Cyclase</keyword><keyword>Adenylate Cyclase: biosynthesis</keyword><keyword>Adult</keyword><keyword>Adult: enzymology</keyword><keyword>Animals</keyword><keyword>Bicarbonates</keyword><keyword>Bicarbonates: metabolism</keyword><keyword>Blood-Air Barrier</keyword><keyword>Blood-Air Barrier: enzymology</keyword><keyword>Blood-Air Barrier: pathology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Endothelium</keyword><keyword>Endothelium: enzymology</keyword><keyword>Endothelium: pathology</keyword><keyword>Enzymologic</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Rats</keyword><keyword>Respiratory Distress Syndrome</keyword></keywords><dates><year>2013</year></dates><isbn>2514607086</isbn><accession-num>23686854</accession-num><electronic-resource-num>10.1152/ajplung.00392.2012</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23686854</url></web-urls></urls><abstract>It is becoming increasingly apparent that cAMP signals within the pulmonary endothelium are highly compartmentalized, and this compartmentalization is critical to maintaining endothelial barrier integrity. Studies demonstrate that the exogenous soluble bacterial toxin, ExoY, and heterologous expression of the forskolin-stimulated soluble mammalian adenylyl cyclase (AC) chimera, sACI/II, elevate cytosolic cAMP and disrupt the pulmonary microvascular endothelial barrier. The barrier-disruptive effects of cytosolic cAMP generated by exogenous soluble ACs are in contrast to the barrier-protective effects of subplasma membrane cAMP generated by transmembrane AC, which strengthens endothelial barrier integrity. Endogenous soluble AC isoform 10 (AC10 or commonly known as sAC) lacks transmembrane domains and localizes within the cytosolic compartment. AC10 is uniquely activated by bicarbonate to generate cytosolic cAMP, yet its role in regulation of endothelial barrier integrity has not been addressed. Here we demonstrate that, within the pulmonary circulation, AC10 is expressed in pulmonary microvascular endothelial cells (PMVECs) and pulmonary artery endothelial cells (PAECs), yet expression in PAECs is lower. Furthermore, pulmonary endothelial cells selectively express bicarbonate cotransporters. While extracellular bicarbonate generates a phosphodiesterase 4-sensitive cAMP pool in PMVECs, no such cAMP response is detected in PAECs. Finally, addition of extracellular bicarbonate decreases resistance across the PMVEC monolayer and increases the filtration coefficient in the isolated perfused lung above osmolality controls. Collectively, these findings suggest that PMVECs have a bicarbonate-sensitive cytosolic cAMP pool that disrupts endothelial barrier integrity. These studies could provide an alternative mechanism for the controversial effects of bicarbonate correction of acidosis of acute respiratory distress syndrome patients.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Marentette, John O</author><author>Hauser, Paul J</author><author>Hurst, Robert E</author><author>Klumpp, David J</author><author>Rickard, Alice</author><author>McHowat, Jane</author></authors></contributors><titles><title>Tryptase activation of immortalized human urothelial cell mitogen-activated protein kinase.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e69948</pages><volume>8</volume><issue>7</issue><keywords/><dates><year>2013</year></dates><accession-num>23922867</accession-num><electronic-resource-num>10.1371/journal.pone.0069948</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3726738&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration</label><abstract>The pathogenesis of interstitial cystitis/painful bladder syndrome (IC/PBS) is multifactorial, but likely involves urothelial cell dysfunction and mast cell accumulation in the bladder wall. Activated mast cells in the bladder wall release several inflammatory mediators, including histamine and tryptase. We determined whether mitogen-activated protein (MAP) kinases are activated in response to tryptase stimulation of urothelial cells derived from human normal and IC/PBS bladders. Tryptase stimulation of normal urothelial cells resulted in a 2.5-fold increase in extracellular signal regulated kinase 1/2 (ERK 1/2). A 5.5-fold increase in ERK 1/2 activity was observed in urothelial cells isolated from IC/PBS bladders. No significant change in p38 MAP kinase was observed in tryptase-stimulated normal urothelial cells but a 2.5-fold increase was observed in cells isolated from IC/PBS bladders. Inhibition of ERK 1/2 with PD98059 or inhibition of p38 MAP kinase with SB203580 did not block tryptase-stimulated iPLA2 activation. Incubation with the membrane phospholipid-derived PLA2 hydrolysis product lysoplasmenylcholine increased ERK 1/2 activity, suggesting the iPLA2 activation is upstream of ERK 1/2. Real time measurements of impedance to evaluate wound healing of cell cultures indicated increased healing rates in normal and IC/PBS urothelial cells in the presence of tryptase, with inhibition of ERK 1/2 significantly decreasing the wound healing rate of IC/PBS urothelium. We conclude that activation of ERK 1/2 in response to tryptase stimulation may facilitate wound healing or cell motility in areas of inflammation in the bladder associated with IC/PBS.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Di Lorenzo, Annarita</author><author>Lin, Michelle I</author><author>Murata, Takahisa</author><author>Landskroner-Eiger, Shira</author><author>Schleicher, Michael</author><author>Kothiya, Milankumar</author><author>Iwakiri, Yasuko</author><author>Yu, Jun</author><author>Huang, Paul L</author><author>Sessa, William C</author></authors></contributors><titles><title>eNOS-derived nitric oxide regulates endothelial barrier function through VE-cadherin and Rho GTPases.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>5541-5552</pages><volume>126</volume><issue>Pt 24</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Endothelium</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: metabolism</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Knockout</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Nitric Oxide</keyword><keyword>Nitric Oxide Synthase Type III</keyword><keyword>Nitric Oxide Synthase Type III: genetics</keyword><keyword>Nitric Oxide Synthase Type III: metabolism</keyword><keyword>Nitric Oxide: physiology</keyword><keyword>Phosphorylation</keyword><keyword>Post-Translational</keyword><keyword>Protein Processing</keyword><keyword>Protein Transport</keyword><keyword>Stress Fibers</keyword><keyword>Stress Fibers: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: physiology</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>src-Family Kinases</keyword><keyword>src-Family Kinases: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>24046447</accession-num><electronic-resource-num>10.1242/jcs.115972</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3860306&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Transient disruption of endothelial adherens junctions and cytoskeletal remodeling are responsible for increases in vascular permeability induced by inflammatory stimuli and vascular endothelial growth factor (VEGF). Nitric oxide (NO) produced by endothelial NO synthase (eNOS) is crucial for VEGF-induced changes in permeability in vivo; however, the molecular mechanism by which endogenous NO modulates endothelial permeability is not clear. Here, we show that the lack of eNOS reduces VEGF-induced permeability, an effect mediated by enhanced activation of the Rac GTPase and stabilization of cortical actin. The loss of NO increased the recruitment of the Rac guanine-nucleotide-exchange factor (GEF) TIAM1 to adherens junctions and VE-cadherin (also known as cadherin 5), and reduced Rho activation and stress fiber formation. In addition, NO deficiency reduced VEGF-induced VE-cadherin phosphorylation and impaired the localization, but not the activation, of c-Src to cell junctions. The physiological role of eNOS activation is clear given that VEGF-, histamine- and inflammation-induced vascular permeability is reduced in mice bearing a non-phosphorylatable knock-in mutation of the key eNOS phosphorylation site S1176. Thus, NO is crucial for Rho GTPase-dependent regulation of cytoskeletal architecture leading to reversible changes in vascular permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jiang, Wen G</author><author>Ye, Lin</author><author>Sanders, Andrew J</author><author>Ruge, Fiona</author><author>Kynaston, Howard G</author><author>Ablin, Richard J</author><author>Mason, Malcolm D</author></authors></contributors><titles><title>Prostate transglutaminase (TGase-4, TGaseP) enhances the adhesion of prostate cancer cells to extracellular matrix, the potential role of TGase-core domain</title><secondary-title>Journal of Translational Medicine</secondary-title></titles><periodical><full-title>Journal of Translational Medicine</full-title></periodical><pages>269</pages><volume>11</volume><issue>1</issue><keywords><keyword>Cell-matrix adhesion</keyword><keyword>Electric cell sensing</keyword><keyword>Focal adhesion kinase</keyword><keyword>Integrins</keyword><keyword>Paxillin</keyword><keyword>Prostate cancer</keyword><keyword>Transglutaminase</keyword><keyword>Transglutaminase-4</keyword><keyword>cell-matrix adhesion</keyword><keyword>electric cell sensing</keyword><keyword>focal adhesion kinase</keyword><keyword>integrins</keyword><keyword>paxillin</keyword><keyword>prostate cancer</keyword><keyword>transglutaminase</keyword><keyword>transglutaminase-4</keyword></keywords><dates><year>2013</year></dates><publisher>Journal of Translational Medicine</publisher><electronic-resource-num>10.1186/1479-5876-11-269</electronic-resource-num><urls><web-urls><url>http://www.translational-medicine.com/content/11/1/269</url></web-urls></urls><label>ECIS Attachment;ECIS Modeling</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rousalova, Ilona</author><author>Banerjee, Sulagna</author><author>Sangwan, Veena</author><author>Evenson, Kristen</author><author>McCauley, Joel a</author><author>Kratzke, Robert</author><author>Vickers, Selwyn M</author><author>Saluja, Ashok</author><author>D'Cunha, Jonathan</author></authors></contributors><titles><title>Minnelide: a novel therapeutic that promotes apoptosis in non-small cell lung carcinoma in vivo.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e77411</pages><volume>8</volume><issue>10</issue><keywords/><dates><year>2013</year></dates><accession-num>24143232</accession-num><electronic-resource-num>10.1371/journal.pone.0077411</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3797124&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>BACKGROUND: Minnelide, a pro-drug of triptolide, has recently emerged as a potent anticancer agent. The precise mechanisms of its cytotoxic effects remain unclear.  METHODS: Cell viability was studied using CCK8 assay. Cell proliferation was measured real-time on cultured cells using Electric Cell Substrate Impedence Sensing (ECIS). Apoptosis was assayed by Caspase activity on cultured lung cancer cells and TUNEL staining on tissue sections. Expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA, APAF-1) was estimated by qRTPCR. Effect of Minnelide on proliferative cells in the tissue was estimated by Ki-67 staining of animal tissue sections.  RESULTS: In this study, we investigated in vitro and in vivo antitumor effects of triptolide/Minnelide in non-small cell lung carcinoma (NSCLC). Triptolide/Minnelide exhibited anti-proliferative effects and induced apoptosis in NSCLC cell lines and NSCLC mouse models. Triptolide/Minnelide significantly down-regulated the expression of pro-survival and anti-apoptotic genes (HSP70, BIRC5, BIRC4, BIRC2, UACA) and up-regulated pro-apoptotic APAF-1 gene, in part, via attenuating the NF-κB signaling activity.  CONCLUSION: In conclusion, our results provide supporting mechanistic evidence for Minnelide as a potential in NSCLC.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sharma, Preety</author><author>Templin, Thomas</author><author>Grabham, Peter</author></authors></contributors><titles><title>Short term effects of gamma radiation on endothelial barrier function: uncoupling of PECAM-1.</title><secondary-title>Microvascular research</secondary-title></titles><periodical><full-title>Microvascular research</full-title></periodical><pages>11-20</pages><volume>86</volume><keywords><keyword>Actins</keyword><keyword>Actins: analysis</keyword><keyword>Antigens</keyword><keyword>CD31</keyword><keyword>CD31: analysis</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: radiation effects</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion Molecules</keyword><keyword>Cell Adhesion Molecules: analysis</keyword><keyword>Cell Adhesion: radiation effects</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cell Culture Techniques: methods</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cultured: chemistry</keyword><keyword>Cultured: physiology</keyword><keyword>Cultured: radiation effects</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: ultrastructure</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: chemistry</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Endothelial Cells: radiation effects</keyword><keyword>Endothelium</keyword><keyword>Gamma Rays</keyword><keyword>Gamma Rays: adverse effects</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: chemistry</keyword><keyword>Human Umbilical Vein Endothelial Cells: physiology</keyword><keyword>Human Umbilical Vein Endothelial Cells: radiation</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: radiation effects</keyword><keyword>Intercellular Junctions: ultrastructure</keyword><keyword>Microvessels</keyword><keyword>Microvessels: cytology</keyword><keyword>Organoids</keyword><keyword>Organoids: chemistry</keyword><keyword>Organoids: physiology</keyword><keyword>Organoids: radiation effects</keyword><keyword>Radiation Injuries</keyword><keyword>Radiation Injuries: etiology</keyword><keyword>Vascular</keyword><keyword>Vascular: chemistry</keyword><keyword>Vascular: physiology</keyword><keyword>Vascular: radiation effects</keyword></keywords><dates><year>2013</year></dates><accession-num>23220351</accession-num><electronic-resource-num>10.1016/j.mvr.2012.11.007</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23220351</url></web-urls></urls><abstract>A limiting factor in the treatment of cancer with radiotherapy is the damage to surrounding normal tissue, particularly the vasculature. Vessel pathologies are a major feature of the side effects of radiotherapy and little is known about early events that could initiate subsequent diseases. We tested the hypothesis that gamma radiation has early damaging effects on the human endothelial barrier. Two models were used; Human Brain Microcapillary Endothelial Cells (HBMEC), and Human Umbilical Vein Endothelial Cells (HUVEC). Endpoints included Trans-Endothelial Electrical Resistance (TEER), barrier permeability to 10 kDa and 70 kDa tracer molecules, and the localization of F-actin, and junction proteins and the Platelet Endothelial Cell Adhesion Molecule (PECAM-1). Radiation induced a rapid and transient decrease in TEER at 3 h, with effects also seen at the radiotherapy doses. This dip in resistance correlated to the transient loss of PECAM-1 in discrete areas where cells often detached from the monolayer leaving gaps. Redistribution of PECAM-1 was also seen in 3-D human tissue models. By 6 h, the remaining cells had migrated to reseal the barrier, coincident with TEER returning to control levels. Resealed monolayers contained fewer cells per unit area and their barrier function was weakened as evidenced by an increased permeability over 24 h. This is the first demonstration of a transient and rapid effect of gamma radiation on human endothelial barriers that involves cell detachment and the loss of PECAM-1. Considering the association of cell adhesion molecules with vasculopathies, such an effect has the potential to be clinically relevant to the longer-term effects of radiotherapy.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ngok, Siu P</author><author>Geyer, Rory</author><author>Kourtidis, Antonis</author><author>Mitin, Natalia</author><author>Feathers, Ryan</author><author>Der, Channing</author><author>Anastasiadis, Panos Z</author></authors></contributors><titles><title>TEM4 is a junctional Rho GEF required for cell-cell adhesion, monolayer integrity and barrier function.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>3271-3277</pages><volume>126</volume><issue>Pt 15</issue><keywords><keyword>catenin</keyword><keyword>cell adhesion</keyword><keyword>cell junction</keyword><keyword>guanine nucleotide exchange factor</keyword><keyword>rhoa</keyword><keyword>tem4</keyword></keywords><dates><year>2013</year></dates><accession-num>23729734</accession-num><electronic-resource-num>10.1242/jcs.123869</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23729734</url></web-urls></urls><abstract>Signaling events mediated by Rho family GTPases orchestrate cytoskeletal dynamics and cell junction formation. The activation of Rho GTPases is tightly regulated by guanine-nucleotide-exchange factors (GEFs). In this study, we identified a novel Rho-specific GEF called TEM4 (tumor endothelial marker 4) that associates with multiple members of the cadherin-catenin complex and with several cytoskeleton-associated proteins. Depending on confluence, TEM4 localized to either actin stress fibers or areas of cell-cell contact. The junctional localization of TEM4 was independent of actin binding. Depletion of endogenous TEM4 by shRNAs impaired Madin-Darby canine kidney (MDCK) and human umbilical vein endothelial cell (HUVEC) cell junctions, disrupted MDCK acini formation in 3D culture and negatively affected endothelial barrier function. Taken together, our findings implicate TEM4 as a novel and crucial junctional Rho GEF that regulates cell junction integrity and epithelial and endothelial cell function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Post, a.</author><author>Pannekoek, W.-J.</author><author>Ross, S H</author><author>Verlaan, I</author><author>Brouwer, P M</author><author>Bos, J L</author></authors></contributors><titles><title>Rasip1 mediates Rap1 regulation of Rho in endothelial barrier function through ArhGAP29</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>1-6</pages><keywords/><dates><year>2013</year></dates><electronic-resource-num>10.1073/pnas.1306595110</electronic-resource-num><urls><web-urls><url>http://www.pnas.org/cgi/doi/10.1073/pnas.1306595110</url></web-urls></urls><label>ECIS Modeling;ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tran, Trong Binh</author><author>Nguyen, Phuong Diem</author><author>Um, Soong Ho</author><author>Son, Sang Jun</author><author>Min, Junhong</author></authors></contributors><titles><title>Real-Time Monitoring In Vitro Cellular Cytotoxicity of Silica Nanotubes Using Electric Cell-Substrate Impedance Sensing (ECIS)</title><secondary-title>Journal of Biomedical Nanotechnology</secondary-title></titles><periodical><full-title>Journal of Biomedical Nanotechnology</full-title></periodical><pages>286-290</pages><volume>9</volume><issue>2</issue><keywords/><dates><year>2013</year></dates><electronic-resource-num>10.1166/jbn.2013.1500</electronic-resource-num><urls><web-urls><url>http://openurl.ingenta.com/content/xref?genre=article&amp;issn=1550-7033&amp;volume=9&amp;issue=2&amp;spage=286</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Aranda, J F</author><author>Reglero-Real, N</author><author>Marcos-Ramiro, B</author><author>Ruiz-Saenz, A</author><author>Fernandez-Martin, L</author><author>Bernabe-Rubio, M</author><author>Kremer, L</author><author>Ridley, A J</author><author>Correas, I</author><author>Alonso, M A</author><author>Millan, J</author></authors></contributors><titles><title>MYADM controls endothelial barrier function through ERM-dependent regulation of ICAM-1 expression</title><secondary-title>Mol.Biol.Cell</secondary-title></titles><periodical><full-title>Mol.Biol.Cell</full-title></periodical><pages>483-494</pages><volume>24</volume><issue>1939-4586 (Electronic)</issue><keywords><keyword>Actin Cytoskeleton</keyword><keyword>Animals</keyword><keyword>Biological Transport</keyword><keyword>Cell Adhesion</keyword><keyword>Cells</keyword><keyword>Cholesterol</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeleton</keyword><keyword>Dogs</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelium</keyword><keyword>Epithelial Cells</keyword><keyword>Gene Expression Regulation</keyword><keyword>Hela Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Humans</keyword><keyword>Inflammation</keyword><keyword>Intercellular Adhesion Molecule-1</keyword><keyword>Madin Darby Canine Kidney Cells</keyword><keyword>Membrane Microdomains</keyword><keyword>Membrane Proteins</keyword><keyword>Microfilament Proteins</keyword><keyword>Myelin and Lymphocyte-Associated Proteolipid Prote</keyword><keyword>Permeability</keyword><keyword>Proteins</keyword><keyword>RNA</keyword><keyword>Rna</keyword><keyword>Signal Transduction</keyword><keyword>Small Interfering</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>adhesion</keyword><keyword>antagonists &amp; inhibitors</keyword><keyword>barrier</keyword><keyword>blood</keyword><keyword>chemistry</keyword><keyword>cytology</keyword><keyword>drug effects</keyword><keyword>genetics</keyword><keyword>junctions</keyword><keyword>metabolism</keyword><keyword>pharmacology</keyword></keywords><dates><year>2013</year></dates><isbn>1939-4586 (Electronic) 1059-1524 (Linking)</isbn><accession-num>23264465</accession-num><electronic-resource-num>10.1091/mbc.E11-11-0914</electronic-resource-num><urls/><label>Inflammation;Signal Transduction</label><abstract>The endothelium maintains a barrier between blood and tissue that becomes more permeable during inflammation. Membrane rafts are ordered assemblies of cholesterol, glycolipids, and proteins that modulate proinflammatory cell signaling and barrier function. In epithelial cells, the MAL family members MAL, MAL2, and myeloid-associated differentiation marker (MYADM) regulate the function and dynamics of ordered membrane domains. We analyzed the expression of these three proteins in human endothelial cells and found that only MYADM is expressed. MYADM was confined in ordered domains at the plasma membrane, where it partially colocalized with filamentous actin and cell-cell junctions. Small interfering RNA (siRNA)-mediated MYADM knockdown increased permeability, ICAM-1 expression, and leukocyte adhesion, all of which are features of an inflammatory response. Barrier function decrease in MYADM-silenced cells was dependent on ICAM-1 expression. Membrane domains and the underlying actin cytoskeleton can regulate each other and are connected by ezrin, radixin, and moesin (ERM) proteins. In endothelial cells, MYADM knockdown induced ERM activation. Triple-ERM knockdown partially inhibited ICAM-1 increase induced by MYADM siRNA. Importantly, ERM knockdown also reduced ICAM-1 expression in response to the proinflammatory cytokine tumor necrosis factor-alpha. MYADM therefore regulates the connection between the plasma membrane and the cortical cytoskeleton and so can control the endothelial inflammatory response</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukova, Anna A</author><author>Tian, Xinyong</author><author>Tian, Yufeng</author><author>Higginbotham, Katherine</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Rap-afadin axis in control of Rho signaling and endothelial barrier recovery.</title><secondary-title>Molecular biology of the cell</secondary-title></titles><periodical><full-title>Molecular biology of the cell</full-title></periodical><pages>2678-2688</pages><volume>24</volume><issue>17</issue><keywords/><dates><year>2013</year></dates><accession-num>23864716</accession-num><electronic-resource-num>10.1091/mbc.E13-02-0098</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23864716</url></web-urls></urls><abstract>Activation of the Rho GTPase pathway determines endothelial cell (EC) hyperpermeability after injurious stimuli. To date, feedback mechanisms of Rho down-regulation critical for barrier restoration remain poorly understood. We tested a hypothesis that Rho down-regulation and barrier recovery of agonist-stimulated ECs is mediated by the Ras family GTPase Rap1. Thrombin-induced EC permeability driven by rapid activation of the Rho GTPase pathway was followed by Src kinase-dependent phosphorylation of the Rap1-specific guanine nucleotide exchange factor (GEF) C3G, activation of Rap1, and initiation of EC barrier recovery. Knockdown experiments showed that Rap1 activation was essential for down-regulation of Rho signaling and actin stress fiber dissolution. Rap1 activation also enhanced interaction between adherens junction (AJ) proteins VE-cadherin and p120-catenin and stimulated AJ reannealing mediated by the Rap1 effector afadin. This mechanism also included Rap1-dependent membrane translocation of the Rac1-specific GEF Tiam1 and activation of Rac1-dependent peripheral cytoskeletal dynamics, leading to resealing of intercellular gaps. These data demonstrate that activation of the Rap1-afadin axis is a physiological mechanism driving restoration of barrier integrity in agonist-stimulated EC monolayers via negative-feedback regulation of Rho signaling, stimulation of actin peripheral dynamics, and reestablishment of cell-cell adhesive complexes.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Szulcek, Robert</author><author>Beckers, Cora M L</author><author>Hodzic, Jasmina</author><author>de Wit, Jelle</author><author>Chen, Zhenlong</author><author>Grob, Tim</author><author>Musters, Rene J P</author><author>Minshall, Richard D</author><author>van Hinsbergh, Victor W M</author><author>van Nieuw Amerongen, Geerten P</author></authors></contributors><titles><title>Localized RhoA GTPase activity regulates dynamics of endothelial monolayer integrity.</title><secondary-title>Cardiovascular research</secondary-title></titles><periodical><full-title>Cardiovascular research</full-title></periodical><pages>471-482</pages><volume>99</volume><issue>3</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: physiology</keyword><keyword>Male</keyword><keyword>Rats</keyword><keyword>Signal Transduction</keyword><keyword>Thrombin</keyword><keyword>Thrombin: metabolism</keyword><keyword>Wistar</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2013</year></dates><isbn>1755-3245 (Electronic) 0008-6363 (Linking)</isbn><accession-num>23536606</accession-num><electronic-resource-num>10.1093/cvr/cvt075</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23536606</url></web-urls></urls><label>Signal Transduction</label><abstract>AIMS: Endothelial cells (ECs) control vascular permeability by forming a monolayer that is sealed by extracellular junctions. Various mediators modulate the endothelial barrier by acting on junctional protein complexes and the therewith connected F-actin cytoskeleton. Different Rho GTPases participate in this modulation, but their mechanisms are still partly resolved. Here, we aimed to elucidate whether the opening and closure of the endothelial barrier are associated with distinct localized RhoA activities at the subcellular level.\n\nMETHODS AND RESULTS: Live fluorescence resonance energy transfer (FRET) microscopy revealed spatially distinct RhoA activities associated with different aspects of the regulation of endothelial monolayer integrity. Unstimulated ECs were characterized by hotspots of RhoA activity at their periphery. Thrombin receptor activation in the femoral vein of male wistar rats and in cultured ECs enhanced RhoA activity at membrane protrusions, followed by a more sustained RhoA activity associated with cytoplasmic F-actin filaments, where prolonged RhoA activity coincided with cellular contractility. Unexpectedly, thrombin-induced peripheral RhoA hotspots were not spatially correlated to the formation of large inter-endothelial gaps. Rather, spontaneous RhoA activity at membrane protrusions coincided with the closure of inter-endothelial gaps. Electrical impedance measurements showed that RhoA signalling is essential for this protrusive activity and maintenance of barrier restoration.\n\nCONCLUSION: Spontaneous RhoA activity at membrane protrusions is spatially associated with closure, but not formation of inter-endothelial gaps, whereas RhoA activity at distant contractile filaments contributes to thrombin-induced disruption of junctional integrity. Thus, these data indicate that distinct RhoA activities are associated with disruption and re-annealing of endothelial junctions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Alieva, Irina B</author><author>Zemskov, Evgeny A</author><author>Smurova, Ksenija M</author><author>Kaverina, Irina N</author><author>Verin, Alexander D</author></authors></contributors><titles><title>The leading role of microtubules in endothelial barrier dysfunction: disassembly of peripheral microtubules leaves behind the cytoskeletal reorganization.</title><secondary-title>Journal of cellular biochemistry</secondary-title></titles><periodical><full-title>Journal of cellular biochemistry</full-title></periodical><pages>2258-2272</pages><volume>114</volume><issue>10</issue><keywords><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Microtubules</keyword><keyword>Microtubules: metabolism</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23606375</accession-num><electronic-resource-num>10.1002/jcb.24575</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3901434&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Disturbance of the endothelial barrier is characterized by dramatic cytoskeleton reorganization, activation of actomyosin contraction and, finally, leads to intercellular gap formation. Here we demonstrate that the edemagenic agent, thrombin, causes a rapid increase in the human pulmonary artery endothelial cell (EC) barrier permeability accompanied by fast decreasing in the peripheral microtubules quantity and reorganization of the microtubule system in the internal cytoplasm of the EC within 5 min of the treatment. The actin stress-fibers formation occurs gradually and the maximal effect is observed relatively later, 30 min of the thrombin treatment. Thus, microtubules reaction develops faster than the reorganization of the actin filaments system responsible for the subsequent changes of the cell shape during barrier dysfunction development. Direct microtubules depolymerization by nocodazole initiates the cascade of barrier dysfunction reactions. Nocodazole-induced barrier disruption is connected directly with the degree of peripheral microtubules depolymerization. Short-term loss of endothelial barrier function occurs at the minimal destruction of peripheral microtubules, when actin filament system is still intact. Specifically, we demonstrate that the EC microtubule dynamics examined by time-lapse imaging of EB3-GFP comets movement has changed under these conditions: microtubule plus ends growth rate significantly decreased near the cell periphery. The microtubules, apparently, are the first target in the circuit of reactions leading to the pulmonary EC barrier compromise. Our results show that dynamic microtubules play an essential role in the barrier function in vitro; peripheral microtubules depolymerization is necessary and sufficient condition for initiation of endothelial barrier dysfunction.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Peng, Zhanglong</author><author>Pati, Shibani</author><author>Potter, Daniel</author><author>Brown, Ryan</author><author>Holcomb, John B</author><author>Grill, Raymond</author><author>Wataha, Kathryn</author><author>Park, Pyong Woo</author><author>Xue, Hasen</author><author>Kozar, Rosemary A</author></authors></contributors><titles><title>Fresh frozen plasma lessens pulmonary endothelial inflammation and hyperpermeability after hemorrhagic shock and is associated with loss of syndecan 1.</title><secondary-title>Shock (Augusta, Ga.)</secondary-title></titles><periodical><full-title>Shock (Augusta, Ga.)</full-title></periodical><pages>195-202</pages><volume>40</volume><issue>3</issue><keywords><keyword>Animals</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Endothelium: metabolism</keyword><keyword>Hemorrhagic</keyword><keyword>Hemorrhagic: metabolism</keyword><keyword>Hemorrhagic: therapy</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Leukocytes</keyword><keyword>Leukocytes: metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Plasma</keyword><keyword>Pneumonia</keyword><keyword>Pneumonia: metabolism</keyword><keyword>Pneumonia: therapy</keyword><keyword>Shock</keyword><keyword>Syndecan-1</keyword><keyword>Syndecan-1: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23807246</accession-num><electronic-resource-num>10.1097/SHK.0b013e31829f91fc</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3764452&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>We have recently demonstrated that injured patients in hemorrhagic shock shed syndecan 1 and that the early use of fresh frozen plasma (FFP) in these patients is correlated with improved clinical outcomes. As the lungs are frequently injured after trauma, we hypothesized that hemorrhagic shock-induced shedding of syndecan 1 exposes the underlying pulmonary vascular endothelium to injury resulting in inflammation and hyperpermeability and that these effects would be mitigated by FFP. In vitro, pulmonary endothelial permeability, endothelial monolayer flux, transendothelial electrical resistance, and leukocyte-endothelial binding were measured in pulmonary endothelial cells after incubation with equal volumes of FFP or lactated Ringer's (LR). In vivo, using a coagulopathic mouse model of trauma and hemorrhagic shock, pulmonary hyperpermeability, neutrophil infiltration, and syndecan 1 expression and systemic shedding were assessed after 3 h of resuscitation with either 1× FFP or 3× LR and compared with shock alone and shams. In vitro, endothelial permeability and flux were decreased, transendothelial electrical resistance was increased, and leukocyte-endothelial binding was inhibited by FFP compared with LR-treated endothelial cells. In vivo, hemorrhagic shock was associated with systemic shedding of syndecan 1, which correlated with decreased pulmonary syndecan 1 and increased pulmonary vascular hyperpermeability and inflammation. Fresh frozen plasma resuscitation, compared with LR resuscitation, abrogated these injurious effects. After hemorrhagic shock, FFP resuscitation inhibits endothelial cell hyperpermeability and inflammation and restores pulmonary syndecan 1 expression. Modulation of pulmonary syndecan 1 expression may mechanistically contribute to the beneficial effects FFP.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Predescu, Sanda</author><author>Knezevic, Ivana</author><author>Bardita, Cristina</author><author>Neamu, Radu Florin</author><author>Brovcovych, Viktor</author><author>Predescu, Dan</author></authors></contributors><titles><title>Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e75846</pages><volume>8</volume><issue>9</issue><keywords/><dates><year>2013</year></dates><accession-num>24086643</accession-num><electronic-resource-num>10.1371/journal.pone.0075846</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3785431&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>The spatial and functional relationship between platelet activating factor-receptor (PAF-R) and nitric oxide synthase (eNOS) in the lateral plane of the endothelial plasma membrane is poorly characterized. In this study, we used intact mouse pulmonary endothelial cells (ECs) as well as endothelial plasma membrane patches and subcellular fractions to define a new microdomain of plasmalemma proper where the two proteins colocalize and to demonstrate how PAF-mediated nitric oxide (NO) production fine-tunes ECs function as gatekeepers of vascular permeability. Using fluorescence microscopy and immunogold labeling electron microscopy (EM) on membrane patches we demonstrate that PAF-R is organized as clusters and colocalizes with a subcellular pool of eNOS, outside recognizable vesicular profiles. Moreover, PAF-induced acid sphingomyelinase activation generates a ceramide-based microdomain on the external leaflet of plasma membrane, inside of which a signalosome containing eNOS shapes PAF-stimulated NO production. Real-time measurements of NO after PAF-R ligation indicated a rapid (5 to 15 min) increase in NO production followed by a &gt; 45 min period of reduction to basal levels. Moreover, at the level of this new microdomain, PAF induces a dynamic phosphorylation/dephosphorylation of Ser, Thr and Tyr residues of eNOS that correlates with NO production. Altogether, our findings establish the existence of a functional partnership PAF-R/eNOS on EC plasma membrane, at the level of PAF-induced ceramide plasma membrane microdomains, outside recognized vesicular profiles.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Adyshev, Djanybek M</author><author>Dudek, Steven M</author><author>Moldobaeva, Nurgul</author><author>Kim, Kyung-mi</author><author>Ma, Shwu-Fan</author><author>Kasa, Anita</author><author>Garcia, Joe G N</author><author>Verin, Alexander D</author></authors></contributors><titles><title>Ezrin/radixin/moesin proteins differentially regulate endothelial hyperpermeability after thrombin.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L240-55</pages><volume>305</volume><issue>3</issue><keywords><keyword>Capillary Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: genetics</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Inflammation</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: genetics</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>RNA</keyword><keyword>RNA Interference</keyword><keyword>Signal Transduction</keyword><keyword>Small Interfering</keyword><keyword>Thrombin</keyword><keyword>Thrombin: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2013</year></dates><accession-num>23729486</accession-num><electronic-resource-num>10.1152/ajplung.00355.2012</electronic-resource-num><urls><web-urls><url>http://ajplung.physiology.org/content/305/3/L240.full-text.pdf+html</url></web-urls></urls><label>Inflammation;Signal Transduction</label><abstract>Endothelial cell (EC) barrier disruption induced by inflammatory agonists such as thrombin leads to potentially lethal physiological dysfunction such as alveolar flooding, hypoxemia, and pulmonary edema. Thrombin stimulates paracellular gap and F-actin stress fiber formation, triggers actomyosin contraction, and alters EC permeability through multiple mechanisms that include protein kinase C (PKC) activation. We previously have shown that the ezrin, radixin, and moesin (ERM) actin-binding proteins differentially participate in sphingosine-1 phosphate-induced EC barrier enhancement. Phosphorylation of a conserved threonine residue in the COOH-terminus of ERM proteins causes conformational changes in ERM to unmask binding sites and is considered a hallmark of ERM activation. In the present study we test the hypothesis that ERM proteins are phosphorylated on this critical threonine residue by thrombin-induced signaling events and explore the role of the ERM family in modulating thrombin-induced cytoskeletal rearrangement and EC barrier function. Thrombin promotes ERM phosphorylation at this threonine residue (ezrin Thr567, radixin Thr564, moesin Thr558) in a PKC-dependent fashion and induces translocation of phosphorylated ERM to the EC periphery. Thrombin-induced ERM threonine phosphorylation is likely synergistically mediated by protease-activated receptors PAR1 and PAR2. Using the siRNA approach, depletion of either moesin alone or of all three ERM proteins significantly attenuates thrombin-induced increase in EC barrier permeability (transendothelial electrical resistance), cytoskeletal rearrangements, paracellular gap formation, and accumulation of phospho-myosin light chain. In contrast, radixin depletion exerts opposing effects on these indexes. These data suggest that ERM proteins play important differential roles in the thrombin-induced modulation of EC permeability, with moesin promoting barrier dysfunction and radixin opposing it.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Generic">31</ref-type><contributors><authors><author>Park, Changwon</author><author>Kim, Tae Min</author><author>Malik, Asrar B</author></authors></contributors><titles><title>Transcriptional regulation of endothelial cell and vascular development</title><secondary-title>Circulation Research</secondary-title></titles><periodical><full-title>Circulation Research</full-title></periodical><pages>1380-1400</pages><volume>112</volume><issue>10</issue><keywords><keyword>Angiogenesis</keyword><keyword>Endothelial cells</keyword><keyword>Reprogramming</keyword><keyword>Transcription factors</keyword><keyword>Vasculogenesis</keyword></keywords><dates><year>2013</year></dates><accession-num>23661712</accession-num><electronic-resource-num>10.1161/CIRCRESAHA.113.301078</electronic-resource-num><urls/><abstract>The establishment and maintenance of the vascular system is critical for embryonic development and postnatal life. Defects in endothelial cell development and vessel formation and function lead to embryonic lethality and are important in the pathogenesis of vascular diseases. Here, we review the underlying molecular mechanisms of endothelial cell differentiation, plasticity, and the development of the vasculature. This review focuses on the interplay among transcription factors and signaling molecules that specify the differentiation of vascular endothelial cells. We also discuss recent progress on reprogramming of somatic cells toward distinct endothelial cell lineages and its promise in regenerative vascular medicine.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mohammad, Ghulam</author><author>Siddiquei, Mohammad Mairaj</author><author>Othman, Amira</author><author>Al-Shabrawey, Mohamed</author><author>Abu El-Asrar, Ahmed M</author></authors></contributors><titles><title>High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.</title><secondary-title>Experimental eye research</secondary-title></titles><periodical><full-title>Experimental eye research</full-title></periodical><pages>101-109</pages><volume>107</volume><keywords><keyword>Animals</keyword><keyword>Anti-Inflammatory Agents</keyword><keyword>Anti-Inflammatory Agents: pharmacology</keyword><keyword>Blood-Retinal Barrier</keyword><keyword>Blood-Retinal Barrier: metabolism</keyword><keyword>Blotting</keyword><keyword>Diabetes Mellitus</keyword><keyword>Diabetic Retinopathy</keyword><keyword>Diabetic Retinopathy: metabolism</keyword><keyword>Diabetic Retinopathy: pathology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Experimental</keyword><keyword>Experimental: metabolism</keyword><keyword>Experimental: pathology</keyword><keyword>Glycyrrhizic Acid</keyword><keyword>Glycyrrhizic Acid: pharmacology</keyword><keyword>HMGB1 Protein</keyword><keyword>HMGB1 Protein: antagonists &amp; inhibitors</keyword><keyword>HMGB1 Protein: physiology</keyword><keyword>Immunohistochemistry</keyword><keyword>Immunologic</keyword><keyword>Immunologic: metabolism</keyword><keyword>Immunoprecipitation</keyword><keyword>Intercellular Adhesion Molecule-1</keyword><keyword>Intercellular Adhesion Molecule-1: metabolism</keyword><keyword>Intravitreal Injections</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>MAP Kinase Signaling System: physiology</keyword><keyword>Male</keyword><keyword>NF-kappa B</keyword><keyword>NF-kappa B: metabolism</keyword><keyword>Occludin</keyword><keyword>Occludin: metabolism</keyword><keyword>Rats</keyword><keyword>Receptors</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Sprague-Dawley</keyword><keyword>Toll-Like Receptor 2</keyword><keyword>Toll-Like Receptor 2: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>Western</keyword></keywords><dates><year>2013</year></dates><publisher>Elsevier Ltd</publisher><accession-num>23261684</accession-num><electronic-resource-num>10.1016/j.exer.2012.12.009</electronic-resource-num><notes>From Duplicate 2 (High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. - Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M)

From Duplicate 2 (High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. - Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M)

From Duplicate 2 ( 

High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.

- Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M )




From Duplicate 2 ( 


High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.


- Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M )</notes><research-notes>From Duplicate 2 (High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. - Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M)

From Duplicate 2 (High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina. - Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M)

From Duplicate 2 ( 

High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.

- Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M )




From Duplicate 2 ( 


High-mobility group box-1 protein activates inflammatory signaling pathway components and disrupts retinal vascular-barrier in the diabetic retina.


- Mohammad, Ghulam; Siddiquei, Mohammad Mairaj; Othman, Amira; Al-Shabrawey, Mohamed; Abu El-Asrar, Ahmed M )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23261684</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Extracellular high-mobility group box-1 (HMGB-1) functions as a pro-inflammatory cytokine and exhibits angiogenic effects. The purpose of this study was to investigate the expression of HMGB-1 signaling pathway components in the retinas of diabetic rats and to examine the effect of intravitreal administration of HMGB-1 on the retinas of rats. The retinas of diabetic and intravitreally injected HMGB-1 rats were studied using immunohistochemistry, Western blotting, co-immunoprecipitation and enzyme-linked immunosorbent assay. The effect of HMGB-1 on retinal endothelial cell barrier function was evaluated using electrical cell-substrate impedance sensing system (ECIS). Diabetes induced significant upregulation of the expression of HMGB-1, receptor for advanced glycation end products (RAGE), ERK(1/2) and nuclear transcription factor Kappa B (NF-κB), whereas the expression of toll-like receptor 2 (TLR2) and occludin was significantly downregulated. Co-immunoprecipitation studies revealed significant increase in interaction between HMGB-1 and RAGE. HMGB-1 reduced transendothelial electrical resistance of bovine retinal endothelial cells. Intravitreal administration of HMGB-1 to normal rats induced significant upregulation of intercellular adhesion molecule-1 (ICAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), HMGB-1, RAGE, ERK(1/2), and NF-κB, and significantly increased retinal vascular permeability, whereas the expression of TLR2 and occludin was downregulated. Oral administration of glycyrrhizin, a specific inhibitor of HMGB-1, attenuated diabetes-induced upregulation of HMGB-1 expression, NF-κB activation and downregulation of occludin expression. Our findings provide evidence that in the diabetic retina, HMGB-1 possibly interacts with RAGE and activates ERK(1/2) and NF-κB to generate an inflammatory response and disrupt retinal vascular barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dzementsei, a.</author><author>Schneider, D</author><author>Janshoff, A</author><author>Pieler, T</author></authors></contributors><titles><title>Migratory and adhesive properties of Xenopus laevis primordial germ cells in vitro</title><secondary-title>Biology Open</secondary-title></titles><periodical><full-title>Biology Open</full-title></periodical><pages>1279-1287</pages><volume>2</volume><issue>12</issue><keywords><keyword>cell adhesion</keyword><keyword>cell migration</keyword><keyword>cellular dynamics</keyword><keyword>primordial germ cells</keyword><keyword>xenopus</keyword></keywords><dates><year>2013</year></dates><electronic-resource-num>10.1242/bio.20135140</electronic-resource-num><urls><web-urls><url>http://bio.biologists.org/cgi/doi/10.1242/bio.20135140</url></web-urls></urls><label>ECIS Micromotion</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Taylor, Shannon L</author><author>Wahl-Jensen, Victoria</author><author>Copeland, Anna Maria</author><author>Jahrling, Peter B</author><author>Schmaljohn, Connie S</author></authors></contributors><titles><title>Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system.</title><secondary-title>PLoS pathogens</secondary-title></titles><periodical><full-title>PLoS pathogens</full-title></periodical><pages>e1003470</pages><volume>9</volume><issue>7</issue><keywords><keyword>Bradykinin</keyword><keyword>Bradykinin: antagonists &amp; inhibitors</keyword><keyword>Bradykinin: metabolism</keyword><keyword>Capillaries</keyword><keyword>Capillaries: drug effects</keyword><keyword>Capillaries: metabolism</keyword><keyword>Capillaries: virology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Coculture Techniques</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Factor XII</keyword><keyword>Factor XII: antagonists &amp; inhibitors</keyword><keyword>Factor XII: metabolism</keyword><keyword>Hantavirus</keyword><keyword>Hantavirus Infections</keyword><keyword>Hantavirus Infections: metabolism</keyword><keyword>Hantavirus Infections: virology</keyword><keyword>Hantavirus: physiology</keyword><keyword>High-Molecular-Weight</keyword><keyword>High-Molecular-Weight: metabolism</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: cytology</keyword><keyword>Human Umbilical Vein Endothelial Cells: drug effec</keyword><keyword>Human Umbilical Vein Endothelial Cells: metabolism</keyword><keyword>Human Umbilical Vein Endothelial Cells: virology</keyword><keyword>Humans</keyword><keyword>Kallikrein-Kinin System</keyword><keyword>Kallikrein-Kinin System: drug effects</keyword><keyword>Kininogen</keyword><keyword>Mesenchymal Stromal Cells</keyword><keyword>Mesenchymal Stromal Cells: cytology</keyword><keyword>Mesenchymal Stromal Cells: drug effects</keyword><keyword>Mesenchymal Stromal Cells: metabolism</keyword><keyword>Mesenchymal Stromal Cells: virology</keyword><keyword>Muscle</keyword><keyword>Prekallikrein</keyword><keyword>Prekallikrein: antagonists &amp; inhibitors</keyword><keyword>Prekallikrein: metabolism</keyword><keyword>Protease Inhibitors</keyword><keyword>Protease Inhibitors: pharmacology</keyword><keyword>Proteolysis</keyword><keyword>Proteolysis: drug effects</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Pulmonary Artery: drug effects</keyword><keyword>Pulmonary Artery: metabolism</keyword><keyword>Pulmonary Artery: virology</keyword><keyword>Smooth</keyword><keyword>Surface Properties</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: virology</keyword><keyword>Virus Replication</keyword></keywords><dates><year>2013</year></dates><accession-num>23874198</accession-num><electronic-resource-num>10.1371/journal.ppat.1003470</electronic-resource-num><notes>From Duplicate 1 (Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. - Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S)

From Duplicate 1 (Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. - Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S)

From Duplicate 3 (Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. - Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S)

From Duplicate 2 ( 


Endothelial Cell Permeability during Hantavirus Infection Involves Factor XII-Dependent Increased Activation of the Kallikrein-Kinin System.


- Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S )












From Duplicate 2 ( 


Endothelial Cell Permeability during Hantavirus Infection Involves Factor XII-Dependent Increased Activation of the Kallikrein-Kinin System.


- Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S )





From Duplicate 2 ( 


Endothelial Cell Permeability during Hantavirus Infection Involves Factor XII-Dependent Increased Activation of the Kallikrein-Kinin System.


- Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S )</notes><research-notes>From Duplicate 1 (Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. - Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S)

From Duplicate 1 (Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. - Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S)

From Duplicate 3 (Endothelial cell permeability during hantavirus infection involves factor XII-dependent increased activation of the kallikrein-kinin system. - Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S)

From Duplicate 2 ( 


Endothelial Cell Permeability during Hantavirus Infection Involves Factor XII-Dependent Increased Activation of the Kallikrein-Kinin System.


- Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S )












From Duplicate 2 ( 


Endothelial Cell Permeability during Hantavirus Infection Involves Factor XII-Dependent Increased Activation of the Kallikrein-Kinin System.


- Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S )





From Duplicate 2 ( 


Endothelial Cell Permeability during Hantavirus Infection Involves Factor XII-Dependent Increased Activation of the Kallikrein-Kinin System.


- Taylor, Shannon L; Wahl-Jensen, Victoria; Copeland, Anna Maria; Jahrling, Peter B; Schmaljohn, Connie S )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3715459&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Hemorrhagic fever with renal syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) are diseases caused by hantavirus infections and are characterized by vascular leakage due to alterations of the endothelial barrier. Hantavirus-infected endothelial cells (EC) display no overt cytopathology; consequently, pathogenesis models have focused either on the influx of immune cells and release of cytokines or on increased degradation of the adherens junction protein, vascular endothelial (VE)-cadherin, due to hantavirus-mediated hypersensitization of EC to vascular endothelial growth factor (VEGF). To examine endothelial leakage in a relevant in vitro system, we co-cultured endothelial and vascular smooth muscle cells (vSMC) to generate capillary blood vessel-like structures. In contrast to results obtained in monolayers of cultured EC, we found that despite viral replication in both cell types as well as the presence of VEGF, infected in vitro vessels neither lost integrity nor displayed evidence of VE-cadherin degradation. Here, we present evidence for a novel mechanism of hantavirus-induced vascular leakage involving activation of the plasma kallikrein-kinin system (KKS). We show that incubation of factor XII (FXII), prekallikrein (PK), and high molecular weight kininogen (HK) plasma proteins with hantavirus-infected EC results in increased cleavage of HK, higher enzymatic activities of FXIIa/kallikrein (KAL) and increased liberation of bradykinin (BK). Measuring cell permeability in real-time using electric cell-substrate impedance sensing (ECIS), we identified dramatic increases in endothelial cell permeability after KKS activation and liberation of BK. Furthermore, the alterations in permeability could be prevented using inhibitors that directly block BK binding, the activity of FXIIa, or the activity of KAL. Lastly, FXII binding and autoactivation is increased on the surface of hantavirus-infected EC. These data are the first to demonstrate KKS activation during hantavirus infection and could have profound implications for treatment of hantavirus infections.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, S</author><author>Huang, W.-C.</author><author>Zhang, L</author><author>Zhang, C</author><author>Lowery, F J</author><author>Ding, Z</author><author>Guo, H</author><author>Wang, H</author><author>Huang, S</author><author>Sahin, A A</author><author>Aldape, K D</author><author>Steeg, P S</author><author>Yu, D</author></authors></contributors><titles><title>Src Family Kinases as Novel Therapeutic Targets to Treat Breast Cancer Brain Metastases</title><secondary-title>Cancer Research</secondary-title></titles><periodical><full-title>Cancer Research</full-title></periodical><pages>5764-5774</pages><volume>73</volume><issue>18</issue><keywords/><dates><year>2013</year></dates><electronic-resource-num>10.1158/0008-5472.CAN-12-1803</electronic-resource-num><urls><web-urls><url>http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.CAN-12-1803</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chan, Chi-Ming</author><author>Chang, Hsun-Hsien</author><author>Wang, Vin-Chi</author><author>Huang, Chuen-Lin</author><author>Hung, Chi-Feng</author></authors></contributors><titles><title>Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e56819</pages><volume>8</volume><issue>2</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: drug effects</keyword><keyword>Humans</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>MAP Kinase Signaling System: drug effects</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Platelet-Derived Growth Factor beta</keyword><keyword>Platelet-Derived Growth Factor beta: metabolism</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>Proto-Oncogene Proteins c-akt: metabolism</keyword><keyword>Proto-Oncogene Proteins c-sis</keyword><keyword>Proto-Oncogene Proteins c-sis: pharmacology</keyword><keyword>Receptor</keyword><keyword>Retinal Pigment Epithelium</keyword><keyword>Retinal Pigment Epithelium: cytology</keyword><keyword>Stilbenes</keyword><keyword>Stilbenes: pharmacology</keyword></keywords><dates><year>2013</year></dates><accession-num>23457620</accession-num><electronic-resource-num>10.1371/journal.pone.0056819</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3572951&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>PURPOSE: In diseases such as proliferative vitreoretinopathy (PVR), proliferative diabetic retinopathy, and age-related macular degeneration, retinal pigment epithelial (RPE) cells proliferate and migrate. Moreover, platelet-derived growth factor (PDGF) has been shown to enhance proliferation and migration of RPE cells in PVR. Even resveratrol can suppress the migration and adhesion of many cell types, its effects on RPE cell migration and adhesion remain unknown. In this study, we investigated the inhibitory effects of resveratrol on RPE cell migration induced by PDGF-BB, an isoform of PDGF, and adhesion to fibronectin, a major ECM component of PVR tissue. METHODS: The migration of RPE cells was assessed by an electric cell-substrate impedance sensing migration assay and a Transwell migration assay. A cell viability assay was used to determine the viability of resveratrol treated-cells. The cell adhesion to fibronectin was examined by an adhesion assay. The interactions of resveratrol with PDGF-BB were analyzed by a dot binding assay. The PDGF-BB-induced signaling pathways were determined by western blotting and scratch wound healing assay. RESULTS: Resveratrol inhibited PDGF-BB-induced RPE cell migration in a dose-dependent manner, but showed no effects on ARPE19 cell adhesion to fibronectin. The cell viability assay showed no cytotoxicity of resveratrol on RPE cells and the dot binding assay revealed no direct interactions of resveratrol with PDGF-BB. Inhibitory effects of resveratrol on PDGF-BB-induced platelet-derived growth factor receptor β (PDGFRβ) and tyrosine phosphorylation and the underlying pathways of PI3K/Akt, ERK and p38 activation were found; however, resveratrol and PDGF-BB showed no effects on PDGFRα and JNK activation. Scratch wound healing assay demonstrated resveratrol and the specific inhibitors of PDGFR, PI3K, MEK or p38 suppressed PDGF-BB-induced cell migration. CONCLUSIONS: These results indicate that resveratrol is an effective inhibitor of PDGF-BB-induced RPE cell migration via PDGFRβ, PI3K/Akt and MAPK pathways, but has no effects on the RPE cell adhesion to fibronectin.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Konya, Viktoria</author><author>Üllen, Andreas</author><author>Kampitsch, Nora</author><author>Theiler, Anna</author><author>Philipose, Sonia</author><author>Parzmair, Gerald P</author><author>Marsche, Gunther</author><author>Peskar, Bernhard A</author><author>Schuligoi, Rufina</author><author>Sattler, Wolfgang</author><author>Heinemann, Akos</author></authors></contributors><titles><title>Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking.</title><secondary-title>The Journal of allergy and clinical immunology</secondary-title></titles><periodical><full-title>The Journal of allergy and clinical immunology</full-title></periodical><pages>532</pages><volume>131</volume><issue>2</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cells</keyword><keyword>Coronary Vessels</keyword><keyword>Coronary Vessels: drug effects</keyword><keyword>Coronary Vessels: metabolism</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: metabolism</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Cytochalasin B</keyword><keyword>Cytochalasin B: pharmacology</keyword><keyword>Dinoprostone</keyword><keyword>Dinoprostone: metabolism</keyword><keyword>EP4 Subtype</keyword><keyword>EP4 Subtype: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: immunology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: drug effects</keyword><keyword>Lung: metabolism</keyword><keyword>Methyl Ethers</keyword><keyword>Methyl Ethers: pharmacology</keyword><keyword>Microvessels</keyword><keyword>Microvessels: drug effects</keyword><keyword>Microvessels: immunology</keyword><keyword>Microvessels: metabolism</keyword><keyword>Naphthalenes</keyword><keyword>Naphthalenes: pharmacology</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: drug effects</keyword><keyword>Neutrophils: immunology</keyword><keyword>Neutrophils: metabolism</keyword><keyword>Nitric Oxide Synthase Type III</keyword><keyword>Nitric Oxide Synthase Type III: metabolism</keyword><keyword>Phenylbutyrates</keyword><keyword>Phenylbutyrates: pharmacology</keyword><keyword>Prostaglandin E</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: drug effects</keyword><keyword>Pulmonary Artery: metabolism</keyword><keyword>Receptors</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: immunology</keyword><keyword>Vascular: metabolism</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: drug effects</keyword><keyword>Wound Healing: physiology</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>22704539</accession-num><electronic-resource-num>10.1016/j.jaci.2012.05.008</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22704539</url></web-urls></urls><label>Wound Healing</label><abstract>BACKGROUND: Increased vascular permeability is a fundamental characteristic of inflammation. Substances that are released during inflammation, such as prostaglandin (PG) E(2), can counteract vascular leakage, thereby hampering tissue damage. OBJECTIVE: In this study we investigated the role of PGE(2) and its receptors in the barrier function of human pulmonary microvascular endothelial cells and in neutrophil trafficking. METHODS: Endothelial barrier function was determined based on electrical impedance measurements. Neutrophil recruitment was assessed based on adhesion and transendothelial migration. Morphologic alterations are shown by using immunofluorescence microscopy. RESULTS: We observed that activation of E-type prostanoid (EP) 4 receptor by PGE(2) or an EP4-selective agonist (ONO AE1-329) enhanced the barrier function of human microvascular lung endothelial cells. EP4 receptor activation prompted similar responses in pulmonary artery and coronary artery endothelial cells. These effects were reversed by an EP4 antagonist (ONO AE3-208), as well as by blocking actin polymerization with cytochalasin B. The EP4 receptor-induced increase in barrier function was independent of the classical cyclic AMP/protein kinase A signaling machinery, endothelial nitric oxide synthase, and Rac1. Most importantly, EP4 receptor stimulation showed potent anti-inflammatory activities by (1) facilitating wound healing of pulmonary microvascular endothelial monolayers, (2) preventing junctional and cytoskeletal reorganization of activated endothelial cells, and (3) impairing neutrophil adhesion to endothelial cells and transendothelial migration. The latter effects could be partially attributed to reduced E-selectin expression after EP4 receptor stimulation. CONCLUSION: These data indicate that EP4 agonists as anti-inflammatory agents represent a potential therapy for diseases with increased vascular permeability and neutrophil extravasation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Banerjee, Sulagna</author><author>Sangwan, Veena</author><author>McGinn, Olivia</author><author>Chugh, Rohit</author><author>Dudeja, Vikas</author><author>Vickers, Selwyn M</author><author>Saluja, Ashok K</author></authors></contributors><titles><title>Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>33927-33938</pages><volume>288</volume><issue>47</issue><keywords><keyword>Acetylglucosamine</keyword><keyword>Acetylglucosamine: genetics</keyword><keyword>Acetylglucosamine: metabolism</keyword><keyword>Active Transport</keyword><keyword>Alkylating</keyword><keyword>Alkylating: pharmacology</keyword><keyword>Antineoplastic Agents</keyword><keyword>Cell Death</keyword><keyword>Cell Death: drug effects</keyword><keyword>Cell Death: genetics</keyword><keyword>Cell Line</keyword><keyword>Cell Nucleus</keyword><keyword>Cell Nucleus: drug effects</keyword><keyword>Cell Nucleus: genetics</keyword><keyword>Cell Nucleus: metabolism</keyword><keyword>Cell Nucleus: pathology</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Cell Survival: genetics</keyword><keyword>DNA-Binding Proteins</keyword><keyword>DNA-Binding Proteins: genetics</keyword><keyword>DNA-Binding Proteins: metabolism</keyword><keyword>Diterpenes</keyword><keyword>Diterpenes: pharmacology</keyword><keyword>Down-Regulation</keyword><keyword>Down-Regulation: drug effects</keyword><keyword>Down-Regulation: genetics</keyword><keyword>Epoxy Compounds</keyword><keyword>Epoxy Compounds: pharmacology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Glycosylation</keyword><keyword>Glycosylation: drug effects</keyword><keyword>HSP70 Heat-Shock Proteins</keyword><keyword>HSP70 Heat-Shock Proteins: biosynthesis</keyword><keyword>HSP70 Heat-Shock Proteins: genetics</keyword><keyword>Humans</keyword><keyword>N-Acetylglucosaminyltransferases</keyword><keyword>N-Acetylglucosaminyltransferases: antagonists &amp; in</keyword><keyword>N-Acetylglucosaminyltransferases: genetics</keyword><keyword>N-Acetylglucosaminyltransferases: metabolism</keyword><keyword>NF-kappa B</keyword><keyword>NF-kappa B: genetics</keyword><keyword>NF-kappa B: metabolism</keyword><keyword>Neoplasm Proteins</keyword><keyword>Neoplasm Proteins: genetics</keyword><keyword>Neoplasm Proteins: metabolism</keyword><keyword>Neoplastic</keyword><keyword>Neoplastic: drug effects</keyword><keyword>Neoplastic: genetics</keyword><keyword>Pancreatic Neoplasms</keyword><keyword>Pancreatic Neoplasms: drug therapy</keyword><keyword>Pancreatic Neoplasms: genetics</keyword><keyword>Pancreatic Neoplasms: metabolism</keyword><keyword>Pancreatic Neoplasms: pathology</keyword><keyword>Phenanthrenes</keyword><keyword>Phenanthrenes: pharmacology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: genetics</keyword><keyword>Sp1 Transcription Factor</keyword><keyword>Sp1 Transcription Factor: genetics</keyword><keyword>Sp1 Transcription Factor: metabolism</keyword><keyword>Transcription Factors</keyword><keyword>Transcription Factors: genetics</keyword><keyword>Transcription Factors: metabolism</keyword><keyword>Tumor</keyword></keywords><dates><year>2013</year></dates><accession-num>24129563</accession-num><electronic-resource-num>10.1074/jbc.M113.500983</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3837133&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Pancreatic cancer, the fourth most prevalent cancer-related cause of death in the United States, is a disease with a dismal survival rate of 5% 5 years after diagnosis. One of the survival proteins responsible for its extraordinary ability to evade cell death is HSP70. A naturally derived compound, triptolide, and its water-soluble prodrug, Minnelide, down-regulate the expression of this protein in pancreatic cancer cells, thereby causing cell death. However, the mechanism of action of triptolide has not been elucidated. Our study shows that triptolide-induced down-regulation of HSP70 expression is associated with a decrease in glycosylation of the transcription factor Sp1. We further show that triptolide inhibits glycosylation of Sp1, inhibiting the hexosamine biosynthesis pathway, particularly the enzyme O-GlcNAc transferase. Inhibition of O-GlcNAc transferase prevents nuclear localization of Sp1 and affects its DNA binding activity. This in turn down-regulates prosurvival pathways like NF-κB, leading to inhibition of HSF1 and HSP70 and eventually to cell death. In this study, we evaluated the mechanism by which triptolide affects glycosylation of Sp1, which in turn affects downstream pathways controlling survival of pancreatic cancer cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ando, Koji</author><author>Fukuhara, Shigetomo</author><author>Moriya, Takahiro</author><author>Obara, Yutaro</author><author>Nakahata, Norimichi</author><author>Mochizuki, Naoki</author></authors></contributors><titles><title>Rap1 potentiates endothelial cell junctions by spatially controlling myosin I activity and actin organization</title><secondary-title>The Journal of cell biology</secondary-title></titles><periodical><full-title>The Journal of cell biology</full-title></periodical><pages>901-916</pages><volume>202</volume><issue>6</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Blotting</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Cell Movement</keyword><keyword>Cell Proliferation</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: cytology</keyword><keyword>Human Umbilical Vein Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Myosin Type II</keyword><keyword>Myosin Type II: genetics</keyword><keyword>Myosin Type II: metabolism</keyword><keyword>Myotonin-Protein Kinase</keyword><keyword>Phosphorylation</keyword><keyword>Protein-Tyrosine Kinases</keyword><keyword>Protein-Tyrosine Kinases: antagonists &amp; inhibitors</keyword><keyword>Protein-Tyrosine Kinases: genetics</keyword><keyword>Protein-Tyrosine Kinases: metabolism</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Telomere-Binding Proteins</keyword><keyword>Telomere-Binding Proteins: antagonists &amp; inhibitor</keyword><keyword>Telomere-Binding Proteins: genetics</keyword><keyword>Telomere-Binding Proteins: metabolism</keyword><keyword>Western</keyword><keyword>cdc42 GTP-Binding Protein</keyword><keyword>cdc42 GTP-Binding Protein: antagonists &amp; inhibitor</keyword><keyword>cdc42 GTP-Binding Protein: genetics</keyword><keyword>cdc42 GTP-Binding Protein: metabolism</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: antagonists &amp; inhibitors</keyword><keyword>rho GTP-Binding Proteins: genetics</keyword><keyword>rho GTP-Binding Proteins: metabolism</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: antagonists &amp; inhibitors</keyword><keyword>rho-Associated Kinases: genetics</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>24019534</accession-num><electronic-resource-num>10.1083/jcb.201301115</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3776352&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Barrier Function;ECIS Modeling</label><abstract>Reorganization of the actin cytoskeleton is responsible for dynamic regulation of endothelial cell (EC) barrier function. Circumferential actin bundles (CAB) promote formation of linear adherens junctions (AJs) and tightening of EC junctions, whereas formation of radial stress fibers (RSF) connected to punctate AJs occurs during junction remodeling. The small GTPase Rap1 induces CAB formation to potentiate EC junctions; however, the mechanism underlying Rap1-induced CAB formation remains unknown. Here, we show that myotonic dystrophy kinase-related CDC42-binding kinase (MRCK)-mediated activation of non-muscle myosin II (NM-II) at cell-cell contacts is essential for Rap1-induced CAB formation. Our data suggest that Rap1 induces FGD5-dependent Cdc42 activation at cell-cell junctions to locally activate the NM-II through MRCK, thereby inducing CAB formation. We further reveal that Rap1 suppresses the NM-II activity stimulated by the Rho-ROCK pathway, leading to dissolution of RSF. These findings imply that Rap1 potentiates EC junctions by spatially controlling NM-II activity through activation of the Cdc42-MRCK pathway and suppression of the Rho-ROCK pathway.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Waheed, Faiza</author><author>Dan, Qinghong</author><author>Amoozadeh, Yasaman</author><author>Zhang, Yuqian</author><author>Tanimura, Susumu</author><author>Speight, Pam</author><author>Kapus, András</author><author>Szászi, Katalin</author></authors></contributors><titles><title>Central role of the exchange factor GEF-H1 in TNF-α-induced sequential activation of Rac, ADAM17/TACE, and RhoA in tubular epithelial cells.</title><secondary-title>Molecular biology of the cell</secondary-title></titles><periodical><full-title>Molecular biology of the cell</full-title></periodical><pages>1068-1082</pages><volume>24</volume><issue>7</issue><keywords><keyword>ADAM Proteins</keyword><keyword>ADAM Proteins: genetics</keyword><keyword>ADAM Proteins: metabolism</keyword><keyword>Animals</keyword><keyword>Blotting</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Epidermal Growth Factor</keyword><keyword>Epidermal Growth Factor: metabolism</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Extracellular Signal-Regulated MAP Kinases</keyword><keyword>Extracellular Signal-Regulated MAP Kinases: metabo</keyword><keyword>Fluorescence</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: genetics</keyword><keyword>Guanine Nucleotide Exchange Factors: metabolism</keyword><keyword>Kidney Tubules</keyword><keyword>LLC-PK1 Cells</keyword><keyword>Matrix Metalloproteinases</keyword><keyword>Matrix Metalloproteinases: metabolism</keyword><keyword>Microscopy</keyword><keyword>Mutation</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Proximal</keyword><keyword>Proximal: cytology</keyword><keyword>RNA Interference</keyword><keyword>Receptor</keyword><keyword>Swine</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: pharmacology</keyword><keyword>Western</keyword><keyword>rac GTP-Binding Proteins</keyword><keyword>rac GTP-Binding Proteins: genetics</keyword><keyword>rac GTP-Binding Proteins: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: genetics</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23389627</accession-num><electronic-resource-num>10.1091/mbc.E12-09-0661</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3608494&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration</label><abstract>Transactivation of the epidermal growth factor receptor (EGFR) by tumor necrosis factor-α (TNF-α) is a key step in mediating RhoA activation and cytoskeleton and junction remodeling in the tubular epithelium. In this study we explore the mechanisms underlying TNF-α-induced EGFR activation. We show that TNF-α stimulates the TNF-α convertase enzyme (TACE/a disintegrin and metalloproteinase-17), leading to activation of the EGFR/ERK pathway. TACE activation requires the mitogen-activated protein kinase p38, which is activated through the small GTPase Rac. TNF-α stimulates both Rac and RhoA through the guanine nucleotide exchange factor (GEF)-H1 but by different mechanisms. EGFR- and ERK-dependent phosphorylation at the T678 site of GEF-H1 is a prerequisite for RhoA activation only, whereas both Rac and RhoA activation require GEF-H1 phosphorylation on S885. Of interest, GEF-H1-mediated Rac activation is upstream from the TACE/EGFR/ERK pathway and regulates T678 phosphorylation. We also show that TNF-α enhances epithelial wound healing through TACE, ERK, and GEF-H1. Taken together, our findings can explain the mechanisms leading to hierarchical activation of Rac and RhoA by TNF-α through a single GEF. This mechanism could coordinate GEF functions and fine-tune Rac and RhoA activation in epithelial cells, thereby promoting complex functions such as sheet migration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Alipour, Misagh</author><author>Lou, Yuefei</author><author>Zimmerman, Daniel</author><author>Bording-Jorgensen, Michael W</author><author>Sergi, Consolato</author><author>Liu, Julia J</author><author>Wine, Eytan</author></authors></contributors><titles><title>A balanced IL-1β activity is required for host response to Citrobacter rodentium infection.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e80656</pages><volume>8</volume><issue>12</issue><keywords/><dates><year>2013</year></dates><accession-num>24312491</accession-num><electronic-resource-num>10.1371/journal.pone.0080656</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3846666&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Barrier Function</label><abstract>Microbial sensing plays essential roles in the innate immune response to pathogens. In particular, NLRP3 forms a multiprotein inflammasome complex responsible for the maturation of interleukin (IL)-1β. Our aim was to delineate the role of the NLRP3 inflammasome in macrophages, and the contribution of IL-1β to the host defense against Citrobacter rodentium acute infection in mice. Nlrp3(-/-) and background C57BL/6 (WT) mice were infected by orogastric gavage, received IL-1β (0.5 µg/mouse; ip) on 0, 2, and 4 days post-infection (DPI), and assessed on 6 and 10 DPI. Infected Nlrp3(-/-) mice developed severe colitis; IL-1β treatments reduced colonization, abrogated dissemination of bacteria to mesenteric lymph nodes, and protected epithelial integrity of infected Nlrp3(-/-) mice. In contrast, IL-1β treatments of WT mice had an opposite effect with increased penetration of bacteria and barrier disruption. Microscopy showed reduced damage in Nlrp3(-/-) mice, and increased severity of disease in WT mice with IL-1β treatments, in particular on 10 DPI. Secretion of some pro-inflammatory plasma cytokines was dissipated in Nlrp3(-/-) compared to WT mice. IL-1β treatments elevated macrophage infiltration into infected crypts in Nlrp3(-/-) mice, suggesting that IL-1β may improve macrophage function, as exogenous administration of IL-1β increased phagocytosis of C. rodentium by peritoneal Nlrp3(-/-) macrophages in vitro. As well, the exogenous administration of IL-1β to WT peritoneal macrophages damaged the epithelial barrier of C. rodentium-infected polarized CMT-93 cells. Treatment of Nlrp3(-/-) mice with IL-1β seems to confer protection against C. rodentium infection by reducing colonization, protecting epithelial integrity, and improving macrophage activity, while extraneous IL-1β appeared to be detrimental to WT mice. Together, these findings highlight the importance of balanced cytokine responses as IL-1β improved bacterial clearance in Nlrp3(-/-) mice but increased tissue damage when given to WT mice.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yin, Yukun</author><author>Sanders, Andrew J</author><author>Jiang, Wen G</author></authors></contributors><titles><title>The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.</title><secondary-title>Anticancer research</secondary-title></titles><periodical><full-title>Anticancer research</full-title></periodical><pages>1499-1509</pages><volume>33</volume><issue>4</issue><keywords><keyword>Blotting</keyword><keyword>Breast</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: genetics</keyword><keyword>Breast Neoplasms: metabolism</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Breast: genetics</keyword><keyword>Breast: metabolism</keyword><keyword>Breast: secondary</keyword><keyword>Carcinoma</keyword><keyword>Cohort Studies</keyword><keyword>Cultured</keyword><keyword>Ductal</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>In Vitro Techniques</keyword><keyword>Lobular</keyword><keyword>Lobular: genetics</keyword><keyword>Lobular: metabolism</keyword><keyword>Lobular: secondary</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Neoplasm Grading</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Staging</keyword><keyword>RNA</keyword><keyword>Real-Time Polymerase Chain Reaction</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Tumor Cells</keyword><keyword>Western</keyword></keywords><dates><year>2013</year></dates><isbn>0030229505338</isbn><accession-num>23564791</accession-num><urls><web-urls><url>http://ar.iiarjournals.org/content/33/4/1499.short</url><url>http://www.ncbi.nlm.nih.gov/pubmed/23564791</url></web-urls></urls><abstract>BACKGROUND/AIM: Angio-associated migratory cell protein (AAMP), which belongs to the immunoglobulin superfamily, was found to be expressed in different human cell lines and exhibited a predominant cytosolic localization in epithelial cells. Previous studies show that the specific gene product is functional in cell migration and angiogenesis and can also be used as a marker of poor prognosis in invasive gastrointestinal stromal tumours and ductal carcinoma in situ (DCIS) of the breast. However, the cellular role of AAMP in breast cancer is still unclear. The aim of the current study was to provide new insights into the implication of AAMP in breast cancer. MATERIALS AND METHODS: We knocked-down the expression of AAMP through transfection of MCF-7 and MDA-MB-231 breast cancer cells with a hammerhead ribozyme transgene (MCF-7(AAMPrib) and MDA-MB-231(AAMPrib)) and examined the impact on cell function using in vitro assays. Additionally, AAMP expression was examined in a cohort of breast specimens (normal, n=28; cancer, n=102) using quantitative-real-time polymerase chain reaction (Q-PCR) and immunohistochemical methods. RESULTS: AAMP knock-down dramatically reduced cell adhesion and cell growth of MCF-7 cells (p&lt;0.05), and suppressed cell invasion of MDA-MB-231 cells (p&lt;0.05). Increased expression of AAMP in breast cancer was observed compared with that in normal tissues (p&lt;0.05). High levels of AAMP transcripts were associated with disease progression, metastasis, and poor prognosis of the patients. Disease-free and overall survival time of patients with lower levels of AAMP were significantly longer compared to those of patients with high levels (p&lt;0.05). CONCLUSION: AAMP has a significant influence on the biological functions of breast cancer cells and its high expression correlates with poor prognosis and metastasis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Parker, James C</author><author>Hashizumi, Masahiro</author><author>Kelly, Sarah V</author><author>Francis, Michael</author><author>Mouner, Marc</author><author>Meyer, Angela L</author><author>Townsley, Mary I</author><author>Wu, Songwei</author><author>Cioffi, Donna L</author><author>Taylor, Mark S</author></authors></contributors><titles><title>TRPV4 calcium entry and surface expression attenuated by inhibition of myosin light chain kinase in rat pulmonary microvascular endothelial cells.</title><secondary-title>Physiological reports</secondary-title></titles><periodical><full-title>Physiological reports</full-title></periodical><pages>e00121</pages><volume>1</volume><issue>5</issue><keywords><keyword>biotinylation</keyword><keyword>dynasore</keyword><keyword>ecis</keyword><keyword>induced lung injury</keyword><keyword>ventilator-</keyword><keyword>vesicles</keyword></keywords><dates><year>2013</year></dates><accession-num>24303188</accession-num><electronic-resource-num>10.1002/phy2.121</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3841052&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>In previous studies, blockade or gene deletion of either myosin light chain kinase (MLCK) or the mechanogated transient receptor potential vanilloid 4 (TRPV4) channel attenuated mechanical lung injury. To determine their effects on calcium entry, rat pulmonary microvascular endothelial cells (RPMVEC) were labeled with fluo-4 and calcium entry initiated with the TRPV4 agonist, 4α-phorbol 12, 13-didecanoate (4αPDD). Mean calcium transients peaked at ∼25 sec and persisted ∼500 sec. The 4αPDD response was essentially abolished in calcium-free media, or after pretreatment with the MLCK inhibitor, ML-7. ML-7 also attenuated the 4αPDD-induced inward calcium current measured directly using whole-cell patch clamp. Pretreatment with dynasore, an inhibitor of dynamin produced an initial calcium transient followed by a 4αPDD transient of unchanged peak intensity. Automated averaging of areas under the curve (AUC) of calcium transients in individual cells indicated total calcium activity with a relationship between treatment groups of ML-7 + 4αPDD &lt; 4αPDD only &lt; dynasore + 4αPDD. Measurement of biotinylated surface TRPV4 protein indicated a significant reduction after ML-7 pretreatment, but no significant change with dynasore treatment. RPMVEC monolayer electrical resistances were decreased by only 3% with 10 μmol/L 4αPDD and the response was dose-related. Dynasore alone produced a 29% decrease in resistance, but neither ML-7 nor dynasore affected the subsequent 4αPDD resistance response. These studies suggest that MLCK may inhibit mechanogated calcium responses through reduced surface expression of stretch activated TRPV4 channels in the plasma membrane.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Nikolic, Iva</author><author>Dudvarski Stankovic, Nevenka</author><author>Bicker, Frank</author><author>Meister, Jeannette</author><author>Braun, Helene</author><author>Awwad, Khader</author><author>Baumgart, Jan</author><author>Simon, Kirsten</author><author>Thal, Serge C</author><author>Patra, Chinmoy</author><author>Harter, Patrick N</author><author>Plate, Karl H</author><author>Engel, Felix B</author><author>Dimmeler, Stefanie</author><author>Eble, Johannes A</author><author>Mittelbronn, Michel</author><author>Schäfer, Michael K</author><author>Jungblut, Benno</author><author>Chavakis, Emmanouil</author><author>Fleming, Ingrid</author><author>Schmidt, Mirko H H</author></authors></contributors><titles><title>EGFL7 ligates αvβ3 integrin to enhance vessel formation.</title><secondary-title>Blood</secondary-title></titles><periodical><full-title>Blood</full-title></periodical><pages>3041-3050</pages><volume>121</volume><issue>15</issue><keywords/><dates><year>2013</year></dates><accession-num>23386126</accession-num><electronic-resource-num>10.1182/blood-2011-11-394882</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23386126</url></web-urls></urls><abstract>Angiogenesis, defined as blood vessel formation from a preexisting vasculature, is governed by multiple signal cascades including integrin receptors, in particular integrin α(v)β(3). Here we identify the endothelial cell (EC)-secreted factor epidermal growth factor-like protein 7 (EGFL7) as a novel specific ligand of integrin α(v)β(3) thus providing mechanistic insight into its proangiogenic actions in vitro and in vivo. Specifically, EGFL7 attaches to the ECM and by its interaction with integrin α(v)β(3) increases the motility of EC, which allows EC to move on a sticky underground during vessel remodeling. We provide evidence that the deregulation of EGFL7 in zebrafish embryos leads to a severe integrin-dependent malformation of the caudal venous plexus (CVP), pointing towards the significance of EGFL7 in vessel development. In biopsies of patients with neurological diseases, vascular EGFL7 expression rose with increasing EC proliferation. Further, EGFL7 became upregulated in vessels of the stroke penumbra using a mouse model of reversible middle cerebral artery occlusion (MCAO). Our data suggest that EGFL7 expression depends on the remodeling state of the existing vasculature rather than on the phenotype of neurological disease analyzed. In sum, our work sheds a novel light on the molecular mechanism EGFL7 engages to govern physiological and pathological angiogenesis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Benson, Kathrin</author><author>Cramer, Sandra</author><author>Galla, Hans-Joachim</author></authors></contributors><titles><title>Impedance-based cell monitoring: barrier properties and beyond.</title><secondary-title>Fluids and barriers of the CNS</secondary-title></titles><periodical><full-title>Fluids and barriers of the CNS</full-title></periodical><pages>5</pages><volume>10</volume><issue>1</issue><keywords/><dates><year>2013</year></dates><accession-num>23305242</accession-num><electronic-resource-num>10.1186/2045-8118-10-5</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3560213&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>In multicellular organisms epithelial and endothelial cells form selective permeable interfaces between tissue compartments of different chemical compositions. Tight junctions which connect adjacent cells, control the passage of molecules across the barrier and, in addition, facilitate active transport processes. The cellular barriers are not static but can be deliberately modulated by exposure to specific external stimuli. In vitro models representing the essential absorption barriers of the body are nowadays available, thus allowing investigation of the parameters that control permeability as well as transport processes across those barriers. Independent of the origin of the barrier forming cells, techniques are needed to quantify their barrier integrity. One simple assay is to measure the permeability for given hydrophilic substrates possessing different molecular weights like sucrose or dextrans. However, this technique is time-consuming and labor-intensive. Moreover, radioactive or fluorescently-labeled substrates are needed to allow easy analytical detection. Finally, if transport processes are investigated, the standard permeant may interfere with the transport process under investigation or might even alter the barrier integrity by itself. Thus, independent, non-invasive techniques are needed to quantify the barrier integrity continuously during the experiment. Such techniques are available and are mainly based on the measurement of the transendothelial or transepithelial electrical resistance (TEER) of barrier forming cells grown on porous membranes. Simple devices using two sets of electrodes (so-called Voltohmeters) are widely used. In addition, an easy-to-use physical technique called impedance spectroscopy allows the continuous analysis of both the TEER and the electrical capacitance giving additional information about the barrier properties of cells grown on permeable membranes. This technique is useful as a quality control for barrier forming cells. Another impedance-based approach requires cells to be grown directly on solid, micro-structured electrodes. Here, we will discuss the physical background of the different techniques; advantages, disadvantages, and applications will be scrutinized. The aim is to give the reader a comprehensive understanding concerning the range and limits of the application, mainly focusing on endothelial cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Martin, Tracey a</author><author>Lane, Jane</author><author>Ozupek, Hulya</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Claudin-20 promotes an aggressive phenotype in human breast cancer cells.</title><secondary-title>Tissue barriers</secondary-title></titles><periodical><full-title>Tissue barriers</full-title></periodical><pages>e26518</pages><volume>1</volume><issue>3</issue><keywords><keyword>abbreviations</keyword><keyword>breast cancer</keyword><keyword>claudin-20</keyword><keyword>ecis</keyword><keyword>electric cell impedence sensing</keyword><keyword>emp-1</keyword><keyword>epithelial</keyword><keyword>hepatocyte growth factor</keyword><keyword>hgf</keyword><keyword>membrane protein-1</keyword><keyword>metastasis</keyword><keyword>nottingham prognostic indicator</keyword><keyword>npi</keyword><keyword>paracellular permeability</keyword><keyword>pcp</keyword><keyword>survival</keyword><keyword>ter</keyword><keyword>tight junction</keyword><keyword>tj</keyword><keyword>tmp</keyword><keyword>tnm</keyword><keyword>transepithelial resistance</keyword><keyword>tumour nodal</keyword><keyword>tumour-associated membrane protein</keyword></keywords><dates><year>2013</year></dates><accession-num>24665404</accession-num><electronic-resource-num>10.4161/tisb.26518</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3866195&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Claudin-20 is a member of the Claudin family of transmembrane proteins located in the tight junction (TJ) of cells of epithelial origin. Due to the increasing evidence supporting the role of TJ proteins in preventing tumor cell metastatic behavior, this study sought to evaluate the distribution of Claudin-20 in human breast cancer and the effect of Claudin-20 overexpression in human breast cancer cells. Q-PCR data from breast cancer primary tumors (n = 114) and matched background tissue (n = 30) showed that high claudin-20 expression was correlated with poor survival of patients with breast cancer (p = 0.022). Following transformation of the breast cancer cell lines MDA-MB-231 and MCF7 with a Claudin-20 expression construct functional assays were performed to ascertain changes in cell behavior. Claudin-20 transformed cells showed significantly increased invasion (p &lt; 0.005) and were significantly less adhesive than wild type cells (p &lt; 0.05). There was no effect on growth (either in vitro or in vivo) for either cell line. Overexpression of Claudin-20 resulted in reduced transepithelial resistance (induced by the motogen HGF at 25 ng/ml, p = 0.0007). Interestingly, this was not mirrored by paracellular permeability, as overexpression of Claudin-20 caused a decrease in permeability. The introduction of Claudin-20 into human breast cancer cells resulted in breast cancer cells with an aggressive phenotype and reduced trans-epithelial resistance. There was no corresponding decrease in paracellular permeability, indicating that this Claudin has a differential function in epithelial TJ. This provides further insight into the importance of correctly functioning TJ in preventing the progression of human breast cancer.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kluger, Martin S</author><author>Clark, Paul R</author><author>Tellides, George</author><author>Gerke, Volker</author><author>Pober, Jordan S</author></authors></contributors><titles><title>Claudin-5 controls intercellular barriers of human dermal microvascular but not human umbilical vein endothelial cells</title><secondary-title>Arteriosclerosis, Thrombosis, and Vascular Biology</secondary-title></titles><periodical><full-title>Arteriosclerosis, Thrombosis, and Vascular Biology</full-title></periodical><pages>489-500</pages><volume>33</volume><issue>3</issue><keywords><keyword>endothelial cell</keyword><keyword>heterogeneity</keyword><keyword>microvessel</keyword><keyword>permeability</keyword><keyword>tight junction</keyword></keywords><dates><year>2013</year></dates><accession-num>23288152</accession-num><electronic-resource-num>10.1161/ATVBAHA.112.300893</electronic-resource-num><urls/><label>ECIS TEER</label><abstract>OBJECTIVE: To assess the role claudin-5, an endothelial cell (EC) tight junction protein, plays in establishing basal permeability levels in humans by comparing claudin-5 expression levels in situ and analyzing junctional organization and function in 2 widely used models of cultured ECs, namely human dermal microvascular (HDM)ECs and human umbilical vein (HUV)ECs.\n\nMETHODS AND RESULTS: By immunofluorescence microscopy, ECs more highly express claudin-5 (but equivalently express vascular endothelial-cadherin) in human dermal capillaries versus postcapillary venules and in umbilical and coronary arteries versus veins, correlating with known segmental differences in tight junction frequencies and permeability barriers. Postconfluent cultured HDMECs express more claudin-5 (but equivalent vascular endothelial-cadherin) and show higher transendothelial electric resistance and lower macromolecular flux than similarly cultured HUVECs. HDMEC junctions are more complex by transmission electron microscopy and show more continuous claudin-5 immunofluorescence than HUVEC junctions. Calcium chelation or dominant negative vascular endothelial-cadherin overexpression decreases transendothelial electric resistance and disrupts junctions in HUVECs, but not in HDMECs. Claudin-5 overexpression in HUVECs fails to increase transendothelial electric resistance or claudin-5 continuity, whereas claudin-5 knockdown in HDMECs, but not in HUVECs, reduces transendothelial electric resistance and increases antibody accessibility to junctional proteins.\n\nCONCLUSIONS: Claudin-5 expression and junctional organization control HDMEC and arteriolar-capillary paracellular barriers, whereas HUVEC and venular junctions use vascular endothelial-cadherin.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Reijerkerk, Arie</author><author>Lopez-Ramirez, M Alejandro</author><author>van Het Hof, Bert</author><author>Drexhage, Joost A R</author><author>Kamphuis, Wouter W</author><author>Kooij, Gijs</author><author>Vos, Joost B</author><author>van der Pouw Kraan, Tineke C T M</author><author>van Zonneveld, Anton J</author><author>Horrevoets, Anton J</author><author>Prat, Alexandre</author><author>Romero, Ignacio A</author><author>de Vries, Helga E</author></authors></contributors><titles><title>MicroRNAs regulate human brain endothelial cell-barrier function in inflammation: implications for multiple sclerosis.</title><secondary-title>The Journal of neuroscience : the official journal of the Society for Neuroscience</secondary-title></titles><periodical><full-title>The Journal of neuroscience : the official journal of the Society for Neuroscience</full-title></periodical><pages>6857-6863</pages><volume>33</volume><issue>16</issue><keywords><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: drug effects</keyword><keyword>Blood-Brain Barrier: physiopathology</keyword><keyword>Brain</keyword><keyword>Brain: pathology</keyword><keyword>Cell Line</keyword><keyword>Cytokines</keyword><keyword>Cytokines: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: drug effects</keyword><keyword>Genetic Vectors</keyword><keyword>Genetic Vectors: physiology</keyword><keyword>Humans</keyword><keyword>Inflammation</keyword><keyword>Inflammation: pathology</keyword><keyword>MicroRNAs</keyword><keyword>MicroRNAs: genetics</keyword><keyword>MicroRNAs: metabolism</keyword><keyword>Multiple Sclerosis</keyword><keyword>Multiple Sclerosis: pathology</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: pharmacology</keyword><keyword>Transendothelial and Transepithelial Migration</keyword><keyword>Transendothelial and Transepithelial Migration: dr</keyword><keyword>Transfection</keyword><keyword>Transformed</keyword></keywords><dates><year>2013</year></dates><accession-num>23595744</accession-num><electronic-resource-num>10.1523/JNEUROSCI.3965-12.2013</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23595744</url></web-urls></urls><label>Blood Brain Barrier;Inflammation</label><abstract>Blood-brain barrier (BBB) dysfunction is a major hallmark of many neurological diseases, including multiple sclerosis (MS). Using a genomics approach, we defined a microRNA signature that is diminished at the BBB of MS patients. In particular, miR-125a-5p is a key regulator of brain endothelial tightness and immune cell efflux. Our findings suggest that repair of a disturbed BBB through microRNAs may represent a novel avenue for effective treatment of MS.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Doeppler, Heike R</author><author>Bastea, Ligia I</author><author>Lewis-Tuffin, Laura J</author><author>Anastasiadis, Panos Z</author><author>Storz, Peter</author></authors></contributors><titles><title>Protein Kinase D1 mediated phosphorylations regulate vasodilator-stimulated phosphoprotein (VASP) localization and cell migration.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><keywords/><dates><year>2013</year></dates><accession-num>23846685</accession-num><electronic-resource-num>10.1074/jbc.M113.474676</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23846685</url></web-urls></urls><abstract>Enabled/Vasodilator-stimulated phospho-protein (Ena/VASP) protein family members link actin dynamics and cellular signaling pathways. VASP localizes to regions of dynamic actin reorganization such as the focal adhesion contacts, the leading edge or filopodia, where it contributes to F-actin filament elongation. Here we identify VASP as a novel substrate for Protein Kinase D1 (PKD1). We show that PKD1 directly phosphorylates VASP at two serine residues, S157 and S322. These phosphorylations occur in response to RhoA activation and mediate VASP re-localization from focal contacts to the leading edge region. Net result of this PKD1-mediated phosphorylation switch in VASP is increased filopodia formation and length at the leading edge. However, such signaling when persistent induced membrane ruffling and decreased cell motility.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Goc, Anna</author><author>Al-Azayzih, Ahmad</author><author>Abdalla, Maha</author><author>Al-Husein, Belal</author><author>Kavuri, Sravankumar</author><author>Lee, Jeffrey</author><author>Moses, Kelvin</author><author>Somanath, Payaningal R</author></authors></contributors><titles><title>P21 activated kinase-1 (Pak1) promotes prostate tumor growth and microinvasion via inhibition of transforming growth factor β expression and enhanced matrix metalloproteinase 9 secretion.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>3025-3035</pages><volume>288</volume><issue>5</issue><keywords><keyword>Androgens</keyword><keyword>Androgens: pharmacology</keyword><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Matrix Metalloproteinase 9</keyword><keyword>Matrix Metalloproteinase 9: secretion</keyword><keyword>Mice</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplastic</keyword><keyword>Neoplastic: drug effects</keyword><keyword>Neovascularization</keyword><keyword>Pathologic</keyword><keyword>Pathologic: enzymology</keyword><keyword>Prostatic Neoplasms</keyword><keyword>Prostatic Neoplasms: blood supply</keyword><keyword>Prostatic Neoplasms: enzymology</keyword><keyword>Prostatic Neoplasms: genetics</keyword><keyword>Prostatic Neoplasms: pathology</keyword><keyword>Transforming Growth Factor beta</keyword><keyword>Transforming Growth Factor beta: metabolism</keyword><keyword>Tumor</keyword><keyword>Xenograft Model Antitumor Assays</keyword><keyword>p21-Activated Kinases</keyword><keyword>p21-Activated Kinases: antagonists &amp; inhibitors</keyword><keyword>p21-Activated Kinases: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23258534</accession-num><electronic-resource-num>10.1074/jbc.M112.424770</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3561527&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Invasion</label><abstract>P21-activated kinases (Paks) are major effectors downstream of the small Rho family of GTPases. Among the six isoforms, Pak1 is the most ubiquitous and the best characterized member. Previous studies have shown that inhibition of Pak6, which is predominantly present in the prostate compared with other tissues, inhibits prostate tumor growth in vivo. Even though Pak1 has been identified in normal prostatic epithelial cells and cancer cells, its specific role in the development of prostate cancer remains unclear. We report here that highly invasive prostate cancer cells express significantly higher levels of Pak1 protein compared with non-invasive prostate cancer cells. Furthermore, prostate tumor tissues and prostate cancer metastasized to lungs showed a higher expression of Pak1 compared with normal tissues. Interestingly, Pak6 protein expression levels did not change with the invasive/metastatic potential of the cancer cells or tumors. Although inhibition of Pak1, and not Pak6, resulted in impaired PC3 cell migration, the effects of Pak1 knockdown on transendothelial migration (microinvasion), tumor growth, and tumor angiogenesis was higher compared with Pak6 knockdown. Finally, gene array data revealed reduced expression of matrix metalloproteinase 9 with the ablation of either Pak1 or Pak6 gene expression in PC3 cells, whereas protein levels of TGFβ was elevated significantly with specific modulation of Pak1 activity or ablation of the Pak1 gene. Our observations suggest that although some level of functional redundancy exists between Pak1 and Pak6 in prostate cancer cells, targeting Pak1 is a potential option for the management of prostate tumor growth, microinvasion, and metastasis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zehendner, Christoph M</author><author>Librizzi, Laura</author><author>Hedrich, Jana</author><author>Bauer, Nina M</author><author>Angamo, Eskedar a.</author><author>de Curtis, Marco</author><author>Luhmann, Heiko J</author></authors></contributors><titles><title>Moderate Hypoxia Followed by Reoxygenation Results in Blood-Brain Barrier Breakdown via Oxidative Stress-Dependent Tight-Junction Protein Disruption</title><secondary-title>PLoS ONE</secondary-title></titles><periodical><full-title>PLoS ONE</full-title></periodical><pages>e82823</pages><volume>8</volume><issue>12</issue><keywords/><dates><year>2013</year></dates><electronic-resource-num>10.1371/journal.pone.0082823</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0082823</url></web-urls></urls><label>ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Boratkó, Anita</author><author>Csortos, Csilla</author></authors></contributors><titles><title>NHERF2 is crucial in ERM phosphorylation in pulmonary endothelial cells.</title><secondary-title>Cell communication and signaling : CCS</secondary-title></titles><periodical><full-title>Cell communication and signaling : CCS</full-title></periodical><pages>99</pages><volume>11</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: genetics</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: genetics</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Neovascularization</keyword><keyword>Neurofibromin 2</keyword><keyword>Neurofibromin 2: genetics</keyword><keyword>Neurofibromin 2: metabolism</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Physiologic</keyword><keyword>Protein Structure</keyword><keyword>Pseudopodia</keyword><keyword>Pseudopodia: metabolism</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: metabolism</keyword><keyword>Sodium-Hydrogen Antiporter</keyword><keyword>Sodium-Hydrogen Antiporter: metabolism</keyword><keyword>Tertiary</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2013</year></dates><isbn>1478-811X (Electronic)\r1478-811X (Linking)</isbn><accession-num>24364877</accession-num><electronic-resource-num>10.1186/1478-811X-11-99</electronic-resource-num><urls><web-urls><url>http://www.biosignaling.com/content/11/1/99</url><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3880038&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Barrier Function</label><abstract>BACKGROUND: EBP50 and NHERF2 adaptor proteins are incriminated in various signaling pathways of the cell. They can bind ERM proteins and mediate ERM-membrane protein interactions.\n\nRESULTS: Binding of ERM to EBP50 and NHERF2 was compared in pulmonary artery endothelial cells by immunoprecipitation. NHERF2 associates with all three ERM, but EBP50 appeared to be a weak binding partner if at all. Furthermore, we detected co-localization of NHERF2 and phospho-ERM at the cell membrane and in the filopodia of dividing cells. Silencing of NHERF2 prevented agonist or angiogenesis induced phosphorylation of ERM, while overexpression of the adaptor elevated the phosphorylation level of ERM, likely catalyzed by Rho kinase 2, which co-immunoprecipitated with NHERF2/ERM in control EC, but did not bind to ERM in NHERF2 depleted cells. Dependence of ERM phosphorylation on NHERF2 was also shown in Matrigel tube formation assay, and NHERF2 was proved to be important in angiogenesis as well. Furthermore, when NHERF2 was depleted or cells were overexpressing a mutant form of NHERF2 unable to bind ERM, we found attenuated cell attachment with ECIS measurements, while it was supported by overexpression of wild type NHERF2.\n\nCONCLUSIONS: Pivotal role of NHERF2 in the phosphorylation process of ERM in pulmonary artery endothelial cells is shown. We propose that NHERF2 provides a common anchoring surface for ERM and Rho kinase 2. Our results demonstrate the essential role of NHERF2 in endothelial cell adhesion/migration and angiogenesis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lipiski, Miriam</author><author>Deuel, Jeremy W</author><author>Baek, Jin Hyen</author><author>Engelsberger, Wolfgang R</author><author>Buehler, Paul W</author><author>Schaer, Dominik J</author></authors></contributors><titles><title>Human Hp1-1 and Hp2-2 phenotype-specific haptoglobin therapeutics are both effective in vitro and in guinea pigs to attenuate hemoglobin toxicity.</title><secondary-title>Antioxidants &amp; redox signaling</secondary-title></titles><periodical><full-title>Antioxidants &amp; redox signaling</full-title></periodical><pages>1619-1633</pages><volume>19</volume><issue>14</issue><keywords><keyword>Animals</keyword><keyword>Guinea Pigs</keyword><keyword>Haptoglobins</keyword><keyword>Haptoglobins: chemistry</keyword><keyword>Haptoglobins: pharmacokinetics</keyword><keyword>Haptoglobins: therapeutic use</keyword><keyword>Hemoglobins</keyword><keyword>Hemoglobins: metabolism</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Humans</keyword><keyword>Hydrogen Peroxide</keyword><keyword>Hydrogen Peroxide: chemistry</keyword><keyword>Hydrogen Peroxide: metabolism</keyword><keyword>LDL</keyword><keyword>LDL: metabolism</keyword><keyword>Lipid Peroxidation</keyword><keyword>Lipid Peroxidation: drug effects</keyword><keyword>Lipoproteins</keyword><keyword>Male</keyword></keywords><dates><year>2013</year></dates><accession-num>23418677</accession-num><electronic-resource-num>10.1089/ars.2012.5089</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3809386&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>AIMS: Infusion of purified haptoglobin (Hp) functions as an effective hemoglobin (Hb) scavenging therapeutic in animal models of hemolysis to prevent cardiovascular and renal injury. Epidemiologic studies demonstrate the phenotype heterogeneity of human Hp proteins and suggest differing vascular protective potential imparted by the dimeric Hp1-1 and the polymeric Hp2-2. RESULTS: In vitro experiments and in vivo studies in guinea pigs were performed to evaluate phenotype-specific differences in Hp therapeutics. We found no differences between the two phenotypes in Hb binding and intravascular compartmentalization of Hb in vivo. Both Hp1-1 and Hp2-2 attenuate Hb-induced blood pressure response and renal iron deposition. These findings were consistent with equal prevention of Hb endothelial translocation. The modulation of oxidative Hb reactions by the two Hp phenotypes was not found to be different. Both phenotypes stabilize the ferryl (Fe(4+)) Hb transition state, provide heme retention within the complex, and prevent Hb-driven low-density lipoprotein (LDL) peroxidation. Hb-mediated peroxidation of LDL resulted in endothelial toxicity, which was equally blocked by the addition of Hp1-1 and Hp2-2. INNOVATION AND CONCLUSION: The present data do not provide support for the concept that phenotype-specific Hp therapeutics offer differential efficacy in mitigating acute Hb toxicity.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Walters, Shaun B</author><author>Kieckbusch, Jens</author><author>Nagalingam, Gayathri</author><author>Swain, Ashleigh</author><author>Latham, Sharissa L</author><author>Grau, Georges E R</author><author>Britton, Warwick J</author><author>Combes, Valéry</author><author>Saunders, Bernadette M</author></authors></contributors><titles><title>Microparticles from mycobacteria-infected macrophages promote inflammation and cellular migration.</title><secondary-title>Journal of immunology (Baltimore, Md. : 1950)</secondary-title></titles><periodical><full-title>Journal of immunology (Baltimore, Md. : 1950)</full-title></periodical><pages>669-677</pages><volume>190</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Bacterial</keyword><keyword>Bacterial: immunology</keyword><keyword>Biological Transport</keyword><keyword>CD4-Positive T-Lymphocytes</keyword><keyword>CD4-Positive T-Lymphocytes: immunology</keyword><keyword>Cell Communication</keyword><keyword>Cell Communication: immunology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: immunology</keyword><keyword>Cell-Derived Microparticles</keyword><keyword>Cell-Derived Microparticles: immunology</keyword><keyword>Cell-Derived Microparticles: metabolism</keyword><keyword>Chemokines</keyword><keyword>Chemokines: biosynthesis</keyword><keyword>Chemokines: immunology</keyword><keyword>Cytokines</keyword><keyword>Cytokines: biosynthesis</keyword><keyword>Cytokines: immunology</keyword><keyword>Dendritic Cells</keyword><keyword>Dendritic Cells: immunology</keyword><keyword>Dendritic Cells: microbiology</keyword><keyword>Endosomes</keyword><keyword>Endosomes: metabolism</keyword><keyword>Humans</keyword><keyword>Inflammation Mediators</keyword><keyword>Inflammation Mediators: immunology</keyword><keyword>Inflammation Mediators: metabolism</keyword><keyword>Leukocytes</keyword><keyword>Leukocytes: immunology</keyword><keyword>Leukocytes: metabolism</keyword><keyword>Lymphocyte Activation</keyword><keyword>Lymphocyte Activation: immunology</keyword><keyword>Macrophages</keyword><keyword>Macrophages: immunology</keyword><keyword>Macrophages: metabolism</keyword><keyword>Macrophages: microbiology</keyword><keyword>Mice</keyword><keyword>Mycobacterium tuberculosis</keyword><keyword>Mycobacterium tuberculosis: immunology</keyword><keyword>Transgenic</keyword><keyword>Tuberculosis</keyword><keyword>Tuberculosis: immunology</keyword><keyword>Tuberculosis: metabolism</keyword><keyword>rab GTP-Binding Proteins</keyword><keyword>rab GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23241892</accession-num><electronic-resource-num>10.4049/jimmunol.1201856</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23241892</url></web-urls></urls><abstract>Mycobacterium tuberculosis infection is characterized by a strong inflammatory response whereby a few infected macrophages within the granuloma induce sustained cellular accumulation. The mechanisms coordinating this response are poorly characterized. We hypothesized that microparticles (MPs), which are submicron, plasma membrane-derived vesicles released by cells under both physiological and pathological conditions, are involved in this process. Aerosol infection of mice with M. tuberculosis increased CD45(+) MPs in the blood after 4 wk of infection, and in vitro infection of human and murine macrophages with mycobacteria enhanced MP release. MPs derived from mycobacteria-infected macrophages were proinflammatory, and when injected into uninfected mice they induced significant neutrophil, macrophage, and dendritic cell recruitment to the injection site. When incubated with naive macrophages, these MPs enhanced proinflammatory cytokine and chemokine release, and they aided in the disruption of the integrity of a respiratory epithelial cell monolayer, providing a mechanism for the egress of cells to the site of M. tuberculosis infection in the lung. In addition, MPs colocalized with the endocytic recycling marker Rab11a within macrophages, and this association increased when the MPs were isolated from mycobacteria-infected cells. M. tuberculosis-derived MPs also carried mycobacterial Ag and were able to activate M. tuberculosis-specific CD4(+) T cells in vivo and in vitro in a dendritic cell-dependent manner. Collectively, these data identify an unrecognized role for MPs in host response against M. tuberculosis by promoting inflammation, intercellular communication, and cell migration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hashimoto, M</author><author>Suizu, F</author><author>Tokuyama, W</author><author>Noguchi, H</author><author>Hirata, N</author><author>Matsuda-Lennikov, M</author><author>Edamura, T</author><author>Masuzawa, M</author><author>Gotoh, N</author><author>Tanaka, S</author><author>Noguchi, M</author></authors></contributors><titles><title>Protooncogene TCL1b functions as an Akt kinase co-activator that exhibits oncogenic potency in vivo.</title><secondary-title>Oncogenesis</secondary-title></titles><periodical><full-title>Oncogenesis</full-title></periodical><pages>e70</pages><volume>2</volume><issue>9</issue><keywords><keyword>akt</keyword><keyword>angiosarcoma</keyword><keyword>protooncogene tcl1b</keyword><keyword>transgenic mice</keyword></keywords><dates><year>2013</year></dates><publisher>Nature Publishing Group</publisher><accession-num>24042734</accession-num><electronic-resource-num>10.1038/oncsis.2013.30</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3816220&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Protooncogene T-cell leukemia 1 (TCL1), which is implicated in human T-cell prolymphocytic leukemia (T-PLL), interacts with Akt and enhances its kinase activity, functioning as an Akt kinase co-activator. Two major isoforms of TCL1 Protooncogenes (TCL1 and TCL1b) are present adjacent to each other on human chromosome 14q.32. In human T-PLL, both TCL1 and TCL1b are activated by chromosomal translocation. Moreover, TCL1b-transgenic mice have never been created. Therefore, it remains unclear whether TCL1b itself, independent of TCL1, exhibits oncogenicity. In co-immunoprecipitation assays, both ectopic and endogenous TCL1b interacted with Akt. In in vitro Akt kinase assays, TCL1b enhanced Akt kinase activity in dose- and time-dependent manners. Bioinformatics approaches utilizing multiregression analysis, cluster analysis, KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway mapping, Venn diagrams and Gene Ontology (GO) demonstrated that TCL1b showed highly homologous gene-induction signatures similar to Myr-Akt or TCL1. TCL1b exhibited oncogenicity in in vitro colony-transformation assay. Further, two independent lines of β-actin promoter-driven TCL1b-transgenic mice developed angiosarcoma on the intestinal tract. Angiosarcoma is a rare form of cancer in humans with poor prognosis. Using immunohistochemistry, 11 out of 13 human angiosarcoma samples were positively stained with both anti-TCL1b and anti-phospho-Akt antibodies. Consistently, in various cancer tissues, 69 out of 146 samples were positively stained with anti-TCL1b, out of which 46 were positively stained with anti-phospho-Akt antibodies. Moreover, TCL1b structure-based inhibitor 'TCL1b-Akt-in' inhibited Akt kinase activity in in vitro kinase assays and PDGF (platelet-derived growth factor)-induced Akt kinase activities-in turn, 'TCL1b-Akt-in' inhibited cellular proliferation of sarcoma. The current study disclosed TCL1b bears oncogenicity and hence serves as a novel therapeutic target for human neoplastic diseases.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schaer, C A</author><author>Deuel, J W</author><author>Bittermann, A G</author><author>Rubio, I G</author><author>Schoedon, G</author><author>Spahn, D R</author><author>Wepf, R A</author><author>Vallelian, F</author><author>Schaer, D J</author></authors></contributors><titles><title>Mechanisms of haptoglobin protection against hemoglobin peroxidation triggered endothelial damage.</title><secondary-title>Cell death and differentiation</secondary-title></titles><periodical><full-title>Cell death and differentiation</full-title></periodical><pages>1569-1579</pages><volume>20</volume><issue>11</issue><keywords><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Gene Expression</keyword><keyword>Haptoglobins</keyword><keyword>Haptoglobins: metabolism</keyword><keyword>Haptoglobins: pharmacology</keyword><keyword>Hemoglobins</keyword><keyword>Hemoglobins: metabolism</keyword><keyword>Humans</keyword><keyword>LDL</keyword><keyword>LDL: metabolism</keyword><keyword>Lipid Peroxidation</keyword><keyword>Lipoproteins</keyword><keyword>Oxidation-Reduction</keyword></keywords><dates><year>2013</year></dates><accession-num>23995229</accession-num><electronic-resource-num>10.1038/cdd.2013.113</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3792434&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Extracellular hemoglobin (Hb) has been recognized as a disease trigger in hemolytic conditions such as sickle cell disease, malaria, and blood transfusion. In vivo, many of the adverse effects of free Hb can be attenuated by the Hb scavenger acute-phase protein haptoglobin (Hp). The primary physiologic disturbances that can be caused by free Hb are found within the cardiovascular system and Hb-triggered oxidative toxicity toward the endothelium has been promoted as a potential mechanism. The molecular mechanisms of this toxicity as well as of the protective activities of Hp are not yet clear. Within this study, we systematically investigated the structural, biochemical, and cell biologic nature of Hb toxicity in an endothelial cell system under peroxidative stress. We identified two principal mechanisms of oxidative Hb toxicity that are mediated by globin degradation products and by modified lipoprotein species, respectively. The two damage pathways trigger diverse and discriminative inflammatory and cytotoxic responses. Hp provides structural stabilization of Hb and shields Hb's oxidative reactions with lipoproteins, providing dramatic protection against both pathways of toxicity. By these mechanisms, Hp shifts Hb's destructive pseudo-peroxidative reaction to a potential anti-oxidative function during peroxidative stress.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hofmann, Ute</author><author>Michaelis, Stefanie</author><author>Winckler, Thomas</author><author>Wegener, Joachim</author><author>Feller, Karl-Heinz</author></authors></contributors><titles><title>A whole-cell biosensor as in vitro alternative to skin irritation tests.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>156-162</pages><volume>39</volume><issue>1</issue><keywords><keyword>Cell-based assay</keyword><keyword>Electric cell-substrate impedance sensing</keyword><keyword>Heat shock protein</keyword><keyword>Lab on a Chip</keyword><keyword>Reporter gene</keyword><keyword>Time-lapse microscopy</keyword><keyword>Whole-cell biosensor</keyword></keywords><dates><year>2013</year></dates><publisher>Elsevier</publisher><accession-num>22917920</accession-num><electronic-resource-num>10.1016/j.bios.2012.07.075</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22917920</url><url>http://linkinghub.elsevier.com/retrieve/pii/S0956566312005179</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>This study presents the time-resolved detection of chemically induced stress upon intracellular signaling cascades by using genetically modified sensor cells based on the human keratinocyte cell line HaCaT. The cells were stably transfected with a HSP72-GFP reporter gene construct to create an optical sensor cell line expressing a stress-inducible reporter protein. The time- and dose-dependent performance of the sensor cells is demonstrated and discussed in comparison to a label-free impedimetric monitoring approach (electric cell-substrate impedance sensing, ECIS). Moreover, a microfluidic platform was established based on μSlidesI(0,4)Luer to allow for a convenient, sterile and incubator-independent time-lapse microscopic observation of the sensor cells. Cell growth was successfully achieved in this microfluidic setup and the cellular response to a cytotoxic substance could be followed in real-time and in a non-invasive, sensitive manner. This study paves the way for the development of micro-total analysis systems that combine optical and impedimetric readouts to enable an overall quantitative characterization of changes in cell metabolism and morphology as a response to toxin exposure. By recording multiple parameters, a detailed discrimination between competing stress- or growth-related mechanisms is possible, thereby presenting an entirely new in vitro alternative to skin irritation tests.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Heijink, Irene</author><author>van Oosterhout, Antoon</author><author>Kliphuis, Nathalie</author><author>Jonker, Marnix</author><author>Hoffmann, Roland</author><author>Telenga, Eef</author><author>Klooster, Karin</author><author>Slebos, Dirk-Jan</author><author>Ten Hacken, Nick</author><author>Postma, Dirkje</author><author>van den Berge, Maarten</author></authors></contributors><titles><title>Oxidant-induced corticosteroid unresponsiveness in human bronchial epithelial cells.</title><secondary-title>Thorax</secondary-title></titles><periodical><full-title>Thorax</full-title></periodical><keywords/><dates><year>2013</year></dates><accession-num>23980116</accession-num><electronic-resource-num>10.1136/thoraxjnl-2013-203520</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23980116</url></web-urls></urls><abstract>BACKGROUND: We hypothesised that increased oxidative stress, as present in the airways of asthma and chronic obstructive pulmonary disease (COPD) patients, induces epithelial damage and reduces epithelial responsiveness to suppressive effects of corticosteroids on proinflammatory cytokine production and barrier function. METHODS: We induced oxidative stress by H2O2 and/or cigarette smoke extract (CSE) in human bronchial epithelial 16HBE cells and primary bronchial epithelial cells (PBEC) derived by brushings from asthma patients, COPD patients, and smoking and non-smoking control individuals. We investigated effects of budesonide on barrier function (electrical resistance) and TNF-α-induced proinflammatory cytokine production (IL-8/CXCL8, granulocyte macrophage-colony stimulating factor (GM-CSF)). RESULTS: We observed that H2O2 and CSE reduce epithelial resistance. Budesonide significantly counteracted this effect, likely by protection against epidermal growth factor receptor-dependent cell-cell contact disruption. Furthermore, budesonide suppressed proinflammatory cytokine production. H2O2 pretreatment reduced this effect of budesonide on cytokine production in both 16HBE cells and PBECs. Importantly, PBECs from asthma and COPD patients were less sensitive to budesonide with respect to cytokine production and barrier function than PBECs from control subjects. CONCLUSIONS: Together, our data indicate that budesonide suppresses epithelial proinflammatory responses and barrier dysfunction and that oxidative stress reduces these effects in airway epithelium from asthma and COPD patients. Therefore, restoration of corticosteroid responsiveness in asthma and COPD may act to improve the airway epithelial barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Fox, Elizabeth D</author><author>Heffernan, Daithi S</author><author>Cioffi, William G</author><author>Reichner, Jonathan S</author></authors></contributors><titles><title>Neutrophils from critically ill septic patients mediate profound loss of endothelial barrier integrity.</title><secondary-title>Critical care (London, England)</secondary-title></titles><periodical><full-title>Critical care (London, England)</full-title></periodical><pages>R226</pages><volume>17</volume><issue>5</issue><keywords><keyword>Neutriphils</keyword><keyword>Sepsis</keyword><keyword>TNF</keyword></keywords><dates><year>2013</year></dates><accession-num>24099563</accession-num><electronic-resource-num>10.1186/cc13049</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24099563</url></web-urls></urls><label>ECIS Barrier Function;ECIS TEER</label><abstract>INTRODUCTION: Sepsis is characterized by systemic immune activation and neutrophil-mediated endothelial barrier integrity compromise, contributing to end-organ dysfunction. Studies evaluating endothelial barrier dysfunction induced by neutrophils from septic patients are lacking, despite its clinical significance. We hypothesized that septic neutrophils would cause characteristic patterns of endothelial barrier dysfunction, distinct from experimental stimulation of normal neutrophils, and that treatment with the immunomodulatory drug β-glucan would attenuate this effect.\n\nMETHODS: Blood was obtained from critically ill septic patients. Patients were either general surgery patients (Primary Sepsis (PS)) or those with sepsis following trauma (Secondary Sepsis (SS)). Those with acute respiratory distress syndrome (ARDS) were identified. Healthy volunteers served as controls. Neutrophils were purified and aliquots were untreated, or treated with fMLP or β-glucan. Endothelial cells were grown to confluence and activated with tissue necrosis factor (TNF)-α . Electric Cell-substrate Impedance Sensing (ECIS) was used to determine monolayer resistance after neutrophils were added. Groups were analyzed by two-way analysis of variance (ANOVA).\n\nRESULTS: Neutrophils from all septic patients, as well as fMLP-normal neutrophils, reduced endothelial barrier integrity to a greater extent than untreated normal neutrophils (normalized resistance of cells from septic patients at 30 mins = 0.90 ± 0.04; at 60 mins = 0.73 ± 0.6 and at 180 mins = 0.56 ± 0.05; p &lt; 0.05 vs normal). Compared to untreated PS neutrophils, fMLP-treated PS neutrophils caused further loss of barrier function at all time points; no additive effect was noted in stimulation of SS neutrophils beyond 30 min. Neutrophils from ARDS patients caused greater loss of barrier integrity than those from non-ARDS patients, despite similarities in age, sex, septic source, and neutrophil count. Neutrophils obtained after resolution of sepsis caused less barrier dysfunction at all time points. β-glucan treatment of septic patients' neutrophils attenuated barrier compromise, rendering the effect similar to that induced by neutrophils obtained once sepsis had resolved.\n\nCONCLUSIONS: Neutrophils from septic patients exert dramatic compromise of endothelial barrier integrity. This pattern is mimicked by experimental activation of healthy neutrophils. The effect of septic neutrophils on the endothelium depends upon the initial inflammatory event, correlates with organ dysfunction and resolution of sepsis, and is ameliorated by β-glucan.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Burghardt, Tillmann</author><author>Kastner, Jürgen</author><author>Suleiman, Hani</author><author>Rivera-Milla, Eric</author><author>Stepanova, Natalya</author><author>Lottaz, Claudio</author><author>Kubitza, Marion</author><author>Böger, Carsten A</author><author>Schmidt, Sarah</author><author>Gorski, Mathias</author><author>de Vries, Uwe</author><author>Schmidt, Helga</author><author>Hertting, Irmgard</author><author>Kopp, Jeffrey</author><author>Rascle, Anne</author><author>Moser, Markus</author><author>Heid, Iris M</author><author>Warth, Richard</author><author>Spang, Rainer</author><author>Wegener, Joachim</author><author>Mierke, Claudia T</author><author>Englert, Christoph</author><author>Witzgall, Ralph</author></authors></contributors><titles><title>LMX1B is Essential for the Maintenance of Differentiated Podocytes in Adult Kidneys.</title><secondary-title>Journal of the American Society of Nephrology : JASN</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology : JASN</full-title></periodical><keywords/><dates><year>2013</year></dates><accession-num>23990680</accession-num><electronic-resource-num>10.1681/ASN.2012080788</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23990680</url></web-urls></urls><abstract>Mutations of the LMX1B gene cause nail-patella syndrome, a rare autosomal-dominant disorder affecting the development of the limbs, eyes, brain, and kidneys. The characterization of conventional Lmx1b knockout mice has shown that LMX1B regulates the development of podocyte foot processes and slit diaphragms, but studies using podocyte-specific Lmx1b knockout mice have yielded conflicting results regarding the importance of LMX1B for maintaining podocyte structures. In order to address this question, we generated inducible podocyte-specific Lmx1b knockout mice. One week of Lmx1b inactivation in adult mice resulted in proteinuria with only minimal foot process effacement. Notably, expression levels of slit diaphragm and basement membrane proteins remained stable at this time point, and basement membrane charge properties also did not change, suggesting that alternative mechanisms mediate the development of proteinuria in these mice. Cell biological and biophysical experiments with primary podocytes isolated after 1 week of Lmx1b inactivation indicated dysregulation of actin cytoskeleton organization, and time-resolved DNA microarray analysis identified the genes encoding actin cytoskeleton-associated proteins, including Abra and Arl4c, as putative LMX1B targets. Chromatin immunoprecipitation experiments in conditionally immortalized human podocytes and gel shift assays showed that LMX1B recognizes AT-rich binding sites (FLAT elements) in the promoter regions of ABRA and ARL4C, and knockdown experiments in zebrafish support a model in which LMX1B and ABRA act in a common pathway during pronephros development. Our report establishes the importance of LMX1B in fully differentiated podocytes and argues that LMX1B is essential for the maintenance of an appropriately structured actin cytoskeleton in podocytes.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dubrovskyi, Oleksii</author><author>Birukova, Anna A</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Measurement of local permeability at subcellular level in cell models of agonist- and ventilator-induced lung injury.</title><secondary-title>Laboratory investigation; a journal of technical methods and pathology</secondary-title></titles><periodical><full-title>Laboratory investigation; a journal of technical methods and pathology</full-title></periodical><pages>254-263</pages><volume>93</volume><issue>2</issue><keywords><keyword>Avidin</keyword><keyword>Avidin: metabolism</keyword><keyword>Avidin: pharmacokinetics</keyword><keyword>Biological Transport</keyword><keyword>Biological Transport: physiology</keyword><keyword>Biotinylation</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cell Culture Techniques</keyword><keyword>Collagen</keyword><keyword>Collagen: metabolism</keyword><keyword>Culture Media</keyword><keyword>Culture Media: chemistry</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Fluorescein-5-isothiocyanate</keyword><keyword>Fluorescein-5-isothiocyanate: analogs &amp; derivative</keyword><keyword>Fluorescein-5-isothiocyanate: metabolism</keyword><keyword>Fluorescein-5-isothiocyanate: pharmacokinetics</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Gelatin</keyword><keyword>Gelatin: metabolism</keyword><keyword>Humans</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Tissue Array Analysis</keyword><keyword>Tissue Array Analysis: methods</keyword><keyword>Ventilator-Induced Lung Injury</keyword><keyword>Ventilator-Induced Lung Injury: physiopathology</keyword></keywords><dates><year>2013</year></dates><accession-num>23212101</accession-num><electronic-resource-num>10.1038/labinvest.2012.159</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3668557&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Alterations of cell monolayer integrity and increased vascular permeability are key to many pathologies, including atherosclerosis, stroke, lung injury, cancer, digestive disorders and others. Current approaches to probe cell permeability require specific culture conditions and provide an average estimation of trans-monolayer permeability, while analysis of regional monolayer permeability in static and mechanically challenged monolayer at a single-cell scale resolution remains unavailable. We describe a novel method for visualization and rapid quantification of trans-monolayer permeability based on high-affinity interactions between ligand (FITC-conjugated avidin) added in the culture medium, which permeates cell monolayer to reach substrate-bound acceptor (biotinylated gelatin or collagen). This approach was used to simultaneously evaluate general and local permeability responses by endothelial cell (EC) monolayer to a spectrum of barrier protective and barrier disruptive agonists and their combinations. The results revealed the paracellular pathway as the predominant mechanism of agonist-induced mass transport by pulmonary EC. We also detected for the first time, in a direct assay, a synergistic effect of pathologically relevant levels of cyclic stretch (CS) and edemagenic agent thrombin in the development of pulmonary EC hyper-permeability response observed in ventilator-induced lung injury. The reported novel assay provides unique information about local monolayer permeability changes induced by agonists, mechanical factors or molecular perturbations in single cells. However, the spectrum of substrates, assay formats and experimental conditions compatible with this assay suggest its broad application in the areas of endothelial and epithelial biology, cancer research and other fields.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ke, Yunbo</author><author>Lei, Ming</author><author>Wang, Xin</author><author>Solaro, R John</author></authors></contributors><titles><title>Unique catalytic activities and scaffolding of p21 activated kinase-1 in cardiovascular signaling.</title><secondary-title>Frontiers in pharmacology</secondary-title></titles><periodical><full-title>Frontiers in pharmacology</full-title></periodical><pages>116</pages><volume>4</volume><issue>September</issue><keywords><keyword>auto-phosphorylation</keyword><keyword>cardiovascular diseases</keyword><keyword>cytoskeletal re</keyword><keyword>cytoskeletal reorganization</keyword><keyword>fty720</keyword><keyword>scaffolding</keyword></keywords><dates><year>2013</year></dates><accession-num>24098283</accession-num><electronic-resource-num>10.3389/fphar.2013.00116</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3784770&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>P21 activated kinase-1 (Pak1) has diverse functions in mammalian cells. Although a large number of phosphoproteins have been designated as Pak1 substrates from in vitro studies, emerging evidence has indicated that Pak1 may function as a signaling molecule through a unique molecular mechanism - scaffolding. By scaffolding, Pak1 delivers signals through an auto-phosphorylation-induced conformational change without transfer of a phosphate group to its immediate downstream effector(s). Here we review evidence for this regulatory mechanism based on structural and functional studies of Pak1 in different cell types and research models as well as in vitro biochemical assays. We also discuss the implications of Pak1 scaffolding in disease-related signaling processes and the potential in cardiovascular drug development.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Keil, Jason M</author><author>Liu, Xuwen</author><author>Antonetti, David A</author></authors></contributors><titles><title>Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO</title><secondary-title>Investigative Ophthalmology and Visual Science</secondary-title></titles><periodical><full-title>Investigative Ophthalmology and Visual Science</full-title></periodical><pages>4007-4015</pages><volume>54</volume><issue>6</issue><keywords><keyword>Blood-retinal barrier</keyword><keyword>Enhancer</keyword><keyword>Gene expression</keyword><keyword>Tight junction</keyword></keywords><dates><year>2013</year></dates><accession-num>23640037</accession-num><electronic-resource-num>10.1167/iovs.13-11980</electronic-resource-num><urls/><abstract>PURPOSE: Glucocorticoids (GCs) effectively reduce retinal edema and induce vascular barrier properties but possess unwanted side effects. Understanding GC induction of barrier properties may lead to more effective and specific therapies. Previous work identified the occludin enhancer element (OEE) as a GC-responsive cis-element in the promoters of multiple junctional genes, including occludin, claudin-5, and cadherin-9. Here, we identify two OEE-binding factors and determine their contribution to GC induction of tight junction (TJ) gene expression and endothelial barrier properties.\n\nMETHODS: OEE-binding factors were isolated from human retinal endothelial cells (HREC) using DNA affinity purification followed by MALDI-TOF MS/MS. Chromatin immunoprecipitation (ChIP) assays determined in situ binding. siRNA was used to evaluate the role of trans-acting factors in transcription of TJ genes in response to GC stimulation. Paracellular permeability was determined by quantifying flux through a cell monolayer, whereas transendothelial electrical resistance (TER) was measured using the ECIS system.\n\nRESULTS: MS/MS analysis of HREC nuclear extracts identified the heterodimer of transcription factors p54/NONO (p54) and polypyrimidine tract-binding protein-associated splicing factor (PSF) as OEE-binding factors, which was confirmed by ChIP assay from GC-treated endothelial cells and rat retina. siRNA knockdown of p54 demonstrated that this factor is necessary for GC induction of occludin and claudin-5 expression. Further, p54 knockdown ablated the pro-barrier effects of GC treatment.\n\nCONCLUSIONS: p54 is essential for GC-mediated expression of occludin, claudin-5, and barrier induction, and the p54/PSF heterodimer may contribute to normal blood-retinal barrier (BRB) induction in vivo. Understanding the mechanism of GC induction of BRB properties may provide novel therapies for macular edema.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Audia, Jonathon P</author><author>Lindsey, Ashley S</author><author>Housley, Nicole a.</author><author>Ochoa, Courtney R</author><author>Zhou, Chun</author><author>Toba, Michie</author><author>Oka, Masahiko</author><author>Annamdevula, Naga S</author><author>Fitzgerald, Meshann S</author><author>Frank, Dara W</author><author>Alvarez, Diego F</author></authors></contributors><titles><title>In the Absence of Effector Proteins, the Pseudomonas aeruginosa Type Three Secretion System Needle Tip Complex Contributes to Lung Injury and Systemic Inflammatory Responses</title><secondary-title>PLoS ONE</secondary-title></titles><periodical><full-title>PLoS ONE</full-title></periodical><pages>e81792</pages><volume>8</volume><issue>11</issue><keywords/><dates><year>2013</year></dates><electronic-resource-num>10.1371/journal.pone.0081792</electronic-resource-num><urls><web-urls><url>http://dx.plos.org/10.1371/journal.pone.0081792</url></web-urls></urls><label>ECIS Barrier Function</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Fu, Panfeng</author><author>Mohan, Vijay</author><author>Mansoor, Syed</author><author>Tiruppathi, Chinnaswamy</author><author>Sadikot, Ruxana T</author><author>Natarajan, Viswanathan</author></authors></contributors><titles><title>Role of Nicotinamide Adenine Dinucleotide Phosphate–Reduced Oxidase Proteins in Pseudomonas aeruginosa –Induced Lung Inflammation and Permeability</title><secondary-title>American Journal of Respiratory Cell and Molecular Biology</secondary-title></titles><periodical><full-title>American Journal of Respiratory Cell and Molecular Biology</full-title></periodical><pages>477-488</pages><volume>48</volume><issue>4</issue><keywords/><dates><year>2013</year></dates><electronic-resource-num>10.1165/rcmb.2012-0242OC</electronic-resource-num><urls><web-urls><url>http://www.atsjournals.org/doi/abs/10.1165/rcmb.2012-0242OC</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schäfer, Edith</author><author>Aue, Dennis</author><author>Tarantola, Marco</author><author>Polo, Elena</author><author>Westendorf, Christian</author><author>Oikawa, Noriko</author><author>Bodenschatz, Eberhard</author><author>Geil, Burkhard</author><author>Janshoff, Andreas</author></authors></contributors><titles><title>Collective behavior of Dictyostelium discoideum monitored by impedance analysis</title><secondary-title>Communicative and Integrative Biology</secondary-title></titles><periodical><full-title>Communicative and Integrative Biology</full-title></periodical><pages>e23894</pages><volume>6</volume><issue>3</issue><keywords><keyword>CAMP</keyword><keyword>Chemotaxis</keyword><keyword>Dictyostelium discoideum</keyword><keyword>Impedance analysis</keyword><keyword>Oscillation</keyword><keyword>Starvation</keyword></keywords><dates><year>2013</year></dates><electronic-resource-num>10.4161/cib.23894</electronic-resource-num><urls><web-urls><url>http://www.tandfonline.com/doi/abs/10.4161/cib.23894</url></web-urls></urls><label>ECIS Micromotion</label><abstract>Dictyostelium discoideum cells respond to periodic signals of extracellular cAMP by collective changes of cell-cell and cell-substrate contacts. This was confirmed by dielectric analysis employing electric cell-substrate impedance sensing (ECIS) and impedance measurements involving cell-filled micro channels in conjunction with optical microscopy providing a comprehensive picture of chemotaxis under conditions of starvation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pathak, Ravi Ramesh</author><author>Grover, Aditya</author><author>Malaney, Prerna</author><author>Quarni, Waise</author><author>Pandit, Ashish</author><author>Allen-Gipson, Diane</author><author>Davé, Vrushank</author></authors></contributors><titles><title>Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>29821-29835</pages><volume>288</volume><issue>41</issue><keywords><keyword>Adipocytes</keyword><keyword>Adipocytes: drug effects</keyword><keyword>Adipocytes: metabolism</keyword><keyword>Animals</keyword><keyword>CCAAT-Enhancer-Binding Protein-delta</keyword><keyword>CCAAT-Enhancer-Binding Protein-delta: genetics</keyword><keyword>CCAAT-Enhancer-Binding Protein-delta: metabolism</keyword><keyword>Cell Line</keyword><keyword>Gene Expression</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression: drug effects</keyword><keyword>Genetic</keyword><keyword>Genetic: genetics</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Knockout</keyword><keyword>Leptin</keyword><keyword>Leptin: genetics</keyword><keyword>Leptin: metabolism</keyword><keyword>Leptin: pharmacology</keyword><keyword>Lung</keyword><keyword>Lung: metabolism</keyword><keyword>Lung: pathology</keyword><keyword>Mice</keyword><keyword>Mitogen-Activated Protein Kinase Kinases</keyword><keyword>Mitogen-Activated Protein Kinase Kinases: genetics</keyword><keyword>Mitogen-Activated Protein Kinase Kinases: metaboli</keyword><keyword>NF-E2-Related Factor 1</keyword><keyword>NF-E2-Related Factor 1: genetics</keyword><keyword>NF-E2-Related Factor 1: metabolism</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>PTEN Phosphohydrolase</keyword><keyword>PTEN Phosphohydrolase: genetics</keyword><keyword>PTEN Phosphohydrolase: metabolism</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: genetics</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Promoter Regions</keyword><keyword>Protein Binding</keyword><keyword>RNA Interference</keyword><keyword>Receptors</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>STAT3 Transcription Factor</keyword><keyword>STAT3 Transcription Factor: genetics</keyword><keyword>STAT3 Transcription Factor: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: genetics</keyword><keyword>Transgenic</keyword><keyword>Tumor</keyword></keywords><dates><year>2013</year></dates><accession-num>23963458</accession-num><electronic-resource-num>10.1074/jbc.M113.481523</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3795281&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Elevated levels of systemic and pulmonary leptin are associated with diseases related to lung injury and lung cancer. However, the role of leptin in lung biology and pathology, including the mechanism of leptin gene expression in the pathogenesis of lung diseases, including lung cancer, remains elusive. Here, using conditional deletion of tumor suppressor gene Pten in the lung epithelium in vivo in transgenic mice and human PTEN-null lung epithelial cells, we identify the leptin-driven feed-forward signaling loop in the lung epithelial cells. Leptin-mediated leptin/leptin-receptor gene expression likely amplifies leptin signaling that may contribute to the pathogenesis and severity of lung diseases, resulting in poor clinical outcomes. Loss of Pten in the lung epithelial cells in vivo activated adipokine signaling and induced leptin synthesis as ascertained by genome-wide mRNA profiling and pathway analysis. Leptin gene transcription was mediated by binding of transcription factors NRF-1 and CCAAT/enhancer-binding protein δ (C/EBP) to the proximal promoter regions and STAT3 to the distal promoter regions as revealed by leptin promoter-mutation, chromatin immunoprecipitation, and gain- and loss-of-function studies in lung epithelial cells. Leptin treatment induced expression of the leptin/leptin receptor in the lung epithelial cells via activation of MEK/ERK, PI3K/AKT/mammalian target of rapamycin (mTOR), and JAK2/STAT3 signaling pathways. Expression of constitutively active MEK-1, AKT, and STAT3 proteins increased expression, and treatment with MEK, PI3K, AKT, and mTOR inhibitors decreased LEP expression, indicating that leptin via MAPK/ERK1/2, PI3K/AKT/mTOR, and JAK2/STAT3 pathways, in turn, further induces its own gene expression. Thus, targeted inhibition of the leptin-mediated feed-forward loop provides a novel rationale for pharmacotherapy of disease associated with lung injury and remodeling, including lung cancer.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wijesinghe, Dayanjali</author><author>Arachchige, Mohan C M</author><author>Lu, Andrew</author><author>Reshetnyak, Yana K</author><author>Andreev, Oleg a.</author></authors></contributors><titles><title>pH dependent transfer of nano-pores into membrane of cancer cells to induce apoptosis</title><secondary-title>Scientific Reports</secondary-title></titles><periodical><full-title>Scientific Reports</full-title></periodical><pages>2-8</pages><volume>3</volume><issue>L</issue><keywords/><dates><year>2013</year></dates><electronic-resource-num>10.1038/srep03560</electronic-resource-num><urls><web-urls><url>http://www.nature.com/doifinder/10.1038/srep03560</url></web-urls></urls><label>ECIS Cytotoxicity</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Whidbey, Christopher</author><author>Harrell, Maria Isabel</author><author>Burnside, Kellie</author><author>Ngo, Lisa</author><author>Becraft, Alexis K</author><author>Iyer, Lakshminarayan M</author><author>Aravind, L</author><author>Hitti, Jane</author><author>Waldorf, Kristina M Adams</author><author>Rajagopal, Lakshmi</author></authors></contributors><titles><title>A hemolytic pigment of Group B Streptococcus allows bacterial penetration of human placenta.</title><secondary-title>The Journal of experimental medicine</secondary-title></titles><periodical><full-title>The Journal of experimental medicine</full-title></periodical><pages>1265-1281</pages><volume>210</volume><issue>6</issue><keywords><keyword>Amniotic Fluid</keyword><keyword>Amniotic Fluid: metabolism</keyword><keyword>Amniotic Fluid: microbiology</keyword><keyword>Biological</keyword><keyword>Biological: metabolism</keyword><keyword>Endopeptidase K</keyword><keyword>Endopeptidase K: metabolism</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Epithelial Cells: microbiology</keyword><keyword>Female</keyword><keyword>Fetus</keyword><keyword>Fetus: metabolism</keyword><keyword>Fetus: microbiology</keyword><keyword>Glycolipids</keyword><keyword>Glycolipids: metabolism</keyword><keyword>Hemolysin Proteins</keyword><keyword>Hemolysin Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Infectious</keyword><keyword>Infectious: metabolism</keyword><keyword>Infectious: microbiology</keyword><keyword>NF-kappa B</keyword><keyword>NF-kappa B: metabolism</keyword><keyword>Obstetric Labor</keyword><keyword>Ornithine</keyword><keyword>Ornithine: metabolism</keyword><keyword>Pigments</keyword><keyword>Placenta</keyword><keyword>Placenta: metabolism</keyword><keyword>Placenta: microbiology</keyword><keyword>Pregnancy</keyword><keyword>Pregnancy Complications</keyword><keyword>Premature</keyword><keyword>Premature: metabolism</keyword><keyword>Premature: microbiology</keyword><keyword>Streptococcal Infections</keyword><keyword>Streptococcal Infections: metabolism</keyword><keyword>Streptococcal Infections: microbiology</keyword><keyword>Streptococcus agalactiae</keyword><keyword>Streptococcus agalactiae: metabolism</keyword></keywords><dates><year>2013</year></dates><isbn>1540-9538 (Electronic) 0022-1007 (Linking)</isbn><accession-num>23712433</accession-num><electronic-resource-num>10.1084/jem.20122753</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3674703&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Microbial infection of the amniotic fluid is a significant cause of fetal injury, preterm birth, and newborn infections. Group B Streptococcus (GBS) is an important human bacterial pathogen associated with preterm birth, fetal injury, and neonatal mortality. Although GBS has been isolated from amniotic fluid of women in preterm labor, mechanisms of in utero infection remain unknown. Previous studies indicated that GBS are unable to invade human amniotic epithelial cells (hAECs), which represent the last barrier to the amniotic cavity and fetus. We show that GBS invades hAECs and strains lacking the hemolysin repressor CovR/S accelerate amniotic barrier failure and penetrate chorioamniotic membranes in a hemolysin-dependent manner. Clinical GBS isolates obtained from women in preterm labor are hyperhemolytic and some are associated with covR/S mutations. We demonstrate for the first time that hemolytic and cytolytic activity of GBS is due to the ornithine rhamnolipid pigment and not due to a pore-forming protein toxin. Our studies emphasize the importance of the hemolytic GBS pigment in ascending infection and fetal injury.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dreher, Lena</author><author>Elvers-Hornung, Susanne</author><author>Brinkmann, Irena</author><author>Huck, Volker</author><author>Henschler, Reinhard</author><author>Gloe, Torsten</author><author>Klüter, Harald</author><author>Bieback, Karen</author></authors></contributors><titles><title>Cultivation in human serum reduces adipose tissue-derived mesenchymal stromal cell adhesion to laminin and endothelium and reduces capillary entrapment.</title><secondary-title>Stem cells and development</secondary-title></titles><periodical><full-title>Stem cells and development</full-title></periodical><pages>791-803</pages><volume>22</volume><issue>5</issue><keywords><keyword>Adipose Tissue</keyword><keyword>Adipose Tissue: cytology</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Movement</keyword><keyword>Cell Proliferation</keyword><keyword>Cells</keyword><keyword>Culture Media</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Endothelium: metabolism</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: physiology</keyword><keyword>Humans</keyword><keyword>Inbred NOD</keyword><keyword>Laminin</keyword><keyword>Laminin: metabolism</keyword><keyword>Mesenchymal Stromal Cells</keyword><keyword>Mesenchymal Stromal Cells: physiology</keyword><keyword>Mice</keyword><keyword>SCID</keyword><keyword>Serum</keyword><keyword>Serum: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23025550</accession-num><electronic-resource-num>10.1089/scd.2012.0051</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23025550</url></web-urls></urls><abstract>The increasing use of mesenchymal stromal cells (MSC) in clinical cellular therapy requires a safe and controlled production process compliant with Good Manufacturing Practice guidelines. Pooled blood group AB human serum (HS) has been used to replace fetal bovine serum (FBS), critically rated by the regulatory agencies, since it can support the expansion of adipose tissue-derived mesenchymal stromal cells (ASC). However, it remains unknown whether the choice of serum affects application-relevant characteristics of ASC. A microarray-based screen has revealed differentially expressed adhesion and extracellular matrix-associated molecules in HS- and FBS-ASC. Since cell therapy relies on the cells' efficacy to home and engraft, HS- and FBS-ASC were compared by analyzing adhesion, migration, and transmigration as well as short-term homing in vivo. HS-cultivated ASC demonstrated a higher adhesion to plastic, but reduced adhesion to extracellular matrix molecules, that is, laminin, and to endothelial cells both under static and flow conditions. Migration and transmigration assays confirmed the attraction of ASC by the tumor conditioned medium irrespective of the supplement. Coinjecting differently labeled HS- and FBS-ASC into nonobese diabetic, severe combined immunodeficiency mice revealed reduced numbers of HS-ASC in lungs and liver. This has been interpreted as reduced capillary entrapment. Our data indicate that varying the serum supplement may alter application-relevant characteristics of ASC, such as adhesion, as well as lung entrapment after infusion. Appropriate injury models and further molecular analyses are required to provide mechanistic insight into the differential effects of HS versus FBS on ASC cultures.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Adyshev, Djanybek M</author><author>Moldobaeva, Nurgul</author><author>Mapes, Brandon</author><author>Elangovan, Venkate</author><author>Garcia, Joe G N</author></authors></contributors><titles><title>MicroRNA regulation of nonmuscle myosin light chain kinase expression in human lung endothelium</title><secondary-title>American Journal of Respiratory Cell and Molecular Biology</secondary-title></titles><periodical><full-title>American Journal of Respiratory Cell and Molecular Biology</full-title></periodical><pages>58-66</pages><volume>49</volume><issue>1</issue><keywords><keyword>Acute lung injury</keyword><keyword>Endothelial cells</keyword><keyword>MLCK</keyword><keyword>MiRNA</keyword><keyword>Ventilator-induced lung injury</keyword></keywords><dates><year>2013</year></dates><isbn>1535-4989</isbn><accession-num>23492194</accession-num><electronic-resource-num>10.1165/rcmb.2012-0397OC</electronic-resource-num><urls/><label>ECIS Barrier Function;Signal Transduction</label><abstract>Increased lung vascular permeability, the consequence of endothelial cell (EC) barrier dysfunction, is a cardinal feature of inflammatory conditions such as acute lung injury and sepsis and leads to lethal physiological dysfunction characterized by alveolar flooding, hypoxemia, and pulmonary edema. We previously demonstrated that the nonmuscle myosin light chain kinase isoform (nmMLCK) plays a key role in agonist-induced pulmonary EC barrier regulation. The present study evaluated posttranscriptional regulation of MYLK expression, the gene encoding nmMLCK, via 3' untranslated region (UTR) binding by microRNAs (miRNAs) with in silico analysis identifying hsa-miR-374a, hsa-miR-374b, hsa-miR-520c-3p, and hsa-miR-1290 as miRNA candidates. We identified increased MYLK gene transcription induced by TNF-α (24 h; 4.7 ± 0.45 fold increase [FI]), LPS (4 h; 2.85 ± 0.15 [FI]), and 18% cyclic stretch (24 h; 4.6 ± 0.24 FI) that was attenuated by transfection of human lung ECs with mimics of hsa-miR-374a, hsa-miR-374b, hsa-miR-520c-3p, or hsa-miR-1290 (20-80% reductions by each miRNA). TNF-α, LPS, and 18% cyclic stretch each increased the activity of a MYLK 3'UTR luciferase reporter (2.5-7.0 FI) with induction reduced by mimics of each miRNA (30-60% reduction). MiRNA inhibitors (antagomirs) for each MYLK miRNA significantly increased 3'UTR luciferase activity (1.2-2.3 FI) and rescued the decreased MLCK-3'UTR reporter activity produced by miRNA mimics (70-110% increases for each miRNA; P &lt; 0.05). These data demonstrate that increased human lung EC expression of MYLK by bioactive agonists (excessive mechanical stress, LPS, TNF-α) is regulated in part by specific miRNAs (hsa-miR-374a, hsa-miR-374b, hsa-miR-520c-3p, and hsa-miR-1290), representing a novel therapeutic strategy for reducing inflammatory lung injury.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bennet, Devasier</author><author>Kim, Min-Gon</author><author>Kim, Sanghyo</author></authors></contributors><titles><title>Light-induced anatomical alterations in retinal cells.</title><secondary-title>Analytical biochemistry</secondary-title></titles><periodical><full-title>Analytical biochemistry</full-title></periodical><pages>84-92</pages><volume>436</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Dielectric Spectroscopy</keyword><keyword>Dielectric Spectroscopy: instrumentation</keyword><keyword>Dielectric Spectroscopy: methods</keyword><keyword>Electric Impedance</keyword><keyword>Electrodes</keyword><keyword>Equipment Design</keyword><keyword>Fluorescence</keyword><keyword>Lasers</keyword><keyword>Light</keyword><keyword>Light: adverse effects</keyword><keyword>Microscopy</keyword><keyword>Neurites</keyword><keyword>Neurites: physiology</keyword><keyword>Oxidative Stress</keyword><keyword>Physiological</keyword><keyword>Rats</keyword><keyword>Retina</keyword><keyword>Retina: anatomy &amp; histology</keyword><keyword>Retina: cytology</keyword><keyword>Retinal Ganglion Cells</keyword><keyword>Retinal Ganglion Cells: cytology</keyword><keyword>Retinal Ganglion Cells: physiology</keyword><keyword>Semiconductor</keyword><keyword>Stress</keyword></keywords><dates><year>2013</year></dates><accession-num>23376573</accession-num><electronic-resource-num>10.1016/j.ab.2013.01.025</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23376573</url></web-urls></urls><abstract>Exploring the cellular behavior and real-time evaluation of light-induced stress in retinal cells requires advanced sensitive methods. Here, an analytical application of a bioimpedance system was developed to quantify cell morphology changes in light-induced anatomical response. Hence, an unprecedented light setup was established using a bioimpedance system to generate artificial light that stresses retinal ganglion cells (RGCs), and the corresponding impedance was recorded. The dynamics of initial light-induced stress and the morphological changes were examined. This examination showed impedance drop, and the normalized variance ratios were used to quantify the changes. A rapid impedance drop was measured after exposure to the red and blue lights, whereas it was found that a minimum impedance drop was analyzed under the green light exposure. These data have revealed a strong, unconventional reliable model to detect the onset changes for photo-oxidative stress-related studies by the morphological changes of neurite retraction and cell body shrinkage. The data revealed that functions of the RGC-5 cell line under light exposure were diminished in cell strength and activity was hindered. These reduced functions might be related to the declined levels of some protein markers and stress factors. This is an effective model to study stress, morphological changes, and photodamage.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sasi, W</author><author>Ye, L</author><author>Jiang, W G</author><author>Mokbel, K</author><author>Sharma, A</author></authors></contributors><titles><title>Observations on the effects of Suppressor of Cytokine Signaling 7 (SOCS7) knockdown in breast cancer cells: their in vitro response to Insulin Like Growth Factor I (IGF-I).</title><secondary-title>Clinical &amp; translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</secondary-title></titles><periodical><full-title>Clinical &amp; translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico</full-title></periodical><volume>7</volume><keywords><keyword>breast cancer</keyword><keyword>c c -1 á</keyword><keyword>cranmer terrace</keyword><keyword>cytokine signaling á phospholipase</keyword><keyword>insulin-like growth factor-i á</keyword><keyword>mokbel á a</keyword><keyword>s</keyword><keyword>sasi</keyword><keyword>sharma</keyword><keyword>st george</keyword><keyword>suppressor of</keyword><keyword>university of london</keyword><keyword>w</keyword><keyword>á k</keyword></keywords><dates><year>2013</year></dates><accession-num>24046004</accession-num><electronic-resource-num>10.1007/s12094-013-1107-0</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/24046004</url></web-urls></urls><abstract>PURPOSE: Suppressor of cytokine signaling 7 (SOCS7) is a member of the SOCS family and is known to interact with phospholipase Cγ-1 (PLCγ-1), one of the insulin-like growth factor-I (IGF-I) receptor downstream molecules. In this study, we sought to observe the effect of knocking down SOCS7 gene on breast cancer cells in vitro growth and migration and to elucidate whether this involves IGF-I-PLCγ1 route using the PLCγ-1 blocker U73122. METHODS: Suitable breast cancer cells (MCF7 and MDA-MB-231) were transfected with anti-SOCS7 ribozymal transgene, to create sub-lines with SOCS7 knockdown verified by RT-PCR. The growth and migration of the cells were evaluated in the presence or absence of IGF-I and PLCγ-1 inhibitor using growth assay, scratch-wound and electrical cell impedance sensing (ECIS) migration assays. RESULTS: IGF-I treatment produced more pronounced influence on MCF7 growth and migration and on MDA-MB-231 migration when SOCS7 gene was knocked down in both lines (p &lt; 0.05). The absence of IGF-I-induced growth response in MDA-MB-231 could be due to the intrinsic characteristics of these cells. PLCγ-1 pharmacological inhibition during their in vitro migration seemed to only occur when SOCS7 gene was knocked down. CONCLUSIONS: To the best of our knowledge, this is the first report of the SOCS7 regulatory role in IGF-I induced in vitro functions in ER-positive and ER-negative breast cancer cells. IGF-I treatment and SOCS7 loss have synergistically resulted in increased growth and migration of MCF7 and in increased migration of MDA-MB-231 cells. The migratory effects could be due to a precise anti-PLCγ-1 role.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhao, Yutong</author><author>Zhao, Jing</author><author>Mialki, Rachel K</author><author>Wei, Jianxin</author><author>Spannhake, Ernst W</author><author>Salgia, Ravi</author><author>Natarajan, Viswanathan</author></authors></contributors><titles><title>Lipopolysaccharide-induced phosphorylation of c-Met tyrosine residue 1003 regulates c-Met intracellular trafficking and lung epithelial barrier function.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L56-63</pages><volume>305</volume><issue>1</issue><keywords><keyword>Blotting</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: pharmacology</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Lung: drug effects</keyword><keyword>Lung: metabolism</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Phosphorylation</keyword><keyword>Protein Kinase C-alpha</keyword><keyword>Protein Kinase C-alpha: metabolism</keyword><keyword>Protein Transport</keyword><keyword>Proto-Oncogene Proteins c-met</keyword><keyword>Proto-Oncogene Proteins c-met: antagonists &amp; inhib</keyword><keyword>Proto-Oncogene Proteins c-met: genetics</keyword><keyword>Proto-Oncogene Proteins c-met: metabolism</keyword><keyword>RNA</keyword><keyword>Real-Time Polymerase Chain Reaction</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Western</keyword></keywords><dates><year>2013</year></dates><isbn>1522-1504 (Electronic)\n1040-0605 (Linking)</isbn><accession-num>23624790</accession-num><electronic-resource-num>10.1152/ajplung.00417.2012</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23624790</url></web-urls></urls><abstract>c-Met, the receptor tyrosine kinase whose natural ligand is hepatocyte growth factor, is known to have a key role in cell motility. We have previously shown that lysophosphatidic acid (LPA) induced a decrease in c-Met activation via serine phosphorylation of c-Met at cell-cell contacts. Here, we demonstrate that lipopolysaccharide (LPS) treatment of human bronchial epithelial cells induced internalization of c-Met via phosphorylation at its tyrosine residue 1003. In addition, it induced epithelial barrier dysfunction as evidenced by a decrease in transepithelial resistance (TER) in a time-dependent manner. Pretreatment with a c-Met inhibitor (PHA-665752) or inhibition of protein kinase C (PKC)-α attenuated the LPS-mediated phosphorylation of c-Met and its internalization. LPS-induced c-Met tyrosine 1003 phosphorylation, activation of PKCα, and c-Met internalization were, however, reversed by pretreatment of cells with LPA, which increased c-Met accumulation at cell-cell contacts. Inhibition of LPS-mediated c-Met tyrosine (Y1003) phosphorylation and internalization by prior treatment with PHA-665752, inhibition of PKCα, or overexpression of c-MetY1003A mutant attenuated LPS-induced reduction of TER. Furthermore, we found that c-Met accumulation at cell-cell contacts contributed to LPA-enhanced epithelial barrier integrity, since downregulation of c-Met by specific small-interfering RNA attenuated LPA-increased TER. The data reveal a novel biological function of c-Met in the regulation of lung epithelial barrier integrity.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Öz, Simin</author><author>Maercker, Christian</author><author>Breiling, Achim</author></authors></contributors><titles><title>Embryonic carcinoma cells show specific dielectric resistance profiles during induced differentiation.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e59895</pages><volume>8</volume><issue>3</issue><keywords><keyword>Cell Differentiation</keyword><keyword>Cell Differentiation: drug effects</keyword><keyword>Cell Line</keyword><keyword>Electric Impedance</keyword><keyword>Embryonal Carcinoma Stem Cells</keyword><keyword>Embryonal Carcinoma Stem Cells: drug effects</keyword><keyword>Embryonal Carcinoma Stem Cells: metabolism</keyword><keyword>Humans</keyword><keyword>RNA</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Small Interfering</keyword><keyword>Tretinoin</keyword><keyword>Tretinoin: pharmacology</keyword><keyword>Tumor</keyword></keywords><dates><year>2013</year></dates><accession-num>23533658</accession-num><electronic-resource-num>10.1371/journal.pone.0059895</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3606267&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Differentiation</label><abstract>Induction of differentiation in cancer stem cells by drug treatment represents an important approach for cancer therapy. The understanding of the mechanisms that regulate such a forced exit from malignant pluripotency is fundamental to enhance our knowledge of tumour stability. Certain nucleoside analogues, such as 2'-deoxy-5-azacytidine and 1β-arabinofuranosylcytosine, can induce the differentiation of the embryonic cancer stem cell line NTERA 2 D1 (NT2). Such induced differentiation is associated with drug-dependent DNA-damage, cellular stress and the proteolytic depletion of stem cell factors. In order to further elucidate the mode of action of these nucleoside drugs, we monitored differentiation-specific changes of the dielectric properties of growing NT2 cultures using electric cell-substrate impedance sensing (ECIS). We measured resistance values of untreated and retinoic acid treated NT2 cells in real-time and compared their impedance profiles to those of cell populations triggered to differentiate with several established substances, including nucleoside drugs. Here we show that treatment with retinoic acid and differentiation-inducing drugs can trigger specific, concentration-dependent changes in dielectric resistance of NT2 cultures, which can be observed as early as 24 hours after treatment. Further, low concentrations of nucleoside drugs induce differentiation-dependent impedance values comparable to those obtained after retinoic acid treatment, whereas higher concentrations induce proliferation defects. Finally, we show that impedance profiles of substance-induced NT2 cells and those triggered to differentiate by depletion of the stem cell factor OCT4 are very similar, suggesting that reduction of OCT4 levels has a dominant function for differentiation induced by nucleoside drugs and retinoic acid. The data presented show that NT2 cells have specific dielectric properties, which allow the early identification of differentiating cultures and real-time label-free monitoring of differentiation processes. This work might provide a basis for further analyses of drug candidates for differentiation therapy of cancers.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kuckleburg, Christopher J</author><author>Newman, Peter J</author></authors></contributors><titles><title>Neutrophil proteinase 3 acts on protease-activated receptor-2 to enhance vascular endothelial cell barrier function.</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arteriosclerosis, thrombosis, and vascular biology</full-title></periodical><pages>275-284</pages><volume>33</volume><issue>2</issue><keywords><keyword>Calcium Signaling</keyword><keyword>Capillary Permeability</keyword><keyword>Cell Surface</keyword><keyword>Cell Surface: metabolism</keyword><keyword>Coculture Techniques</keyword><keyword>GPI-Linked Proteins</keyword><keyword>GPI-Linked Proteins: metabolism</keyword><keyword>HEK293 Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: enzymology</keyword><keyword>Humans</keyword><keyword>Isoantigens</keyword><keyword>Isoantigens: metabolism</keyword><keyword>Myeloblastin</keyword><keyword>Myeloblastin: genetics</keyword><keyword>Myeloblastin: metabolism</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: enzymology</keyword><keyword>PAR-1</keyword><keyword>PAR-1: genetics</keyword><keyword>PAR-1: metabolism</keyword><keyword>PAR-2</keyword><keyword>PAR-2: metabolism</keyword><keyword>RNA Interference</keyword><keyword>Receptor</keyword><keyword>Receptors</keyword><keyword>Time Factors</keyword><keyword>Transendothelial and Transepithelial Migration</keyword><keyword>Transfection</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23202369</accession-num><electronic-resource-num>10.1161/ATVBAHA.112.300474</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3562705&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Calcium Signaling;ECIS TEER</label><abstract>OBJECTIVE: The principle role of the vascular endothelium is to present a semi-impermeable barrier to soluble factors and circulating cells, while still permitting the passage of leukocytes from the bloodstream into the tissue. The process of diapedesis involves the selective disruption of endothelial cell junctions, which could compromise vascular integrity. It is therefore somewhat surprising that neutrophil transmigration does not significantly impair endothelial barrier function. We examined whether neutrophils might secrete factors that promote vascular integrity during the latter stages of neutrophil transmigration, in particular, the role of neutrophil serine proteinase 3 (PR3). METHODS AND RESULTS: Endothelial cells were treated with PR3 either in its soluble form or in a complex form with cell surface NB1. We observed that PR3 mediated the enhancement of endothelial cell junctional integrity and that this required its proteolytic activity, as well as endothelial cell expression of the protease-activated receptor-2. Importantly, PR3 suppressed the vascular permeability changes and disruption of junctional proteins induced by the action of protease-activated receptor-1 agonists. CONCLUSIONS: These findings establish the potential for neutrophil-derived PR3 to play a role in reestablishing vascular integrity after leukocyte transmigration and in protecting endothelial cells from protease-activated receptor-1-induced permeability changes that occur during thrombotic and inflammatory events.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kása, Anita</author><author>Czikora, István</author><author>Verin, Alexander D</author><author>Gergely, Pál</author><author>Csortos, Csilla</author></authors></contributors><titles><title>Protein phosphatase 2A activity is required for functional adherent junctions in endothelial cells</title><secondary-title>Microvascular Research</secondary-title></titles><periodical><full-title>Microvascular Research</full-title></periodical><pages>86-94</pages><volume>89</volume><keywords/><dates><year>2013</year></dates><accession-num>23721711</accession-num><electronic-resource-num>10.1016/j.mvr.2013.05.003</electronic-resource-num><urls/><abstract>Reversible Ser/Thr phosphorylation of cytoskeletal and adherent junction (AJ) proteins has a critical role in the regulation of endothelial cell (EC) barrier function. We have demonstrated earlier that protein phosphatase 2A (PP2A) activity is important in EC barrier integrity. In the present work, macro- and microvascular EC were examined and we provided further evidence on the significance of PP2A in the maintenance of EC cytoskeleton and barrier function with special focus on the Bα (regulatory) subunit of PP2A. Immunofluorescent staining revealed that the inhibition of PP2A results in changes in the organization of EC cytoskeleton as microtubule dissolution and actin re-arrangement were detected. Depletion of Bα regulatory subunit of PP2A had similar effect on the cytoskeleton structure of the cells. Furthermore, transendothelial electric resistance measurements demonstrated significantly slower barrier recovery of Bα depleted EC after thrombin treatment. AJ proteins, VE-cadherin and β-catenin, were detected along with Bα in pull-down assay. Also, the inhibition of PP2A (by okadaic acid or fostriecin) or depletion of Bα caused β-catenin translocation from the membrane to the cytoplasm in parallel with its phosphorylation on Ser552. In conclusion, our data suggest that the A/Bα/C holoenzyme form of PP2A is essential in EC barrier integrity both in micro- and macrovascular EC. © 2013 Elsevier Inc.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Foster, Rebecca R</author><author>Armstrong, Lynne</author><author>Baker, Siân</author><author>Wong, Dickson W.L.</author><author>Wylie, Emma C</author><author>Ramnath, Raina</author><author>Jenkins, Robert</author><author>Singh, Anurag</author><author>Steadman, Robert</author><author>Welsh, Gavin I</author><author>Mathieson, Peter W</author><author>Satchell, Simon C</author></authors></contributors><titles><title>Glycosaminoglycan Regulation by VEGFA and VEGFC of the Glomerular Microvascular Endothelial Cell Glycocalyx in Vitro</title><secondary-title>The American Journal of Pathology</secondary-title></titles><periodical><full-title>The American Journal of Pathology</full-title></periodical><pages>604-616</pages><volume>183</volume><issue>2</issue><keywords/><dates><year>2013</year></dates><accession-num>23770346</accession-num><electronic-resource-num>10.1016/j.ajpath.2013.04.019</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0002944013003386</url></web-urls></urls><abstract>Damage to endothelial glycocalyx impairs vascular barrier function and may contribute to progression of chronic vascular disease. An early indicator is microalbuminuria resulting from glomerular filtration barrier damage. We investigated the contributions of hyaluronic acid (HA) and chondroitin sulfate (CS) to glomerular microvascular endothelial cell (GEnC) glycocalyx and examined whether these are modified by vascular endothelial growth factors A and C (VEGFA and VEGFC). HA and CS were imaged on GEnCs and their resynthesis was examined. The effect of HA and CS on transendothelial electrical resistance (TEER) and labeled albumin flux across monolayers was assessed. Effects of VEGFA and VEGFC on production and charge characteristics of glycosaminoglycan (GAG) were examined via metabolic labeling and liquid chromatography. GAG shedding was quantified using Alcian Blue. NDST2 expression was examined using real-time PCR. GEnCs expressed HA and CS in the glycocalyx. CS contributed to the barrier to both ion (TEER) and protein flux across the monolayer; HA had only a limited effect. VEGFC promoted HA synthesis and increased the charge density of synthesized GAGs. In contrast, VEGFA induced shedding of charged GAGs. CS plays a role in restriction of macromolecular flux across GEnC monolayers, and VEGFA and VEGFC differentially regulate synthesis, charge, and shedding of GAGs in GEnCs. These observations have important implications for endothelial barrier regulation in glomerular and other microvascular beds. © 2013 American Society for Investigative Pathology.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiao, Bo</author><author>Laroui, Hamed</author><author>Ayyadurai, Saravanan</author><author>Viennois, Emilie</author><author>Charania, Moiz A</author><author>Zhang, Yuchen</author><author>Merlin, Didier</author></authors></contributors><titles><title>Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-α RNA interference for IBD therapy</title><secondary-title>Biomaterials</secondary-title></titles><periodical><full-title>Biomaterials</full-title></periodical><pages>7471-7482</pages><volume>34</volume><issue>30</issue><keywords><keyword>Bioreducible polymer</keyword><keyword>IBD therapy</keyword><keyword>Macrophage-targeted delivery</keyword><keyword>Mannosylation</keyword><keyword>RNA interference</keyword></keywords><dates><year>2013</year></dates><accession-num>23820013</accession-num><electronic-resource-num>10.1016/j.biomaterials.2013.06.008</electronic-resource-num><urls/><abstract>The application of RNA interference (RNAi) for inflammatory bowel disease (IBD) therapy has been limited by the lack of non-cytotoxic, efficient and targetable small interfering RNA (siRNA) carriers. TNF-α is the major pro-inflammatory cytokine mainly secreted by macrophages during IBD. Here, a mannosylated bioreducible cationic polymer (PPM) was synthesized and further spontaneously assembled nanoparticles (NPs) assisted by sodium triphosphate (TPP). The TPP-PPM/siRNA NPs exhibited high uniformity (polydispersity index=0.004), a small particle size (211-275nm), excellent bioreducibility, and enhanced cellular uptake. Additionally, the generated NPs had negative cytotoxicity compared to control NPs fabricated by branched polyethylenimine (bPEI, 25kDa) or Oligofectamine (OF) and siRNA. Invitro gene silencing experiments revealed that TPP-PPM/TNF-α siRNA NPs with a weight ratio of 40:1 showed the most efficient inhibition of the expression and secretion of TNF-α (approximately 69.9%, which was comparable to the 71.4% obtained using OF/siRNA NPs), and its RNAi efficiency was highly inhibited in the presence of mannose (20m. m). Finally, TPP-PPM/siRNA NPs showed potential therapeutic effects on colitis tissues, remarkably reducing TNF-α level. Collectively, these results suggest that non-toxic TPP-PPM/siRNA NPs can be exploited as efficient, macrophage-targeted carriers for IBD therapy. © 2013.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Conference Proceedings">3</ref-type><contributors><authors><author>Liu, Fei</author><author>Nordin, Anis N</author><author>Li, Fang</author><author>Voiculescu, Ioana</author></authors></contributors><titles><title>A Sensitive Multiparametric Biosensor With Capabilities of Rapid Toxicity Detection of Drinking Water</title><secondary-title>Volume 10: Micro- and Nano-Systems Engineering and Packaging</secondary-title></titles><periodical><full-title>Volume 10: Micro- and Nano-Systems Engineering and Packaging</full-title></periodical><pages>V010T11A001</pages><keywords/><dates><year>2013</year></dates><publisher>ASME</publisher><isbn>978-0-7918-5639-0</isbn><electronic-resource-num>10.1115/IMECE2013-62281</electronic-resource-num><urls><web-urls><url>http://proceedings.asmedigitalcollection.asme.org/proceeding.aspx?doi=10.1115/IMECE2013-62281</url></web-urls></urls><abstract>Recently, there has been interest to develop biosensors based on live mammalian cells to monitor the toxicity of water. The cell viability after exposure to toxic water can be monitored by electric cell-substrate impedance sensing (ECIS) of the cell membrane. However, these impedance based toxicity sensors can only provide one single sensing endpoint (impedance measurement), and many toxicants cannot be detected at the concentration between Military Exposure Guideline levels and estimated Human Lethal Concentrations. The goal of this paper is to provide a rapid and sensitive sensing platform for long-term water toxicity detection. In this paper a novel multiparametric biosensor with integrated microfluidic channels for water toxicity detection is presented. Toxicity tests to study bovine aortic endothelial cells (BAECs) responsiveness to health-threatening concentrations of ammonia in de-ionized (DI) water will be presented. We demonstrated the BAECs can rapidly respond to ammonia concentrations between the military exposure guideline of 2mM and human lethal concentration of 55mM. The successful testing of water toxicity by simultaneous gravimetric and impedimetric measurements indicates that the multiparametric biosensor platform is able to perform rapid and sensitive detection of water toxicity and minimize the false-positive rate.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Migliorini, Adriana</author><author>Angelotti, Maria L</author><author>Mulay, Shrikant R</author><author>Kulkarni, Onkar O</author><author>Demleitner, Jana</author><author>Dietrich, Alexander</author><author>Sagrinati, Costanza</author><author>Ballerini, Lara</author><author>Peired, Anna</author><author>Shankland, Stuart J</author><author>Liapis, Helen</author><author>Romagnani, Paola</author><author>Anders, Hans-Joachim</author></authors></contributors><titles><title>The antiviral cytokines IFN-α and IFN-β modulate parietal epithelial cells and promote podocyte loss: implications for IFN toxicity, viral glomerulonephritis, and glomerular regeneration.</title><secondary-title>The American journal of pathology</secondary-title></titles><periodical><full-title>The American journal of pathology</full-title></periodical><pages>431-440</pages><volume>183</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Antiviral Agents</keyword><keyword>Antiviral Agents: pharmacology</keyword><keyword>Cell Death</keyword><keyword>Cell Death: drug effects</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Differentiation: drug effects</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Doxorubicin</keyword><keyword>Doxorubicin: toxicity</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Female</keyword><keyword>Glomerulonephritis</keyword><keyword>Glomerulonephritis: drug therapy</keyword><keyword>Glomerulonephritis: physiopathology</keyword><keyword>HIV Infections</keyword><keyword>HIV Infections: drug therapy</keyword><keyword>HIV Infections: physiopathology</keyword><keyword>Humans</keyword><keyword>Interferon-alpha</keyword><keyword>Interferon-alpha: pharmacology</keyword><keyword>Interferon-beta</keyword><keyword>Interferon-beta: pharmacology</keyword><keyword>Kidney Glomerulus</keyword><keyword>Kidney Glomerulus: physiology</keyword><keyword>Mice</keyword><keyword>Podocytes</keyword><keyword>Podocytes: drug effects</keyword><keyword>Regeneration</keyword><keyword>Regeneration: drug effects</keyword><keyword>SCID</keyword></keywords><dates><year>2013</year></dates><publisher>American Society for Investigative Pathology</publisher><accession-num>23747509</accession-num><electronic-resource-num>10.1016/j.ajpath.2013.04.017</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23747509</url></web-urls></urls><abstract>Interferon (IFN)-α and IFN-β are the central regulators of antiviral immunity but little is known about their roles in viral glomerulonephritis (eg, HIV nephropathy). We hypothesized that IFN-α and IFN-β would trigger local inflammation and podocyte loss. We found that both IFNs consistently activated human and mouse podocytes and parietal epithelial cells to express numerous IFN-stimulated genes. However, only IFN-β significantly induced podocyte death and increased the permeability of podocyte monolayers. In contrast, only IFN-α caused cell-cycle arrest and inhibited the migration of parietal epithelial cells. Both IFNs suppressed renal progenitor differentiation into mature podocytes. In Adriamycin nephropathy, injections with either IFN-α or IFN-β aggravated proteinuria, macrophage influx, and glomerulosclerosis. A detailed analysis showed that only IFN-β induced podocyte mitosis. This did not, however, lead to proliferation, but was associated with podocyte loss via podocyte detachment and/or mitotic podocyte death (mitotic catastrophe). We did not detect TUNEL-positive podocytes. Thus, IFN-α and IFN-β have both common and differential effects on podocytes and parietal epithelial cells, which together promote glomerulosclerosis by enhancing podocyte loss while suppressing podocyte regeneration from local progenitors.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>de Kreuk, Bart-Jan</author><author>Schaefer, Antje</author><author>Anthony, Eloise C</author><author>Tol, Simon</author><author>Fernandez-Borja, Mar</author><author>Geerts, Dirk</author><author>Pool, Jos</author><author>Hambach, Lothar</author><author>Goulmy, Els</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>The human minor Histocompatibility Antigen1 is a RhoGAP.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e73962</pages><volume>8</volume><issue>9</issue><keywords/><dates><year>2013</year></dates><accession-num>24086303</accession-num><electronic-resource-num>10.1371/journal.pone.0073962</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3781157&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>The human minor Histocompatibility Antigen HMHA-1 is a major target of immune responses after allogeneic stem cell transplantation applied for the treatment of leukemia and solid tumors. The restriction of its expression to hematopoietic cells and many solid tumors raised questions regarding its cellular functions. Sequence analysis of the HMHA-1 encoding HMHA1 protein revealed the presence of a possible C-terminal RhoGTPase Activating Protein (GAP) domain and an N-terminal BAR domain. Rho-family GTPases, including Rac1, Cdc42, and RhoA are key regulators of the actin cytoskeleton and control cell spreading and migration. RhoGTPase activity is under tight control as aberrant signaling can lead to pathology, including inflammation and cancer. Whereas Guanine nucleotide Exchange Factors (GEFs) mediate the exchange of GDP for GTP resulting in RhoGTPase activation, GAPs catalyze the low intrinsic GTPase activity of active RhoGTPases, resulting in inactivation. Here we identify the HMHA1 protein as a novel RhoGAP. We show that HMHA1 constructs, lacking the N-terminal region, negatively regulate the actin cytoskeleton as well as cell spreading. Furthermore, we show that HMHA1 regulates RhoGTPase activity in vitro and in vivo. Finally, we demonstrate that the HMHA1 N-terminal BAR domain is auto-inhibitory as HMHA1 mutants lacking this region, but not full-length HMHA1, showed GAP activity towards RhoGTPases. In conclusion, this study shows that HMHA1 acts as a RhoGAP to regulate GTPase activity, cytoskeletal remodeling and cell spreading, which are crucial functions in normal hematopoietic and cancer cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Usatyuk, PeterV V</author><author>Kotha, SainathR R</author><author>Parinandi, NarasimhamL L</author><author>Natarajan, Viswanathan</author></authors></contributors><titles><title>Phospholipase D signaling mediates reactive oxygen species-induced lung endothelial barrier dysfunction</title><secondary-title>Pulmonary Circulation</secondary-title></titles><periodical><full-title>Pulmonary Circulation</full-title></periodical><pages>108</pages><volume>3</volume><issue>1</issue><keywords><keyword>a ubiquitous enzyme present</keyword><keyword>bacteria</keyword><keyword>cytoskeleton</keyword><keyword>endothelial cells</keyword><keyword>hydrolyzes the membrane</keyword><keyword>in fungi</keyword><keyword>lipid signaling</keyword><keyword>lung permeability</keyword><keyword>oxidants</keyword><keyword>phosphatidic acid</keyword><keyword>phospholipase d</keyword><keyword>plants and mammals</keyword><keyword>pld</keyword><keyword>reactive oxygen species</keyword></keywords><dates><year>2013</year></dates><accession-num>23662182</accession-num><electronic-resource-num>10.4103/2045-8932.109925</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3641713&amp;tool=pmcentrez&amp;rendertype=abstract</url><url>http://www.jstor.org/stable/10.4103/2045-8932.109925</url></web-urls></urls><abstract>Reactive oxygen species (ROS) have emerged as critical players in the pathophysiology of pulmonary disorders and diseases. Earlier, we have demonstrated that ROS stimulate lung endothelial cell (EC) phospholipase D (PLD) that generates phosphatidic acid (PA), a second messenger involved in signal transduction. In the current study, we investigated the role of PLD signaling in the ROS-induced lung vascular EC barrier dysfunction. Our results demonstrated that hydrogen peroxide (H2O2), a typical physiological ROS, induced PLD activation and altered the barrier function in bovine pulmonary artery ECs (BPAECs). 1-Butanol, the quencher of PLD, generated PA leading to the formation of physiologically inactive phosphatidyl butanol but not its biologically inactive analog, 2-butanol, blocked the H2O2-mediated barrier dysfunction. Furthermore, cell permeable C2 ceramide, an inhibitor of PLD but not the C2 dihydroceramide, attenuated the H2O2-induced PLD activation and enhancement of paracellular permeability of Evans blue conjugated albumin across the BPAEC monolayers. In addition, transfection of BPAECs with adenoviral constructs of hPLD1 and mPLD2 mutants attenuated the H2O2-induced barrier dysfunction, cytoskeletal reorganization and distribution of focal adhesion proteins. For the first time, this study demonstrated that the PLD-generated intracellular bioactive lipid signal mediator, PA, played a critical role in the ROS-induced barrier dysfunction in lung vascular ECs. This study also underscores the importance of PLD signaling in vascular leak and associated tissue injury in the etiology of lung diseases among critically ill patients encountering oxygen toxicity and excess ROS production during ventilator-assisted breathing.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Klamer, Sofieke E</author><author>Kuijk, Carlijn G M</author><author>Hordijk, Peter L</author><author>van der Schoot, C Ellen</author><author>von Lindern, Marieke</author><author>van Hennik, Paula B</author><author>Voermans, Carlijn</author></authors></contributors><titles><title>BIGH3 modulates adhesion and migration of hematopoietic stem and progenitor cells.</title><secondary-title>Cell adhesion &amp; migration</secondary-title></titles><periodical><full-title>Cell adhesion &amp; migration</full-title></periodical><pages>434-449</pages><volume>7</volume><issue>5</issue><keywords><keyword>abbreviations</keyword><keyword>adhesion</keyword><keyword>big</keyword><keyword>bigh3</keyword><keyword>bigh3-transduced</keyword><keyword>bm</keyword><keyword>bone marrow</keyword><keyword>bovine serum albumine</keyword><keyword>bsa</keyword><keyword>cxc-ligand 12</keyword><keyword>cxc-receptor 4</keyword><keyword>cxcl12</keyword><keyword>cxcr4</keyword><keyword>ecis</keyword><keyword>ecm</keyword><keyword>electric electrical cell-substrate impedance</keyword><keyword>empty-vector-transduced</keyword><keyword>erk</keyword><keyword>ev</keyword><keyword>extracellular</keyword><keyword>extracellular regulated kinase</keyword><keyword>facs</keyword><keyword>flow cytometry activated cell</keyword><keyword>hematopoiesis</keyword><keyword>hspc</keyword><keyword>integrins</keyword><keyword>matrix molecules</keyword><keyword>migration</keyword><keyword>rac1</keyword><keyword>sensing</keyword><keyword>sorting</keyword><keyword>tgf-beta induced gene h3</keyword></keywords><dates><year>2013</year></dates><accession-num>24152593</accession-num><electronic-resource-num>10.4161/cam.26596</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3903689&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Cell adhesion and migration are important determinants of homing and development of hematopoietic stem and progenitor cells (HSPCs) in bone marrow (BM) niches. The extracellular matrix protein transforming growth factor-β (TGF-β) inducible gene H3 (BIGH3) is involved in adhesion and migration, although the effect of BIGH3 is highly cell type-dependent. BIGH3 is abundantly expressed by mesenchymal stromal cells, while its expression in HSPCs is relatively low unless induced by certain BM stressors. Here, we set out to determine how BIGH3 modulates HSPC adhesion and migration. We show that primary HSPCs adhere to BIGH3-coated substrates, which is, in part, integrin-dependent. Overexpression of BIGH3 in HSPCs and HL60 cells reduced the adhesion to the substrate fibronectin in adhesion assays, which was even more profound in electrical cell-substrate impedance sensing (ECIS) assays. Accordingly, the CXCL12 induced migration over fibronectin-coated surface was reduced in BIGH3-expressing HSPCs. The integrin expression profile of HSPCs was not altered upon BIGH3 expression. Although expression of BIGH3 did not alter actin polymerization in response to CXCL12, it inhibited the PMA-induced activation of the small GTPase RAC1 as well as the phosphorylation and activation of extracellular-regulated kinases (ERKs). Reduced activation of ERK and RAC1 may be responsible for the inhibition of cell adhesion and migration by BIGH3 in HSPCs. Induced BIGH3 expression upon BM stress may contribute to the regulation of BM homeostasis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukova, Anna A</author><author>Starosta, Vitaliy</author><author>Tian, Xinyong</author><author>Higginbotham, Katherine</author><author>Koroniak, Lukas</author><author>Berliner, Judith A</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Fragmented oxidation products define barrier disruptive endothelial cell response to OxPAPC</title><secondary-title>Translational Research</secondary-title></titles><periodical><full-title>Translational Research</full-title></periodical><pages>495-504</pages><volume>161</volume><issue>6</issue><keywords/><dates><year>2013</year></dates><accession-num>23305708</accession-num><electronic-resource-num>10.1016/j.trsl.2012.12.008</electronic-resource-num><urls/><abstract>Excessive concentrations of oxidized phospholipids (OxPL), the products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylcholine (PAPC) oxidation have been detected in atherosclerosis, septic inflammation, and acute lung injury (ALI) and have been shown to induce vascular barrier dysfunction. In contrast, oxidized PAPC (OxPAPC) at low concentrations exhibit potent barrier protective effects. The nature of such biphasic effects remains unclear. We tested the hypothesis that barrier-disruptive effects of high OxPAPC doses on endothelial cell (EC) monolayer are defined by fragmented products of PAPC oxidation (lysophosphatidyl choline [lyso-PC], 1-palmitoyl-2-(5-oxovaleroyl)-sn- glycero-phosphatidylcholine [POVPC], 1-palmitoyl-2-glutaroyl-sn-glycero- phosphatidylcholine [PGPC]), whereas barrier enhancing effects are mediated by full length oxidated PAPC products and may be reproduced by single compounds contained in the OxPAPC such as 1-palmitoyl-2-(5,6-epoxyisoprostane E2)-sn-glycero-3-phosphatidyl choline (PEIPC). All 3 fragmented OxPAPC products increased EC permeability in a dose-dependent manner, whereas PEIPC decreased it and reversed barrier disruptive effects of lyso-PC, POVPC, and PGPC monitored by measurements of transendothelial electrical resistance. Immunofluorescence staining and western blot analysis showed that PGPC mimicked the cytoskeletal remodeling and tyrosine phosphorylation of adherens junction (AJ) protein vascular endothelial (VE)-cadherin leading to EC barrier dysfunction induced by high OxPAPC concentrations. Barrier-disruptive effects of PGPC were abrogated by reactive oxygen species (ROS) inhibitor, N-acetyl cysteine, or Src kinase inhibitor, PP-2. The results of this study show that barrier disruptive effects of fragmented OxPAPC constituents (lyso-PC, POVPC, PGPC) are balanced by barrier enhancing effects of full length oxygenated products (PEIPC). These data strongly suggest that barrier disruptive effects of OxPAPC at higher concentrations are dictated by predominant effects of fragmented phospholipids such as PGPC, which promote ROS-dependent activation of Src kinase and VE-cadherin phosphorylation at Tyr658 and Tyr731 leading to disruption of endothelial cell AJs. ?? 2013 Mosby, Inc. All rights reserved.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dalli, Jesmond</author><author>Winkler, Jeremy W. W</author><author>Colas, Romain A. A</author><author>Arnardottir, Hildur</author><author>Cheng, Chien-Yee C. Yee C</author><author>Chiang, Nan</author><author>Petasis, Nicos A. A</author><author>Serhan, Charles N. N</author></authors></contributors><titles><title>Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents</title><secondary-title>Chemistry and Biology</secondary-title></titles><periodical><full-title>Chemistry and Biology</full-title></periodical><pages>188-201</pages><volume>20</volume><issue>2</issue><keywords/><dates><year>2013</year></dates><publisher>Elsevier Ltd</publisher><isbn>1879-1301 (Electronic) 1074-5521 (Linking)</isbn><accession-num>23438748</accession-num><electronic-resource-num>10.1016/j.chembiol.2012.11.010</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S1074552112004619</url></web-urls></urls><abstract>Resolvins are a family of n-3 lipid mediators initially identified in resolving inflammatory exudates that temper inflammatory responses to promote catabasis. Here, temporal metabololipidomics with self-limited resolving exudates revealed that resolvin (Rv) D3 has a distinct time frame from other lipid mediators, appearing late in the resolution phase. Using synthetic materials prepared by stereocontrolled total organic synthesis and metabololipidomics, we established complete stereochemistry of RvD3 and its aspirin-triggered 17R-epimer (AT-RvD3). Both synthetic resolvins potently regulated neutrophils and mediators, reducing murine peritonitis and dermal inflammation. RvD3 and AT-RvD3 displayed leukocyte-directed actions, e.g., blocking human neutrophil transmigration and enhancing macrophage phagocytosis and efferocytosis. These results position RvD3 uniquely within the inflammation-resolution time frame to vantage and contribute to the beneficial actions of aspirin and essential n-3 fatty acids. © 2013 Elsevier Ltd.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Shinde, Arti V</author><author>Motiani, Rajender K</author><author>Zhang, Xuexin</author><author>Abdullaev, Iskandar F</author><author>Adam, Alejandro P</author><author>González-Cobos, José C</author><author>Zhang, Wei</author><author>Matrougui, Khalid</author><author>Vincent, Peter A</author><author>Trebak, Mohamed</author></authors></contributors><titles><title>STIM1 controls endothelial barrier function independently of Orai1 and Ca2+ entry.</title><secondary-title>Science signaling</secondary-title></titles><periodical><full-title>Science signaling</full-title></periodical><pages>ra18</pages><volume>6</volume><issue>267</issue><keywords><keyword>Blotting</keyword><keyword>Calcium</keyword><keyword>Calcium Channels</keyword><keyword>Calcium Channels: metabolism</keyword><keyword>Calcium: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endoplasmic Reticulum</keyword><keyword>Endoplasmic Reticulum: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>HEK293 Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: drug effec</keyword><keyword>Human Umbilical Vein Endothelial Cells: metabolism</keyword><keyword>Human Umbilical Vein Endothelial Cells: physiology</keyword><keyword>Humans</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Myosin-Light-Chain Kinase</keyword><keyword>Myosin-Light-Chain Kinase: genetics</keyword><keyword>Myosin-Light-Chain Kinase: metabolism</keyword><keyword>Neoplasm Proteins</keyword><keyword>Neoplasm Proteins: genetics</keyword><keyword>Neoplasm Proteins: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>RNA Interference</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: genetics</keyword><keyword>Signal Transduction: physiology</keyword><keyword>TRPC Cation Channels</keyword><keyword>TRPC Cation Channels: genetics</keyword><keyword>TRPC Cation Channels: metabolism</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Western</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: genetics</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23512989</accession-num><electronic-resource-num>10.1126/scisignal.2003425</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23512989</url></web-urls></urls><label>Signal Transduction</label><abstract>Endothelial barrier function is critical for tissue fluid homeostasis, and its disruption contributes to various pathologies, including inflammation and sepsis. Thrombin is an endogenous agonist that impairs endothelial barrier function. We showed that the thrombin-induced decrease in transendothelial electric resistance of cultured human endothelial cells required the endoplasmic reticulum-localized, calcium-sensing protein stromal interacting molecule 1 (STIM1), but was independent of Ca2+ entry across the plasma membrane and the Ca2+ release-activated Ca2+ channel protein Orai1, which is the target of STIM1 in the store-operated calcium entry pathway. We found that STIM1 coupled the thrombin receptor to activation of the guanosine triphosphatase RhoA, stimulation of myosin light chain phosphorylation, formation of actin stress fibers, and loss of cell-cell adhesion. Thus, STIM1 functions in pathways that are dependent on and independent of Ca2+ entry.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Khare, Vineeta</author><author>Lyakhovich, Alex</author><author>Dammann, Kyle</author><author>Lang, Michaela</author><author>Borgmann, Melanie</author><author>Tichy, Boris</author><author>Pospisilova, Sarka</author><author>Luciani, Gloria</author><author>Campregher, Christoph</author><author>Evstatiev, Rayko</author><author>Pflueger, Maren</author><author>Hundsberger, Harald</author><author>Gasche, Christoph</author></authors></contributors><titles><title>Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1</title><secondary-title>Biochemical Pharmacology</secondary-title></titles><periodical><full-title>Biochemical Pharmacology</full-title></periodical><pages>234-244</pages><volume>85</volume><issue>2</issue><keywords><keyword>Beta-catenin</keyword><keyword>Cell adhesion</keyword><keyword>E-cadherin</keyword><keyword>Mesalamine</keyword><keyword>PAK1</keyword></keywords><dates><year>2013</year></dates><accession-num>23146664</accession-num><electronic-resource-num>10.1016/j.bcp.2012.10.026</electronic-resource-num><urls/><abstract>Mesalamine (5-ASA) is widely used for the treatment of ulcerative colitis, a remitting condition characterized by chronic inflammation of the colon. Knowledge about the molecular and cellular targets of 5-ASA is limited and a clear understanding of its activity in intestinal homeostasis and interference with neoplastic progression is lacking. We sought to identify molecular pathways interfered by 5-ASA, using CRC cell lines with different genetic background. Microarray was performed for gene expression profile of 5-ASA-treated and untreated cells (HCT116 and HT29). Filtering and analysis of data identified three oncogenic pathways interfered by 5-ASA: MAPK/ERK pathway, cell adhesion and ??-catenin/Wnt signaling. PAK1 emerged as a consensus target of 5-ASA, orchestrating these pathways. We further investigated the effect of 5-ASA on cell adhesion. 5-ASA increased cell adhesion which was measured by cell adhesion assay and transcellular-resistance measurement. Moreover, 5-ASA treatment restored membranous expression of adhesion molecules E-cadherin and ??-catenin. Role of PAK1 as a mediator of mesalamine activity was validated in vitro and in vivo. Inhibition of PAK1 by RNA interference also increased cell adhesion. PAK1 expression was elevated in APCmin polyps and 5-ASA treatment reduced its expression. Our data demonstrates novel pharmacological mechanism of mesalamine in modulation of cell adhesion and role of PAK1 in APCmin polyposis. We propose that inhibition of PAK1 expression by 5-ASA can impede with neoplastic progression in colorectal carcinogenesis. The mechanism of PAK1 inhibition and induction of membranous translocation of adhesion proteins by 5-ASA might be independent of its known anti-inflammatory action. ?? 2012 Elsevier Inc.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Martins, Tânia</author><author>Burgoyne, Thomas</author><author>Kenny, Bridget Ann</author><author>Hudson, Natalie</author><author>Futter, Clare E</author><author>Ambrósio, António F</author><author>Silva, Ana P</author><author>Greenwood, John</author><author>Turowski, Patric</author></authors></contributors><titles><title>Methamphetamine-induced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells</title><secondary-title>Neuropharmacology</secondary-title></titles><periodical><full-title>Neuropharmacology</full-title></periodical><pages>74-82</pages><volume>65</volume><keywords><keyword>Blood-brain barrier</keyword><keyword>Fluid-phase transcytosis</keyword><keyword>Methamphetamine</keyword><keyword>Nitric oxide</keyword><keyword>Transendothelial leukocyte migration</keyword></keywords><dates><year>2013</year></dates><accession-num>22960442</accession-num><electronic-resource-num>10.1016/j.neuropharm.2012.08.021</electronic-resource-num><urls/><label>Blood Brain Barrier</label><abstract>Methamphetamine's (METH) neurotoxicity is thought to be in part due to its ability to induce blood-brain barrier (BBB) dysfunction. Here, we investigated the effect of METH on barrier properties of cultured rat primary brain microvascular endothelial cells (BMVECs). Transendothelial flux doubled in response to METH, irrespective of the size of tracer used. At the same time, transendothelial electrical resistance was unchanged as was the ultrastructural appearance of inter-endothelial junctions and the distribution of key junction proteins, suggesting that METH promoted vesicular but not junctional transport. Indeed, METH significantly increased uptake of horseradish peroxidase into vesicular structures. METH also enhanced transendothelial migration of lymphocytes indicating that the endothelial barrier against both molecules and cells was compromised. Barrier breakdown was only observed in response to METH at low micromolar concentrations, with enhanced vesicular uptake peaking at 1 μM METH. The BMVEC response to METH also involved rapid activation of endothelial nitric oxide synthase and its inhibition abrogated METH-induced permeability and lymphocyte migration, indicating that nitric oxide was a key mediator of BBB disruption in response to METH. This study underlines the key role of nitric oxide in BBB function and describes a novel mechanism of drug-induced fluid-phase transcytosis at the BBB. © 2012 Elsevier Ltd. All rights reserved.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bennet, Devasier</author><author>Kang, Se Chan</author><author>Gang, Jongback</author><author>Kim, Sanghyo</author></authors></contributors><titles><title>Photoprotective effects of apple peel nanoparticles</title><secondary-title>International Journal of Nanomedicine</secondary-title></titles><periodical><full-title>International Journal of Nanomedicine</full-title></periodical><pages>93-108</pages><volume>9</volume><issue>1</issue><keywords><keyword>Antioxidant</keyword><keyword>Apple peel ethanolic extract</keyword><keyword>Cellular uptake</keyword><keyword>Electric cell-substrate impedance sensing</keyword><keyword>Light-induced damage</keyword><keyword>Phyto-drugs</keyword></keywords><dates><year>2013</year></dates><accession-num>24379668</accession-num><electronic-resource-num>10.2147/IJN.S54048</electronic-resource-num><urls/><label>ECIS Cytotoxicity</label><abstract>Plants contain enriched bioactive molecules that can protect against skin diseases. Bioactive molecules become unstable and ineffective due to unfavorable conditions. In the present study, to improve the therapeutic efficacy of phytodrugs and enhance photoprotective capability, we used poly(D,L-lactide-co-glycolide) as a carrier of apple peel ethanolic extract (APETE) on permeation-enhanced nanoparticles (nano-APETE). The in vitro toxicity of nano-APETE-treated dermal fibroblast cells were studied in a bioimpedance system, and the results coincided with the viability assay. In addition, the continuous real-time evaluations of photodamage and photoprotective effect of nano-APETE on cells were studied. Among three different preparations of nano-APETE, the lowest concentration provided small, spherical, monodispersed, uniform particles which show high encapsulation, enhanced uptake, effective scavenging, and sustained intracellular delivery. Also, the nano-APETE is more flexible, allowing it to permeate through skin lipid membrane and release the drug in a sustained manner, thus confirming its ability as a sustained transdermal delivery. In summary, 50 μM nano-APETE shows strong synergistic photoprotective effects, thus demonstrating its higher activity on target sites for the treatment of skin damage, and would be of broad interest in the field of skin therapeutics.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Al-Husein, Belal</author><author>Goc, Anna</author><author>Somanath, Payaningal R</author></authors></contributors><titles><title>Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis.</title><secondary-title>Journal of cellular physiology</secondary-title></titles><periodical><full-title>Journal of cellular physiology</full-title></periodical><pages>2139-2148</pages><volume>228</volume><issue>11</issue><keywords><keyword>Biological</keyword><keyword>Cell Communication</keyword><keyword>Cell Communication: drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: drug effects</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Integrin alphaVbeta3</keyword><keyword>Integrin alphaVbeta3: metabolism</keyword><keyword>Intercellular Adhesion Molecule-1</keyword><keyword>Intercellular Adhesion Molecule-1: metabolism</keyword><keyword>Male</keyword><keyword>Models</keyword><keyword>Neoplasm Micrometastasis</keyword><keyword>Neoplasm Micrometastasis: drug therapy</keyword><keyword>Neoplasm Micrometastasis: pathology</keyword><keyword>Neoplastic</keyword><keyword>Neoplastic: drug effects</keyword><keyword>Neovascularization</keyword><keyword>Pathologic</keyword><keyword>Pathologic: genetics</keyword><keyword>Prostatic Neoplasms</keyword><keyword>Prostatic Neoplasms: blood supply</keyword><keyword>Prostatic Neoplasms: genetics</keyword><keyword>Prostatic Neoplasms: metabolism</keyword><keyword>Prostatic Neoplasms: pathology</keyword><keyword>Protein Binding</keyword><keyword>Protein Binding: drug effects</keyword><keyword>Protein Stability</keyword><keyword>Protein Stability: drug effects</keyword><keyword>Simvastatin</keyword><keyword>Simvastatin: pharmacology</keyword><keyword>Simvastatin: therapeutic use</keyword><keyword>Tumor</keyword><keyword>beta Catenin</keyword><keyword>beta Catenin: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23559257</accession-num><electronic-resource-num>10.1002/jcp.24381</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4038100&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Invasion</label><abstract>Cancer micrometastasis relies on the ability of cancer cells to secrete angiogenic modulators, to interact with the vascular endothelium, and to overcome the resistance offered by the endothelial-barrier. Being an essential step prior to metastasis, blockage of micrometastasis can have potential applications in cancer therapy and metastasis prevention. Due to poorly known molecular mechanisms leading to micrometastasis, developing therapeutic strategies to target prostate cancer utilizing drugs that block micrometastasis is far from reality. Here, we demonstrate the potential benefits of simvastatin in the inhibition of prostate cancer micrometastasis and reveal the novel molecular mechanisms underlying this process. First, we showed that simvastatin inhibited the ability of human PC3 prostate cancer cells for transendothelial migration in vitro. Second, our data indicated that simvastatin modulates the expression of tumor-derived factors such as angiopoietins and VEGF-A at the mRNA and protein levels by the PC3 cells, thus preventing endothelial-barrier disruption. Third, simvastatin directly activated endothelial cells and enhances endothelial-barrier resistance. Apart from this, our study revealed that simvastatin-mediated effect on PC3 micrometastasis was mediated through inhibition of integrin αv β3 activity and suppression of interaction between prostate cancer cell integrin αv β3 with endothelial ICAM-1.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Profirovic, Jasmina</author><author>Strekalova, Elena</author><author>Urao, Norifumi</author><author>Krbanjevic, Aleksandar</author><author>Andreeva, Alexandra V</author><author>Varadarajan, Sudhahar</author><author>Fukai, Tohru</author><author>Hen, René</author><author>Ushio-Fukai, Masuko</author><author>Voyno-Yasenetskaya, Tatyana a.</author></authors></contributors><titles><title>A novel regulator of angiogenesis in endothelial cells: 5-hydroxytriptamine 4 receptor</title><secondary-title>Angiogenesis</secondary-title></titles><periodical><full-title>Angiogenesis</full-title></periodical><pages>15-28</pages><volume>16</volume><issue>1</issue><keywords><keyword>5-hydroxytriptamine 4 receptor</keyword><keyword>Angiogenesis</keyword><keyword>Endothelial cell migration</keyword><keyword>Hindlimb ischemia model</keyword><keyword>angiogenesis á 5-hydroxytriptamine 4</keyword><keyword>hindlimb ischemia model</keyword><keyword>jasmina profirovic and elena</keyword><keyword>migration á</keyword><keyword>receptor á endothelial cell</keyword><keyword>strekalova have contributed equally</keyword><keyword>to</keyword></keywords><dates><year>2013</year></dates><isbn>1045601292</isbn><accession-num>22903372</accession-num><electronic-resource-num>10.1007/s10456-012-9296-7</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s10456-012-9296-7</url></web-urls></urls><abstract>The 5-hydroxytryptamine type 4 receptor (5-HT(4)R) regulates many physiological processes, including learning and memory, cognition, and gastrointestinal motility. Little is known about its role in angiogenesis. Using mouse hindlimb ischemia model of angiogenesis, we observed a significant reduction of limb blood flow recovery 14 days after ischemia and a decrease in density of CD31-positive vessels in adductor muscles in 5-HT(4)R(-/-) mice compared to wild type littermates. Our in vitro data indicated that 5-HT(4)R endogenously expressed in endothelial cells (ECs) may promote angiogenesis. Inhibition of the receptor with 5-HT(4)R antagonist RS 39604 reduced EC capillary tube formation in the reconstituted basement membrane. Using Boyden chamber migration assay and wound healing &quot;scratch&quot; assay, we demonstrated that RS 39604 treatment significantly suppressed EC migration. Transendothelial resistance measurement and immunofluorescence analysis showed that a 5-HT(4)R agonist RS 67333 led to an increase in endothelial permeability, actin stress fiber and interendothelial gap formation. Importantly, we provided the evidence that 5-HT(4)R-regulated EC migration may be mediated by Gα13 and RhoA. Our results suggest a prominent role of 5-HT(4)R in promoting angiogenesis and identify 5-HT(4)R as a potential therapeutic target for modulating angiogenesis under pathological conditions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Conference Proceedings">3</ref-type><contributors><authors><author>Bennet, Devasier</author><author>Kim, Sanghyo</author></authors></contributors><titles><title>ECIS to assess human skin cell photo-oxidative damage</title><secondary-title>International Conference on Advanced Nanomaterials &amp; Emerging Engineering Technologies</secondary-title></titles><periodical><full-title>International Conference on Advanced Nanomaterials &amp; Emerging Engineering Technologies</full-title></periodical><pages>696-701</pages><keywords/><dates><year>2013</year></dates><publisher>IEEE</publisher><isbn>978-1-4799-1379-4</isbn><electronic-resource-num>10.1109/ICANMEET.2013.6609393</electronic-resource-num><urls><web-urls><url>http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=6609393</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lam, B Daniel</author><author>Anthony, Eloise C</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>Cytoplasmic targeting of the proto-oncogene SET promotes cell spreading and migration.</title><secondary-title>FEBS letters</secondary-title></titles><periodical><full-title>FEBS letters</full-title></periodical><pages>111-119</pages><volume>587</volume><issue>2</issue><keywords><keyword>Active Transport</keyword><keyword>Base Sequence</keyword><keyword>Cell Membrane Structures</keyword><keyword>Cell Membrane Structures: metabolism</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cell Nucleus</keyword><keyword>Confocal</keyword><keyword>Cytoplasm</keyword><keyword>Cytoplasm: metabolism</keyword><keyword>DNA Primers</keyword><keyword>DNA Primers: genetics</keyword><keyword>HeLa Cells</keyword><keyword>Histone Chaperones</keyword><keyword>Histone Chaperones: genetics</keyword><keyword>Histone Chaperones: metabolism</keyword><keyword>Humans</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>Microscopy</keyword><keyword>Mutant Proteins</keyword><keyword>Mutant Proteins: genetics</keyword><keyword>Mutant Proteins: metabolism</keyword><keyword>Nuclear Localization Signals</keyword><keyword>Nuclear Localization Signals: genetics</keyword><keyword>Protein Phosphatase 2</keyword><keyword>Protein Phosphatase 2: antagonists &amp; inhibitors</keyword><keyword>Recombinant Fusion Proteins</keyword><keyword>Recombinant Fusion Proteins: genetics</keyword><keyword>Recombinant Fusion Proteins: metabolism</keyword><keyword>Transcription Factors</keyword><keyword>Transcription Factors: genetics</keyword><keyword>Transcription Factors: metabolism</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2013</year></dates><accession-num>23195690</accession-num><electronic-resource-num>10.1016/j.febslet.2012.11.013</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23195690</url></web-urls></urls><abstract>The RhoGTPase Rac1 is activated in a polarised fashion and controls cell motility. We previously showed that Rac1 binds the PP2A inhibitor SET and recruits nuclear SET to the cytosol. We show that a SET mutant, lacking a nuclear localization signal, SET(ΔNLS), promotes cell spreading and motility. This was accompanied by an increase in the number and frequency of membrane ruffles. Pharmacological inhibition of PP2A did not mimic the effects of SET(ΔNLS), however, we found that expression of SET and SET(ΔNLS) increases the levels of the MAP kinases ERK1 and ERK2.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>MacKenzie, Tiffany N</author><author>Mujumdar, Nameeta</author><author>Banerjee, Sulagna</author><author>Sangwan, Veena</author><author>Sarver, Aaron</author><author>Vickers, Selwyn</author><author>Subramanian, Subbaya</author><author>Saluja, Ashok K</author></authors></contributors><titles><title>Triptolide induces the expression of miR-142-3p: a negative regulator of heat shock protein 70 and pancreatic cancer cell proliferation.</title><secondary-title>Molecular cancer therapeutics</secondary-title></titles><periodical><full-title>Molecular cancer therapeutics</full-title></periodical><pages>1266-1275</pages><volume>12</volume><issue>7</issue><keywords><keyword>Alkylating</keyword><keyword>Alkylating: pharmacology</keyword><keyword>Animals</keyword><keyword>Antineoplastic Agents</keyword><keyword>Apoptosis</keyword><keyword>Carcinoma</keyword><keyword>Cell Line</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Diterpenes</keyword><keyword>Diterpenes: pharmacology</keyword><keyword>Epoxy Compounds</keyword><keyword>Epoxy Compounds: pharmacology</keyword><keyword>Female</keyword><keyword>Gene Expression</keyword><keyword>HEK293 Cells</keyword><keyword>HSP70 Heat-Shock Proteins</keyword><keyword>HSP70 Heat-Shock Proteins: genetics</keyword><keyword>HSP70 Heat-Shock Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>MicroRNAs</keyword><keyword>MicroRNAs: genetics</keyword><keyword>MicroRNAs: metabolism</keyword><keyword>Pancreatic Ductal</keyword><keyword>Pancreatic Ductal: drug therapy</keyword><keyword>Pancreatic Ductal: genetics</keyword><keyword>Pancreatic Ductal: metabolism</keyword><keyword>Pancreatic Ductal: pathology</keyword><keyword>Pancreatic Neoplasms</keyword><keyword>Pancreatic Neoplasms: drug therapy</keyword><keyword>Pancreatic Neoplasms: genetics</keyword><keyword>Pancreatic Neoplasms: metabolism</keyword><keyword>Pancreatic Neoplasms: pathology</keyword><keyword>Phenanthrenes</keyword><keyword>Phenanthrenes: pharmacology</keyword><keyword>Random Allocation</keyword><keyword>SCID</keyword><keyword>Transfection</keyword><keyword>Tumor</keyword><keyword>Xenograft Model Antitumor Assays</keyword></keywords><dates><year>2013</year></dates><accession-num>23635652</accession-num><electronic-resource-num>10.1158/1535-7163.MCT-12-1231</electronic-resource-num><urls><web-urls><url>http://mct.aacrjournals.org/content/12/7/1266.long</url><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3707985&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Apoptosis</label><abstract>Pancreatic ductal adenocarcinoma (PDAC), one of the deadliest malignancies, is resistant to current chemotherapies. We previously showed that triptolide inhibits PDAC cell growth in vitro and blocks metastatic spread in vivo. Triptolide downregulates HSP70, a molecular chaperone upregulated in several tumor types. This study investigates the mechanism by which triptolide inhibits HSP70. Because microRNAs (miRNA) are becoming increasingly recognized as negative regulators of gene expression, we tested whether triptolide regulates HSP70 via miRNAs. Here, we show that triptolide as well as quercetin, but not gemcitabine, upregulated miR-142-3p in PDAC cells (MIA PaCa-2, Capan-1, and S2-013). Ectopic expression of miR-142-3p inhibited cell proliferation, measured by electric cell-substrate impedance sensing, and decreased HSP70 expression, measured by real-time PCR and immunoblotting, compared with controls. We showed that miR-142-3p directly binds to the 3'UTR of HSP70, and that this interaction is important as HSP70 overexpression rescued miR-142-3p-induced cell death. We found that miR-142-3p regulates HSP70 independently of heat shock factor 1. Furthermore, Minnelide, a water-soluble prodrug of triptolide, induced the expression of miR-142-3p in vivo. This is the first description of an miRNA-mediated mechanism of HSP70 regulation in cancer, making miR-142-3p an attractive target for PDAC therapeutic intervention.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Barabutis, Nektarios</author><author>Handa, Vaishali</author><author>Dimitropoulou, Christiana</author><author>Rafikov, Ruslan</author><author>Snead, Connie</author><author>Kumar, Sanjiv</author><author>Joshi, Atul</author><author>Thangjam, Gagan</author><author>Fulton, David</author><author>Black, Stephen M</author><author>Patel, Vijay</author><author>Catravas, John D</author></authors></contributors><titles><title>LPS induces pp60c-src-mediated tyrosine phosphorylation of Hsp90 in lung vascular endothelial cells and mouse lung.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L883-93</pages><volume>304</volume><issue>12</issue><keywords><keyword>Animals</keyword><keyword>Benzoquinones</keyword><keyword>Benzoquinones: pharmacology</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: immunology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>HSP90 Heat-Shock Proteins</keyword><keyword>HSP90 Heat-Shock Proteins: genetics</keyword><keyword>HSP90 Heat-Shock Proteins: immunology</keyword><keyword>HSP90 Heat-Shock Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Lactams</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: pharmacology</keyword><keyword>Lung</keyword><keyword>Lung: drug effects</keyword><keyword>Lung: immunology</keyword><keyword>Lung: metabolism</keyword><keyword>Macrocyclic</keyword><keyword>Macrocyclic: pharmacology</keyword><keyword>Mice</keyword><keyword>Nitric Oxide Synthase Type III</keyword><keyword>Nitric Oxide Synthase Type III: genetics</keyword><keyword>Nitric Oxide Synthase Type III: immunology</keyword><keyword>Nitric Oxide Synthase Type III: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Post-Translational</keyword><keyword>Post-Translational: drug effec</keyword><keyword>Protein Binding</keyword><keyword>Protein Binding: drug effects</keyword><keyword>Protein Processing</keyword><keyword>Proto-Oncogene Proteins pp60(c-src)</keyword><keyword>Proto-Oncogene Proteins pp60(c-src): genetics</keyword><keyword>Proto-Oncogene Proteins pp60(c-src): immunology</keyword><keyword>Proto-Oncogene Proteins pp60(c-src): metabolism</keyword><keyword>Pyrimidines</keyword><keyword>Pyrimidines: pharmacology</keyword><keyword>RNA</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Tyrosine</keyword><keyword>Tyrosine: metabolism</keyword></keywords><dates><year>2013</year></dates><isbn>00218499</isbn><accession-num>23585225</accession-num><electronic-resource-num>10.1152/ajplung.00419.2012</electronic-resource-num><urls/><label>Signal Transduction</label><abstract>Heat shock protein 90 (Hsp90) inhibitors were initially developed as anticancer agents; however, it is becoming increasing clear that they also possess potent anti-inflammatory properties. Posttranslational modifications of Hsp90 have been reported in tumors and have been hypothesized to affect client protein- and inhibitor-binding activities. In the present study we investigated the posttranslational modification of Hsp90 in inflammation. LPS, a prototypical inflammatory agent, induced concentration- and time-dependent tyrosine (Y) phosphorylation of Hsp90α and Hsp90β in bovine pulmonary arterial and human lung microvascular endothelial cells (HLMVEC). Mass spectrometry identified Y309 as a major site of Y phosphorylation on Hsp90α (Y300 of Hsp90β). LPS-induced Hsp90 phosphorylation was prevented by the Hsp90 inhibitor 17-allyl-amino-demethoxy-geldanamycin (17-AAG) in vitro as well as in lungs from LPS-treated mice, in vivo. Furthermore, 17-AAG prevented LPS-induced pp60src activation. LPS-induced Hsp90 phosphorylation was also prevented by the pp60src inhibitor PP2. Additionally, Hsp90 phosphorylation was induced by infecting cells with a constitutively active pp60src adenovirus, whereas either a dominant-negative pp60src adenovirus or reduced expression of pp60src by a specific siRNA prevented the LPS-induced Y phosphorylation of Hsp90. Transfection of HLMVEC with the nonphosphorylatable Hsp90β Y300F mutant prevented LPS-induced Hsp90β tyrosine phosphorylation but not pp60src activation. Furthermore, the Hsp90β Y300F mutant showed a reduced ability to bind the Hsp90 client proteins eNOS and pp60src and HLMVEC transfected with the mutant exhibited reduced LPS-induced barrier dysfunction. We conclude that inflammatory stimuli cause posttranslational modifications of Hsp90 that are Hsp90-inhibitor sensitive and may be important to the proinflammatory actions of Hsp90.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rom, Slava</author><author>Zuluaga-Ramirez, Viviana</author><author>Dykstra, Holly</author><author>Reichenbach, Nancy L</author><author>Pacher, Pal</author><author>Persidsky, Yuri</author></authors></contributors><titles><title>Selective activation of cannabinoid receptor 2 in leukocytes suppresses their engagement of the brain endothelium and protects the blood-brain barrier.</title><secondary-title>The American journal of pathology</secondary-title></titles><periodical><full-title>The American journal of pathology</full-title></periodical><pages>1548-1558</pages><volume>183</volume><issue>5</issue><keywords><keyword>Actin Depolymerizing Factors</keyword><keyword>Actin Depolymerizing Factors: metabolism</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: metabolism</keyword><keyword>Blood-Brain Barrier: pathology</keyword><keyword>CB2</keyword><keyword>CB2: agonists</keyword><keyword>CB2: metabolism</keyword><keyword>CD29</keyword><keyword>CD29: metabolism</keyword><keyword>Cannabinoid</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion Molecules</keyword><keyword>Cell Adhesion Molecules: metabolism</keyword><keyword>Cell Line</keyword><keyword>Cerebral Cortex</keyword><keyword>Cerebral Cortex: blood supply</keyword><keyword>Cerebral Cortex: pathology</keyword><keyword>Encephalitis</keyword><keyword>Encephalitis: metabolism</keyword><keyword>Encephalitis: pathology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Endothelium</keyword><keyword>Endothelium: metabolism</keyword><keyword>Endothelium: pathology</keyword><keyword>Humans</keyword><keyword>Integrin alpha4beta1</keyword><keyword>Integrin alpha4beta1: chemistry</keyword><keyword>Integrin alpha4beta1: metabolism</keyword><keyword>Leukocytes</keyword><keyword>Leukocytes: metabolism</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lymphocyte Function-Associated Antigen-1</keyword><keyword>Lymphocyte Function-Associated Antigen-1: chemistr</keyword><keyword>Lymphocyte Function-Associated Antigen-1: metaboli</keyword><keyword>Mice</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Microvessels</keyword><keyword>Microvessels: pathology</keyword><keyword>Monocytes</keyword><keyword>Monocytes: metabolism</keyword><keyword>Monocytes: pathology</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Pseudopodia</keyword><keyword>Pseudopodia: metabolism</keyword><keyword>Receptor</keyword><keyword>Transendothelial and Transepithelial Migration</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword></keywords><dates><year>2013</year></dates><accession-num>24055259</accession-num><electronic-resource-num>10.1016/j.ajpath.2013.07.033</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3814716&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier</label><abstract>Cannabinoid receptor 2 (CB2) is highly expressed in immune cells and stimulation decreases inflammatory responses. We tested the idea that selective CB2 activation in human monocytes suppresses their ability to engage the brain endothelium and migrate across the blood-brain barrier (BBB), preventing consequent injury. Intravital videomicroscopy was used to quantify adhesion of leukocytes to cortical vessels in lipopolysaccharide-induced neuroinflammation, after injection of ex vivo CB2-activated leukocytes into mice; CB2 agonists markedly decreased adhesion of ex vivo labeled cells in vivo. In an in vitro BBB model, CB2 activation in monocytes largely attenuated adhesion to and migration across monolayers of primary human brain microvascular endothelial cells and diminished BBB damage. CB2 stimulation in monocytes down-regulated active forms of integrins, lymphocyte function-associated antigen 1 (LFA-1), and very late antigen 4 (VLA-4). Cells treated with CB2 agonists exhibited increased phosphorylation levels of inhibitory sites of the actin-binding proteins cofilin and VASP, which are upstream regulators of conformational integrin changes. Up-regulated by relevant stimuli, Rac1 and RhoA were suppressed by CB2 agonists in monocytes. CB2 stimulation decreased formation of lamellipodia, which play a key role in monocyte migration. These results indicate that selective CB2 activation in leukocytes decreases key steps in monocyte-BBB engagement, thus suppressing inflammatory leukocyte responses and preventing neuroinflammation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Davidson, Bruce a</author><author>Vethanayagam, R Robert</author><author>Grimm, Melissa J</author><author>Mullan, Barbara a</author><author>Raghavendran, Krishnan</author><author>Blackwell, Timothy S</author><author>Freeman, Michael L</author><author>Ayyasamy, Vanniarajan</author><author>Singh, Keshav K</author><author>Sporn, Michael B</author><author>Itagaki, Kiyoshi</author><author>Hauser, Carl J</author><author>Knight, Paul R</author><author>Segal, Brahm H</author></authors></contributors><titles><title>NADPH oxidase and Nrf2 regulate gastric aspiration-induced inflammation and acute lung injury.</title><secondary-title>Journal of immunology (Baltimore, Md. : 1950)</secondary-title></titles><periodical><full-title>Journal of immunology (Baltimore, Md. : 1950)</full-title></periodical><pages>1714-1724</pages><volume>190</volume><issue>4</issue><keywords><keyword>129 Strain</keyword><keyword>Acute Lung Injury</keyword><keyword>Acute Lung Injury: enzymology</keyword><keyword>Acute Lung Injury: etiology</keyword><keyword>Acute Lung Injury: metabolism</keyword><keyword>Animal</keyword><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Disease Models</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Inflammation Mediators</keyword><keyword>Inflammation Mediators: metabolism</keyword><keyword>Inflammation Mediators: physiology</keyword><keyword>Intratracheal</keyword><keyword>Intubation</keyword><keyword>Knockout</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>NADPH Oxidase</keyword><keyword>NADPH Oxidase: deficiency</keyword><keyword>NADPH Oxidase: metabolism</keyword><keyword>NADPH Oxidase: physiology</keyword><keyword>NF-E2-Related Factor 2</keyword><keyword>NF-E2-Related Factor 2: deficiency</keyword><keyword>NF-E2-Related Factor 2: metabolism</keyword><keyword>NF-E2-Related Factor 2: physiology</keyword><keyword>Neutrophil Infiltration</keyword><keyword>Neutrophil Infiltration: immunology</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: enzymology</keyword><keyword>Neutrophils: immunology</keyword><keyword>Neutrophils: pathology</keyword><keyword>Tumor</keyword></keywords><dates><year>2013</year></dates><accession-num>23296708</accession-num><electronic-resource-num>10.4049/jimmunol.1202410</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3563868&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Recruitment of neutrophils and release of reactive oxygen species are considered to be major pathogenic components driving acute lung injury (ALI). However, NADPH oxidase, the major source of reactive oxygen species in activated phagocytes, can paradoxically limit inflammation and injury. We hypothesized that NADPH oxidase protects against ALI by limiting neutrophilic inflammation and activating Nrf2, a transcriptional factor that induces antioxidative and cytoprotective pathways. Our objective was to delineate the roles of NADPH oxidase and Nrf2 in modulating acute lung inflammation and injury in clinically relevant models of acute gastric aspiration injury, a major cause of ALI. Acid aspiration caused increased ALI (as assessed by bronchoalveolar lavage fluid albumin concentration) in both NADPH oxidase-deficient mice and Nrf2(-/-) mice compared with wild-type mice. NADPH oxidase reduced airway neutrophil accumulation, but Nrf2 decreased ALI without affecting neutrophil recovery. Acid injury resulted in a 120-fold increase in mitochondrial DNA, a proinflammatory and injurious product of cellular necrosis, in cell-free bronchoalveolar lavage fluid. Pharmacologic activation of Nrf2 by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9 (11)-dien-28-oyl]imidazole limited aspiration-induced ALI in wild-type mice and reduced endothelial cell injury caused by mitochondrial extract-primed human neutrophils, leading to the conclusion that NADPH oxidase and Nrf2 have coordinated, but distinct, functions in modulating inflammation and injury. These results also point to Nrf2 as a therapeutic target to limit ALI by attenuating neutrophil-induced cellular injury.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sun, Chongxiu</author><author>Beard, Richard S</author><author>McLean, Danielle L</author><author>Rigor, Robert R</author><author>Konia, Thomas</author><author>Wu, Mack H</author><author>Yuan, Sarah Y</author></authors></contributors><titles><title>ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L135-42</pages><volume>304</volume><issue>3</issue><keywords><keyword>ADAM Proteins</keyword><keyword>ADAM Proteins: deficiency</keyword><keyword>ADAM Proteins: genetics</keyword><keyword>Acute Lung Injury</keyword><keyword>Acute Lung Injury: chemically induced</keyword><keyword>Acute Lung Injury: genetics</keyword><keyword>Acute Lung Injury: metabolism</keyword><keyword>Acute Lung Injury: pathology</keyword><keyword>Animals</keyword><keyword>Bronchoalveolar Lavage Fluid</keyword><keyword>Bronchoalveolar Lavage Fluid: cytology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Knockout</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: pharmacology</keyword><keyword>Lung</keyword><keyword>Lung: metabolism</keyword><keyword>Lung: pathology</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: deficiency</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Mice</keyword><keyword>Neutrophil Infiltration</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: metabolism</keyword><keyword>Neutrophils: pathology</keyword><keyword>Permeability</keyword><keyword>Peroxidase</keyword><keyword>Peroxidase: genetics</keyword><keyword>Peroxidase: metabolism</keyword><keyword>Primary Cell Culture</keyword><keyword>Pulmonary Edema</keyword><keyword>Pulmonary Edema: chemically induced</keyword><keyword>Pulmonary Edema: genetics</keyword><keyword>Pulmonary Edema: metabolism</keyword><keyword>Pulmonary Edema: pathology</keyword><keyword>Transendothelial and Transepithelial Migration</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2013</year></dates><accession-num>23161886</accession-num><electronic-resource-num>10.1152/ajplung.00133.2012</electronic-resource-num><notes>From Duplicate 1 (ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice. - Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y)

From Duplicate 2 ( 

ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice.

- Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y )










From Duplicate 2 (ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice. - Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y)

From Duplicate 2 ( 


ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice.


- Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y )





From Duplicate 2 ( 

ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice.

- Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y )</notes><research-notes>From Duplicate 1 (ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice. - Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y)

From Duplicate 2 ( 

ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice.

- Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y )










From Duplicate 2 (ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice. - Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y)

From Duplicate 2 ( 


ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice.


- Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y )





From Duplicate 2 ( 

ADAM15 deficiency attenuates pulmonary hyperpermeability and acute lung injury in lipopolysaccharide-treated mice.

- Sun, Chongxiu; Beard, Richard S; McLean, Danielle L; Rigor, Robert R; Konia, Thomas; Wu, Mack H; Yuan, Sarah Y )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3567368&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>ADAM15 is a disintegrin and metalloprotease recently implicated in cancer and chronic immune disorders. We have recently characterized ADAM15 as a mediator of endothelial barrier dysfunction. Whether this molecule contributes to acute inflammation has not been evaluated. The purpose of this study was to investigate the role of ADAM15 in mediating pulmonary microvascular leakage during acute inflammatory injury. Immunofluorescent staining and Western blotting revealed that the endothelium was the main source of ADAM15 in lung tissue. In a mouse model of acute lung injury induced by lipopolysaccharide (LPS), upregulation of ADAM15 was observed in association with pulmonary edema and neutrophil infiltration. The LPS-induced inflammatory injury, as demonstrated by bronchoalveolar lavage neutrophil count, lung wet-to-dry weight ratio, and myeloperoxidase activity, was significantly attenuated in Adam15(-/-) mice. Studies with primary cell culture demonstrated abundant ADAM15 expression in endothelial cells (ECs) of mouse lung but not in neutrophils. Deficiency of ADAM15 in ECs had no obvious effect on basal permeability but significantly attenuated hyperpermeability response to LPS as evidenced by albumin flux assay and measurements of transendothelial electrical resistance, respectively. ADAM15 deficiency also reduced neutrophil chemotactic transmigration across endothelial barriers in the presence or absence of formyl-methionyl-leucyl-phenylalanine (fMLP). Rescue expression of ADAM15 in Adam15(-/-) ECs restored neutrophil transendothelial migration. These data indicate that ADAM15 upregulation contributes to inflammatory lung injury by promoting endothelial hyperpermeability and neutrophil transmigration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sun, Shiqin</author><author>Sursal, Tolga</author><author>Adibnia, Yasaman</author><author>Zhao, Cong</author><author>Zheng, Yi</author><author>Li, Haipeng</author><author>Otterbein, Leo E</author><author>Hauser, Carl J</author><author>Itagaki, Kiyoshi</author></authors></contributors><titles><title>Mitochondrial DAMPs increase endothelial permeability through neutrophil dependent and independent pathways.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e59989</pages><volume>8</volume><issue>3</issue><keywords/><dates><year>2013</year></dates><accession-num>23527291</accession-num><electronic-resource-num>10.1371/journal.pone.0059989</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3603956&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Trauma and sepsis can cause acute lung injury (ALI) and Acute Respiratory Distress Syndrome (ARDS) in part by triggering neutrophil (PMN)-mediated increases in endothelial cell (EC) permeability. We had shown that mitochondrial (mt) damage-associated molecular patterns (DAMPs) appear in the blood after injury or shock and activate human PMN. So we now hypothesized that mitochondrial DAMPs (MTD) like mitochondrial DNA (mtDNA) and peptides might play a role in increased EC permeability during systemic inflammation and proceeded to evaluate the underlying mechanisms. MtDNA induced changes in EC permeability occurred in two phases: a brief, PMN-independent 'spike' in permeability was followed by a prolonged PMN-dependent increase in permeability. Fragmented mitochondria (MTD) caused PMN-independent increase in EC permeability that were abolished with protease treatment. Exposure to mtDNA caused PMN-EC adherence by activating expression of adherence molecule expression in both cell types. Cellular activation was manifested as an increase in PMN calcium flux and EC MAPK phosphorylation. Permeability and PMN adherence were attenuated by endosomal TLR inhibitors. EC lacked formyl peptide receptors but were nonetheless activated by mt-proteins, showing that non-formylated mt-protein DAMPs can activate EC. Mitochondrial DAMPs can be released into the circulation by many processes that cause cell injury and lead to pathologic endothelial permeability. We show here that mitochondria contain multiple DAMP motifs that can act on EC and/or PMN via multiple pathways. This can enhance PMN adherence to EC, activate PMN-EC interactions and subsequently increase systemic endothelial permeability. Mitochondrial DAMPs may be important therapeutic targets in conditions where inflammation pathologically increases endothelial permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rigor, Robert R</author><author>Beard, Richard S</author><author>Litovka, Olesya P</author><author>Yuan, Sarah Y</author></authors></contributors><titles><title>Interleukin-1β-induced barrier dysfunction is signaled through PKC-θ in human brain microvascular endothelium.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C1513-22</pages><volume>302</volume><issue>10</issue><keywords><keyword>Brain</keyword><keyword>Brain: blood supply</keyword><keyword>Brain: enzymology</keyword><keyword>Brain: pathology</keyword><keyword>Carbazoles</keyword><keyword>Carbazoles: pharmacology</keyword><keyword>Catalytic</keyword><keyword>Catalytic: antagonists &amp; inhibitors</keyword><keyword>Catalytic: physiology</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Membrane Permeability: genetics</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Inflammation Mediators</keyword><keyword>Inflammation Mediators: physiology</keyword><keyword>Interleukin-1beta</keyword><keyword>Interleukin-1beta: physiology</keyword><keyword>Isoenzymes</keyword><keyword>Isoenzymes: antagonists &amp; inhibitors</keyword><keyword>Isoenzymes: genetics</keyword><keyword>Isoenzymes: physiology</keyword><keyword>Microvessels</keyword><keyword>Microvessels: enzymology</keyword><keyword>Microvessels: pathology</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C: antagonists &amp; inhibitors</keyword><keyword>Protein Kinase C: genetics</keyword><keyword>Protein Kinase C: physiology</keyword><keyword>RNA</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: genetics</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Vascular</keyword><keyword>Vascular: enzymology</keyword><keyword>Vascular: pathology</keyword></keywords><dates><year>2012</year></dates><accession-num>22403784</accession-num><electronic-resource-num>10.1152/ajpcell.00371.2011</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3362001&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Blood-brain barrier dysfunction is a serious consequence of inflammatory brain diseases, cerebral infections, and trauma. The proinflammatory cytokine interleukin (IL)-1β is central to neuroinflammation and contributes to brain microvascular leakage and edema formation. Although it is well known that IL-1β exposure directly induces hyperpermeability in brain microvascular endothelium, the molecular mechanisms mediating this response are not completely understood. In the present study, we found that exposure of the human brain microvascular endothelium to IL-1β triggered activation of novel PKC isoforms δ, μ, and θ, followed by decreased transendothelial electrical resistance (TER). The IL-1β-induced decrease in TER was prevented by small hairpin RNA silencing of PKC-θ or by treatment with the isoform-selective PKC inhibitor Gö6976 but not by PKC inhibitors that are selective for all PKC isoforms other than PKC-θ. Decreased TER coincided with increased phosphorylation of regulatory myosin light chain and with increased proapoptotic signaling indicated by decreased uptake of mitotracker red in response to IL-1β treatment. However, neither of these observed effects were prevented by Gö6976 treatment, indicating lack of causality with respect to decreased TER. Instead, our data indicated that the mechanism of decreased TER involves PKC-θ-dependent phosphorylation of the tight junction protein zona occludens (ZO)-1. Because IL-1β is a central inflammatory mediator, our interpretation is that inhibition of PKC-θ or inhibition of ZO-1 phosphorylation could be viable strategies for preventing blood-brain barrier dysfunction under a variety of neuroinflammatory conditions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Abdul Muneer, P M</author><author>Alikunju, Saleena</author><author>Szlachetka, Adam M</author><author>Haorah, James</author></authors></contributors><titles><title>The Mechanisms of Cerebral Vascular Dysfunction and Neuroinflammation by MMP-Mediated Degradation of VEGFR-2 in Alcohol Ingestion.</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arteriosclerosis, thrombosis, and vascular biology</full-title></periodical><pages>1167-1177</pages><volume>32</volume><issue>5</issue><keywords><keyword>alcohol n blood-brain barrier</keyword><keyword>bbb</keyword><keyword>cialized intercellular tight junction</keyword><keyword>factor-r2 n vascular inflammation</keyword><keyword>he blood-brain barrier</keyword><keyword>is consisted of highly</keyword><keyword>n matrix metalloproteinase n</keyword><keyword>n vascular endothelial growth</keyword><keyword>proteins that reg-</keyword><keyword>spe-</keyword><keyword>tj</keyword><keyword>vascular endothelial growth factor</keyword></keywords><dates><year>2012</year></dates><accession-num>22402362</accession-num><electronic-resource-num>10.1161/ATVBAHA.112.247668</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22402362</url></web-urls></urls><label>Blood Brain Barrier;ECIS TEER</label><abstract>Blood-brain barrier (BBB) dysfunction caused by activation of matrix metalloproteinases (MMPs) is a pathological feature in vascular/neurological disease. We describe the mechanisms of BBB dysfunction and neuroinflammation as a result of MMP-3/9 activation and disruption of vascular endothelial growth factor (VEGF)-A/VEGFR-2 interaction, impairing effective angiogenesis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sun, Ping-Hui</author><author>Ye, Lin</author><author>Mason, Malcolm D</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Protein tyrosine phosphatase µ (PTP µ or PTPRM), a negative regulator of proliferation and invasion of breast cancer cells, is associated with disease prognosis.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e50183</pages><volume>7</volume><issue>11</issue><keywords/><dates><year>2012</year></dates><accession-num>23185569</accession-num><electronic-resource-num>10.1371/journal.pone.0050183</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3502354&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>PTPRM has been shown to exhibit homophilic binding and confer cell-cell adhesion in cells including epithelial and cancer cells. The present study investigated the expression of PTPRM in breast cancer and the biological impact of PTPRM on breast cancer cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cioffi, Donna L</author><author>Pandey, Subha</author><author>Alvarez, Diego F</author><author>Cioffi, Eugene a</author></authors></contributors><titles><title>Terminal sialic acids are an important determinant of pulmonary endothelial barrier integrity.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L1067-77</pages><volume>302</volume><issue>10</issue><keywords/><dates><year>2012</year></dates><accession-num>22387293</accession-num><electronic-resource-num>10.1152/ajplung.00190.2011</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22387293</url></web-urls></urls><label>ECIS TEER</label><abstract>The surface of vascular endothelium bears a glycocalyx comprised, in part, of a complex mixture of oligosaccharide chains attached to cell-surface proteins and membrane lipids. Importantly, understanding of the structure and function of the endothelial glycocalyx is poorly understood. Preliminary studies have demonstrated structural differences in the glycocalyx of pulmonary artery endothelial cells compared with pulmonary microvascular endothelial cells. Herein we begin to probe in more detail structural and functional attributes of endothelial cell-surface carbohydrates. In this study we focus on the expression and function of sialic acids in pulmonary endothelium. We observed that, although pulmonary microvascular endothelial cells express similar amounts of total sialic acids as pulmonary artery endothelial cells, the nature of the sialic acid linkages differs between the two cell types such that pulmonary artery endothelial cells express both α(2,3)- and α(2,6)-linked sialic acids on the surface (i.e., surficially), whereas microvascular endothelial cells principally express α(2,3)-linked sialic acids. To determine whether sialic acids play a role in endothelial barrier function, cells were treated with neuraminidases to hydrolyze sialic acid moieties. Disruption of cell-cell and cell-matrix adhesions was observed following neuraminidase treatment, suggesting that terminal sialic acids promote endothelial barrier integrity. When we measured transendothelial resistance, differential responses of pulmonary artery and microvascular endothelial cells to neuraminidase from Clostridium perfringens suggest that the molecular architecture of the sialic acid glycomes differs between these two cell types. Collectively our observations reveal critical structural and functional differences of terminally linked sialic acids on the pulmonary endothelium.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lee, Yen-Hsien</author><author>Chang, Jung-Jhih</author><author>Yang, Ming-Chien</author><author>Chien, Chiang-Ting</author><author>Lai, Wen-Fu</author></authors></contributors><titles><title>Acceleration of wound healing in diabetic rats by layered hydrogel dressing</title><secondary-title>Carbohydrate Polymers</secondary-title></titles><periodical><full-title>Carbohydrate Polymers</full-title></periodical><pages>809-819</pages><volume>88</volume><issue>3</issue><keywords/><dates><year>2012</year></dates><electronic-resource-num>10.1016/j.carbpol.2011.12.045</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0144861712000483</url></web-urls></urls><abstract>n this study, a novel layered hydrogel composing of alginate (AL), chitosan (CS), and poly(γ-glutamic acid) (PGA) was prepared. The resulting hydrogel was characterized, including the swelling ratio, water vapor transmission rate, the release of Ca2+ and blood coagulation activity. In vitro evaluation of cell migration and proliferation were carried out on electric cell-substrate impedance sensing (ECIS). Effect of the hydrogels on wound healing was examined in type 1 diabetic rat model induced by streptozotoxin (STZ). After grafting to full-thickness wounds in diabetic rats, AL–CS–PGA exhibited higher rate of wound healing than conventional AL hydrogels. Epithelialization and collagen deposition were examined histologically. Hydroxyproline levels also were assessed in the wound skin. The results indicated AL–CS–PGA treated wounds showed increased collagen regeneration and epithelialization. Therefore AL–CS–PGA can improve wound healing of diabetic rat models comparing to conventional AL wound dressing.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pradhan, Rangadhar</author><author>Mitra, Analava</author><author>Das, Soumen</author></authors></contributors><titles><title>Characterization of Electrode/Electrolyte Interface of ECIS Devices</title><secondary-title>Electroanalysis</secondary-title></titles><periodical><full-title>Electroanalysis</full-title></periodical><pages>2405-2414</pages><volume>24</volume><issue>12</issue><keywords><keyword>COMSOL Multiphysics</keyword><keyword>ECIS</keyword><keyword>EIS</keyword><keyword>Electrochemical impedance</keyword><keyword>ZsimpWin</keyword></keywords><dates><year>2012</year></dates><electronic-resource-num>10.1002/elan.201200455</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1002/elan.201200455</url></web-urls></urls><abstract>Electric cell-substrate impedance sensing requires low electrode/electrolyte interface impedance for effective biomedical and biophysical applications. Thus a complete understanding of physical processes involved in the formation of an electric double layer is required to design a low interface impedance device. This paper presents the numerical simulation of the impedance for the electrode/electrolyte interface of three-electrode devices along with the practical realization for the effective workout of impedance sensing devices. The three-electrode based impedance sensing devices along with phosphate buffered saline as electrolyte is simulated using COMSOL Multiphysics to evaluate the impedance of the electrode/electrolyte interface. Microfabrication technology is used to realize three-electrode impedance sensing devices with diverse configuration which are used to measure the electrode/electrolyte interface impedance. The measured impedance data were then compared with the COMSOL simulated results and it is found that both the data sets fitted well with less than 5 % RSE. The results obtained from simulation and experiments indicate that the impedance due to double layer diffusion dominates in the low frequency region up to few kHz whereas electrolytic bulk resistance plays a major role in the higher frequency range. The experimental impedance data were further interpreted by electrochemical impedance spectroscopy analysis software to model the equivalent circuit of the electrochemical system.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lucas, R</author><author>Sridhar, S</author><author>Rick, F G</author><author>Gorshkov, B</author><author>Umapathy, N S</author><author>Yang, G</author><author>Oseghale, A</author><author>Verin, a. D</author><author>Chakraborty, T</author><author>Matthay, M a.</author><author>Zemskov, E a.</author><author>White, R</author><author>Block, N L</author><author>Schally, a. V</author></authors></contributors><titles><title>Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>2084-2089</pages><volume>109</volume><issue>6</issue><keywords><keyword>cyclic AMP</keyword><keyword>pneumonia</keyword></keywords><dates><year>2012</year></dates><electronic-resource-num>10.1073/pnas.1121075109</electronic-resource-num><urls><web-urls><url>http://www.pnas.org/cgi/doi/10.1073/pnas.1121075109</url></web-urls></urls><label>ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Langer, M</author><author>Duggan, E S</author><author>Booth, J L</author><author>Patel, V I</author><author>Zander, R a.</author><author>Silasi-Mansat, R</author><author>Ramani, V</author><author>Veres, T Z</author><author>Prenzler, F</author><author>Sewald, K</author><author>Williams, D M</author><author>Coggeshall, K M</author><author>Awasthi, S</author><author>Lupu, F</author><author>Burian, D</author><author>Ballard, J D</author><author>Braun, A</author><author>Metcalf, J P</author></authors></contributors><titles><title>Bacillus anthracis Lethal Toxin Reduces Human Alveolar Epithelial Barrier Function</title><secondary-title>Infection and Immunity</secondary-title></titles><periodical><full-title>Infection and Immunity</full-title></periodical><pages>4374-4387</pages><volume>80</volume><issue>12</issue><keywords/><dates><year>2012</year></dates><electronic-resource-num>10.1128/IAI.01011-12</electronic-resource-num><urls><web-urls><url>http://iai.asm.org/cgi/doi/10.1128/IAI.01011-12</url></web-urls></urls><label>ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Srinivas, Sangly P</author></authors></contributors><titles><title>Cell signaling in regulation of the barrier integrity of the corneal endothelium.</title><secondary-title>Experimental eye research</secondary-title></titles><periodical><full-title>Experimental eye research</full-title></periodical><pages>8-15</pages><volume>95</volume><issue>1</issue><keywords><keyword>Actin Cytoskeleton</keyword><keyword>Actin Cytoskeleton: metabolism</keyword><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Cornea</keyword><keyword>Cornea: blood supply</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Signal Transduction</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: metabolism</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: metabolism</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>p38 Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>21963716</accession-num><electronic-resource-num>10.1016/j.exer.2011.09.009</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3271188&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>The barrier integrity of the corneal endothelium, which is conferred by its tight and adherens junctions, is critical for the maintenance of deturgescence of the corneal stroma. Although characteristically leaky, the barrier integrity restricts fluid leakage into the stroma such that the rate of leak does not exceed the rate of the endothelial active fluid transport directed toward the aqueous humor. At a molecular level, the barrier integrity is influenced by the actin cytoskeleton and microtubules, which are coupled to tight and adherens junctions via a variety of linker proteins. Since the cytoskeleton is affected by Rho family small GTPases and p38 MAP kinase, among others, many pathophysiological stimuli induce plasticity to the cytoskeleton and thereby elicit dynamic regulation of the barrier integrity. This review presents an overview of the impact of several bioactive factors on the barrier integrity of the corneal endothelium through altered actin cytoskeleton and/or disassembly of microtubules. The main focus is on the effect of TNF-α (tumor necrosis factor-α) which is a pro-inflammatory molecule found in the intraocular milieu during allograft rejection and anterior uveitis. This cytokine elicits acute activation of p38 MAP kinase, induces disassembly of microtubules, disrupts the peri-junctional actomyosin ring, and concomitantly breaks down the barrier integrity. These effects of TNF-α could be inhibited by stabilizing the microtubules, co-treating with a selective p38 MAP kinase inhibitor, and elevating intracellular cAMP via A2B receptors or direct exposure to forskolin. Overall, the corneal edema following a potential breakdown of the endothelial barrier integrity can be rescued pharmacologically by inhibiting specific cell-signaling mechanisms.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chang, Jung-Jhih</author><author>Lee, Yen-Hsien</author><author>Wu, Meng-Hsiu</author><author>Yang, Ming-Chien</author><author>Chien, Chiang-Ting</author></authors></contributors><titles><title>Electrospun anti-adhesion barrier made of chitosan alginate for reducing peritoneal adhesions</title><secondary-title>Carbohydrate Polymers</secondary-title></titles><periodical><full-title>Carbohydrate Polymers</full-title></periodical><pages>1304-1312</pages><volume>88</volume><issue>4</issue><keywords/><dates><year>2012</year></dates><electronic-resource-num>10.1016/j.carbpol.2012.02.011</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0144861712001361</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukova, Anna a</author><author>Lee, Sangderk</author><author>Starosta, Vitaliy</author><author>Wu, Tinghuai</author><author>Ho, Tiffany</author><author>Kim, Jin</author><author>Berliner, Judith a</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>A role for VEGFR2 activation in endothelial responses caused by barrier disruptive OxPAPC concentrations.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e30957</pages><volume>7</volume><issue>1</issue><keywords/><dates><year>2012</year></dates><accession-num>22303475</accession-num><electronic-resource-num>10.1371/journal.pone.0030957</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3269437&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Oxidation products of 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphatidylcholine (OxPAPC) differentially modulate endothelial cell (EC) barrier function in a dose-dependent fashion. Vascular endothelial growth factor receptor-2 (VEGFR2) is involved in the OxPAPC-induced EC inflammatory activation. This study examined a role of VEGFR2 in barrier dysfunction caused by high concentrations of OxPAPC and evaluated downstream signaling mechanisms resulting from the effect of OxPAPC in EC from pulmonary and systemic circulation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Escudero-Esparza, Astrid</author><author>Jiang, Wen G</author><author>Martin, Tracey A</author></authors></contributors><titles><title>Claudin-5 participates in the regulation of endothelial cell motility.</title><secondary-title>Molecular and cellular biochemistry</secondary-title></titles><periodical><full-title>Molecular and cellular biochemistry</full-title></periodical><pages>71-85</pages><volume>362</volume><issue>1-2</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: genetics</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: genetics</keyword><keyword>Cell Movement: physiology</keyword><keyword>Claudin-5</keyword><keyword>Claudins</keyword><keyword>Claudins: biosynthesis</keyword><keyword>Claudins: genetics</keyword><keyword>Claudins: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelium</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Hepatocyte Growth Factor</keyword><keyword>Hepatocyte Growth Factor: metabolism</keyword><keyword>Humans</keyword><keyword>Neovascularization</keyword><keyword>Neuronal</keyword><keyword>Neuronal: antagonists &amp; inhibitors</keyword><keyword>Neuronal: metabolism</keyword><keyword>Physiologic</keyword><keyword>Physiologic: genetics</keyword><keyword>Signal Transduction</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: metabolism</keyword><keyword>Tight Junctions: physiology</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>Wiskott-Aldrich Syndrome Protein</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: antagonists &amp; inhibitors</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>22038628</accession-num><electronic-resource-num>10.1007/s11010-011-1129-2</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22038628</url></web-urls></urls><label>Signal Transduction</label><abstract>A key step in metastasis is the interaction and penetration of the vascular endothelium by cancer cells. Tight Junctions (TJ) are located between the cancer epithelial cells and between the endothelial cells functioning in an adhesive manner. They represent a critical barrier which the cancer cells must overcome in order to penetrate and initiate metastasis. Claudin-5 is a protein member of the Claudin family, a group of TJ proteins expressed in both endothelial and epithelial cells. This study examined in vitro the effect of altering levels of expression of Claudin-5 in HECV cells. Insertion of Claudin-5 gene in HECV cells resulted in cells that were significantly less motile and less adhesive to matrix (P &lt; 0.001). These cells also exhibited a significant decreased in the angiogenic potential (P &lt; 0.001). Results also revealed a link between Claudin-5 and cell motility. Furthermore, a possible link between Claudin-5 and N-WASP, and Claudin-5 and ROCK was demonstrated when interactions between these proteins were seen in the cell line. Moreover, followed by treatment of N-WASP inhibitor (Wiskostatin) and ROCK inhibitor (Y-27632), cell motility and angiogenic potential were assessed in response to the inhibitors. Results showed that the knockdown of Claudin-5 in HECV cells masked their response to both N-WASP and ROCK inhibitors. In conclusion, this study portrays a new and interesting role for Claudin-5 in cell motility involving the N-WASP and ROCK signalling cascade which is beyond the primarily role of Claudin-5 in keeping the cell barrier tight as it was originally reported.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Aikio, Mari</author><author>Alahuhta, Ilkka</author><author>Nurmenniemi, Sini</author><author>Suojanen, Juho</author><author>Palovuori, Riitta</author><author>Teppo, Susanna</author><author>Sorsa, Timo</author><author>López-Otín, Carlos</author><author>Pihlajaniemi, Taina</author><author>Salo, Tuula</author><author>Heljasvaara, Ritva</author><author>Nyberg, Pia</author></authors></contributors><titles><title>Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e51044</pages><volume>7</volume><issue>12</issue><keywords/><dates><year>2012</year></dates><accession-num>23227231</accession-num><electronic-resource-num>10.1371/journal.pone.0051044</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3515547&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Attachment</label><abstract>The turnover of extracellular matrix liberates various cryptic molecules with novel biological activity. Among these are the collagen-derived anti-angiogenic fragments, some of which are suggested to affect carcinoma cells also directly. Arresten is an endogenous angiogenesis inhibitor that is derived from the non-collagenous domain of the basement membrane collagen IV α1 chain. As the mere prevention of tumor angiogenesis leads to hypoxia that can result in selection of more aggressive cell types and reduces the efficacy of chemotherapy, we aimed here to elucidate how arresten influences the aggressive human carcinoma cells. Arresten efficiently inhibited migration and invasion of HSC-3 tongue carcinoma cells in culture and in an organotypic model. Subcutaneous Arr-HSC xenografts grew markedly more slowly in nude mice and showed reduced tumor cell proliferation, vessel density and local invasiveness. In the organotypic assay, HSC-3 cells overproducing arresten (Arr-HSC) showed induction of cell death. In monolayer culture the Arr-HSC cells grew in aggregated cobblestone-like clusters and, relative to the control cells, showed increased expression and localization of epithelial marker E-cadherin in cell-cell contacts. Application of electric cell-substrate impedance sensing (ECIS) further supported our observations on altered morphology and motility of the Arr-HSC cells. Administration of a function-blocking α1 integrin antibody abolished the impedance difference between the Arr-HSC and control cells suggesting that the effect of arresten on promotion of HSC-3 cell-cell contacts and cell spreading is at least partly mediated by α1β1 integrin. Collectively, our data suggest novel roles for arresten in the regulation of oral squamous carcinoma cell proliferation, survival, motility and invasion through the modulation of cell differentiation state and integrin signaling.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Post, S</author><author>Nawijn, M C</author><author>Hackett, T L</author><author>Baranowska, M</author><author>Gras, R</author><author>van Oosterhout, a. J M</author><author>Heijink, I H</author></authors></contributors><titles><title>The composition of house dust mite is critical for mucosal barrier dysfunction and allergic sensitisation.</title><secondary-title>Thorax</secondary-title></titles><periodical><full-title>Thorax</full-title></periodical><pages>488-495</pages><volume>67</volume><issue>6</issue><keywords/><dates><year>2012</year></dates><accession-num>22167364</accession-num><electronic-resource-num>10.1136/thoraxjnl-2011-200606</electronic-resource-num><urls><web-urls><url>http://thorax.bmj.com/cgi/doi/10.1136/thoraxjnl-2011-200606</url><url>http://www.ncbi.nlm.nih.gov/pubmed/22167364</url></web-urls></urls><label>ECIS TEER</label><abstract>House dust mite (HDM) allergens have been reported to increase airway epithelial permeability, thereby facilitating access of allergens and allergic sensitisation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Simet, Samantha M</author><author>Wyatt, Todd a</author><author>DeVasure, Jane</author><author>Yanov, Daniel</author><author>Allen-Gipson, Diane</author><author>Sisson, Joseph H</author></authors></contributors><titles><title>Alcohol increases the permeability of airway epithelial tight junctions in Beas-2B and NHBE cells.</title><secondary-title>Alcoholism, clinical and experimental research</secondary-title></titles><periodical><full-title>Alcoholism, clinical and experimental research</full-title></periodical><pages>432-442</pages><volume>36</volume><issue>3</issue><keywords><keyword>Carbazoles</keyword><keyword>Carbazoles: pharmacology</keyword><keyword>Cell Line</keyword><keyword>Claudin-1</keyword><keyword>Claudin-5</keyword><keyword>Claudins</keyword><keyword>Claudins: metabolism</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Drug Interactions</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Ethanol</keyword><keyword>Ethanol: administration &amp; dosage</keyword><keyword>Ethanol: antagonists &amp; inhibitors</keyword><keyword>Ethanol: pharmacology</keyword><keyword>Humans</keyword><keyword>Isoenzymes</keyword><keyword>Isoenzymes: metabolism</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Permeability</keyword><keyword>Permeability: drug effects</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C: antagonists &amp; inhibitors</keyword><keyword>Protein Kinase C: genetics</keyword><keyword>Protein Kinase C: metabolism</keyword><keyword>Respiratory Mucosa</keyword><keyword>Respiratory Mucosa: drug effects</keyword><keyword>Respiratory Mucosa: metabolism</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: drug effects</keyword><keyword>Tight Junctions: metabolism</keyword><keyword>Transformed</keyword><keyword>Zonula Occludens-1 Protein</keyword></keywords><dates><year>2012</year></dates><accession-num>21950588</accession-num><electronic-resource-num>10.1111/j.1530-0277.2011.01640.x</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3251733&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>BACKGROUND: Tight junctions form a continuous belt-like structure between cells and act to regulate paracellular signaling. Protein kinase C (PKC) has been shown to regulate tight junction assembly and disassembly and is activated by alcohol. Previous research has shown that alcohol increases the permeability of tight junctions in lung alveolar cells. However, little is known about alcohol's effect on tight junctions in epithelium of the conducting airways. We hypothesized that long-term alcohol exposure reduces zonula occluden-1 (ZO-1) and claudin-1 localization at the cell membrane and increases permeability through a PKC-dependent mechanism. METHODS: To test this hypothesis, we exposed normal human bronchial epithelial (NHBE) cells, cells from a human bronchial epithelial transformed cell line (Beas-2B), and Beas-2B expressing a PKCα dominant negative (DN) to alcohol (20, 50, and 100 mM) for up to 48 hours. Immunofluorescence was used to assess changes in ZO-1, claudin-1, claudin-5, and claudin-7 localization. Electric cell-substrate impedance sensing was used to measure the permeability of tight junctions between monolayers of NHBE, Beas-2B, and DN cells. RESULTS: Alcohol increased tight junction permeability in a concentration-dependent manner and decreased ZO-1, claudin-1, claudin-5, and claudin-7 localization at the cell membrane. To determine a possible signaling mechanism, we measured the activity of PKC isoforms (alpha, delta, epsilon, and zeta). PKCα activity significantly increased in Beas-2B cells from 1 to 6 hours of 100 mM alcohol exposure, while PKCζ activity significantly decreased at 1 hour and increased at 3 hours. Inhibiting PKCα with Gö-6976 prevented the alcohol-induced protein changes in both ZO-1 and claudin-1 at the cell membrane. PKCα DN Beas-2B cells were resistant to alcohol-induced protein alterations. CONCLUSIONS: These results suggest that alcohol disrupts ZO-1, claudin-1, claudin-5, and claudin-7 through the activation of PKCα, leading to an alcohol-induced &quot;leakiness&quot; in bronchial epithelial cells. Such alcohol-induced airway-leak state likely contributes to the impaired airway host defenses associated with acute and chronic alcohol ingestion.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Csiszar, Anna</author><author>Sosnowska, Danuta</author><author>Tucsek, Zsuzsanna</author><author>Gautam, Tripti</author><author>Toth, Peter</author><author>Losonczy, Gyorgy</author><author>Colman, Ricki J</author><author>Weindruch, Richard</author><author>Anderson, Rozalyn M</author><author>Sonntag, William E</author><author>Ungvari, Zoltan</author></authors></contributors><titles><title>Circulating Factors Induced by Caloric Restriction in the Nonhuman Primate Macaca Mulatta Activate Angiogenic Processes in Endothelial Cells.</title><secondary-title>The journals of gerontology. Series A, Biological sciences and medical sciences</secondary-title></titles><periodical><full-title>The journals of gerontology. Series A, Biological sciences and medical sciences</full-title></periodical><pages>1-15</pages><issue>15</issue><keywords><keyword>2012</keyword><keyword>accepted june 1</keyword><keyword>angiogenesis</keyword><keyword>cardiovascular system</keyword><keyword>decision editor</keyword><keyword>dietary restriction</keyword><keyword>microcirculation</keyword><keyword>phd</keyword><keyword>rafael de cabo</keyword><keyword>received april 9</keyword><keyword>vascular aging</keyword></keywords><dates><year>2012</year></dates><accession-num>22904098</accession-num><electronic-resource-num>10.1093/gerona/gls158</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22904098</url></web-urls></urls><label>ECIS Attachment;ECIS Migration</label><abstract>Moderate caloric restriction (CR) without malnutrition increases healthspan in virtually every species studied, including nonhuman primates. In mice, CR exerts significant microvascular protective effects resulting in increased microvascular density in the heart and the brain, which likely contribute to enhanced tolerance to ischemia and improved cardiac performance and cognitive function. Yet, the underlying mechanisms by which CR confer microvascular protection remain elusive. To test the hypothesis that circulating factors triggered by CR regulate endothelial angiogenic capacity, we treated cultured human endothelial cells with sera derived from Macaca mulatta on long-term (over 10 years) CR. Cells treated with sera derived from ad-libitum-fed control monkeys served as controls. We found that factors present in CR sera upregulate vascular endothelial growth factor (VEGF) signaling and stimulate angiogenic processes, including endothelial cell proliferation and formation of capillary-like structures. Treatment with CR sera also tended to increase cellular migration (measured by a wound-healing assay using electric cell-substrate impedance sensing [ECIS] technology) and adhesion to collagen. Collectively, we find that circulating factors induced by CR promote endothelial angiogenic processes, suggesting that increased angiogenesis may be a potential mechanism by which CR improves cardiac function and prevents vascular cognitive impairment.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Du, Peng</author><author>Ye, Lin</author><author>Li, Han</author><author>Yang, Yong</author><author>Jiang, Wen G</author></authors></contributors><titles><title>The tumour suppressive role of metastasis suppressor-1, MTSS1, in human kidney cancer, a possible connection with the SHH pathway.</title><secondary-title>Journal of experimental therapeutics &amp; oncology</secondary-title></titles><periodical><full-title>Journal of experimental therapeutics &amp; oncology</full-title></periodical><pages>91-99</pages><volume>10</volume><issue>2</issue><keywords><keyword>Apoptosis</keyword><keyword>Blotting</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Cell Proliferation</keyword><keyword>Cultured</keyword><keyword>Flow Cytometry</keyword><keyword>Hedgehog Proteins</keyword><keyword>Hedgehog Proteins: antagonists &amp; inhibitors</keyword><keyword>Hedgehog Proteins: genetics</keyword><keyword>Hedgehog Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Kidney Neoplasms</keyword><keyword>Kidney Neoplasms: genetics</keyword><keyword>Kidney Neoplasms: metabolism</keyword><keyword>Kidney Neoplasms: pathology</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: genetics</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Neoplasm Proteins</keyword><keyword>Neoplasm Proteins: genetics</keyword><keyword>Neoplasm Proteins: metabolism</keyword><keyword>RNA</keyword><keyword>Real-Time Polymerase Chain Reaction</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Tumor Cells</keyword><keyword>Veratrum Alkaloids</keyword><keyword>Veratrum Alkaloids: pharmacology</keyword><keyword>Western</keyword></keywords><dates><year>2012</year></dates><accession-num>23350348</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23350348</url></web-urls></urls><label>Apoptosis</label><abstract>Metastasis suppressor 1 (MTSS1), a cytoskeletal associated protein, has been indicated in certain types of human cancers, but its role in kidney cancer remains unknown. We have investigated the expression of MTSS1 in normal and malignant human kidney tissues and its molecular interaction within kidney cancer cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bhattacharya, Mallar</author><author>Su, George</author><author>Su, Xiao</author><author>Oses-Prieto, Juan a</author><author>Li, John T</author><author>Huang, Xiaozhu</author><author>Hernandez, Hilda</author><author>Atakilit, Amha</author><author>Burlingame, Alma L</author><author>Matthay, Michael a</author><author>Sheppard, Dean</author></authors></contributors><titles><title>IQGAP1 is necessary for pulmonary vascular barrier protection in murine acute lung injury and pneumonia.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>12-19</pages><volume>94158</volume><issue>10</issue><keywords><keyword>S1P</keyword><keyword>cortical actin</keyword><keyword>proteomics</keyword></keywords><dates><year>2012</year></dates><accession-num>22561460</accession-num><electronic-resource-num>10.1152/ajplung.00375.2011</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22561460</url></web-urls></urls><label>ECIS TEER</label><abstract>We recently reported that integrin αvβ3 is necessary for vascular barrier protection in mouse models of acute lung injury and peritonitis. Here, we used mass spectrometric sequencing of integrin complexes to isolate the novel β3-integrin binding partner IQGAP1. Like integrin β3, IQGAP1 localized to the endothelial cell-cell junction after S1P treatment, and IQGAP1 knockdown prevented cortical actin formation and barrier enhancement in response to S1P. Furthermore, knockdown of IQGAP1 prevented localization of integrin αvβ3 to the cell-cell junction. Similar to β3 null animals, IQGAP1 null mice had increased pulmonary vascular leak compared with wild type controls three days after intratracheal LPS. In an E. coli pneumonia model, IQGAP1 knockout mice had increased lung weights, lung water, and lung extravascular plasma equivalents of 125I-albumin compared with wild type controls. Taken together, these experiments indicate that IQGAP1 is necessary for S1P-mediated vascular barrier protection during acute lung injury and is required for junctional localization of the barrier protective integrin αvβ3.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Evans, Jason V</author><author>Ammer, Amanda G</author><author>Jett, John E</author><author>Bolcato, Chris a</author><author>Breaux, Jason C</author><author>Martin, Karen H</author><author>Culp, Mark V</author><author>Gannett, Peter M</author><author>Weed, Scott a</author></authors></contributors><titles><title>Src binds cortactin through an SH2 domain cystine-mediated linkage.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>6185-6197</pages><volume>125</volume><issue>Pt 24</issue><keywords><keyword>Amino Acid Sequence</keyword><keyword>Cell Line</keyword><keyword>Cortactin</keyword><keyword>Cortactin: genetics</keyword><keyword>Cortactin: metabolism</keyword><keyword>Cystine</keyword><keyword>Cystine: genetics</keyword><keyword>Cystine: metabolism</keyword><keyword>Humans</keyword><keyword>Models</keyword><keyword>Molecular</keyword><keyword>Molecular Sequence Data</keyword><keyword>Phosphorylation</keyword><keyword>Protein Binding</keyword><keyword>Signal Transduction</keyword><keyword>cortactin</keyword><keyword>cystine</keyword><keyword>sh2 domain</keyword><keyword>src</keyword><keyword>src Homology Domains</keyword><keyword>src-Family Kinases</keyword><keyword>src-Family Kinases: genetics</keyword><keyword>src-Family Kinases: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>23097045</accession-num><electronic-resource-num>10.1242/jcs.121046</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23097045</url><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3585525&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Attachment;ECIS Migration;Signal Transduction</label><abstract>Tyrosine-kinase-based signal transduction mediated by modular protein domains is critical for cellular function. The Src homology (SH)2 domain is an important conductor of intracellular signaling that binds to phosphorylated tyrosines on acceptor proteins, producing molecular complexes responsible for signal relay. Cortactin is a cytoskeletal protein and tyrosine kinase substrate that regulates actin-based motility through interactions with SH2-domain-containing proteins. The Src kinase SH2 domain mediates cortactin binding and tyrosine phosphorylation, but how Src interacts with cortactin is unknown. Here we demonstrate that Src binds cortactin through cystine bonding between Src C185 in the SH2 domain within the phosphotyrosine binding pocket and cortactin C112/246 in the cortactin repeats domain, independent of tyrosine phosphorylation. Interaction studies show that the presence of reducing agents ablates Src-cortactin binding, eliminates cortactin phosphorylation by Src, and prevents Src SH2 domain binding to cortactin. Tandem MS/MS sequencing demonstrates cystine bond formation between Src C185 and cortactin C112/246. Mutational studies indicate that an intact cystine binding interface is required for Src-mediated cortactin phosphorylation, cell migration, and pre-invadopodia formation. Our results identify a novel phosphotyrosine-independent binding mode between the Src SH2 domain and cortactin. Besides Src, one quarter of all SH2 domains contain cysteines at or near the analogous Src C185 position. This provides a potential alternative mechanism to tyrosine phosphorylation for cysteine-containing SH2 domains to bind cognate ligands that may be widespread in propagating signals regulating diverse cellular functions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Powers, Michael E</author><author>Kim, Hwan Keun</author><author>Wang, Yang</author><author>Bubeck Wardenburg, Juliane</author></authors></contributors><titles><title>ADAM10 Mediates Vascular Injury Induced by Staphylococcus aureus α-Hemolysin.</title><secondary-title>The Journal of infectious diseases</secondary-title></titles><periodical><full-title>The Journal of infectious diseases</full-title></periodical><pages>1-5</pages><volume>206</volume><issue>3</issue><keywords/><dates><year>2012</year></dates><accession-num>22474035</accession-num><electronic-resource-num>10.1093/infdis/jis192</electronic-resource-num><notes>From Duplicate 1 (ADAM10 Mediates Vascular Injury Induced by Staphylococcus aureus α-Hemolysin. - Powers, Michael E; Kim, Hwan Keun; Wang, Yang; Bubeck Wardenburg, Juliane)

From Duplicate 3 ( 

ADAM10 Mediates Vascular Injury Induced by Staphylococcus aureus α-Hemolysin.

- Powers, Michael E; Kim, Hwan Keun; Wang, Yang; Bubeck Wardenburg, Juliane )</notes><research-notes>From Duplicate 1 (ADAM10 Mediates Vascular Injury Induced by Staphylococcus aureus α-Hemolysin. - Powers, Michael E; Kim, Hwan Keun; Wang, Yang; Bubeck Wardenburg, Juliane)

From Duplicate 3 ( 

ADAM10 Mediates Vascular Injury Induced by Staphylococcus aureus α-Hemolysin.

- Powers, Michael E; Kim, Hwan Keun; Wang, Yang; Bubeck Wardenburg, Juliane )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22474035</url></web-urls></urls><label>ECIS TEER</label><abstract>Staphylococcus aureus is a leading cause of bacteremia and sepsis. The interaction of S. aureus with the endothelium is central to bloodstream infection pathophysiology yet remains ill-understood. We show herein that staphylococcal α-hemolysin, a pore-forming cytotoxin, is required for full virulence in a murine sepsis model. The α-hemolysin binding to its receptor A-disintegrin and metalloprotease 10 (ADAM10) upregulates the receptor's metalloprotease activity on endothelial cells, causing vascular endothelial-cadherin cleavage and concomitant loss of endothelial barrier function. These cellular injuries and sepsis severity can be mitigated by ADAM10 inhibition. This study therefore provides mechanistic insight into toxin-mediated endothelial injury and suggests new therapeutic approaches for staphylococcal sepsis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Weissmann, Norbert</author><author>Sydykov, Akylbek</author><author>Kalwa, Hermann</author><author>Storch, Ursula</author><author>Fuchs, Beate</author><author>Mederos y Schnitzler, Michael</author><author>Brandes, Ralf P</author><author>Grimminger, Friedrich</author><author>Meissner, Marcel</author><author>Freichel, Marc</author><author>Offermanns, Stefan</author><author>Veit, Florian</author><author>Pak, Oleg</author><author>Krause, Karl-Heinz</author><author>Schermuly, Ralph T</author><author>Brewer, Alison C</author><author>Schmidt, Harald H H W</author><author>Seeger, Werner</author><author>Shah, Ajay M</author><author>Gudermann, Thomas</author><author>Ghofrani, Hossein a</author><author>Dietrich, Alexander</author></authors></contributors><titles><title>Activation of TRPC6 channels is essential for lung ischaemia-reperfusion induced oedema in mice.</title><secondary-title>Nature communications</secondary-title></titles><periodical><full-title>Nature communications</full-title></periodical><pages>649</pages><volume>3</volume><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Calcium</keyword><keyword>Calcium: metabolism</keyword><keyword>Diacylglycerol Kinase</keyword><keyword>Diacylglycerol Kinase: metabolism</keyword><keyword>Edema</keyword><keyword>Edema: pathology</keyword><keyword>Edema: therapy</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Gene Deletion</keyword><keyword>Inbred C57BL</keyword><keyword>Lung</keyword><keyword>Lung: pathology</keyword><keyword>Membrane Glycoproteins</keyword><keyword>Membrane Glycoproteins: genetics</keyword><keyword>Mice</keyword><keyword>Models</keyword><keyword>NADPH Oxidase</keyword><keyword>NADPH Oxidase: genetics</keyword><keyword>Permeability</keyword><keyword>Phospholipase C gamma</keyword><keyword>Phospholipase C gamma: metabolism</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reperfusion Injury</keyword><keyword>TRPC Cation Channels</keyword><keyword>TRPC Cation Channels: genetics</keyword><keyword>Time Factors</keyword><keyword>Transgenic</keyword></keywords><dates><year>2012</year></dates><publisher>Nature Publishing Group</publisher><accession-num>22337127</accession-num><electronic-resource-num>10.1038/ncomms1660</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3272568&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Lung ischaemia-reperfusion-induced oedema (LIRE) is a life-threatening condition that causes pulmonary oedema induced by endothelial dysfunction. Here we show that lungs from mice lacking nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (Nox2(y/-)) or the classical transient receptor potential channel 6 (TRPC6(-/-)) are protected from LIR-induced oedema (LIRE). Generation of chimeric mice by bone marrow cell transplantation and endothelial-specific Nox2 deletion showed that endothelial Nox2, but not leukocytic Nox2 or TRPC6, are responsible for LIRE. Lung endothelial cells from Nox2- or TRPC6-deficient mice showed attenuated ischaemia-induced Ca(2+) influx, cellular shape changes and impaired barrier function. Production of reactive oxygen species was completely abolished in Nox2(y/-) cells. A novel mechanistic model comprising endothelial Nox2-derived production of superoxide, activation of phospholipase C-γ, inhibition of diacylglycerol (DAG) kinase, DAG-mediated activation of TRPC6 and ensuing LIRE is supported by pharmacological and molecular evidence. This mechanism highlights novel pharmacological targets for the treatment of LIRE.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Konya, Viktoria</author><author>Kampitsch, Nora</author><author>Theiler, Anna</author></authors></contributors><titles><title>Endothelial E-type prostanoid 4 receptors promote barrier function and inhibit neutrophil trafficking</title><secondary-title>Journal of Allergy and</secondary-title></titles><periodical><full-title>Journal of Allergy and</full-title></periodical><keywords><keyword>acute lung</keyword><keyword>chronic obstructive pulmonary disease</keyword><keyword>endothelial barrier</keyword><keyword>injury</keyword><keyword>neutro-</keyword><keyword>prostaglandins</keyword><keyword>vascular leakage</keyword></keywords><dates><year>2012</year></dates><electronic-resource-num>10.1016/j.jaci.2012.05.008</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0091674912007828</url><url>http://www.sciencedirect.com/science/article/pii/S0091674912007828</url></web-urls></urls><label>ECIS Migration;ECIS TEER;Signal Transduction</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Heijink, I H</author><author>Brandenburg, S M</author><author>Postma, D S</author><author>van Oosterhout, a J M</author></authors></contributors><titles><title>Cigarette smoke impairs airway epithelial barrier function and cell-cell contact recovery.</title><secondary-title>The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology</secondary-title></titles><periodical><full-title>The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology</full-title></periodical><pages>419-428</pages><volume>39</volume><issue>2</issue><keywords><keyword>Cell Communication</keyword><keyword>Cell Communication: physiology</keyword><keyword>Cell Division</keyword><keyword>Cell Division: physiology</keyword><keyword>Cells</keyword><keyword>Chronic Obstructive</keyword><keyword>Chronic Obstructive: etiology</keyword><keyword>Chronic Obstructive: metabolism</keyword><keyword>Chronic Obstructive: pathology</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Electroporation</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Epidermal Growth Factor</keyword><keyword>Epidermal Growth Factor: antagonists &amp; inhibitors</keyword><keyword>Epidermal Growth Factor: metabolism</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Permeability</keyword><keyword>Pulmonary Disease</keyword><keyword>Quinazolines</keyword><keyword>Quinazolines: pharmacology</keyword><keyword>Receptor</keyword><keyword>Respiratory Mucosa</keyword><keyword>Respiratory Mucosa: cytology</keyword><keyword>Respiratory Mucosa: drug effects</keyword><keyword>Smoking</keyword><keyword>Smoking: adverse effects</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: physiology</keyword><keyword>Tyrphostins</keyword><keyword>Tyrphostins: pharmacology</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: physiology</keyword></keywords><dates><year>2012</year></dates><accession-num>21778164</accession-num><electronic-resource-num>10.1183/09031936.00193810</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21778164</url></web-urls></urls><label>ECIS TEER;Wound Healing</label><abstract>Cigarette smoking, the major cause of chronic obstructive pulmonary disease (COPD), induces aberrant airway epithelial structure and function. The underlying mechanisms are unresolved so far. We studied effects of cigarette smoke extract (CSE) on epithelial barrier function and wound regeneration in human bronchial epithelial 16HBE cells and primary bronchial epithelial cells (PBECs) from COPD patients, nonsmokers and healthy smokers. We demonstrate that CSE rapidly and transiently impairs 16HBE barrier function, largely due to disruption of cell-cell contacts. CSE induced a similar, but stronger and more sustained, defect in PBECs. Application of the specific epidermal growth factor receptor (EGFR) inhibitor AG1478 showed that EGFR activation contributes to the CSE-induced defects in both 16HBE cells and PBECs. Furthermore, our data indicate that the endogenous protease calpain mediates these defects through tight junction protein degradation. CSE also delayed the reconstitution of 16HBE intercellular contacts during wound healing and attenuated PBEC barrier function upon wound regeneration. These findings were comparable between PBECs from smokers, healthy smokers and COPD patients. In conclusion, we demonstrate for the first time that CSE reduces epithelial integrity, probably by EGFR and calpain-dependent disruption of intercellular contacts. This may increase susceptibility to environmental insults, e.g. inhaled pathogens. Thus, EGFR may be a promising target for therapeutic strategies to improve mucosal barrier function in cigarette smoking-related disease.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van Doorn, Ruben</author><author>Lopes Pinheiro, Melissa A</author><author>Kooij, Gijs</author><author>Lakeman, Kim</author><author>van het Hof, Bert</author><author>van der Pol, Susanne M A</author><author>Geerts, Dirk</author><author>van Horssen, Jack</author><author>van der Valk, Paul</author><author>van der Kam, Elizabeth</author><author>Ronken, Eric</author><author>Reijerkerk, Arie</author><author>de Vries, Helga E</author></authors></contributors><titles><title>Sphingosine 1-phosphate receptor 5 mediates the immune quiescence of the human brain endothelial barrier.</title><secondary-title>Journal of neuroinflammation</secondary-title></titles><periodical><full-title>Journal of neuroinflammation</full-title></periodical><pages>133</pages><volume>9</volume><keywords><keyword>80 and over</keyword><keyword>Aged</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: cytology</keyword><keyword>Blood-Brain Barrier: immunology</keyword><keyword>Blood-Brain Barrier: metabolism</keyword><keyword>Cell Line</keyword><keyword>Cells</keyword><keyword>Cellular</keyword><keyword>Cellular: genetics</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Humans</keyword><keyword>Immunity</keyword><keyword>Lentivirus</keyword><keyword>Lentivirus: genetics</keyword><keyword>Lysosphingolipid</keyword><keyword>Lysosphingolipid: deficiency</keyword><keyword>Lysosphingolipid: genetics</keyword><keyword>Lysosphingolipid: physiology</keyword><keyword>Male</keyword><keyword>Receptors</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: immunology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>22715976</accession-num><electronic-resource-num>10.1186/1742-2094-9-133</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3425155&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier</label><abstract>BACKGROUND: The sphingosine 1-phosphate (S1P) receptor modulator FTY720P (Gilenya®) potently reduces relapse rate and lesion activity in the neuroinflammatory disorder multiple sclerosis. Although most of its efficacy has been shown to be related to immunosuppression through the induction of lymphopenia, it has been suggested that a number of its beneficial effects are related to altered endothelial and blood-brain barrier (BBB) functionality. However, to date it remains unknown whether brain endothelial S1P receptors are involved in the maintenance of the function of the BBB thereby mediating immune quiescence of the brain. Here we demonstrate that the brain endothelial receptor S1P5 largely contributes to the maintenance of brain endothelial barrier function. METHODS: We analyzed the expression of S1P5 in human post-mortem tissues using immunohistochemistry. The function of S1P5 at the BBB was assessed in cultured human brain endothelial cells (ECs) using agonists and lentivirus-mediated knockdown of S1P5. Subsequent analyses of different aspects of the brain EC barrier included the formation of a tight barrier, the expression of BBB proteins and markers of inflammation and monocyte transmigration. RESULTS: We show that activation of S1P5 on cultured human brain ECs by a selective agonist elicits enhanced barrier integrity and reduced transendothelial migration of monocytes in vitro. These results were corroborated by genetically silencing S1P5 in brain ECs. Interestingly, functional studies with these cells revealed that S1P5 strongly contributes to brain EC barrier function and underlies the expression of specific BBB endothelial characteristics such as tight junctions and permeability. In addition, S1P5 maintains the immunoquiescent state of brain ECs with low expression levels of leukocyte adhesion molecules and inflammatory chemokines and cytokines through lowering the activation of the transcription factor NFκB. CONCLUSION: Our findings demonstrate that S1P5 in brain ECs contributes to optimal barrier formation and maintenance of immune quiescence of the barrier endothelium.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sundivakkam, Premanand C</author><author>Freichel, Marc</author><author>Singh, Vandana</author><author>Yuan, Joseph P</author><author>Vogel, Stephen M</author><author>Flockerzi, Veit</author><author>Malik, Asrar B</author><author>Tiruppathi, Chinnaswamy</author></authors></contributors><titles><title>The Ca(2+) sensor stromal interaction molecule 1 (STIM1) is necessary and sufficient for the store-operated Ca(2+) entry function of transient receptor potential canonical (TRPC) 1 and 4 channels in endothelial cells.</title><secondary-title>Molecular pharmacology</secondary-title></titles><periodical><full-title>Molecular pharmacology</full-title></periodical><pages>510-526</pages><volume>81</volume><issue>4</issue><keywords><keyword>Animals</keyword><keyword>Blotting</keyword><keyword>Calcium</keyword><keyword>Calcium: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Knockout</keyword><keyword>Membrane Glycoproteins</keyword><keyword>Membrane Glycoproteins: physiology</keyword><keyword>Mice</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>TRPC Cation Channels</keyword><keyword>TRPC Cation Channels: physiology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>Western</keyword></keywords><dates><year>2012</year></dates><accession-num>22210847</accession-num><electronic-resource-num>10.1124/mol.111.074658</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3310414&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>We addressed the requirement for stromal interaction molecule 1 (STIM1), the endoplasmic reticulum (ER) Ca(2+)-sensor, and Orai1, a Ca(2+) selective channel, in regulating Ca(2+) entry through the store-operated channels mouse transient receptor potential canonical (TRPC) 4 or human TRPC1. Studies were made using murine and human lung endothelial cells (ECs) challenged with thrombin known to induce Ca(2+) entry via TRPC1/4. Deletion or knockdown of TRPC4 abolished Ca(2+) entry secondary to depletion of ER Ca(2+) stores, preventing the disruption of the endothelial barrier. Knockdown of STIM1 (but not of Orai1or Orai3) or expression of the dominant-negative STIM1(K684E-K685E) mutant in ECs also suppressed Ca(2+) entry secondary to store depletion. Ectopic expression of WT-STIM1 or WT-Orai1 in TRPC4(-/-)-ECs failed to rescue Ca(2+) entry; however, WT-TRPC4 expression in TRPC4(-/-)-ECs restored Ca(2+) entry indicating the requirement for TRPC4 in mediating store-operated Ca(2+) entry. Moreover, expression of the dominant-negative Orai1(R91W) mutant or Orai3(E81W) mutant in WT-ECs failed to prevent thrombin-induced Ca(2+) entry. In contrast, expression of the dominant-negative TRPC4(EE647-648KK) mutant in WT-ECs markedly reduced thrombin-induced Ca(2+) entry. In ECs expressing YFP-STIM1, ER-store Ca(2+) depletion induced formation of fluorescent membrane puncta in WT but not in TRPC4(-/-) cells, indicating that mobilization of STIM1 and engagement of its Ca(2+) sensing function required TRPC4 expression. Coimmunoprecipitation studies showed coupling of TRPC1 and TRPC4 with STIM1 on depletion of ER Ca(2+) stores. Thus, TRPC1 and TRPC4 can interact with STIM1 to form functional store-operated Ca(2+)-entry channels, which are essential for mediating Ca(2+) entry-dependent disruption of the endothelial barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Liu, Yinan</author><author>Sanders, Andrew J</author><author>Zhang, Lijian</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Expression Profile of Epithelial Protein Lost in Neoplasm-Alpha ( EPLIN-α ) in Human Pulmonary Cancer and Its Impact on SKMES-1 Cells in Vitro</title></titles><periodical/><volume>2012</volume><issue>September</issue><keywords><keyword>cell migration</keyword><keyword>ecis</keyword><keyword>eplin-α</keyword><keyword>pulmonary cancer</keyword></keywords><dates><year>2012</year></dates><urls/></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pietrosimone, Kathryn M</author><author>Yin, Xiuyin</author><author>Knecht, David A</author><author>Lynes, Michael a</author></authors></contributors><titles><title>Measurement of Cellular Chemotaxis with ECIS/Taxis.</title><secondary-title>Journal of visualized experiments : JoVE</secondary-title></titles><periodical><full-title>Journal of visualized experiments : JoVE</full-title></periodical><pages>2-7</pages><issue>62</issue><keywords><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Chemokine CXCL12</keyword><keyword>Chemokine CXCL12: chemistry</keyword><keyword>Chemotactic Factors</keyword><keyword>Chemotactic Factors: chemistry</keyword><keyword>Chemotaxis</keyword><keyword>Chemotaxis: physiology</keyword><keyword>Electric Impedance</keyword><keyword>Electrodes</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Leukocyte</keyword><keyword>Sepharose</keyword></keywords><dates><year>2012</year></dates><accession-num>22491349</accession-num><electronic-resource-num>10.3791/3840</electronic-resource-num><notes>From Duplicate 2 ( 

Measurement of Cellular Chemotaxis with ECIS/Taxis.

- Pietrosimone, Kathryn M; Yin, Xiuyin; Knecht, David A; Lynes, Michael A )</notes><research-notes>From Duplicate 2 ( 

Measurement of Cellular Chemotaxis with ECIS/Taxis.

- Pietrosimone, Kathryn M; Yin, Xiuyin; Knecht, David A; Lynes, Michael A )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22491349</url></web-urls></urls><label>ECIS Chemotaxis</label><abstract>Cellular movement in response to external stimuli is fundamental to many cellular processes including wound healing, inflammation and the response to infection. A common method to measure chemotaxis is the Boyden chamber assay, in which cells and chemoattractant are separated by a porous membrane. As cells migrate through the membrane toward the chemoattractant, they adhere to the underside of the membrane, or fall into the underlying media, and are subsequently stained and visually counted (1). In this method, cells are exposed to a steep and transient chemoattractant gradient, which is thought to be a poor representation of gradients found in tissues (2). Another assay system, the under-agarose chemotaxis assay, (3, 4) measures cell movement across a solid substrate in a thin aqueous film that forms under the agarose layer. The gradient that develops in the agarose is shallow and is thought to be an appropriate representation of naturally occurring gradients. Chemotaxis can be evaluated by microscopic imaging of the distance traveled. Both the Boyden chamber assay and the under-agarose assay are usually configured as endpoint assays. The automated ECIS/Taxis system combines the under-agarose approach with Electric Cell-substrate Impedance Sensing (ECIS) (5, 6). In this assay, target electrodes are located in each of 8 chambers. A large counter-electrode runs through each of the 8 chambers (Figure 2). Each chamber is filled with agarose and two small wells are the cut in the agarose on either side of the target electrode. One well is filled with the test cell population, while the other holds the sources of diffusing chemoattractant (Figure 3). Current passed through the system can be used to determine the change in resistance that occurs as cells pass over the target electrode. Cells on the target electrode increase the resistance of the system (6). In addition, rapid fluctuations in the resistance represent changes in the interactions of cells with the electrode surface and are indicative of ongoing cellular shape changes. The ECIS/Taxis system can measure movement of the cell population in real-time over extended periods of time, but is also sensitive enough to detect the arrival of a single cell at the target electrode. Dictyostelium discoidium is known to migrate in the presence of a folate gradient (7, 8) and its chemotactic response can be accurately measured by ECIS/Taxis (9). Leukocyte chemotaxis, in response to SDF1α and to chemotaxis antagonists has also been measured with ECIS/Taxis (10, 11). An example of the leukocyte response to SDF1α is shown in Figure 1.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Timmerman, Ilse</author><author>Hoogenboezem, Mark</author><author>Bennett, Anton M</author><author>Geerts, Dirk</author><author>Hordijk, Peter L</author><author>van Buul, Jaap D</author></authors></contributors><titles><title>The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.</title><secondary-title>Molecular biology of the cell</secondary-title></titles><periodical><full-title>Molecular biology of the cell</full-title></periodical><pages>4212-4225</pages><volume>23</volume><issue>21</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: drug effects</keyword><keyword>Adherens Junctions: enzymology</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>COS Cells</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Gene Silencing</keyword><keyword>Gene Silencing: drug effects</keyword><keyword>HEK293 Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Humans</keyword><keyword>Non-Receptor Type 11</keyword><keyword>Non-Receptor Type 11: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Phosphotyrosine</keyword><keyword>Phosphotyrosine: metabolism</keyword><keyword>Protein Tyrosine Phosphatase</keyword><keyword>Substrate Specificity</keyword><keyword>Substrate Specificity: drug effects</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>beta Catenin</keyword><keyword>beta Catenin: metabolism</keyword><keyword>cdc42 GTP-Binding Protein</keyword><keyword>cdc42 GTP-Binding Protein: metabolism</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>22956765</accession-num><electronic-resource-num>10.1091/mbc.E12-01-0038</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3484100&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Impaired endothelial barrier function results in a persistent increase in endothelial permeability and vascular leakage. Repair of a dysfunctional endothelial barrier requires controlled restoration of adherens junctions, comprising vascular endothelial (VE)-cadherin and associated β-, γ-, α-, and p120-catenins. Little is known about the mechanisms by which recovery of VE-cadherin-mediated cell-cell junctions is regulated. Using the inflammatory mediator thrombin, we demonstrate an important role for the Src homology 2-domain containing tyrosine phosphatase (SHP2) in mediating recovery of the VE-cadherin-controlled endothelial barrier. Using SHP2 substrate-trapping mutants and an in vitro phosphatase activity assay, we validate β-catenin as a bona fide SHP2 substrate. SHP2 silencing and SHP2 inhibition both result in delayed recovery of endothelial barrier function after thrombin stimulation. Moreover, on thrombin challenge, we find prolonged elevation in tyrosine phosphorylation levels of VE-cadherin-associated β-catenin in SHP2-depleted cells. No disassembly of the VE-cadherin complex is observed throughout the thrombin response. Using fluorescence recovery after photobleaching, we show that loss of SHP2 reduces the mobility of VE-cadherin at recovered cell-cell junctions. In conclusion, our data show that the SHP2 phosphatase plays an important role in the recovery of disrupted endothelial cell-cell junctions by dephosphorylating VE-cadherin-associated β-catenin and promoting the mobility of VE-cadherin at the plasma membrane.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bodor, Csaba</author><author>Nagy, János Péter</author><author>Végh, Borbála</author><author>Németh, Adrienn</author><author>Jenei, Attila</author><author>MirzaHosseini, Shahrokh</author><author>Sebe, Attila</author><author>Rosivall, László</author></authors></contributors><titles><title>Angiotensin II increases the permeability and PV-1 expression of endothelial cells.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C267-76</pages><volume>302</volume><issue>1</issue><keywords><keyword>Angiotensin</keyword><keyword>Angiotensin II</keyword><keyword>Angiotensin II: metabolism</keyword><keyword>Angiotensin II: physiology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: genetics</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Carrier Proteins</keyword><keyword>Carrier Proteins: biosynthesis</keyword><keyword>Caveolae</keyword><keyword>Caveolae: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Developmental</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Endothelium</keyword><keyword>Gene Expression Regulation</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Humans</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: biosynthesis</keyword><keyword>Protein Transport</keyword><keyword>Protein Transport: genetics</keyword><keyword>Receptor</keyword><keyword>Type 1</keyword><keyword>Type 1: biosynthesis</keyword><keyword>Type 1: physiology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2012</year></dates><accession-num>22012329</accession-num><electronic-resource-num>10.1152/ajpcell.00138.2011</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22012329</url></web-urls></urls><label>ECIS TEER</label><abstract>Angiotensin II (ANG II), the major effector molecule of the renin-angiotensin system (RAS), is a powerful vasoactive mediator associated with hypertension and renal failure. In this study the permeability changes and its morphological attributes in endothelial cells of human umbilical vein (HUVECs) were studied considering the potential regulatory role of ANG II. The effects of ANG II were compared with those of vascular endothelial growth factor (VEGF). Permeability was determined by 40 kDa FITC-Dextran and electrical impedance measurements. Plasmalemmal vesicle-1 (PV-1) mRNA levels were measured by PCR. Endothelial cell surface was studied by atomic force microscopy (AFM), and caveolae were visualized by transmission electron microscopy (TEM) in HUVEC monolayers. ANG II (10(-7) M), similarly to VEGF (100 ng/ml), increased the endothelial permeability parallel with an increase in the number of cell surface openings and caveolae. AT1 and VEGF-R2 receptor blockers (candesartan and ZM-323881, respectively) blunted these effects. ANG II and VEGF increased the expression of PV-1, which could be blocked by candesartan or ZM-323881 pretreatments and by the p38 mitogem-activated protein (MAP) kinase inhibitor SB-203580. Additionally, SB-203580 blocked the increase in endothelial permeability and the number of surface openings and caveolae. In conclusion, we have demonstrated that ANG II plays a role in regulation of permeability and formation of cell surface openings through AT1 receptor and PV-1 protein synthesis in a p38 MAP kinase-dependent manner in endothelial cells. The surface openings that increase in parallel with permeability may represent transcellular channels, caveolae, or both. These morphological and permeability changes may be involved in (patho-) physiological effects of ANG II.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xu, Mei</author><author>Chen, Gang</author><author>Fu, Wei</author><author>Liao, Mingjun</author><author>Frank, Jacqueline A</author><author>Bower, Kimberly A</author><author>Fang, Shengyun</author><author>Zhang, Zhuo</author><author>Shi, Xianglin</author><author>Luo, Jia</author></authors></contributors><titles><title>Ethanol disrupts vascular endothelial barrier: implication in cancer metastasis.</title><secondary-title>Toxicological sciences : an official journal of the Society of Toxicology</secondary-title></titles><periodical><full-title>Toxicological sciences : an official journal of the Society of Toxicology</full-title></periodical><pages>42-53</pages><volume>127</volume><issue>1</issue><keywords/><dates><year>2012</year></dates><accession-num>22331491</accession-num><electronic-resource-num>10.1093/toxsci/kfs087</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22331491</url></web-urls></urls><label>ECIS TEER</label><abstract>Both epidemiological and experimental studies indicate that ethanol exposure enhances tumor progression. Ethanol exposure promotes cancer cell invasion and is implicated in tumor metastasis. Metastasis consists of multiple processes involving intravasation and extravasation of cancer cells across the blood vessel walls. The integrity of the vascular endothelial barrier that lines the inner surface of blood vessels plays a critical role in cancer cell intravasation/extravasation. We examined the effects of ethanol on the endothelial integrity in vitro. Ethanol at physiologically relevant concentrations did not alter cell viability but disrupted the endothelial monolayer integrity, which was evident by a decrease in the electric resistance and the appearance of intercellular gaps in the endothelial monolayer. The effect of ethanol was reversible once ethanol was removed. The disruption of the endothelial monolayer integrity was associated with an increased invasion of cancer cells through the endothelial monolayer. Ethanol induced the formation of stress fibers; stabilization of actin filaments by jasplakinolide prevented ethanol-induced disruption of endothelial integrity and cancer cell invasion. VE-cadherin is a critical component of the adherens junctions, which regulates vascular endothelial integrity. Ethanol induced the endocytosis of VE-cadherin and the effect was blocked by jasplakinolide. Our results indicate that ethanol may facilitate cancer metastasis by disrupting the vascular endothelial barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Grinnell, Katie L</author><author>Chichger, Havovi</author><author>Braza, Julie</author><author>Duong, Huetran</author><author>Harrington, Elizabeth O</author></authors></contributors><titles><title>Protection against LPS-induced pulmonary edema through the attenuation of protein tyrosine phosphatase-1B oxidation.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>623-632</pages><volume>46</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Enzyme Activation</keyword><keyword>Immunohistochemistry</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: toxicity</keyword><keyword>Mice</keyword><keyword>Non-Receptor Type 1</keyword><keyword>Non-Receptor Type 1: metabolism</keyword><keyword>Oxidation-Reduction</keyword><keyword>Protein Tyrosine Phosphatase</keyword><keyword>Pulmonary Edema</keyword><keyword>Pulmonary Edema: chemically induced</keyword><keyword>Pulmonary Edema: enzymology</keyword><keyword>Pulmonary Edema: prevention &amp; control</keyword><keyword>Rats</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reactive Oxygen Species: metabolism</keyword><keyword>beta Catenin</keyword><keyword>beta Catenin: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>22180868</accession-num><electronic-resource-num>10.1165/rcmb.2011-0271OC</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22180868</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>One hallmark of acute lung injury is the disruption of the pulmonary endothelial barrier. Such disruption correlates with increased endothelial permeability, partly through the disruption of cell-cell contacts. Protein tyrosine phosphatases (PTPs) are known to affect the stability of both cell-extracellular matrix adhesions and intercellular adherens junctions (AJs). However, evidence for the role of select PTPs in regulating endothelial permeability is limited. Our investigations noted that the inhibition of PTP1B in cultured pulmonary endothelial cells (ECs), as well as in the vasculature of intact murine lungs via the transient overexpression of a catalytically inactive PTP1B, decreased the baseline resistance of cultured EC monolayers and increased the formation of edema in murine lungs, respectively. In addition, we observed that the overexpression of wild-type PTP1B enhanced basal barrier function in vitro. Immunohistochemical analyses of pulmonary ECs and the coimmunoprecipitation of murine lung homogenates demonstrated the association of PTP1B with the AJ proteins β-catenin, p120-catenin, and VE-cadherin both in vitro and ex vivo. Using LPS in a model of sepsis-induced acute lung injury, we showed that reactive oxygen species were generated in response to LPS, which correlated with enhanced PTP1B oxidation, inhibited phosphatase activity, and attenuation of the interactions between PTP1B and β-catenin, as well as enhanced β-catenin tyrosine phosphorylation. Finally, the overexpression of a cytosolic PTP1B fragment, shown to be resistant to nicotinamide adenine dinucleotide phosphate-reduced oxidase-4 (Nox4)-mediated oxidation, significantly attenuated LPS-induced endothelial barrier dysfunction and the formation of lung edema, and preserved the associations of PTP1B with AJ protein components, independent of PTP1B phosphatase activity. We conclude that PTP1B plays an important role in maintaining the pulmonary endothelial barrier, and PTP1B oxidation appears to contribute to sepsis-induced pulmonary vascular dysfunction, possibly through the disruption of AJs.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jiang, Wen G</author><author>Ye, Lin</author><author>Ji, Ke</author><author>Frewer, Natasha</author><author>Ji, Jiafu</author><author>Mason, Malcolm D</author></authors></contributors><titles><title>Inhibitory effects of Yangzheng Xiaoji on angiogenesis and the role of the focal adhesion kinase pathway.</title><secondary-title>International journal of oncology</secondary-title></titles><periodical><full-title>International journal of oncology</full-title></periodical><pages>1635-1642</pages><volume>41</volume><issue>5</issue><keywords><keyword>Angiogenesis Inhibitors</keyword><keyword>Angiogenesis Inhibitors: pharmacology</keyword><keyword>Angiogenesis Inhibitors: therapeutic use</keyword><keyword>Antineoplastic Agents</keyword><keyword>Antineoplastic Agents: pharmacology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Cells</keyword><keyword>Chinese Herbal</keyword><keyword>Chinese Herbal: pharmacology</keyword><keyword>Cultured</keyword><keyword>Drug Synergism</keyword><keyword>Drugs</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases: antagonis</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases: metabolis</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: drug effec</keyword><keyword>Human Umbilical Vein Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Neovascularization</keyword><keyword>Pathologic</keyword><keyword>Pathologic: drug therapy</keyword><keyword>Pathologic: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Physiologic</keyword><keyword>Physiologic: drug effects</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword></keywords><dates><year>2012</year></dates><accession-num>22971748</accession-num><electronic-resource-num>10.3892/ijo.2012.1627</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22971748</url></web-urls></urls><label>Signal Transduction</label><abstract>Angiogenesis is an essential event during the excessive growth and metastatic spread of solid tumours. Anti-angiogenic agents have become a new choice of therapy for patients with cancer. In the present study, we investigated the potential effect of Yangzheng Xiaoji, a traditional Chinese medicinal formula presently used in the treatment of several solid tumours including liver cancer and gastric cancer, on angiogenesis, in vitro. The human vascular endothelial cell line HECV was used. A Matrigel-based sandwich tubule formation assay was employed to assess in vitro angiogenesis, a colorimetric method for assessing in vitro cell growth. Electric cell-substrate impedance sensing (ECIS) was used to evaluate the adhesion and migration of endothelial cells. The effects on activation of focal adhesion kinase (FAK) were evaluated using western blotting and immunofluorescence methods. Yangzhen Xiaoji extract DME25 significantly inhibited tube formation (p=0.046 vs control). This was seen together with a concentration-dependent inhibition on cell-matrix adhesion and cellular migration. It was demonstrated that the focal adhesion kinase (FAK) inhibitor PF557328 had a significant synergistic effect on DME25-induced inhibition of cell adhesion, migration and tube formation. The study showed that DME25 inhibited the phosphorylation of FAK in endothelial cells. In conclusion, Yangzhen Xiaoji has a marked effect on angiogenesis, in vitro and that this effect is at least partly mediated by the focal adhesion kinase (FAK) pathway.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Nagalingam, Arumugam</author><author>Arbiser, Jack L</author><author>Bonner, Michael Y</author><author>Saxena, Neeraj K</author><author>Sharma, Dipali</author></authors></contributors><titles><title>Honokiol activates AMP-activated protein kinase in breast cancer cells via LKB1-dependent pathway and inhibits breast carcinogenesis.</title><secondary-title>Breast cancer research : BCR</secondary-title></titles><periodical><full-title>Breast cancer research : BCR</full-title></periodical><pages>R35</pages><volume>14</volume><issue>1</issue><keywords/><dates><year>2012</year></dates><publisher>BioMed Central Ltd</publisher><accession-num>22353783</accession-num><electronic-resource-num>10.1186/bcr3128</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22353783</url></web-urls></urls><label>ECIS Migration</label><abstract>ABSTRACT: INTRODUCTION: Honokiol, a small-molecule polyphenol isolated from magnolia species, is widely known for its therapeutic potential as an anti-inflammatory, anti-thrombosis, anti-oxidant agent and more recently for its protective function in the pathogenesis of carcinogenesis. In the present study, we sought to examine the effectiveness of honokiol in inhibiting migration and invasion of breast cancer cells and elucidate the underlying molecular mechanisms. METHODS: Clonogenicity and 3D-colony formation assays were used to examine breast cancer cell growth upon honokiol treatment. The effect of honokiol on invasion and migration of breast cancer cells was evaluated by utilizing matrigel invasion, scratch-migration, spheroid-migration and electric cell-substrate impedance sensing (ECIS)-based migration assays. Western blot and immunofluorescence analysis were used to examine activation of Liver kinase B1 (LKB1) - AMP-activated protein kinase (AMPK) axis. Isogenic LKB1-knockdown breast cancer cell line pairs were developed. Functional importance of AMPK activation and LKB1 overexpression in biological effects of honokiol was examined by using AMPK-null and AMPK-wild type (WT) immortalized mouse embryonic fibroblasts (MEFs) and isogenic LKB1-knockdown cell line pairs. Finally, mouse xenografts, immunohistochemical and western blot analysis of tumors were used. RESULTS: Analysis of the underlying molecular mechanisms revealed that honokiol treatment increases AMP-activated protein kinase (AMPK) phosphorylation and activity as evident by increased phosphorylation of downstream target of AMPK, acetyl-coenzyme A carboxylase (ACC) and inhibition of phosphorylation of p70S6kinase (pS6K) and eukaryotic translation initiation factor 4E binding protein 1 (4EBP1). Using AMPK-null and AMPK-WT (MEFs); we found that AMPK is required for honokiol-mediated modulation of pACC-pS6K. Intriguingly, we discovered that honokiol treatment increased the expression and cytoplasmic translocation of tumor suppressor gene LKB1 in breast cancer cells. LKB1 knockdown inhibited honokiol-mediated activation of AMPK and more importantly, inhibition of migration and invasion of breast cancer cells. Furthermore, honokiol treatment resulted in inhibition of breast tumorigenesis in vivo. Analysis of tumors showed significant increase in the levels of cytoplasmic LKB1 and phospho-AMPK in honokiol-treated tumors. CONCLUSIONS: Taken together, these data provide first in vitro and in vivo evidence of the integral role of LKB1-AMPK axis in honokiol mediated inhibition of invasion and migration of breast cancer cells. In conclusion, honokiol treatment could potentially be a rational therapeutic strategy for breast carcinoma.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Male, Keith B</author><author>Lam, Edmond</author><author>Montes, Johnny</author><author>Luong, John H T</author></authors></contributors><titles><title>Noninvasive cell-based impedance spectroscopy for real-time probing inhibitory effects of graphene derivatives.</title><secondary-title>ACS applied materials &amp; interfaces</secondary-title></titles><periodical><full-title>ACS applied materials &amp; interfaces</full-title></periodical><pages>3643-3649</pages><volume>4</volume><issue>7</issue><keywords><keyword>Animals</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Cell Tracking</keyword><keyword>Cell Tracking: methods</keyword><keyword>Computer Systems</keyword><keyword>Dielectric Spectroscopy</keyword><keyword>Dielectric Spectroscopy: methods</keyword><keyword>Graphite</keyword><keyword>Graphite: chemistry</keyword><keyword>Graphite: pharmacology</keyword><keyword>Materials Testing</keyword><keyword>Materials Testing: methods</keyword><keyword>Oxides</keyword><keyword>Oxides: chemistry</keyword><keyword>Oxides: pharmacology</keyword><keyword>Sf9 Cells</keyword><keyword>Spodoptera</keyword><keyword>Tissue Scaffolds</keyword><keyword>Tissue Scaffolds: chemistry</keyword></keywords><dates><year>2012</year></dates><accession-num>22746697</accession-num><electronic-resource-num>10.1021/am301060z</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22746697</url></web-urls></urls><abstract>Three water-dispersible graphene derivatives, graphene oxide (GO), sulfonated graphene oxide (SGO), and sulfonated graphene (SG), were prepared and probed for their plausible cytotoxicity by non-invasive electric cell-substrate impedance sensing (ECIS). With Spodoptera frugiperda Sf9 insect cells adhered on gold microelectrodes as an active interface, it is feasible to monitor changes in impedance upon exposure to different graphene derivatives. Sf9 insect cells were then exposed to different concentrations of graphene derivatives and their spreading and viability were monitored and quantified by ECIS in real-time. On the basis of the 50% inhibition concentration (ECIS50), none of the graphene derivatives were judged to have any significant cytotoxicity with respect to the chosen cell line as the ECIS50 values were all above 100 μg/mL. However, all graphene derivatives exhibited inhibitory effects on the Sf9 response at the cell spreading level with the following order: SG (ECIS50 = 121 ± 8 μg/mL), SGO (ECIS50 = 151 ± 9 μg/mL), and GO (ECIS50 = 232 ± 27 μg/mL), reflecting differences observed in their ζ-potential and surface area. The presence of phenyl sulfonyl groups in SGO and SG improves their aqueous dispersity which enables these materials to have a greater inhibitory effect on Sf9 insect cells in comparison to GO. Such results were corroborated well with the cell count and viability by the Trypan Blue exclusion assay.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Nethe, Micha</author><author>de Kreuk, Bart-Jan</author><author>Tauriello, Daniele V F</author><author>Anthony, Eloise C</author><author>Snoek, Barbara</author><author>Stumpel, Thomas</author><author>Salinas, Patricia C</author><author>Maurice, Madelon M</author><author>Geerts, Dirk</author><author>Deelder, André M</author><author>Hensbergen, Paul J</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>Rac1 acts in conjunction with Nedd4 and dishevelled-1 to promote maturation of cell-cell contacts.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>3430-3442</pages><volume>125</volume><issue>Pt 14</issue><keywords><keyword>Adaptor Proteins</keyword><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Amino Acid Sequence</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Communication</keyword><keyword>Cell Communication: physiology</keyword><keyword>Cell Line</keyword><keyword>Endosomal Sorting Complexes Required for Transport</keyword><keyword>HeLa Cells</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Structure</keyword><keyword>Signal Transducing</keyword><keyword>Signal Transducing: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Tertiary</keyword><keyword>Ubiquitin-Protein Ligases</keyword><keyword>Ubiquitin-Protein Ligases: metabolism</keyword><keyword>Ubiquitination</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>22467858</accession-num><electronic-resource-num>10.1242/jcs.100925</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3516380&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>The Rho-GTPase Rac1 promotes actin polymerization and membrane protrusion that mediate initial contact and subsequent maturation of cell-cell junctions. Here we report that Rac1 associates with the ubiquitin-protein ligase neural precursor cell expressed developmentally down-regulated 4 (Nedd4). This interaction requires the hypervariable C-terminal domain of Rac1 and the WW domains of Nedd4. Activated Rac1 colocalises with endogenous Nedd4 at epithelial cell-cell contacts. Reduction of Nedd4 expression by shRNA results in reduced transepithelial electrical resistance (TER) and concomitant changes in the distribution of adherens and tight junction markers. Conversely, expression of Nedd4 promotes TER, suggesting that Nedd4 cooperates with Rac1 in the induction of junctional maturation. We found that Nedd4, but not Nedd4-2, mediates the ubiquitylation and degradation of the adapter protein dishevelled-1 (Dvl1), the expression of which negatively regulates cell-cell contact. Nedd4-mediated ubiquitylation requires its binding to the C-terminal domain of Dvl1, comprising the DEP domain, and targets an N-terminal lysine-rich region upstream of the Dvl1 DIX domain. We found that endogenous Rac1 colocalises with endogenous Dvl1 in intracellular puncta as well as on cell-cell junctions. Finally, activated Rac1 was found to stimulate Nedd4 activity, resulting in increased ubiquitylation of Dvl1. Together, these data reveal a novel Rac1-dependent signalling pathway that, through Nedd4-mediated ubiquitylation of Dvl1, stimulates the maturation of epithelial cell-cell contacts.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tai, Yun-Yuan</author><author>Chen, Rung-Shu</author><author>Lin, Yi</author><author>Ling, Thai-Yen</author><author>Chen, Min-Huey</author></authors></contributors><titles><title>FGF-9 accelerates epithelial invagination for ectodermal organogenesis in real time bioengineered organ manipulation.</title><secondary-title>Cell communication and signaling : CCS</secondary-title></titles><periodical><full-title>Cell communication and signaling : CCS</full-title></periodical><pages>34</pages><volume>10</volume><issue>1</issue><keywords><keyword>combined bioengineered organ-ecis model</keyword><keyword>ectodermal organogenesis</keyword><keyword>epithelial invagination</keyword><keyword>fgf-9</keyword><keyword>fgf-bmp balancing system</keyword></keywords><dates><year>2012</year></dates><accession-num>23176204</accession-num><electronic-resource-num>10.1186/1478-811X-10-34</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3515343&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Growth</label><abstract>ABSTRACT:</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jiang, Wen G</author><author>Sanders, Andrew J</author><author>Ruge, Fiona</author><author>Harding, Keith G</author></authors></contributors><titles><title>Influence of interleukin-8 (IL-8) and IL-8 receptors on the migration of human keratinocytes, the role of PLC-γ and potential clinical implications.</title><secondary-title>Experimental and therapeutic medicine</secondary-title></titles><periodical><full-title>Experimental and therapeutic medicine</full-title></periodical><pages>231-236</pages><volume>3</volume><issue>2</issue><keywords><keyword>1</keyword><keyword>2</keyword><keyword>3</keyword><keyword>belongs to the cxc</keyword><keyword>by the il-8 gene</keyword><keyword>chemokine family</keyword><keyword>chromosome 4q12-q21</keyword><keyword>il-8 has been shown</keyword><keyword>il-8 is a small</keyword><keyword>interleukin-8</keyword><keyword>interleukin-8 receptor</keyword><keyword>protein that is encoded</keyword><keyword>to be linked to</keyword><keyword>which is located on</keyword><keyword>wound healing</keyword></keywords><dates><year>2012</year></dates><accession-num>22969874</accession-num><electronic-resource-num>10.3892/etm.2011.402</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/etm/3/2/231</url><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3438606&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Wound Healing</label><abstract>Interleukin (IL)-8 is a pro-inflammatory cytokine that has a direct effect on immune cells, including polymorphonuclear cells. Keratinocytes are a rich source of IL-8. However, there is little knowledge on the role of IL-8 in clinical wound healing and the direct biological effect of IL-8 on keratinocytes. In this study, the effect of recombinant human IL-8 (rhIL-8) on migration and adhesion was tested using HaCaT keratinocytes as a cell model. The cell functions were evaluated using impedance cell sensing. The expression of IL-8 receptor (IL-8R) transcripts in human skin and wounds (acute and chronic) was assessed using real-time transcript analysis. rhIL-8 significantly increased the migration of keratinocytes (3.5±0.3 for cells treated with IL-8 vs. 2.7±0.6 for controls; p=0.029). It is interesting to note that treatment of keratinocytes with IL-8 resulted in a marked shift in the responsive frequencies. IL-8 only resulted in a marginal increase in cell adhesion, which was particularly noticeable at high frequencies. The PLC-γ inhibitor completely eradicated the action of IL-8 on the migration of HaCaT cells. Using real time PCR, it was found that chronic wounds had significantly lower levels of the B form of the IL-8R (IL-8RB) (p=0.045) and marginally lower levels of the A form, IL-8RA, in comparison with acute wounds. Therefore, IL-8 has a direct and profound stimulatory effect on the migration of human keratinocytes, which is likely to occur via the PLC-γ pathway. Together with a reduced level of IL-8Rs in difficult-healing wounds, IL-8 has a clear prognostic and therapeutic value in wound healing.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Starosta, Vitaliy</author><author>Wu, Tinghuai</author><author>Zimman, Alejandro</author><author>Pham, Donald</author><author>Tian, Xinyong</author><author>Oskolkova, Olga</author><author>Bochkov, Valery</author><author>Berliner, Judith a</author><author>Birukova, Anna a</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Differential Regulation of Endothelial Cell Permeability by High and Low Doses of Oxidized 1-Palmitoyl-2-Arachidonyl-sn-Glycero-3-Phosphocholine.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>331-341</pages><volume>46</volume><issue>3</issue><keywords><keyword>endothelium</keyword><keyword>oxidized phospholipids</keyword><keyword>permeability</keyword><keyword>phosphorylation</keyword><keyword>protein tyrosine</keyword><keyword>ve-cadherin</keyword></keywords><dates><year>2012</year></dates><accession-num>21997484</accession-num><electronic-resource-num>10.1165/rcmb.2011-0153OC</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21997484</url></web-urls></urls><label>ECIS TEER</label><abstract>The generation of phospholipid oxidation products in atherosclerosis, sepsis, and lung pathologies affects endothelial barrier function, which exerts significant consequences on disease outcomes in general. Our group previously showed that oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphocholine (OxPAPC) at low concentrations increases endothelial cell (EC) barrier function, but decreases it at higher concentrations. In this study, we determined the mechanisms responsible for the pulmonary endothelial cell barrier dysfunction induced by high OxPAPC concentrations. OxPAPC at a range of 5-20 μg/ml enhanced EC barriers, as indicated by increased transendothelial electrical resistance. In contrast, higher OxPAPC concentrations (50-100 μg/ml) rapidly increased EC permeability, which was accompanied by increased total cell protein tyrosine (Tyr) phosphorylation, phosphorylation at Tyr-418, the activation of Src kinase, and the phosphorylation of adherens junction (AJ) protein vascular endothelial cadherin (VE-cadherin) at Tyr-731 and Tyr-658, which was not observed in ECs stimulated with low OxPAPC doses. The early tyrosine phosphorylation of VE-cadherin was linked to the dissociation of VE-cadherin-p120-catenin/β-catenin complexes and VE-cadherin internalization, whereas low OxPAPC doses promoted the formation of VE-cadherin-p120-catenin/β-catenin complexes. High but not low doses of OxPAPC increased the production of reactive oxygen species (ROS) and protein oxidation. The inhibition of Src by PP2 and ROS production by N-acetyl cysteine inhibited the disassembly of VE-cadherin-p120-catenin complexes, and attenuated high OxPAPC-induced EC barrier disruption. These results show the differential effects of OxPAPC doses on VE-cadherin-p120-catenin complex assembly and EC barrier function. These data suggest that the rapid tyrosine phosphorylation of VE-cadherin and other potential targets mediated by Src and ROS-dependent mechanisms plays a key role in the dissociation of AJ complexes and EC barrier dysfunction induced by high OxPAPC doses.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chen, Szi-Wen</author><author>Yang, Jen Ming Jhe-Hao</author><author>Yang, Jen Ming Jhe-Hao</author><author>Yang, Shu Jyuan</author><author>Wang, Jong-Shyan</author></authors></contributors><titles><title>A computational modeling and analysis in cell biological dynamics using electric cell-substrate impedance sensing (ECIS).</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>196-203</pages><volume>33</volume><issue>1</issue><keywords><keyword>3T3 Cells</keyword><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Cell Movement</keyword><keyword>Cell Proliferation</keyword><keyword>Computer Simulation</keyword><keyword>Electric Impedance</keyword><keyword>Mice</keyword></keywords><dates><year>2012</year></dates><accession-num>22261483</accession-num><electronic-resource-num>10.1016/j.bios.2011.12.052</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22261483</url></web-urls></urls><abstract>In this paper, a study of computational modeling and multi-scale analysis in cell dynamics is presented. Our study aims at: (1) deriving and validating a mathematical model for cell growth, and (2) quantitatively detecting and analyzing the biological interdependencies across multiple observational scales with a variety of time and frequency resolutions. This research was conducted using the time series data practically measured from a novel on-line cell monitoring technique, referred to as electric cell-substrate impedance sensing (ECIS), which allows continuously tracking the cellular behavior such as adhesion, proliferation, spreading and micromotion. First, comparing our ECIS-based cellular growth modeling analysis results with those determined by hematocytometer measurement using different time intervals, we found that the results obtained from both experimental methods consistently agreed. However, our study demonstrated that it is much easier and more convenient to operate with the ECIS system for on-line cellular growth monitoring. Secondly, for multi-scale analysis our results showed that the proposed wavelet-based methodology can effectively quantify the fluctuations associated with cell micromotions and quantitatively capture the biological interdependencies across multiple observational scales. Note that although the wavelet method is well known, its application into the ECIS time series analysis is novel and unprecedented in computational cell biology. Our analyses indicated that the proposed study on ECIS time series could provide a hopeful start and great potentials in both modeling and elucidating the complex mechanisms of cell biological systems.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Fernández-Martín, Laura</author><author>Marcos-Ramiro, Beatriz</author><author>Bigarella, Carolina L</author><author>Graupera, Mariona</author><author>Cain, Robert J</author><author>Reglero-Real, Natalia</author><author>Jiménez, Anaïs</author><author>Cernuda-Morollón, Eva</author><author>Correas, Isabel</author><author>Cox, Susan</author><author>Ridley, Anne J</author><author>Millán, Jaime</author></authors></contributors><titles><title>Crosstalk between reticular adherens junctions and platelet endothelial cell adhesion molecule-1 regulates endothelial barrier function.</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arteriosclerosis, thrombosis, and vascular biology</full-title></periodical><pages>e90-e102</pages><volume>32</volume><issue>8</issue><keywords/><dates><year>2012</year></dates><accession-num>22723439</accession-num><electronic-resource-num>10.1161/ATVBAHA.112.252080</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22723439</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Endothelial cells provide a barrier between the blood and tissues, which is reduced during inflammation to allow selective passage of molecules and cells. Adherens junctions (AJ) play a central role in regulating this barrier. We aim to investigate the role of a distinctive 3-dimensional reticular network of AJ found in the endothelium.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wilkerson, Brent A</author><author>Grass, G Daniel</author><author>Wing, Shane B</author><author>Argraves, W Scott</author><author>Argraves, Kelley M</author></authors></contributors><titles><title>Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>44645-44653</pages><volume>287</volume><issue>53</issue><keywords><keyword>Endothelium</keyword><keyword>HDL</keyword><keyword>HDL: metabolism</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Lipoproteins</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: metabolism</keyword><keyword>Lysosphingolipid</keyword><keyword>Lysosphingolipid: genetics</keyword><keyword>Lysosphingolipid: metabolism</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: genetics</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Protein Transport</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>Proto-Oncogene Proteins c-akt: genetics</keyword><keyword>Proto-Oncogene Proteins c-akt: metabolism</keyword><keyword>Receptors</keyword><keyword>Serum Albumin</keyword><keyword>Serum Albumin: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>23135269</accession-num><electronic-resource-num>10.1074/jbc.M112.423426</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3531779&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Sphingosine 1-phosphate (S1P) is a blood-borne lysosphingolipid that acts to promote endothelial cell (EC) barrier function. In plasma, S1P is associated with both high density lipoproteins (HDL) and albumin, but it is not known whether the carriers impart different effects on S1P signaling. Here we establish that HDL-S1P sustains EC barrier longer than albumin-S1P. We showed that the sustained barrier effects of HDL-S1P are dependent on signaling by the S1P receptor, S1P1, and involve persistent activation of Akt and endothelial NOS (eNOS), as well as activity of the downstream NO target, soluble guanylate cyclase (sGC). Total S1P1 protein levels were found to be higher in response to HDL-S1P treatment as compared with albumin-S1P, and this effect was not associated with increased S1P1 mRNA or dependent on de novo protein synthesis. Several pieces of evidence indicate that long term EC barrier enhancement activity of HDL-S1P is due to specific effects on S1P1 trafficking. First, the rate of S1P1 degradation, which is proteasome-mediated, was slower in HDL-S1P-treated cells as compared with cells treated with albumin-S1P. Second, the long term barrier-promoting effects of HDL-S1P were abrogated by treatment with the recycling blocker, monensin. Finally, cell surface levels of S1P1 and levels of S1P1 in caveolin-enriched microdomains were higher after treatment with HDL-S1P as compared with albumin-S1P. Together, the findings reveal S1P carrier-specific effects on S1P1 and point to HDL as the physiological mediator of sustained S1P1-PI3K-Akt-eNOS-sGC-dependent EC barrier function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Li, Jin</author><author>Ye, Lin</author><author>Kynaston, Howard G</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Repulsive guidance molecules, novel bone morphogenetic protein co-receptors, are key regulators of the growth and aggressiveness of prostate cancer cells.</title><secondary-title>International journal of oncology</secondary-title></titles><periodical><full-title>International journal of oncology</full-title></periodical><pages>544-550</pages><volume>40</volume><issue>2</issue><keywords><keyword>Bone Morphogenetic Protein Receptors</keyword><keyword>Bone Morphogenetic Protein Receptors: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion Molecules</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Proliferation</keyword><keyword>GPI-Linked Proteins</keyword><keyword>GPI-Linked Proteins: genetics</keyword><keyword>GPI-Linked Proteins: metabolism</keyword><keyword>Gene Expression</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Histocompatibility Antigens Class I</keyword><keyword>Histocompatibility Antigens Class I: genetics</keyword><keyword>Histocompatibility Antigens Class I: metabolism</keyword><keyword>Humans</keyword><keyword>Inhibitor of Differentiation Protein 1</keyword><keyword>Inhibitor of Differentiation Protein 1: genetics</keyword><keyword>Inhibitor of Differentiation Protein 1: metabolism</keyword><keyword>Male</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Nerve Tissue Proteins</keyword><keyword>Nerve Tissue Proteins: genetics</keyword><keyword>Nerve Tissue Proteins: metabolism</keyword><keyword>Neuronal</keyword><keyword>Neuronal: genetics</keyword><keyword>Neuronal: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Prostatic Neoplasms</keyword><keyword>Prostatic Neoplasms: metabolism</keyword><keyword>Prostatic Neoplasms: pathology</keyword><keyword>Signal Transduction</keyword><keyword>Smad1 Protein</keyword><keyword>Smad1 Protein: metabolism</keyword><keyword>Smad3 Protein</keyword><keyword>Smad3 Protein: metabolism</keyword><keyword>Tumor</keyword></keywords><dates><year>2012</year></dates><accession-num>22076499</accession-num><electronic-resource-num>10.3892/ijo.2011.1251</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22076499</url><url>http://www.ingentaconnect.com/content/sp/ijo/2012/00000040/00000002/art00025</url></web-urls></urls><label>Signal Transduction</label><abstract>Repulsive guidance molecule (RGM) family members RGMA, RGMB and RGMC are GPI-linked membrane proteins recently identified as co-receptor of bone morphogenetic proteins (BMPs). BMPs are a group of proteins enriched in bone and play important roles in prostate cancer. The current study aimed to investigate roles played by RGMs in prostate cancer. Expression of RGMs was examined in prostate cancer cell lines and prostate cancer tissues using RT-PCR and immunohistochemical staining. Knockdown of each RGM in prostate cancer cells was performed using the respective anti-RGMA, RGMB and RGMC transgenes. A variety of in vitro function tests were employed to analyze the influence on cancer cell functions by RGM knockdown. The implications of RGM knockdown in BMP signalling were also examined using both Western blot and real-time quantitative PCR. Knockdown of RGMA had no effect on cell growth, migration and invasion, but promoted cell-matrix adhesion. Knockdown of RGMB and RGMC increased growth and adhesion, but only RGMB knockdown increased capacities of migration and invasion in PC-3 cells. Further investigations showed an increase in Smad-3 activation and reduced levels of Smad-1 in PC-3 cells by RGMB and RGMC knockdown, and also an up-regulation of ID1, a BMP target gene particularly in exposure to BMP7. RGMs play inhibitory roles in prostate cancer by suppressing cell growth, adhesion, migration and invasion. RGMs can coordinate Smad-dependent signalling of BMPs in prostate cancer cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Escudero-Esparza, Astrid</author><author>Jiang, Wen G</author><author>Martin, Tracey a</author></authors></contributors><titles><title>Claudin-5 is involved in breast cancer cell motility through the N-WASP and ROCK signalling pathways.</title><secondary-title>Journal of experimental &amp; clinical cancer research : CR</secondary-title></titles><periodical><full-title>Journal of experimental &amp; clinical cancer research : CR</full-title></periodical><pages>43</pages><volume>31</volume><keywords><keyword>Animal</keyword><keyword>Animals</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: genetics</keyword><keyword>Breast Neoplasms: metabolism</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Claudin-5</keyword><keyword>Claudin-5: genetics</keyword><keyword>Claudin-5: metabolism</keyword><keyword>Disease Models</keyword><keyword>Female</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Mice</keyword><keyword>Neoplastic</keyword><keyword>Neuronal</keyword><keyword>Neuronal: metabo</keyword><keyword>Nude</keyword><keyword>Real-Time Polymerase Chain Reaction</keyword><keyword>Signal Transduction</keyword><keyword>Transfection</keyword><keyword>Tumor</keyword><keyword>Wiskott-Aldrich Syndrome Protein</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>22559840</accession-num><electronic-resource-num>10.1186/1756-9966-31-43</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3432004&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Recent studies have shown dysregulation in TJ structure of several cancers including breast. Claudin-5 is a protein member of the TJ structure expressed in both endothelial and epithelial cells. This study examined the level of expression and distribution of Claudin-5 in human breast cancer tissues and the effect of knockdown and forced expression of Claudin-5 in the MDA-MB-231 breast cancer cell line.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Brennan, Linda M</author><author>Widder, Mark W</author><author>Lee, Lucy E J</author><author>van der Schalie, William H</author></authors></contributors><titles><title>Long-term storage and impedance-based water toxicity testing capabilities of fluidic biochips seeded with RTgill-W1 cells.</title><secondary-title>Toxicology in vitro : an international journal published in association with BIBRA</secondary-title></titles><periodical><full-title>Toxicology in vitro : an international journal published in association with BIBRA</full-title></periodical><pages>736-745</pages><volume>26</volume><issue>5</issue><keywords/><dates><year>2012</year></dates><publisher>Elsevier Ltd</publisher><accession-num>22469871</accession-num><electronic-resource-num>10.1016/j.tiv.2012.03.010</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22469871</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>Rainbow trout gill epithelial cells (RTgill-W1) are used in a cell-based biosensor that can respond within one hour to toxic chemicals that have the potential to contaminate drinking water supplies. RTgill-W1 cells seeded on enclosed fluidic biochips and monitored using electric cell-substrate impedance sensing (ECIS) technology responded to 18 out of the 18 toxic chemicals tested within one hour of exposure. Nine of these chemical responses were within established concentration ranges specified by the U.S. Army for comparison of toxicity sensors for field application. The RTgill-W1 cells remain viable on the biochips at ambient carbon dioxide levels at 6°C for 78weeks without media changes. RTgill-W1 biochips stored in this manner were challenged with 9.4μM sodium pentachlorophenate (PCP), a benchmark toxicant, and impedance responses were significant (p&lt;0.001) for all storage times tested. This poikilothermic cell line has toxicant sensitivity comparable to a mammalian cell line (bovine lung microvessel endothelial cells (BLMVECs)) that was tested on fluidic biochips with the same chemicals. In order to remain viable, the BLMVEC biochips required media replenishments 3 times per week while being maintained at 37°C. The ability of RTgill-W1 biochips to maintain monolayer integrity without media replenishments for 78weeks, combined with their chemical sensitivity and rapid response time, make them excellent candidates for use in low cost, maintenance-free field-portable biosensors.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van Rijssel, Jos</author><author>Hoogenboezem, Mark</author><author>Wester, Lynn</author><author>Hordijk, Peter L</author><author>Van Buul, Jaap D</author></authors></contributors><titles><title>The N-terminal DH-PH domain of Trio induces cell spreading and migration by regulating lamellipodia dynamics in a Rac1-dependent fashion.</title><secondary-title>PloS one</secondary-title></titles><periodical><full-title>PloS one</full-title></periodical><pages>e29912</pages><volume>7</volume><issue>1</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: genetics</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Movement: genetics</keyword><keyword>Cell Movement: physiology</keyword><keyword>Electron</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: pharmacology</keyword><keyword>Fluorescence</keyword><keyword>Gene Expression Regulation</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: antagonists &amp;</keyword><keyword>Guanine Nucleotide Exchange Factors: chemistry</keyword><keyword>Guanine Nucleotide Exchange Factors: genetics</keyword><keyword>Guanine Nucleotide Exchange Factors: physiology</keyword><keyword>HeLa Cells</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword><keyword>Microscopy</keyword><keyword>Neoplastic</keyword><keyword>Neoplastic: drug effects</keyword><keyword>Protein Interaction Domains and Motifs</keyword><keyword>Protein Interaction Domains and Motifs: genetics</keyword><keyword>Protein Interaction Domains and Motifs: physiology</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: antagonists &amp; in</keyword><keyword>Protein-Serine-Threonine Kinases: chemistry</keyword><keyword>Protein-Serine-Threonine Kinases: genetics</keyword><keyword>Protein-Serine-Threonine Kinases: physiology</keyword><keyword>Pseudopodia</keyword><keyword>Pseudopodia: drug effects</keyword><keyword>Pseudopodia: genetics</keyword><keyword>Pseudopodia: metabolism</keyword><keyword>RNA</keyword><keyword>Scanning</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: pharmacology</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: genetics</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword><keyword>rac1 GTP-Binding Protein: physiology</keyword></keywords><dates><year>2012</year></dates><accession-num>22238672</accession-num><electronic-resource-num>10.1371/journal.pone.0029912</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3253119&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>The guanine-nucleotide exchange factor Trio encodes two DH-PH domains that catalyze nucleotide exchange on Rac1, RhoG and RhoA. The N-terminal DH-PH domain is known to activate Rac1 and RhoG, whereas the C-terminal DH-PH domain can activate RhoA. The current study shows that the N-terminal DH-PH domain, upon expression in HeLa cells, activates Rac1 and RhoG independently from each other. In addition, we show that the flanking SH3 domain binds to the proline-rich region of the C-terminus of Rac1, but not of RhoG. However, this SH3 domain is not required for Rac1 or RhoG GDP-GTP exchange. Rescue experiments in Trio-shRNA-expressing cells showed that the N-terminal DH-PH domain of Trio, but not the C-terminal DH-PH domain, restored fibronectin-mediated cell spreading and migration defects that are observed in Trio-silenced cells. Kymograph analysis revealed that the N-terminal DH-PH domain, independent of its SH3 domain, controls the dynamics of lamellipodia. Using siRNA against Rac1 or RhoG, we found that Trio-D1-induced lamellipodia formation required Rac1 but not RhoG expression. Together, we conclude that the GEF Trio is responsible for lamellipodia formation through its N-terminal DH-PH domain in a Rac1-dependent manner during fibronectin-mediated spreading and migration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>YE, L I N</author><author>JI, K E</author><author>FREWER, N</author></authors></contributors><titles><title>Impact of Yangzheng Xiaoji on the Adhesion and Migration of Human Cancer Cells: the Role of the AKT Signalling Pathway</title><secondary-title>Anticancer …</secondary-title></titles><periodical><full-title>Anticancer …</full-title></periodical><pages>2537-2543</pages><volume>32</volume><issue>7</issue><keywords><keyword>AKT</keyword><keyword>Cancer cells</keyword><keyword>ECIS</keyword><keyword>PI3K.</keyword><keyword>cell adhesion</keyword><keyword>cellular migration</keyword><keyword>osteosarcoma</keyword><keyword>prostate cancer</keyword><keyword>signal transduction pathways</keyword></keywords><dates><year>2012</year></dates><isbn>0030229505338</isbn><urls><web-urls><url>http://ar.iiarjournals.org/content/32/7/2537.short</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ramirez, Servio H</author><author>Haskó, János</author><author>Skuba, Andrew</author><author>Fan, Shongshan</author><author>Dykstra, Holly</author><author>McCormick, Ryan</author><author>Reichenbach, Nancy</author><author>Krizbai, Istvan</author><author>Mahadevan, Anu</author><author>Zhang, Ming</author><author>Tuma, Ronald</author><author>Son, Young-Jin</author><author>Persidsky, Yuri</author></authors></contributors><titles><title>Activation of Cannabinoid Receptor 2 Attenuates Leukocyte-Endothelial Cell Interactions and Blood-Brain Barrier Dysfunction under Inflammatory Conditions.</title><secondary-title>The Journal of neuroscience : the official journal of the Society for Neuroscience</secondary-title></titles><periodical><full-title>The Journal of neuroscience : the official journal of the Society for Neuroscience</full-title></periodical><pages>4004-4016</pages><volume>32</volume><issue>12</issue><keywords/><dates><year>2012</year></dates><accession-num>22442067</accession-num><electronic-resource-num>10.1523/JNEUROSCI.4628-11.2012</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22442067</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Previous studies have shown that modulation of the receptor-mediated cannabinoid system during neuroinflammation can produce potent neuroprotective and anti-inflammatory effects. However, in this context, little is known about how selective activation of the cannabinoid type-2 receptor (CB2R) affects the activated state of the brain endothelium and blood-brain barrier (BBB) function. Using human brain tissues and primary human brain microvascular endothelial cells (BMVECs), we demonstrate that the CB2R is highly upregulated during inflammatory insult. We then examined whether the CB2R agonists could attenuate inflammatory responses at the BBB using a mouse model of LPS-induced encephalitis and highly selective CB2R agonists. Visualization by intravital microscopy revealed that administration of JWH133 [(6aR,10aR)-3-(1,1-dimethylbutyl)-6a,7,10,10a-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran] or a novel resorcinol-based compound, O-1966 (1-[4-(1,1-dimethyl-heptyl)-2,6-dimethoxy-phenyl]-3-methyl-cyclohexanol), greatly attenuated leukocyte adhesion in surface pial vessels and in deep ascending cortical postcapillary venules. BBB permeability assessments with small and large fluorescent tracers showed that CB2R agonists were effective at preventing barrier leakiness after LPS administration. To determine whether the effects by CB2R agonists on barrier protection are not only due to the CB2R modulation of immune cell function, we tested the agonists in vitro with barrier-forming primary BMVECs. Remarkably, the addition of CB2R agonist increased transendothelial electrical resistance and increased the amount of tight junction protein present in membrane fractions. Furthermore, CB2R agonists decreased the induction of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 surface expression in BMVECs exposed to various proinflammatory mediators. Together, these results suggest that pharmacological CB2R ligands offer a new strategy for BBB protection during neuroinflammation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Li, Xin</author><author>Martin, Tracey A</author><author>Jiang, Wen G</author></authors></contributors><titles><title>COM-1/p8 acts as a tumour growth enhancer in colorectal cancer cell lines.</title><secondary-title>Anticancer research</secondary-title></titles><periodical><full-title>Anticancer research</full-title></periodical><pages>1229-1237</pages><volume>32</volume><issue>4</issue><keywords><keyword>Apoptosis</keyword><keyword>Base Sequence</keyword><keyword>Basic Helix-Loop-Helix Transcription Factors</keyword><keyword>Basic Helix-Loop-Helix Transcription Factors: gene</keyword><keyword>Basic Helix-Loop-Helix Transcription Factors: phys</keyword><keyword>Cell Division</keyword><keyword>Cell Division: physiology</keyword><keyword>Cell Line</keyword><keyword>Colorectal Neoplasms</keyword><keyword>Colorectal Neoplasms: pathology</keyword><keyword>DNA Primers</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Humans</keyword><keyword>Neoplasm Proteins</keyword><keyword>Neoplasm Proteins: genetics</keyword><keyword>Neoplasm Proteins: physiology</keyword><keyword>Tumor</keyword></keywords><dates><year>2012</year></dates><isbn>0030229505338</isbn><accession-num>22493353</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22493353</url><url>http://ar.iiarjournals.org/content/32/4/1229.short</url></web-urls></urls><label>Apoptosis</label><abstract>BACKGROUND: Candidate of metastasis-1 (COM-1) is a molecule which is stress-induced and cell growth-related. The current study investigated the impact of COM-1 and role of Peroxisome Proliferating Activator Receptor-gamma (PPARγ) agonists on COM-1 knock down in colorectal cancer cells. MATERIALS AND METHODS: Expression of COM-1 was knocked out in the colorectal cancer cell lines RKO and CaCO2 by transfection with ribozyme transgenes which specifically targeted COM-1. Cell growth, cell migration and apoptosis were measured in wild-type, control and COM-1 knock down cells. The impact or treatment with the PPARγ agonists on the function of COM-1 knock down cells was monitored. RESULTS: COM-1 knock-down cells grew slower than wild-type and control cells. When treated with the PPARγ agonist ciglitazone and bisphenol A diglycidyl ether (BADGE) at several different concentrations, all types of cells grew slower to some extent. Cells with COM-1 knock-down had the same mobility as wild-type and control cells. More apoptotic and dead cells were detected when cells were treated with ciglitazone at 3 μM, especially of COM-1 knock down cells. CONCLUSION: COM-1 is an anti-apoptotic gene and a cell growth promoter. Furthermore, the PPARγ agonist could increase the inhibitory effect seen in COM-1 knock-down cell growth and to promote apoptosis. In regards to metastasis, COM-1 appears to play no role in cell motility.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Desai, Shyamal D</author><author>Reed, Ryan E</author><author>Burks, Julian</author><author>Wood, Laurence M</author><author>Pullikuth, Ashok K</author><author>Haas, Arthur L</author><author>Liu, Leroy F</author><author>Breslin, Jerome W</author><author>Meiners, Sally</author><author>Sankar, Surendran</author></authors></contributors><titles><title>ISG15 disrupts cytoskeletal architecture and promotes motility in human breast cancer cells.</title><secondary-title>Experimental biology and medicine (Maywood, N.J.)</secondary-title></titles><periodical><full-title>Experimental biology and medicine (Maywood, N.J.)</full-title></periodical><pages>38-49</pages><volume>237</volume><issue>1</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: metabolism</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cytokines</keyword><keyword>Cytokines: genetics</keyword><keyword>Cytokines: metabolism</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Cytoskeleton: pathology</keyword><keyword>Female</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Interferons</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplastic</keyword><keyword>Proteasome Endopeptidase Complex</keyword><keyword>Proteasome Endopeptidase Complex: metabolism</keyword><keyword>RNA</keyword><keyword>RNA Interference</keyword><keyword>Signal Transduction</keyword><keyword>Small Interfering</keyword><keyword>Tumor</keyword><keyword>Ubiquitin</keyword><keyword>Ubiquitin-Conjugating Enzymes</keyword><keyword>Ubiquitin-Conjugating Enzymes: genetics</keyword><keyword>Ubiquitin-Conjugating Enzymes: metabolism</keyword><keyword>Ubiquitin: metabolism</keyword><keyword>Ubiquitins</keyword><keyword>Ubiquitins: genetics</keyword><keyword>Ubiquitins: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>22185919</accession-num><electronic-resource-num>10.1258/ebm.2011.011236</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22185919</url></web-urls></urls><label>ECIS Migration;Signal Transduction</label><abstract>The interferon-stimulated gene 15 (ISG15) pathway is highly elevated in breast cancer; however, very little is known about how the ISG15 pathway contributes to breast tumorigenesis. In the current study, using the gene disruption approach, we demonstrate that both ISG15 and UbcH8 (ISG15-specific conjugating enzyme) disrupt F-actin architecture and formation of focal adhesions in ZR-75-1 breast cancer cells. In addition, ISG15 and UbcH8 promote breast cancer cell migration. We also demonstrate that ISG15 inhibits ubiquitin/26S proteasome-mediated turnover of proteins implicated in tumor cell motility, invasion and metastasis. Together, our results suggest that the aberrant activation of the ISG15 pathway confers a motile phenotype to breast cancer cells by disrupting cell architecture and stabilizing proteins involved in cell motility, invasion and metastasis. Because the cellular architecture is conserved and the ISG15 pathway is constitutively activated in tumor cells of different lineages, it is reasonable to assume that our observations in breast cancer must hold true for many other tumors.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Liu, Shuo</author><author>Yu, Chuanhui</author><author>Yang, Fan</author><author>Paganini-Hill, Annlia</author><author>Fisher, Mark J</author></authors></contributors><titles><title>Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.</title><secondary-title>Journal of the neurological sciences</secondary-title></titles><periodical><full-title>Journal of the neurological sciences</full-title></periodical><pages>45-51</pages><volume>320</volume><issue>1-2</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Brain</keyword><keyword>Brain: blood supply</keyword><keyword>Brain: drug effects</keyword><keyword>Brain: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Carbazoles</keyword><keyword>Carbazoles: pharmacology</keyword><keyword>Cells</keyword><keyword>Claudin-5</keyword><keyword>Claudin-5: metabolism</keyword><keyword>Cultured</keyword><keyword>Dipyridamole</keyword><keyword>Dipyridamole: pharmacology</keyword><keyword>Drug Interactions</keyword><keyword>Drug Interactions: physiology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Histamine</keyword><keyword>Histamine: pharmacology</keyword><keyword>Humans</keyword><keyword>Isoquinolines</keyword><keyword>Isoquinolines: pharmacology</keyword><keyword>Phosphodiesterase Inhibitors</keyword><keyword>Phosphodiesterase Inhibitors: pharmacology</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>Pyrroles</keyword><keyword>Pyrroles: pharmacology</keyword><keyword>Rolipram</keyword><keyword>Rolipram: pharmacology</keyword><keyword>Sulfonamides</keyword><keyword>Sulfonamides: pharmacology</keyword><keyword>Tetrazoles</keyword><keyword>Tetrazoles: antagonists &amp; inhibitors</keyword><keyword>Tetrazoles: pharmacology</keyword></keywords><dates><year>2012</year></dates><accession-num>22819056</accession-num><electronic-resource-num>10.1016/j.jns.2012.06.005</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3504123&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>BACKGROUND AND PURPOSE: Brain microvascular disorders, including cerebral microscopic hemorrhage, have high prevalence but few treatment options. To develop new strategies for these disorders, we analyzed the effects of several phosphodiesterase (PDE) inhibitors on human brain microvascular endothelial cells (HBECs). METHODS: We modified barrier properties and response to histamine of HBECs using cilostazol (PDE3 inhibitor), rolipram (PDE4 inhibitor), and dipyridamole (non-specific PDE inhibitor). RESULTS: Cilostazol and dipyridamole altered the distribution of endothelial F-actin. Cilostazol increased expression of tight junction protein claudin-5 by 118% compared to control (p&lt;.001). Permeability to albumin was decreased by cilostazol (21% vs control, p&lt;.05), and permeability to dextran (70Kd) was decreased by both cilostazol (37% vs control, p&lt;.001) and dipyridamole (44% vs control, p&lt;.0001). Cilostazol increased trans-endothelial electrical resistance (TEER) after 12h by 111% compared to control (p&lt;.0001). Protein kinase A (PKA) inhibitors H89 and KT5720 attenuated the TEER increase by cilostazol. Transient increased permeability in response to histamine was significantly mitigated by cilostazol, but not by other PDE inhibitors. CONCLUSIONS: These findings demonstrate distinctive effects of cilostazol and other PDE inhibitors on HBECs, including enhanced barrier characteristics and mitigation of response to histamine. PKA-mediated effects of cilostazol were prominent in this model. These in vitro findings are consistent with therapeutic potential of PDE inhibitors in human brain microvascular disorders.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hiemstra, Ida H</author><author>Bouma, Gerd</author><author>Geerts, Dirk</author><author>Kraal, Georg</author><author>den Haan, Joke M M</author></authors></contributors><titles><title>Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses.</title><secondary-title>Molecular immunology</secondary-title></titles><periodical><full-title>Molecular immunology</full-title></periodical><pages>264-272</pages><volume>52</volume><issue>3-4</issue><keywords><keyword>Acetylmuramyl-Alanyl-Isoglutamine</keyword><keyword>Acetylmuramyl-Alanyl-Isoglutamine: genetics</keyword><keyword>Acetylmuramyl-Alanyl-Isoglutamine: immunology</keyword><keyword>Acetylmuramyl-Alanyl-Isoglutamine: metabolism</keyword><keyword>Animals</keyword><keyword>Cells</keyword><keyword>Chemokines</keyword><keyword>Chemokines: biosynthesis</keyword><keyword>Crohn Disease</keyword><keyword>Crohn Disease: genetics</keyword><keyword>Crohn Disease: immunology</keyword><keyword>Cultured</keyword><keyword>Cytokines</keyword><keyword>Cytokines: biosynthesis</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Epithelial Cells: ultrastructure</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: immunology</keyword><keyword>Intestinal Mucosa: metabolism</keyword><keyword>Intestines</keyword><keyword>Intestines: immunology</keyword><keyword>Intestines: metabolism</keyword><keyword>Mice</keyword><keyword>Nod2 Signaling Adaptor Protein</keyword><keyword>Nod2 Signaling Adaptor Protein: genetics</keyword><keyword>Nod2 Signaling Adaptor Protein: metabolism</keyword><keyword>RNA</keyword><keyword>RNA Interference</keyword><keyword>Small Interfering</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: ultrastructure</keyword><keyword>Toll-Like Receptor 2</keyword><keyword>Toll-Like Receptor 2: genetics</keyword><keyword>Toll-Like Receptor 2: immunology</keyword><keyword>Toll-Like Receptor 2: metabolism</keyword><keyword>Toll-Like Receptor 4</keyword><keyword>Toll-Like Receptor 4: genetics</keyword><keyword>Toll-Like Receptor 4: immunology</keyword><keyword>Toll-Like Receptor 4: metabolism</keyword></keywords><dates><year>2012</year></dates><accession-num>22750073</accession-num><electronic-resource-num>10.1016/j.molimm.2012.06.007</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22750073</url></web-urls></urls><abstract>Intestinal epithelial cells (IECs) form a physical barrier between the internal milieu and the intestinal microflora via the expression of tight junctions. TLR-mediated recognition of intestinal microflora by IECs is important for tight junction preservation, production of chemokines, and cell survival. Disturbance of the IEC barrier function results in bacterial invasion and contributes to the development of inflammatory bowel disease. We observed that muramyl dipeptide (MDP), a breakdown product of bacterial peptidoglycan, strongly enhances subsequent Toll-like receptor (TLR) responses in murine colonic epithelium cell lines. Prior exposure to MDP significantly increased the production of chemokines and cytokines and improved the barrier function induced by different TLR2 and TLR4 ligands. shRNA knock-down studies showed that MDP recognition by Nod2 mediated the enhancement of TLR responses. Our studies indicate that Nod2 stimulation by MDP significantly enhances TLR-mediated IEC barrier function and chemokine production. Failure of this protective mechanism may contribute to the increased risk of Crohn's disease in individuals with a loss-of-function mutation in NOD2.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bosanquet, David C</author><author>Ye, Lin</author><author>Harding, Keith G</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Role of HuR in keratinocyte migration and wound healing.</title><secondary-title>Molecular medicine reports</secondary-title></titles><periodical><full-title>Molecular medicine reports</full-title></periodical><pages>529-534</pages><volume>5</volume><issue>2</issue><keywords><keyword>Apoptosis</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Hu Paraneoplastic Encephalomyelitis Antigens</keyword><keyword>Hu Paraneoplastic Encephalomyelitis Antigens: gene</keyword><keyword>Hu Paraneoplastic Encephalomyelitis Antigens: meta</keyword><keyword>Humans</keyword><keyword>Interphase</keyword><keyword>Keratinocytes</keyword><keyword>Keratinocytes: cytology</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2012</year></dates><accession-num>22086295</accession-num><electronic-resource-num>10.3892/mmr.2011.675</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22086295</url></web-urls></urls><label>Apoptosis;Wound Healing</label><abstract>Human antigen R (HuR) is a post-translational modifier of mRNAs rich in AU- and U-rich elements. These mRNAs typically code for proteins involved in cell growth and differentiation, signal transduction, transcriptional and translational control, apoptosis, nutrient transport and metabolism. Thus, HuR affects a variety of biological functions and processes. Via its effect on growth and cellular migration, HuR has been shown to enhance clinical progression of a number of cancers. Its role in wound healing remains unknown. In the present study, we evaluated HuR tissue expression in a cohort of chronic healed and non-healed leg ulcers. We also evaluated the effect of HuR knockdown on a number of cellular processes using the HaCaT human keratinocyte cell line. HuR was expressed in greater levels in the 'chronic healed' cohort of ulcers, compared to the 'chronic non-healed', although this failed to reach statistical significance (p=0.13). HuR knockdown resulted in greater cellular growth, faster progression through the cell cycle and reduced apoptosis. Furthermore, it reduced cellular adhesion rates without affecting migration. We, therefore, concluded that HuR promotes wound healing, primarily through its effect on cellular adhesion. It also slows cellular growth rate via its effect on both cell cycle progression and rates of apoptosis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Aman, Jurjan</author><author>van Bezu, Jan</author><author>Damanafshan, Amin</author><author>Huveneers, Stephan</author><author>Eringa, Etto C</author><author>Vogel, Steven M</author><author>Groeneveld, A B Johan</author><author>Vonk Noordegraaf, Anton</author><author>van Hinsbergh, Victor W M</author><author>van Nieuw Amerongen, Geerten P</author></authors></contributors><titles><title>Effective treatment of edema and endothelial barrier dysfunction with imatinib.</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>2728-2738</pages><volume>126</volume><issue>23</issue><keywords><keyword>Animals</keyword><keyword>Benzamides</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Inbred BALB C</keyword><keyword>Inbred C57BL</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Piperazines</keyword><keyword>Piperazines: pharmacology</keyword><keyword>Piperazines: therapeutic use</keyword><keyword>Pulmonary Edema</keyword><keyword>Pulmonary Edema: drug therapy</keyword><keyword>Pulmonary Edema: metabolism</keyword><keyword>Pulmonary Edema: physiopathology</keyword><keyword>Pyrimidines</keyword><keyword>Pyrimidines: pharmacology</keyword><keyword>Pyrimidines: therapeutic use</keyword><keyword>Skin</keyword><keyword>Skin: blood supply</keyword><keyword>Skin: drug effects</keyword><keyword>Skin: metabolism</keyword><keyword>Treatment Outcome</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: physiopathology</keyword></keywords><dates><year>2012</year></dates><accession-num>23099479</accession-num><electronic-resource-num>10.1161/CIRCULATIONAHA.112.134304</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23099479</url></web-urls></urls><label>ECIS Barrier Function;Signal Transduction</label><abstract>BACKGROUND: Tissue edema and endothelial barrier dysfunction as observed in sepsis and acute lung injury carry high morbidity and mortality, but currently lack specific therapy. In a recent case report, we described fast resolution of pulmonary edema on treatment with the tyrosine kinase inhibitor imatinib through an unknown mechanism. Here, we explored the effect of imatinib on endothelial barrier dysfunction and edema formation. METHODS AND RESULTS: We evaluated the effect of imatinib on endothelial barrier function in vitro and in vivo. In human macro- and microvascular endothelial monolayers, imatinib attenuated endothelial barrier dysfunction induced by thrombin and histamine. Small interfering RNA knock-downs of the imatinib-sensitive kinases revealed that imatinib attenuates endothelial barrier dysfunction via inhibition of Abl-related gene kinase (Arg/Abl2), a previously unknown mediator of endothelial barrier dysfunction. Indeed, Arg was activated by endothelial stimulation with thrombin, histamine, and vascular endothelial growth factor. Imatinib limited Arg-mediated endothelial barrier dysfunction by enhancing Rac1 activity and enforcing adhesion of endothelial cells to the extracellular matrix. Using mouse models of vascular leakage as proof-of-concept, we found that pretreatment with imatinib protected against vascular endothelial growth factor-induced vascular leakage in the skin, and effectively prevented edema formation in the lungs. In a murine model of sepsis, imatinib treatment (6 hours and 18 hours after induction of sepsis) attenuated vascular leakage in the kidneys and the lungs (24 hours after induction of sepsis). CONCLUSIONS: Thus, imatinib prevents endothelial barrier dysfunction and edema formation via inhibition of Arg. These findings identify imatinib as a promising approach to permeability edema and indicate Arg as novel target for edema treatment.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Valcarcel-Ares, M Noa</author><author>Gautam, Tripti</author><author>Warrington, Junie P</author><author>Bailey-Downs, Lora</author><author>Sosnowska, Danuta</author><author>de Cabo, Rafael</author><author>Losonczy, Gyorgy</author><author>Sonntag, William E</author><author>Ungvari, Zoltan</author><author>Csiszar, Anna</author></authors></contributors><titles><title>Disruption of Nrf2 Signaling Impairs Angiogenic Capacity of Endothelial Cells: Implications for Microvascular Aging.</title><secondary-title>The journals of gerontology. Series A, Biological sciences and medical sciences</secondary-title></titles><periodical><full-title>The journals of gerontology. Series A, Biological sciences and medical sciences</full-title></periodical><pages>1-9</pages><keywords><keyword>2011</keyword><keyword>accepted november 12</keyword><keyword>angiogenesis</keyword><keyword>capillary density</keyword><keyword>decision editor</keyword><keyword>heart</keyword><keyword>here is increasing evidence</keyword><keyword>ladora thompson</keyword><keyword>microcirculation</keyword><keyword>phd</keyword><keyword>received october 3</keyword><keyword>to suggest that the</keyword><keyword>vascular aging</keyword></keywords><dates><year>2012</year></dates><accession-num>22219515</accession-num><electronic-resource-num>10.1093/gerona/glr229</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22219515</url></web-urls></urls><label>ECIS Attachment;ECIS Migration</label><abstract>The redox-sensitive transcription factor NF-E2-related factor 2 (Nrf2) plays a key role in preserving a healthy endothelial phenotype and maintaining the functional integrity of the vasculature. Previous studies demonstrated that aging is associated with Nrf2 dysfunction in endothelial cells, which alters redox signaling and likely promotes the development of large vessel disease. Much less is known about the consequences of Nrf2 dysfunction at the level of the microcirculation. To test the hypothesis that Nrf2 regulates angiogenic capacity of endothelial cells, we determined whether disruption of Nrf2 signaling (by siRNA knockdown of Nrf2 and overexpression of Keap1, the cytosolic repressor of Nrf2) impairs angiogenic processes in cultured human coronary arterial endothelial cells stimulated with vascular endothelial growth factor and insulin-like growth factor-1. In the absence of functional Nrf2, coronary arterial endothelial cells exhibited impaired proliferation and adhesion to vitronectin and collagen. Disruption of Nrf2 signaling also reduced cellular migration (measured by a wound-healing assay using electric cell-substrate impedance sensing technology) and impaired the ability of coronary arterial endothelial cells to form capillary-like structures. Collectively, we find that Nrf2 is essential for normal endothelial angiogenic processes, suggesting that Nrf2 dysfunction may be a potential mechanism underlying impaired angiogenesis and microvascular rarefaction in aging.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Book">1</ref-type><contributors><secondary-authors><author>Jiang, Wen G</author></secondary-authors></contributors><titles><title>Electric Cell-Substrate Impedance Sensing and Cancer Metastasis</title></titles><periodical/><keywords/><dates><year>2012</year></dates><pub-location>Dordrecht</pub-location><publisher>Springer Netherlands</publisher><isbn>978-94-007-4926-9</isbn><electronic-resource-num>10.1007/978-94-007-4927-6</electronic-resource-num><urls><web-urls><url>http://www.springerlink.com/index/10.1007/978-94-007-4927-6</url><url>http://link.springer.com/10.1007/978-94-007-4927-6</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Baig, Ruqia Mehmood</author><author>Sanders, Andrew J</author><author>Kayani, Mahmood Akhtar</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Association of Differentiation-Related Gene-1 (DRG1) with Breast Cancer Survival and in Vitro Impact of DRG1 Suppression</title><secondary-title>Cancers</secondary-title></titles><periodical><full-title>Cancers</full-title></periodical><pages>658-672</pages><volume>4</volume><issue>4</issue><keywords><keyword>breast cancer</keyword><keyword>drg1</keyword><keyword>metastasis</keyword><keyword>prognosis</keyword></keywords><dates><year>2012</year></dates><electronic-resource-num>10.3390/cancers4030658</electronic-resource-num><urls><web-urls><url>http://www.mdpi.com/2072-6694/4/3/658/</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Liu, Yinan</author><author>Sanders, A J Andrew J</author><author>Zhang, Lijian</author><author>Jiang, Wen G</author></authors></contributors><titles><title>EPLIN-Î± Expression in Human Oesophageal Cancer and its Impact on Cellular Aggressiveness and Clinical Outcome</title><secondary-title>Anticancer …</secondary-title></titles><periodical><full-title>Anticancer …</full-title></periodical><pages>1283-1289</pages><volume>32</volume><issue>4</issue><keywords><keyword>Base Sequence</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Division</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: genetics</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Cytoskeletal Proteins: physiology</keyword><keyword>DNA Primers</keyword><keyword>ECIS</keyword><keyword>EPLINα</keyword><keyword>Esophageal Neoplasms</keyword><keyword>Esophageal Neoplasms: metabolism</keyword><keyword>Esophageal Neoplasms: pathology</keyword><keyword>Humans</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>RNA</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Treatment Outcome</keyword><keyword>cell migration</keyword><keyword>ecis</keyword><keyword>eplin-α</keyword><keyword>oesophageal cancer</keyword><keyword>pulmonary cancer</keyword></keywords><dates><year>2012</year></dates><isbn>0030229505338</isbn><accession-num>22493360</accession-num><urls><web-urls><url>http://ar.iiarjournals.org/content/32/4/1283.short</url><url>http://www.ncbi.nlm.nih.gov/pubmed/22493360</url></web-urls></urls><abstract>Epithelial protein lost in neoplasm-α (EPLIN-α) is a cytoskeletal protein whose expression is often lost or is aberrant in cancerous cells and tissues and whose loss is believed to be involved in aggressive phenotype. Our current study examined this molecule in human oesophageal tissues and investigated the cellular impact of EPLIN-α on oesophageal cancer cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xie, Fengbo</author><author>Xu, Youchun</author><author>Wang, Lei</author><author>Mitchelson, Keith</author><author>Xing, Wanli</author><author>Cheng, Jing</author></authors></contributors><titles><title>Use of cellular electrical impedance sensing to assess in vitro cytotoxicity of anticancer drugs in a human kidney cell nephrotoxicity model.</title><secondary-title>The Analyst</secondary-title></titles><periodical><full-title>The Analyst</full-title></periodical><pages>1343</pages><volume>137</volume><issue>6</issue><keywords><keyword>Animals</keyword><keyword>Antidotes</keyword><keyword>Antidotes: pharmacology</keyword><keyword>Antineoplastic Agents</keyword><keyword>Antineoplastic Agents: adverse effects</keyword><keyword>Antineoplastic Agents: pharmacology</keyword><keyword>Apoptosis</keyword><keyword>Apoptosis: drug effects</keyword><keyword>Biological Assay</keyword><keyword>Biological Assay: instrumentation</keyword><keyword>Biological Assay: methods</keyword><keyword>Carboplatin</keyword><keyword>Carboplatin: adverse effects</keyword><keyword>Carboplatin: pharmacology</keyword><keyword>Cell Line</keyword><keyword>Cell Line: drug effects</keyword><keyword>Cisplatin</keyword><keyword>Cisplatin: adverse effects</keyword><keyword>Cisplatin: pharmacology</keyword><keyword>Cyclophosphamide</keyword><keyword>Cyclophosphamide: adverse effects</keyword><keyword>Cyclophosphamide: pharmacology</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Fluorouracil</keyword><keyword>Fluorouracil: adverse effects</keyword><keyword>Fluorouracil: pharmacology</keyword><keyword>Glutathione</keyword><keyword>Glutathione: pharmacology</keyword><keyword>Humans</keyword><keyword>Kidney</keyword><keyword>Kidney Tubules</keyword><keyword>Kidney Tubules: cytology</keyword><keyword>Kidney: cytology</keyword><keyword>Kidney: drug effects</keyword><keyword>Kidney: metabolism</keyword><keyword>Thiosulfates</keyword><keyword>Thiosulfates: pharmacology</keyword></keywords><dates><year>2012</year></dates><accession-num>22214987</accession-num><electronic-resource-num>10.1039/c2an16141a</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22214987</url></web-urls></urls><label>Apoptosis;ECIS Cytotoxicity</label><abstract>Nephrotoxicity is one of the major concerns for anticancer drug safety because most drugs are metabolized and excreted by the kidneys. Convenient tools able to perform rapid in vitro cytotoxicity analysis and identify drug side effects in kidney cells during early phases of drug discovery could be beneficial to drug development programs. Here we developed an electrical cell-substrate impedance sensing system (ECIS) capable of continuously measuring the dosage and time response of human proximal tubular epithelial (HK2) cells exposed to four drugs throughout the experimental period. These drugs induced HK2 cell apoptosis/death in a dose-dependent manner, although with very different dose-response effects. DDP (50 μM) was the most cytotoxic and induced obvious HK2 cell apoptosis rapidly after exposure. The other three drugs had much lower cytotoxicity, even at concentrations approaching 1 mM. The results obtained from our ECIS system correlated well with conventional in vitro assays such as flow cytometry and cell viability assays. Notably, the continuous and automatic measurements provided by ECIS system allow for better resolution for drugs with different temporal toxicity profiles. Furthermore, we investigated the effect of DDP's antidotes, glutathione and sodium subsulfite, on DDP-induced cytotoxicity, both of which decreased nephrotoxicity of DDP in a dose-dependent manner. Overall this study illustrates the convenience of ECIS for direct, continuous assessment of the cytotoxicity of anticancer drugs in vitro. ECIS has the potential to become a useful, non-invasive analytical method for early evaluation of drugs and antidotes of toxins.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Du, Peng</author><author>Ye, Lin</author><author>Li, Han</author><author>Ruge, Fiona</author><author>Yang, Yong</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Growth differentiation factor-9 expression is inversely correlated with an aggressive behaviour in human bladder cancer cells.</title><secondary-title>International journal of molecular medicine</secondary-title></titles><periodical><full-title>International journal of molecular medicine</full-title></periodical><pages>428-434</pages><volume>29</volume><issue>3</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: genetics</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: genetics</keyword><keyword>Cell Proliferation</keyword><keyword>Gene Expression</keyword><keyword>Gene Expression Regulation</keyword><keyword>Growth Differentiation Factor 9</keyword><keyword>Growth Differentiation Factor 9: genetics</keyword><keyword>Growth Differentiation Factor 9: metabolism</keyword><keyword>Humans</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Invasiveness: genetics</keyword><keyword>Neoplastic</keyword><keyword>Tumor</keyword><keyword>Urinary Bladder Neoplasms</keyword><keyword>Urinary Bladder Neoplasms: genetics</keyword><keyword>Urinary Bladder Neoplasms: metabolism</keyword><keyword>Urinary Bladder Neoplasms: pathology</keyword></keywords><dates><year>2012</year></dates><accession-num>22159313</accession-num><electronic-resource-num>10.3892/ijmm.2011.858</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22159313</url></web-urls></urls><abstract>Growth differentiation factor-9 (GDF-9) is a family member of bone morphogenetic proteins (BMPs), which belong to the TGF-β superfamily. There has been a recent surge of interest in the role of growth differentiation factors and other BMPs in the development and spread of cancer. However, the role of GDF-9 in bladder cancer remains unknown. The present study investigated the expression of GDF-9 in normal and malignant human bladder tissue and its molecular interactions within bladder cancer cells. The expression of GDF-9 in human bladder tissues and bladder cancer cell lines was assessed at both the mRNA and protein levels using RT-PCR and immunohistochemistry, respectively. Full-length GDF-9 cDNA was amplified from normal mammary tissues. GDF-9 was overexpressed in bladder cancer cell lines using a mammalian expression construct. The effect of GDF-9 on cellular functions, was examined in bladder cancer cells overexpressing GDF-9 using a variety of in vitro assays. In normal bladder tissues, stronger staining of GDF-9 was seen in transitional cells, both in the cytoplasm and in the nucleus. In contrast, the staining of GDF-9 was notably weak or absent in cancer cells of tumour tissues. Similarly, the bladder cancer cell lines RT112 and EJ138, expressed very low levels of GDF-9. Moreover, overexpression of GDF-9 reduced the growth, adhesion and migration of bladder cell lines in vitro. However, the overexpression of GDF-9 had little bearing on the invasion of bladder cell lines in vitro. In conclusion, GDF-9 is expressed at lower levels in human bladder cancer cells compared with normal transitional cells of the bladder. GDF-9 levels are inversely correlated with the growth, adhesion and migration of bladder cancer cells in vitro. The results of the present study suggest that GDF-9 is a potential tumour suppressor in human bladder cancer.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bosanquet, David C</author><author>Harding, Keith G</author><author>Ruge, Fiona</author><author>Sanders, Andrew J</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Expression of IL-24 and IL-24 receptors in human wound tissues and the biological implications of IL-24 on keratinocytes.</title><secondary-title>Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</secondary-title></titles><periodical><full-title>Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</full-title></periodical><pages>896-903</pages><volume>20</volume><issue>6</issue><keywords><keyword>Acute Disease</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Movement</keyword><keyword>Cell Proliferation</keyword><keyword>Cells</keyword><keyword>Chronic Disease</keyword><keyword>Cultured</keyword><keyword>Gene Expression</keyword><keyword>Humans</keyword><keyword>Interleukins</keyword><keyword>Interleukins: metabolism</keyword><keyword>Keratinocytes</keyword><keyword>Keratinocytes: metabolism</keyword><keyword>Keratinocytes: pathology</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Signal Transduction</keyword><keyword>Wound Healing</keyword><keyword>Wounds and Injuries</keyword><keyword>Wounds and Injuries: metabolism</keyword><keyword>Wounds and Injuries: pathology</keyword></keywords><dates><year>2012</year></dates><accession-num>23110359</accession-num><electronic-resource-num>10.1111/j.1524-475X.2012.00840.x</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23110359</url></web-urls></urls><label>Signal Transduction;Wound Healing</label><abstract>Interleukin (IL)-24, also known as melanoma differentiation-associated gene-7, is a cytokine initially identified from cancerous cells and expressed in a range of cell types. It is a regulator of cell differentiation, growth, and apoptosis, and a promising anticancer agent. IL-24 acts via its heterodimic receptors: the IL-20R1 and IL-20R2 complex and the IL-22R1 and IL-20R2 complex. There is limited information on the effect of IL-24 in wound healing. Human acute and chronic wound tissues were used to analyze the transcript levels and histological staining of IL-24 and the IL-24 receptors. The biological response of human keratinocytes to recombinant human IL-24 was evaluated using electric cell-substrate impedance sensing-based methods in conjunction with inhibitors to candidate signaling pathways. IL-24 significantly slowed the migration of keratinocytes (p = 0.01), with only a marginal effect on cellular adhesion. The inhibitory effect of IL-24 on migration was completed reversed following addition of an AKT inhibitor (p = 0.004) but not an SMAD3 pathway inhibitor. Human chronic wound tissues showed raised levels of both IL-24 (p = 0.003) and its receptor (p = 0.0305) compared with acute wound tissues. We conclude that IL-24 appears to promote wound chronicity via its inhibitory effect on the migratory behavior of human keratinocytes, mediated through an AKT-dependent pathway.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ungvari, Zoltan</author><author>Tucsek, Zsuzsanna</author><author>Sosnowska, Danuta</author><author>Toth, Peter</author><author>Gautam, Tripti</author><author>Podlutsky, Andrej</author><author>Csiszar, Agnes Anna</author><author>Losonczy, Gyorgy</author><author>Valcarcel-Ares, M Noa</author><author>Sonntag, William E</author><author>Csiszar, Agnes Anna</author></authors></contributors><titles><title>Aging-Induced Dysregulation of Dicer1-Dependent MicroRNA Expression Impairs Angiogenic Capacity of Rat Cerebromicrovascular Endothelial Cells.</title><secondary-title>The journals of gerontology. Series A, Biological sciences and medical sciences</secondary-title></titles><periodical><full-title>The journals of gerontology. Series A, Biological sciences and medical sciences</full-title></periodical><pages>1-15</pages><volume>1</volume><issue>ribonuclease III</issue><keywords><keyword>2012</keyword><keyword>accepted november 10</keyword><keyword>angiogenesis</keyword><keyword>capillary density</keyword><keyword>cardiovascular aging</keyword><keyword>cerebrovascular</keyword><keyword>decision editor</keyword><keyword>epigenetics</keyword><keyword>phd</keyword><keyword>rafael de cabo</keyword><keyword>received july 23</keyword><keyword>vascular aging</keyword></keywords><dates><year>2012</year></dates><accession-num>23239824</accession-num><electronic-resource-num>10.1093/gerona/gls242</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23239824</url></web-urls></urls><label>ECIS Migration</label><abstract>Age-related impairment of angiogenesis is likely to play a central role in cerebromicrovascular rarefaction and development of vascular cognitive impairment, but the underlying mechanisms remain elusive. To test the hypothesis that dysregulation of Dicer1 (ribonuclease III, a key enzyme of the microRNA [miRNA] machinery) impairs endothelial angiogenic capacity in aging, primary cerebromicrovascular endothelial cells (CMVECs) were isolated from young (3 months old) and aged (24 months old) Fischer 344 × Brown Norway rats. We found an age-related downregulation of Dicer1 expression both in CMVECs and in small cerebral vessels isolated from aged rats. In aged CMVECs, Dicer1 expression was increased by treatment with polyethylene glycol-catalase. Compared with young cells, aged CMVECs exhibited altered miRNA expression profile, which was associated with impaired proliferation, adhesion to vitronectin, collagen and fibronectin, cellular migration (measured by a wound-healing assay using electric cell-substrate impedance sensing technology), and impaired ability to form capillary-like structures. Overexpression of Dicer1 in aged CMVECs partially restored miRNA expression profile and significantly improved angiogenic processes. In young CMVECs, downregulation of Dicer1 (siRNA) resulted in altered miRNA expression profile associated with impaired proliferation, adhesion, migration, and tube formation, mimicking the aging phenotype. Collectively, we found that Dicer1 is essential for normal endothelial angiogenic processes, suggesting that age-related dysregulation of Dicer1-dependent miRNA expression may be a potential mechanism underlying impaired angiogenesis and cerebromicrovascular rarefaction in aging.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Krishnamoorthy, Sriram</author><author>Recchiuti, Antonio</author><author>Chiang, Nan</author><author>Fredman, Gabrielle</author><author>Serhan, Charles N</author></authors></contributors><titles><title>Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs.</title><secondary-title>The American journal of pathology</secondary-title></titles><periodical><full-title>The American journal of pathology</full-title></periodical><pages>2018-2027</pages><volume>180</volume><issue>5</issue><keywords><keyword>Acute Disease</keyword><keyword>Animals</keyword><keyword>Arrestins</keyword><keyword>Arrestins: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Docosahexaenoic Acids</keyword><keyword>Docosahexaenoic Acids: pharmacology</keyword><keyword>Docosahexaenoic Acids: physiology</keyword><keyword>Docosahexaenoic Acids: therapeutic use</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Formyl Peptide</keyword><keyword>Formyl Peptide: physiology</keyword><keyword>G-Protein-Coupled</keyword><keyword>G-Protein-Coupled: physiology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: drug effects</keyword><keyword>Gene Expression Regulation: physiology</keyword><keyword>Humans</keyword><keyword>Inflammation</keyword><keyword>Inflammation: genetics</keyword><keyword>Inflammation: metabolism</keyword><keyword>Interleukin-10</keyword><keyword>Interleukin-10: biosynthesis</keyword><keyword>Interleukin-10: genetics</keyword><keyword>Knockout</keyword><keyword>Ligands</keyword><keyword>Lipoxin</keyword><keyword>Lipoxin: physiology</keyword><keyword>Macrophages</keyword><keyword>Macrophages: metabolism</keyword><keyword>Mice</keyword><keyword>MicroRNAs</keyword><keyword>MicroRNAs: genetics</keyword><keyword>Neutrophil Infiltration</keyword><keyword>Neutrophil Infiltration: drug effects</keyword><keyword>Neutrophil Infiltration: physiology</keyword><keyword>Peritonitis</keyword><keyword>Peritonitis: drug therapy</keyword><keyword>Peritonitis: metabolism</keyword><keyword>Peritonitis: pathology</keyword><keyword>Receptors</keyword><keyword>Transgenic</keyword><keyword>Up-Regulation</keyword><keyword>Up-Regulation: drug effects</keyword></keywords><dates><year>2012</year></dates><accession-num>22449948</accession-num><electronic-resource-num>10.1016/j.ajpath.2012.01.028</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3349829&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Inflammation</label><abstract>Resolution of acute inflammation is an active process that involves the biosynthesis of specialized proresolving lipid mediators. Among them, resolvin D1 (RvD1) actions are mediated by two G protein-coupled receptors (GPCRs), ALX/FPR2 and GPR32, that also regulate specific microRNAs (miRNAs) and their target genes in novel resolution circuits. We report the ligand selectivity of RvD1 activation of ALX/FPR2 and GPR32. In addition to RvD1, its aspirin-triggered epimer and RvD1 analogs each dose dependently and effectively activated ALX/FPR2 and GPR32 in GPCR-overexpressing β-arrestin systems using luminescence and electric cell-substrate impedance sensing. To corroborate these findings in vivo, neutrophil infiltration in self-limited peritonitis was reduced in human ALX/FPR2-overexpressing transgenic mice that was further limited to 50% by RvD1 treatment with as little as 10 ng of RvD1 per mouse. Analysis of miRNA expression revealed that RvD1 administration significantly up-regulated miR-208a and miR-219 in exudates isolated from ALX/FPR2 transgenic mice compared with littermates. Overexpression of miR-208a in human macrophages up-regulated IL-10. In comparison, in ALX/FPR2 knockout mice, RvD1 neither significantly reduced leukocyte infiltration in zymosan-induced peritonitis nor regulated miR-208a and IL-10 in these mice. Together, these results demonstrate the selectivity of RvD1 interactions with receptors ALX/FPR2 and GPR32. Moreover, they establish a new molecular circuit that is operative in the resolution of acute inflammation activated by the proresolving mediator RvD1 involving specific GPCRs and miRNAs.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Du, Peng</author><author>Ye, Lin</author><author>Li, Han</author><author>Ruge, Fiona</author><author>Yang, Yong</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Loss of expression of growth differentiation factor-9 (GDF9) in human kidney cancer and regulation of growth and migration of kidney cancer cells by GDF9.</title><secondary-title>Anticancer research</secondary-title></titles><periodical><full-title>Anticancer research</full-title></periodical><pages>4375-4383</pages><volume>32</volume><issue>10</issue><keywords><keyword>Carcinoma</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Growth Differentiation Factor 9</keyword><keyword>Growth Differentiation Factor 9: analysis</keyword><keyword>Growth Differentiation Factor 9: biosynthesis</keyword><keyword>Growth Differentiation Factor 9: genetics</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Kidney Neoplasms</keyword><keyword>Kidney Neoplasms: pathology</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Renal Cell</keyword><keyword>Renal Cell: pathology</keyword><keyword>Transfection</keyword><keyword>Tumor</keyword></keywords><dates><year>2012</year></dates><accession-num>23060562</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/23060562</url></web-urls></urls><abstract>Growth differentiation factor-9 (GDF9), a member of the bone morphogenetic protein (BMP) family and the transforming growth factor (TGF)-beta superfamily, has recently been implicated in the biological control of cancer cell behaviour. It has also been implicated in the development and spread of solid cancer. However, the role of GDF9 in kidney cancer remains to be investigated. In the present study, the expression of GDF9 in normal and malignant human kidney tissues and its molecular and cellular impact on human kidney cancer cells were investigated.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yuan, Lei</author><author>Le Bras, Alexandra</author><author>Sacharidou, Anastasia</author><author>Itagaki, Kiyoshi</author><author>Zhan, Yumei</author><author>Kondo, Maiko</author><author>Carman, Christopher V</author><author>Davis, George E</author><author>Aird, William C</author><author>Oettgen, Peter</author></authors></contributors><titles><title>ETS-related gene (ERG) controls endothelial cell permeability via transcriptional regulation of the claudin 5 (CLDN5) gene.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>6582-6591</pages><volume>287</volume><issue>9</issue><keywords><keyword>Adenoviridae</keyword><keyword>Adenoviridae: genetics</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Claudins</keyword><keyword>Claudins: genetics</keyword><keyword>Coronary Vessels</keyword><keyword>Coronary Vessels: cytology</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: physiology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: physiology</keyword><keyword>Microvessels</keyword><keyword>Microvessels: cytology</keyword><keyword>Mutagenesis</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Site-Directed</keyword><keyword>Trans-Activators</keyword><keyword>Trans-Activators: genetics</keyword><keyword>Trans-Activators: metabolism</keyword><keyword>Transcriptional Activation</keyword><keyword>Transcriptional Activation: physiology</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: pharmacology</keyword></keywords><dates><year>2012</year></dates><accession-num>22235125</accession-num><electronic-resource-num>10.1074/jbc.M111.300236</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22235125</url><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3307294&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>ETS-related gene (ERG) is a member of the ETS transcription factor family. Our previous studies have shown that ERG expression is highly enriched in endothelial cells (EC) both in vitro and in vivo. ERG expression is markedly repressed in response to inflammatory stimuli. It has been shown that ERG is a positive regulator of several EC-restricted genes including VE-cadherin, endoglin, and von Willebrand factor, and a negative regulator of other genes such as interleukin (IL)-8 and intercellular adhesion molecule (ICAM)-1. In this study we have identified a novel role for ERG in the regulation of EC barrier function. ERG knockdown results in marked increases in EC permeability. This is associated with a significant increase of stress fiber and gap formation in EC. Furthermore, we identify CLDN5 as a downstream target of ERG in EC. Thus, our results suggest that ERG plays a pivotal role in regulating EC barrier function and that this effect is mediated in part through its regulation of CLDN5 gene expression.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xie, Zhihui</author><author>Ghosh, Chandra C</author><author>Patel, Roshni</author><author>Iwaki, Shoko</author><author>Gaskins, Donna</author><author>Nelson, Celeste</author><author>Jones, Nina</author><author>Greipp, Philip R</author><author>Parikh, Samir M</author><author>Druey, Kirk M</author></authors></contributors><titles><title>Vascular endothelial hyperpermeability induces the clinical symptoms of Clarkson disease (the systemic capillary leak syndrome).</title><secondary-title>Blood</secondary-title></titles><periodical><full-title>Blood</full-title></periodical><pages>4321-4332</pages><volume>119</volume><issue>18</issue><keywords><keyword>Acute Disease</keyword><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: drug effects</keyword><keyword>Adherens Junctions: ultrastructure</keyword><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Angiopoietin-2</keyword><keyword>Angiopoietin-2: antagonists &amp; inhibitors</keyword><keyword>Angiopoietin-2: blood</keyword><keyword>Antibodies</keyword><keyword>Apoptosis</keyword><keyword>Apoptosis: drug effects</keyword><keyword>Capillary Leak Syndrome</keyword><keyword>Capillary Leak Syndrome: blood</keyword><keyword>Capillary Leak Syndrome: etiology</keyword><keyword>Capillary Leak Syndrome: physiopathology</keyword><keyword>Capillary Permeability</keyword><keyword>Cells</keyword><keyword>Chronic Disease</keyword><keyword>Convalescence</keyword><keyword>Cultured</keyword><keyword>Cultured: drug effects</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: ultrastructure</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelium</keyword><keyword>Female</keyword><keyword>Humanized</keyword><keyword>Humanized: pharmacology</keyword><keyword>Humans</keyword><keyword>Immunoglobulins</keyword><keyword>Intravenous</keyword><keyword>Intravenous: therapeutic use</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Monoclonal</keyword><keyword>Paraproteinemias</keyword><keyword>Paraproteinemias: blood</keyword><keyword>Paraproteinemias: complications</keyword><keyword>Recombinant Proteins</keyword><keyword>Recombinant Proteins: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: antagonists</keyword><keyword>Vascular Endothelial Growth Factor A: blood</keyword><keyword>Vascular Endothelial Growth Factor A: genetics</keyword><keyword>Vascular Endothelial Growth Factor A: pharmacology</keyword><keyword>Vascular: physiopathology</keyword></keywords><dates><year>2012</year></dates><accession-num>22411873</accession-num><electronic-resource-num>10.1182/blood-2011-08-375816</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3359743&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Apoptosis</label><abstract>The systemic capillary leak syndrome (SCLS) is a rare disorder characterized by transient episodes of hypotensive shock and anasarca thought to arise from reversible microvascular barrier dysfunction. Although the high prevalence of a monoclonal gammopathy of unknown significance in SCLS suggests a pathogenic contribution of endogenous immunoglobulins, the mechanisms of vascular hyperpermeability remain obscure. Herein, we report clinical and molecular findings on 23 patients, the largest SCLS case series to date. Application of episodic SCLS sera, but neither the purified immunoglobulin fraction nor sera obtained from patients during remission, to human microvascular endothelial cells caused vascular endothelial cadherin internalization, disruption of interendothelial junctions, actin stress fiber formation, and increased permeability in complementary functional assays without inducing endothelial apoptosis. Intravenous immunoglobulin, one promising therapy for SCLS, mitigated the permeability effects of episodic sera. Consistent with the presence of endogenous, nonimmunoglobulin, circulating permeability factor(s) constrained to SCLS episodes, we found that vascular endothelial growth factor (VEGF) and angiopoietin 2 (Ang2), were elevated in episodic SCLS sera but not in remission sera. Ab-based inhibition of Ang2 counteracted permeability induced by episodic SCLS sera. Comparable experiments with anti-VEGF Ab (bevacizumab) yielded less interpretable results, probably because of endothelial toxicity of VEGF withdrawal. Our results support a model of SCLS pathogenesis in which nonimmunoglobulin humoral factors such as VEGF and Ang2 contribute to transient endothelial contraction, suggesting a molecular mechanism for this highly lethal disorder.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ngok, Siu P</author><author>Geyer, Rory</author><author>Liu, Miaoliang</author><author>Kourtidis, Antonis</author><author>Agrawal, Sudesh</author><author>Wu, Chuanshen</author><author>Seerapu, Himabindu Reddy</author><author>Lewis-Tuffin, Laura J</author><author>Moodie, Karen L</author><author>Huveldt, Deborah</author><author>Marx, Ruth</author><author>Baraban, Jay M</author><author>Storz, Peter</author><author>Horowitz, Arie</author><author>Anastasiadis, Panos Z</author></authors></contributors><titles><title>VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx.</title><secondary-title>The Journal of cell biology</secondary-title></titles><periodical><full-title>The Journal of cell biology</full-title></periodical><pages>1103-1115</pages><volume>199</volume><issue>7</issue><keywords><keyword>Angiopoietin-1</keyword><keyword>Angiopoietin-1: physiology</keyword><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Carrier Proteins</keyword><keyword>Carrier Proteins: metabolism</keyword><keyword>Dogs</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: genetics</keyword><keyword>Guanine Nucleotide Exchange Factors: metabolism</keyword><keyword>Human Umbilical Vein Endothelial Cells</keyword><keyword>Human Umbilical Vein Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Knockout</keyword><keyword>Left</keyword><keyword>Left: genetics</keyword><keyword>Left: metabolism</keyword><keyword>Left: pathology</keyword><keyword>Madin Darby Canine Kidney Cells</keyword><keyword>Mice</keyword><keyword>Phosphorylation</keyword><keyword>Post-Translational</keyword><keyword>Protein Binding</keyword><keyword>Protein Processing</keyword><keyword>Protein Stability</keyword><keyword>Protein Transport</keyword><keyword>RNA Interference</keyword><keyword>Signal Transduction</keyword><keyword>Stroke Volume</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: physiology</keyword><keyword>Ventricular Dysfunction</keyword></keywords><dates><year>2012</year></dates><accession-num>23253477</accession-num><electronic-resource-num>10.1083/jcb.201207009</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3529520&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Vascular endothelial growth factor (VEGF) and Ang1 (Angiopoietin-1) have opposing effects on vascular permeability, but the molecular basis of these effects is not fully known. We report in this paper that VEGF and Ang1 regulate endothelial cell (EC) junctions by determining the localization of the RhoA-specific guanine nucleotide exchange factor Syx. Syx was recruited to junctions by members of the Crumbs polarity complex and promoted junction integrity by activating Diaphanous. VEGF caused translocation of Syx from cell junctions, promoting junction disassembly, whereas Ang1 maintained Syx at the junctions, inducing junction stabilization. The VEGF-induced translocation of Syx from EC junctions was caused by PKD1 (protein kinase D1)-mediated phosphorylation of Syx at Ser(806), which reduced Syx association to its junctional anchors. In support of the pivotal role of Syx in regulating EC junctions, syx(-/-) mice had defective junctions, resulting in vascular leakiness, edema, and impaired heart function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Conference Proceedings">3</ref-type><contributors><authors><author>Yang, Jhe-Hao Jen-Ming Jhe-Hao Jen-Ming</author><author>Chen, Szi-Wen</author><author>Yang, Jhe-Hao Jen-Ming Jhe-Hao Jen-Ming</author><author>Wang, Jong-Shyan</author></authors></contributors><titles><title>Computational modeling analysis for cell growth using Electric Cell-substrate Impedance Sensing (ECIS) based time series data</title><secondary-title>2011 4th International Conference on Biomedical Engineering and Informatics (BMEI)</secondary-title></titles><periodical><full-title>2011 4th International Conference on Biomedical Engineering and Informatics (BMEI)</full-title></periodical><pages>938-941</pages><keywords/><dates><year>2011</year></dates><publisher>IEEE</publisher><isbn>978-1-4244-9352-4</isbn><electronic-resource-num>10.1109/BMEI.2011.6098447</electronic-resource-num><urls><web-urls><url>http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=6098447</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Stolwijk, Judith A</author><author>Hartmann, Christoph</author><author>Balani, Poonam</author><author>Albermann, Silke</author><author>Keese, Charles R</author><author>Giaever, Ivar</author><author>Wegener, Joachim</author></authors></contributors><titles><title>Impedance analysis of adherent cells after in situ electroporation: non-invasive monitoring during intracellular manipulations.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>4720-4727</pages><volume>26</volume><issue>12</issue><keywords><keyword>Animals</keyword><keyword>Antibiotics</keyword><keyword>Antineoplastic</keyword><keyword>Antineoplastic: administration &amp; dosage</keyword><keyword>Bleomycin</keyword><keyword>Bleomycin: administration &amp; dosage</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Electric Impedance</keyword><keyword>Electroporation</keyword><keyword>Electroporation: instrumentation</keyword><keyword>Equipment Design</keyword><keyword>Fluorescent Dyes</keyword><keyword>Fluorescent Dyes: administration &amp; dosage</keyword><keyword>Humans</keyword><keyword>Kinetics</keyword></keywords><dates><year>2011</year></dates><accession-num>21684144</accession-num><electronic-resource-num>10.1016/j.bios.2011.05.033</electronic-resource-num><notes>From Duplicate 2 (Impedance analysis of adherent cells after in situ electroporation: non-invasive monitoring during intracellular manipulations. - Stolwijk, Judith A; Hartmann, Christoph; Balani, Poonam; Albermann, Silke; Keese, Charles R; Giaever, Ivar; Wegener, Joachim)

From Duplicate 2 ( Impedance analysis of adherent cells after in situ electroporation: non-invasive monitoring during intracellular manipulations. - Stolwijk, Judith A; Hartmann, Christoph; Balani, Poonam; Albermann, Silke; Keese, Charles R; Giaever, Ivar; Wegener, Joachim )</notes><research-notes>From Duplicate 2 (Impedance analysis of adherent cells after in situ electroporation: non-invasive monitoring during intracellular manipulations. - Stolwijk, Judith A; Hartmann, Christoph; Balani, Poonam; Albermann, Silke; Keese, Charles R; Giaever, Ivar; Wegener, Joachim)

From Duplicate 2 ( Impedance analysis of adherent cells after in situ electroporation: non-invasive monitoring during intracellular manipulations. - Stolwijk, Judith A; Hartmann, Christoph; Balani, Poonam; Albermann, Silke; Keese, Charles R; Giaever, Ivar; Wegener, Joachim )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21684144</url></web-urls></urls><label>ECIS Electroporation</label><abstract>In this study adherent animal cells were grown to confluence on circular gold-film electrodes of 250 μm diameter that had been deposited on the surface of a regular culture dish. The impedance of the cell-covered electrode was measured at designated frequencies to monitor the behavior of the cells with time. This approach is referred to as electric cell-substrate impedance sensing or short ECIS in the literature. The gold-film electrodes were also used to deliver well-defined AC voltage pulses of several volts amplitude and several hundred milliseconds duration to the adherent cells in order to achieve reversible membrane electroporation (in situ electroporation=ISE). Electroporation-assisted introduction of membrane impermeable molecules into the cytoplasm was studied by using FITC-labeled dextran molecules of different molecular weights. Probes as big as 2MDa were successfully loaded into the cells residing on the electrode surface. Time-resolved impedance measurements before and immediately after the electroporation pulse revealed the kinetics of membrane resealing as well as subsequent changes in cell morphology. Cells recovered from the electroporation pulse within less than 90 min. When membrane-impermeable, bioactive compounds like N(3)(-) or bleomycin were introduced into the cells by in situ electroporation, concomitant ECIS readings sensitively reported on the associated response of the cells to these toxins as a function of time (ISE-ECIS).</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Angstmann, Michael</author><author>Brinkmann, Irena</author><author>Bieback, Karen</author><author>Breitkreutz, Dirk</author><author>Maercker, Christian</author></authors></contributors><titles><title>Monitoring human mesenchymal stromal cell differentiation by electrochemical impedance sensing.</title><secondary-title>Cytotherapy</secondary-title></titles><periodical><full-title>Cytotherapy</full-title></periodical><pages>1074-1089</pages><volume>13</volume><issue>9</issue><keywords><keyword>Adipogenesis</keyword><keyword>Adipogenesis: physiology</keyword><keyword>Adipose Tissue</keyword><keyword>Adipose Tissue: metabolism</keyword><keyword>Antigens</keyword><keyword>Bone Marrow</keyword><keyword>Bone Marrow: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Growth Processes</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Differentiation</keyword><keyword>Differentiation: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Electrophysiology</keyword><keyword>Electrophysiology: methods</keyword><keyword>Feasibility Studies</keyword><keyword>High-Throughput Screening Assays</keyword><keyword>Humans</keyword><keyword>Induced Pluripotent Stem Cells</keyword><keyword>Induced Pluripotent Stem Cells: cytology</keyword><keyword>Induced Pluripotent Stem Cells: metabolism</keyword><keyword>Mesenchymal Stromal Cells</keyword><keyword>Mesenchymal Stromal Cells: cytology</keyword><keyword>Mesenchymal Stromal Cells: metabolism</keyword><keyword>Osteogenesis</keyword><keyword>Osteogenesis: physiology</keyword><keyword>Quality Control</keyword><keyword>Tissue Engineering</keyword><keyword>Tissue Engineering: methods</keyword><keyword>Tissue Engineering: standards</keyword><keyword>Transcriptional Activation</keyword></keywords><dates><year>2011</year></dates><accession-num>21619493</accession-num><electronic-resource-num>10.3109/14653249.2011.584863</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21619493</url></web-urls></urls><label>ECIS Differentiation;ECIS Migration</label><abstract>BACKGROUND AIMS: For their wide mesodermal differentiation potential, mesenchymal stromal/stem cells (MSC) are attractive candidates for tissue engineering. However, standardized quality control assays monitoring differentiation that are non-invasive and continuous over time are lacking. METHODS: We employed a non-invasive assay, using two different systems, to discriminate osteogenic and adipogenic differentiation of MSC by monitoring impedance. Fibroblasts and keratinocytes served as non-specific controls. Impedance profiles were recorded comparing MSC from bone marrow and adipose tissue, either non-induced or induced for osteogenesis or adipogenesis, for 5-14 days, and correlated with differentiation markers assessed by reverse transcription-quantitative polymerase chain reaction and Western blot. Additionally, differentiation modulating effects of extracellular matrix components were analyzed. RESULTS: Adhesion and growth-related impedance profiles of non-induced MSC roughly resembled those of fibroblasts, whereas keratinocytes differed significantly. Distinct from that, osteogenic induction of MSC revealed initially rapid and continuously rising impedance, corresponding to mineralized calcium matrix formation. Conversely, adipogenic induction caused shallower initial slopes and eventually declining profiles, corresponding to more compact, adipocyte-like cells with numerous lipid vacuoles. Pre-coating with either collagen type I or IV apparently favored osteogenesis and fibronectin adipogenesis. Impedance recordings correlated well with the extent of differentiation evaluated by histochemical staining and protein and gene expression. CONCLUSIONS: Overall, our data demonstrate that impedance profiling offers a basis for standardized real-time, non-invasive high-throughput screening of MSC properties. It enables further testing of the influence of diffusible factors or extracellular matrix composites on MSC differentiation or maintenance of stemness, thus substantiating therapeutic application.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hong, Jongin</author><author>Kandasamy, Karthikeyan</author><author>Marimuthu, Mohana</author><author>Choi, Cheol Soo</author><author>Kim, Sanghyo</author></authors></contributors><titles><title>Electrical cell-substrate impedance sensing as a non-invasive tool for cancer cell study.</title><secondary-title>The Analyst</secondary-title></titles><periodical><full-title>The Analyst</full-title></periodical><pages>237-245</pages><volume>136</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Antitumor</keyword><keyword>Antitumor: instrumentation</keyword><keyword>Antitumor: methods</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Culture Techniques</keyword><keyword>Culture Techniques: instrumentation</keyword><keyword>Culture Techniques: methods</keyword><keyword>Cytological Techniques</keyword><keyword>Cytological Techniques: instrumentation</keyword><keyword>Cytological Techniques: methods</keyword><keyword>Drug Screening Assays</keyword><keyword>Electric Impedance</keyword><keyword>Equipment Design</keyword><keyword>Humans</keyword><keyword>Neoplasms</keyword><keyword>Neoplasms: drug therapy</keyword><keyword>Neoplasms: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>20963234</accession-num><electronic-resource-num>10.1039/c0an00560f</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20963234</url></web-urls></urls><label>ECIS Review</label><abstract>Cell-substrate interactions are investigated in a number of studies for drug targets including angiogenesis, arteriosclerosis, chronic inflammatory diseases and carcinogenesis. One characteristic of malignant cancerous cells is their ability to invade tissue. Cell adhesion and cytoskeletal activity have served as valuable indicators for understanding the cancer cell behaviours, such as proliferation, migration and invasion. This review focuses on bio-impedance based measurement for monitoring the behaviours in real time and without using labels. Electric cell-substrate impedance sensing (ECIS) provides rich information about cell-substrate interactions, cell-cell communication and cell adhesion. High sensitivity of the ECIS method allows for observing events down to single-cell level and achieving nanoscale resolution of cell-substrate distances. Recently, its miniaturization and integration with fluorescent detection techniques have been highlighted as a new tool to deliver a high-content platform for anticancer drug development.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sanders, Andrew J</author><author>Jiang, David G</author><author>Jiang, Wen G</author><author>Harding, Keith G</author><author>Patel, Girish K</author></authors></contributors><titles><title>Activated leukocyte cell adhesion molecule impacts on clinical wound healing and inhibits HaCaT migration.</title><secondary-title>International wound journal</secondary-title></titles><periodical><full-title>International wound journal</full-title></periodical><pages>500-507</pages><volume>8</volume><issue>5</issue><keywords><keyword>Activated-Leukocyte Cell Adhesion Molecule</keyword><keyword>Activated-Leukocyte Cell Adhesion Molecule: biosyn</keyword><keyword>Activated-Leukocyte Cell Adhesion Molecule: geneti</keyword><keyword>Biopsy</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: genetics</keyword><keyword>Cell Movement</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>RNA</keyword><keyword>RNA: genetics</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Varicose Ulcer</keyword><keyword>Varicose Ulcer: genetics</keyword><keyword>Varicose Ulcer: metabolism</keyword><keyword>Varicose Ulcer: pathology</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: physiology</keyword></keywords><dates><year>2011</year></dates><accession-num>21816001</accession-num><electronic-resource-num>10.1111/j.1742-481X.2011.00823.x</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21816001</url></web-urls></urls><label>Wound Healing</label><abstract>Activated leukocyte cell adhesion molecule (ALCAM) is a glycoprotein of the immunoglobulin superfamily that has been implicated in the processes of cell adhesion and migration. The current study examines the importance of ALCAM in regulating HaCaT cell growth and migration and its potential to impact on wound healing. ALCAM levels were examined in a range of clinical wound and normal skin samples using Q-PCR and immunohistochemistry. ALCAM expression was targeted in HaCaT keratinocyte cells using a hammerhead ribozyme transgene system. Subsequently, the impact of ALCAM suppression on HaCaT migration and growth was assessed. ALCAM protein was detected mainly in keratinocytes. ALCAM transcript levels were found to be significantly higher in the non-healed chronic wound samples compared with healed samples (P = 0·026). In addition, targeting of ALCAM in HaCaT cells brought about a substantial increase in cellular migration and growth compared with HaCaT control cells.Our results suggest that ALCAM plays an important role in the migration of HaCaT keratinocyte cells. The data also suggests that higher levels of ALCAM may impair healing in chronic wounds. The impact of ALCAM in wound healing may thus be somewhat due to its impact on cell migration and growth.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schäfer, Edith</author><author>Westendorf, Christian</author><author>Bodenschatz, Eberhard</author><author>Beta, Carsten</author><author>Geil, Burkhard</author><author>Janshoff, Andreas</author></authors></contributors><titles><title>Shape oscillations of Dictyostelium discoideum cells on ultramicroelectrodes monitored by impedance analysis.</title><secondary-title>Small (Weinheim an der Bergstrasse, Germany)</secondary-title></titles><periodical><full-title>Small (Weinheim an der Bergstrasse, Germany)</full-title></periodical><pages>723-726</pages><volume>7</volume><issue>6</issue><keywords><keyword>Dictyostelium</keyword><keyword>Dictyostelium: cytology</keyword><keyword>Electric Impedance</keyword><keyword>Microelectrodes</keyword></keywords><dates><year>2011</year></dates><accession-num>21425455</accession-num><electronic-resource-num>10.1002/smll.201001955</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21425455</url></web-urls></urls><abstract>Time-resolved analysis employing electric cell–substrate impedance sensing reveals periodic impedance changes of small ensembles of Dictyostelium discoideum amoebae oscillating synchronously upon deprivation of food. Impedance changes are attributed to periodic alter­ations of cell shape and cell–substrate distance. Ultrasmall electrodes allow the detection of single cell traces.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Young, Erik F</author><author>Smilenov, Lubomir B</author></authors></contributors><titles><title>Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation</title><secondary-title>Radiation Research</secondary-title></titles><periodical><full-title>Radiation Research</full-title></periodical><pages>415-424</pages><volume>424</volume><keywords/><dates><year>2011</year></dates><electronic-resource-num>10.1667/RR2665.1</electronic-resource-num><notes>From Duplicate 1 (Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B)

From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )








From Duplicate 2 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )










From Duplicate 2 (Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B)

From Duplicate 2 (Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B)

From Duplicate 1 ( 

Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation

- Young, Erik F; Smilenov, Lubomir B )




From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )








From Duplicate 2 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )












From Duplicate 2 ( 

Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation

- Young, Erik F; Smilenov, Lubomir B )




From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )




From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )








From Duplicate 2 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )












From Duplicate 2 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )




From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )



From Duplicate 2 (Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B)

From Duplicate 1 ( Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B )



From Duplicate 2 ( Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B )</notes><research-notes>From Duplicate 1 (Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B)

From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )








From Duplicate 2 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )










From Duplicate 2 (Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B)

From Duplicate 2 (Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B)

From Duplicate 1 ( 

Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation

- Young, Erik F; Smilenov, Lubomir B )




From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )








From Duplicate 2 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )












From Duplicate 2 ( 

Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation

- Young, Erik F; Smilenov, Lubomir B )




From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )




From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )








From Duplicate 2 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )












From Duplicate 2 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )




From Duplicate 1 ( 


Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation


- Young, Erik F; Smilenov, Lubomir B )



From Duplicate 2 (Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B)

From Duplicate 1 ( Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B )



From Duplicate 2 ( Impedance-Based Surveillance of Transient Permeability Changes in Coronary Endothelial Monolayers after Exposure to Ionizing Radiation - Young, Erik F; Smilenov, Lubomir B )</research-notes><urls/><label>ECIS Micromotion;ECIS Modeling;ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sarrab, Ramadan M</author><author>Lennon, Rachel</author><author>Ni, Lan</author><author>Wherlock, Matthew D</author><author>Welsh, Gavin I</author><author>Saleem, Moin A</author></authors></contributors><titles><title>Establishment of conditionally immortalized human glomerular mesangial cells in culture, with unique migratory properties.</title><secondary-title>American journal of physiology. Renal physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Renal physiology</full-title></periodical><pages>F1131-8</pages><volume>301</volume><issue>5</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Antimetabolites</keyword><keyword>Antimetabolites: diagnostic use</keyword><keyword>Biological Markers</keyword><keyword>Blotting</keyword><keyword>Bromodeoxyuridine</keyword><keyword>Bromodeoxyuridine: diagnostic use</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cytological Techniques</keyword><keyword>Electrophysiological Phenomena</keyword><keyword>Endothelium</keyword><keyword>Endothelium: physiology</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: metabolism</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Immunoprecipitation</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Mesangial Cells</keyword><keyword>Mesangial Cells: metabolism</keyword><keyword>Mesangial Cells: physiology</keyword><keyword>Platelet-Derived Growth Factor beta</keyword><keyword>Platelet-Derived Growth Factor beta: biosynthesis</keyword><keyword>Podocytes</keyword><keyword>Podocytes: physiology</keyword><keyword>Receptor</keyword><keyword>Western</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: physiology</keyword></keywords><dates><year>2011</year></dates><accession-num>21653636</accession-num><electronic-resource-num>10.1152/ajprenal.00589.2010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3213908&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Wound Healing</label><abstract>The aim of this study was to establish an immortalized human mesangial cell line similar to mesangial cells in vivo for use as a tool for understanding glomerular cell function. Mesangial cells were isolated from glomerular outgrowths from a normal human kidney, then retrovirally transfected with a temperature-sensitive SV40T antigen+human telomerase (hTERT). Mesangial cells exhibited features of compact cells with small bodies in a confluent monolayer at 33°C, but the cell shape changed to flat and stellate after 5 days in growth-restrictive conditions (37°C). Western blot and immunofluorescence analysis showed that podocyte markers (nephrin, CD2AP, podocin, Wilms' tumor-1) and an endothelial-specific molecule (VE-cadherin) were not detectable in this cell line, whereas markers characteristic of mesangial cells (α-SMA, fibronectin, and PDGFβ-R) were strongly expressed. In migration assays, a significant reduction in wound surface was observed in podocyte and endothelial cells as soon as 12 h (75 and 62%, respectively) and complete wound closure after 24 h. In contrast, no significant change was observed in mesangial cells after 12 h, and even after 48 h the wounds were not completely closed. Until now, conditionally immortalized podocyte and endothelial cell lines derived from mice and humans have been described, and this has greatly boosted research on glomerular physiology and pathology. We have established the first conditionally immortalized human glomerular mesangial cell line, which will be an important adjunct in studies of representative glomerular cells, as well as in coculture studies. Unexpectedly, mesangial cells' ability to migrate seems to be slower than for other glomerular cells, suggesting this line will demonstrate functional properties distinct from previously available mesangial cell cultures. This conditionally immortalized human mesangial cell line represents a new tool for the study of human mesangial cell biology in vitro.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Singh, a</author><author>Fridén, V</author><author>Dasgupta, I</author><author>Foster, R R</author><author>Welsh, G I</author><author>Tooke, J E</author><author>Haraldsson, B</author><author>Mathieson, P W</author><author>Satchell, S C</author></authors></contributors><titles><title>High glucose causes dysfunction of the human glomerular endothelial glycocalyx.</title><secondary-title>American journal of physiology. Renal physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Renal physiology</full-title></periodical><pages>F40-8</pages><volume>300</volume><issue>1</issue><keywords><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Glucose</keyword><keyword>Glucose: administration &amp; dosage</keyword><keyword>Glucose: pharmacology</keyword><keyword>Glycocalyx</keyword><keyword>Glycocalyx: metabolism</keyword><keyword>Glycocalyx: ultrastructure</keyword><keyword>Glycosaminoglycans</keyword><keyword>Glycosaminoglycans: biosynthesis</keyword><keyword>Heparan Sulfate Proteoglycans</keyword><keyword>Heparan Sulfate Proteoglycans: biosynthesis</keyword><keyword>Humans</keyword><keyword>Kidney Glomerulus</keyword><keyword>Kidney Glomerulus: cytology</keyword><keyword>Kidney Glomerulus: drug effects</keyword><keyword>Kidney Glomerulus: physiopathology</keyword></keywords><dates><year>2011</year></dates><accession-num>20980411</accession-num><electronic-resource-num>10.1152/ajprenal.00103.2010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3023224&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>The endothelial glycocalyx is a gel-like layer which covers the luminal side of blood vessels. The glomerular endothelial cell (GEnC) glycocalyx is composed of proteoglycan core proteins, glycosaminoglycan (GAG) chains, and sialoglycoproteins and has been shown to contribute to the selective sieving action of the glomerular capillary wall. Damage to the systemic endothelial glycocalyx has recently been associated with the onset of albuminuria in diabetics. In this study, we analyze the effects of high glucose on the biochemical structure of the GEnC glycocalyx and quantify functional changes in its protein-restrictive action. We used conditionally immortalized human GEnC. Proteoglycans were analyzed by Western blotting and indirect immunofluorescence. Biosynthesis of GAG was analyzed by radiolabeling and quantified by anion exchange chromatography. FITC-albumin was used to analyze macromolecular passage across GEnC monolayers using an established in vitro model. We observed a marked reduction in the biosynthesis of GAG by the GEnC under high-glucose conditions. Further analysis confirmed specific reduction in heparan sulfate GAG. Expression of proteoglycan core proteins remained unchanged. There was also a significant increase in the passage of albumin across GEnC monolayers under high-glucose conditions without affecting interendothelial junctions. These results reproduce changes in GEnC barrier properties caused by enzymatic removal of heparan sulfate from the GEnC glycocalyx. They provide direct evidence of high glucose-induced alterations in the GEnC glycocalyx and demonstrate changes to its function as a protein-restrictive layer, thus implicating glycocalyx damage in the pathogenesis of proteinuria in diabetes.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>von Wedel-Parlow, Magdalena</author><author>Schrot, Sebastian</author><author>Lemmen, Julia</author><author>Treeratanapiboon, Lertyot</author><author>Wegener, Joachim</author><author>Galla, Hans-Joachim</author></authors></contributors><titles><title>Neutrophils cross the BBB primarily on transcellular pathways: an in vitro study.</title><secondary-title>Brain research</secondary-title></titles><periodical><full-title>Brain research</full-title></periodical><pages>62-76</pages><volume>1367</volume><keywords><keyword>Animals</keyword><keyword>Atomic Force</keyword><keyword>Atomic Force: methods</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: metabolism</keyword><keyword>Blood-Brain Barrier: ultrastructure</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Electron</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Epithelial Cells: ultrastructure</keyword><keyword>Fluoresceins</keyword><keyword>Fluoresceins: metabolism</keyword><keyword>Microscopy</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: physiology</keyword><keyword>Neutrophils: ultrastructure</keyword><keyword>Scanning</keyword><keyword>Scanning: methods</keyword><keyword>Swine</keyword><keyword>Transcytosis</keyword><keyword>Transcytosis: physiology</keyword></keywords><dates><year>2011</year></dates><publisher>Elsevier B.V.</publisher><accession-num>20875807</accession-num><electronic-resource-num>10.1016/j.brainres.2010.09.076</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20875807</url></web-urls></urls><label>Blood Brain Barrier;ECIS Modeling;ECIS TEER</label><abstract>The cerebral microcapillary endothelium forms a highly important barrier between the blood and the interstitial fluid of the brain (blood-brain barrier) that controls the passage of molecules and cells in and out of the CNS. Several CNS diseases include leukocyte extravasation through the endothelium via two mechanistically distinct routes, the paracellular and the transcellular pathway. We established a new in vitro model of the inflamed blood-brain barrier consisting of primary cultured porcine brain capillary endothelial cells which express a tight endothelial barrier even under inflammatory conditions. By means of this specialized blood-brain barrier model we extensively studied the transmigration of neutrophils. Electron and scanning force microscopy as well as immunofluorescence imaging captured the penetrating neutrophil on the endothelial cellular body in between the junctions clearly suggesting a transcellular migration pathway. Electric cell-substrate impedance sensing and transendothelial electrical resistance measurements in combination with expression analysis of tight junction proteins demonstrate that the neutrophil-endothelial interaction does not disrupt the barrier. In conclusion, this study, based on an in vitro model of the blood-brain barrier under inflammatory conditions, evidently implicates that neutrophils preferentially migrate across the BBB via the transcellular route without impairing endothelial barrier function whereas paracellular transmigration plays only a minor role if the barrier is strongly expressed.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tarantola, Marco</author><author>Sunnick, Eva</author><author>Schneider, David</author><author>Marel, Anna-Kristina</author><author>Kunze, Angelika</author><author>Janshoff, Andreas</author></authors></contributors><titles><title>Dynamic changes of acoustic load and complex impedance as reporters for the cytotoxicity of small molecule inhibitors.</title><secondary-title>Chemical research in toxicology</secondary-title></titles><periodical><full-title>Chemical research in toxicology</full-title></periodical><pages>1494-1506</pages><volume>24</volume><issue>9</issue><keywords/><dates><year>2011</year></dates><accession-num>21815656</accession-num><electronic-resource-num>10.1021/tx200115q</electronic-resource-num><notes>From Duplicate 1 (Dynamic changes of acoustic load and complex impedance as reporters for the cytotoxicity of small molecule inhibitors. - Tarantola, Marco; Sunnick, Eva; Schneider, David; Marel, Anna-Kristina; Kunze, Angelika; Janshoff, Andreas)

From Duplicate 1 ( Dynamic changes of acoustic load and complex impedance as reporters for the cytotoxicity of small molecule inhibitors. - Tarantola, Marco; Sunnick, Eva; Schneider, David; Marel, Anna-Kristina; Kunze, Angelika; Janshoff, Andreas )



From Duplicate 2 ( Dynamic changes of acoustic load and complex impedance as reporters for the cytotoxicity of small molecule inhibitors. - Tarantola, Marco; Sunnick, Eva; Schneider, David; Marel, Anna-Kristina; Kunze, Angelika; Janshoff, Andreas )</notes><research-notes>From Duplicate 1 (Dynamic changes of acoustic load and complex impedance as reporters for the cytotoxicity of small molecule inhibitors. - Tarantola, Marco; Sunnick, Eva; Schneider, David; Marel, Anna-Kristina; Kunze, Angelika; Janshoff, Andreas)

From Duplicate 1 ( Dynamic changes of acoustic load and complex impedance as reporters for the cytotoxicity of small molecule inhibitors. - Tarantola, Marco; Sunnick, Eva; Schneider, David; Marel, Anna-Kristina; Kunze, Angelika; Janshoff, Andreas )



From Duplicate 2 ( Dynamic changes of acoustic load and complex impedance as reporters for the cytotoxicity of small molecule inhibitors. - Tarantola, Marco; Sunnick, Eva; Schneider, David; Marel, Anna-Kristina; Kunze, Angelika; Janshoff, Andreas )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21815656</url></web-urls></urls><label>ECIS Cytotoxicity;ECIS Micromotion</label><abstract>Cellular motility is the major driving force of numerous biological phenomena including wound healing, immune response, embryogenesis, cancer formation, and metastasis. We studied the response of epithelial FaDu monolayers cultured on gold electrodes of an acoustic resonator (quartz crystal microbalance, QCM) and impedance sensor (electric cell-substrate impedance sensing, ECIS) to externally applied chemical stimuli interfering with cytoskeleton organization. Epithelial cell motility of confluent monolayers is characterized by subtle cell shape changes and variations in the cell-substrate as well as cell-cell distance without net directionality of individual cells. The impact of small molecules such as cytochalasin D, phalloidin, and blebbistatin as well as paclitaxel, nocodazol, and colchicin on actin and microtubules organization was quantified by conventional sensors' readouts and by comparing the noise pattern of the signals which is attributed to cellular dynamics. The responsiveness of noninvasive and label-free techniques relying on cellular dynamics is compared to classical viability assays and changes of the overall impedance of ultrasmall electrodes or acoustic loads of a thickness shear mode resonator. Depending on the agent used, a distinct sensor response was found, which can be used as a fingerprint of the cellular response. Cytoskeletal rearrangements and nuclear integrity were corroborated by fluorescence microscopy and correlated to the readouts of QCM and ECIS.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Halterman, Julia A</author><author>Kwon, H Moo</author><author>Zargham, Ramin</author><author>Bortz, Pamela D Schoppee</author><author>Wamhoff, Brian R</author></authors></contributors><titles><title>Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation.</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arteriosclerosis, thrombosis, and vascular biology</full-title></periodical><pages>2287-2296</pages><volume>31</volume><issue>10</issue><keywords><keyword>Actins</keyword><keyword>Actins: genetics</keyword><keyword>Actins: metabolism</keyword><keyword>Angiotensin II</keyword><keyword>Angiotensin II: metabolism</keyword><keyword>Animal</keyword><keyword>Animals</keyword><keyword>Apolipoproteins E</keyword><keyword>Apolipoproteins E: deficiency</keyword><keyword>Apolipoproteins E: genetics</keyword><keyword>Atherosclerosis</keyword><keyword>Atherosclerosis: genetics</keyword><keyword>Atherosclerosis: metabolism</keyword><keyword>Atherosclerosis: pathology</keyword><keyword>Binding Sites</keyword><keyword>Carotid Artery Injuries</keyword><keyword>Carotid Artery Injuries: genetics</keyword><keyword>Carotid Artery Injuries: metabolism</keyword><keyword>Carotid Artery Injuries: pathology</keyword><keyword>Cell Movement</keyword><keyword>Cell Proliferation</keyword><keyword>Cells</keyword><keyword>Chromatin Immunoprecipitation</keyword><keyword>Coculture Techniques</keyword><keyword>Computational Biology</keyword><keyword>Cultured</keyword><keyword>Disease Models</keyword><keyword>Gene Expression Regulation</keyword><keyword>Genes</keyword><keyword>Genetic</keyword><keyword>Humans</keyword><keyword>Hyperplasia</keyword><keyword>Introns</keyword><keyword>Knockout</keyword><keyword>Messenger</keyword><keyword>Messenger: metabolism</keyword><keyword>Mice</keyword><keyword>Muscle</keyword><keyword>Myocytes</keyword><keyword>NFATC Transcription Factors</keyword><keyword>NFATC Transcription Factors: genetics</keyword><keyword>NFATC Transcription Factors: metabolism</keyword><keyword>Phenotype</keyword><keyword>Platelet-Derived Growth Factor</keyword><keyword>Platelet-Derived Growth Factor: metabolism</keyword><keyword>Promoter Regions</keyword><keyword>Protein Transport</keyword><keyword>RNA</keyword><keyword>RNA Interference</keyword><keyword>Rats</keyword><keyword>Reporter</keyword><keyword>Smooth</keyword><keyword>Smooth Muscle</keyword><keyword>Smooth Muscle: metabolism</keyword><keyword>Smooth Muscle: pathology</keyword><keyword>Transcription Factors</keyword><keyword>Transcription Factors: metabolism</keyword><keyword>Transfection</keyword><keyword>Tunica Intima</keyword><keyword>Tunica Intima: metabolism</keyword><keyword>Tunica Intima: pathology</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: pathology</keyword></keywords><dates><year>2011</year></dates><accession-num>21757659</accession-num><electronic-resource-num>10.1161/ATVBAHA.111.232165</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3188807&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>The tonicity-responsive transcription factor, nuclear factor of activated T cells 5 (NFAT5/tonicity enhancer binding protein [TonEBP]), has been well characterized in numerous cell types; however, NFAT5 function in vascular smooth muscle cells (SMCs) is unknown. Our main objective was to determine the role of NFAT5 regulation in SMCs.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Starosta, Vitaliy</author><author>Wu, Tinghuai</author><author>Zimman, Alejandro</author><author>Pham, Donald</author><author>Tian, Xinyong</author><author>Oskolkova, Olga</author><author>Bochkov, Valery</author><author>Berliner, Judith A</author><author>Birukova, Anna A</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Differential Regulation of Endothelial Cell Permeability by High and low Doses of OxPAPC.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><keywords/><dates><year>2011</year></dates><accession-num>21997484</accession-num><electronic-resource-num>10.1165/rcmb.2011-0153OC</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21997484</url></web-urls></urls><abstract>Generation of phospholipid oxidation products in atherosclerosis, sepsis and lung pathologies affects endothelial barrier function which has significant consequences on disease outcome in general. Our group has shown that OxPAPC at low concentrations increases endothelial cell (EC) barrier function but decreases it at higher concentrations. In this study we determined the mechanisms responsible for the pulmonary endothelial cell barrier dysfunction induced by high OxPAPC concentrations. OxPAPC in the 5-20 µg/ml range enhanced EC barrier monitored by increased ransendothelial electrical resistance. In contrast, higher OxPAPC concentrations (50-100 µg/ml) rapidly increased EC permeability, which was accompanied by increased total cell protein tyrosine phosphorylation, phosphorylation at Tyr-418 and activation of Src kinase, and phosphorylation of adherens junction (AJ) protein VE-cadherin at Tyr-731 and Tyr-658, which was not observed in EC stimulated with low OxPAPC doses. Early tyrosine phosphorylation of VE-cadherin was linked to dissociation of VE-cadherin - p120-catenin/β-catenin complexes and VE-cadherin internalization, while low OxPAPC doses promoted VE-cadherin - p120-catenin/β-catenin complex formation. High, but not low OxPAPC doses increased ROS production and protein oxidation. Inhibition of Src by PP2 and ROS production by NAC inhibited disassembly of VE-cadherin - p120-catenin complexes and attenuated high OxPAPC-induced EC barrier disruption. These results show differential effects of OxPAPC doses on VE-cadherin - p120-catenin complex assembly and EC barrier function. These data suggest that rapid tyrosine phosphorylation of VE-cadherin and other potential targets mediated by Src and ROS-dependent mechanisms plays a key role in dissociation of AJ complexes and EC barrier dysfunction induced by high OxPAPC doses.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schneider, David</author><author>Tarantola, Marco</author><author>Janshoff, Andreas</author></authors></contributors><titles><title>Dynamics of TGF-β induced epithelial-to-mesenchymal transition monitored by Electric Cell-Substrate Impedance Sensing.</title><secondary-title>Biochimica et biophysica acta</secondary-title></titles><periodical><full-title>Biochimica et biophysica acta</full-title></periodical><pages>2099-2107</pages><volume>1813</volume><issue>12</issue><keywords><keyword>Detrended fluctuation analysis</keyword><keyword>Epithelial-to-mesenchymal transition</keyword><keyword>Variance</keyword><keyword>electric cell-substrate impedance sensing</keyword></keywords><dates><year>2011</year></dates><publisher>Elsevier B.V.</publisher><accession-num>21839117</accession-num><electronic-resource-num>10.1016/j.bbamcr.2011.07.016</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21839117</url></web-urls></urls><label>ECIS Differentiation;ECIS Micromotion</label><abstract>The epithelial-to-mesenchymal transition (EMT) is a program of cellular development associated with loss of cell-cell contacts, a decreased cell adhesion and substantial morphological changes. Besides its importance for numerous developmental processes, EMT has also been held responsible for the development and progression of tumors and formation of metastases. The influence of the cytokine transforming growth factor β1 (TGF-β1) induced EMT on structure, migration, cytoskeletal dynamics and long-term correlations of the mammalian epithelial cell lines NMuMG, A549 and MDA-MB231 was investigated with time-resolved impedance analysis. The three cell lines show important differences in concentration dependency, cellular morphology and dynamics upon their response to TGF-β1. A549 cells and the non-tumor mouse epithelial cell line NMuMG show a substantial change in morphology mirrored in stepwise changes of their phenotype upon cytokine treatment. Impedance based measurements of micromotility reveal a complex dynamic response to TGF-β1 exposure which leads to a transient increase in fluctuation amplitude and long-term correlation. These changes in fluctuation amplitude are also detectable for MDA-MB231 cells, whereas the long-term correlation remains unvaried. We were able to distinguish three time domains during EMT. Initially, all cell lines display an increase in micromotion lasting 4 to 9h termed transitional state I. This regime is followed by transitional state II lasting approximately 20h, where cellular dynamics are diminished and, in case of the NMuMG cell line, a loss of cell-cell contacts occurs. Finally, the transformation into the mesenchymal-like phenotype occurs 24-30h after exposure to TGF-β1.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Raufman, Jean-Pierre</author><author>Cheng, Kunrong</author><author>Saxena, Neeraj</author><author>Chahdi, Ahmed</author><author>Belo, Angelica</author><author>Khurana, Sandeep</author><author>Xie, Guofeng</author></authors></contributors><titles><title>Muscarinic receptor agonists stimulate matrix metalloproteinase 1-dependent invasion of human colon cancer cells.</title><secondary-title>Biochemical and biophysical research communications</secondary-title></titles><periodical><full-title>Biochemical and biophysical research communications</full-title></periodical><pages>319-324</pages><volume>415</volume><issue>2</issue><keywords><keyword>Acetylcholine</keyword><keyword>Acetylcholine: metabolism</keyword><keyword>Acetylcholine: pharmacology</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Colonic Neoplasms</keyword><keyword>Colonic Neoplasms: enzymology</keyword><keyword>Colonic Neoplasms: pathology</keyword><keyword>HT29 Cells</keyword><keyword>Humans</keyword><keyword>Matrix Metalloproteinase 1</keyword><keyword>Matrix Metalloproteinase 1: genetics</keyword><keyword>Matrix Metalloproteinase 1: metabolism</keyword><keyword>Muscarinic</keyword><keyword>Muscarinic Agonists</keyword><keyword>Muscarinic Agonists: pharmacology</keyword><keyword>Muscarinic: metabolism</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Receptors</keyword><keyword>Taurodeoxycholic Acid</keyword><keyword>Taurodeoxycholic Acid: pharmacology</keyword></keywords><dates><year>2011</year></dates><accession-num>22027145</accession-num><electronic-resource-num>10.1016/j.bbrc.2011.10.052</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3221914&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Mammalian matrix metalloproteinases (MMPs) which degrade extracellular matrix facilitate colon cancer cell invasion into the bloodstream and extra-colonic tissues; in particular, MMP1 expression correlates strongly with advanced colon cancer stage, hematogenous metastasis and poor prognosis. Likewise, muscarinic receptor signaling plays an important role in colon cancer; muscarinic receptors are over-expressed in colon cancer compared to normal colon epithelial cells. Muscarinic receptor activation stimulates proliferation, migration and invasion of human colon cancer cells. In mouse intestinal neoplasia models genetic ablation of muscarinic receptors attenuates carcinogenesis. In the present work, we sought to link these observations by showing that MMP1 expression and activation plays a mechanistic role in muscarinic receptor agonist-induced colon cancer cell invasion. We show that acetylcholine, which robustly increases MMP1 expression, stimulates invasion of HT29 and H508 human colon cancer cells into human umbilical vein endothelial cell monolayers - this was abolished by pre-incubation with atropine, a non-selective muscarinic receptor inhibitor, and by pre-incubation with anti-MMP1 neutralizing antibody. Similar results were obtained using a Matrigel chamber assay and deoxycholyltaurine (DCT), an amidated dihydroxy bile acid associated with colon neoplasia in animal models and humans, and previously shown to interact functionally with muscarinic receptors. DCT treatment of human colon cancer cells resulted in time-dependent, 10-fold increased MMP1 expression, and DCT-induced cell invasion was also blocked by pre-treatment with anti-MMP1 antibody. This study contributes to understanding mechanisms underlying muscarinic receptor agonist-induced promotion of colon cancer and, more importantly, indicates that blocking MMP1 expression and activation has therapeutic promise to stop or retard colon cancer invasion and dissemination.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chen, W</author><author>Gassner, B</author><author>Borner, S</author><author>Nikolaev, V O</author><author>Schlegel, N</author><author>Waschke, J</author><author>Steinbronn, N</author><author>Strasser, R</author><author>Kuhn, M</author></authors></contributors><titles><title>Atrial natriuretic peptide enhances microvascular albumin permeability by the caveolae-mediated transcellular pathway</title><secondary-title>Cardiovascular Research</secondary-title></titles><periodical><full-title>Cardiovascular Research</full-title></periodical><pages>141-151</pages><volume>93</volume><issue>1</issue><keywords><keyword>atrial natriuretic peptide</keyword><keyword>caveolin-1</keyword><keyword>microvessel permeability</keyword></keywords><dates><year>2011</year></dates><electronic-resource-num>10.1093/cvr/cvr279</electronic-resource-num><urls><web-urls><url>http://cardiovascres.oxfordjournals.org/cgi/doi/10.1093/cvr/cvr279</url></web-urls></urls><label>ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Stokman, Geurt</author><author>Qin, Yu</author><author>Genieser, Hans-Gottfried</author><author>Schwede, Frank</author><author>de Heer, Emile</author><author>Bos, Johannes L</author><author>Bajema, Ingeborg M</author><author>van de Water, Bob</author><author>Price, Leo S</author></authors></contributors><titles><title>Epac-Rap signaling reduces cellular stress and ischemia-induced kidney failure.</title><secondary-title>Journal of the American Society of Nephrology : JASN</secondary-title></titles><periodical><full-title>Journal of the American Society of Nephrology : JASN</full-title></periodical><pages>859-872</pages><volume>22</volume><issue>5</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: physiology</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Hypoxia</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: physiology</keyword><keyword>Cyclic AMP: analogs &amp; derivatives</keyword><keyword>Cyclic AMP: pharmacology</keyword><keyword>Focal Adhesions</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: physiology</keyword><keyword>Inbred C57BL</keyword><keyword>Ischemia</keyword><keyword>Ischemia: complications</keyword><keyword>Kidney</keyword><keyword>Kidney Tubules</keyword><keyword>Kidney: blood supply</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Physiological</keyword><keyword>Proximal</keyword><keyword>Proximal: metabolism</keyword><keyword>Renal Insufficiency</keyword><keyword>Renal Insufficiency: etiology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Stress</keyword><keyword>rap1 GTP-Binding Proteins</keyword><keyword>rap1 GTP-Binding Proteins: physiology</keyword></keywords><dates><year>2011</year></dates><accession-num>21493776</accession-num><electronic-resource-num>10.1681/ASN.2010040423</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3083308&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Renal ischemia-reperfusion injury is associated with the loss of tubular epithelial cell-cell and cell-matrix interactions which contribute to renal failure. The Epac-Rap signaling pathway is a potent regulator of cell-cell and cell-matrix adhesion. The cyclic AMP analogue 8-pCPT-2'-O-Me-cAMP has been shown to selectively activate Epac, whereas the addition of an acetoxymethyl (AM) ester to 8-pCPT-2'-O-Me-cAMP enhanced in vitro cellular uptake. Here we demonstrate that pharmacological activation of Epac-Rap signaling using acetoxymethyl-8-pCPT-2'-O-Me-cAMP preserves cell adhesions during hypoxia in vitro, maintaining the barrier function of the epithelial monolayer. Intrarenal administration in vivo of 8-pCPT-2'-O-Me-cAMP also reduced renal failure in a mouse model for ischemia-reperfusion injury. This was accompanied by decreased expression of the tubular cell stress marker clusterin-α, and lateral expression of β-catenin after ischemia indicative of sustained tubular barrier function. Our study emphasizes the undervalued importance of maintaining tubular epithelial cell adhesion in renal ischemia and demonstrates the potential of pharmacological modulation of cell adhesion as a new therapeutic strategy to reduce the extent of injury in kidney disease and transplantation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wang, Youxue</author><author>Zang, Qun S</author><author>Liu, Zijuan</author><author>Wu, Qian</author><author>Maass, David</author><author>Dulan, Genevieve</author><author>Shaul, Philip W</author><author>Melito, Lisa</author><author>Frantz, Doug E</author><author>Kilgore, Jessica A</author><author>Williams, Noelle S</author><author>Terada, Lance S</author><author>Nwariaku, Fiemu E</author></authors></contributors><titles><title>Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C695-704</pages><volume>301</volume><issue>3</issue><keywords/><dates><year>2011</year></dates><accession-num>21653897</accession-num><electronic-resource-num>10.1152/ajpcell.00322.2010</electronic-resource-num><notes>From Duplicate 2 (Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. - Wang, Youxue; Zang, Qun S; Liu, Zijuan; Wu, Qian; Maass, David; Dulan, Genevieve; Shaul, Philip W; Melito, Lisa; Frantz, Doug E; Kilgore, Jessica A; Williams, Noelle S; Terada, Lance S; Nwariaku, Fiemu E)

From Duplicate 1 ( Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. - Wang, Youxue; Zang, Qun S; Liu, Zijuan; Wu, Qian; Maass, David; Dulan, Genevieve; Shaul, Philip W; Melito, Lisa; Frantz, Doug E; Kilgore, Jessica A; Williams, Noelle S; Terada, Lance S; Nwariaku, Fiemu E )



From Duplicate 2 ( Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. - Wang, Youxue; Zang, Qun S; Liu, Zijuan; Wu, Qian; Maass, David; Dulan, Genevieve; Shaul, Philip W; Melito, Lisa; Frantz, Doug E; Kilgore, Jessica A; Williams, Noelle S; Terada, Lance S; Nwariaku, Fiemu E )</notes><research-notes>From Duplicate 2 (Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. - Wang, Youxue; Zang, Qun S; Liu, Zijuan; Wu, Qian; Maass, David; Dulan, Genevieve; Shaul, Philip W; Melito, Lisa; Frantz, Doug E; Kilgore, Jessica A; Williams, Noelle S; Terada, Lance S; Nwariaku, Fiemu E)

From Duplicate 1 ( Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. - Wang, Youxue; Zang, Qun S; Liu, Zijuan; Wu, Qian; Maass, David; Dulan, Genevieve; Shaul, Philip W; Melito, Lisa; Frantz, Doug E; Kilgore, Jessica A; Williams, Noelle S; Terada, Lance S; Nwariaku, Fiemu E )



From Duplicate 2 ( Regulation of VEGF-induced endothelial cell migration by mitochondrial reactive oxygen species. - Wang, Youxue; Zang, Qun S; Liu, Zijuan; Wu, Qian; Maass, David; Dulan, Genevieve; Shaul, Philip W; Melito, Lisa; Frantz, Doug E; Kilgore, Jessica A; Williams, Noelle S; Terada, Lance S; Nwariaku, Fiemu E )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3174570&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration</label><abstract>Endothelial migration is a crucial aspect of a variety of physiologic and pathologic conditions including atherosclerosis and vascular repair. Reactive oxygen species (ROS) function as second messengers during endothelial migration. Multiple intracellular sources of ROS are regulated by cellular context, external stimulus, and the microenvironment. However, the predominant source of ROS during endothelial cell (EC) migration and the mechanisms by which ROS regulate cell migration are incompletely understood. In this study, we tested the hypothesis that mitochondria-derived ROS (mtROS) regulate EC migration. In cultured human umbilical vein endothelial cells, VEGF increased mitochondrial metabolism, promoted mtROS production, and induced cell migration. Either the targeted mitochondrial delivery of the antioxidant, vitamin E (Mito-Vit-E), or the depletion of mitochondrial DNA abrogated VEGF-mediated mtROS production. Overexpression of mitochondrial catalase also inhibited VEGF-induced mitochondrial metabolism, Rac activation, and cell migration. Furthermore, these interventions suppressed VEGF-stimulated EC migration and blocked Rac1 activation in endothelial cells. Constitutively active Rac1 reversed Mito-Vit-E-induced inhibition of EC migration. Mito-Vit-E also attenuated carotid artery reendothelialization in vivo. These results provide strong evidence that mtROS regulate EC migration through Rac-1.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Müller, Jakob</author><author>Thirion, Christian</author><author>Pfaffl, Michael W</author></authors></contributors><titles><title>Electric cell-substrate impedance sensing (ECIS) based real-time measurement of titer dependent cytotoxicity induced by adenoviral vectors in an IPI-2I cell culture model.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>2000-2005</pages><volume>26</volume><issue>5</issue><keywords><keyword>Adenoviridae</keyword><keyword>Adenoviridae: genetics</keyword><keyword>Adenoviridae: physiology</keyword><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Biological Assay</keyword><keyword>Biological Assay: instrumentation</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Cell Line</keyword><keyword>Computer Systems</keyword><keyword>Conductometry</keyword><keyword>Conductometry: instrumentation</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Epithelial Cells: virology</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Genetic Vectors</keyword><keyword>Genetic Vectors: administration &amp; dosage</keyword><keyword>Swine</keyword></keywords><dates><year>2011</year></dates><accession-num>20875729</accession-num><electronic-resource-num>10.1016/j.bios.2010.08.075</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20875729</url></web-urls></urls><label>Apoptosis;ECIS Cytotoxicity</label><abstract>Recombinant viral vectors are widespread tools for transfer of genetic material in various modern biotechnological applications like for example RNA interference (RNAi). However, an accurate and reproducible titer assignment represents the basic step for most downstream applications regarding a precise multiplicity of infection (MOI) adjustment. As necessary scaffold for the studies described in this work we introduce a quantitative real-time PCR (qPCR) based approach for viral particle measurement. Still an implicated problem concerning physiological effects is that the appliance of viral vectors is often attended by toxic effects on the individual target. To determine the critical viral dose leading to cell death we developed an electric cell-substrate impedance sensing (ECIS) based assay. With ECIS technology the impedance change of a current flow through the cell culture medium in an array plate is measured in a non-invasive manner, visualizing effects like cell attachment, cell-cell contacts or proliferation. Here we describe the potential of this online measurement technique in an in vitro model using the porcine ileal epithelial cell line IPI-2I in combination with an adenoviral transfection vector (Ad5-derivate). This approach shows a clear dose-depending toxic effect, as the amount of applied virus highly correlates (p&lt;0.001) with the level of cell death. Thus this assay offers the possibility to discriminate the minimal non-toxic dose of the individual transfection method. In addition this work suggests that the ECIS-device bears the feasibility to transfer this assay to multiple other cytotoxicological questions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ebrahimi, Celia M</author><author>Sheen, Tamsin R</author><author>Renken, Christian W</author><author>Gottlieb, Roberta a</author><author>Doran, Kelly S</author></authors></contributors><titles><title>Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.</title><secondary-title>Infection and immunity</secondary-title></titles><periodical><full-title>Infection and immunity</full-title></periodical><pages>2510-2518</pages><volume>79</volume><issue>7</issue><keywords><keyword>Animals</keyword><keyword>Anthrax</keyword><keyword>Anthrax: microbiology</keyword><keyword>Anthrax: mortality</keyword><keyword>Anthrax: pathology</keyword><keyword>Antigens</keyword><keyword>Autophagy</keyword><keyword>Bacillus anthracis</keyword><keyword>Bacillus anthracis: genetics</keyword><keyword>Bacillus anthracis: pathogenicity</keyword><keyword>Bacterial</keyword><keyword>Bacterial Toxins</keyword><keyword>Bacterial Toxins: biosynthesis</keyword><keyword>Bacterial Toxins: genetics</keyword><keyword>Bacterial Toxins: metabolism</keyword><keyword>Bacterial: biosynthesis</keyword><keyword>Bacterial: genetics</keyword><keyword>Bacterial: metabolism</keyword><keyword>Bacterial: microbiology</keyword><keyword>Bacterial: mortality</keyword><keyword>Bacterial: pathology</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: microbiology</keyword><keyword>Blood-Brain Barrier: pathology</keyword><keyword>Brain</keyword><keyword>Brain: blood supply</keyword><keyword>Brain: pathology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Humans</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Meningitis</keyword><keyword>Mice</keyword><keyword>Microvessels</keyword><keyword>Microvessels: pathology</keyword><keyword>Mutation</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: ultrastructure</keyword></keywords><dates><year>2011</year></dates><accession-num>21518787</accession-num><electronic-resource-num>10.1128/IAI.00006-11</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3191953&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier;ECIS Invasion;ECIS TEER</label><abstract>Bacillus anthracis is a Gram-positive spore-forming bacterium that causes anthrax disease in humans and animals. Systemic infection is characterized by septicemia, toxemia, and meningitis, the main neurological complication associated with high mortality. We have shown previously that B. anthracis Sterne is capable of blood-brain barrier (BBB) penetration, establishing the classic signs of meningitis, and that infection is dependent on the expression of both major anthrax toxins, lethal toxin (LT) and edema toxin (ET). Here we further investigate the contribution of the individual toxins to BBB disruption using isogenic toxin mutants deficient in lethal factor, ΔLF, and edema factor, ΔEF. Acute infection with B. anthracis Sterne and the ΔLF mutant resulted in disruption of human brain microvascular endothelial cell (hBMEC) monolayer integrity and tight junction protein zona occludens-1, while the result for cells infected with the ΔEF mutant was similar to that for the noninfected control. A significant decrease in bacterial invasion of BBB endothelium in vitro was observed during infection with the ΔLF strain, suggesting a prominent role for LT in promoting BBB interaction. Further, treatment of hBMECs with purified LT or chemicals that mimic LT action on host signaling pathways rescued the hypoinvasive phenotype of the ΔLF mutant and resulted in increased bacterial uptake. We also observed that toxin expression reduced bacterial intracellular survival by inducing the bulk degradative autophagy pathway in host cells. Finally, in a murine model of anthrax meningitis, mice infected with the ΔLF mutant exhibited no mortality, brain bacterial load, or evidence of meningitis compared to mice infected with the parental or ΔEF strains.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yan, Tao</author><author>Skaftnesmo, Kai Ove</author><author>Leiss, Lina</author><author>Sleire, Linda</author><author>Wang, Jian</author><author>Li, Xingang</author><author>Enger, Per Øyvind</author></authors></contributors><titles><title>Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.</title><secondary-title>BMC cancer</secondary-title></titles><periodical><full-title>BMC cancer</full-title></periodical><pages>524</pages><volume>11</volume><keywords><keyword>Adult</keyword><keyword>Aged</keyword><keyword>Alkylating</keyword><keyword>Alkylating: pharmacology</keyword><keyword>Antineoplastic Agents</keyword><keyword>Biological</keyword><keyword>Biological: metabolism</keyword><keyword>Biopsy</keyword><keyword>Blotting</keyword><keyword>Brain Neoplasms</keyword><keyword>Brain Neoplasms: metabolism</keyword><keyword>Brain Neoplasms: therapy</keyword><keyword>Cell Hypoxia</keyword><keyword>Cell Hypoxia: drug effects</keyword><keyword>Cell Hypoxia: radiation effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Dacarbazine</keyword><keyword>Dacarbazine: analogs &amp; derivatives</keyword><keyword>Dacarbazine: pharmacology</keyword><keyword>Electric Impedance</keyword><keyword>Female</keyword><keyword>Gene Knockout Techniques</keyword><keyword>Glioblastoma</keyword><keyword>Glioblastoma: metabolism</keyword><keyword>Glioblastoma: therapy</keyword><keyword>Glioma</keyword><keyword>Glioma: metabolism</keyword><keyword>Glioma: therapy</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Male</keyword><keyword>Microtubule-Associated Proteins</keyword><keyword>Microtubule-Associated Proteins: metabolism</keyword><keyword>Middle Aged</keyword><keyword>Neurofilament Proteins</keyword><keyword>Neurofilament Proteins: metabolism</keyword><keyword>Phosphopyruvate Hydratase</keyword><keyword>Phosphopyruvate Hydratase: metabolism</keyword><keyword>Real-Time Polymerase Chain Reaction</keyword><keyword>Tubulin</keyword><keyword>Tubulin: metabolism</keyword><keyword>Tumor</keyword><keyword>Tumor Markers</keyword><keyword>Western</keyword><keyword>Young Adult</keyword></keywords><dates><year>2011</year></dates><accession-num>22185371</accession-num><electronic-resource-num>10.1186/1471-2407-11-524</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3259117&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration</label><abstract>Expression of neuronal elements has been identified in various glial tumors, and glioblastomas (GBMs) with neuronal differentiation patterns have reportedly been associated with longer survival. However, the neuronal class III β-tubulin has been linked to increasing malignancy in astrocytomas. Thus, the significance of neuronal markers in gliomas is not established.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bagnaninchi, Pierre O</author><author>Holmes, Christina</author><author>Drummond, Nicola</author><author>Daoud, Jamal</author><author>Tabrizian, Maryam</author></authors></contributors><titles><title>Two-dimensional and three-dimensional viability measurements of adult stem cells with optical coherence phase microscopy</title><secondary-title>Journal of Biomedical Optics</secondary-title></titles><periodical><full-title>Journal of Biomedical Optics</full-title></periodical><pages>86003</pages><volume>16</volume><issue>8</issue><keywords><keyword>1</keyword><keyword>2011</keyword><keyword>7</keyword><keyword>8</keyword><keyword>accepted for publication jun</keyword><keyword>cell motility</keyword><keyword>online aug</keyword><keyword>optical coherence phase microscopy</keyword><keyword>paper 11009prr received jan</keyword><keyword>phase fluctuations</keyword><keyword>published</keyword><keyword>revised manuscript received jun</keyword><keyword>three-dimensional scaffold</keyword><keyword>tissue engineering</keyword></keywords><dates><year>2011</year></dates><electronic-resource-num>10.1117/1.3606561</electronic-resource-num><urls><web-urls><url>http://link.aip.org/link/JBOPFO/v16/i8/p086003/s1&amp;Agg=doi</url></web-urls></urls><label>ECIS Micromotion</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>McGuire, Paul G</author><author>Rangasamy, Sampathkumar</author><author>Maestas, Joann</author><author>Das, Arup</author></authors></contributors><titles><title>Pericyte-derived sphinogosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier.</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arteriosclerosis, thrombosis, and vascular biology</full-title></periodical><pages>e107-15</pages><volume>31</volume><issue>12</issue><keywords/><dates><year>2011</year></dates><accession-num>21940944</accession-num><electronic-resource-num>10.1161/ATVBAHA.111.235408</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3225006&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>The mechanisms that regulate the physical interaction of pericytes and endothelial cells and the effects of these interactions on interendothelial cell junctions are not well understood. We determined the extent to which vascular pericytes could regulate pericyte-endothelial adhesion and the consequences that this disruption might have on the function of the endothelial barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Griffiths, G S</author><author>Grundl, M</author><author>Allen, J S</author><author>Matter, M L</author></authors></contributors><titles><title>R-Ras interacts with filamin a to maintain endothelial barrier function.</title><secondary-title>Journal of cellular physiology</secondary-title></titles><periodical><full-title>Journal of cellular physiology</full-title></periodical><pages>2287-2296</pages><volume>226</volume><issue>9</issue><keywords><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Contractile Proteins</keyword><keyword>Contractile Proteins: metabolism</keyword><keyword>Coronary Vessels</keyword><keyword>Coronary Vessels: cytology</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Humans</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphoserine</keyword><keyword>Phosphoserine: metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Transport</keyword><keyword>Proto-Oncogene Proteins pp60(c-src)</keyword><keyword>Proto-Oncogene Proteins pp60(c-src): metabolism</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: metabolism</keyword><keyword>ras Proteins</keyword><keyword>ras Proteins: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>21660952</accession-num><electronic-resource-num>10.1002/jcp.22565</electronic-resource-num><notes>From Duplicate 2 (R-Ras interacts with filamin a to maintain endothelial barrier function. - Griffiths, G S; Grundl, M; Allen, J S; Matter, M L)

From Duplicate 2 ( R-Ras interacts with filamin a to maintain endothelial barrier function. - Griffiths, G S; Grundl, M; Allen, J S; Matter, M L )</notes><research-notes>From Duplicate 2 (R-Ras interacts with filamin a to maintain endothelial barrier function. - Griffiths, G S; Grundl, M; Allen, J S; Matter, M L)

From Duplicate 2 ( R-Ras interacts with filamin a to maintain endothelial barrier function. - Griffiths, G S; Grundl, M; Allen, J S; Matter, M L )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21660952</url></web-urls></urls><label>ECIS TEER</label><abstract>The molecular mechanisms regulating vascular barrier integrity remain incompletely elucidated. We have previously reported an association between the GTPase R-Ras and repeat 3 of Filamin A (FLNa). Loss of FLNa has been linked to increased vascular permeability. We sought to determine whether FLNa's association with R-Ras affects endothelial barrier function. We report that in endothelial cells endogenous R-Ras interacts with endogenous FLNa as determined by co-immunoprecipitations and pulldowns with the FLNa-GST fusion protein repeats 1-10. Deletion of FLNa repeat 3 (FLNaΔ3) abrogated this interaction. In these cells FLNa and R-Ras co-localize at the plasma membrane. Knockdown of R-Ras and/or FLNa by siRNA promotes vascular permeability, as determined by TransEndothelial Electrical Resistance and FITC-dextran transwell assays. Re-expression of FLNa restored endothelial barrier function in cells lacking FLNa whereas re-expression of FLNaΔ3 did not. Immunostaining for VE-Cadherin in cells with knocked down R-Ras and FLNa demonstrated a disorganization of VE-Cadherin at adherens junctions. Loss of R-Ras and FLNa or blocking R-Ras function via GGTI-2133, a selective R-Ras inhibitor, induced vascular permeability and increased phosphorylation of VE-Cadherin (Y731) and Src (Y416). Expression of dominant negative R-Ras promoted vascular permeability that was blocked by the Src inhibitor PP2. These findings demonstrate that maintaining endothelial barrier function is dependent upon active R-Ras and association between R-Ras and FLNa and that loss of this interaction promotes VE-Cadherin phosphorylation and changes in downstream effectors that lead to endothelial leakiness.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Breslin, Jerome W</author></authors></contributors><titles><title>ROCK and cAMP Promote Lymphatic Endothelial Cell Barrier Integrity and Modulate Histamine and Thrombin-Induced Barrier Dysfunction</title><secondary-title>Lymphatic Research and Biology</secondary-title></titles><periodical><full-title>Lymphatic Research and Biology</full-title></periodical><pages>3-11</pages><volume>9</volume><issue>1</issue><keywords/><dates><year>2011</year></dates><electronic-resource-num>10.1089/lrb.2010.0016</electronic-resource-num><urls><web-urls><url>http://www.liebertonline.com/doi/abs/10.1089/lrb.2010.0016</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sun, Chongxiu</author><author>Wu, Mack H</author><author>Yuan, Sarah Y</author></authors></contributors><titles><title>Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration.</title><secondary-title>Circulation</secondary-title></titles><periodical><full-title>Circulation</full-title></periodical><pages>48-57</pages><volume>124</volume><issue>1</issue><keywords><keyword>Animal</keyword><keyword>Animals</keyword><keyword>Aorta</keyword><keyword>Aorta: pathology</keyword><keyword>Apolipoproteins E</keyword><keyword>Apolipoproteins E: deficiency</keyword><keyword>Apolipoproteins E: genetics</keyword><keyword>Apolipoproteins E: physiology</keyword><keyword>Atherosclerosis</keyword><keyword>Atherosclerosis: pathology</keyword><keyword>Atherosclerosis: physiopathology</keyword><keyword>Atherosclerosis: prevention &amp; control</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cells</keyword><keyword>Collagen</keyword><keyword>Collagen: metabolism</keyword><keyword>Cultured</keyword><keyword>Disease Models</keyword><keyword>Endothelium</keyword><keyword>Knockout</keyword><keyword>Lipid Metabolism</keyword><keyword>Lipid Metabolism: physiology</keyword><keyword>Macrophages</keyword><keyword>Macrophages: pathology</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Monocytes</keyword><keyword>Monocytes: pathology</keyword><keyword>Monocytes: physiology</keyword><keyword>Myosin-Light-Chain Kinase</keyword><keyword>Myosin-Light-Chain Kinase: deficiency</keyword><keyword>Myosin-Light-Chain Kinase: genetics</keyword><keyword>Myosin-Light-Chain Kinase: physiology</keyword><keyword>Phosphorylation</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Tunica Intima</keyword><keyword>Tunica Intima: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: pathology</keyword><keyword>Vascular: physiopathology</keyword><keyword>src-Family Kinases</keyword><keyword>src-Family Kinases: physiology</keyword></keywords><dates><year>2011</year></dates><accession-num>21670231</accession-num><electronic-resource-num>10.1161/CIRCULATIONAHA.110.988915</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3136817&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Endothelial dysfunction and monocyte migration are key events in the pathogenesis of atherosclerosis. Nonmuscle myosin light-chain kinase (nmMLCK), the predominant MLCK isoform in endothelial cells, has been shown to contribute to vascular inflammation by altering endothelial barrier function. However, its impact on atherogenesis remains unknown.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>de Kreuk, Bart-Jan</author><author>Nethe, Micha</author><author>Fernandez-Borja, Mar</author><author>Anthony, Eloise C</author><author>Hensbergen, Paul J</author><author>Deelder, Andre M</author><author>Plomann, Markus</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>The F-BAR domain protein PACSIN2 associates with Rac1 and regulates cell spreading and migration.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>2375-2388</pages><volume>124</volume><issue>Pt 14</issue><keywords><keyword>f-bar</keyword><keyword>gtpase</keyword><keyword>pacsin2</keyword><keyword>rac1</keyword></keywords><dates><year>2011</year></dates><accession-num>21693584</accession-num><electronic-resource-num>10.1242/jcs.080630</electronic-resource-num><notes>From Duplicate 2 (The F-BAR domain protein PACSIN2 associates with Rac1 and regulates cell spreading and migration. - de Kreuk, Bart-Jan; Nethe, Micha; Fernandez-Borja, Mar; Anthony, Eloise C; Hensbergen, Paul J; Deelder, Andre M; Plomann, Markus; Hordijk, Peter L)

From Duplicate 1 ( The F-BAR domain protein PACSIN2 associates with Rac1 and regulates cell spreading and migration. - de Kreuk, Bart-Jan; Nethe, Micha; Fernandez-Borja, Mar; Anthony, Eloise C; Hensbergen, Paul J; Deelder, Andre M; Plomann, Markus; Hordijk, Peter L )



From Duplicate 2 ( The F-BAR domain protein PACSIN2 associates with Rac1 and regulates cell spreading and migration. - de Kreuk, Bart-Jan; Nethe, Micha; Fernandez-Borja, Mar; Anthony, Eloise C; Hensbergen, Paul J; Deelder, Andre M; Plomann, Markus; Hordijk, Peter L )</notes><research-notes>From Duplicate 2 (The F-BAR domain protein PACSIN2 associates with Rac1 and regulates cell spreading and migration. - de Kreuk, Bart-Jan; Nethe, Micha; Fernandez-Borja, Mar; Anthony, Eloise C; Hensbergen, Paul J; Deelder, Andre M; Plomann, Markus; Hordijk, Peter L)

From Duplicate 1 ( The F-BAR domain protein PACSIN2 associates with Rac1 and regulates cell spreading and migration. - de Kreuk, Bart-Jan; Nethe, Micha; Fernandez-Borja, Mar; Anthony, Eloise C; Hensbergen, Paul J; Deelder, Andre M; Plomann, Markus; Hordijk, Peter L )



From Duplicate 2 ( The F-BAR domain protein PACSIN2 associates with Rac1 and regulates cell spreading and migration. - de Kreuk, Bart-Jan; Nethe, Micha; Fernandez-Borja, Mar; Anthony, Eloise C; Hensbergen, Paul J; Deelder, Andre M; Plomann, Markus; Hordijk, Peter L )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21693584</url></web-urls></urls><label>ECIS Migration</label><abstract>The Rac1 GTPase controls cytoskeletal dynamics and is a key regulator of cell spreading and migration mediated by signaling through effector proteins, such as the PAK kinases and the Scar and WAVE proteins. We previously identified a series of regulatory proteins that associate with Rac1 through its hypervariable C-terminal domain, including the Rac1 activator β-Pix (also known as Rho guanine-nucleotide-exchange factor 7) and the membrane adapter caveolin-1. Here, we show that Rac1 associates, through its C-terminus, with the F-BAR domain protein PACSIN2, an inducer of membrane tubulation and a regulator of endocytosis. We show that Rac1 localizes with PACSIN2 at intracellular tubular structures and on early endosomes. Active Rac1 induces a loss of PACSIN2-positive tubular structures. By contrast, Rac1 inhibition results in an accumulation of PACSIN2-positive tubules. In addition, PACSIN2 appears to regulate Rac1 signaling; siRNA-mediated loss of PACSIN2 increases the levels of Rac1-GTP and promotes cell spreading and migration in a wound healing assay. Moreover, ectopic expression of PACSIN2 reduces Rac1-GTP levels in a fashion that is dependent on the PACSIN2-Rac1 interaction, on the membrane-tubulating capacity of PACSIN2 and on dynamin. These data identify the BAR-domain protein PACSIN2 as a Rac1 interactor that regulates Rac1-mediated cell spreading and migration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Amatschek, S</author><author>Lucas, R</author><author>Eger, A</author><author>Pflueger, M</author><author>Hundsberger, H</author><author>Knoll, C</author><author>Grosse-Kracht, S</author><author>Schuett, W</author><author>Koszik, F</author><author>Maurer, D</author><author>Wiesner, C</author></authors></contributors><titles><title>CXCL9 induces chemotaxis, chemorepulsion and endothelial barrier disruption through CXCR3-mediated activation of melanoma cells.</title><secondary-title>British journal of cancer</secondary-title></titles><periodical><full-title>British journal of cancer</full-title></periodical><pages>469-479</pages><volume>104</volume><issue>3</issue><keywords><keyword>CXCR3</keyword><keyword>CXCR3: biosynthesis</keyword><keyword>Chemokine CXCL9</keyword><keyword>Chemokine CXCL9: secretion</keyword><keyword>Chemotaxis</keyword><keyword>Humans</keyword><keyword>Melanoma</keyword><keyword>Melanoma: metabolism</keyword><keyword>Receptors</keyword><keyword>Skin Neoplasms</keyword><keyword>Skin Neoplasms: metabolism</keyword><keyword>Transendothelial and Transepithelial Migration</keyword><keyword>Transendothelial and Transepithelial Migration: im</keyword></keywords><dates><year>2011</year></dates><accession-num>21179030</accession-num><electronic-resource-num>10.1038/sj.bjc.6606056</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3049560&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Invasion</label><abstract>BACKGROUND: Metastasis is associated with poor prognosis for melanoma. The formation of metastases is a multi-step process, in which cancer cells can subsequently acquire the potential to intravasate into the blood or lymph vessels, disseminate through the circulation, extravasate through the endothelium and invade the connective tissue. There is increasing evidence that chemokines have a pivotal role in the dissemination and establishment of melanoma metastasis. METHODS: We isolated melanoma cells from melanoma metastasis and performed different migration assays and transendothelial resistance measurements of endothelial monolayers co-cultured with melanoma cells, in order to monitor barrier function and diapedesis and confirmed these results by confocal microscopy. RESULTS: We observed that tumour endothelial cells (ECs) secrete high levels of CXCL9 in all, and CXCL10 in most melanoma metastases. Migration studies revealed that low concentrations of these chemokines induce chemotaxis, whereas high concentrations induce spontaneous migration of melanoma cells (chemokinesis/chemorepulsion) and the disruption of the endothelial barrier, resulting in an accelerated transendothelial migration (TEM). Addition of anti-CXCL9 or anti-CXCR3 antibodies to the co-cultures delayed the TEM of melanoma cells. CONCLUSION: Our data represent novel mechanisms by which tumour cells in melanoma metastases might use the chemokine-expressing endothelium to leave the tumour and eventually to form additional metastases at distinct sites.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tarantola, Marco</author><author>Pietuch, Anna</author><author>Schneider, David</author><author>Rother, Jan</author><author>Sunnick, Eva</author><author>Rosman, Christina</author><author>Pierrat, Sebastien</author><author>Sönnichsen, Carsten</author><author>Wegener, Joachim</author><author>Janshoff, Andreas</author></authors></contributors><titles><title>Toxicity of gold-nanoparticles: synergistic effects of shape and surface functionalization on micromotility of epithelial cells.</title><secondary-title>Nanotoxicology</secondary-title></titles><periodical><full-title>Nanotoxicology</full-title></periodical><pages>254-268</pages><volume>5</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cetrimonium Compounds</keyword><keyword>Cetrimonium Compounds: chemistry</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Gold</keyword><keyword>Gold: chemistry</keyword><keyword>Metal Nanoparticles</keyword><keyword>Metal Nanoparticles: toxicity</keyword><keyword>Particle Size</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reactive Oxygen Species: metabolism</keyword><keyword>Surface Properties</keyword><keyword>Surface-Active Agents</keyword><keyword>Surface-Active Agents: chemistry</keyword></keywords><dates><year>2011</year></dates><accession-num>21050076</accession-num><electronic-resource-num>10.3109/17435390.2010.528847</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21050076</url></web-urls></urls><abstract>Nanoparticle exposure is monitored by a combination of two label-free and non-invasive biosensor devices which detect cellular shape and viscoelasticity (quartz crystal microbalance), cell motility and the dynamics of epithelial cell-cell contacts (electric cell-substrate impedance sensing). With these tools we have studied the impact of nanoparticle shape on cellular physiology. Gold (Au) nanoparticles coated with CTAB were synthesized and studied in two distinct shapes: Spheres with a diameter of (43 ± 4) nm and rods with a size of (38 ± 7) nm × (17 ± 3) nm. Dose-response experiments were accompanied by conventional cytotoxicity tests as well as fluorescence and dark-field microscopy to visualize the intracellular particle distribution. We found that spherical gold nanoparticles with identical surface functionalization are generally more toxic and more efficiently ingested than rod-shaped particles. We largely attribute the higher toxicity of CTAB-coated spheres as compared to rod-shaped particles to a higher release of toxic CTAB upon intracellular aggregation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hatanaka, Kunihiko</author><author>Simons, Michael</author><author>Murakami, Masahiro</author></authors></contributors><titles><title>Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.</title><secondary-title>American journal of physiology. Heart and circulatory physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Heart and circulatory physiology</full-title></periodical><pages>H162-72</pages><volume>300</volume><issue>1</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Blotting</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Catenins</keyword><keyword>Catenins: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelium</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Immunoprecipitation</keyword><keyword>Phosphorylation</keyword><keyword>RNA Interference</keyword><keyword>Rats</keyword><keyword>Signal Transduction</keyword><keyword>Umbilical Veins</keyword><keyword>Umbilical Veins: cytology</keyword><keyword>Umbilical Veins: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>Western</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>21037229</accession-num><electronic-resource-num>10.1152/ajpheart.00650.2010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3023264&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>To establish the role of vascular endothelial (VE)-cadherin in the regulation of endothelial cell functions, we investigated the effect of phosphorylation of a VE-cadherin site sought to be involved in p120-catenin binding on vascular permeability and endothelial cell migration. To this end, we introduced either wild-type VE-cadherin or Y658 phosphomimetic (Y658E) or dephosphomimetic (Y658F) VE-cadherin mutant constructs into an endothelial cell line (rat fat pad endothelial cells) lacking endogenous VE-cadherin. Remarkably, neither wild-type- nor Y658E VE-cadherin was retained at cell-cell contacts because of p120-catenin preferential binding to N-cadherin, resulting in the targeting of N-cadherin to cell-cell junctions and the exclusion of VE-cadherin. However, Y658F VE-cadherin was able to bind p120-catenin and to localize at adherence junctions displacing N-cadherin. This resulted in an enhanced barrier function and a complete abrogation of Rac1 activation and lamellipodia formation, thereby inhibiting cell migration. These findings demonstrate that VE-cadherin, through the regulation of Y658 phosphorylation, competes for junctional localization with N-cadherin and controls vascular permeability and endothelial cell migration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rangasamy, Sampathkumar</author><author>Srinivasan, Ramprasad</author><author>Maestas, Joann</author><author>McGuire, Paul G</author><author>Das, Arup</author></authors></contributors><titles><title>A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy.</title><secondary-title>Investigative ophthalmology &amp; visual science</secondary-title></titles><periodical><full-title>Investigative ophthalmology &amp; visual science</full-title></periodical><pages>3784-3791</pages><volume>52</volume><issue>6</issue><keywords><keyword>Angiopoietin-1</keyword><keyword>Angiopoietin-1: metabolism</keyword><keyword>Angiopoietin-2</keyword><keyword>Angiopoietin-2: physiology</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Blood-Retinal Barrier</keyword><keyword>Blood-Retinal Barrier: physiology</keyword><keyword>Blotting</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Diabetes Mellitus</keyword><keyword>Diabetic Retinopathy</keyword><keyword>Diabetic Retinopathy: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Experimental</keyword><keyword>Experimental: metabolism</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Glucose</keyword><keyword>Glucose: pharmacology</keyword><keyword>Humans</keyword><keyword>Hyperglycemia</keyword><keyword>Hyperglycemia: metabolism</keyword><keyword>Indirect</keyword><keyword>Male</keyword><keyword>Messenger</keyword><keyword>Messenger: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>RNA</keyword><keyword>Rats</keyword><keyword>Retinal Vessels</keyword><keyword>Retinal Vessels: metabolism</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Sprague-Dawley</keyword><keyword>Tyrosine</keyword><keyword>Tyrosine: metabolism</keyword><keyword>Up-Regulation</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Western</keyword></keywords><dates><year>2011</year></dates><accession-num>21310918</accession-num><electronic-resource-num>10.1167/iovs.10-6386</electronic-resource-num><notes>From Duplicate 1 (A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. - Rangasamy, Sampathkumar; Srinivasan, Ramprasad; Maestas, Joann; McGuire, Paul G; Das, Arup)

From Duplicate 1 ( A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. - Rangasamy, Sampathkumar; Srinivasan, Ramprasad; Maestas, Joann; McGuire, Paul G; Das, Arup )



From Duplicate 2 ( A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. - Rangasamy, Sampathkumar; Srinivasan, Ramprasad; Maestas, Joann; McGuire, Paul G; Das, Arup )</notes><research-notes>From Duplicate 1 (A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. - Rangasamy, Sampathkumar; Srinivasan, Ramprasad; Maestas, Joann; McGuire, Paul G; Das, Arup)

From Duplicate 1 ( A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. - Rangasamy, Sampathkumar; Srinivasan, Ramprasad; Maestas, Joann; McGuire, Paul G; Das, Arup )



From Duplicate 2 ( A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. - Rangasamy, Sampathkumar; Srinivasan, Ramprasad; Maestas, Joann; McGuire, Paul G; Das, Arup )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3109054&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Although VEGF has been identified as an important mediator of the blood-retinal barrier alteration in diabetic retinopathy, the hypothesis for this study was that that other molecules, including the angiopoietins (Ang-1 and -2), may play a role. The expression of angiopoietins was analyzed in an animal model of diabetic retinopathy, and the role of Ang-2 in the regulation of diabetes-induced alterations of vascular permeability was characterized.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cheng, Shan</author><author>A. Martin, Tracey</author><author>Teng, Xu</author><author>Jiang, Wen G</author><author>G. Jiang, Wen</author></authors></contributors><titles><title>Putative Breast Tumor Suppressor TACC2 Suppresses the Aggressiveness of Breast Cancer Cells through a PLCγ Pathway</title><secondary-title>Current Signal Transduction Therapy</secondary-title></titles><periodical><full-title>Current Signal Transduction Therapy</full-title></periodical><pages>55-64</pages><volume>6</volume><issue>1</issue><keywords><keyword>aggressiveness</keyword><keyword>breast tumor suppressor</keyword><keyword>plc pathway</keyword><keyword>tacc2</keyword></keywords><dates><year>2011</year></dates><electronic-resource-num>10.2174/157436211794109361</electronic-resource-num><urls><web-urls><url>http://www.ingentaconnect.com/content/ben/cst/2011/00000006/00000001/art00006</url><url>http://www.eurekaselect.com/openurl/content.php?genre=article&amp;issn=1574-3624&amp;volume=6&amp;issue=1&amp;spage=55</url></web-urls></urls><label>ECIS Attachment;ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mehta, Rajeshwari R</author><author>Yamada, Tohru</author><author>Taylor, Brad N</author><author>Christov, Konstantin</author><author>King, Marissa L</author><author>Majumdar, Dibyen</author><author>Lekmine, Fatima</author><author>Tiruppathi, Chinnaswamy</author><author>Shilkaitis, Anne</author><author>Bratescu, Laura</author><author>Green, Albert</author><author>Beattie, Craig W</author><author>Das Gupta, Tapas K</author></authors></contributors><titles><title>A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt.</title><secondary-title>Angiogenesis</secondary-title></titles><periodical><full-title>Angiogenesis</full-title></periodical><pages>355-369</pages><volume>14</volume><issue>3</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Antineoplastic Agents</keyword><keyword>Antineoplastic Agents: chemistry</keyword><keyword>Antineoplastic Agents: pharmacokinetics</keyword><keyword>Azurin</keyword><keyword>Azurin: chemistry</keyword><keyword>Azurin: pharmacology</keyword><keyword>CD31</keyword><keyword>CD31: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell-Penetrating Peptides</keyword><keyword>Cell-Penetrating Peptides: chemistry</keyword><keyword>Cell-Penetrating Peptides: pharmacology</keyword><keyword>Clinical Trials</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Kinase 1: metabolism</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: metabolism</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Neoplasms</keyword><keyword>Neoplasms: drug therapy</keyword><keyword>Neoplasms: metabolism</keyword><keyword>Neoplasms: pathology</keyword><keyword>Neovascularization</keyword><keyword>Nude</keyword><keyword>Pathologic</keyword><keyword>Pathologic: drug therapy</keyword><keyword>Pathologic: metabolism</keyword><keyword>Pathologic: pathology</keyword><keyword>Peptide Fragments</keyword><keyword>Peptide Fragments: chemistry</keyword><keyword>Peptide Fragments: pharmacology</keyword><keyword>Phase II as Topic</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>Proto-Oncogene Proteins c-akt: metabolism</keyword><keyword>Pseudomonas aeruginosa</keyword><keyword>Pseudomonas aeruginosa: chemistry</keyword><keyword>Tumor</keyword><keyword>Umbilical Veins</keyword><keyword>Umbilical Veins: metabolism</keyword><keyword>Umbilical Veins: pathology</keyword><keyword>Vascular Endothelial Growth Factor Receptor-2</keyword><keyword>Vascular Endothelial Growth Factor Receptor-2: met</keyword></keywords><dates><year>2011</year></dates><accession-num>21667138</accession-num><electronic-resource-num>10.1007/s10456-011-9220-6</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21667138</url></web-urls></urls><label>ECIS Migration</label><abstract>Amino acids 50-77 (p28) of azurin, a 128 aa cupredoxin isolated from Pseudomonas aeruginosa, is essentially responsible for azurin's preferential penetration of cancer cells. We now report that p28 also preferentially penetrates human umbilical vein endothelial cells (HUVEC), co-localized with caveolin-1 and VEGFR-2, and inhibits VEGF- and bFGF-induced migration, capillary tube formation and neoangiogenesis in multiple xenograft models. The antiangiogenic effect of p28 in HUVEC is associated with a dose-related non-competitive inhibition of VEGFR-2 kinase activity. However, unlike other antiangiogenic agents that inhibit the VEGFR-2 kinase, p28 decreased the downstream phosphorylation of FAK and Akt that normally precedes cellular repositioning of the cytoskeletal (F-actin), focal adhesion (FAK and paxillin), and cell to cell junction protein PECAM-1, inhibiting HUVEC motility and migration. The decrease in pFAK and pAkt levels suggests that p28 induces a pFAK-mediated loss of HUVEC motility and migration and a parallel Akt-associated reduction in cell matrix attachment and survival. This novel, direct antiangiogenic effect of p28 on endothelial cells may enhance the cell cycle inhibitory and apoptotic properties of this prototype peptide on tumor cell proliferation as it enters a Phase II clinical trial.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dudek, Steven M</author><author>Muñoz, Nilda M</author><author>Desai, Anjali</author><author>Osan, Christopher M</author><author>Meliton, Angelo Y</author><author>Leff, Alan R</author></authors></contributors><titles><title>Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>361-368</pages><volume>44</volume><issue>3</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Antibodies</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Dextrans</keyword><keyword>Dextrans: chemistry</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Fluorescence</keyword><keyword>Fluorescence: methods</keyword><keyword>Group V Phospholipases A2</keyword><keyword>Group V Phospholipases A2: metabolism</keyword><keyword>Humans</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: metabolism</keyword><keyword>Lung</keyword><keyword>Lung: enzymology</keyword><keyword>Messenger</keyword><keyword>Messenger: metabolism</keyword><keyword>Microcirculation</keyword><keyword>Microscopy</keyword><keyword>Monoclonal</keyword><keyword>Monoclonal: chemistry</keyword><keyword>Mutation</keyword><keyword>RNA</keyword><keyword>Recombinant Proteins</keyword><keyword>Recombinant Proteins: chemistry</keyword><keyword>Time Factors</keyword></keywords><dates><year>2011</year></dates><accession-num>20448053</accession-num><electronic-resource-num>10.1165/rcmb.2009-0446OC</electronic-resource-num><notes>From Duplicate 1 (Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. - Dudek, Steven M; Muñoz, Nilda M; Desai, Anjali; Osan, Christopher M; Meliton, Angelo Y; Leff, Alan R)

From Duplicate 1 ( Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. - Dudek, Steven M; Muñoz, Nilda M; Desai, Anjali; Osan, Christopher M; Meliton, Angelo Y; Leff, Alan R )



From Duplicate 2 ( Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. - Dudek, Steven M; Muñoz, Nilda M; Desai, Anjali; Osan, Christopher M; Meliton, Angelo Y; Leff, Alan R )</notes><research-notes>From Duplicate 1 (Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. - Dudek, Steven M; Muñoz, Nilda M; Desai, Anjali; Osan, Christopher M; Meliton, Angelo Y; Leff, Alan R)

From Duplicate 1 ( Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. - Dudek, Steven M; Muñoz, Nilda M; Desai, Anjali; Osan, Christopher M; Meliton, Angelo Y; Leff, Alan R )



From Duplicate 2 ( Group V phospholipase A2 mediates barrier disruption of human pulmonary endothelial cells caused by LPS in vitro. - Dudek, Steven M; Muñoz, Nilda M; Desai, Anjali; Osan, Christopher M; Meliton, Angelo Y; Leff, Alan R )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3095937&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>We examined the functional role of 14-kD secretory group V phospholipase A(2) (gVPLA(2)) on the barrier function of pulmonary endothelial cells (ECs) after LPS activation in vitro. Expression of gVPLA(2) was elicited by 20 ng/ml LPS as demonstrated by increased (1) mRNA, (2) protein content, and (3) cell surface expression of gVPLA(2) within 4 hours. The effect of LPS on EC barrier function was measured by transendothelial monolayer electrical resistance (TER). LPS increased permeability across EC monolayers at 2-3 hours, and was sustained for 10 hours or more. Blockade of gVPLA(2) with mouse monoclonal 3G1 (MCL-3G1) monoclonal antibody directed against gVPLA(2) inhibited EC barrier dysfunction elicited by LPS in a time- and concentration-dependent manner; control IgG had no effect on TER. Like LPS, exogenous gVPLA(2) caused increased EC permeability in a time- and concentration-dependent manner; neither gIIaPLA(2), a close homolog of gVPLA(2), nor W31A, an inactive mutant of gVPLA(2), caused a decrease in EC TER. Immunofluorescence analysis revealed comparable F-actin stress fiber and intercellular gap formation for ECs treated with either gVPLA(2) or LPS. Treatment with gVPLA(2) disrupted vascular endothelial-cadherin junctional complexes on ECs. Coincubation of ECs with MCL-3G1 substantially attenuated the structural changes caused by gVPLA(2) or LPS. We demonstrate that (1) gVPLA(2) is constitutively expressed in ECs and is up-regulated after LPS activation, (2) endogenously secreted gVPLA(2) from ECs after LPS increases EC permeability through F-actin and junctional complex rearrangement, and (3) inhibition of endogenous gVPLA(2) from ECs is sufficient to block disruption of the EC barrier function after LPS in vitro.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>David, Sascha</author><author>Ghosh, Chandra C</author><author>Kümpers, Philipp</author><author>Shushakova, Nelli</author><author>Van Slyke, Paul</author><author>Khankin, Eliyahu V</author><author>Karumanchi, S Ananth</author><author>Dumont, Dan</author><author>Parikh, Samir M</author></authors></contributors><titles><title>Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L851-62</pages><volume>300</volume><issue>6</issue><keywords><keyword>Animals</keyword><keyword>Blotting</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Endothelium</keyword><keyword>Endotoxemia</keyword><keyword>Endotoxemia: chemically induced</keyword><keyword>Endotoxemia: mortality</keyword><keyword>Endotoxemia: prevention &amp; control</keyword><keyword>Endotoxins</keyword><keyword>Endotoxins: adverse effects</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Inbred C57BL</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: pharmacology</keyword><keyword>Lung Injury</keyword><keyword>Lung Injury: chemically induced</keyword><keyword>Lung Injury: mortality</keyword><keyword>Lung Injury: prevention &amp; control</keyword><keyword>Male</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Mice</keyword><keyword>Peptide Fragments</keyword><keyword>Peptide Fragments: chemical synthesis</keyword><keyword>Peptide Fragments: pharmacology</keyword><keyword>Polyethylene Glycols</keyword><keyword>Polyethylene Glycols: administration &amp; dosage</keyword><keyword>Polyethylene Glycols: chemistry</keyword><keyword>Polyethylene Glycols: metabolism</keyword><keyword>RNA</keyword><keyword>Receptor</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Survival Rate</keyword><keyword>TIE-2</keyword><keyword>TIE-2: agonists</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Western</keyword></keywords><dates><year>2011</year></dates><accession-num>21421750</accession-num><electronic-resource-num>10.1152/ajplung.00459.2010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3119126&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>A synthetic 7-mer, HHHRHSF, was recently identified by screening a phage display library for binding to the Tie-2 receptor. A polyethylene-oxide clustered version of this peptide, termed vasculotide (VT), was reported to activate Tie-2 and promote angiogenesis in a mouse model of diabetic ulcer. We hypothesized that VT administration would defend endothelial barrier function against sepsis-associated mediators of permeability, prevent lung vascular leakage arising in endotoxemia, and improve mortality in endotoxemic mice. In confluent human microvascular endothelial cells, VT prevented endotoxin-induced (lipopolysaccharides, LPS O111:B4) gap formation, loss of monolayer resistance, and translocation of labeled albumin. In 8-wk-old male C57Bl6/J mice given a ∼70% lethal dose of endotoxin (15 mg/kg ip), VT prevented lung vascular leakage and reversed the attenuation of lung vascular endothelial cadherin induced by endotoxemia. These protective effects of VT were associated with activation of Tie-2 and its downstream mediator, Akt. Echocardiographic studies showed only a nonsignificant trend toward improved myocardial performance associated with VT. Finally, we evaluated survival in this mouse model. Pretreatment with VT improved survival by 41.4% (n = 15/group, P = 0.02) and post-LPS administration of VT improved survival by 33.3% (n = 15/group, P = 0.051). VT-mediated protection from LPS lethality was lost in Tie-2 heterozygous mice, in agreement with VT's proposed receptor specificity. We conclude that this synthetic Tie-2 agonist, completely unrelated to endogenous Tie-2 ligands, is sufficient to activate the receptor and its downstream pathways in vivo and that the Tie-2 receptor may be an important target for therapeutic evaluation in conditions of pathological vascular leakage.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schlegel, Nicolas</author><author>Meir, Michael</author><author>Spindler, Volker</author><author>Germer, Christoph-Thomas</author><author>Waschke, Jens</author></authors></contributors><titles><title>Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro.</title><secondary-title>Journal of cellular physiology</secondary-title></titles><periodical><full-title>Journal of cellular physiology</full-title></periodical><pages>1196-1203</pages><volume>226</volume><issue>5</issue><keywords><keyword>ADP Ribose Transferases</keyword><keyword>ADP Ribose Transferases: pharmacology</keyword><keyword>Amides</keyword><keyword>Amides: pharmacology</keyword><keyword>Bacterial Proteins</keyword><keyword>Bacterial Proteins: pharmacology</keyword><keyword>Bacterial Toxins</keyword><keyword>Bacterial Toxins: pharmacology</keyword><keyword>Botulinum Toxins</keyword><keyword>Botulinum Toxins: pharmacology</keyword><keyword>Caco-2 Cells</keyword><keyword>Dextrans</keyword><keyword>Dextrans: metabolism</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Enzyme Activation</keyword><keyword>Escherichia coli Proteins</keyword><keyword>Escherichia coli Proteins: pharmacology</keyword><keyword>Fluorescein-5-isothiocyanate</keyword><keyword>Fluorescein-5-isothiocyanate: analogs &amp; derivative</keyword><keyword>Fluorescein-5-isothiocyanate: metabolism</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: drug effects</keyword><keyword>Intercellular Junctions: enzymology</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: drug effects</keyword><keyword>Intestinal Mucosa: enzymology</keyword><keyword>Permeability</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>Pyridines</keyword><keyword>Pyridines: pharmacology</keyword><keyword>Time Factors</keyword><keyword>cdc42 GTP-Binding Protein</keyword><keyword>cdc42 GTP-Binding Protein: metabolism</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: metabolism</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: antagonists &amp; inhibitors</keyword><keyword>rho-Associated Kinases: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>20945370</accession-num><electronic-resource-num>10.1002/jcp.22446</electronic-resource-num><notes>From Duplicate 2 (Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro. - Schlegel, Nicolas; Meir, Michael; Spindler, Volker; Germer, Christoph-Thomas; Waschke, Jens)

From Duplicate 1 ( Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro. - Schlegel, Nicolas; Meir, Michael; Spindler, Volker; Germer, Christoph-Thomas; Waschke, Jens )



From Duplicate 2 ( Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro. - Schlegel, Nicolas; Meir, Michael; Spindler, Volker; Germer, Christoph-Thomas; Waschke, Jens )</notes><research-notes>From Duplicate 2 (Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro. - Schlegel, Nicolas; Meir, Michael; Spindler, Volker; Germer, Christoph-Thomas; Waschke, Jens)

From Duplicate 1 ( Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro. - Schlegel, Nicolas; Meir, Michael; Spindler, Volker; Germer, Christoph-Thomas; Waschke, Jens )



From Duplicate 2 ( Differential role of Rho GTPases in intestinal epithelial barrier regulation in vitro. - Schlegel, Nicolas; Meir, Michael; Spindler, Volker; Germer, Christoph-Thomas; Waschke, Jens )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20945370</url></web-urls></urls><label>ECIS TEER</label><abstract>Maintenance of intestinal epithelial barrier functions is crucial to prevent systemic contamination by microbes that penetrate from the gut lumen. GTPases of the Rho-family such as RhoA, Rac1, and Cdc42 are known to be critically involved in the regulation of intestinal epithelial barrier functions. However, it is still unclear whether inactivation or activation of these GTPases exerts barrier protection or not. We tested the effects of Rho GTPase activities on intestinal epithelial barrier functions by using the bacterial toxins cytotoxic necrotizing factor 1 (CNF-1), toxin B, C3 transferase (C3 TF), and lethal toxin (LT) in an in vitro model of the intestinal epithelial barrier. Incubation of cell monolayers with CNF-1 for 3 h induced exclusive activation of RhoA whereas Rac1 and Cdc42 activities were unchanged. As revealed by FITC-dextran flux and measurements of transepithelial electrical resistance (TER) intestinal epithelial permeability was significantly increased under these conditions. Inhibition of Rho kinase via Y27632 blocked barrier destabilization of CNF-1 after 3 h. In contrast, after 24 h of incubation with CNF-1 only Rac1 and Cdc42 but not RhoA were activated which resulted in intestinal epithelial barrier stabilization. Toxin B to inactivate RhoA, Rac1, and Cdc42 as well as Rac1 inhibitor LT increased intestinal epithelial permeability. Similar effects were observed after inhibition of RhoA/Rho kinase signaling by C3 TF or Y27632. Taken together, these data demonstrate that both activation and inactivation of RhoA signaling increased paracellular permeability whereas activation of Rac1 and Cdc42 correlated with stabilized barrier functions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Creighton, Judy</author><author>Jian, MingYuan</author><author>Sayner, Sarah</author><author>Alexeyev, Mikhail</author><author>Insel, Paul A</author></authors></contributors><titles><title>Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.</title><secondary-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</secondary-title></titles><periodical><full-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</full-title></periodical><pages>3356-3365</pages><volume>25</volume><issue>10</issue><keywords><keyword>AMP-Activated Protein Kinases</keyword><keyword>AMP-Activated Protein Kinases: genetics</keyword><keyword>AMP-Activated Protein Kinases: metabolism</keyword><keyword>Animals</keyword><keyword>Cadherins</keyword><keyword>Calcium</keyword><keyword>Calcium Signaling</keyword><keyword>Calcium: metabolism</keyword><keyword>Caveolin 1</keyword><keyword>Caveolin 1: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Endothelium</keyword><keyword>Enzymologic</keyword><keyword>Enzymologic: physiolog</keyword><keyword>Enzymologic: physiology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Male</keyword><keyword>Protein Transport</keyword><keyword>Rats</keyword><keyword>Sprague-Dawley</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: injuries</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2011</year></dates><accession-num>21680893</accession-num><electronic-resource-num>10.1096/fj.10-179218</electronic-resource-num><notes>From Duplicate 1 (Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A)

From Duplicate 1 ( Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )



From Duplicate 2 ( Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )


From Duplicate 2 (Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A)

From Duplicate 2 (Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A)

From Duplicate 2 ( 

Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.

- Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )




From Duplicate 1 ( 


Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.


- Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul a )








From Duplicate 2 ( 


Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.


- Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )




From Duplicate 2 ( 


Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.


- Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )</notes><research-notes>From Duplicate 1 (Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A)

From Duplicate 1 ( Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )



From Duplicate 2 ( Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )


From Duplicate 2 (Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A)

From Duplicate 2 (Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair. - Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A)

From Duplicate 2 ( 

Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.

- Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )




From Duplicate 1 ( 


Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.


- Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul a )








From Duplicate 2 ( 


Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.


- Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )




From Duplicate 2 ( 


Adenosine monophosphate-activated kinase alpha1 promotes endothelial barrier repair.


- Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3177581&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Calcium Signaling;ECIS TEER</label><abstract>The vascular endothelium responds to damage through activation of multiple signaling events that restore cell-cell adhesion and vascular integrity. However, the molecular mechanisms that integrate these events are not clearly defined. Herein, we identify a previously unexpected role for adenosine monophosphate-activated protein kinase (AMPK) in pulmonary microvascular endothelial cell (PMVEC) repair. PMVECs selectively express the AMPKα1 catalytic subunit, pharmacological and short hairpin RNA-mediated inhibition of which attenuates Ca(2+) entry in these cells induced by the inflammatory Ca(2+)-signaling mimetic thapsigargin. We find that AMPKα1 activity is required for the formation of PMVEC cell-cell networks in a prorepair environment and for monolayer resealing after wounding. Decreasing AMPKα1 expression reduces barrier resistance in PMVEC monolayers, results consistent with a role for AMPKα1 in cell-cell adhesion. AMPKα1 colocalizes and coimmunoprecipitates with the adherens junction protein N-cadherin and cofractionates with proteins selectively expressed in caveolar membranes. Assessment of permeability, by measuring the filtration coefficient (K(f)) in isolated perfused lungs, confirmed that AMPK activation contributes to barrier repair in vivo. Our findings thus provide novel evidence for AMPKα1 in Ca(2+) influx-mediated signaling and wound repair in the endothelium.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sidhaye, Venkataramana K</author><author>Chau, Eric</author><author>Breysse, Patrick N</author><author>King, Landon S</author></authors></contributors><titles><title>Septin-2 mediates airway epithelial barrier function in physiologic and pathologic conditions.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>120-126</pages><volume>45</volume><issue>1</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Cell Membrane: pathology</keyword><keyword>Dogs</keyword><keyword>Epidermal Growth Factor</keyword><keyword>Epidermal Growth Factor: metabolism</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Epithelial Cells: pathology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Protein Transport</keyword><keyword>Respiratory Mucosa</keyword><keyword>Respiratory Mucosa: metabolism</keyword><keyword>Respiratory Mucosa: pathology</keyword><keyword>Septins</keyword><keyword>Signal Transduction</keyword></keywords><dates><year>2011</year></dates><accession-num>20870893</accession-num><electronic-resource-num>10.1165/rcmb.2010-0235OC</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3145065&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Epithelial cells have the ability to regulate paracellular permeability dynamically in response to extracellular stimuli. With every respiratory effort, airway epithelial cells are exposed to both physiologic as well as pathologic stimuli, and regulation of the epithelial barrier in response to these stimuli is crucial to respiratory function. We report that increased membrane septin-2 localization mediates decreases in paracellular permeability by altering cortical actin arrangement in human airway epithelial cells. This phenomenon occurs in response to both physiologic levels of shear stress and a pathologic stimulus, particular matter exposure. The resulting changes in barrier function in response to septin-2 redistribution have a significant impact on the ability of the apical ligand, epidermal growth factor, to interact with its receptor, epidermal growth factor receptor, which is segregated to the basolateral side in airway epithelial cells. This suggests that the dynamic regulation of the epithelial barrier function is essential in regulating signaling responses to extracellular stimuli. These findings indicate that septin-2 plays a fundamental role in regulating barrier function by altering cortical actin expression.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Alvarez, Jorge Ivan</author><author>Dodelet-Devillers, Aurore</author><author>Kebir, Hania</author><author>Ifergan, Igal</author><author>Fabre, Pierre J</author><author>Terouz, Simone</author><author>Sabbagh, Mike</author><author>Wosik, Karolina</author><author>Bourbonniere, L.</author><author>Bernard, Monique</author><author>van Horssen, Jack</author><author>de Vries, Helga E</author><author>Charron, Frédéric</author><author>Prat, Alexandre</author></authors></contributors><titles><title>The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence</title><secondary-title>Science</secondary-title></titles><periodical><full-title>Science</full-title></periodical><pages>1727-1731</pages><volume>334</volume><issue>6063</issue><keywords><keyword>Animals</keyword><keyword>Astrocytes</keyword><keyword>Astrocytes: metabolism</keyword><keyword>Autoimmune</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: cytology</keyword><keyword>Blood-Brain Barrier: physiology</keyword><keyword>Brain</keyword><keyword>Brain: immunology</keyword><keyword>Brain: physiology</keyword><keyword>CD4-Positive T-Lymphocytes</keyword><keyword>CD4-Positive T-Lymphocytes: physiology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Cells</keyword><keyword>Chemokines</keyword><keyword>Chemokines: metabolism</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Encephalomyelitis</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Experimental</keyword><keyword>Experimental: immun</keyword><keyword>Experimental: immunology</keyword><keyword>Experimental: metab</keyword><keyword>Experimental: metabolism</keyword><keyword>Female</keyword><keyword>Hedgehog Proteins</keyword><keyword>Hedgehog Proteins: genetics</keyword><keyword>Hedgehog Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Inflammation Mediators</keyword><keyword>Inflammation Mediators: metabolism</keyword><keyword>Mice</keyword><keyword>Multiple Sclerosis</keyword><keyword>Multiple Sclerosis: immunology</keyword><keyword>Multiple Sclerosis: metabolism</keyword><keyword>Permeability</keyword><keyword>Signal Transduction</keyword><keyword>Veratrum Alkaloids</keyword><keyword>Veratrum Alkaloids: pharmacology</keyword></keywords><dates><year>2011</year></dates><accession-num>22144466</accession-num><electronic-resource-num>10.1126/science.1206936</electronic-resource-num><notes>From Duplicate 2 (The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. - Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre)

From Duplicate 1 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )








From Duplicate 2 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




From Duplicate 2 ( 


The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )














From Duplicate 2 (The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. - Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre)

From Duplicate 2 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




From Duplicate 1 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )








From Duplicate 2 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




From Duplicate 2 ( 


The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




















From Duplicate 1 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )








From Duplicate 2 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




From Duplicate 2 ( 


The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )</notes><research-notes>From Duplicate 2 (The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. - Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre)

From Duplicate 1 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )








From Duplicate 2 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




From Duplicate 2 ( 


The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )














From Duplicate 2 (The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. - Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre)

From Duplicate 2 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




From Duplicate 1 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )








From Duplicate 2 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




From Duplicate 2 ( 


The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




















From Duplicate 1 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )








From Duplicate 2 ( 


The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )




From Duplicate 2 ( 


The Hedgehog Pathway Promotes Blood-Brain Barrier Integrity and CNS Immune Quiescence.


- Alvarez, Jorge Ivan; Dodelet-Devillers, Aurore; Kebir, Hania; Ifergan, Igal; Fabre, Pierre J; Terouz, Simone; Sabbagh, Mike; Wosik, Karolina; Bourbonnière, Lyne; Bernard, Monique; van Horssen, Jack; de Vries, Helga E; Charron, Frédéric; Prat, Alexandre )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/22144466</url><url>http://www.sciencemag.org/cgi/doi/10.1126/science.1206936</url></web-urls></urls><label>Blood Brain Barrier;ECIS TEER;Signal Transduction</label><abstract>The blood-brain barrier (BBB) is composed of tightly bound endothelial cells (ECs) and perivascular astrocytes that regulate central nervous system (CNS) homeostasis. Here, we show that astrocytes secrete Sonic hedgehog (Shh) and that BBB-ECs express Hh receptors, which together promote BBB formation and integrity during embryonic development and adulthood. Using pharmacological inhibition and genetic inactivation of the Hh signaling pathway in ECs, we also demonstrate a critical role of the Hh pathway in promoting immune quiescence of BBB-ECs by decreasing the expression of proinflammatory mediators and the adhesion and migration of leukocytes, in vivo and in vitro. Overall, the Hh pathway provides a barrier-promoting effect and an endogenous anti-inflammatory balance to CNS-directed immune attacks, as occurs in multiple sclerosis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Burnside, Kellie</author><author>Lembo, Annalisa</author><author>Harrell, Maria Isabel</author><author>Gurney, Michael</author><author>Xue, Liang</author><author>BinhTran, Nguyen-Thao</author><author>Connelly, James E</author><author>Jewell, Kelsea a</author><author>Schmidt, Byron Z</author><author>de los Reyes, Melissa</author><author>Tao, Weiguo Andy</author><author>Doran, Kelly S</author><author>Rajagopal, Lakshmi</author></authors></contributors><titles><title>Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>44197-44210</pages><volume>286</volume><issue>51</issue><keywords><keyword>Animals</keyword><keyword>Arylsulfotransferase</keyword><keyword>Arylsulfotransferase: metabolism</keyword><keyword>Brain</keyword><keyword>Brain: metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Hemolysin Proteins</keyword><keyword>Hemolysin Proteins: chemistry</keyword><keyword>Hemolysin Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Microcirculation</keyword><keyword>Newborn</keyword><keyword>Phosphoprotein Phosphatases</keyword><keyword>Phosphoprotein Phosphatases: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Post-Transcriptional</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: metabolism</keyword><keyword>Proteomics</keyword><keyword>Proteomics: methods</keyword><keyword>RNA Processing</keyword><keyword>Rats</keyword><keyword>Streptococcus agalactiae</keyword><keyword>Streptococcus agalactiae: metabolism</keyword><keyword>Virulence</keyword></keywords><dates><year>2011</year></dates><accession-num>22081606</accession-num><electronic-resource-num>10.1074/jbc.M111.313486</electronic-resource-num><notes>From Duplicate 1 ( 

Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.

- Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Gurney, Michael; Xue, Liang; BinhTran, Nguyen-Thao; Connelly, James E; Jewell, Kelsea a; Schmidt, Byron Z; de los Reyes, Melissa; Tao, Weiguo Andy; Doran, Kelly S; Rajagopal, Lakshmi )








From Duplicate 2 ( 

Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.

- Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Gurney, Michael; Xue, Liang; BinhTran, Nguyen-Thao; Connelly, James E; Jewell, Kelsea a; Schmidt, Byron Z; de los Reyes, Melissa; Tao, Weiguo Andy; Doran, Kelly S; Rajagopal, Lakshmi )




From Duplicate 1 ( 


Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.


- Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Gurney, Michael; Xue, Liang; BinhTran, Nguyen-Thao; Connelly, James E; Jewell, Kelsea a; Schmidt, Byron Z; de los Reyes, Melissa; Tao, Weiguo Andy; Doran, Kelly S; Rajagopal, Lakshmi )</notes><research-notes>From Duplicate 1 ( 

Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.

- Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Gurney, Michael; Xue, Liang; BinhTran, Nguyen-Thao; Connelly, James E; Jewell, Kelsea a; Schmidt, Byron Z; de los Reyes, Melissa; Tao, Weiguo Andy; Doran, Kelly S; Rajagopal, Lakshmi )








From Duplicate 2 ( 

Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.

- Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Gurney, Michael; Xue, Liang; BinhTran, Nguyen-Thao; Connelly, James E; Jewell, Kelsea a; Schmidt, Byron Z; de los Reyes, Melissa; Tao, Weiguo Andy; Doran, Kelly S; Rajagopal, Lakshmi )




From Duplicate 1 ( 


Serine/threonine phosphatase Stp1 mediates post-transcriptional regulation of hemolysin, autolysis, and virulence of group B Streptococcus.


- Burnside, Kellie; Lembo, Annalisa; Harrell, Maria Isabel; Gurney, Michael; Xue, Liang; BinhTran, Nguyen-Thao; Connelly, James E; Jewell, Kelsea a; Schmidt, Byron Z; de los Reyes, Melissa; Tao, Weiguo Andy; Doran, Kelly S; Rajagopal, Lakshmi )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3243546&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Elucidating how serine/threonine phosphatases regulate kinase function and bacterial virulence is critical for our ability to combat these infections. Group B streptococci (GBS) are β-hemolytic Gram-positive bacteria that cause invasive infections in humans. To adapt to environmental changes, GBS encodes signaling mechanisms comprising two component systems and eukaryotic-like enzymes. We have previously described the importance of the serine/threonine kinase Stk1 to GBS pathogenesis. However, how the presence or absence of the cognate serine/threonine phosphatase Stp1 affects Stk1 function and GBS virulence is not known. Here, we show that GBS deficient only in Stp1 expression are markedly reduced for their ability to cause systemic infections, exhibit decreased β-hemolysin/cytolysin activity, and show increased sensitivity to autolysis. Although transcription of genes important for β-hemolysin/cytolysin expression and export is similar to the wild type (WT), 294 genes (excluding stp1) showed altered expression in the stp1 mutant and included autolysin genes. Furthermore, phosphopeptide enrichment analysis identified that 35 serine/threonine phosphopeptides, corresponding to 27 proteins, were unique to the stp1 mutant. This included phosphorylation of ATP synthase, DNA and RNA helicases, and proteins important for cell division and protein synthesis. Collectively, our results indicate that Stp1 is important for appropriate regulation of Stk1 function, hemolysin activity, autolysis, and GBS virulence.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bevan, Heather S</author><author>Slater, Sadie C</author><author>Clarke, Hayley</author><author>Cahill, Paul A</author><author>Mathieson, Peter W</author><author>Welsh, Gavin I</author><author>Satchell, Simon C</author></authors></contributors><titles><title>Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase.</title><secondary-title>American journal of physiology. Renal physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Renal physiology</full-title></periodical><pages>F733-42</pages><volume>301</volume><issue>4</issue><keywords><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Humans</keyword><keyword>Kidney Glomerulus</keyword><keyword>Kidney Glomerulus: drug effects</keyword><keyword>Kidney Glomerulus: enzymology</keyword><keyword>Kidney Glomerulus: physiology</keyword><keyword>Mechanical</keyword><keyword>NG-Nitroarginine Methyl Ester</keyword><keyword>NG-Nitroarginine Methyl Ester: pharmacology</keyword><keyword>Nitric Oxide Synthase Type III</keyword><keyword>Nitric Oxide Synthase Type III: antagonists &amp; inhi</keyword><keyword>Nitric Oxide Synthase Type III: biosynthesis</keyword><keyword>Nitric Oxide Synthase Type III: physiology</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: antagonists &amp; inhi</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>Proto-Oncogene Proteins c-akt: antagonists &amp; inhib</keyword><keyword>Proto-Oncogene Proteins c-akt: metabolism</keyword><keyword>Shear Strength</keyword><keyword>Stress</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: enzymology</keyword><keyword>Vascular: physiology</keyword><keyword>omega-N-Methylarginine</keyword><keyword>omega-N-Methylarginine: pharmacology</keyword></keywords><dates><year>2011</year></dates><accession-num>21775480</accession-num><electronic-resource-num>10.1152/ajprenal.00458.2010</electronic-resource-num><notes>From Duplicate 1 ( 


Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase.


- Bevan, Heather S; Slater, Sadie C; Clarke, Hayley; Cahill, Paul A; Mathieson, Peter W; Welsh, Gavin I; Satchell, Simon C )








From Duplicate 2 ( 


Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase.


- Bevan, Heather S; Slater, Sadie C; Clarke, Hayley; Cahill, Paul A; Mathieson, Peter W; Welsh, Gavin I; Satchell, Simon C )</notes><research-notes>From Duplicate 1 ( 


Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase.


- Bevan, Heather S; Slater, Sadie C; Clarke, Hayley; Cahill, Paul A; Mathieson, Peter W; Welsh, Gavin I; Satchell, Simon C )








From Duplicate 2 ( 


Acute laminar shear stress reversibly increases human glomerular endothelial cell permeability via activation of endothelial nitric oxide synthase.


- Bevan, Heather S; Slater, Sadie C; Clarke, Hayley; Cahill, Paul A; Mathieson, Peter W; Welsh, Gavin I; Satchell, Simon C )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3191806&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Flow;ECIS TEER</label><abstract>Laminar shear stress is a key determinant of systemic vascular behavior, including through activation of endothelial nitric oxide synthase (eNOS), but little is known of its role in the glomerulus. We confirmed eNOS expression by glomerular endothelial cells (GEnC) in tissue sections and examined effects of acute exposure (up to 24 h) to physiologically relevant levels of laminar shear stress (10-20 dyn/cm(2)) in conditionally immortalized human GEnC. Laminar shear stress caused an orientation of GEnC and stress fibers parallel to the direction of flow and induced Akt and eNOS phosphorylation along with NO production. Inhibition of the phophatidylinositol (PI)3-kinase/Akt pathway attenuated laminar shear stress-induced eNOS phosphorylation and NO production. Laminar shear stress of 10 dyn/cm(2) had a dramatic effect on GEnC permeability, reversibly decreasing the electrical resistance across GEnC monolayers. Finally, the laminar shear stress-induced reduction in electrical resistance was attenuated by the NOS inhibitors l-N(G)-monomethyl arginine (l-NMMA) and l-N(G)-nitroarginine methyl ester (l-NAME) and also by inhibition of the PI3-kinase/Akt pathway. Hence we have shown for GEnC in vitro that acute permeability responses to laminar shear stress are dependent on NO, produced via activation of the PI3-kinase/Akt pathway and increased eNOS phosphorylation. These results suggest the importance of laminar shear stress and NO in regulating the contribution of GEnC to the permeability properties of the glomerular capillary wall.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ablin, Richard J</author><author>Kynaston, Howard G</author><author>Mason, Malcolm D</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.</title><secondary-title>Journal of translational medicine</secondary-title></titles><periodical><full-title>Journal of translational medicine</full-title></periodical><pages>49</pages><volume>9</volume><issue>1</issue><keywords><keyword>Antineoplastic Agents</keyword><keyword>Antineoplastic Agents: antagonists &amp; inhibitors</keyword><keyword>Antineoplastic Agents: pharmacology</keyword><keyword>Biological Assay</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Cell Surface</keyword><keyword>Cell Surface: metabolism</keyword><keyword>Humans</keyword><keyword>Interleukins</keyword><keyword>Interleukins: antagonists &amp; inhibitors</keyword><keyword>Interleukins: pharmacology</keyword><keyword>Male</keyword><keyword>Prostatic Neoplasms</keyword><keyword>Prostatic Neoplasms: enzymology</keyword><keyword>Prostatic Neoplasms: pathology</keyword><keyword>Protein Transport</keyword><keyword>Protein Transport: drug effects</keyword><keyword>Receptors</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Staining and Labeling</keyword><keyword>Transglutaminases</keyword><keyword>Transglutaminases: metabolism</keyword><keyword>Tumor</keyword></keywords><dates><year>2011</year></dates><publisher>BioMed Central Ltd</publisher><accession-num>21524313</accession-num><electronic-resource-num>10.1186/1479-5876-9-49</electronic-resource-num><notes>From Duplicate 2 (Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer. - Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G)

From Duplicate 1 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added





From Duplicate 2 (Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer. - Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G)

From Duplicate 1 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added





From Duplicate 2 (Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer. - Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G)

From Duplicate 1 ( 

Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.

- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added



From Duplicate 2 ( 

Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.

- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )




From Duplicate 1 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )




From Duplicate 1 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added







From Duplicate 2 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added</notes><research-notes>From Duplicate 2 (Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer. - Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G)

From Duplicate 1 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added





From Duplicate 2 (Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer. - Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G)

From Duplicate 1 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added





From Duplicate 2 (Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer. - Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G)

From Duplicate 1 ( 

Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.

- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added



From Duplicate 2 ( 

Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.

- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )




From Duplicate 1 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )




From Duplicate 1 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added







From Duplicate 2 ( 


Prostate transglutaminase (TGase-4) antagonizes the anti-tumour action of MDA-7/IL-24 in prostate cancer.


- Ablin, Richard J; Kynaston, Howard G; Mason, Malcolm D; Jiang, Wen G )



Two models of ECIS instrument were used: ECIS 9600 for screening and ECIS1600R for modeling. In both sys- tems, 8W10 arrays were used (Applied Biophysics Inc, Troy, NY, USA) [21,22]. Following treatment of the array surface with a Cysteine solution, the arrays were incu- bated with complete medium for 1 hr. The same number of prostate cancer cells, PC-3pEF/His,PC-3TGase4exp,or PC-3wt when appropriate CA-HPV-10∆TGase4,CA-HPV- 10pEF/His or CA-HPV-10wt (300,000 per well) were added</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3113954&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Attachment;Signal Transduction</label><abstract>Transglutamiase-4 (TGase-4), also known as prostate transglutaminase, belongs to the TGase family and is uniquely expressed in the prostate gland. The functions of this interesting protein are not clearly defined. In the present study, we have investigated an unexpected link between TGase-4 and the melanoma differentiation-associated gene-7/interleukin-24 (MDA-7/IL-24), a cytokine known to regulate the growth and apoptosis of certain cancer and immune cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Park, Hyo Eun</author><author>Kim, Donghee</author><author>Koh, Hyun Sook</author><author>Cho, Sungbo</author><author>Sung, Jung-Suk</author><author>Kim, Jae Young</author></authors></contributors><titles><title>Real-time monitoring of neural differentiation of human mesenchymal stem cells by electric cell-substrate impedance sensing.</title><secondary-title>Journal of biomedicine &amp; biotechnology</secondary-title></titles><periodical><full-title>Journal of biomedicine &amp; biotechnology</full-title></periodical><pages>485173</pages><volume>2011</volume><keywords/><dates><year>2011</year></dates><accession-num>21716652</accession-num><electronic-resource-num>10.1155/2011/485173</electronic-resource-num><notes>From Duplicate 1 (Real-time monitoring of neural differentiation of human mesenchymal stem cells by electric cell-substrate impedance sensing. - Park, Hyo Eun; Kim, Donghee; Koh, Hyun Sook; Cho, Sungbo; Sung, Jung-Suk; Kim, Jae Young)

From Duplicate 1 ( Real-time monitoring of neural differentiation of human mesenchymal stem cells by electric cell-substrate impedance sensing. - Park, Hyo Eun; Kim, Donghee; Koh, Hyun Sook; Cho, Sungbo; Sung, Jung-Suk; Kim, Jae Young )



From Duplicate 2 ( Real-time monitoring of neural differentiation of human mesenchymal stem cells by electric cell-substrate impedance sensing. - Park, Hyo Eun; Kim, Donghee; Koh, Hyun Sook; Cho, Sungbo; Sung, Jung-Suk; Kim, Jae Young )</notes><research-notes>From Duplicate 1 (Real-time monitoring of neural differentiation of human mesenchymal stem cells by electric cell-substrate impedance sensing. - Park, Hyo Eun; Kim, Donghee; Koh, Hyun Sook; Cho, Sungbo; Sung, Jung-Suk; Kim, Jae Young)

From Duplicate 1 ( Real-time monitoring of neural differentiation of human mesenchymal stem cells by electric cell-substrate impedance sensing. - Park, Hyo Eun; Kim, Donghee; Koh, Hyun Sook; Cho, Sungbo; Sung, Jung-Suk; Kim, Jae Young )



From Duplicate 2 ( Real-time monitoring of neural differentiation of human mesenchymal stem cells by electric cell-substrate impedance sensing. - Park, Hyo Eun; Kim, Donghee; Koh, Hyun Sook; Cho, Sungbo; Sung, Jung-Suk; Kim, Jae Young )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3116536&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Differentiation;ECIS Growth</label><abstract>Stem cells are useful for cell replacement therapy. Stem cell differentiation must be monitored thoroughly and precisely prior to transplantation. In this study we evaluated the usefulness of electric cell-substrate impedance sensing (ECIS) for in vitro real-time monitoring of neural differentiation of human mesenchymal stem cells (hMSCs). We cultured hMSCs in neural differentiation media (NDM) for 6 days and examined the time-course of impedance changes with an ECIS array. We also monitored the expression of markers for neural differentiation, total cell count, and cell cycle profiles. Cellular expression of neuron and oligodendrocyte markers increased. The resistance value of cells cultured in NDM was automatically measured in real-time and found to increase much more slowly over time compared to cells cultured in non-differentiation media. The relatively slow resistance changes observed in differentiating MSCs were determined to be due to their lower growth capacity achieved by induction of cell cycle arrest in G0/G1. Overall results suggest that the relatively slow change in resistance values measured by ECIS method can be used as a parameter for slowly growing neural-differentiating cells. However, to enhance the competence of ECIS for in vitro real-time monitoring of neural differentiation of MSCs, more elaborate studies are needed.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Knight, Brandi B</author><author>Oprea-Ilies, Gabriela M</author><author>Nagalingam, Arumugam</author><author>Yang, Lily</author><author>Cohen, Cynthia</author><author>Saxena, Neeraj K</author><author>Sharma, Dipali</author></authors></contributors><titles><title>Survivin upregulation, dependent on leptin-EGFR-Notch1 axis, is essential for leptin-induced migration of breast carcinoma cells.</title><secondary-title>Endocrine-related cancer</secondary-title></titles><periodical><full-title>Endocrine-related cancer</full-title></periodical><pages>413-428</pages><volume>18</volume><issue>4</issue><keywords><keyword>Animals</keyword><keyword>Blotting</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: genetics</keyword><keyword>Breast Neoplasms: metabolism</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Chromatin Immunoprecipitation</keyword><keyword>Epidermal Growth Factor</keyword><keyword>Epidermal Growth Factor: genetics</keyword><keyword>Epidermal Growth Factor: metabolism</keyword><keyword>Female</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Immunoprecipitation</keyword><keyword>Inhibitor of Apoptosis Proteins</keyword><keyword>Inhibitor of Apoptosis Proteins: antagonists &amp; inh</keyword><keyword>Inhibitor of Apoptosis Proteins: genetics</keyword><keyword>Inhibitor of Apoptosis Proteins: metabolism</keyword><keyword>Leptin</keyword><keyword>Leptin: metabolism</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Mice</keyword><keyword>Notch1</keyword><keyword>Notch1: genetics</keyword><keyword>Notch1: metabolism</keyword><keyword>Nude</keyword><keyword>RNA</keyword><keyword>Receptor</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Signal Transduction</keyword><keyword>Tumor</keyword><keyword>Up-Regulation</keyword><keyword>Western</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2011</year></dates><accession-num>21555376</accession-num><electronic-resource-num>10.1530/ERC-11-0075</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3361735&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction;Wound Healing</label><abstract>Obese breast cancer patients exhibit a higher risk for larger tumor burden and an increased likelyhood of metastasis. The molecular effects of obesity on carcinogenesis are mediated by the autocrine and paracrine effects of the adipocytokine leptin. Leptin participates in the tumor progression and metastasis of human breast. We show that leptin induces clonogenicity and increases the migration potential of breast cancer cells. We found that survivin expression is induced in response to leptin. In this study, we examine the role and leptin-mediated regulation of survivin. Leptin treatment leads to survivin upregulation, due in part to the activation of Notch1 and the release of a transcriptionally active Notch1 intracellular domain (NICD). Chromatin immunoprecipitation analysis shows that NICD gets recruited to the survivin promoter at the CSL (CBF1/RBP-Jk, Su(H), Lag-1) binding site in response to leptin treatment. Inhibition of Notch1 activity inhibits leptin-induced survivin upregulation. Leptin-induced transactivation of epidermal growth factor receptor (EGFR) is involved in leptin-mediated Notch1 and survivin upregulation, demonstrating a novel upstream role of leptin-EGFR-Notch1 axis. We further show that leptin-induced migration of breast cancer cells requires survivin, as overexpression of survivin further increases, whereas silencing survivin abrogates leptin-induced migration. Using a pharmacological approach to inhibit survivin, we show that 3-hydroxy-3-methylglutaryl-coenzyme-A-reductase inhibitors, such as lovastatin, can effectively inhibit leptin-induced survivin expression and migration. Importantly, leptin increased breast tumor growth in nude mice. These data show a novel role for survivin in leptin-induced migration and put forth pharmacological survivin inhibition as a potential novel therapeutic strategy. This conclusion is supported by in vivo data showing the overexpression of leptin and survivin in epithelial cells of high-grade ductal carcinomas in situ and in high-grade invasive carcinomas.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>David, Sascha</author><author>Ghosh, Chandra C</author><author>Mukherjee, Aditi</author><author>Parikh, Samir M</author></authors></contributors><titles><title>Angiopoietin-1 requires IQ domain GTPase-activating protein 1 to activate Rac1 and promote endothelial barrier defense.</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arteriosclerosis, thrombosis, and vascular biology</full-title></periodical><pages>2643-2652</pages><volume>31</volume><issue>11</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: physiology</keyword><keyword>Angiopoietin-1</keyword><keyword>Angiopoietin-1: metabolism</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Gap Junctions</keyword><keyword>Gap Junctions: physiology</keyword><keyword>Humans</keyword><keyword>RNA</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword><keyword>ras GTPase-Activating Proteins</keyword><keyword>ras GTPase-Activating Proteins: antagonists &amp; inhi</keyword><keyword>ras GTPase-Activating Proteins: drug effects</keyword><keyword>ras GTPase-Activating Proteins: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>21885850</accession-num><electronic-resource-num>10.1161/ATVBAHA.111.233189</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3249617&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>OBJECTIVE: IQ domain GTPase-activating protein 1 (IQGAP1) contributes to cytoskeletal network regulation in epithelial cells by its scaffolding properties and by binding the Rho GTPase Rac1 to maintain its activity. The functions of IQGAP1 in endothelial cells beyond angiogenesis remain unclear. We hypothesized that IQGAP1 participates in the regulation of endothelial barrier function. METHODS AND RESULTS: Silencing IQGAP1 in human microvascular endothelial cells resulted in a disruption of adherens junctions, formation of interendothelial gaps, and a reduction in barrier function. Furthermore, silencing of IQGAP1 abrogated the barrier enhancement effect of angiopoietin-1 (Angpt-1) and abolished the barrier-stabilizing effect of Angpt-1 on thrombin-stimulated cells. Coimmunoprecipitation detected binding of endogenous IQGAP1 with Rac1 at baseline that was stronger when Rac1 was activated and weaker when it was deactivated. Measurement of GTP-bound Rac1 revealed that Angpt-1 failed to activate Rac1 not only if IQGAP1 was silenced but also if cells were transfected with a mutant disabled in Rac1 binding (T1050AX2). Furthermore, a dominant-active Rac1 was sufficient to completely reverse the morphological and functional changes induced by reduction in IQGAP1. CONCLUSION: These experiments are the first demonstration of IQGAP1 regulating barrier function in any cell type. Further, our data show that Angpt-1 requires IQGAP1 as an indispensable activator of Rac1.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Baumer, Yvonne</author><author>Scholz, Beate</author><author>Ivanov, Svetlana</author><author>Schlosshauer, Burkhard</author></authors></contributors><titles><title>Telomerase-based immortalization modifies the angiogenic/inflammatory responses of human coronary artery endothelial cells.</title><secondary-title>Experimental biology and medicine (Maywood, N.J.)</secondary-title></titles><periodical><full-title>Experimental biology and medicine (Maywood, N.J.)</full-title></periodical><pages>692-700</pages><volume>236</volume><issue>6</issue><keywords><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Gene Expression</keyword><keyword>Gene Expression Profiling</keyword><keyword>Humans</keyword><keyword>Inflammation Mediators</keyword><keyword>Inflammation Mediators: metabolism</keyword><keyword>LDL</keyword><keyword>LDL: metabolism</keyword><keyword>Lipoproteins</keyword><keyword>Neovascularization</keyword><keyword>Physiologic</keyword><keyword>Telomerase</keyword><keyword>Telomerase: genetics</keyword><keyword>Telomerase: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>21558092</accession-num><electronic-resource-num>10.1258/ebm.2011.010300</electronic-resource-num><notes>From Duplicate 2 (Telomerase-based immortalization modifies the angiogenic/inflammatory responses of human coronary artery endothelial cells. - Baumer, Yvonne; Scholz, Beate; Ivanov, Svetlana; Schlosshauer, Burkhard)

From Duplicate 2 ( Telomerase-based immortalization modifies the angiogenic/inflammatory responses of human coronary artery endothelial cells. - Baumer, Yvonne; Scholz, Beate; Ivanov, Svetlana; Schlosshauer, Burkhard )</notes><research-notes>From Duplicate 2 (Telomerase-based immortalization modifies the angiogenic/inflammatory responses of human coronary artery endothelial cells. - Baumer, Yvonne; Scholz, Beate; Ivanov, Svetlana; Schlosshauer, Burkhard)

From Duplicate 2 ( Telomerase-based immortalization modifies the angiogenic/inflammatory responses of human coronary artery endothelial cells. - Baumer, Yvonne; Scholz, Beate; Ivanov, Svetlana; Schlosshauer, Burkhard )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21558092</url></web-urls></urls><label>ECIS TEER</label><abstract>Telomerase reverse transcriptase (TERT) is fundamental in determining the life span by regulating telomere length of chromosomes. To address the question whether the enhancement of the proliferative potential hampers cell differentiation, we generated TERT-over-expressing endothelial cells (ECs) and analyzed in vitro their (1) barrier function; (2) low-density lipoprotein uptake; (3) expression pattern of six selected marker proteins; (4) angiogenic potential in four assays; and (5) inflammatory responses. In contrast to investigations with focus on other cell parameters, we demonstrate that immortalization of ECs by over-expression of TERT resulted in different angiogenic and inflammatory behavior in comparison to cells with low native telomerase levels.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bogatcheva, Natalia V</author><author>Zemskova, Marina A</author><author>Gorshkov, Boris A</author><author>Kim, Kyung Mi</author><author>Daglis, Gregory A</author><author>Poirier, Christophe</author><author>Verin, Alexander D</author></authors></contributors><titles><title>Ezrin, radixin, and moesin are phosphorylated in response to 2-methoxyestradiol and modulate endothelial hyperpermeability.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>1185-1194</pages><volume>45</volume><issue>6</issue><keywords><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: genetics</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: genetics</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Enzyme Activation: genetics</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Estradiol</keyword><keyword>Estradiol: analogs &amp; derivatives</keyword><keyword>Estradiol: pharmacology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: drug effects</keyword><keyword>Gene Expression Regulation: genetics</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Humans</keyword><keyword>Indoles</keyword><keyword>Indoles: pharmacology</keyword><keyword>Male</keyword><keyword>Maleimides</keyword><keyword>Maleimides: pharmacology</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Mice</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: genetics</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Paclitaxel</keyword><keyword>Paclitaxel: pharmacology</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Phosphorylation: genetics</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C: antagonists &amp; inhibitors</keyword><keyword>Protein Kinase C: genetics</keyword><keyword>Protein Kinase C: metabolism</keyword><keyword>Pyrroles</keyword><keyword>Pyrroles: pharmacology</keyword><keyword>Tubulin Modulators</keyword><keyword>Tubulin Modulators: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>p38 Mitogen-Activated Protein Kinases: genetics</keyword><keyword>p38 Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: genetics</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>21659656</accession-num><electronic-resource-num>10.1165/rcmb.2011-0092OC</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21659656</url><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3262663&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>We showed previously that microtubule disruptor 2-methoxyestradiol (2ME) induces hyperpermeability of the endothelial monolayer via mechanisms that include the activation of p38 and Rho kinase (ROCK) and rearrangement of the actin cytoskeleton. Using the protein kinase C (PKC) inhibitors Ro-31-7549 and Ro-32-0432, we show in vitro and in vivo that 2ME-induced barrier dysfunction is also PKC-dependent. The known PKC substrates ezrin, radixin, and moesin (ERM) were recently implicated in the regulation of endothelial permeability. This study tested the hypotheses that ERM proteins are phosphorylated in response to 2ME, and that this phosphorylation is involved in 2ME-induced barrier dysfunction. We show that the application of 2ME leads to a dramatic increase in the level of ERM phosphorylation. This increase is attenuated in cells pretreated with the microtubule stabilizer taxol. In human pulmonary artery endothelial cells (HPAECs), the phosphorylation of ERM occurs in a p38-dependent and PKC-dependent manner. The activation of p38 appears to occur upstream from the activation of PKC, in response to 2ME. Phosphorylated ERM are localized at the cell periphery during the early phase of response to 2ME (15 minutes), and colocalize with F-actin branching points during the later phase of response (60 minutes). Using the short interfering RNA approach, we also showed that individual ERM depletion significantly attenuates 2ME-induced hyperpermeability. HPAEC monolayers, depleted of ERM proteins and monolayers, overexpressing phosphorylation-deficient ERM mutants, exhibit less attenuation of 2ME-induced barrier disruption in response to the PKC inhibitor Ro-31-7549. These results suggest a critical role of PKC activation in response to microtubule-disrupting agents, and implicate the phosphorylation of ERM in the barrier dysfunction induced by 2ME.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bagnaninchi, Pierre O</author><author>Drummond, Nicola</author></authors></contributors><titles><title>Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>6462-6467</pages><volume>108</volume><issue>16</issue><keywords><keyword>Adipose Tissue</keyword><keyword>Adipose Tissue: cytology</keyword><keyword>Adipose Tissue: physiology</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Differentiation: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Humans</keyword><keyword>Osteogenesis</keyword><keyword>Osteogenesis: physiology</keyword><keyword>Stem Cells</keyword><keyword>Stem Cells: cytology</keyword><keyword>Stem Cells: physiology</keyword></keywords><dates><year>2011</year></dates><accession-num>21464296</accession-num><electronic-resource-num>10.1073/pnas.1018260108</electronic-resource-num><notes>From Duplicate 1 (Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing. - Bagnaninchi, Pierre O; Drummond, Nicola)

From Duplicate 2 ( Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing. - Bagnaninchi, Pierre O; Drummond, Nicola )</notes><research-notes>From Duplicate 1 (Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing. - Bagnaninchi, Pierre O; Drummond, Nicola)

From Duplicate 2 ( Real-time label-free monitoring of adipose-derived stem cell differentiation with electric cell-substrate impedance sensing. - Bagnaninchi, Pierre O; Drummond, Nicola )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3080969&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Differentiation</label><abstract>Real-time monitoring of stem cells (SCs) differentiation will be critical to scale-up SC technologies, while label-free techniques will be desirable to quality-control SCs without precluding their therapeutic potential. We cultured adipose-derived stem cells (ADSCs) on top of multielectrode arrays and measured variations in the complex impedance Z* throughout induction of ADSCs toward osteoblasts and adipocytes. Z* was measured up to 17 d, every 180 s, over a 62.5-64 kHz frequency range with an ECIS Z instrument. We found that osteogenesis and adipogenesis were characterized by distinct Z* time-courses. Significant differences were found (P = 0.007) as soon as 12 h post induction. An increase in the barrier resistance (Rb) up to 1.7 ohm·cm(2) was associated with early osteo-induction, whereas Rb peaked at 0.63 ohm·cm(2) for adipo-induced cells before falling to zero at t = 129 h. Dissimilarities in Z* throughout early induction (&lt;24 h) were essentially attributed to variations in the cell-substrate parameter α. Four days after induction, cell membrane capacitance (Cm) of osteo-induced cells (Cm = 1.72 ± 0.10 μF/cm(2)) was significantly different from that of adipo-induced cells (Cm = 2.25 ± 0.27 μF/cm(2)), indicating that Cm could be used as an early marker of differentiation. Finally, we demonstrated long-term monitoring and measured a shift in the complex plane in the middle frequency range (1 kHz to 8 kHz) between early (t = 100 h) and late induction (t = 380 h). This study demonstrated that the osteoblast and adipocyte lineages have distinct dielectric properties and that such differences can be used to perform real-time label-free quantitative monitoring of adult stem cell differentiation with impedance sensing.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dalmasso, Guillaume</author><author>Nguyen, Hang Thi Thu</author><author>Yan, Yutao</author><author>Laroui, Hamed</author><author>Charania, Moiz A</author><author>Obertone, Tracy S</author><author>Sitaraman, Shanthi V</author><author>Merlin, Didier</author></authors></contributors><titles><title>MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells.</title><secondary-title>American journal of physiology. Gastrointestinal and liver physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Gastrointestinal and liver physiology</full-title></periodical><pages>G52-9</pages><volume>300</volume><issue>1</issue><keywords><keyword>Caco-2 Cells</keyword><keyword>Cell Differentiation</keyword><keyword>Diaminopimelic Acid</keyword><keyword>Diaminopimelic Acid: analogs &amp; derivatives</keyword><keyword>Diaminopimelic Acid: pharmacology</keyword><keyword>Down-Regulation</keyword><keyword>Humans</keyword><keyword>Inflammation</keyword><keyword>Inflammation: chemically induced</keyword><keyword>Inflammation: prevention &amp; control</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: cytology</keyword><keyword>Intestinal Mucosa: metabolism</keyword><keyword>MicroRNAs</keyword><keyword>MicroRNAs: physiology</keyword><keyword>Oligopeptides</keyword><keyword>Oligopeptides: pharmacology</keyword><keyword>Symporters</keyword><keyword>Symporters: biosynthesis</keyword></keywords><dates><year>2011</year></dates><accession-num>21030610</accession-num><electronic-resource-num>10.1152/ajpgi.00394.2010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3025505&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Inflammation</label><abstract>MicroRNAs (miRNAs), which are noncoding RNAs that posttranscriptionally inhibit expression of target genes, have recently emerged as important regulators of many cellular functions such as cell differentiation. The epithelial di/tripeptide membrane transporter PepT1 is expressed in highly differentiated cells (the villous tip) but not in undifferentiated cells (the crypt) of the small intestine. Here, we investigated the regulation of PepT1 expression by miRNAs and its functional consequences. We observed a reverse correlation between the expression levels of PepT1 and mature miRNA-92b (miR-92b) during the differentiation of intestinal epithelial Caco2-BBE cells, suggesting a miR-92b-mediated regulation of PepT1 expression. We demonstrate that miR-92b suppressed PepT1 expression at both mRNA and protein levels, with subsequent reduced PepT1 transport activity, in Caco2-BBE cells by directly targeting the PepT1 3'-untranslated region. In addition, miR-92b suppresses bacterial peptide-induced proinflammatory responses in intestinal epithelial cells by inhibiting PepT1 expression. Altogether, our study provides for the first time evidence for the regulation of PepT1 expression at a posttranscriptional level by miRNAs in intestinal epithelial cells during pathophysiological states.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Du, Peng</author><author>Ye, Lin</author><author>Ruge, Fiona</author><author>Yang, Yong</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.</title><secondary-title>Anticancer research</secondary-title></titles><periodical><full-title>Anticancer research</full-title></periodical><pages>3205-3212</pages><volume>31</volume><issue>10</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Proliferation</keyword><keyword>Cell-Matrix Junctions</keyword><keyword>Cell-Matrix Junctions: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Humans</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Proteins</keyword><keyword>Neoplasm Proteins: metabolism</keyword><keyword>Tumor</keyword><keyword>Tumor Suppressor Proteins</keyword><keyword>Tumor Suppressor Proteins: metabolism</keyword><keyword>Urinary Bladder Neoplasms</keyword><keyword>Urinary Bladder Neoplasms: metabolism</keyword><keyword>Urinary Bladder Neoplasms: pathology</keyword></keywords><dates><year>2011</year></dates><accession-num>21965727</accession-num><notes>From Duplicate 1 ( 

Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.

- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )




From Duplicate 1 ( 


Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.


- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )












From Duplicate 2 ( 

Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.

- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )




From Duplicate 1 ( 


Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.


- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )




From Duplicate 1 ( 


Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.


- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )












From Duplicate 2 ( 


Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.


- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )</notes><research-notes>From Duplicate 1 ( 

Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.

- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )




From Duplicate 1 ( 


Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.


- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )












From Duplicate 2 ( 

Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.

- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )




From Duplicate 1 ( 


Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.


- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )




From Duplicate 1 ( 


Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.


- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )












From Duplicate 2 ( 


Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.


- Du, Peng; Ye, Lin; Ruge, Fiona; Yang, Yong; Jiang, Wen G )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21965727</url><url>http://ar.iiarjournals.org/content/31/10/3205.short</url></web-urls></urls><label>ECIS Attachment;ECIS Migration</label><abstract>Metastasis suppressor 1 (MTSS1) is proposed to function as a cytoskeletal-associated protein, which may play a role in the aggressiveness of cancer cells. Recent studies have demonstrated a clinical significance of MTSS1 in certain types of cancer, but its role in bladder cancer remains unknown. We investigated the expression of MTSS1 in normal and malignant human bladder tissues and its molecular interaction within bladder cancer cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Herron, Crystal R</author><author>Lowery, Anthony M</author><author>Hollister, Patricia R</author><author>Reynolds, Albert B</author><author>Vincent, Peter a</author></authors></contributors><titles><title>p120 regulates endothelial permeability independently of its NH2 terminus and Rho binding.</title><secondary-title>American journal of physiology. Heart and circulatory physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Heart and circulatory physiology</full-title></periodical><pages>H36-48</pages><volume>300</volume><issue>1</issue><keywords><keyword>Analysis of Variance</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Catenins</keyword><keyword>Catenins: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Humans</keyword><keyword>Permeability</keyword><keyword>RNA Interference</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>gamma Catenin</keyword><keyword>gamma Catenin: metabolism</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>20971762</accession-num><electronic-resource-num>10.1152/ajpheart.00812.2010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3023255&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>The association of p120-catenin (p120) with the juxtamembrane domain (JMD) of vascular endothelial (VE)-cadherin is required to maintain VE-cadherin levels and transendothelial resistance (TEER) of endothelial cell monolayers. To distinguish whether decreased TEER was due to a loss of p120 and not to the decrease in VE-cadherin, we established a system in which p120 was depleted by short hairpin RNA delivered by lentivirus and VE-cadherin was restored via expression of VE-cadherin fused to green fluorescent protein (GFP). Loss of p120 resulted in decreased TEER, which was associated with decreased expression of VE-cadherin, β-catenin, plakoglobin, and α-catenin. Decreased TEER was rescued by restoration of p120 but not by the expression of VE-cadherin-GFP, despite localization of VE-cadherin-GFP at cell-cell borders. Expression of VE-cadherin-GFP restored levels of β-catenin and α-catenin but not plakoglobin, indicating that p120 may be important for recruitment of plakoglobin to the VE-cadherin complex. To evaluate the role of p120 interaction with Rho GTPase in regulating endothelial permeability, we expressed a recombinant form of p120, lacking the NH(2) terminus and containing alanine substitutions, that eliminates binding of Rho to p120. Expression of this isoform restored expression of the adherens junction complex and rescued permeability as measured by TEER. These results demonstrate that p120 is required for maintaining VE-cadherin expression and TEER independently of its NH(2) terminus and its role in regulating Rho.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Martin, Tracey A</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Claudin-16/paracellin-1, cloning, expression, and its role in tight junction functions in cancer and endothelial cells.</title><secondary-title>Methods in molecular biology (Clifton, N.J.)</secondary-title></titles><periodical><full-title>Methods in molecular biology (Clifton, N.J.)</full-title></periodical><pages>383-407</pages><volume>762</volume><keywords><keyword>Animals</keyword><keyword>Blotting</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: metabolism</keyword><keyword>Breast Neoplasms: physiopathology</keyword><keyword>Claudins</keyword><keyword>Cloning</keyword><keyword>DNA Primers</keyword><keyword>DNA Primers: genetics</keyword><keyword>Electrophoresis</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Female</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Fluorescent Antibody Technique: methods</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Immunohistochemistry: methods</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Mice</keyword><keyword>Molecular</keyword><keyword>Molecular: methods</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplasm Metastasis: physiopathology</keyword><keyword>Polyacrylamide Gel</keyword><keyword>Polyacrylamide Gel: methods</keyword><keyword>Prognosis</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction: m</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: metabolism</keyword><keyword>Western</keyword><keyword>Western: methods</keyword></keywords><dates><year>2011</year></dates><accession-num>21717372</accession-num><electronic-resource-num>10.1007/978-1-61779-185-7_28</electronic-resource-num><urls><web-urls><url>http://www.springerlink.com/index/R342J880876WMM85.pdf</url><url>http://www.ncbi.nlm.nih.gov/pubmed/21717372</url></web-urls></urls><label>ECIS Migration</label><abstract>Metastatic spread of cancer is the major reason for patient mortality in human breast cancer. We examined expression of claudin-16 in human breast cells and tissues to identify a possible link between expression and aggressiveness in cells and between claudin-16 levels and patient prognosis. Forced expression of claudin-16 in breast cancer cells resulted in a less aggressive phenotype and reduced in vivo tumour volume. Claudin-16 expression was reduced in human breast cancer, particularly in patients with aggressive tumours and high mortality (Martin et al. J Cell Biochem 105:41-52,2008). This suggests that claudin-16 plays a role beyond that of an initial metastasis repressor in this cancer type.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kim, Su-Hyeong</author><author>Nagalingam, Arumugam</author><author>Saxena, Neeraj K</author><author>Singh, Shivendra V</author><author>Sharma, Dipali</author></authors></contributors><titles><title>Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.</title><secondary-title>Carcinogenesis</secondary-title></titles><periodical><full-title>Carcinogenesis</full-title></periodical><pages>359-367</pages><volume>32</volume><issue>3</issue><keywords><keyword>Apoptosis</keyword><keyword>Apoptosis: drug effects</keyword><keyword>Blotting</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: drug therapy</keyword><keyword>Breast Neoplasms: genetics</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Transformation</keyword><keyword>Chromatin Immunoprecipitation</keyword><keyword>Cyclin D1</keyword><keyword>Cyclin D1: genetics</keyword><keyword>Cyclin D1: metabolism</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Isothiocyanates</keyword><keyword>Isothiocyanates: pharmacology</keyword><keyword>Leptin</keyword><keyword>Leptin: genetics</keyword><keyword>Leptin: metabolism</keyword><keyword>Luciferases</keyword><keyword>Luciferases: metabolism</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Neoplastic</keyword><keyword>Oncogenes</keyword><keyword>RNA</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>STAT3 Transcription Factor</keyword><keyword>STAT3 Transcription Factor: antagonists &amp; inhibito</keyword><keyword>STAT3 Transcription Factor: genetics</keyword><keyword>STAT3 Transcription Factor: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Tumor</keyword><keyword>Western</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2011</year></dates><accession-num>21163886</accession-num><electronic-resource-num>10.1093/carcin/bgq267</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3105585&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Apoptosis;ECIS Migration;Signal Transduction;Wound Healing</label><abstract>Molecular effects of obesity, a well-established risk factor for breast cancer progression, are mediated by adipocytokine leptin. Given the important role of leptin in breast cancer growth and metastasis, novel strategies to antagonize biological effects of this adipocytokine are much desired. We showed previously that benzyl isothiocyanate (BITC), a constituent of edible cruciferous vegetables (e.g. garden cress), confers significant protection against mammary carcinogenesis in a transgenic mouse model. The present study provides first evidence for the efficacy of BITC against oncogenic effects of leptin. The BITC treatment circumvented leptin-induced clonogenicity and anchorage-independent growth of MDA-MB-231 and MCF-7 human breast cancer cells. Leptin-stimulated migration and invasion of these cells was also inhibited in the presence of BITC. Analysis of the underlying molecular mechanisms revealed that BITC treatment suppressed leptin-induced Stat3 phosphorylation and cyclin D1 transactivation. The BITC-mediated inhibition of MDA-MB-231 xenograft growth correlated with a modest yet significant decrease in levels of Tyr705 phosphorylated Stat3. The BITC treatment efficiently inhibited Stat3 and SRC1 recruitment to cyclin D1 promoter in a chromatin immunoprecipitation analysis. Furthermore, overexpression of constitutively active Stat3 imparted significant protection against BITC-mediated inhibition of cyclin D1 transactivation, whereas RNA interference of Stat3 resulted in a significant increase in BITC-mediated inhibition of cyclin D1 transactivation in the presence of leptin. These results indicate that Stat3 plays an important role in BITC-mediated inhibition of leptin-induced cyclin D1 transactivation. In conclusion, BITC could potentially be a rational therapeutic strategy for breast carcinoma in obese patients with high leptin levels.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xue, Meilang</author><author>Chow, Shu-Oi</author><author>Dervish, Suat</author><author>Chan, Yee-Ka Agnes</author><author>Julovi, Sohel M</author><author>Jackson, Christopher J</author></authors></contributors><titles><title>Activated protein C enhances human keratinocyte barrier integrity via sequential activation of epidermal growth factor receptor and Tie2.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>6742-6750</pages><volume>286</volume><issue>8</issue><keywords><keyword>Cell Communication</keyword><keyword>Cell Communication: drug effects</keyword><keyword>Cell Communication: physiology</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Enzyme Activation: physiology</keyword><keyword>Epidermal Growth Factor</keyword><keyword>Epidermal Growth Factor: metabolism</keyword><keyword>Humans</keyword><keyword>Infant</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Keratinocytes</keyword><keyword>Keratinocytes: cytology</keyword><keyword>Keratinocytes: metabolism</keyword><keyword>Male</keyword><keyword>Newborn</keyword><keyword>PAR-1</keyword><keyword>PAR-1: genetics</keyword><keyword>PAR-1: metabolism</keyword><keyword>Peptides</keyword><keyword>Peptides: pharmacology</keyword><keyword>Permeability</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: genetics</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Protein C</keyword><keyword>Protein C: metabolism</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>RNA</keyword><keyword>Receptor</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Small Interfering</keyword><keyword>TIE-2</keyword><keyword>TIE-2: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>21173154</accession-num><electronic-resource-num>10.1074/jbc.M110.181388</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3057790&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Keratinocytes play a critical role in maintaining epidermal barrier function. Activated protein C (APC), a natural anticoagulant with anti-inflammatory and endothelial barrier protective properties, significantly increased the barrier impedance of keratinocyte monolayers, measured by electric cell substrate impedance sensing and FITC-dextran flux. In response to APC, Tie2, a tyrosine kinase receptor, was rapidly activated within 30 min, and relocated to cell-cell contacts. APC also increased junction proteins zona occludens, claudin-1 and VE-cadherin. Inhibition of Tie2 by its peptide inhibitor or small interfering RNA abolished the barrier protective effect of APC. Interestingly, APC did not activate Tie2 through its major ligand, angiopoietin-1, but instead acted by binding to endothelial protein C receptor, cleaving protease-activated receptor-1 and transactivating EGF receptor. Furthermore, when activation of Akt, but not ERK, was inhibited, the barrier protective effect of APC on keratinocytes was abolished. Thus, APC activates Tie2, via a mechanism requiring, in sequential order, the receptors, endothelial protein C receptor, protease-activated receptor-1, and EGF receptor, which selectively enhances the PI3K/Akt signaling to enhance junctional complexes and reduce keratinocyte permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Guiseppi-Elie, Anthony</author><author>Koch, Lauren</author><author>Finley, Stephen H</author><author>Wnek, Gary E</author></authors></contributors><titles><title>The effect of temperature on the impedimetric response of bioreceptor hosting hydrogels.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>2275-2280</pages><volume>26</volume><issue>5</issue><keywords><keyword>Biocompatible Materials</keyword><keyword>Biocompatible Materials: chemistry</keyword><keyword>Cell Surface</keyword><keyword>Cell Surface: chemistry</keyword><keyword>Electric Conductivity</keyword><keyword>Hydrogels</keyword><keyword>Hydrogels: chemistry</keyword><keyword>Receptors</keyword><keyword>Temperature</keyword></keywords><dates><year>2011</year></dates><publisher>Elsevier B.V.</publisher><accession-num>20970984</accession-num><electronic-resource-num>10.1016/j.bios.2010.09.050</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20970984</url></web-urls></urls><label>ECIS Attachment</label><abstract>Biocompatible hydrogels that serve as the hosting membrane for various bioreceptors contribute to the response of impedimetric biosensors. The temperature response of poly(2-hydroxymethacrylate) [p(HEMA)]-based hydrogel networks prepared with poly(ethylene glycol) methacrylate (PEGMA) for enhanced biocompatibility and with N-[tris(hydroxymethyl)methyl] acrylamide (HMMA) was studied. Hydrogels were cross-linked with tetraethyleneglycol diacrylate (TEGDA) and synthesized by UV initiation (2M% DMPA photoinitiator). The p(HEMA-co-PEGMA-co-HMMA) based hydrogels were fabricated as discrete gel pads (D=2.5 mm, H=2 mm and V=9.82 μL) on top of 250 μm diameter cysteamine modified and acryloyl (polyethylene glycol)(110) N-hydroxy succinamide ester (acryloyl-PEG-NHS) derivatized gold microelectrodes set within 8-well (8W1E) cell culture biochips. Gel pads were fabricated with cross-link densities corresponding to 1, 3, 5, 7, 9 and 12 M% TEGDA and were studied by frequency dependent 3-electrode electrochemical impedance spectroscopy (1 mHz to 100 kHz; 50 mV p-t-p) and by temporal 2-electrode impedimetry (64 kHz; 50 mV p-t-p) over the temperature range 30-45°C at 90% RH or in aqueous 0.1 M Tris/KCl at pH 7.2 buffer. The p(HEMA-co-PEGMA-co-HMMA) hydrogels showed an increase in the real component of impedance with increasing cross-link density and demonstrated activation energies for impedimetric transport that ranged from 15 kJ/mol (3 M%) to 20 kJ/mol (12 M%) confirming the dominance of proton migration in the impedance of the hydrogels.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wolfson, Rachel K</author><author>Chiang, Eddie T</author><author>Garcia, Joe G N</author></authors></contributors><titles><title>HMGB1 induces human lung endothelial cell cytoskeletal rearrangement and barrier disruption.</title><secondary-title>Microvascular research</secondary-title></titles><periodical><full-title>Microvascular research</full-title></periodical><pages>189-197</pages><volume>81</volume><issue>2</issue><keywords><keyword>Actin Cytoskeleton</keyword><keyword>Actin Cytoskeleton: drug effects</keyword><keyword>Actin Cytoskeleton: metabolism</keyword><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Antigens</keyword><keyword>Biological</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: drug effects</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Gap Junctions</keyword><keyword>Gap Junctions: drug effects</keyword><keyword>HMGB1 Protein</keyword><keyword>HMGB1 Protein: genetics</keyword><keyword>HMGB1 Protein: pharmacology</keyword><keyword>HSP27 Heat-Shock Proteins</keyword><keyword>HSP27 Heat-Shock Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Intracellular Signaling Peptides and Proteins: gen</keyword><keyword>Intracellular Signaling Peptides and Proteins: met</keyword><keyword>Mitogen-Activated Protein Kinases</keyword><keyword>Mitogen-Activated Protein Kinases: genetics</keyword><keyword>Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>Models</keyword><keyword>Neoplasm</keyword><keyword>Neoplasm: genetics</keyword><keyword>Neoplasm: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: genetics</keyword><keyword>Protein-Serine-Threonine Kinases: metabolism</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>RNA</keyword><keyword>Recombinant Proteins</keyword><keyword>Recombinant Proteins: genetics</keyword><keyword>Recombinant Proteins: pharmacology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Stress Fibers</keyword><keyword>Stress Fibers: drug effects</keyword><keyword>Stress Fibers: metabolism</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>p38 Mitogen-Activated Protein Kinases: antagonists</keyword><keyword>p38 Mitogen-Activated Protein Kinases: genetics</keyword><keyword>p38 Mitogen-Activated Protein Kinases: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>21146549</accession-num><electronic-resource-num>10.1016/j.mvr.2010.11.010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3678727&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>Acute lung injury (ALI) results from loss of alveolar-capillary barrier integrity and the evolution of high-permeability pulmonary edema resulting in alveolar flooding and significant morbidity and mortality. HMGB1 is a late mediator of sepsis which uniquely participates in the evolution of sepsis and sepsis-induced ALI. The molecular events by which HMGB1 contributes to ALI remain poorly characterized. We characterized the role of HMGB1 in endothelial cell (EC) cytoskeletal rearrangement and vascular permeability, events essential to paracellular gap formation and barrier dysfunction characteristic of ALI. Initial experiments demonstrated HMGB1-mediated dose-dependent (5-20 μg/ml) decreases in transendothelial cell electrical resistance (TER) in the human pulmonary artery EC, a reflection of loss of barrier integrity. Furthermore, HMGB1 produced dose-dependent increases in paracellular gap formation in concert with loss of peripheral organized actin fibers, dissociation of cell-cell junctional cadherins, and the development of central stress fibers, a phenotypic change associated with increased contractile activity and increased EC permeability. Using siRNA strategies directed against known HMGB1 receptors (RAGE, TLR2, TLR4), we systematically determined that the receptor for advanced glycation end products (RAGE) is the primary receptor signaling HMGB1-induced TER decreases and paracellular gap formation via p38 MAP kinase activation and phosphorylation of the actin-binding protein, Hsp27. These studies add to the understanding of HMGB1-induced inflammatory events and vascular barrier disruption and offer the potential for clinical intervention in sepsis-induced ALI.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Inoshima, Ichiro</author><author>Inoshima, Naoko</author><author>Wilke, Georgia a</author><author>Powers, Michael E</author><author>Frank, Karen M</author><author>Wang, Yang</author><author>Bubeck Wardenburg, Juliane</author></authors></contributors><titles><title>A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice.</title><secondary-title>Nature medicine</secondary-title></titles><periodical><full-title>Nature medicine</full-title></periodical><pages>1310-1314</pages><volume>17</volume><issue>10</issue><keywords><keyword>ADAM Proteins</keyword><keyword>ADAM Proteins: genetics</keyword><keyword>ADAM Proteins: metabolism</keyword><keyword>Amyloid Precursor Protein Secretases</keyword><keyword>Amyloid Precursor Protein Secretases: genetics</keyword><keyword>Amyloid Precursor Protein Secretases: metabolism</keyword><keyword>Animals</keyword><keyword>Bacterial</keyword><keyword>Bacterial Toxins</keyword><keyword>Bacterial Toxins: metabolism</keyword><keyword>Bacterial Toxins: poisoning</keyword><keyword>Bacterial: genetics</keyword><keyword>Bacterial: physiology</keyword><keyword>Bronchoalveolar Lavage</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Epithelium</keyword><keyword>Epithelium: metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Hemolysin Proteins</keyword><keyword>Hemolysin Proteins: metabolism</keyword><keyword>Hemolysin Proteins: poisoning</keyword><keyword>Knockout</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Mice</keyword><keyword>Pneumonia</keyword><keyword>Pneumonia: genetics</keyword><keyword>Staphylococcus aureus</keyword><keyword>Staphylococcus aureus: chemistry</keyword></keywords><dates><year>2011</year></dates><accession-num>21926978</accession-num><electronic-resource-num>10.1038/nm.2451</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3192248&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Staphylococcus aureus is a major cause of human disease, responsible for half a million infections and approximately 20,000 deaths per year in the United States alone. This pathogen secretes α-hemolysin, a pore-forming cytotoxin that contributes to the pathogenesis of pneumonia. α-hemolysin injures epithelial cells in vitro by interacting with its receptor, the zinc-dependent metalloprotease ADAM10 (ref. 6). We show here that mice harboring a conditional disruption of the Adam10 gene in lung epithelium are resistant to lethal pneumonia. Investigation of the molecular mechanism of toxin-receptor function revealed that α-hemolysin upregulates ADAM10 metalloprotease activity in alveolar epithelial cells, resulting in cleavage of the adherens junction protein E-cadherin. Cleavage is associated with disruption of epithelial barrier function, contributing to the pathogenesis of lethal acute lung injury. A metalloprotease inhibitor of ADAM10 prevents E-cadherin cleavage in response to Hla; similarly, toxin-dependent E-cadherin proteolysis and barrier disruption is attenuated in ADAM10-knockout mice. Together, these data attest to the function of ADAM10 as the cellular receptor for α-hemolysin. The observation that α-hemolysin can usurp the metalloprotease activity of its receptor reveals a previously unknown mechanism of pore-forming cytotoxin action in which pathologic insults are not solely the result of irreversible membrane injury and defines ADAM10 inhibition as a strategy to attenuate α-hemolysin-induced disease.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Doherty, Gary J</author><author>Åhlund, Monika K</author><author>Howes, Mark T</author><author>Morén, Björn</author><author>Parton, Robert G</author><author>McMahon, Harvey T</author><author>Lundmark, Richard</author><author>Ahlund, Monika K</author><author>Howes, Mark T</author><author>Morén, Björn</author><author>Parton, Robert G</author><author>McMahon, Harvey T</author><author>Lundmark, Richard</author></authors></contributors><titles><title>The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.</title><secondary-title>Molecular biology of the cell</secondary-title></titles><periodical><full-title>Molecular biology of the cell</full-title></periodical><pages>4380-4389</pages><volume>22</volume><issue>22</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Membrane</keyword><keyword>Cell Movement</keyword><keyword>Cell-Matrix Junctions</keyword><keyword>Cell-Matrix Junctions: metabolism</keyword><keyword>Clathrin</keyword><keyword>Clathrin: metabolism</keyword><keyword>Endocytosis</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Kinase 1: metabolism</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: metabolism</keyword><keyword>GTPase-Activating Proteins</keyword><keyword>GTPase-Activating Proteins: metabolism</keyword><keyword>HeLa Cells</keyword><keyword>Humans</keyword><keyword>Lipids</keyword><keyword>Membrane Microdomains</keyword><keyword>Membrane Microdomains: metabolism</keyword><keyword>Protein Structure</keyword><keyword>Protein Transport</keyword><keyword>RNA Interference</keyword><keyword>Tertiary</keyword></keywords><dates><year>2011</year></dates><accession-num>21965292</accession-num><electronic-resource-num>10.1091/mbc.E10-12-0936</electronic-resource-num><notes>From Duplicate 2 (The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading. - Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard)

From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )










From Duplicate 2 (The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading. - Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard)

From Duplicate 1 (The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading. - Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard)

From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )




From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )












From Duplicate 2 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard; Åhlund, Monika K )




From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )




From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )












From Duplicate 2 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )





From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )</notes><research-notes>From Duplicate 2 (The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading. - Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard)

From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )










From Duplicate 2 (The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading. - Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard)

From Duplicate 1 (The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading. - Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard)

From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )




From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )












From Duplicate 2 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard; Åhlund, Monika K )




From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Åhlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )




From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )












From Duplicate 2 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )





From Duplicate 1 ( 


The endocytic protein GRAF1 is directed to cell-matrix adhesion sites and regulates cell spreading.


- Doherty, Gary J; Ahlund, Monika K; Howes, Mark T; Morén, Björn; Parton, Robert G; McMahon, Harvey T; Lundmark, Richard )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3216663&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration</label><abstract>The rho GTPase-activating protein GTPase regulator associated with focal adhesion kinase-1 (GRAF1) remodels membranes into tubulovesicular clathrin-independent carriers (CLICs) mediating lipid-anchored receptor endocytosis. However, the cell biological functions of this highly prevalent endocytic pathway are unclear. In this article, we present biochemical and cell biological evidence that GRAF1 interacted with a network of endocytic and adhesion proteins and was found enriched at podosome-like adhesions and src-induced podosomes. We further demonstrate that these sites comprise microdomains of highly ordered lipid enriched in GRAF1 endocytic cargo. GRAF1 activity was upregulated in spreading cells and uptake via CLICs was concentrated at the leading edge of migrating cells. Depletion of GRAF1, which inhibits CLIC generation, resulted in profound defects in cell spreading and migration. We propose that GRAF1 remodels membrane microdomains at adhesion sites into endocytic carriers, facilitating membrane turnover during cell morphological changes.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, Xianming</author><author>Tan, Fulong</author><author>Brovkovych, Viktor</author><author>Zhang, Yongkang</author><author>Skidgel, Randal a</author></authors></contributors><titles><title>Cross-talk between carboxypeptidase M and the kinin B1 receptor mediates a new mode of G protein-coupled receptor signaling.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>18547-18561</pages><volume>286</volume><issue>21</issue><keywords><keyword>Amino Acid Substitution</keyword><keyword>Bradykinin</keyword><keyword>Bradykinin B1</keyword><keyword>Bradykinin B1: agonists</keyword><keyword>Bradykinin B1: genetics</keyword><keyword>Bradykinin B1: metabolism</keyword><keyword>Bradykinin: genetics</keyword><keyword>Bradykinin: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>GPI-Linked Proteins</keyword><keyword>GPI-Linked Proteins: genetics</keyword><keyword>GPI-Linked Proteins: metabolism</keyword><keyword>HEK293 Cells</keyword><keyword>Humans</keyword><keyword>Kallidin</keyword><keyword>Kallidin: genetics</keyword><keyword>Kallidin: metabolism</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Lung: metabolism</keyword><keyword>Metalloendopeptidases</keyword><keyword>Metalloendopeptidases: genetics</keyword><keyword>Metalloendopeptidases: metabolism</keyword><keyword>Missense</keyword><keyword>Mutation</keyword><keyword>Protein Multimerization</keyword><keyword>Protein Multimerization: physiology</keyword><keyword>Receptor</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword></keywords><dates><year>2011</year></dates><isbn>3129969179</isbn><accession-num>21454694</accession-num><electronic-resource-num>10.1074/jbc.M110.214940</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3099671&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>G protein-coupled receptor (GPCR) signaling is affected by formation of GPCR homo- or heterodimers, but GPCR regulation by other cell surface proteins is not well understood. We reported that the kinin B1 receptor (B1R) heterodimerizes with membrane carboxypeptidase M (CPM), facilitating receptor signaling via CPM-mediated conversion of bradykinin or kallidin to des-Arg kinin B1R agonists. Here, we found that a catalytically inactive CPM mutant that still binds substrate (CPM-E264Q) also facilitates efficient B1R signaling by B2 receptor agonists bradykinin or kallidin. This response required co-expression of B1R and CPM-E264Q in the same cell, was disrupted by antibody that dissociates CPM from B1R, and was not found with a CPM-E264Q-B1R fusion protein. An additional mutation that reduced the affinity of CPM for C-terminal Arg and increased the affinity for C-terminal Lys inhibited the B1R response to bradykinin (with C-terminal Arg) but generated a response to Lys(9)-bradykinin. CPM-E264Q-mediated activation of B1Rs by bradykinin resulted in increased intramolecular fluorescence resonance energy transfer (FRET) in a B1R FRET construct, similar to that generated directly by a B1R agonist. In cytokine-treated human lung microvascular endothelial cells, disruption of B1R-CPM heterodimers inhibited B1R-dependent NO production stimulated by bradykinin and blocked the increased endothelial permeability caused by treatment with bradykinin and pyrogallol (a superoxide generator). Thus, CPM and B1Rs on cell membranes form a critical complex that potentiates B1R signaling. Kinin peptide binding to CPM causes a conformational change in the B1R leading to intracellular signaling and reveals a new mode of GPCR activation by a cell surface peptidase.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cullen, Mike</author><author>Elzarrad, Mohammed K</author><author>Seaman, Steven</author><author>Zudaire, Enrique</author><author>Stevens, Janine</author><author>Yang, Mi Young</author><author>Li, Xiujie</author><author>Chaudhary, Amit</author><author>Xu, Lihong</author><author>Hilton, Mary Beth</author><author>Logsdon, Daniel</author><author>Hsiao, Emily</author><author>Stein, Erica V</author><author>Cuttitta, Frank</author><author>Haines, Diana C</author><author>Nagashima, Kunio</author><author>Tessarollo, Lino</author><author>St Croix, Brad</author></authors></contributors><titles><title>GPR124, an orphan G protein-coupled receptor, is required for CNS-specific vascularization and establishment of the blood-brain barrier.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>5759-5764</pages><volume>108</volume><issue>14</issue><keywords><keyword>Animals</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: embryology</keyword><keyword>Blood-Brain Barrier: metabolism</keyword><keyword>Blotting</keyword><keyword>Central Nervous System</keyword><keyword>Central Nervous System: blood supply</keyword><keyword>Central Nervous System: embryology</keyword><keyword>DNA Primers</keyword><keyword>DNA Primers: genetics</keyword><keyword>Electron</keyword><keyword>Embryo</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescence</keyword><keyword>G-Protein-Coupled</keyword><keyword>G-Protein-Coupled: physiology</keyword><keyword>Histological Techniques</keyword><keyword>In Situ Hybridization</keyword><keyword>Mammalian</keyword><keyword>Mammalian: blood supply</keyword><keyword>Mammalian: metabolism</keyword><keyword>Mice</keyword><keyword>Microscopy</keyword><keyword>Receptors</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Western</keyword></keywords><dates><year>2011</year></dates><accession-num>21421844</accession-num><electronic-resource-num>10.1073/pnas.1017192108</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3078373&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier;ECIS TEER</label><abstract>Every organ in the body requires blood vessels for efficient delivery of oxygen and nutrients, but independent vascular beds are highly specialized to meet the individual needs of specific organs. The vasculature of the brain is tightly sealed, with blood-brain barrier (BBB) properties developing coincident with neural vascularization. G protein-coupled receptor 124 (GPR124) (tumor endothelial marker 5, TEM5), an orphan member of the adhesion family of G protein-coupled receptors, was previously identified on the basis of its overexpression in tumor vasculature. Here, we show that global deletion or endothelial-specific deletion of GPR124 in mice results in embryonic lethality associated with abnormal angiogenesis of the forebrain and spinal cord. Expression of GPR124 was found to be required for invasion and migration of blood vessels into neuroepithelium, establishment of BBB properties, and expansion of the cerebral cortex. Thus, GPR124 is an important regulator of neurovasculature development and a potential drug target for cerebrovascular diseases.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yang, Fan</author><author>Liu, Shuo</author><author>Wang, Shur-jen</author><author>Yu, Chuanhui</author><author>Fisher, Mark J</author></authors></contributors><titles><title>Cellular Physiology Biochemistry and Biochemistr y Tissue Plasminogen Activator Expression and Barrier Properties of Human Brain Microvascular Endothelial Cells</title><secondary-title>Cellular Physiology and Biochemistry</secondary-title></titles><periodical><full-title>Cellular Physiology and Biochemistry</full-title></periodical><pages>631-638</pages><volume>92868</volume><keywords><keyword>endothelium</keyword><keyword>fibrinolysis</keyword><keyword>microvasculature</keyword><keyword>stroke</keyword><keyword>tissue plasminogen activator</keyword></keywords><dates><year>2011</year></dates><urls/><label>ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Maingat, Ferdinand</author><author>Halloran, Brendan</author><author>Acharjee, Shaona</author><author>van Marle, Guido</author><author>Church, Deirdre</author><author>Gill, M John</author><author>Uwiera, Richard R E</author><author>Cohen, Eric a</author><author>Meddings, Jon</author><author>Madsen, Karen</author><author>Power, Christopher</author></authors></contributors><titles><title>Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress.</title><secondary-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</secondary-title></titles><periodical><full-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</full-title></periodical><pages>2211-2220</pages><volume>25</volume><issue>7</issue><keywords><keyword>1</keyword><keyword>2</keyword><keyword>cd4 ϩ t lymphocytes</keyword><keyword>disease</keyword><keyword>er stress</keyword><keyword>fiv</keyword><keyword>gut</keyword><keyword>hiv</keyword><keyword>lentivirus</keyword><keyword>lym-</keyword><keyword>occurs in the gut-associated</keyword><keyword>of this population of</keyword><keyword>phoid tissues</keyword><keyword>proximal to the mucosa</keyword><keyword>t cells may contribute</keyword><keyword>the loss</keyword><keyword>to mucosal</keyword></keywords><dates><year>2011</year></dates><accession-num>21427211</accession-num><electronic-resource-num>10.1096/fj.10-175992</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3114526&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Immunosuppressive lentivirus infections, including human, simian, and feline immunodeficiency viruses (HIV, SIV, and FIV, respectively), cause the acquired immunodeficiency syndrome (AIDS), frequently associated with AIDS enteropathy. Herein, we investigated the extent to which lentivirus infections affected mucosal integrity and intestinal permeability in conjunction with immune responses and activation of endoplasmic reticulum (ER) stress pathways. Duodenal biopsies from individuals with HIV/AIDS exhibited induction of IL-1β, CD3ε, HLA-DRA, spliced XBP-1(Xbp-1s), and CHOP expression compared to uninfected persons (P&lt;0.05). Gut epithelial cells exposed to HIV-1 Vpr demonstrated elevated TNF-α, IL-1β, spliced Xbp-1s, and CHOP expression (P&lt;0.05) together with calcium activation and disruption of epithelial cell monolayer permeability. In addition to reduced blood CD4(+) T lymphocyte levels, viral loads in the gut and plasma were high in FIV-infected animals (P&lt;0.05). FIV-infected animals also exhibited a failure to gain weight and increased lactulose/mannitol ratios compared with uninfected animals (P&lt;0.05). Proinflammatory and ER stress gene expression were activated in the ileum of FIV-infected animals (P&lt;0.05), accompanied by intestinal epithelial damage with loss of epithelial cells and leukocyte infiltration of the lamina propria. Lentivirus infections cause gut inflammation and ensuing damage to intestinal epithelial cells, likely through induction of ER stress pathways, resulting in disruption of gut functional integrity.-Maingat, F., Halloran, B., Acharjee, S., van Marle, G., Church, D., Gill, M. J., Uwiera, R. R. E., Cohen, E. A., Meddings, J., Madsen, K., Power, C. Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Privratsky, Jamie R</author><author>Paddock, Cathy M</author><author>Florey, Oliver</author><author>Newman, Debra K</author><author>Muller, William A</author><author>Newman, Peter J</author></authors></contributors><titles><title>Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>1477-1485</pages><volume>124</volume><issue>Pt 9</issue><keywords><keyword>Antigens</keyword><keyword>CD31</keyword><keyword>CD31: genetics</keyword><keyword>CD31: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: genetics</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Line</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: genetics</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Protein Binding</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: genetics</keyword><keyword>Signal Transduction: physiology</keyword></keywords><dates><year>2011</year></dates><accession-num>21486942</accession-num><electronic-resource-num>10.1242/jcs.082271</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3078814&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>PECAM-1 (CD31) is a cellular adhesion and signaling receptor that is highly expressed at endothelial cell-cell junctions in confluent vascular beds. Previous studies have implicated PECAM-1 in the maintenance of vascular barrier integrity; however, the mechanisms behind PECAM-1-mediated barrier protection are still poorly understood. The goal of the present study, therefore, was to examine the pertinent biological properties of PECAM-1 (i.e. adhesion and/or signaling) that allow it to support barrier integrity. We found that, compared with PECAM-1-deficient endothelial cells, PECAM-1-expressing endothelial cell monolayers exhibit increased steady-state barrier function, as well as more rapid restoration of barrier integrity following thrombin-induced perturbation of the endothelial cell monolayer. The majority of PECAM-1-mediated barrier protection was found to be due to the ability of PECAM-1 to interact homophilically and become localized to cell-cell junctions, because a homophilic binding-crippled mutant form of PECAM-1 was unable to support efficient barrier function when re-expressed in cells. By contrast, cells expressing PECAM-1 variants lacking residues known to be involved in PECAM-1-mediated signal transduction exhibited normal to near-normal barrier integrity. Taken together, these studies suggest that PECAM-1-PECAM-1 homophilic interactions are more important than its signaling function for maintaining the integrity of endothelial cell junctions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lee, Wing-Kee</author><author>Torchalski, Blazej</author><author>Kohistani, Naschla</author><author>Thévenod, Frank</author></authors></contributors><titles><title>ABCB1 protects kidney proximal tubule cells against cadmium-induced apoptosis: roles of cadmium and ceramide transport.</title><secondary-title>Toxicological sciences : an official journal of the Society of Toxicology</secondary-title></titles><periodical><full-title>Toxicological sciences : an official journal of the Society of Toxicology</full-title></periodical><pages>343-356</pages><volume>121</volume><issue>2</issue><keywords><keyword>4-Chloro-7-nitrobenzofurazan</keyword><keyword>4-Chloro-7-nitrobenzofurazan: analogs &amp; derivative</keyword><keyword>4-Chloro-7-nitrobenzofurazan: metabolism</keyword><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Benzimidazoles</keyword><keyword>Benzimidazoles: diagnostic use</keyword><keyword>Biological Transport</keyword><keyword>Cadmium</keyword><keyword>Cadmium: toxicity</keyword><keyword>Cell Line</keyword><keyword>Ceramides</keyword><keyword>Ceramides: metabolism</keyword><keyword>Cyclosporins</keyword><keyword>Cyclosporins: metabolism</keyword><keyword>Dogs</keyword><keyword>Electrophoresis</keyword><keyword>Fluorescent Dyes</keyword><keyword>Fluorescent Dyes: diagnostic use</keyword><keyword>Glucosylceramides</keyword><keyword>Glucosylceramides: metabolism</keyword><keyword>Glucosyltransferases</keyword><keyword>Glucosyltransferases: antagonists &amp; inhibitors</keyword><keyword>Humans</keyword><keyword>Kidney Tubules</keyword><keyword>Oxadiazoles</keyword><keyword>Oxadiazoles: metabolism</keyword><keyword>P-Glycoproteins</keyword><keyword>P-Glycoproteins: genetics</keyword><keyword>P-Glycoproteins: metabolism</keyword><keyword>Phosphotransferases (Alcohol Group Acceptor)</keyword><keyword>Phosphotransferases (Alcohol Group Acceptor): meta</keyword><keyword>Plasmids</keyword><keyword>Polyacrylamide Gel</keyword><keyword>Polyacrylamide Gel: methods</keyword><keyword>Proximal</keyword><keyword>Proximal: cytology</keyword><keyword>Proximal: pathology</keyword><keyword>Rats</keyword><keyword>Sphingolipids</keyword><keyword>Sphingolipids: metabolism</keyword><keyword>Transfection</keyword><keyword>Transfection: methods</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2011</year></dates><accession-num>21436125</accession-num><electronic-resource-num>10.1093/toxsci/kfr071</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21436125</url></web-urls></urls><label>Apoptosis;ECIS Cytotoxicity</label><abstract>Cadmium (Cd(2+)) damages the kidney proximal tubule (PT) by ceramide-dependent apoptosis and is also a class I carcinogen. Multidrug resistance P-glycoprotein (MDR1, ABCB1) confers resistance to Cd(2+) apoptosis, and it has been hypothesized that ABCB1 can directly transport Cd(2+) as a mode of cellular protection. Our aim was to investigate the role of ABCB1 in Cd(2+) transport and ceramide apoptosis. In rat PT or Madin-Darby canine kidney (MDCK) cells overexpressing ABCB1, ABCB1-dependent efflux of rhodamine 123(+) (Rh123(+)) or (109)Cd(2+) were determined, and cell death was assayed with MTT, H-33342 nuclear staining, and monolayer integrity by impedance sensing (Electric cell-substrate impedance sensing [ECIS]). ABCB1 inhibitors (PSC833, UIC-2 antibody) did not affect (109)Cd(2+) efflux in PT cells though Rh123(+) transport was blocked. Furthermore, increased ABCB1 expression did not augment (109)Cd(2+) efflux but attenuated apoptosis by 10-50μM Cd(2+) or 5-25μM C(6)-ceramide, which was abolished by PSC833 (1μM). ECIS measurements of ABCB1-MDCK monolayers exhibited similar effects. Moreover, in ABCB1-MDCK cells, Cd(2+)-induced ceramide formation, determined by a diacylglycerol kinase assay, was abolished and increased extrusion of nitro-2-1,3-benzoxadiazol-4-yl (NBD)-C(6)-ceramide, and NBD-C(6)-glucosylceramide was observed compared with MDCK cells. Whereas pharmacological block of sphingomyelin synthase (0.1mM D609) or sphingosine kinase (1μM dimethylsphingosine), which increase the levels of ceramide and its metabolites, augmented Cd(2+)-induced apoptosis, Cd(2+) apoptosis was significantly decreased not only by prevention of de novo ceramide synthesis (0.1μM fumonisin B(1)) but also by inhibition of glucosylceramide synthase (2μM C(9)DGJ). We therefore conclude that Cd(2+) efflux is not the mechanism behind ABCB1-mediated protection from Cd(2+) apoptosis. Rather, the sphingolipid glucosylceramide may be the proapoptotic substrate extruded by ABCB1.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kakiashvili, Eli</author><author>Dan, Qinghong</author><author>Vandermeer, Matthew</author><author>Zhang, Yuqian</author><author>Waheed, Faiza</author><author>Pham, Monica</author><author>Szászi, Katalin</author></authors></contributors><titles><title>The epidermal growth factor receptor mediates tumor necrosis factor-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular epithelium.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>9268-9279</pages><volume>286</volume><issue>11</issue><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Dogs</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: physiology</keyword><keyword>Epidermal Growth Factor</keyword><keyword>Epidermal Growth Factor: genetics</keyword><keyword>Epidermal Growth Factor: metabolism</keyword><keyword>Extracellular Signal-Regulated MAP Kinases</keyword><keyword>Extracellular Signal-Regulated MAP Kinases: geneti</keyword><keyword>Extracellular Signal-Regulated MAP Kinases: metabo</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: genetics</keyword><keyword>Guanine Nucleotide Exchange Factors: metabolism</keyword><keyword>Humans</keyword><keyword>Kidney Tubules</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>MAP Kinase Signaling System: physiology</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: physiology</keyword><keyword>Proximal</keyword><keyword>Proximal: metabolism</keyword><keyword>Receptor</keyword><keyword>Rho Guanine Nucleotide Exchange Factors</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: genetics</keyword><keyword>Tumor Necrosis Factor-alpha: metabolism</keyword><keyword>Urothelium</keyword><keyword>Urothelium: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: genetics</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2011</year></dates><accession-num>21212278</accession-num><electronic-resource-num>10.1074/jbc.M110.179903</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3059019&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Tumor necrosis factor (TNF)-α induces cytoskeleton and intercellular junction remodeling in tubular epithelial cells; the underlying mechanisms, however, are incompletely explored. We have previously shown that ERK-mediated stimulation of the RhoA GDP/GTP exchange factor GEF-H1/Lfc is critical for TNF-α-induced RhoA stimulation. Here we investigated the upstream mechanisms of ERK/GEF-H1 activation. Surprisingly, TNF-α-induced ERK and RhoA stimulation in tubular cells were prevented by epidermal growth factor receptor (EGFR) inhibition or silencing. TNF-α also enhanced phosphorylation of the EGFR. EGF treatment mimicked the effects of TNF-α, as it elicited potent, ERK-dependent GEF-H1 and RhoA activation. Moreover, EGF-induced RhoA activation was prevented by GEF-H1 silencing, indicating that GEF-H1 is a key downstream effector of the EGFR. The TNF-α-elicited EGFR, ERK, and RhoA stimulation were mediated by the TNF-α convertase enzyme (TACE) that can release EGFR ligands. Further, EGFR transactivation also required the tyrosine kinase Src, as Src inhibition prevented TNF-α-induced activation of the EGFR/ERK/GEF-H1/RhoA pathway. Importantly, a bromodeoxyuridine (BrdU) incorporation assay and electric cell substrate impedance-sensing (ECIS) measurements revealed that TNF-α stimulated cell growth in an EGFR-dependent manner. In contrast, TNF-α-induced NFκB activation was not prevented by EGFR or Src inhibition, suggesting that TNF-α exerts both EGFR-dependent and -independent effects. In summary, in the present study we show that the TNF-α-induced activation of the ERK/GEF-H1/RhoA pathway in tubular cells is mediated through Src- and TACE-dependent EGFR activation. Such a mechanism could couple inflammatory and proliferative stimuli and, thus, may play a key role in the regulation of wound healing and fibrogenesis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cai, Wei</author><author>Ye, Lin</author><author>Sun, Jiabang</author><author>Mansel, Robert E</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Expression of MLN64 influences cellular matrix adhesion of breast cancer cells, the role for focal adhesion kinase.</title><secondary-title>International journal of molecular medicine</secondary-title></titles><periodical><full-title>International journal of molecular medicine</full-title></periodical><pages>573-580</pages><volume>25</volume><issue>4</issue><keywords><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: enzymology</keyword><keyword>Breast Neoplasms: genetics</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Carrier Proteins</keyword><keyword>Carrier Proteins: genetics</keyword><keyword>Carrier Proteins: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Line</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: drug effects</keyword><keyword>Extracellular Matrix: metabolism</keyword><keyword>Female</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases: antagonis</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases: metabolis</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Humans</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Messenger: metabolism</keyword><keyword>Neoplastic</keyword><keyword>Neoplastic: drug effects</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>RNA</keyword><keyword>Survival Analysis</keyword><keyword>Treatment Outcome</keyword><keyword>Tumor</keyword></keywords><dates><year>2010</year></dates><accession-num>20198306</accession-num><electronic-resource-num>10.3892/ijmm_00000379</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/ijmm/25/4/573</url><url>http://www.ncbi.nlm.nih.gov/pubmed/20198306</url></web-urls></urls><abstract>The metastatic lymph node 64 (MLN64) gene was initially identified as highly expressed in the metastatic lymph node from breast cancer. It is localized in q12-q21 of the human chromosome 17 and is often co-amplified with erbB-2. However, the role played by MLN64 in breast cancer remains unclear. In the present study, the expression of MLN64 was examined in a breast cancer cohort using quantitative real-time PCR and immunohistochemical staining. It demonstrated that MLN64 was highly expressed in breast tumours compared to corresponding background tissues at both transcript level and protein level. The elevated level of MLN64 transcripts was correlated with the poor prognosis and overall survival of the patients. A panel of breast cancer cell sublines was subsequently developed by knockdown of MLN64 expression. Loss of MLN64 expression in MCF-7 cells resulted in a significant reduction of cell growth (absorbance for MCF-7DeltaMLN64 being 0.87+/-0.07, P&lt;0.01 vs. wild-type control (MCF-7WT 1.13+/-0.06) and transfection control (MCF-7pEF 1.27+/-0.05). In cell-matrix adhesion assay, MDA-MB-231DeltaMLN64 cells showed a significant increase in adhesion (86+/-14), p&lt;0.01 compared with both MDA-MB-231WT (61+/-20) and MDA-MB-231pEF (45+/-27). Further investigations demonstrated an increase in protein level of the focal adhesion kinase (FAK) in MDA-MB-231DeltaMLN64 cells using Western blot analysis and immunofluorescent staining of FAK. Moreover, addition of FAK inhibitor to these cells diminished the effect of MLN64 on cell-matrix adhesion, suggesting that FAK contributed to the increased adhesion in MDA-MB-231DeltaMLN64 cells. In conclusion, MLN64 is overexpressed in breast cancer, and its level correlates with poor prognosis and patient survival. MLN64 contributes to the development and progression of breast cancer through the regulation of cell proliferation and adhesive capacity.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiong, Chenling</author><author>Yang, Guang</author><author>Kumar, Sanjiv</author><author>Aggarwal, Saurabh</author><author>Leustik, Martin</author><author>Snead, Connie</author><author>Hamacher, Juerg</author><author>Fischer, Bernhard</author><author>Umapathy, Nagavedi S</author><author>Hossain, Hamid</author><author>Wendel, Albrecht</author><author>Catravas, John D</author><author>Verin, Alexander D</author><author>Fulton, David</author><author>Black, Stephen M</author><author>Chakraborty, Trinad</author><author>Lucas, Rudolf</author></authors></contributors><titles><title>The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition.</title><secondary-title>Vascular pharmacology</secondary-title></titles><periodical><full-title>Vascular pharmacology</full-title></periodical><pages>207-213</pages><volume>52</volume><issue>5-6</issue><keywords><keyword>Animals</keyword><keyword>Bacterial Toxins</keyword><keyword>Bacterial Toxins: toxicity</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Heat-Shock Proteins</keyword><keyword>Heat-Shock Proteins: toxicity</keyword><keyword>Hemolysin Proteins</keyword><keyword>Hemolysin Proteins: toxicity</keyword><keyword>Humans</keyword><keyword>Listeria monocytogenes</keyword><keyword>Listeria monocytogenes: pathogenicity</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Lung: metabolism</keyword><keyword>Lung: microbiology</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Peptides</keyword><keyword>Peptides: pharmacology</keyword><keyword>Permeability</keyword><keyword>Phosphorylation</keyword><keyword>Protein Kinase C-alpha</keyword><keyword>Protein Kinase C-alpha: antagonists &amp; inhibitors</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: metabolism</keyword><keyword>Pulmonary Artery: microbiology</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reactive Oxygen Species: metabolism</keyword><keyword>Sheep</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: chemistry</keyword><keyword>Tumor Necrosis Factor-alpha: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: microbiology</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2010</year></dates><publisher>Elsevier Inc.</publisher><accession-num>20074664</accession-num><electronic-resource-num>10.1016/j.vph.2009.12.010</electronic-resource-num><notes>From Duplicate 2 (The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. - Xiong, Chenling; Yang, Guang; Kumar, Sanjiv; Aggarwal, Saurabh; Leustik, Martin; Snead, Connie; Hamacher, Juerg; Fischer, Bernhard; Umapathy, Nagavedi S; Hossain, Hamid; Wendel, Albrecht; Catravas, John D; Verin, Alexander D; Fulton, David; Black, Stephen M; Chakraborty, Trinad; Lucas, Rudolf)

From Duplicate 1 ( The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. - Xiong, Chenling; Yang, Guang; Kumar, Sanjiv; Aggarwal, Saurabh; Leustik, Martin; Snead, Connie; Hamacher, Juerg; Fischer, Bernhard; Umapathy, Nagavedi S; Hossain, Hamid; Wendel, Albrecht; Catravas, John D; Verin, Alexander D; Fulton, David; Black, Stephen M; Chakraborty, Trinad; Lucas, Rudolf )



From Duplicate 2 ( The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. - Xiong, Chenling; Yang, Guang; Kumar, Sanjiv; Aggarwal, Saurabh; Leustik, Martin; Snead, Connie; Hamacher, Juerg; Fischer, Bernhard; Umapathy, Nagavedi S; Hossain, Hamid; Wendel, Albrecht; Catravas, John D; Verin, Alexander D; Fulton, David; Black, Stephen M; Chakraborty, Trinad; Lucas, Rudolf )</notes><research-notes>From Duplicate 2 (The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. - Xiong, Chenling; Yang, Guang; Kumar, Sanjiv; Aggarwal, Saurabh; Leustik, Martin; Snead, Connie; Hamacher, Juerg; Fischer, Bernhard; Umapathy, Nagavedi S; Hossain, Hamid; Wendel, Albrecht; Catravas, John D; Verin, Alexander D; Fulton, David; Black, Stephen M; Chakraborty, Trinad; Lucas, Rudolf)

From Duplicate 1 ( The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. - Xiong, Chenling; Yang, Guang; Kumar, Sanjiv; Aggarwal, Saurabh; Leustik, Martin; Snead, Connie; Hamacher, Juerg; Fischer, Bernhard; Umapathy, Nagavedi S; Hossain, Hamid; Wendel, Albrecht; Catravas, John D; Verin, Alexander D; Fulton, David; Black, Stephen M; Chakraborty, Trinad; Lucas, Rudolf )



From Duplicate 2 ( The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - a crucial role for protein kinase C-alpha inhibition. - Xiong, Chenling; Yang, Guang; Kumar, Sanjiv; Aggarwal, Saurabh; Leustik, Martin; Snead, Connie; Hamacher, Juerg; Fischer, Bernhard; Umapathy, Nagavedi S; Hossain, Hamid; Wendel, Albrecht; Catravas, John D; Verin, Alexander D; Fulton, David; Black, Stephen M; Chakraborty, Trinad; Lucas, Rudolf )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20074664</url></web-urls></urls><label>ECIS TEER</label><abstract>Listeriosis can lead to potentially lethal pulmonary complications in newborns and immune compromised patients, characterized by extensive permeability edema. Listeriolysin (LLO), the main virulence factor of Listeria monocytogenes, induces a dose-dependent hyperpermeability in monolayers of human lung microvascular endothelial cells in vitro. The permeability increasing activity of LLO, which is accompanied by an increased reactive oxygen species (ROS) generation, RhoA activation and myosin light chain (MLC) phosphorylation, can be completely inhibited by the protein kinase C (PKC) alpha/beta inhibitor GO6976, indicating a crucial role for PKC in the induction of barrier dysfunction. The TNF-derived TIP peptide, which mimics the lectin-like domain of the cytokine, blunts LLO-induced hyperpermeability in vitro, upon inhibiting LLO-induced protein kinase C-alpha activation, ROS generation and MLC phosphorylation and upon restoring the RhoA/Rac 1 balance. These results indicate that the lectin-like domain of TNF has a potential therapeutic value in protecting from LLO-induced pulmonary endothelial hyperpermeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yang, Jinling</author><author>Duh, Elia J</author><author>Caldwell, Ruth B</author><author>Behzadian, M Ali</author></authors></contributors><titles><title>Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.</title><secondary-title>Investigative ophthalmology &amp; visual science</secondary-title></titles><periodical><full-title>Investigative ophthalmology &amp; visual science</full-title></periodical><pages>3273-3280</pages><volume>51</volume><issue>6</issue><keywords><keyword>Animals</keyword><keyword>Blotting</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cattle</keyword><keyword>Confocal</keyword><keyword>Dextrans</keyword><keyword>Dextrans: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Eye Proteins</keyword><keyword>Eye Proteins: pharmacology</keyword><keyword>Fluorescein-5-isothiocyanate</keyword><keyword>Fluorescein-5-isothiocyanate: analogs &amp; derivative</keyword><keyword>Fluorescein-5-isothiocyanate: metabolism</keyword><keyword>Glycogen Synthase Kinase 3</keyword><keyword>Glycogen Synthase Kinase 3: antagonists &amp; inhibito</keyword><keyword>Glycogen Synthase Kinase 3: metabolism</keyword><keyword>Immunohistochemistry</keyword><keyword>Microscopy</keyword><keyword>Mitogen-Activated Protein Kinases</keyword><keyword>Mitogen-Activated Protein Kinases: antagonists &amp; i</keyword><keyword>Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>Nerve Growth Factors</keyword><keyword>Nerve Growth Factors: pharmacology</keyword><keyword>Phosphorylation</keyword><keyword>Receptors</keyword><keyword>Retinal Vessels</keyword><keyword>Retinal Vessels: cytology</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Serpins</keyword><keyword>Serpins: pharmacology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Urokinase Plasminogen Activator</keyword><keyword>Urokinase Plasminogen Activator: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: pharmacology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Western</keyword><keyword>beta Catenin</keyword><keyword>beta Catenin: antagonists &amp; inhibitors</keyword><keyword>beta Catenin: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20089873</accession-num><electronic-resource-num>10.1167/iovs.08-2878</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2891479&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Pigment epithelium-derived factor (PEDF) is a potent inhibitor of vascular endothelial growth factor (VEGF)-induced endothelial permeability. The goal of this study was to understand the mechanism by which PEDF blocks VEGF-induced increases in vascular permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Catravas, John D</author><author>Snead, Connie</author><author>Dimitropoulou, Christiana</author><author>Chang, Albert S Y</author><author>Lucas, Rudolf</author><author>Verin, Alexander D</author><author>Black, Stephen M</author></authors></contributors><titles><title>Harvesting, identification and barrier function of human lung microvascular endothelial cells.</title><secondary-title>Vascular pharmacology</secondary-title></titles><periodical><full-title>Vascular pharmacology</full-title></periodical><pages>175-181</pages><volume>52</volume><issue>5-6</issue><keywords><keyword>Acute Lung Injury</keyword><keyword>Acute Lung Injury: physiopathology</keyword><keyword>Adult</keyword><keyword>Adult: physiopathology</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cell Culture Techniques: methods</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Microvessels</keyword><keyword>Nitric Oxide Synthase Type III</keyword><keyword>Nitric Oxide Synthase Type III: metabolism</keyword><keyword>Permeability</keyword><keyword>Respiratory Distress Syndrome</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>von Willebrand Factor</keyword><keyword>von Willebrand Factor: metabolism</keyword></keywords><dates><year>2010</year></dates><publisher>Elsevier Inc.</publisher><accession-num>20060932</accession-num><electronic-resource-num>10.1016/j.vph.2009.12.009</electronic-resource-num><notes>From Duplicate 2 (Harvesting, identification and barrier function of human lung microvascular endothelial cells. - Catravas, John D; Snead, Connie; Dimitropoulou, Christiana; Chang, Albert S Y; Lucas, Rudolf; Verin, Alexander D; Black, Stephen M)

From Duplicate 1 ( Harvesting, identification and barrier function of human lung microvascular endothelial cells. - Catravas, John D; Snead, Connie; Dimitropoulou, Christiana; Chang, Albert S Y; Lucas, Rudolf; Verin, Alexander D; Black, Stephen M )



From Duplicate 2 ( Harvesting, identification and barrier function of human lung microvascular endothelial cells. - Catravas, John D; Snead, Connie; Dimitropoulou, Christiana; Chang, Albert S Y; Lucas, Rudolf; Verin, Alexander D; Black, Stephen M )</notes><research-notes>From Duplicate 2 (Harvesting, identification and barrier function of human lung microvascular endothelial cells. - Catravas, John D; Snead, Connie; Dimitropoulou, Christiana; Chang, Albert S Y; Lucas, Rudolf; Verin, Alexander D; Black, Stephen M)

From Duplicate 1 ( Harvesting, identification and barrier function of human lung microvascular endothelial cells. - Catravas, John D; Snead, Connie; Dimitropoulou, Christiana; Chang, Albert S Y; Lucas, Rudolf; Verin, Alexander D; Black, Stephen M )



From Duplicate 2 ( Harvesting, identification and barrier function of human lung microvascular endothelial cells. - Catravas, John D; Snead, Connie; Dimitropoulou, Christiana; Chang, Albert S Y; Lucas, Rudolf; Verin, Alexander D; Black, Stephen M )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20060932</url></web-urls></urls><label>ECIS TEER</label><abstract>Endothelial barrier dysfunction is an important contributor to the pathogenesis of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Even though approaches that target the prevention and repair of endothelial barrier dysfunction are clearly needed, our understanding of the molecular regulation of pulmonary microvascular endothelial permeability remains incomplete. Cultured pulmonary microvascular endothelial cells represent an attractive paradigm for the study of barrier function. Here, we describe a method for the harvest, identification and culture of human lung microvascular endothelial cells (HLMVEC). HLMVEC thus obtained, grow as a monolayer, exhibit contact inhibition and have the typical cobblestone appearance. They express endothelial proteins, such as von Willebrand factor and endothelial nitric oxide synthase and take up an acetylated LDL. Furthermore, HLMVEC respond predictably and with superior sensitivity to the barrier disruptive effects of Gram positive and Gram negative bacterial products, thrombin, vascular endothelial growth factor and microtubule disrupting agents. These HLMVEC present an in-house-derived alternative to commercially available human cells for the study of mechanisms contributing to ALI and ARDS.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Renken, Christian</author><author>Keese, Charles</author><author>Giaever, Ivar</author></authors></contributors><titles><title>Automated assays for quantifying cell migration</title><secondary-title>BioTechniques</secondary-title></titles><periodical><full-title>BioTechniques</full-title></periodical><pages>844</pages><volume>49</volume><issue>5</issue><keywords/><dates><year>2010</year></dates><electronic-resource-num>10.2144/000113554</electronic-resource-num><urls><web-urls><url>http://www.biotechniques.com/article/000113554</url></web-urls></urls><label>ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lv, Shan</author><author>Wu, Lin</author><author>Cheng, Peng</author><author>Yu, Jing</author><author>Zhang, Aisen</author><author>Zha, Juanmin</author><author>Liu, Juan</author><author>Wang, Long</author><author>DI, Wenjuan</author><author>Hu, Miao</author><author>Qi, Hanmei</author><author>Li, Yujie</author><author>Ding, Guoxian</author></authors></contributors><titles><title>Correlation of obesity and osteoporosis: Effect of free fatty acids on bone marrow-derived mesenchymal stem cell differentiation.</title><secondary-title>Experimental and therapeutic medicine</secondary-title></titles><periodical><full-title>Experimental and therapeutic medicine</full-title></periodical><pages>603-610</pages><volume>1</volume><issue>4</issue><keywords><keyword>1</keyword><keyword>2</keyword><keyword>3</keyword><keyword>belongs to the cxc</keyword><keyword>by the il-8 gene</keyword><keyword>chemokine family</keyword><keyword>chromosome 4q12-q21</keyword><keyword>il-8 has been shown</keyword><keyword>il-8 is a small</keyword><keyword>interleukin-8</keyword><keyword>interleukin-8 receptor</keyword><keyword>protein that is encoded</keyword><keyword>to be linked to</keyword><keyword>which is located on</keyword><keyword>wound healing</keyword></keywords><dates><year>2010</year></dates><accession-num>22993583</accession-num><electronic-resource-num>10.3892/etm_00000095</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3445940&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Wound Healing</label><abstract>Studies on the relationship between obesity and bone have recently become widespread. The aim of this study was to investigate the effect of obesity on bone, utilizing a diet-induced obese mouse model, and to explore the role of free fatty acids (FFAs) in the osteogenesis/adipogenesis of mouse bone marrow-derived mesenchymal stem cells (BMSCs). An obese mouse model was established by a high-fat diet (HFD). Proximal femurs were collected at sacrifice, and bone mineral density (BMD) in the proximal femurs was measured by dual-energy X-ray absorptiometry. Bone histomorphometry was performed using undecalcified sections of the proximal femurs. The effect of obesity on the differentiation of mouse BMSCs was assessed by colony formation assays and gene expression analysis. In vitro, various osteogenic and adipogenic genes were determined by real-time quantitative PCR in mouse BMSCs after exposure to conditioned medium (CM) from FFA-treated 3T3-L1 adipocytes. Western blotting was further performed to analyze the representative protein expression of PPARγ and Runx2. BMD and trabecular thickness were significantly greater in the HFD mice than in the control mice. CFU-osteo assay showed significantly increased osteogenesis of BMSCs. The mRNA level of Runx2 was significantly higher, while PPARγ and Pref-1 were significantly lower in BMSCs from the HFD mice compared to the control mice. In mouse BMSCs, the Sox9 and Runx2 genes were significantly up-regulated after exposure to CM from FFA-treated adipocytes, while PPARγ and CEBP-α were significantly down-regulated. Osteogenesis was significantly increased, while adipogenesis was significantly decreased. In conclusion, HFD-induced obesity may play a protective role in bone formation by concomitantly promoting osteogenic and suppressing adipogenic differentiation of BMSCs through factors secreted by FFA-treated adipocytes.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tsapara, Anna</author><author>Luthert, Phillip</author><author>Greenwood, John</author><author>Hill, Caroline S</author><author>Matter, Karl</author><author>Balda, Maria S</author></authors></contributors><titles><title>The RhoA Activator GEF-H1 / Lfc Is a Transforming Growth Factor- ␤ Target Gene and Effector That Regulates ␣ -Smooth Muscle Actin Expression and Cell Migration</title><secondary-title>Molecular Biology of the Cell</secondary-title></titles><periodical><full-title>Molecular Biology of the Cell</full-title></periodical><pages>860-870</pages><volume>21</volume><keywords/><dates><year>2010</year></dates><electronic-resource-num>10.1091/mbc.E09</electronic-resource-num><urls/><label>ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sun, Chongxiu</author><author>Wu, Mack H</author><author>Guo, Mingzhang</author><author>Day, Mark L</author><author>Lee, Eugene S</author><author>Yuan, Sarah Y</author></authors></contributors><titles><title>ADAM15 regulates endothelial permeability and neutrophil migration via Src/ERK1/2 signalling.</title><secondary-title>Cardiovascular research</secondary-title></titles><periodical><full-title>Cardiovascular research</full-title></periodical><pages>348-355</pages><volume>87</volume><issue>2</issue><keywords><keyword>ADAM Proteins</keyword><keyword>ADAM Proteins: genetics</keyword><keyword>ADAM Proteins: metabolism</keyword><keyword>Albumins</keyword><keyword>Albumins: metabolism</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Coculture Techniques</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Kinase 1: metabolism</keyword><keyword>Humans</keyword><keyword>Leukocyte Rolling</keyword><keyword>Leukocyte Rolling: drug effects</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Mitogen-Activated Protein Kinase 1</keyword><keyword>Mitogen-Activated Protein Kinase 1: antagonists &amp;</keyword><keyword>Mitogen-Activated Protein Kinase 1: metabolism</keyword><keyword>Mitogen-Activated Protein Kinase 3</keyword><keyword>Mitogen-Activated Protein Kinase 3: antagonists &amp;</keyword><keyword>Mitogen-Activated Protein Kinase 3: metabolism</keyword><keyword>Mutation</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: drug effects</keyword><keyword>Neutrophils: enzymology</keyword><keyword>Phosphorylation</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>RNA Interference</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Thrombin</keyword><keyword>Thrombin: metabolism</keyword><keyword>Time Factors</keyword><keyword>Transfection</keyword><keyword>src-Family Kinases</keyword><keyword>src-Family Kinases: antagonists &amp; inhibitors</keyword><keyword>src-Family Kinases: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20189953</accession-num><electronic-resource-num>10.1093/cvr/cvq060</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2895539&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Endothelial barrier dysfunction is a key event in the pathogenesis of vascular diseases associated with inflammation. ADAM (a disintegrin and metalloprotease) 15 has been shown to contribute to the development of vascular inflammation. However, its role in regulating endothelial barrier function is unknown. The aim of this study was to examine the effect of ADAM15 on endothelial permeability and its underlying mechanisms.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sansom, Sarah E</author><author>Nuovo, Gerard J</author><author>Martin, Mickey M</author><author>Kotha, Sainath R</author><author>Parinandi, Narasimham L</author><author>Elton, Terry S</author></authors></contributors><titles><title>miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells.</title><secondary-title>American journal of physiology. Gastrointestinal and liver physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Gastrointestinal and liver physiology</full-title></periodical><pages>G632-42</pages><volume>299</volume><issue>3</issue><keywords><keyword>3' Untranslated Regions</keyword><keyword>Angiotensin</keyword><keyword>Animals</keyword><keyword>CHO Cells</keyword><keyword>Cell Line</keyword><keyword>Colon</keyword><keyword>Colon: anatomy &amp; histology</keyword><keyword>Cricetinae</keyword><keyword>Cricetulus</keyword><keyword>Humans</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: cytology</keyword><keyword>Intestinal Mucosa: metabolism</keyword><keyword>Intestine</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Messenger: metabolism</keyword><keyword>MicroRNAs</keyword><keyword>MicroRNAs: genetics</keyword><keyword>MicroRNAs: metabolism</keyword><keyword>Muscle</keyword><keyword>RNA</keyword><keyword>Receptor</keyword><keyword>Small</keyword><keyword>Small: anatomy &amp; histology</keyword><keyword>Smooth</keyword><keyword>Smooth: metabolism</keyword><keyword>Tumor</keyword><keyword>Type 1</keyword><keyword>Type 1: genetics</keyword><keyword>Type 1: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20558762</accession-num><electronic-resource-num>10.1152/ajpgi.00120.2010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2950689&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Studies have demonstrated that angiotensin II (Ang II) can regulate intestinal fluid and electrolyte transport and control intestinal wall muscular activity. Ang II is also a proinflammatory mediator that participates in inflammatory responses such as apoptosis, angiogenesis, and vascular remodeling; accumulating evidence suggests that this hormone may be involved in gastrointestinal (GI) inflammation and carcinogenesis. Ang II binds to two distinct G protein-coupled receptor subtypes, the AT(1)R and AT(2)R, which are widely expressed in the GI system. Together these studies suggest that Ang II-AT(1)R/-AT(2)R actions may play an important role in GI tract physiology and pathophysiology. Currently it is not known whether miRNAs can regulate the expression of the human AT(1)R (hAT(1)R) in the GI system. PCR and in situ hybridization experiments demonstrated that miR-802 was abundantly expressed in human colon and intestine. Luciferase reporter assays demonstrated that miR-802 could directly interact with the bioinformatics-predicted target site harbored within the 3'-untranslated region of the hAT(1)R mRNA. To validate that the levels of miR-802 were physiologically relevant in the GI system, we demonstrated that miR-802 &quot;loss-of-function&quot; experiments resulted in augmented hAT(1)R levels and enhanced Ang II-induced signaling in a human intestinal epithelial cell line. These results suggest that miR-802 can modulate the expression of the hAT(1)R in the GI tract and ultimately play a role in regulating the biological efficacy of Ang II in this system.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sharma, Dipali</author><author>Wang, Jason</author><author>Fu, Ping P</author><author>Sharma, Shvetank</author><author>Nagalingam, Arumugam</author><author>Mells, Jamie</author><author>Handy, Jeffrey</author><author>Page, Andrew J</author><author>Cohen, Cynthia</author><author>Anania, Frank A</author><author>Saxena, Neeraj K</author></authors></contributors><titles><title>Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis.</title><secondary-title>Hepatology (Baltimore, Md.)</secondary-title></titles><periodical><full-title>Hepatology (Baltimore, Md.)</full-title></periodical><pages>1713-1722</pages><volume>52</volume><issue>5</issue><keywords><keyword>Adiponectin</keyword><keyword>Adiponectin: therapeutic use</keyword><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Apoptosis: drug effects</keyword><keyword>Carcinoma</keyword><keyword>Cell Division</keyword><keyword>Cell Division: drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>DNA</keyword><keyword>Hepatocellular</keyword><keyword>Hepatocellular: epidemiology</keyword><keyword>Hepatocellular: genetics</keyword><keyword>Hepatocellular: pathology</keyword><keyword>Hepatocellular: prevention &amp; control</keyword><keyword>Heterologous</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>In Situ Nick-End Labeling</keyword><keyword>Leptin</keyword><keyword>Leptin: antagonists &amp; inhibitors</keyword><keyword>Leptin: metabolism</keyword><keyword>Liver Neoplasms</keyword><keyword>Liver Neoplasms: epidemiology</keyword><keyword>Liver Neoplasms: genetics</keyword><keyword>Liver Neoplasms: pathology</keyword><keyword>Liver Neoplasms: prevention &amp; control</keyword><keyword>Mice</keyword><keyword>Neoplasm</keyword><keyword>Neoplasm: analysis</keyword><keyword>Nude</keyword><keyword>Obesity</keyword><keyword>Obesity: complications</keyword><keyword>Phosphorylation</keyword><keyword>Transplantation</keyword><keyword>Tumor</keyword></keywords><dates><year>2010</year></dates><accession-num>20941777</accession-num><electronic-resource-num>10.1002/hep.23892</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2967627&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Apoptosis;ECIS Migration;Wound Healing</label><abstract>UNLABELLED: Obesity is rapidly becoming a pandemic and is associated with increased carcinogenesis. Obese populations have higher circulating levels of leptin in contrast to low concentrations of adiponectin. Hence, it is important to evaluate the dynamic role between adiponectin and leptin in obesity-related carcinogenesis. Recently, we reported the oncogenic role of leptin including its potential to increase tumor invasiveness and migration of hepatocellular carcinoma (HCC) cells. In the present study we investigated whether adiponectin could antagonize the oncogenic actions of leptin in HCC. We employed HCC cell lines HepG2 and Huh7, the nude mice-xenograft model of HCC, and immunohistochemistry data from tissue-microarray to demonstrate the antagonistic role of adiponectin on the oncogenic actions of leptin. Adiponectin treatment inhibited leptin-induced cell proliferation of HCC cells. Using scratch-migration and electric cell-substrate impedance-sensing-based migration assays, we found that adiponectin inhibited leptin-induced migration of HCC cells. Adiponectin treatment effectively blocked leptin-induced invasion of HCC cells in Matrigel invasion assays. Although leptin inhibited apoptosis in HCC cells, we found that adiponectin treatment induced apoptosis even in the presence of leptin. Analysis of the underlying molecular mechanisms revealed that adiponectin treatment reduced leptin-induced Stat3 and Akt phosphorylation. Adiponectin also increased suppressor of cytokine signaling (SOCS3), a physiologic negative regulator of leptin signal transduction. Importantly, adiponectin significantly reduced leptin-induced tumor burden in nude mice. In HCC samples, leptin expression significantly correlated with HCC proliferation as evaluated by Ki-67, whereas adiponectin expression correlated significantly with increased disease-free survival and inversely with tumor size and local recurrence. CONCLUSION: Collectively, these data demonstrate that adiponectin has the molecular potential to inhibit the oncogenic actions of leptin by blocking downstream effector molecules.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mahmoud, Khaled A</author><author>Mena, Jimmy A</author><author>Male, Keith B</author><author>Hrapovic, Sabahudin</author><author>Kamen, Amine</author><author>Luong, John H T</author></authors></contributors><titles><title>Effect of surface charge on the cellular uptake and cytotoxicity of fluorescent labeled cellulose nanocrystals.</title><secondary-title>ACS applied materials &amp; interfaces</secondary-title></titles><periodical><full-title>ACS applied materials &amp; interfaces</full-title></periodical><pages>2924-2932</pages><volume>2</volume><issue>10</issue><keywords><keyword>Animals</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Cellulose</keyword><keyword>Cellulose: chemistry</keyword><keyword>Cellulose: pharmacokinetics</keyword><keyword>Fluorescein-5-isothiocyanate</keyword><keyword>Fluorescein-5-isothiocyanate: chemistry</keyword><keyword>Fluorescein-5-isothiocyanate: pharmacology</keyword><keyword>Fluorescent Dyes</keyword><keyword>Fluorescent Dyes: chemistry</keyword><keyword>Fluorescent Dyes: pharmacology</keyword><keyword>HEK293 Cells</keyword><keyword>Humans</keyword><keyword>Nanoparticles</keyword><keyword>Rhodamines</keyword><keyword>Rhodamines: chemistry</keyword><keyword>Rhodamines: pharmacology</keyword><keyword>Spodoptera</keyword></keywords><dates><year>2010</year></dates><accession-num>20919683</accession-num><electronic-resource-num>10.1021/am1006222</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20919683</url></web-urls></urls><abstract>Probing of cellular uptake and cytotoxicity was conducted for two fluorescent cellulose nanocrystals (CNCs): CNC-fluorescein isothiocyanate (FITC) and newly synthesized CNC-rhodamine B isothiocyanate (RBITC). The positively charged CNC-RBITC was uptaken by human embryonic kidney 293 (HEK 293) and Spodoptera frugiperda (Sf9) cells without affecting the cell membrane integrity. The cell viability assay and cell-based impedance spectroscopy revealed no noticeably cytotoxic effect of the CNC-RBITC conjugate. However, no significant internalization of negatively charged CNC-FITC was observed at physiological pH. Indeed, the effector cells were surrounded by CNC-FITC, leading to eventual cell rupture. As the surface charge of CNC played an important role in cellular uptake and cytotoxicity, facile surface functionalization together with observed noncytotoxicity rendered modified CNC as a promising candidate for bioimaging and drug delivery systems.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wang, Lei</author><author>Yin, Hongying</author><author>Xing, Wanli</author><author>Yu, Zhongyao</author><author>Guo, Min</author><author>Cheng, Jing</author></authors></contributors><titles><title>Real-time, label-free monitoring of the cell cycle with a cellular impedance sensing chip.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>990-995</pages><volume>25</volume><issue>5</issue><keywords><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Cell Cycle</keyword><keyword>Cell Cycle: physiology</keyword><keyword>Computer Systems</keyword><keyword>Electric Impedance</keyword><keyword>Electrochemistry</keyword><keyword>Electrochemistry: instrumentation</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Staining and Labeling</keyword></keywords><dates><year>2010</year></dates><accession-num>19818595</accession-num><electronic-resource-num>10.1016/j.bios.2009.09.012</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19818595</url></web-urls></urls><abstract>The cell cycle plays a crucial role in many cellular physiological processes and has drawn an increasing interest in past decades. In the current study, we have developed a bioelectronic chip-based system capable of performing real-time dynamic analysis of the cell cycle in live cells via non-invasive cellular impedance sensing. The cells were cultured on the cellular impedance sensing chip comprising microfabricated interdigitated electrode structures. HeLa cells were synchronized with double thymidine block and the cellular impedances were monitored in a time resolution of minutes during the whole 5 days' experiment. Our results show that real-time impedance sensing can clearly mirror the progression of the cell cycle-in G(1) phase and S phase, the cellular impedance increased with time, while in G(2) phase and M phase, the cellular impedance decreased. Correspondingly, the time-course impedance curves for the synchronized cells have marked &quot;M-valleys&quot; corresponding to the periods of mitosis of the cells. The cell cycle information revealed by the cellular impedance data was confirmed using flow cytometry and microscopy. This paper presents the first step towards in situ and label-free monitoring of the cell cycle of mammalian cells on chip in a real-time, non-invasive manner.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wang, Zhen</author><author>Ginnan, Roman</author><author>Abdullaev, Iskandar F</author><author>Trebak, Mohamed</author><author>Vincent, Peter a</author><author>Singer, Harold a</author></authors></contributors><titles><title>Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>21303-21312</pages><volume>285</volume><issue>28</issue><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Calcium</keyword><keyword>Calcium-Calmodulin-Dependent Protein Kinase Type 2</keyword><keyword>Calcium: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelium</keyword><keyword>Endothelium: metabolism</keyword><keyword>Endothelium: pathology</keyword><keyword>Enzymologic</keyword><keyword>Extracellular Signal-Regulated MAP Kinases</keyword><keyword>Extracellular Signal-Regulated MAP Kinases: metabo</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Models</keyword><keyword>Protein Isoforms</keyword><keyword>Rats</keyword><keyword>Sprague-Dawley</keyword><keyword>Thrombin</keyword><keyword>Thrombin: chemistry</keyword><keyword>Thrombin: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2010</year></dates><isbn>0040420000</isbn><accession-num>20442409</accession-num><electronic-resource-num>10.1074/jbc.M110.120790</electronic-resource-num><notes>From Duplicate 2 (Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. - Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F; Trebak, Mohamed; Vincent, Peter a; Singer, Harold a)

From Duplicate 1 ( Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. - Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F; Trebak, Mohamed; Vincent, Peter a; Singer, Harold a )



From Duplicate 2 ( Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. - Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F; Trebak, Mohamed; Vincent, Peter a; Singer, Harold a )</notes><research-notes>From Duplicate 2 (Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. - Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F; Trebak, Mohamed; Vincent, Peter a; Singer, Harold a)

From Duplicate 1 ( Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. - Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F; Trebak, Mohamed; Vincent, Peter a; Singer, Harold a )



From Duplicate 2 ( Calcium/Calmodulin-dependent protein kinase II delta 6 (CaMKIIdelta6) and RhoA involvement in thrombin-induced endothelial barrier dysfunction. - Wang, Zhen; Ginnan, Roman; Abdullaev, Iskandar F; Trebak, Mohamed; Vincent, Peter a; Singer, Harold a )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2898399&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Multiple Ca(2+) release and entry mechanisms and potential cytoskeletal targets have been implicated in vascular endothelial barrier dysfunction; however, the immediate downstream effectors of Ca(2+) signals in the regulation of endothelial permeability still remain unclear. In the present study, we evaluated the contribution of multifunctional Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) as a mediator of thrombin-stimulated increases in human umbilical vein endothelial cell (HUVEC) monolayer permeability. For the first time, we identified the CaMKIIdelta(6) isoform as the predominant CaMKII isoform expressed in endothelium. As little as 2.5 nM thrombin maximally increased CaMKIIdelta(6) activation assessed by Thr(287) autophosphorylation. Electroporation of siRNA targeting endogenous CaMKIIdelta (siCaMKIIdelta) suppressed expression of the kinase by &gt;80% and significantly inhibited 2.5 nM thrombin-induced increases in monolayer permeability assessed by electrical cell-substrate impedance sensing (ECIS). siCaMKIIdelta inhibited 2.5 nM thrombin-induced activation of RhoA, but had no effect on thrombin-induced ERK1/2 activation. Although Rho kinase inhibition strongly suppressed thrombin-induced HUVEC hyperpermeability, inhibiting ERK1/2 activation had no effect. In contrast to previous reports, these results indicate that thrombin-induced ERK1/2 activation in endothelial cells is not mediated by CaMKII and is not involved in endothelial barrier hyperpermeability. Instead, CaMKIIdelta(6) mediates thrombin-induced HUVEC barrier dysfunction through RhoA/Rho kinase as downstream intermediates. Moreover, the relative contribution of the CaMKIIdelta(6)/RhoA pathway(s) diminished with increasing thrombin stimulation, indicating recruitment of alternative signaling pathways mediating endothelial barrier dysfunction, dependent upon thrombin concentration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Bernas, Michael J</author><author>Cardoso, Filipa L</author><author>Daley, Sarah K</author><author>Weinand, Martin E</author><author>Campos, Alexandre R</author><author>Ferreira, António J Gonçalves</author><author>Hoying, James B</author><author>Witte, Marlys H</author><author>Brites, Dora</author><author>Persidsky, Yuri</author><author>Ramirez, Servio H</author><author>Brito, Maria a</author></authors></contributors><titles><title>Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier.</title><secondary-title>Nature protocols</secondary-title></titles><periodical><full-title>Nature protocols</full-title></periodical><pages>1265-1272</pages><volume>5</volume><issue>7</issue><keywords><keyword>Biological</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: cytology</keyword><keyword>Blood-Brain Barrier: physiology</keyword><keyword>Caveolin 1</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cells</keyword><keyword>Collagen Type I</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Glucose Transporter Type 1</keyword><keyword>Hippocampus</keyword><keyword>Hippocampus: cytology</keyword><keyword>Humans</keyword><keyword>Models</keyword><keyword>P-Glycoprotein</keyword><keyword>Pericytes</keyword><keyword>Temporal Lobe</keyword><keyword>Temporal Lobe: cytology</keyword><keyword>Tight Junctions</keyword><keyword>von Willebrand Factor</keyword></keywords><dates><year>2010</year></dates><publisher>Nature Publishing Group</publisher><accession-num>20595955</accession-num><electronic-resource-num>10.1038/nprot.2010.76</electronic-resource-num><notes>From Duplicate 1 (Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. - Bernas, Michael J; Cardoso, Filipa L; Daley, Sarah K; Weinand, Martin E; Campos, Alexandre R; Ferreira, António J Gonçalves; Hoying, James B; Witte, Marlys H; Brites, Dora; Persidsky, Yuri; Ramirez, Servio H; Brito, Maria a)

From Duplicate 2 ( Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. - Bernas, Michael J; Cardoso, Filipa L; Daley, Sarah K; Weinand, Martin E; Campos, Alexandre R; Ferreira, António J Gonçalves; Hoying, James B; Witte, Marlys H; Brites, Dora; Persidsky, Yuri; Ramirez, Servio H; Brito, Maria a )</notes><research-notes>From Duplicate 1 (Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. - Bernas, Michael J; Cardoso, Filipa L; Daley, Sarah K; Weinand, Martin E; Campos, Alexandre R; Ferreira, António J Gonçalves; Hoying, James B; Witte, Marlys H; Brites, Dora; Persidsky, Yuri; Ramirez, Servio H; Brito, Maria a)

From Duplicate 2 ( Establishment of primary cultures of human brain microvascular endothelial cells to provide an in vitro cellular model of the blood-brain barrier. - Bernas, Michael J; Cardoso, Filipa L; Daley, Sarah K; Weinand, Martin E; Campos, Alexandre R; Ferreira, António J Gonçalves; Hoying, James B; Witte, Marlys H; Brites, Dora; Persidsky, Yuri; Ramirez, Servio H; Brito, Maria a )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3109429&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier;ECIS Growth;ECIS TEER</label><abstract>We describe a method for generating primary cultures of human brain microvascular endothelial cells (HBMVECs). HBMVECs are derived from microvessels isolated from temporal tissue removed during operative treatment of epilepsy. The tissue is mechanically fragmented and size filtered using polyester meshes. The resulting microvessel fragments are placed onto type I collagen-coated flasks to allow HBMVECs to migrate and proliferate. The overall process takes less than 3 h and does not require specialized equipment or enzymatic processes. HBMVECs are typically cultured for approximately 1 month until confluent. Cultures are highly pure ( approximately 97% endothelial cells; approximately 3% pericytes), are reproducible, and show characteristic brain endothelial markers (von Willebrand factor, glucose transporter-1) and robust expression of tight and adherens junction proteins as well as caveolin-1 and efflux protein P-glycoprotein. Monolayers of HBMVECs show characteristically high transendothelial electric resistance and have proven useful in multiple functional studies for in vitro modeling of the human blood-brain barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Male, Keith B</author><author>Crowley, Stephan M</author><author>Collins, Stuart G</author><author>Tzeng, Yew-Min</author><author>Luong, John H T</author></authors></contributors><titles><title>Cell-based impedance spectroscopy for probing inhibitory effects of steroids and ergostane/lanosta-related compounds</title><secondary-title>Analytical Methods</secondary-title></titles><periodical><full-title>Analytical Methods</full-title></periodical><pages>870</pages><volume>2</volume><issue>7</issue><keywords/><dates><year>2010</year></dates><electronic-resource-num>10.1039/c0ay00105h</electronic-resource-num><urls><web-urls><url>http://xlink.rsc.org/?DOI=c0ay00105h</url></web-urls></urls><abstract>Electric cell–substrate impedance sensing (ECIS) was used for probing inhibitory effects on Spodoptera frugiperda Sf9 insect cells exposed to five synthesized steroid compounds. The results were compared to the levels obtained using three ergostane-related steroids and five lanosta-related triterpenes purified from the fruiting bodies of Antrodia camphorata. The half-inhibition concentration (ECIS50), the level of 50% inhibition of the resistance response, was determined from the response function to establish inhibitory effects of the different compounds. Significant effects on inhibition as probed by impedance spectroscopy were noticed because of slight changes in chemical structure. Only two of the synthesized compounds, 24(R,S)-5α-lanost-8-ene-3,24,25-triol and 5α-lanost-8-ene-3,7,11-trione, showed inhibitory effects which were much less significant compared to the A. camphorata steroids. The ECIS50 values were 150–250 µM, similar to the value for the least inhibitory lanosta-related triterpene. This noninvasive measurement in combination with Sf9 insect cells has been proven as a simple and reliable tool for screening inhibition/cytotoxicity and designing steroid-related compounds.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kandasamy, Karthikeyan</author><author>Choi, Cheol Soo</author><author>Kim, Sanghyo</author></authors></contributors><titles><title>An efficient analysis of nanomaterial cytotoxicity based on bioimpedance.</title><secondary-title>Nanotechnology</secondary-title></titles><periodical><full-title>Nanotechnology</full-title></periodical><pages>375501</pages><volume>21</volume><issue>37</issue><keywords><keyword>Animals</keyword><keyword>Biophysics</keyword><keyword>Biophysics: methods</keyword><keyword>Carbon</keyword><keyword>Carbon: adverse effects</keyword><keyword>Carbon: ultrastructure</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Survival</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Cytotoxins</keyword><keyword>Cytotoxins: adverse effects</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Gold</keyword><keyword>Gold: adverse effects</keyword><keyword>Nanoparticles</keyword><keyword>Nanoparticles: adverse effects</keyword><keyword>Nanoparticles: ultrastructure</keyword><keyword>Nanotubes</keyword><keyword>Vero Cells</keyword></keywords><dates><year>2010</year></dates><accession-num>20714049</accession-num><electronic-resource-num>10.1088/0957-4484/21/37/375501</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20714049</url></web-urls></urls><abstract>In the emerging nanotechnology field, there is an urgent need for the development of a significant and sensitive method that can be used to analyse and compare the cytotoxicities of nanomaterials such as carbon nanotubes (CNTs) and gold nanoparticles (AuNPs), since such materials can be applied as contrast agents or drug delivery carriers. The bioimpedance system possesses great potential in many medical research fields including nanotechnology. Electric cell-substrate impedance sensing (ECIS) is a particular bioimpedance system that offers a real-time, non-invasive, and quantitative measurement method for the cytotoxicity of various materials. The present work compared the cytotoxicity of AuNPs to that of purchased single-walled carbon nanotubes (SWCNTs). The size-controlled and monodispersed AuNPs were synthesized under autoclaved conditions and reduced by ascorbic acid (AA) whereas the purchased SWCNTs were used without any surface modifications. Bioimpedance results were validated by conventional WST-1 and trypan blue assays, and transmission electron microscopy (TEM) and field emission scanning electron microscopy (FE-SEM) were performed to examine nanomaterials inside the VERO cells. This research evaluates the ability of the ECIS system compared to those of conventional methods in analyzing the cytotoxicity of AuNPs and SWCNTs with higher sensitivity under real-time conditions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Nethe, Micha</author><author>Anthony, Eloise C</author><author>Fernandez-Borja, Mar</author><author>Dee, Rob</author><author>Geerts, Dirk</author><author>Hensbergen, Paul J</author><author>Deelder, André M</author><author>Schmidt, Gudula</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>Focal-adhesion targeting links caveolin-1 to a Rac1-degradation pathway.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>1948-1958</pages><volume>123</volume><issue>Pt 11</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Caveolin 1</keyword><keyword>Caveolin 1: genetics</keyword><keyword>Caveolin 1: metabolism</keyword><keyword>Cell Movement</keyword><keyword>Cell Surface Extensions</keyword><keyword>Cell Surface Extensions: drug effects</keyword><keyword>Cell Surface Extensions: metabolism</keyword><keyword>Confocal</keyword><keyword>Feedback</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: drug effects</keyword><keyword>Fibroblasts: metabolism</keyword><keyword>Fibroblasts: pathology</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: drug effects</keyword><keyword>Focal Adhesions: metabolism</keyword><keyword>Hela Cells</keyword><keyword>Humans</keyword><keyword>Mice</keyword><keyword>Microscopy</keyword><keyword>Physiological</keyword><keyword>Pyrones</keyword><keyword>Pyrones: pharmacology</keyword><keyword>Quinolines</keyword><keyword>Quinolines: pharmacology</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: antagonists &amp; inhibitors</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20460433</accession-num><electronic-resource-num>10.1242/jcs.062919</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20460433</url></web-urls></urls><label>ECIS Attachment</label><abstract>Directional cell migration is crucially dependent on the spatiotemporal control of intracellular signalling events. These events regulate polarized actin dynamics, resulting in protrusion at the front of the cell and contraction at the rear. The actin cytoskeleton is regulated through signalling by Rho-like GTPases, such as RhoA, which stimulates myosin-based contractility, and CDC42 and Rac1, which promote actin polymerization and protrusion. Here, we show that Rac1 binds the adapter protein caveolin-1 (Cav1) and that Rac1 activity promotes Cav1 accumulation at Rac1-positive peripheral adhesions. Using Cav1-deficient mouse fibroblasts and depletion of Cav1 expression in human epithelial and endothelial cells mediated by small interfering RNA and short hairpin RNA, we show that loss of Cav1 induces an increase in Rac1 protein and its activated, GTP-bound form. Cav1 controls Rac1 protein levels by regulating ubiquitylation and degradation of activated Rac1 in an adhesion-dependent fashion. Finally, we show that Rac1 ubiquitylation is not required for effector binding, but regulates the dynamics of Rac1 at the periphery of the cell. These data extend the canonical model of Rac1 inactivation and uncover Cav1-regulated polyubiquitylation as an additional mechanism to control Rac1 signalling.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Grinnell, K L</author><author>Casserly, B</author><author>Harrington, E O</author></authors></contributors><titles><title>Role of protein tyrosine phosphatase SHP2 in barrier function of pulmonary endothelium.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L361-70</pages><volume>298</volume><issue>3</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: drug effects</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Biocatalysis</keyword><keyword>Biocatalysis: drug effects</keyword><keyword>Blood-Air Barrier</keyword><keyword>Blood-Air Barrier: drug effects</keyword><keyword>Blood-Air Barrier: enzymology</keyword><keyword>Blood-Air Barrier: pathology</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Catenins</keyword><keyword>Catenins: metabolism</keyword><keyword>Cattle</keyword><keyword>Endothelium</keyword><keyword>Endothelium: drug effects</keyword><keyword>Endothelium: enzymology</keyword><keyword>Endothelium: pathology</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Non-Receptor Type 11</keyword><keyword>Non-Receptor Type 11: antagonists &amp; inhibitors</keyword><keyword>Non-Receptor Type 11: metabolism</keyword><keyword>Phosphotyrosine</keyword><keyword>Phosphotyrosine: metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Binding: drug effects</keyword><keyword>Protein Tyrosine Phosphatase</keyword><keyword>Pulmonary Edema</keyword><keyword>Pulmonary Edema: enzymology</keyword><keyword>Pulmonary Edema: pathology</keyword><keyword>Rats</keyword><keyword>Repressor Proteins</keyword><keyword>Repressor Proteins: metabolism</keyword><keyword>Stress Fibers</keyword><keyword>Stress Fibers: drug effects</keyword><keyword>Stress Fibers: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20023173</accession-num><electronic-resource-num>10.1152/ajplung.00374.2009</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2838678&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Pulmonary edema is mediated in part by disruption of interendothelial cell contacts. Protein tyrosine phosphatases (PTP) have been shown to affect both cell-extracellular matrix and cell-cell junctions. The SH2 domain-containing nonreceptor PTP, SHP2, is involved in intercellular signaling through direct interaction with adherens junction proteins. In this study, we examined the role of SHP2 in pulmonary endothelial barrier function. Inhibition of SHP2 promoted edema formation in rat lungs and increased monolayer permeability in cultured lung endothelial cells. In addition, pulmonary endothelial cells demonstrated a decreased level of p190RhoGAP activity following inhibition of SHP2, events that were accompanied by a concomitant increase in RhoA activity. Furthermore, immunofluorescence microscopy confirmed enhanced actin stress fiber formation and diminished interendothelial staining of adherens junction complex-associated proteins upon SHP2 inhibition. Finally, immunoprecipitation and immunoblot analyses demonstrated increased tyrosine phosphorylation of VE-cadherin, beta-catenin, and p190RhoGAP proteins, as well as decreased association between p120-catenin and VE-cadherin proteins. Our findings suggest that SHP2 supports basal pulmonary endothelial barrier function by coordinating the tyrosine phosphorylation profile of VE-cadherin, beta-catenin, and p190RhoGAP and the activity of RhoA, signaling molecules important in adherens junction complex integrity.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jiang, Wen G</author><author>Ye, Lin</author><author>Patel, Girish</author><author>Harding, Keith G</author></authors></contributors><titles><title>Expression of WAVEs, the WASP (Wiskott-Aldrich syndrome protein) family of verprolin homologous proteins in human wound tissues and the biological influence on human keratinocytes.</title><secondary-title>Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</secondary-title></titles><periodical><full-title>Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</full-title></periodical><pages>594-604</pages><volume>18</volume><issue>6</issue><keywords><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Keratinocytes</keyword><keyword>Keratinocytes: metabolism</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Skin</keyword><keyword>Skin: injuries</keyword><keyword>Skin: metabolism</keyword><keyword>Staining and Labeling</keyword><keyword>Wiskott-Aldrich Syndrome Protein Family</keyword><keyword>Wiskott-Aldrich Syndrome Protein Family: metabolis</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: physiology</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20946142</accession-num><electronic-resource-num>10.1111/j.1524-475X.2010.00630.x</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20946142</url></web-urls></urls><label>ECIS Migration;Wound Healing</label><abstract>WAVEs (Wiskott-Aldrich syndrome protein family verprolin homologs) regulate actin polymerization and influence cellular motility. Here, we investigated the pattern of expression of WAVE-1, WAVE-2, and WAVE-3, in a cohort of human wound tissues together with normal skins and evaluated the role of these molecules in the reepithelialization and migration of keratinocytes. It was shown that there was a significant reduction of the WAVE-3 transcripts in chronic wound tissues, when compared with normal skin and acute wound tissue (p=0.002). Marginal reduction of the WAVE-1 and WAVE-2 transcripts in chronic wounds were also seen. Immunohistochemical analysis showed a significant reduction of all three WAVE proteins in chronic wound tissues in comparison with the acute. We created in vitro cell models using keratinocytes in which we overexpressed WAVE-2, and knocked down the expression of WAVE-1 and WAVE-3. Using ECIS assay, it was shown that knocking down WAVE-3 had a significant effect on the migration and reepithelialization of keratinocytes and that overexpression of WAVE-2 also increased the migration of keratinocytes. We further demonstrated that the impact of WAVE on cell migration was independent upon the PLCg and ERK pathways, but in the downstream requires PI3K pathway and ROCK pathways. In conclusion, the WAVE family proteins are essential for the reepithelialization of keratinocytes. Aberrant expression of WAVEs is linked to the healing process of clinical wounds and loss of WAVE-3 is a particular indicator of an abnormally healing wound. The WAVE proteins have a significant predicative and therapeutic value in wound healing.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Minshall, Richard D</author><author>Vandenbroucke, Emily E</author><author>Holinstat, Michael</author><author>Place, Aaron T</author><author>Tiruppathi, Chinnaswamy</author><author>Vogel, Stephen M</author><author>van Nieuw Amerongen, Geerten P</author><author>Mehta, Dolly</author><author>Malik, Asrar B</author></authors></contributors><titles><title>Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers.</title><secondary-title>Microvascular research</secondary-title></titles><periodical><full-title>Microvascular research</full-title></periodical><pages>240-249</pages><volume>80</volume><issue>2</issue><keywords><keyword>Benzophenanthridines</keyword><keyword>Benzophenanthridines: pharmacology</keyword><keyword>Calcium</keyword><keyword>Calcium Signaling</keyword><keyword>Calcium Signaling: drug effects</keyword><keyword>Calcium Signaling: physiology</keyword><keyword>Calcium: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cell Line</keyword><keyword>Cytosol</keyword><keyword>Cytosol: drug effects</keyword><keyword>Cytosol: metabolism</keyword><keyword>Dermis</keyword><keyword>Dermis: blood supply</keyword><keyword>Dermis: enzymology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Gene Silencing</keyword><keyword>Hemostatics</keyword><keyword>Hemostatics: pharmacology</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: drug effects</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Microfilaments</keyword><keyword>Microfilaments: drug effects</keyword><keyword>Microfilaments: metabolism</keyword><keyword>Microvessels</keyword><keyword>Microvessels: cytology</keyword><keyword>Microvessels: drug effects</keyword><keyword>Microvessels: enzymology</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C: antagonists &amp; inhibitors</keyword><keyword>Protein Kinase C: genetics</keyword><keyword>Protein Kinase C: metabolism</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: administration &amp; dosage</keyword><keyword>Small Interfering: genetics</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Transfection</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: biosynthesis</keyword></keywords><dates><year>2010</year></dates><publisher>Elsevier Inc.</publisher><accession-num>20417648</accession-num><electronic-resource-num>10.1016/j.mvr.2010.04.007</electronic-resource-num><notes>From Duplicate 2 (Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. - Minshall, Richard D; Vandenbroucke, Emily E; Holinstat, Michael; Place, Aaron T; Tiruppathi, Chinnaswamy; Vogel, Stephen M; van Nieuw Amerongen, Geerten P; Mehta, Dolly; Malik, Asrar B)

From Duplicate 1 ( Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. - Minshall, Richard D; Vandenbroucke, Emily E; Holinstat, Michael; Place, Aaron T; Tiruppathi, Chinnaswamy; Vogel, Stephen M; van Nieuw Amerongen, Geerten P; Mehta, Dolly; Malik, Asrar B )



From Duplicate 2 ( Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. - Minshall, Richard D; Vandenbroucke, Emily E; Holinstat, Michael; Place, Aaron T; Tiruppathi, Chinnaswamy; Vogel, Stephen M; van Nieuw Amerongen, Geerten P; Mehta, Dolly; Malik, Asrar B )</notes><research-notes>From Duplicate 2 (Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. - Minshall, Richard D; Vandenbroucke, Emily E; Holinstat, Michael; Place, Aaron T; Tiruppathi, Chinnaswamy; Vogel, Stephen M; van Nieuw Amerongen, Geerten P; Mehta, Dolly; Malik, Asrar B)

From Duplicate 1 ( Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. - Minshall, Richard D; Vandenbroucke, Emily E; Holinstat, Michael; Place, Aaron T; Tiruppathi, Chinnaswamy; Vogel, Stephen M; van Nieuw Amerongen, Geerten P; Mehta, Dolly; Malik, Asrar B )



From Duplicate 2 ( Role of protein kinase Czeta in thrombin-induced RhoA activation and inter-endothelial gap formation of human dermal microvessel endothelial cell monolayers. - Minshall, Richard D; Vandenbroucke, Emily E; Holinstat, Michael; Place, Aaron T; Tiruppathi, Chinnaswamy; Vogel, Stephen M; van Nieuw Amerongen, Geerten P; Mehta, Dolly; Malik, Asrar B )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2919649&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Calcium Signaling;ECIS TEER;Signal Transduction</label><abstract>We studied the potential involvement of the Ca(2+)-independent atypical protein kinase C isoform PKCzeta in mediating the thrombin-induced increase in endothelial permeability. Studies were done using human dermal microvessel endothelial cells (HMEC), which we showed constitutively expressed PKCzeta. We quantified the patency of inter-endothelial junctions (IEJs) and endothelial barrier function by measuring transendothelial electrical resistance (TER) in confluent HMEC monolayers. In control monolayers, thrombin decreased TER by approximately 50%, indicating thrombin-dependent opening of IEJs. Thrombin also elicited increases in cytosolic Ca(2+) concentration [Ca(2+)](i), actin stress fiber formation, and myosin light chain (MLC) phosphorylation. Pan-PKC inhibitors, calphostin C and chelerythrine, abrogated these responses. Thrombin also decreased TER after depletion of conventional and novel Ca(2+)-dependent PKC isoforms using phorbol 12-myristate 13-acetate (PMA). In these PMA-treated cells, thrombin induced inter-endothelial gap formation, MLC phosphorylation, and actin stress fiber formation, but failed to increase [Ca(2+)](i). Inhibition of PKCzeta activation using the PKCzeta pseudosubstrate peptide (PSI), depletion of PKCzeta protein with siRNA, and competitive inhibition of PKCzeta activity using dominant-negative (dn) PKCzeta mutant all prevented the thrombin-induced decrease in TER and MLC phosphorylation. Expression of dn-PKCzeta also inhibited thrombin-induced RhoA activation. These findings reveal a novel Ca(2+)-independent, PKCzeta-dependent mechanism of thrombin-induced increase in endothelial permeability. The results raise the possibility that inhibition of PKCzeta may be a novel drug target for thrombin-induced inflammatory hyperpermeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yun, YeoHeung</author><author>Dong, Zhongyun</author><author>Tan, Zongqing</author><author>Schulz, Mark J</author></authors></contributors><titles><title>Development of an electrode cell impedance method to measure osteoblast cell activity in magnesium-conditioned media.</title><secondary-title>Analytical and bioanalytical chemistry</secondary-title></titles><periodical><full-title>Analytical and bioanalytical chemistry</full-title></periodical><pages>3009-3015</pages><volume>396</volume><issue>8</issue><keywords><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Conditioned</keyword><keyword>Culture Media</keyword><keyword>Electric Impedance</keyword><keyword>Electrochemical Techniques</keyword><keyword>Electrochemical Techniques: methods</keyword><keyword>Electrodes</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Magnesium</keyword><keyword>Magnesium: metabolism</keyword><keyword>Osteoblasts</keyword><keyword>Osteoblasts: chemistry</keyword><keyword>Osteoblasts: cytology</keyword><keyword>Osteoblasts: metabolism</keyword><keyword>Tumor</keyword></keywords><dates><year>2010</year></dates><accession-num>20213174</accession-num><electronic-resource-num>10.1007/s00216-010-3521-2</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20213174</url></web-urls></urls><label>ECIS Attachment</label><abstract>Magnesium (Mg) as a biodegradable metal has potential advantages as an implant material. This paper studies the effect of magnesium ions on osteoblast (U2-OS) behavior since magnesium implants mainly dissolve as divalent magnesium ions (Mg(2+)). A real-time monitoring technique based on electric cell-substrate impedance sensing (ECIS) was used for measuring cell proliferation, migration, adhesion, and cytotoxicity in magnesium-conditioned media. The impedance results show that U2-OS proliferation and adhesion were inhibited in not only a magnesium-free medium but also in a medium with a high concentration of magnesium. The impedance method produced more sensitive results than the output of an MTT assay. Other standard bioanalytical tests were conducted for comparison with the ECIS method. Immunochemistry was carried out to study cell adhesion in magnesium-conditioned media by staining using F-actin and alpha-tubulin and correlated cell density on the electrode with impedance. Bone tissue formation was studied using von Kossa staining and indicated the mineralization level of cells in magnesium-conditioned media decreased with the increase of magnesium ion concentration. Real-time PCR provided gene expression indicators of cell growth, apoptosis, inflammation, and migration. Compared to the bioanalytical methods of immunochemistry and MTT assays, which need preparation time and post-washing step, ECIS was able to measure cell activity in real time without any cell culture modification. In summary, ECIS might be an effective way to study biodegradable magnesium implants.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Scott, Clay W</author><author>Peters, Matthew F</author></authors></contributors><titles><title>Label-free whole-cell assays: expanding the scope of GPCR screening.</title><secondary-title>Drug discovery today</secondary-title></titles><periodical><full-title>Drug discovery today</full-title></periodical><pages>704-716</pages><volume>15</volume><issue>17-18</issue><keywords><keyword>Animals</keyword><keyword>Biological Assay</keyword><keyword>Biological Assay: instrumentation</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Drug Discovery</keyword><keyword>Drug Discovery: instrumentation</keyword><keyword>Drug Discovery: methods</keyword><keyword>G-Protein-Coupled</keyword><keyword>G-Protein-Coupled: drug effects</keyword><keyword>Humans</keyword><keyword>Receptors</keyword></keywords><dates><year>2010</year></dates><accession-num>20601093</accession-num><electronic-resource-num>10.1016/j.drudis.2010.06.008</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20601093</url></web-urls></urls><abstract>A new class of instruments offers an unprecedented combination of label-free detection with exquisite sensitivity to live-cell responses. These instruments can quantify G-protein-coupled receptor (GPCR) signaling through G(s), G(i) and G(q) pathways and in some cases distinguish G-protein coupling, with sensitivity high enough to detect endogenous receptors. Here, we review emerging data evaluating impedance- and optical-based label-free instruments for GPCR drug discovery. In comparison with traditional GPCR assays, we highlight strengths, weaknesses and future opportunities for label-free biosensors. The ability to qualitatively distinguish G-protein coupling has groundbreaking potential for assessing functional selectivity, a concept that is changing the way GPCR pharmacology is defined and screening strategies are designed.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiao, Caide</author><author>Luong, John H T</author><author>Xiaoa, Caide</author><author>Luong, John H T</author></authors></contributors><titles><title>A simple mathematical model for electric cell-substrate impedance sensing with extended applications.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>1774-1780</pages><volume>25</volume><issue>7</issue><keywords><keyword>Anti-Bacterial Agents</keyword><keyword>Anti-Bacterial Agents: administration &amp; dosage</keyword><keyword>Antibiotics resistance</keyword><keyword>Bacteria</keyword><keyword>Bacterial Physiological Phenomena</keyword><keyword>Bacterial Physiological Phenomena: drug effects</keyword><keyword>Bacterial Physiological Phenomena: radiation effec</keyword><keyword>Biological</keyword><keyword>Biological Assay</keyword><keyword>Biological Assay: instrumentation</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Computer Simulation</keyword><keyword>Computer-Aided Design</keyword><keyword>Conductometry</keyword><keyword>Conductometry: instrumentation</keyword><keyword>Conductometry: methods</keyword><keyword>Doubling time</keyword><keyword>Electric cell-substrate impedance sensing</keyword><keyword>Electromagnetic Fields</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Ferri/ferrocyanide</keyword><keyword>Impedance</keyword><keyword>Impedance: instrumentation</keyword><keyword>L-Cysteine</keyword><keyword>Mathematical model</keyword><keyword>Models</keyword><keyword>Plethysmography</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2010</year></dates><publisher>Elsevier B.V.</publisher><accession-num>20096558</accession-num><electronic-resource-num>10.1016/j.bios.2009.12.025</electronic-resource-num><notes>From Duplicate 1 (A simple mathematical model for electric cell-substrate impedance sensing with extended applications - Xiaoa, Caide; Luong, John H T)

From Duplicate 1 ( A simple mathematical model for electric cell-substrate impedance sensing with extended applications. - Xiao, Caide; Luong, John H T )



From Duplicate 2 ( A simple mathematical model for electric cell-substrate impedance sensing with extended applications. - Xiao, Caide; Luong, John H T )</notes><research-notes>From Duplicate 1 (A simple mathematical model for electric cell-substrate impedance sensing with extended applications - Xiaoa, Caide; Luong, John H T)

From Duplicate 1 ( A simple mathematical model for electric cell-substrate impedance sensing with extended applications. - Xiao, Caide; Luong, John H T )



From Duplicate 2 ( A simple mathematical model for electric cell-substrate impedance sensing with extended applications. - Xiao, Caide; Luong, John H T )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20096558</url></web-urls></urls><label>ECIS Modeling</label><abstract>This paper presents a simple mathematical model to predict the impedance data acquired by electric cell-substrate impedance sensing (ECIS) at frequencies between 25 Hz and 60 kHz. With this model, the equivalent resistance (R) and capacitance (C) of biological samples adhered on gold surfaces could be more precisely measured at 4 kHz. ECIS applications were extended for real-time monitoring of living bacteria cultivated in Luria Bertani (LB) culture medium by two different approaches. In the former, we used a ferri/ferrocyanide redox couple in LB medium as an indicator for bacterial multiplication. Because the redox couple was toxic to some bacteria, we developed a second approach, in which l-cysteine self-assembled monolayers (SAM) on gold electrodes were used to detect living bacteria. The l-cysteine SAM could also be detected by ECIS. Unlike traditional impedance microbiological methods which need special culture media with low ions, our procedures significantly enhanced signal/noise ratios so bacteria could be detected in general purpose culture media. It was easy and convenient to obtain bacterial doubling times and evaluate the resistance of bacteria to antibiotics from ECIS spectra.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Heijink, I H</author><author>van Oosterhout, A</author><author>Kapus, A</author></authors></contributors><titles><title>Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction.</title><secondary-title>The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology</secondary-title></titles><periodical><full-title>The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology</full-title></periodical><pages>1016-1026</pages><volume>36</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Bronchi</keyword><keyword>Bronchi: cytology</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cell Communication</keyword><keyword>Cell Communication: immunology</keyword><keyword>Cell Line</keyword><keyword>Electroporation</keyword><keyword>Epidermal Growth Factor</keyword><keyword>Epidermal Growth Factor: immunology</keyword><keyword>Epidermal Growth Factor: metabolism</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: immunology</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Permeability</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Pyroglyphidae</keyword><keyword>Pyroglyphidae: immunology</keyword><keyword>Receptor</keyword><keyword>Respiratory Mucosa</keyword><keyword>Respiratory Mucosa: cytology</keyword><keyword>Respiratory Mucosa: immunology</keyword><keyword>Respiratory Mucosa: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: immunology</keyword><keyword>Transforming Growth Factor beta</keyword><keyword>Transforming Growth Factor beta: metabolism</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: physiology</keyword><keyword>Zonula Occludens-1 Protein</keyword></keywords><dates><year>2010</year></dates><accession-num>20351035</accession-num><electronic-resource-num>10.1183/09031936.00125809</electronic-resource-num><notes>From Duplicate 1 (Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. - Heijink, I H; van Oosterhout, A; Kapus, A)

From Duplicate 1 ( Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. - Heijink, I H; van Oosterhout, A; Kapus, A )



From Duplicate 2 ( Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. - Heijink, I H; van Oosterhout, A; Kapus, A )




From Duplicate 2 ( 

Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction.

- Heijink, I H; van Oosterhout, A; Kapus, A )</notes><research-notes>From Duplicate 1 (Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. - Heijink, I H; van Oosterhout, A; Kapus, A)

From Duplicate 1 ( Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. - Heijink, I H; van Oosterhout, A; Kapus, A )



From Duplicate 2 ( Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction. - Heijink, I H; van Oosterhout, A; Kapus, A )




From Duplicate 2 ( 

Epidermal growth factor receptor signalling contributes to house dust mite-induced epithelial barrier dysfunction.

- Heijink, I H; van Oosterhout, A; Kapus, A )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20351035</url></web-urls></urls><label>ECIS Migration;ECIS TEER;Signal Transduction;Wound Healing</label><abstract>Impaired airway epithelial barrier function has emerged as a key factor in the pathogenesis of allergic asthma. We aimed to discern the involvement of the epidermal growth factor receptor (EGFR) in allergen-induced epithelial barrier impairment, as we previously observed that house dust mite (HDM) signals through EGFR. We investigated the junctional integrity of human bronchial epithelial cells using electric cell-substrate impedance sensing and immunofluorescent staining. HDM induced a rapid, transient fall in epithelial resistance, concomitant with delocalisation of E-cadherin and zona occludens (ZO)-1, and proteolytic cleavage of the latter. EGFR inhibition by AG1478 reduced the HDM-triggered decrease in epithelial resistance and improved restoration of epithelial junctions. Similarly, AG1478 increased epithelial barrier recovery upon electroporation-induced injury, although it delayed the migration phase of the wound healing response. HDM-promoted redistribution of E-cadherin was mediated via EGFR-dependent activation of protease-activated receptor (PAR)-2, while the concomitant ZO-1 degradation was PAR-2/EGFR-independent. Importantly, the fibrogenic cytokine transforming growth factor (TGF)-β prolonged HDM-induced EGFR phosphorylation and inhibited ligand-induced EGFR internalisation/degradation, which resulted in sustained E-cadherin and ZO-1 redistribution. Thus, allergen-induced, PAR-2/EGFR-mediated signalling decreases epithelial resistance and promotes junction disassembly. The TGF-β-enhanced EGFR signalling may be an important contributor to barrier dysfunction and increased epithelial vulnerability in response to HDM.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van Duijn, Trynette J</author><author>Anthony, Eloise C</author><author>Hensbergen, Paul J</author><author>Deelder, André M</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>Rac1 recruits the adapter protein CMS/CD2AP to cell-cell contacts.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>20137-20146</pages><volume>285</volume><issue>26</issue><keywords><keyword>Adaptor Proteins</keyword><keyword>Binding Sites</keyword><keyword>Binding Sites: genetics</keyword><keyword>Blotting</keyword><keyword>CapZ Actin Capping Protein</keyword><keyword>CapZ Actin Capping Protein: genetics</keyword><keyword>CapZ Actin Capping Protein: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Communication</keyword><keyword>Cell Line</keyword><keyword>Cortactin</keyword><keyword>Cortactin: genetics</keyword><keyword>Cortactin: metabolism</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: genetics</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Green Fluorescent Proteins</keyword><keyword>Green Fluorescent Proteins: genetics</keyword><keyword>Green Fluorescent Proteins: metabolism</keyword><keyword>HeLa Cells</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Mutation</keyword><keyword>Protein Binding</keyword><keyword>Protein Interaction Mapping</keyword><keyword>RNA Interference</keyword><keyword>Signal Transducing</keyword><keyword>Signal Transducing: genetics</keyword><keyword>Signal Transducing: metabolism</keyword><keyword>Transfection</keyword><keyword>Tumor</keyword><keyword>Western</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: genetics</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword><keyword>src Homology Domains</keyword></keywords><dates><year>2010</year></dates><accession-num>20404345</accession-num><electronic-resource-num>10.1074/jbc.M109.099481</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2888426&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>Rac1 is a member of the Rho family of small GTPases, which regulate cell adhesion and migration through their control of the actin cytoskeleton. Rho-GTPases are structurally very similar, with the exception of a hypervariable domain in the C terminus. Using peptide-based pulldown assays in combination with mass spectrometry, we previously showed that the hypervariable domain in Rac1 mediates specific protein-protein interactions. Most recently, we found that the Rac1 C terminus associates to the ubiquitously expressed adapter protein CMS/CD2AP. CD2AP is critical for the formation and maintenance of a specialized cell-cell contact between kidney podocyte foot processes, the slit diaphragm. Here, CD2AP links the cell adhesion protein nephrin to the actin cytoskeleton. In addition, CMS/CD2AP binds actin-regulating proteins, such as CAPZ and cortactin, and has been implicated in the internalization of growth factor receptors. We found that CD2AP specifically interacts with the C-terminal domain of Rac1 but not with that of other Rho family members. Efficient interaction between Rac1 and CD2AP requires both the proline-rich domain and the poly-basic region in the Rac1 C terminus, and at least two of the three N-terminal SH3 domains of CD2AP. CD2AP co-localizes with Rac1 to membrane ruffles, and small interfering RNA-based experiments showed that CD2AP links Rac1 to CAPZ and cortactin. Finally, expression of constitutive active Rac1 recruits CD2AP to cell-cell contacts in epithelial cells, where we found CD2AP to participate in the control of the epithelial barrier function. These data identify CD2AP as a novel Rac1-associated adapter protein that participates in the regulation of epithelial cell-cell contact.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Huppert, Jula</author><author>Closhen, Dorothea</author><author>Croxford, Andrew</author><author>White, Robin</author><author>Kulig, Paulina</author><author>Pietrowski, Eweline</author><author>Bechmann, Ingo</author><author>Becher, Burkhard</author><author>Luhmann, Heiko J</author><author>Waisman, Ari</author><author>Kuhlmann, Christoph R W</author></authors></contributors><titles><title>Cellular mechanisms of IL-17-induced blood-brain barrier disruption.</title><secondary-title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</secondary-title></titles><periodical><full-title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</full-title></periodical><pages>1023-1034</pages><volume>24</volume><issue>4</issue><keywords><keyword>Animals</keyword><keyword>Antibodies</keyword><keyword>Autoimmune</keyword><keyword>Azepines</keyword><keyword>Azepines: pharmacology</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: immunology</keyword><keyword>Blood-Brain Barrier: metabolism</keyword><keyword>Blood-Brain Barrier: pathology</keyword><keyword>Cell Line</keyword><keyword>Down-Regulation</keyword><keyword>Down-Regulation: drug effects</keyword><keyword>Down-Regulation: immunology</keyword><keyword>Encephalomyelitis</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: immunology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Experimental</keyword><keyword>Experimental: immun</keyword><keyword>Experimental: immunology</keyword><keyword>Experimental: metab</keyword><keyword>Experimental: metabolism</keyword><keyword>Experimental: patho</keyword><keyword>Experimental: pathology</keyword><keyword>Helper-Inducer</keyword><keyword>Helper-Inducer: immunology</keyword><keyword>Helper-Inducer: metabolism</keyword><keyword>Helper-Inducer: pathology</keyword><keyword>Inbred BALB C</keyword><keyword>Interleukin-17</keyword><keyword>Interleukin-17: antagonists &amp; inhibitors</keyword><keyword>Interleukin-17: immunology</keyword><keyword>Interleukin-17: metabolism</keyword><keyword>Interleukin-17: pharmacology</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: immunology</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Mice</keyword><keyword>Myosin-Light-Chain Kinase</keyword><keyword>NADPH Oxidase</keyword><keyword>NADPH Oxidase: immunology</keyword><keyword>NADPH Oxidase: metabolism</keyword><keyword>Naphthalenes</keyword><keyword>Naphthalenes: pharmacology</keyword><keyword>Neutralizing</keyword><keyword>Neutralizing: immunology</keyword><keyword>Neutralizing: pharmacology</keyword><keyword>Occludin</keyword><keyword>Oxidative Stress</keyword><keyword>Oxidative Stress: drug effects</keyword><keyword>Oxidative Stress: immunology</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reactive Oxygen Species: immunology</keyword><keyword>Reactive Oxygen Species: metabolism</keyword><keyword>T-Lymphocytes</keyword><keyword>Transformed</keyword><keyword>Xanthine Oxidase</keyword><keyword>Xanthine Oxidase: immunology</keyword><keyword>Xanthine Oxidase: metabolism</keyword><keyword>multiple sclerosis</keyword><keyword>neuroinflammation</keyword><keyword>reactive</keyword></keywords><dates><year>2010</year></dates><accession-num>19940258</accession-num><electronic-resource-num>10.1096/fj.09-141978</electronic-resource-num><notes>From Duplicate 1 (Cellular mechanisms of IL-17-induced blood-brain barrier disruption. - Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W)

From Duplicate 1 ( Cellular mechanisms of IL-17-induced blood-brain barrier disruption. - Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )



From Duplicate 2 ( Cellular mechanisms of IL-17-induced blood-brain barrier disruption. - Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )


From Duplicate 2 (Cellular mechanisms of IL-17-induced blood-brain barrier disruption. - Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W)

From Duplicate 3 ( 

Cellular mechanisms of IL-17-induced blood-brain barrier disruption.

- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )




From Duplicate 1 ( 


Cellular mechanisms of IL-17-induced blood-brain barrier disruption


- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )
And Duplicate 2 ( 


Cellular mechanisms of IL-17-induced blood-brain barrier disruption.


- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )








From Duplicate 3 ( 


Cellular mechanisms of IL-17-induced blood-brain barrier disruption.


- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )




From Duplicate 2 ( 


Cellular mechanisms of IL-17-induced blood-brain barrier disruption.


- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )</notes><research-notes>From Duplicate 1 (Cellular mechanisms of IL-17-induced blood-brain barrier disruption. - Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W)

From Duplicate 1 ( Cellular mechanisms of IL-17-induced blood-brain barrier disruption. - Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )



From Duplicate 2 ( Cellular mechanisms of IL-17-induced blood-brain barrier disruption. - Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )


From Duplicate 2 (Cellular mechanisms of IL-17-induced blood-brain barrier disruption. - Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W)

From Duplicate 3 ( 

Cellular mechanisms of IL-17-induced blood-brain barrier disruption.

- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )




From Duplicate 1 ( 


Cellular mechanisms of IL-17-induced blood-brain barrier disruption


- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )
And Duplicate 2 ( 


Cellular mechanisms of IL-17-induced blood-brain barrier disruption.


- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )








From Duplicate 3 ( 


Cellular mechanisms of IL-17-induced blood-brain barrier disruption.


- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )




From Duplicate 2 ( 


Cellular mechanisms of IL-17-induced blood-brain barrier disruption.


- Huppert, Jula; Closhen, Dorothea; Croxford, Andrew; White, Robin; Kulig, Paulina; Pietrowski, Eweline; Bechmann, Ingo; Becher, Burkhard; Luhmann, Heiko J; Waisman, Ari; Kuhlmann, Christoph R W )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19940258</url></web-urls></urls><label>Blood Brain Barrier;ECIS TEER</label><abstract>Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to examine the mechanisms that underlie IL-17A-induced BBB breakdown. Barrier integrity was analyzed in the murine brain endothelial cell line bEnd.3 by measuring the electrical resistance values using electrical call impedance sensing technology. Furthermore, in-cell Western blots, fluorescence imaging, and monocyte adhesion and transendothelial migration assays were performed. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice. IL-17A induced NADPH oxidase- or xanthine oxidase-dependent reactive oxygen species (ROS) production. The resulting oxidative stress activated the endothelial contractile machinery, which was accompanied by a down-regulation of the tight junction molecule occludin. Blocking either ROS formation or myosin light chain phosphorylation or applying IL-17A-neutralizing antibodies prevented IL-17A-induced BBB disruption. Treatment of mice with EAE using ML-7, an inhibitor of the myosin light chain kinase, resulted in less BBB disruption at the spinal cord and less infiltration of lymphocytes via the BBB and subsequently reduced the clinical characteristics of EAE. These observations indicate that IL-17A accounts for a crucial step in the development of EAE by impairing the integrity of the BBB, involving augmented production of ROS.-Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., Kuhlmann, C. R. W. Cellular mechanisms of IL-17-induced blood-brain barrier disruption.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Adam, Alejandro P</author><author>Sharenko, Amy L</author><author>Pumiglia, Kevin</author><author>Vincent, Peter A</author></authors></contributors><titles><title>Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>7045-7055</pages><volume>285</volume><issue>10</issue><keywords><keyword>Adenoviridae</keyword><keyword>Adenoviridae: genetics</keyword><keyword>Adenoviridae: metabolism</keyword><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>CD: genetics</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: genetics</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Humans</keyword><keyword>Phosphorylation</keyword><keyword>RNA</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Small Interfering: metabolism</keyword><keyword>Tyrosine</keyword><keyword>Tyrosine: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: metabolism</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>beta Catenin</keyword><keyword>beta Catenin: metabolism</keyword><keyword>p120 GTPase Activating Protein</keyword><keyword>p120 GTPase Activating Protein: metabolism</keyword><keyword>src-Family Kinases</keyword><keyword>src-Family Kinases: genetics</keyword><keyword>src-Family Kinases: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20048167</accession-num><electronic-resource-num>10.1074/jbc.M109.079277</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2844154&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Activation of Src family kinases (SFK) and the subsequent phosphorylation of VE-cadherin have been proposed as major regulatory steps leading to increases in vascular permeability in response to inflammatory mediators and growth factors. To investigate Src signaling in the absence of parallel signaling pathways initiated by growth factors or inflammatory mediators, we activated Src and SFKs by expression of dominant negative Csk, expression of constitutively active Src, or knockdown of Csk. Activation of SFK by overexpression of dominant negative Csk induced VE-cadherin phosphorylation at tyrosines 658, 685, and 731. However, dominant negative Csk expression was unable to induce changes in the monolayer permeability. In contrast, expression of constitutively active Src decreased barrier function and promoted VE-cadherin phosphorylation on tyrosines 658 and 731, although the increase in VE-cadherin phosphorylation preceded the increase in permeability by 4-6 h. Csk knockdown induced VE-cadherin phosphorylation at sites 658 and 731 but did not induce a loss in barrier function. Co-immunoprecipitation and immunofluorescence studies suggest that phosphorylation of those sites did not impair VE-cadherin ability to bind p120 and beta-catenin or the ability of these proteins to localize at the plasma membrane. Taken together, our data show that Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to promote an increase in endothelial cell monolayer permeability and suggest that signaling leading to changes in vascular permeability in response to inflammatory mediators or growth factors may require VE-cadherin tyrosine phosphorylation concurrently with other signaling pathways to promote loss of barrier function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cain, Robert J</author><author>Vanhaesebroeck, Bart</author><author>Ridley, Anne J</author></authors></contributors><titles><title>The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1.</title><secondary-title>The Journal of cell biology</secondary-title></titles><periodical><full-title>The Journal of cell biology</full-title></periodical><pages>863-876</pages><volume>188</volume><issue>6</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Focal Adhesion Kinase 2</keyword><keyword>Focal Adhesion Kinase 2: metabolism</keyword><keyword>Humans</keyword><keyword>Isoenzymes</keyword><keyword>Isoenzymes: metabolism</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: metabolism</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20308428</accession-num><electronic-resource-num>10.1083/jcb.200907135</electronic-resource-num><notes>From Duplicate 2 (The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. - Cain, Robert J; Vanhaesebroeck, Bart; Ridley, Anne J)

From Duplicate 1 ( The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. - Cain, Robert J; Vanhaesebroeck, Bart; Ridley, Anne J )



From Duplicate 2 ( The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. - Cain, Robert J; Vanhaesebroeck, Bart; Ridley, Anne J )</notes><research-notes>From Duplicate 2 (The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. - Cain, Robert J; Vanhaesebroeck, Bart; Ridley, Anne J)

From Duplicate 1 ( The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. - Cain, Robert J; Vanhaesebroeck, Bart; Ridley, Anne J )



From Duplicate 2 ( The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. - Cain, Robert J; Vanhaesebroeck, Bart; Ridley, Anne J )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2845076&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Endothelial cell-cell junctions control efflux of small molecules and leukocyte transendothelial migration (TEM) between blood and tissues. Inhibitors of phosphoinositide 3-kinases (PI3Ks) increase endothelial barrier function, but the roles of different PI3K isoforms have not been addressed. In this study, we determine the contribution of each of the four class I PI3K isoforms (p110alpha, -beta, -gamma, and -delta) to endothelial permeability and leukocyte TEM. We find that depletion of p110alpha but not other p110 isoforms decreases TNF-induced endothelial permeability, Tyr phosphorylation of the adherens junction protein vascular endothelial cadherin (VE-cadherin), and leukocyte TEM. p110alpha selectively mediates activation of the Tyr kinase Pyk2 and GTPase Rac1 to regulate barrier function. Additionally, p110alpha mediates the association of VE-cadherin with Pyk2, the Rac guanine nucleotide exchange factor Tiam-1 and the p85 regulatory subunit of PI3K. We propose that p110alpha regulates endothelial barrier function by inducing the formation of a VE-cadherin-associated protein complex that coordinates changes to adherens junctions with the actin cytoskeleton.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hynes, Anne</author><author>Mohanraj, Bhavana</author><author>Schiele, Nate</author><author>Corr, David T</author><author>Plopper, George E</author><author>Dinu, Cerasela Zoica</author><author>Chrisey, Douglas B</author></authors></contributors><titles><title>Cell-Based Detection of Bacillus Cereus Anthrax Simulant Using Cell Impedance Sensing</title><secondary-title>Sensor Letters</secondary-title></titles><periodical><full-title>Sensor Letters</full-title></periodical><pages>528-533</pages><volume>8</volume><issue>3</issue><keywords/><dates><year>2010</year></dates><electronic-resource-num>10.1166/sl.2010.1306</electronic-resource-num><urls><web-urls><url>http://openurl.ingenta.com/content/xref?genre=article&amp;issn=1546-198X&amp;volume=8&amp;issue=3&amp;spage=528</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chung, Seok</author><author>Sudo, Ryo</author><author>Vickerman, Vernella</author><author>Zervantonakis, Ioannis K</author><author>Kamm, Roger D</author></authors></contributors><titles><title>Microfluidic Platforms for Studies of Angiogenesis, Cell Migration, and Cell–Cell Interactions</title><secondary-title>Annals of Biomedical Engineering</secondary-title></titles><periodical><full-title>Annals of Biomedical Engineering</full-title></periodical><pages>1164-1177</pages><volume>38</volume><issue>3</issue><keywords><keyword>Cancer</keyword><keyword>Cell culture</keyword><keyword>Liver</keyword><keyword>Tissue engineering</keyword><keyword>Vascular networks</keyword></keywords><dates><year>2010</year></dates><electronic-resource-num>10.1007/s10439-010-9899-3</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s10439-010-9899-3</url></web-urls></urls><abstract>Recent advances in microfluidic technologies have opened the door for creating more realistic in vitro cell culture methods that replicate many aspects of the true in vivo microenvironment. These new designs (i) provide enormous flexibility in controlling the critical biochemical and biomechanical factors that influence cell behavior, (ii) allow for the introduction of multiple cell types in a single system, (iii) provide for the establishment of biochemical gradients in two- or three-dimensional geometries, and (iv) allow for high quality, time-lapse imaging. Here, some of the recent developments are reviewed, with a focus on studies from our own laboratory in three separate areas: angiogenesis, cell migration in the context of tumor cell-endothelial interactions, and liver tissue engineering.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hsu, Chih-Chin</author><author>Tsai, Wen-Chung</author><author>Chen, Carl Pai-Chu</author><author>Lu, Yun-Mei</author><author>Wang, Jong-Shyan</author></authors></contributors><titles><title>Effects of negative pressures on epithelial tight junctions and migration in wound healing.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C528-34</pages><volume>299</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Dogs</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Humans</keyword><keyword>Keratinocytes</keyword><keyword>Keratinocytes: cytology</keyword><keyword>Keratinocytes: physiology</keyword><keyword>Negative-Pressure Wound Therapy</keyword><keyword>Negative-Pressure Wound Therapy: methods</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: physiology</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: physiology</keyword></keywords><dates><year>2010</year></dates><accession-num>20445172</accession-num><electronic-resource-num>10.1152/ajpcell.00504.2009</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20445172</url></web-urls></urls><label>ECIS Migration;Wound Healing</label><abstract>Negative-pressure wound therapy has recently gained popularity in chronic wound care. This study attempted to explore effects of different negative pressures on epithelial migration in the wound-healing process. The electric cell-substrate impedance sensing (ECIS) technique was used to create a 5 x 10(-4) cm(2) wound in the Madin-Darby canine kidney (MDCK) and human keratinocyte (HaCaT) cells. The wounded cells were cultured in a negative pressure incubator at ambient pressure (AP) and negative pressures of 75 mmHg (NP(75)), 125 mmHg (NP(125)), and 175 mmHg (NP(175)). The effective time (ET), complete wound healing time (T(max)), healing rate (R(heal)), cell diameter, and wound area over time at different pressures were evaluated. Traditional wound-healing assays were prepared for fluorescent staining of cells viability, cell junction proteins, including ZO-1 and E-cadherin, and actins. Amount of cell junction proteins at AP and NP(125) was also quantified. In MDCK cells, the ET (1.25 +/- 0.27 h), T(max) (1.76 +/- 0.32 h), and R(heal) (2.94 +/- 0.62 x 10(-4) cm(2)/h) at NP(125) were significantly (P &lt; 0.01) different from those at three other pressure conditions. In HaCaT cells, the T(max) (7.34 +/- 0.29 h) and R(heal) (6.82 +/- 0.26 x 10(-5) cm(2)/h) at NP(125) were significantly (P &lt; 0.01) different from those at NP(75). Prominent cell migration features were identified in cells at the specific negative pressure. Cell migration activities at different pressures can be documented with the real-time wound-healing measurement system. Negative pressure of 125 mmHg can help disassemble the cell junction to enhance epithelial migration and subsequently result in quick wound closure.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Cavet, M E</author><author>VanDerMeid, K R</author><author>Harrington, K L</author><author>Tchao, R</author><author>Ward, K W</author><author>Zhang, J-Z</author></authors></contributors><titles><title>Effect of a novel multipurpose contact lens solution on human corneal epithelial barrier function.</title><secondary-title>Contact lens &amp; anterior eye : the journal of the British Contact Lens Association</secondary-title></titles><periodical><full-title>Contact lens &amp; anterior eye : the journal of the British Contact Lens Association</full-title></periodical><pages>S18-23</pages><volume>33 Suppl 1</volume><keywords><keyword>Cells</keyword><keyword>Contact Lens Solutions</keyword><keyword>Contact Lens Solutions: pharmacology</keyword><keyword>Corneal</keyword><keyword>Corneal: cytology</keyword><keyword>Corneal: drug effects</keyword><keyword>Corneal: physiology</keyword><keyword>Cultured</keyword><keyword>Epithelium</keyword><keyword>Humans</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: drug effects</keyword><keyword>Tight Junctions: physiology</keyword><keyword>Tight Junctions: ultrastructure</keyword></keywords><dates><year>2010</year></dates><accession-num>21051274</accession-num><electronic-resource-num>10.1016/j.clae.2010.06.012</electronic-resource-num><notes>From Duplicate 1 (Effect of a novel multipurpose contact lens solution on human corneal epithelial barrier function. - Cavet, M E; VanDerMeid, K R; Harrington, K L; Tchao, R; Ward, K W; Zhang, J-Z)

From Duplicate 1 ( Effect of a novel multipurpose contact lens solution on human corneal epithelial barrier function. - Cavet, M E; VanDerMeid, K R; Harrington, K L; Tchao, R; Ward, K W; Zhang, J-Z )



From Duplicate 2 ( Effect of a novel multipurpose contact lens solution on human corneal epithelial barrier function. - Cavet, M E; VanDerMeid, K R; Harrington, K L; Tchao, R; Ward, K W; Zhang, J-Z )</notes><research-notes>From Duplicate 1 (Effect of a novel multipurpose contact lens solution on human corneal epithelial barrier function. - Cavet, M E; VanDerMeid, K R; Harrington, K L; Tchao, R; Ward, K W; Zhang, J-Z)

From Duplicate 1 ( Effect of a novel multipurpose contact lens solution on human corneal epithelial barrier function. - Cavet, M E; VanDerMeid, K R; Harrington, K L; Tchao, R; Ward, K W; Zhang, J-Z )



From Duplicate 2 ( Effect of a novel multipurpose contact lens solution on human corneal epithelial barrier function. - Cavet, M E; VanDerMeid, K R; Harrington, K L; Tchao, R; Ward, K W; Zhang, J-Z )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/21051274</url></web-urls></urls><label>ECIS TEER</label><abstract>To explore the effect of a novel multipurpose contact lens solution (MPS) on the junction protein distribution and barrier function of cultured human corneal epithelial cell monolayers.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lembo, Annalisa</author><author>Gurney, Michael a</author><author>Burnside, Kellie</author><author>Banerjee, Anirban</author><author>de los Reyes, Melissa</author><author>Connelly, James E</author><author>Lin, Wan-Jung</author><author>Jewell, Kelsea a</author><author>Vo, Anthony</author><author>Renken, Christian W</author><author>Doran, Kelly S</author><author>Rajagopal, Lakshmi</author></authors></contributors><titles><title>Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration.</title><secondary-title>Molecular microbiology</secondary-title></titles><periodical><full-title>Molecular microbiology</full-title></periodical><pages>431-443</pages><volume>77</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Bacterial</keyword><keyword>Bacterial Proteins</keyword><keyword>Bacterial Proteins: genetics</keyword><keyword>Bacterial Proteins: metabolism</keyword><keyword>Bacterial: genetics</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: microbiology</keyword><keyword>Cell Line</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Post-Translational</keyword><keyword>Protein Processing</keyword><keyword>RNA</keyword><keyword>Repressor Proteins</keyword><keyword>Repressor Proteins: genetics</keyword><keyword>Repressor Proteins: metabolism</keyword><keyword>Sepsis</keyword><keyword>Sepsis: microbiology</keyword><keyword>Streptococcal Infections</keyword><keyword>Streptococcal Infections: microbiology</keyword><keyword>Streptococcus agalactiae</keyword><keyword>Streptococcus agalactiae: genetics</keyword><keyword>Streptococcus agalactiae: metabolism</keyword><keyword>Streptococcus agalactiae: pathogenicity</keyword><keyword>Virulence Factors</keyword><keyword>Virulence Factors: genetics</keyword><keyword>Virulence Factors: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20497331</accession-num><electronic-resource-num>10.1111/j.1365-2958.2010.07215.x</electronic-resource-num><notes>From Duplicate 1 (Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. - Lembo, Annalisa; Gurney, Michael a; Burnside, Kellie; Banerjee, Anirban; de los Reyes, Melissa; Connelly, James E; Lin, Wan-Jung; Jewell, Kelsea a; Vo, Anthony; Renken, Christian W; Doran, Kelly S; Rajagopal, Lakshmi)

From Duplicate 1 ( Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. - Lembo, Annalisa; Gurney, Michael a; Burnside, Kellie; Banerjee, Anirban; de los Reyes, Melissa; Connelly, James E; Lin, Wan-Jung; Jewell, Kelsea a; Vo, Anthony; Renken, Christian W; Doran, Kelly S; Rajagopal, Lakshmi )



From Duplicate 2 ( Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. - Lembo, Annalisa; Gurney, Michael a; Burnside, Kellie; Banerjee, Anirban; de los Reyes, Melissa; Connelly, James E; Lin, Wan-Jung; Jewell, Kelsea a; Vo, Anthony; Renken, Christian W; Doran, Kelly S; Rajagopal, Lakshmi )</notes><research-notes>From Duplicate 1 (Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. - Lembo, Annalisa; Gurney, Michael a; Burnside, Kellie; Banerjee, Anirban; de los Reyes, Melissa; Connelly, James E; Lin, Wan-Jung; Jewell, Kelsea a; Vo, Anthony; Renken, Christian W; Doran, Kelly S; Rajagopal, Lakshmi)

From Duplicate 1 ( Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. - Lembo, Annalisa; Gurney, Michael a; Burnside, Kellie; Banerjee, Anirban; de los Reyes, Melissa; Connelly, James E; Lin, Wan-Jung; Jewell, Kelsea a; Vo, Anthony; Renken, Christian W; Doran, Kelly S; Rajagopal, Lakshmi )



From Duplicate 2 ( Regulation of CovR expression in Group B Streptococcus impacts blood-brain barrier penetration. - Lembo, Annalisa; Gurney, Michael a; Burnside, Kellie; Banerjee, Anirban; de los Reyes, Melissa; Connelly, James E; Lin, Wan-Jung; Jewell, Kelsea a; Vo, Anthony; Renken, Christian W; Doran, Kelly S; Rajagopal, Lakshmi )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2909351&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier;ECIS Invasion;ECIS TEER</label><abstract>Group B Streptococcus (GBS) is an important cause of invasive infections in humans. The pathogen encodes a number of virulence factors including the pluripotent beta-haemolysin/cytolysin (beta-H/C). As GBS has the disposition of both a commensal organism and an invasive pathogen, it is important for the organism to appropriately regulate beta-H/C and other virulence factors in response to the environment. GBS can repress transcription of beta-H/C using the two-component system, CovR/CovS. Recently, we described that the serine/threonine kinase Stk1 can phosphorylate CovR at threonine 65 to relieve repression of beta-H/C. In this study, we show that infection with CovR-deficient GBS strains resulted in increased sepsis. Although CovR-deficient GBS showed decreased ability to invade the brain endothelium in vitro, they were more proficient in induction of permeability and pro-inflammatory signalling pathways in brain endothelium and penetration of the blood-brain barrier (BBB) in vivo. Microarray analysis revealed that CovR positively regulates its own expression and regulates the expression of 153 genes. Collectively, our results suggest that the positive feedback loop which regulates CovR transcription modulates host cell interaction and immune defence and may facilitate the transition of GBS from a commensal organism to a virulent meningeal pathogen.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, Ning</author><author>Sanders, Andrew J</author><author>Ye, Lin</author><author>Kynaston, Howard G</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Expression of vascular endothelial growth inhibitor (VEGI) in human urothelial cancer of the bladder and its effects on the adhesion and migration of bladder cancer cells in vitro.</title><secondary-title>Anticancer research</secondary-title></titles><periodical><full-title>Anticancer research</full-title></periodical><pages>87-95</pages><volume>30</volume><issue>1</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Growth Processes</keyword><keyword>Cell Growth Processes: physiology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Messenger</keyword><keyword>Messenger: biosynthesis</keyword><keyword>Messenger: genetics</keyword><keyword>RNA</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Tumor</keyword><keyword>Tumor Necrosis Factor Ligand Superfamily Member 15</keyword><keyword>Urinary Bladder Neoplasms</keyword><keyword>Urinary Bladder Neoplasms: genetics</keyword><keyword>Urinary Bladder Neoplasms: metabolism</keyword><keyword>Urinary Bladder Neoplasms: pathology</keyword><keyword>Urothelium</keyword><keyword>Urothelium: pathology</keyword></keywords><dates><year>2010</year></dates><accession-num>20150621</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20150621</url></web-urls></urls><label>ECIS Attachment</label><abstract>Vascular endothelial growth inhibitor (VEGI) has been implicated in the regulation of tumour-related vasculature in certain solid tumours. However, its role in urothelial tumours is still unclear. In the present study, the role played by VEGI in urothelial tumours of the bladder was investigated.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Patani, Neill</author><author>Douglas-Jones, Anthony</author><author>Mansel, Robert</author><author>Jiang, Wen G</author><author>Mokbel, Kefah</author></authors></contributors><titles><title>Tumour suppressor function of MDA-7/IL-24 in human breast cancer.</title><secondary-title>Cancer cell international</secondary-title></titles><periodical><full-title>Cancer cell international</full-title></periodical><pages>29</pages><volume>10</volume><keywords/><dates><year>2010</year></dates><accession-num>20735832</accession-num><electronic-resource-num>10.1186/1475-2867-10-29</electronic-resource-num><notes>From Duplicate 1 ( 

Tumour suppressor function of MDA-7/IL-24 in human breast cancer.

- Patani, Neill; Douglas-Jones, Anthony; Mansel, Robert; Jiang, Wen G; Mokbel, Kefah )</notes><research-notes>From Duplicate 1 ( 

Tumour suppressor function of MDA-7/IL-24 in human breast cancer.

- Patani, Neill; Douglas-Jones, Anthony; Mansel, Robert; Jiang, Wen G; Mokbel, Kefah )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2936285&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration</label><abstract>Melanoma differentiation associated gene-7 (MDA-7), also known as interleukin (IL)-24, is a tumour suppressor gene associated with differentiation, growth and apoptosis. However, the mechanisms underlying its anti-neoplastic activity, tumour-specificity and efficacy across a spectrum of human cancers have yet to be fully elucidated. In this study, the biological impact of MDA-7 on the behavior of breast cancer (BC) cells is evaluated. Furthermore, mRNA expression of MDA-7 is assessed in a cohort of women with BC and correlated with established pathological parameters and clinical outcome.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Davies, Simon</author><author>Jiang, Wen G</author></authors></contributors><titles><title>ALCAM , Activated Leukocyte Cell Adhesion Molecule Influences the Aggressive Nature of Breast Cancer Cells , a Potential Connection to Bone Metastasis</title><secondary-title>Anticancer research</secondary-title></titles><periodical><full-title>Anticancer research</full-title></periodical><pages>3-9</pages><volume>30</volume><keywords><keyword>alcam</keyword><keyword>bone metastasis</keyword><keyword>breast cancer</keyword><keyword>cd166</keyword><keyword>cell</keyword></keywords><dates><year>2010</year></dates><notes>From Duplicate 1 (I Epidemiological ALCAM , Activated Leukocyte Cell Adhesion Molecule Influences the Aggressive Nature of Breast Cancer Cells , a Potential Connection to Bone Metastasis - Davies, Simon; Jiang, Wen G)

From Duplicate 1 ( ALCAM , Activated Leukocyte Cell Adhesion Molecule Influences the Aggressive Nature of Breast Cancer Cells , a Potential Connection to Bone Metastasis - Davies, Simon; Jiang, Wen G )



From Duplicate 2 ( I Epidemiological ALCAM , Activated Leukocyte Cell Adhesion Molecule Influences the Aggressive Nature of Breast Cancer Cells , a Potential Connection to Bone Metastasis - Davies, Simon; Jiang, Wen G )</notes><research-notes>From Duplicate 1 (I Epidemiological ALCAM , Activated Leukocyte Cell Adhesion Molecule Influences the Aggressive Nature of Breast Cancer Cells , a Potential Connection to Bone Metastasis - Davies, Simon; Jiang, Wen G)

From Duplicate 1 ( ALCAM , Activated Leukocyte Cell Adhesion Molecule Influences the Aggressive Nature of Breast Cancer Cells , a Potential Connection to Bone Metastasis - Davies, Simon; Jiang, Wen G )



From Duplicate 2 ( I Epidemiological ALCAM , Activated Leukocyte Cell Adhesion Molecule Influences the Aggressive Nature of Breast Cancer Cells , a Potential Connection to Bone Metastasis - Davies, Simon; Jiang, Wen G )</research-notes><urls/><label>ECIS Attachment</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zheng, Xiangjian</author><author>Xu, Chong</author><author>Di Lorenzo, Annarita</author><author>Kleaveland, Benjamin</author><author>Zou, Zhiying</author><author>Seiler, Christoph</author><author>Chen, Mei</author><author>Cheng, Lan</author><author>Xiao, Jiping</author><author>He, Jie</author><author>Pack, Michael A</author><author>Sessa, William C</author><author>Kahn, Mark L</author><author>Lorenzo, Annarita Di</author><author>Kleaveland, Benjamin</author><author>Zou, Zhiying</author><author>Seiler, Christoph</author><author>Chen, Mei</author><author>Cheng, Lan</author><author>Xiao, Jiping</author><author>He, Jie</author><author>Pack, Michael A</author><author>Sessa, William C</author><author>Kahn, Mark L</author><author>Di Lorenzo, Annarita</author><author>Kleaveland, Benjamin</author><author>Zou, Zhiying</author><author>Seiler, Christoph</author><author>Chen, Mei</author><author>Cheng, Lan</author><author>Xiao, Jiping</author><author>He, Jie</author><author>Pack, Michael A</author><author>Sessa, William C</author><author>Kahn, Mark L</author></authors></contributors><titles><title>CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations</title><secondary-title>Zebrafish</secondary-title></titles><periodical><full-title>Zebrafish</full-title></periodical><pages>2795-2804</pages><volume>120</volume><issue>8</issue><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Apoptosis Regulatory Proteins</keyword><keyword>Apoptosis Regulatory Proteins: chemistry</keyword><keyword>Apoptosis Regulatory Proteins: genetics</keyword><keyword>Apoptosis Regulatory Proteins: physiology</keyword><keyword>Cardiovascular System</keyword><keyword>Cardiovascular System: embryology</keyword><keyword>Cavernous</keyword><keyword>Central Nervous System</keyword><keyword>Central Nervous System: etiology</keyword><keyword>Conserved Sequence</keyword><keyword>Hemangioma</keyword><keyword>Humans</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Intracellular Signaling Peptides and Proteins: phy</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: chemistry</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Membrane Proteins: physiology</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Microtubule-Associated Proteins</keyword><keyword>Microtubule-Associated Proteins: physiology</keyword><keyword>Molecular Sequence Data</keyword><keyword>Phosphorylation</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: physiology</keyword><keyword>Proto-Oncogene Proteins</keyword><keyword>Proto-Oncogene Proteins: chemistry</keyword><keyword>Proto-Oncogene Proteins: genetics</keyword><keyword>Proto-Oncogene Proteins: physiology</keyword><keyword>Sequence Alignment</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Zebrafish</keyword><keyword>Zebrafish Proteins</keyword><keyword>Zebrafish Proteins: chemistry</keyword><keyword>Zebrafish Proteins: genetics</keyword><keyword>Zebrafish Proteins: physiology</keyword></keywords><dates><year>2010</year></dates><accession-num>20592472</accession-num><electronic-resource-num>10.1172/JCI39679</electronic-resource-num><notes>From Duplicate 1 (CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L)

From Duplicate 1 (CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita)

From Duplicate 1 ( 

CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations

- Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita )




From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )




From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )












From Duplicate 2 ( 


CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations


- Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )



From Duplicate 2 (CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L)

From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )












From Duplicate 1 ( 

CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations

- Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita )




From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )




From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )












From Duplicate 2 ( 


CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations


- Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )



From Duplicate 2 (CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L)

From Duplicate 1 ( CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )



From Duplicate 2 ( CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. - Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )</notes><research-notes>From Duplicate 1 (CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L)

From Duplicate 1 (CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita)

From Duplicate 1 ( 

CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations

- Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita )




From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )




From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )












From Duplicate 2 ( 


CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations


- Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )



From Duplicate 2 (CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L)

From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )












From Duplicate 1 ( 

CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations

- Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L; Di Lorenzo, Annarita )




From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )




From Duplicate 1 ( 


CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations.


- Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )












From Duplicate 2 ( 


CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations


- Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )



From Duplicate 2 (CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L)

From Duplicate 1 ( CCM3 signaling through sterile 20 – like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations - Zheng, Xiangjian; Xu, Chong; Lorenzo, Annarita Di; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )



From Duplicate 2 ( CCM3 signaling through sterile 20-like kinases plays an essential role during zebrafish cardiovascular development and cerebral cavernous malformations. - Zheng, Xiangjian; Xu, Chong; Di Lorenzo, Annarita; Kleaveland, Benjamin; Zou, Zhiying; Seiler, Christoph; Chen, Mei; Cheng, Lan; Xiao, Jiping; He, Jie; Pack, Michael A; Sessa, William C; Kahn, Mark L )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2912181&amp;tool=pmcentrez&amp;rendertype=abstract</url><url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912181/</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Cerebral cavernous malformation is a common human vascular disease that arises due to loss-of-function mutations in genes encoding three intracellular adaptor proteins, cerebral cavernous malformations 1 protein (CCM1), CCM2, and CCM3. CCM1, CCM2, and CCM3 interact biochemically in a pathway required in endothelial cells during cardiovascular development in mice and zebrafish. The downstream effectors by which this signaling pathway regulates endothelial function have not yet been identified. Here we have shown in zebrafish that expression of mutant ccm3 proteins (ccm3Delta) known to cause cerebral cavernous malformation in humans confers cardiovascular phenotypes identical to those associated with loss of ccm1 and ccm2. CCM3Delta proteins interacted with CCM1 and CCM2, but not with other proteins known to bind wild-type CCM3, serine/threonine protein kinase MST4 (MST4), sterile 20-like serine/threonine kinase 24 (STK24), and STK25, all of which have poorly defined biological functions. Cardiovascular phenotypes characteristic of CCM deficiency arose due to stk deficiency and combined low-level deficiency of stks and ccm3 in zebrafish embryos. In cultured human endothelial cells, CCM3 and STK25 regulated barrier function in a manner similar to CCM2, and STKs negatively regulated Rho by directly activating moesin. These studies identify STKs as essential downstream effectors of CCM signaling in development and disease that may regulate both endothelial and epithelial cell junctions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rodriguez-Fraticelli, Alejo E</author><author>Vergarajauregui, Silvia</author><author>Eastburn, Dennis J</author><author>Datta, Anirban</author><author>Alonso, Miguel a</author><author>Mostov, Keith</author><author>Martín-Belmonte, Fernando</author></authors></contributors><titles><title>The Cdc42 GEF Intersectin 2 controls mitotic spindle orientation to form the lumen during epithelial morphogenesis.</title><secondary-title>The Journal of cell biology</secondary-title></titles><periodical><full-title>The Journal of cell biology</full-title></periodical><pages>725-738</pages><volume>189</volume><issue>4</issue><keywords><keyword>Adaptor Proteins</keyword><keyword>Animals</keyword><keyword>Cell Cycle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Dogs</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Epithelial Cells: ultrastructure</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: metabolism</keyword><keyword>Mitotic Spindle Apparatus</keyword><keyword>Mitotic Spindle Apparatus: metabolism</keyword><keyword>Mitotic Spindle Apparatus: ultrastructure</keyword><keyword>Morphogenesis</keyword><keyword>Morphogenesis: physiology</keyword><keyword>RNA Interference</keyword><keyword>Signal Transduction</keyword><keyword>Tubulin</keyword><keyword>Tubulin: analysis</keyword><keyword>Vesicular Transport</keyword><keyword>Vesicular Transport: metabolism</keyword><keyword>cdc42 GTP-Binding Protein</keyword><keyword>cdc42 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20479469</accession-num><electronic-resource-num>10.1083/jcb.201002047</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2872911&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Epithelial organs are made of tubes and cavities lined by a monolayer of polarized cells that enclose the central lumen. Lumen formation is a crucial step in the formation of epithelial organs. The Rho guanosine triphosphatase (GTPase) Cdc42, which is a master regulator of cell polarity, regulates the formation of the central lumen in epithelial morphogenesis. However, how Cdc42 is regulated during this process is still poorly understood. Guanine nucleotide exchange factors (GEFs) control the activation of small GTPases. Using the three-dimensional Madin-Darby canine kidney model, we have identified a Cdc42-specific GEF, Intersectin 2 (ITSN2), which localizes to the centrosomes and regulates Cdc42 activation during epithelial morphogenesis. Silencing of either Cdc42 or ITSN2 disrupts the correct orientation of the mitotic spindle and normal lumen formation, suggesting a direct relationship between these processes. Furthermore, we demonstrated this direct relationship using LGN, a component of the machinery for mitotic spindle positioning, whose disruption also results in lumen formation defects.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chakraborty, Prabir K</author><author>Lee, Wing-Kee</author><author>Molitor, Malte</author><author>Wolff, Natascha A</author><author>Thévenod, Frank</author></authors></contributors><titles><title>Cadmium induces Wnt signaling to upregulate proliferation and survival genes in sub-confluent kidney proximal tubule cells.</title><secondary-title>Molecular cancer</secondary-title></titles><periodical><full-title>Molecular cancer</full-title></periodical><pages>102</pages><volume>9</volume><keywords><keyword>Animals</keyword><keyword>Basic Helix-Loop-Helix Leucine Zipper Transcriptio</keyword><keyword>Cadherins</keyword><keyword>Cadherins: drug effects</keyword><keyword>Cadherins: genetics</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cadmium</keyword><keyword>Cadmium: toxicity</keyword><keyword>Carcinogens</keyword><keyword>Carcinogens: toxicity</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Cell Transformation</keyword><keyword>Cells</keyword><keyword>Confocal</keyword><keyword>Cultured</keyword><keyword>Electrophoretic Mobility Shift Assay</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Immunoblotting</keyword><keyword>Immunoprecipitation</keyword><keyword>Kidney Tubules</keyword><keyword>Microscopy</keyword><keyword>Neoplastic</keyword><keyword>Neoplastic: genetics</keyword><keyword>Neoplastic: metabolism</keyword><keyword>Proximal</keyword><keyword>Proximal: drug effects</keyword><keyword>Proximal: metabolism</keyword><keyword>Rats</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Transcription Factors</keyword><keyword>Transcription Factors: drug effects</keyword><keyword>Transcription Factors: genetics</keyword><keyword>Transcription Factors: metabolism</keyword><keyword>Transfection</keyword><keyword>Up-Regulation</keyword><keyword>Wnt Proteins</keyword><keyword>Wnt Proteins: drug effects</keyword><keyword>Wnt Proteins: genetics</keyword><keyword>Wnt Proteins: metabolism</keyword><keyword>beta Catenin</keyword><keyword>beta Catenin: drug effects</keyword><keyword>beta Catenin: genetics</keyword><keyword>beta Catenin: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20459685</accession-num><electronic-resource-num>10.1186/1476-4598-9-102</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2873433&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>BACKGROUND: The class 1 carcinogen cadmium (Cd2+) disrupts the E-cadherin/beta-catenin complex of epithelial adherens junctions (AJs) and causes renal cancer. Deregulation of E-cadherin adhesion and changes in Wnt/beta-catenin signaling are known to contribute to carcinogenesis. RESULTS: We investigated Wnt signaling after Cd2+-induced E-cadherin disruption in sub-confluent cultured kidney proximal tubule cells (PTC). Cd2+ (25 microM, 3-9 h) caused nuclear translocation of beta-catenin and triggered a Wnt response measured by TOPflash reporter assays. Cd2+ reduced the interaction of beta-catenin with AJ components (E-cadherin, alpha-catenin) and increased binding to the transcription factor TCF4 of the Wnt pathway, which was upregulated and translocated to the nucleus. While Wnt target genes (c-Myc, cyclin D1 and ABCB1) were up-regulated by Cd2+, electromobility shift assays showed increased TCF4 binding to cyclin D1 and ABCB1 promoter sequences with Cd2+. Overexpression of wild-type and mutant TCF4 confirmed Cd2+-induced Wnt signaling. Wnt signaling elicited by Cd2+ was not observed in confluent non-proliferating cells, which showed increased E-cadherin expression. Overexpression of E-cadherin reduced Wnt signaling, PTC proliferation and Cd2+ toxicity. Cd2+ also induced reactive oxygen species dependent expression of the pro-apoptotic ER stress marker and Wnt suppressor CHOP/GADD153 which, however, did not abolish Wnt response and cell viability. CONCLUSIONS: Cd2+ induces Wnt signaling in PTC. Hence, Cd2+ may facilitate carcinogenesis of PTC by promoting Wnt pathway-mediated proliferation and survival of pre-neoplastic cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schiller, Katherine R</author><author>Maniak, Peter J</author><author>O'Grady, Scott M</author></authors></contributors><titles><title>Cystic fibrosis transmembrane conductance regulator is involved in airway epithelial wound repair.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C912-21</pages><volume>299</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Anions</keyword><keyword>Anions: metabolism</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cystic Fibrosis</keyword><keyword>Cystic Fibrosis Transmembrane Conductance Regulato</keyword><keyword>Cystic Fibrosis: metabolism</keyword><keyword>Cystic Fibrosis: pathology</keyword><keyword>Epithelial Sodium Channel</keyword><keyword>Epithelial Sodium Channel: metabolism</keyword><keyword>Humans</keyword><keyword>Ion Channels</keyword><keyword>Ion Channels: metabolism</keyword><keyword>Pseudopodia</keyword><keyword>Pseudopodia: metabolism</keyword><keyword>Pseudopodia: ultrastructure</keyword><keyword>RNA</keyword><keyword>Respiratory Mucosa</keyword><keyword>Respiratory Mucosa: cytology</keyword><keyword>Respiratory Mucosa: pathology</keyword><keyword>Respiratory Mucosa: physiology</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Small Interfering: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20686068</accession-num><electronic-resource-num>10.1152/ajpcell.00215.2010</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2980302&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration</label><abstract>The role of cystic fibrosis (CF) transmembrane conductance regulator (CFTR) in airway epithelial wound repair was investigated using normal human bronchial epithelial (NHBE) cells and a human airway epithelial cell line (Calu-3) of serous gland origin. Measurements of wound repair were performed using continuous impedance sensing to determine the time course for wound closure. Control experiments showed that the increase in impedance corresponding to cell migration into the wound was blocked by treatment with the actin polymerization inhibitor, cytochalasin D. Time lapse imaging revealed that NHBE and Calu-3 cell wound closure was dependent on cell migration, and that movement occurred as a collective sheet of cells. Selective inhibition of CFTR activity with CFTR(inh)-172 or short hairpin RNA silencing of CFTR expression produced a significant delay in wound repair. The CF cell line UNCCF1T also exhibited significantly slower migration than comparable normal airway epithelial cells. Inhibition of CFTR-dependent anion transport by treatment with CFTR(inh)-172 slowed wound closure to the same extent as silencing CFTR protein expression, indicating that ion transport by CFTR plays a critical role in migration. Moreover, morphologic analysis of migrating cells revealed that CFTR inhibition or silencing significantly reduced lamellipodia protrusion. These findings support the conclusion that CFTR participates in airway epithelial wound repair by a mechanism involving anion transport that is coupled to the regulation of lamellipodia protrusion at the leading edge of the cell.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukova, Anna a</author><author>Xing, Junjie</author><author>Fu, Panfeng</author><author>Yakubov, Bakhtiyor</author><author>Dubrovskyi, Oleksii</author><author>Fortune, Jennifer a</author><author>Klibanov, Alexander M</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L652-63</pages><volume>299</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Atrial Natriuretic Factor</keyword><keyword>Atrial Natriuretic Factor: genetics</keyword><keyword>Atrial Natriuretic Factor: pharmacology</keyword><keyword>Bronchoalveolar Lavage Fluid</keyword><keyword>Bronchoalveolar Lavage Fluid: cytology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cell Line</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Knockout</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: pharmacology</keyword><keyword>Lung</keyword><keyword>Lung: blood supply</keyword><keyword>Lung: cytology</keyword><keyword>Lung: drug effects</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Random Allocation</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: metabolism</keyword><keyword>p21-Activated Kinases</keyword><keyword>p21-Activated Kinases: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20729389</accession-num><electronic-resource-num>10.1152/ajplung.00202.2009</electronic-resource-num><notes>From Duplicate 1 (Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1. - Birukova, Anna a; Xing, Junjie; Fu, Panfeng; Yakubov, Bakhtiyor; Dubrovskyi, Oleksii; Fortune, Jennifer a; Klibanov, Alexander M; Birukov, Konstantin G)

From Duplicate 2 ( Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1. - Birukova, Anna a; Xing, Junjie; Fu, Panfeng; Yakubov, Bakhtiyor; Dubrovskyi, Oleksii; Fortune, Jennifer a; Klibanov, Alexander M; Birukov, Konstantin G )</notes><research-notes>From Duplicate 1 (Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1. - Birukova, Anna a; Xing, Junjie; Fu, Panfeng; Yakubov, Bakhtiyor; Dubrovskyi, Oleksii; Fortune, Jennifer a; Klibanov, Alexander M; Birukov, Konstantin G)

From Duplicate 2 ( Atrial natriuretic peptide attenuates LPS-induced lung vascular leak: role of PAK1. - Birukova, Anna a; Xing, Junjie; Fu, Panfeng; Yakubov, Bakhtiyor; Dubrovskyi, Oleksii; Fortune, Jennifer a; Klibanov, Alexander M; Birukov, Konstantin G )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2980395&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Increased levels of atrial natriuretic peptide (ANP) in the models of sepsis, pulmonary edema, and acute respiratory distress syndrome (ARDS) suggest its potential role in the modulation of acute lung injury. We have recently described ANP-protective effects against thrombin-induced barrier dysfunction in pulmonary endothelial cells (EC). The current study examined involvement of the Rac effector p21-activated kinase (PAK1) in ANP-protective effects in the model of lung vascular permeability induced by bacterial wall LPS. C57BL/6J mice or ANP knockout mice (Nppa(-/-)) were treated with LPS (0.63 mg/kg intratracheal) with or without ANP (2 μg/kg iv). Lung injury was monitored by measurements of bronchoalveolar lavage protein content, cell count, Evans blue extravasation, and lung histology. Endothelial barrier properties were assessed by morphological analysis and measurements of transendothelial electrical resistance. ANP treatment stimulated Rac-dependent PAK1 phosphorylation, attenuated endothelial permeability caused by LPS, TNF-α, and IL-6, decreased LPS-induced cell and protein accumulation in bronchoalveolar lavage fluid, and suppressed Evans blue extravasation in the murine model of acute lung injury. More severe LPS-induced lung injury and vascular leak were observed in ANP knockout mice. In rescue experiments, ANP injection significantly reduced lung injury in Nppa(-/-) mice caused by LPS. Molecular inhibition of PAK1 suppressed the protective effects of ANP treatment against LPS-induced lung injury and endothelial barrier dysfunction. This study shows that the protective effects of ANP against LPS-induced vascular leak are mediated at least in part by PAK1-dependent signaling leading to EC barrier enhancement. Our data suggest a direct role for ANP in endothelial barrier regulation via modulation of small GTPase signaling.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lu, Qing</author><author>Harrington, Elizabeth O</author><author>Newton, Julie</author><author>Casserly, Brian</author><author>Radin, Gregory</author><author>Warburton, Rod</author><author>Zhou, Yang</author><author>Blackburn, Michael R</author><author>Rounds, Sharon</author></authors></contributors><titles><title>Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L755-67</pages><volume>298</volume><issue>6</issue><keywords><keyword>Acute Lung Injury</keyword><keyword>Acute Lung Injury: chemically induced</keyword><keyword>Acute Lung Injury: complications</keyword><keyword>Adenosine</keyword><keyword>Adenosine A2</keyword><keyword>Adenosine A2: physiology</keyword><keyword>Adenosine A2A</keyword><keyword>Adenosine A2A: physiology</keyword><keyword>Adenosine A2B</keyword><keyword>Adenosine A2B: physiology</keyword><keyword>Adenosine Deaminase Inhibitors</keyword><keyword>Adenosine: pharmacology</keyword><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: drug effects</keyword><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>Endothelium</keyword><keyword>Endothelium: metabolism</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: metabolism</keyword><keyword>Lung</keyword><keyword>Lung: metabolism</keyword><keyword>Male</keyword><keyword>Nucleoside Transport Proteins</keyword><keyword>Nucleoside Transport Proteins: physiology</keyword><keyword>Pentostatin</keyword><keyword>Pentostatin: pharmacology</keyword><keyword>Pentostatin: therapeutic use</keyword><keyword>Pulmonary Edema</keyword><keyword>Pulmonary Edema: prevention &amp; control</keyword><keyword>Rats</keyword><keyword>Receptor</keyword><keyword>Receptors</keyword><keyword>Sprague-Dawley</keyword><keyword>Thiourea</keyword><keyword>Thiourea: analogs &amp; derivatives</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>20228181</accession-num><electronic-resource-num>10.1152/ajplung.00330.2009</electronic-resource-num><notes>From Duplicate 1 (Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement. - Lu, Qing; Harrington, Elizabeth O; Newton, Julie; Casserly, Brian; Radin, Gregory; Warburton, Rod; Zhou, Yang; Blackburn, Michael R; Rounds, Sharon)

From Duplicate 1 ( Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement. - Lu, Qing; Harrington, Elizabeth O; Newton, Julie; Casserly, Brian; Radin, Gregory; Warburton, Rod; Zhou, Yang; Blackburn, Michael R; Rounds, Sharon )



From Duplicate 2 ( Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement. - Lu, Qing; Harrington, Elizabeth O; Newton, Julie; Casserly, Brian; Radin, Gregory; Warburton, Rod; Zhou, Yang; Blackburn, Michael R; Rounds, Sharon )</notes><research-notes>From Duplicate 1 (Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement. - Lu, Qing; Harrington, Elizabeth O; Newton, Julie; Casserly, Brian; Radin, Gregory; Warburton, Rod; Zhou, Yang; Blackburn, Michael R; Rounds, Sharon)

From Duplicate 1 ( Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement. - Lu, Qing; Harrington, Elizabeth O; Newton, Julie; Casserly, Brian; Radin, Gregory; Warburton, Rod; Zhou, Yang; Blackburn, Michael R; Rounds, Sharon )



From Duplicate 2 ( Adenosine protected against pulmonary edema through transporter- and receptor A2-mediated endothelial barrier enhancement. - Lu, Qing; Harrington, Elizabeth O; Newton, Julie; Casserly, Brian; Radin, Gregory; Warburton, Rod; Zhou, Yang; Blackburn, Michael R; Rounds, Sharon )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2886613&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>We have previously demonstrated that adenosine plus homocysteine enhanced endothelial basal barrier function and protected against agonist-induced barrier dysfunction in vitro through attenuation of RhoA activation by inhibition of isoprenylcysteine-O-carboxyl methyltransferase. In the current study, we tested the effect of elevated adenosine on pulmonary endothelial barrier function in vitro and in vivo. We noted that adenosine alone dose dependently enhanced endothelial barrier function. While adenosine receptor A(1) or A(3) antagonists were ineffective, an adenosine transporter inhibitor, NBTI, or a combination of DPMX and MRS1754, antagonists for adenosine receptors A(2A) and A(2B), respectively, partially attenuated the barrier-enhancing effect of adenosine. Similarly, inhibition of both A(2A) and A(2B) receptors with siRNA also blunted the effect of adenosine on barrier function. Interestingly, inhibition of both transporters and A(2A)/A(2B) receptors completely abolished adenosine-induced endothelial barrier enhancement. The adenosine receptor A(2A) and A(2B) agonist, NECA, also significantly enhanced endothelial barrier function. These data suggest that both adenosine transporters and A(2A) and A(2B) receptors are necessary for exerting maximal effect of adenosine on barrier enhancement. We also found that adenosine enhanced Rac1 GTPase activity and overexpression of dominant negative Rac1 attenuated adenosine-induced increases in focal adhesion complexes. We further demonstrated that elevation of cellular adenosine by inhibition of adenosine deaminase with Pentostatin significantly enhanced endothelial basal barrier function, an effect that was also associated with enhanced Rac1 GTPase activity and with increased focal adhesion complexes and adherens junctions. Finally, using a non-inflammatory acute lung injury (ALI) model induced by alpha-naphthylthiourea, we found that administration of Pentostatin, which elevated lung adenosine level by 10-fold, not only attenuated the development of edema before ALI but also partially reversed edema after ALI. The data suggest that adenosine deaminase inhibition may be useful in treatment of pulmonary edema in settings of ALI.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tarantola, Marco</author><author>Marel, Anna-Kristina</author><author>Sunnick, Eva</author><author>Adam, Holger</author><author>Wegener, Joachim</author><author>Janshoff, Andreas</author></authors></contributors><titles><title>Dynamics of human cancer cell lines monitored by electrical and acoustic fluctuation analysis.</title><secondary-title>Integrative biology : quantitative biosciences from nano to macro</secondary-title></titles><periodical><full-title>Integrative biology : quantitative biosciences from nano to macro</full-title></periodical><pages>139-150</pages><volume>2</volume><issue>2-3</issue><keywords><keyword>Acoustics</keyword><keyword>Acoustics: instrumentation</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Cell Line</keyword><keyword>Humans</keyword><keyword>Micro-Electrical-Mechanical Systems</keyword><keyword>Micro-Electrical-Mechanical Systems: instrumentati</keyword><keyword>Neoplasms</keyword><keyword>Neoplasms: pathology</keyword><keyword>Neoplasms: physiopathology</keyword><keyword>Tumor</keyword></keywords><dates><year>2010</year></dates><accession-num>20473392</accession-num><electronic-resource-num>10.1039/b920815a</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20473392</url></web-urls></urls><label>ECIS Micromotion</label><abstract>Early determination of the metastatic potential of cancer cells is a crucial step for successful oncological treatment. Besides the remarkable progress in molecular genomics- or proteomics-based diagnostics, there is a great demand for in vitro biosensor devices that allow rapid and selective detection of the invasive properties of tumor cells. Here, the classical cancer cell motility in vitro assays for migration and invasion relying on Boyden chambers are compared to a real-time biosensor that analyzes the dynamic properties of adherent cells electro-acoustically with a time resolution on the order of seconds. The sensor relies on the well-established quartz crystal microbalance technique (QCM) that measures the shift in resonance frequency and damping of an oscillating quartz crystal when adsorption, desorption or changes in material properties close to the quartz surface occur. In addition, the QCM is capable of detecting the rather subtle fluctuations of the cell bodies as an indicator for their micromotility. QCM-based micromotility readings of three different cancer cell lines (HT-29, HSC-4, FaDu) are compared with the well-known electrical cell-substrate impedance sensing (ECIS) revealing collective stochastic motion that corresponds to the malignancy of the cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dalmasso, Guillaume</author><author>Nguyen, Hang Thi Thu</author><author>Yan, Yutao</author><author>Laroui, Hamed</author><author>Srinivasan, Shanthi</author><author>Sitaraman, Shanthi V</author><author>Merlin, Didier</author></authors></contributors><titles><title>MicroRNAs determine human intestinal epithelial cell fate.</title><secondary-title>Differentiation; research in biological diversity</secondary-title></titles><periodical><full-title>Differentiation; research in biological diversity</full-title></periodical><pages>147-154</pages><volume>80</volume><issue>2-3</issue><keywords><keyword>Cell Differentiation</keyword><keyword>Cell Line</keyword><keyword>Cell Lineage</keyword><keyword>Cell Lineage: physiology</keyword><keyword>Humans</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: cytology</keyword><keyword>Intestines</keyword><keyword>Intestines: cytology</keyword><keyword>MicroRNAs</keyword><keyword>MicroRNAs: physiology</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword></keywords><dates><year>2010</year></dates><accession-num>20638171</accession-num><electronic-resource-num>10.1016/j.diff.2010.06.005</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2943016&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>MicroRNAs (miRNAs) are small, non-coding RNA molecules that post-transcriptionally regulate gene expression. Evidence has shown that miRNAs play important roles in various cellular processes, including proliferation, differentiation and survival. The intestinal epithelium is regenerated throughout life, and enterocytes undergo differentiation during migration along the crypt/villus axis. Our study aimed at establishing the expression profiles of miRNAs during intestinal epithelial cell (IEC) differentiation and determining a miRNA &quot;signature&quot; that distinguishes between small and large IECs. MiRNA arrays were employed to profile miRNA expression in two IEC models: the enterocyte-like Caco2-BBE and the colonocyte-like HT29-Cl.19A cell lines. Microarray data showed that in both cell lineages, the differentiated stage exhibited a different miRNA expression profile from undifferentiated stage. Interestingly, Caco2-BBE cells were distinguished from HT29-Cl.19A cells by their unique miRNA expression profile. Notably, HT29-Cl.19A cells exhibited down-regulation of miR-1269 and up-regulation of miR-99b and miR-125a-5p compared with Caco2-BBE cells. Most importantly, transfection of Caco2-BBE cells with mature miR-99b, mature miR-125a-5p and antisense of mature miR-1269 decreased growth rate and trans-epithelial resistance of the cells, indicating their shift toward HT29-Cl.19A cell phenotype. In conclusion, our study shows that miRNAs might play a role in determining the unique physiological characteristics of IECs.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Heijink, I H</author><author>Brandenburg, S M</author><author>Noordhoek, J a</author><author>Postma, D S</author><author>Slebos, D-J</author><author>van Oosterhout, a J M</author></authors></contributors><titles><title>Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing.</title><secondary-title>The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology</secondary-title></titles><periodical><full-title>The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology</full-title></periodical><pages>894-903</pages><volume>35</volume><issue>4</issue><keywords><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Communication</keyword><keyword>Cell Communication: physiology</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Respiratory Mucosa</keyword><keyword>Respiratory Mucosa: cytology</keyword></keywords><dates><year>2010</year></dates><accession-num>19741028</accession-num><electronic-resource-num>10.1183/09031936.00065809</electronic-resource-num><notes>From Duplicate 2 (Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing. - Heijink, I H; Brandenburg, S M; Noordhoek, J a; Postma, D S; Slebos, D-J; van Oosterhout, a J M)

From Duplicate 1 ( Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing. - Heijink, I H; Brandenburg, S M; Noordhoek, J a; Postma, D S; Slebos, D-J; van Oosterhout, a J M )</notes><research-notes>From Duplicate 2 (Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing. - Heijink, I H; Brandenburg, S M; Noordhoek, J a; Postma, D S; Slebos, D-J; van Oosterhout, a J M)

From Duplicate 1 ( Characterisation of cell adhesion in airway epithelial cell types using electric cell-substrate impedance sensing. - Heijink, I H; Brandenburg, S M; Noordhoek, J a; Postma, D S; Slebos, D-J; van Oosterhout, a J M )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19741028</url></web-urls></urls><label>ECIS Growth;ECIS Migration;ECIS TEER;Wound Healing</label><abstract>Research on epithelial cell lines and primary epithelium is required to dissect the mechanisms underlying the structural abnormalities in airway epithelium observed for respiratory diseases, including asthma and chronic obstructive pulmonary disease. The novel electric cell-substrate impedance sensing technique was used to monitor cell adhesion/spreading, barrier function and wound healing. Primary bronchial epithelium was compared with airway epithelial cell lines 16HBE14o-, BEAS-2B, NCI-H292 and A549. BEAS-2B, A549 and primary cells form a confluent monolayer more rapidly than do 16HBE14o- cells. In contrast, 16HBE14o- cells form stronger intercellular contacts, with a 10-fold higher resistance than BEAS-2B, A549 and NCI-H292 cells and a five-fold increase over primary cells. Accordingly, expression of the adhesion molecules zona occludens-1 and E-cadherin was highest in 16HBE14o- cells. These molecules were localised in intercellular junctions in both 16HBE14o- and primary cells. Finally, restoration of barrier function upon injury was impaired in BEAS-2B compared to 16HBE14o- cells. In conclusion, epithelial cell types display remarkable phenotypic differences and should, accordingly, be used to address specific research questions. 16HBE14o- cells appear most suitable for studies on barrier formation, whereas resemblance in attachment of primary and BEAS-2B and A549 cells makes the latter more important for translational research on cell-matrix contact.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jiang, W G</author><author>LIN, Y E</author><author>Ablin, R J</author><author>Kynaston, H G</author></authors></contributors><titles><title>The prostate transglutaminase, TGase-4, coordinates with the HGFL/MSP-RON system in stimulating the migration of prostate cancer cells</title><secondary-title>International Journal of Oncology</secondary-title></titles><periodical><full-title>International Journal of Oncology</full-title></periodical><pages>413-418</pages><volume>37</volume><issue>2</issue><keywords/><dates><year>2010</year></dates><electronic-resource-num>10.3892/ijo_00000689</electronic-resource-num><urls><web-urls><url>http://cat.inist.fr/?aModele=afficheN&amp;amp;cpsidt=23005756</url><url>http://www.spandidos-publications.com/ijo/37/2/413</url></web-urls></urls><label>ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ding, Min</author><author>Zhao, Jinshun</author><author>Bowman, Linda</author><author>Lu, Yongju</author><author>Shi, Xianglin</author></authors></contributors><titles><title>Inhibition of AP-1 and MAPK signaling and activation of Nrf2/ARE pathway by quercitrin.</title><secondary-title>International journal of oncology</secondary-title></titles><periodical><full-title>International journal of oncology</full-title></periodical><pages>59-67</pages><volume>36</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Antioxidants</keyword><keyword>Antioxidants: metabolism</keyword><keyword>Carcinogens</keyword><keyword>Comet Assay</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Female</keyword><keyword>Gene Expression Regulation</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>NF-E2-Related Factor 2</keyword><keyword>NF-E2-Related Factor 2: antagonists &amp; inhibitors</keyword><keyword>Neoplastic</keyword><keyword>Quercetin</keyword><keyword>Quercetin: analogs &amp; derivatives</keyword><keyword>Quercetin: pharmacology</keyword><keyword>Response Elements</keyword><keyword>Transcription Factor AP-1</keyword><keyword>Transcription Factor AP-1: antagonists &amp; inhibitor</keyword><keyword>Transcriptional Activation</keyword><keyword>Transgenic</keyword></keywords><dates><year>2010</year></dates><accession-num>19956833</accession-num><electronic-resource-num>10.3892/ijo_00000475</electronic-resource-num><urls><web-urls><url>http://www.spandidos-publications.com/ijo/36/1/59</url><url>http://www.ncbi.nlm.nih.gov/pubmed/19956833</url></web-urls></urls><abstract>Quercitrin, glycosylated form of flavonoid compounds, is widely distributed in nature. Extensive studies have demonstrated that quercitrin exhibits strong antioxidant and anti-carcinogenic activities. However, the molecular mechanism is poorly understood. The present study examines the effects of quercitrin on tumor promotion in mouse JB6 cells, a validated model for screening cancer chemopreventive agents and elucidating the molecular mechanisms. Quercitrin blocked TPA-induced neoplastic transformation in JB6 P+ cells. Pretreatment of JB6 cells with quercitrin down-regulated transactivation of AP-1 and NF-kappaB induced by UVB or TPA. In the skin of AP-1-luciferase transgenic mice, topical treatment of the mouse with quercitrin markedly blocked the TPA-induced AP-1 transactivation. Further studies indicated that these inhibitory actions appear to be mediated through the inhibition of MAPKs phosphorylation, including ERKs, p38 kinase, and JNKs. In addition, quercitrin stimulated the activation of NF-E2-related factor (Nrf2) and GST ARE-luciferase activity. Comet assays showed that quercitrin could block DNA damage induced by UVB. To our knowledge, these results provide the first evidence that quercitrin contributes to the inhibition of neoplastic transformation by blocking activation of the MAPK pathway and stimulation of cellular protection signaling. Moreover, to our knowledge, these findings provide the first molecular basis for the anti-carcinogenic action of quercitrin.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Janshoff, Andreas</author><author>Kunze, Angelika</author><author>Michaelis, Stefanie</author><author>Heitmann, V</author><author>Reiss, B</author><author>Wegener, J</author></authors></contributors><titles><title>Cell Adhesion Monitoring Using Substrate-Integrated Sensors</title><secondary-title>Journal of Adhesion Science and Technology</secondary-title></titles><periodical><full-title>Journal of Adhesion Science and Technology</full-title></periodical><pages>2079-2104</pages><volume>24</volume><issue>13-14</issue><keywords><keyword>1</keyword><keyword>Adhesion</keyword><keyword>Adsorption</keyword><keyword>Biomedical engineering</keyword><keyword>Cell adhesion</keyword><keyword>Cells</keyword><keyword>Electric cell-substrate impedance sensing (ECIS)</keyword><keyword>Electric cells</keyword><keyword>Liposomes</keyword><keyword>Mammals</keyword><keyword>Phospholipids</keyword><keyword>Piezoelectric devices</keyword><keyword>Quartz</keyword><keyword>Quartz crystal microbalances</keyword><keyword>Substrates</keyword><keyword>adhesion of animal cells</keyword><keyword>cell</keyword><keyword>cell adhesion</keyword><keyword>cell spreading</keyword><keyword>cell-matrix interactions</keyword><keyword>cell-surface junction</keyword><keyword>ecis</keyword><keyword>electric cell</keyword><keyword>liposome adsorption</keyword><keyword>qcm</keyword><keyword>quartz crystal microbalance</keyword><keyword>quartz crystal microbalance (QCM)</keyword><keyword>spreading</keyword><keyword>substrate impedance sensing</keyword><keyword>surface junction</keyword><keyword>to in vitro surfaces</keyword><keyword>why bother</keyword></keywords><dates><year>2010</year></dates><isbn>0169-4243</isbn><electronic-resource-num>10.1163/016942410X507939</electronic-resource-num><notes>From Duplicate 2 (Cell Adhesion Monitoring Using Substrate-Integrated Sensors - Janshoff, Andreas; Kunze, Angelika; Michaelis, Stefanie)

From Duplicate 1 ( Cell Adhesion Monitoring Using Substrate-Integrated Sensors - Janshoff, Andreas; Kunze, Angelika; Michaelis, Stefanie )



From Duplicate 2 ( Cell Adhesion Monitoring Using Substrate-Integrated Sensors - Janshoff, Andreas; Kunze, Angelika; Michaelis, Stefanie )</notes><research-notes>From Duplicate 2 (Cell Adhesion Monitoring Using Substrate-Integrated Sensors - Janshoff, Andreas; Kunze, Angelika; Michaelis, Stefanie)

From Duplicate 1 ( Cell Adhesion Monitoring Using Substrate-Integrated Sensors - Janshoff, Andreas; Kunze, Angelika; Michaelis, Stefanie )



From Duplicate 2 ( Cell Adhesion Monitoring Using Substrate-Integrated Sensors - Janshoff, Andreas; Kunze, Angelika; Michaelis, Stefanie )</research-notes><urls><web-urls><url>http://www.scopus.com/inward/record.url?eid=2-s2.0-77957593737&amp;partnerID=40&amp;md5=fdb40cdd9694a1a6890579152eecdfe7</url><url>http://www.ingentaconnect.com/content/vsp/ast/2010/00000024/F0020013/art00003</url></web-urls></urls><label>ECIS Attachment</label><abstract>Adhesion of mammalian cells to in vitro surfaces is an area of active research and it attracts considerable interest from various scientific disciplines, most notably from medical technology and biotechnology. One important issue in the context of cell-surface adhesion is the time course of attachment and spreading upon surfaces that are decorated with proteins to make them cytocompatible. This article reviews two emerging non-microscopic techniques capable of monitoring the adhesion process label-free and in real-time. Both approaches, electric cell-substrate impedance sensing (ECIS) and the quartz crystal microbalance (QCM), are based on substrate-integrated transducers that transduce cellular adhesion into an electrical signal. A short introduction of both techniques is followed by a set of examples that illustrate the performance of these sensors, their individual merits and limitations. In order to analyze the integral and complex signals of both sensors in contact with mammalian cells in more detail, we also studied their individual readouts during the adsorption of liposomes with well-defined structure and chemical composition. Â© 2010 VSP.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Nguyen, Hang Thi Thu</author><author>Dalmasso, Guillaume</author><author>Yan, Yutao</author><author>Laroui, Hamed</author><author>Dahan, Stephanie</author><author>Mayer, Lloyd</author><author>Sitaraman, Shanthi V</author><author>Merlin, Didier</author></authors></contributors><titles><title>MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>1479-1489</pages><volume>285</volume><issue>2</issue><keywords><keyword>3' Untranslated Regions</keyword><keyword>3' Untranslated Regions: genetics</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>CD98</keyword><keyword>CD98: biosynthesis</keyword><keyword>CD98: genetics</keyword><keyword>Caco-2 Cells</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: genetics</keyword><keyword>Cell Communication</keyword><keyword>Cell Communication: genetics</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Polarity</keyword><keyword>Cell Polarity: genetics</keyword><keyword>Crohn Disease</keyword><keyword>Crohn Disease: genetics</keyword><keyword>Crohn Disease: metabolism</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: genetics</keyword><keyword>Extracellular Matrix: metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Inflammation</keyword><keyword>Inflammation: genetics</keyword><keyword>Inflammation: metabolism</keyword><keyword>Interleukin-1beta</keyword><keyword>Interleukin-1beta: genetics</keyword><keyword>Interleukin-1beta: metabolism</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: metabolism</keyword><keyword>Jejunum</keyword><keyword>Jejunum: metabolism</keyword><keyword>Laminin</keyword><keyword>Laminin: genetics</keyword><keyword>Laminin: metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>MicroRNAs</keyword><keyword>MicroRNAs: genetics</keyword><keyword>MicroRNAs: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>19892711</accession-num><electronic-resource-num>10.1074/jbc.M109.057141</electronic-resource-num><notes>From Duplicate 1 (MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. - Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V; Merlin, Didier)

From Duplicate 1 ( MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. - Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V; Merlin, Didier )



From Duplicate 2 ( MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. - Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V; Merlin, Didier )




From Duplicate 2 ( 

MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation.

- Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V; Merlin, Didier )</notes><research-notes>From Duplicate 1 (MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. - Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V; Merlin, Didier)

From Duplicate 1 ( MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. - Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V; Merlin, Didier )



From Duplicate 2 ( MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation. - Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V; Merlin, Didier )




From Duplicate 2 ( 

MicroRNA-7 modulates CD98 expression during intestinal epithelial cell differentiation.

- Nguyen, Hang Thi Thu; Dalmasso, Guillaume; Yan, Yutao; Laroui, Hamed; Dahan, Stephanie; Mayer, Lloyd; Sitaraman, Shanthi V; Merlin, Didier )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2801273&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Attachment;ECIS Growth;Inflammation</label><abstract>The transmembrane glycoprotein CD98 regulates multiple cellular functions, including extracellular signaling, epithelial cell adhesion/polarity, amino acid transport, and cell-cell interactions. MicroRNAs post-transcriptionally regulate gene expression, thereby functioning as modulators of numerous cellular processes, such as cell differentiation, proliferation, and apoptosis. Here, we investigated if microRNAs regulate CD98 expression during intestinal epithelial cell differentiation and inflammation. We found that microRNA-7 repressed CD98 expression in Caco2-BBE cells by directly targeting the 3'-untranslated region of human CD98 mRNA. Expression of CD98 was decreased, whereas that of microRNA-7 was increased in well-differentiated Caco2-BBE cells compared with undifferentiated cells. Undifferentiated crypt cells isolated from mouse jejunum showed higher CD98 levels and lower levels of mmu-microRNA-706, a murine original microRNA candidate for CD98, than well-differentiated villus cells. Importantly, microRNA-7 decreased Caco2-BBE cell attachment on laminin-1, and CD98 overexpression recovered this inhibition, suggesting that microRNA-7 modulates epithelial cell adhesion to extracellular matrix, which in turn could affect proliferation and differentiation during the migration of enterocytes across the crypt-villus axis, by regulating CD98 expression. In a pathological context, the pro-inflammatory cytokine interleukin 1-beta increased CD98 expression in Caco2-BBE cells by decreasing microRNA-7 levels. Consistent with the in vitro findings, microRNA-7 levels were decreased in actively inflamed Crohn disease colonic tissues, where CD98 expression was up-regulated, compared with normal tissues. Together, these results reveal a novel mechanism underlying regulation of CD98 expression during patho-physiological states. This study raises microRNAs as a promising target for therapeutic modulations of CD98 expression in intestinal inflammatory disorders.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ramirez, Servio H</author><author>Fan, Shongshan</author><author>Zhang, Ming</author><author>Papugani, Anil</author><author>Reichenbach, Nancy</author><author>Dykstra, Holly</author><author>Mercer, Aaron J</author><author>Tuma, Ronald F</author><author>Persidsky, Yuri</author></authors></contributors><titles><title>Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells.</title><secondary-title>The American journal of pathology</secondary-title></titles><periodical><full-title>The American journal of pathology</full-title></periodical><pages>881-892</pages><volume>176</volume><issue>2</issue><keywords><keyword>AIDS Dementia Complex</keyword><keyword>AIDS Dementia Complex: drug therapy</keyword><keyword>AIDS Dementia Complex: metabolism</keyword><keyword>AIDS Dementia Complex: pathology</keyword><keyword>Animals</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: drug effects</keyword><keyword>Blood-Brain Barrier: metabolism</keyword><keyword>Blood-Brain Barrier: pathology</keyword><keyword>Brain</keyword><keyword>Brain: blood supply</keyword><keyword>Brain: drug effects</keyword><keyword>Brain: pathology</keyword><keyword>Case-Control Studies</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Drug Evaluation</keyword><keyword>Encephalitis</keyword><keyword>Encephalitis: pathology</keyword><keyword>Encephalitis: prevention &amp; control</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: immunology</keyword><keyword>Glycogen Synthase Kinase 3</keyword><keyword>Glycogen Synthase Kinase 3: antagonists &amp; inhibito</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Inflammation Mediators</keyword><keyword>Inflammation Mediators: metabolism</keyword><keyword>Male</keyword><keyword>Mice</keyword><keyword>Monocytes</keyword><keyword>Monocytes: drug effects</keyword><keyword>Monocytes: metabolism</keyword><keyword>Monocytes: pathology</keyword><keyword>Preclinical</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>Protein Kinase Inhibitors: therapeutic use</keyword><keyword>Thiadiazoles</keyword><keyword>Thiadiazoles: pharmacology</keyword><keyword>Thiadiazoles: therapeutic use</keyword><keyword>Thiazoles</keyword><keyword>Thiazoles: pharmacology</keyword><keyword>Thiazoles: therapeutic use</keyword><keyword>Urea</keyword><keyword>Urea: analogs &amp; derivatives</keyword><keyword>Urea: pharmacology</keyword><keyword>Urea: therapeutic use</keyword></keywords><dates><year>2010</year></dates><accession-num>20056834</accession-num><electronic-resource-num>10.2353/ajpath.2010.090671</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2808093&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier;ECIS TEER</label><abstract>Immune mediators and leukocyte engagement of brain microvascular endothelial cells (BMVECs) contribute to blood-brain barrier impairment during neuroinflammation. Glycogen synthase kinase 3beta (GSK3beta) was recently identified as a potent regulator of immune responses in in vitro systems and animal models. However, the role of GSK3beta in regulation of immune endothelial functions remains undetermined. Here we evaluated the effect of GSK3beta inhibition on the regulation of inflammatory responses in BMVECs. A focused PCR gene array of 84 genes was performed to identify the cytokine and chemokine gene expression profile in tumor necrosis factor (TNF) alpha-stimulated BMVECs after GSK3beta inactivation by specific inhibitors. Fifteen of 39 genes induced by TNFalpha stimulation were down-regulated after GSK3beta inhibition. Genes known to contribute to neuroinflammation that were most negatively affected by GSK3beta inactivation included IP-10/CXCL10, MCP-1/CCL2, IL-8/CXCL8, RANTES/CCL5, and Groalpha/CXCL1. GSK3beta suppression resulted in diminished secretion of these proinflammatory mediators by inflamed BMVECs detected by ELISA. GSK3beta inhibition in BMVECs reduced adhesion molecule expression as well as monocyte adhesion to and migration across cytokine stimulated BMVEC monolayers. Interactions of monocytes with TNFalpha-activated BMVECs led to barrier disruption, and GSK3beta suppression in the endothelium restored barrier integrity. GSK3beta inhibition in vivo substantially decreased leukocyte adhesion to brain endothelium under inflammatory conditions. In summary, inhibition of GSK3beta emerges as an important target for stabilization of the blood-brain barrier in neuroinflammation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schlegel, Nicolas</author><author>Meir, Michael</author><author>Heupel, Wolfgang-Moritz</author><author>Holthöfer, Bastian</author><author>Leube, Rudolf E</author><author>Waschke, Jens</author></authors></contributors><titles><title>Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity.</title><secondary-title>American journal of physiology. Gastrointestinal and liver physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Gastrointestinal and liver physiology</full-title></periodical><pages>G774-83</pages><volume>298</volume><issue>5</issue><keywords><keyword>Antibodies</keyword><keyword>Atomic Force</keyword><keyword>Caco-2 Cells</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Desmoglein 2</keyword><keyword>Desmoglein 2: immunology</keyword><keyword>Desmoglein 2: physiology</keyword><keyword>Humans</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: immunology</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: immunology</keyword><keyword>Microscopy</keyword><keyword>Monoclonal</keyword><keyword>Monoclonal: pharmacology</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: immunology</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: immunology</keyword><keyword>Tight Junctions: physiology</keyword></keywords><dates><year>2010</year></dates><accession-num>20224006</accession-num><electronic-resource-num>10.1152/ajpgi.00239.2009</electronic-resource-num><notes>From Duplicate 2 (Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. - Schlegel, Nicolas; Meir, Michael; Heupel, Wolfgang-Moritz; Holthöfer, Bastian; Leube, Rudolf E; Waschke, Jens)

From Duplicate 1 ( Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. - Schlegel, Nicolas; Meir, Michael; Heupel, Wolfgang-Moritz; Holthöfer, Bastian; Leube, Rudolf E; Waschke, Jens )



From Duplicate 2 ( Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. - Schlegel, Nicolas; Meir, Michael; Heupel, Wolfgang-Moritz; Holthöfer, Bastian; Leube, Rudolf E; Waschke, Jens )</notes><research-notes>From Duplicate 2 (Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. - Schlegel, Nicolas; Meir, Michael; Heupel, Wolfgang-Moritz; Holthöfer, Bastian; Leube, Rudolf E; Waschke, Jens)

From Duplicate 1 ( Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. - Schlegel, Nicolas; Meir, Michael; Heupel, Wolfgang-Moritz; Holthöfer, Bastian; Leube, Rudolf E; Waschke, Jens )



From Duplicate 2 ( Desmoglein 2-mediated adhesion is required for intestinal epithelial barrier integrity. - Schlegel, Nicolas; Meir, Michael; Heupel, Wolfgang-Moritz; Holthöfer, Bastian; Leube, Rudolf E; Waschke, Jens )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/20224006</url></web-urls></urls><label>ECIS TEER</label><abstract>The integrity of intercellular junctions that form the &quot;terminal bar&quot; in intestinal epithelium is crucial for sealing the intestinal barrier. Whereas specific roles of tight and adherens junctions are well known, the contribution of desmosomal adhesion for maintaining the intestinal epithelial barrier has not been specifically addressed. For the present study, we generated a desmoglein 2 antibody directed against the extracellular domain (Dsg2 ED) to test whether impaired Dsg2-mediated adhesion affects intestinal epithelial barrier functions in vitro. This antibody was able to specifically block Dsg2 interaction in cell-free atomic-force microscopy experiments. For in vitro studies of the intestinal barrier we used Caco2 cells following differentiation into tight enterocyte-like epithelial monolayers. Application of Dsg2 ED to Caco2 monolayers resulted in increased cell dissociation compared with controls in a dispase-based enterocyte dissociation assay. Under similar conditions, Dsg2 antibody significantly decreased transepithelial electrical resistance and increased FITC-dextran flux, indicating that Dsg2 interaction is critically involved in the maintenance of epithelial intestinal barrier functions. As revealed by immunostaining, this was due to Dsg2 ED antibody-induced rupture of tight junctions because tight junction proteins claudins 1, 4, and 5, occludin, and tight junction-associated protein zonula occludens-1 were partially removed from cell borders by Dsg2 ED treatment. Similar results were obtained by application of a commercial monoclonal antibody directed against the ED of Dsg2. Antibody-induced effects were blocked by absorption experiments using Dsg2-Fc-coated beads. Our data indicate that Dsg2-mediated adhesion affects tight junction integrity and is required to maintain intestinal epithelial barrier properties.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhao, You-Yang Yidan D You-Yang Yidan D You-yang</author><author>Ohkawara, Hiroshi</author><author>Vogel, Stephen M</author><author>Malik, Asrar B</author></authors></contributors><titles><title>Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L36-44</pages><volume>298</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Bone Marrow Cells</keyword><keyword>Bone Marrow Cells: cytology</keyword><keyword>Bone Marrow Cells: enzymology</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: drug effects</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Lung: drug effects</keyword><keyword>Lung: metabolism</keyword><keyword>Mice</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Stem Cells</keyword><keyword>Stem Cells: cytology</keyword><keyword>Stem Cells: drug effects</keyword><keyword>Stem Cells: enzymology</keyword><keyword>Stem Cells: metabolism</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>cdc42 GTP-Binding Protein</keyword><keyword>cdc42 GTP-Binding Protein: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2010</year></dates><accession-num>19880506</accession-num><electronic-resource-num>10.1152/ajplung.00064.2009</electronic-resource-num><notes>From Duplicate 1 (Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability. - Zhao, You-Yang Yidan D You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B)

From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.


- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )




From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability


- Zhao, Yidan D; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B; Zhao, You-yang )



From Duplicate 2 (Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability. - Zhao, You-Yang Yidan D You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B)

From Duplicate 1 ( 

Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.

- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )




From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.


- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )








From Duplicate 2 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.


- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )












From Duplicate 2 ( 

Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.

- Zhao, You-Yang Yidan D You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )




From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.


- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )




From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability


- Zhao, Yidan D; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B; Zhao, You-yang )</notes><research-notes>From Duplicate 1 (Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability. - Zhao, You-Yang Yidan D You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B)

From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.


- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )




From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability


- Zhao, Yidan D; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B; Zhao, You-yang )



From Duplicate 2 (Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability. - Zhao, You-Yang Yidan D You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B)

From Duplicate 1 ( 

Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.

- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )




From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.


- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )








From Duplicate 2 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.


- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )












From Duplicate 2 ( 

Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.

- Zhao, You-Yang Yidan D You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )




From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability.


- Zhao, You-Yang Yidan D You-yang; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B )




From Duplicate 1 ( 


Bone marrow-derived progenitor cells prevent thrombin-induced increase in lung vascular permeability


- Zhao, Yidan D; Ohkawara, Hiroshi; Vogel, Stephen M; Malik, Asrar B; Zhao, You-yang )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2806201&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Since thrombin activation of endothelial cells (ECs) is well-known to increase endothelial permeability by disassembly of adherens junctions (AJs) and actinomyosin contractility mechanism involving myosin light chain (MLC) phosphorylation, we investigated the effects of bone marrow-derived progenitor cells (BMPCs) on the thrombin-induced endothelial permeability response. We observed that addition of BMPCs to endothelial monolayers at a fixed ratio prevented the thrombin-induced decrease in transendothelial electrical resistance, a measure of AJ integrity, and increased mouse pulmonary microvessel filtration coefficient, a measure of transvascular liquid permeability. The barrier protection was coupled to increased vascular endothelial cadherin expression and increased Cdc42 activity in ECs. Using small interfering RNA (siRNA) to deplete Cdc42 in ECs, we demonstrated a key role of Cdc42 in signaling the BMPC-induced endothelial barrier protection. Endothelial integrity induced by BMPCs was also secondary to inhibition of MLC phosphorylation in ECs. Thus BMPCs interacting with ECs prevent thrombin-induced endothelial hyperpermeability by a mechanism involving AJ barrier annealing, inhibition of MLC phosphorylation, and activation of Cdc42.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Curtis, Theresa M</author><author>Widder, Mark W</author><author>Brennan, Linda M</author><author>Schwager, Steven J</author><author>van der Schalie, William H</author><author>Fey, Julien</author><author>Salazar, Noe</author></authors></contributors><titles><title>A portable cell-based impedance sensor for toxicity testing of drinking water.</title><secondary-title>Lab on a chip</secondary-title></titles><periodical><full-title>Lab on a chip</full-title></periodical><pages>2176-2183</pages><volume>9</volume><issue>15</issue><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Cattle</keyword><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Chemical</keyword><keyword>Chemical: toxicity</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Equipment Design</keyword><keyword>Microfluidic Analytical Techniques</keyword><keyword>Microfluidic Analytical Techniques: instrumentatio</keyword><keyword>Microfluidic Analytical Techniques: methods</keyword><keyword>Toxicity Tests</keyword><keyword>Toxicity Tests: instrumentation</keyword><keyword>Toxicity Tests: methods</keyword><keyword>Water Pollutants</keyword><keyword>Water Supply</keyword><keyword>Water Supply: standards</keyword></keywords><dates><year>2009</year></dates><accession-num>19606294</accession-num><electronic-resource-num>10.1039/b901314h</electronic-resource-num><notes>From Duplicate 1 (A portable cell-based impedance sensor for toxicity testing of drinking water. - Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe)

From Duplicate 2 ( 

A portable cell-based impedance sensor for toxicity testing of drinking water.

- Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe )




From Duplicate 1 ( 


A portable cell-based impedance sensor for toxicity testing of drinking water.


- Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe )








From Duplicate 2 ( 


A portable cell-based impedance sensor for toxicity testing of drinking water.


- Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe )




From Duplicate 1 ( 


A portable cell-based impedance sensor for toxicity testing of drinking water.


- Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe )</notes><research-notes>From Duplicate 1 (A portable cell-based impedance sensor for toxicity testing of drinking water. - Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe)

From Duplicate 2 ( 

A portable cell-based impedance sensor for toxicity testing of drinking water.

- Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe )




From Duplicate 1 ( 


A portable cell-based impedance sensor for toxicity testing of drinking water.


- Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe )








From Duplicate 2 ( 


A portable cell-based impedance sensor for toxicity testing of drinking water.


- Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe )




From Duplicate 1 ( 


A portable cell-based impedance sensor for toxicity testing of drinking water.


- Curtis, Theresa M; Widder, Mark W; Brennan, Linda M; Schwager, Steven J; van der Schalie, William H; Fey, Julien; Salazar, Noe )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19606294</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>A major limitation to using mammalian cell-based biosensors for field testing of drinking water samples is the difficulty of maintaining cell viability and sterility without an on-site cell culture facility. This paper describes a portable automated bench-top mammalian cell-based toxicity sensor that incorporates enclosed fluidic biochips containing endothelial cells monitored by Electric Cell-substrate Impedance Sensing (ECIS) technology. Long-term maintenance of cells on the biochips is made possible by using a compact, self-contained disposable media delivery system. The toxicity sensor monitors changes in impedance of cell monolayers on the biochips after the introduction of water samples. The fluidic biochip includes an ECIS electronic layer and a polycarbonate channel layer, which together reduce initial impedance disturbances seen in commercially available open well ECIS chips caused by the mechanics of pipetting while maintaining the ability of the cells to respond to toxicants. A curve discrimination program was developed that compares impedance values over time between the control and treatment channels on the fluidic biochip and determines if they are significantly different. Toxicant responses of bovine pulmonary artery endothelial cells grown on fluidic biochips are similar to cells on commercially-available open well chips, and these cells can be maintained in the toxicity sensor device for at least nine days using an automated media delivery system. Longer-term cell storage is possible; bovine lung microvessel endothelial cells survive for up to four months on the fluidic biochips and remain responsive to a model toxicant. This is the first demonstration of a portable bench top system capable of both supporting cell health over extended periods of time and obtaining impedance measurements from endothelial cell monolayers after toxicant exposure.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Spiering, Désirée</author><author>Schmolke, Mirco</author><author>Ohnesorge, Nils</author><author>Schmidt, Marc</author><author>Goebeler, Matthias</author><author>Wegener, Joachim</author><author>Wixler, Viktor</author><author>Ludwig, Stephan</author></authors></contributors><titles><title>MEK5/ERK5 signaling modulates endothelial cell migration and focal contact turnover.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>24972-24980</pages><volume>284</volume><issue>37</issue><keywords><keyword>Biological</keyword><keyword>Cell Movement</keyword><keyword>Cell Survival</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Humans</keyword><keyword>MAP Kinase Kinase 5</keyword><keyword>MAP Kinase Kinase 5: metabolism</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>Mitogen-Activated Protein Kinase 7</keyword><keyword>Mitogen-Activated Protein Kinase 7: metabolism</keyword><keyword>Models</keyword><keyword>Neovascularization</keyword><keyword>Pathologic</keyword><keyword>Phenotype</keyword><keyword>Signal Transduction</keyword><keyword>Transfection</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2009</year></dates><accession-num>19605361</accession-num><electronic-resource-num>10.1074/jbc.M109.042911</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2757201&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Micromotion;ECIS Migration;Signal Transduction;Wound Healing</label><abstract>The formation of new blood vessels from pre-existing ones requires highly coordinated restructuring of endothelial cells (EC) and the surrounding extracellular matrix. Directed EC migration is a central step in this process and depends on cellular signaling cascades that initiate and control the structural rearrangements. On the basis of earlier findings that ERK5 deficiency in mouse EC results in massive defects in vessel architecture, we focused on the impact of the MEK5/ERK5 signaling pathway on EC migration. Using a retroviral gene transfer approach, we found that constitutive activation of MEK5/ERK5 signaling strongly inhibits EC migration and results in massive morphological changes. The area covered by spread EC was dramatically enlarged, accompanied by an increase in focal contacts and altered organization of actin filaments. Consequently, cells were more rigid and show reduced motility. This phenotype was most likely based on decreased focal contact turnover caused by reduced expression of p130Cas, a key player in directed cell migration. We demonstrate for the first time that ERK5 signaling not only is involved in EC survival and stress response but also controls migration and morphology of EC.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chen, Yu-Wen</author><author>Chen, Jan-Kan</author><author>Wang, Jong-Shyan</author></authors></contributors><titles><title>Exercise affects platelet-promoted tumor cell adhesion and invasion to endothelium.</title><secondary-title>European journal of applied physiology</secondary-title></titles><periodical><full-title>European journal of applied physiology</full-title></periodical><pages>393-401</pages><volume>105</volume><issue>3</issue><keywords><keyword>Antigens</keyword><keyword>Blood Flow Velocity</keyword><keyword>Blood Platelets</keyword><keyword>Blood Platelets: cytology</keyword><keyword>Blood Platelets: physiology</keyword><keyword>CD44</keyword><keyword>CD44: metabolism</keyword><keyword>Carcinoma</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: genetics</keyword><keyword>Cell Line</keyword><keyword>Constriction</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Endothelium</keyword><keyword>Exercise</keyword><keyword>Exercise: physiology</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Nasopharyngeal Neoplasms</keyword><keyword>Nasopharyngeal Neoplasms: physiopathology</keyword><keyword>P-Selectin</keyword><keyword>P-Selectin: analysis</keyword><keyword>P-Selectin: genetics</keyword><keyword>Pathologic</keyword><keyword>Pathologic: physiopathology</keyword><keyword>Physical Exertion</keyword><keyword>Platelet Adhesiveness</keyword><keyword>Platelet Adhesiveness: physiology</keyword><keyword>Platelet Aggregation</keyword><keyword>Platelet Aggregation: physiology</keyword><keyword>Platelet Count</keyword><keyword>Platelet Glycoprotein GPIIb-IIIa Complex</keyword><keyword>Platelet Glycoprotein GPIIb-IIIa Complex: analysis</keyword><keyword>Platelet Glycoprotein GPIIb-IIIa Complex: metaboli</keyword><keyword>Shear Strength</keyword><keyword>Shear Strength: physiology</keyword><keyword>Tumor</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: physiopathology</keyword><keyword>Young Adult</keyword></keywords><dates><year>2009</year></dates><accession-num>18998154</accession-num><electronic-resource-num>10.1007/s00421-008-0916-2</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18998154</url></web-urls></urls><label>ECIS Invasion</label><abstract>This investigation explored how exercise intensity impacts platelet-mediated interactions of nasopharyngeal carcinoma cells (NPCs) and vascular endothelial cells (ECs) under shear flow in 33 males. Our results showed that (a) platelet-NPC aggregates (PNA) were associated with higher shear-induced P-selectin expression and glycoprotein alpha(II)beta(3) activation than platelet-platelet aggregates (PPA); (b) strenuous exercise (SE, up to VO2max), but not moderate exercise (ME, 60% VO2max for 30 min), increased both PPA and PNA in mimicked venous and arterial circuits and enhanced PNA in mimicked flow of stenotic vessels; (c) the percentages of PNA that remained bound to ECs in mimicked flow of post-capillary venules increased, while platelet-induced CD44 cleavage on NPC and trans-endothelial migration of NPC were enhanced following SE, but were unchanged in response to ME. We conclude that SE, but not ME, enhances the capacity of PNA to adhere to ECs, withstand flowing blood, and facilitate the invasion of NPCs toward ECs.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>He, Donghong</author><author>Su, Yanlin</author><author>Usatyuk, Peter V</author><author>Spannhake, Ernst Wm</author><author>Kogut, Paul</author><author>Solway, Julian</author><author>Natarajan, Viswanathan</author><author>Zhao, Yutong</author></authors></contributors><titles><title>Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>24123-24132</pages><volume>284</volume><issue>36</issue><keywords><keyword>Animals</keyword><keyword>Cadherins</keyword><keyword>Cadherins: genetics</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cytokines</keyword><keyword>Cytokines: genetics</keyword><keyword>Cytokines: metabolism</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Epithelial Cells: pathology</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Kinase 1: genetics</keyword><keyword>Focal Adhesion Kinase 1: metabolism</keyword><keyword>Humans</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: toxicity</keyword><keyword>Lung Injury</keyword><keyword>Lung Injury: chemically induced</keyword><keyword>Lung Injury: genetics</keyword><keyword>Lung Injury: metabolism</keyword><keyword>Lung Injury: pathology</keyword><keyword>Lung Injury: prevention &amp; control</keyword><keyword>Lysophosphatidic Acid</keyword><keyword>Lysophosphatidic Acid: genetics</keyword><keyword>Lysophosphatidic Acid: metabolism</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: pharmacology</keyword><keyword>Mice</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Phosphorylation: genetics</keyword><keyword>Protein Kinase C-delta</keyword><keyword>Protein Kinase C-delta: genetics</keyword><keyword>Protein Kinase C-delta: metabolism</keyword><keyword>Protein Kinase C-epsilon</keyword><keyword>Protein Kinase C-epsilon: genetics</keyword><keyword>Protein Kinase C-epsilon: metabolism</keyword><keyword>Receptors</keyword><keyword>Respiratory Mucosa</keyword><keyword>Respiratory Mucosa: metabolism</keyword><keyword>Respiratory Mucosa: pathology</keyword></keywords><dates><year>2009</year></dates><accession-num>19586906</accession-num><electronic-resource-num>10.1074/jbc.M109.007393</electronic-resource-num><notes>From Duplicate 1 (Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury. - He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong)

From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )








From Duplicate 2 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )




From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )














From Duplicate 2 (Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury. - He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong)

From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )








From Duplicate 2 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )




From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )
















From Duplicate 2 ( 

Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.

- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )




From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )








From Duplicate 2 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )




From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )</notes><research-notes>From Duplicate 1 (Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury. - He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong)

From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )








From Duplicate 2 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )




From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )














From Duplicate 2 (Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury. - He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong)

From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )








From Duplicate 2 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )




From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )
















From Duplicate 2 ( 

Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.

- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )




From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )








From Duplicate 2 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )




From Duplicate 1 ( 


Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.


- He, Donghong; Su, Yanlin; Usatyuk, Peter V; Spannhake, Ernst Wm; Kogut, Paul; Solway, Julian; Natarajan, Viswanathan; Zhao, Yutong )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2782006&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Lysophosphatidic acid (LPA), a bioactive phospholipid, induces a wide range of cellular effects, including gene expression, cytoskeletal rearrangement, and cell survival. We have previously shown that LPA stimulates secretion of pro- and anti-inflammatory cytokines in bronchial epithelial cells. This study provides evidence that LPA enhances pulmonary epithelial barrier integrity through protein kinase C (PKC) delta- and zeta-mediated E-cadherin accumulation at cell-cell junctions. Treatment of human bronchial epithelial cells (HBEpCs) with LPA increased transepithelial electrical resistance (TER) by approximately 2.0-fold and enhanced accumulation of E-cadherin to the cell-cell junctions through Galpha(i)-coupled LPA receptors. Knockdown of E-cadherin with E-cadherin small interfering RNA or pretreatment with EGTA (0.1 mm) prior to LPA (1 microm) treatment attenuated LPA-induced increases in TER in HBEpCs. Furthermore, LPA induced tyrosine phosphorylation of focal adhesion kinase (FAK) and overexpression of the FAK inhibitor, and FAK-related non-kinase-attenuated LPA induced increases in TER and E-cadherin accumulation at cell-cell junctions. Overexpression of dominant negative protein kinase delta and zeta attenuated LPA-induced phosphorylation of FAK, accumulation of E-cadherin at cell-cell junctions, and an increase in TER. Additionally, lipopolysaccharide decreased TER and induced E-cadherin relocalization from cell-cell junctions to cytoplasm in a dose-dependent fashion, which was restored by LPA post-treatment in HBEpCs. Intratracheal post-treatment with LPA (5 microm) reduced LPS-induced neutrophil influx, protein leak, and E-cadherin shedding in bronchoalveolar lavage fluids in a murine model of acute lung injury. These data suggest a protective role of LPA in airway inflammation and remodeling.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zhang, Ning</author><author>Sanders, Andrew J</author><author>Ye, L I N</author><author>Kynaston, Howard G</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Vascular endothelial growth inhibitor , expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro</title><secondary-title>International journal of oncology</secondary-title></titles><periodical><full-title>International journal of oncology</full-title></periodical><pages>1473-1480</pages><volume>35</volume><keywords/><dates><year>2009</year></dates><electronic-resource-num>10.3892/ijo</electronic-resource-num><urls/><label>ECIS Migration</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sun, Xiaoguang</author><author>Shikata, Yasushi</author><author>Wang, Lichun</author><author>Ohmori, Kazuyoshi</author><author>Watanabe, Naoko</author><author>Wada, Jun</author><author>Shikata, Kenichi</author><author>Birukov, Konstantin G</author><author>Makino, Hirofumi</author><author>Jacobson, Jeffrey R</author><author>Dudek, Steven M</author><author>Garcia, Joe G N</author></authors></contributors><titles><title>Enhanced interaction between focal adhesion and adherens junction proteins: involvement in sphingosine 1-phosphate-induced endothelial barrier enhancement.</title><secondary-title>Microvascular research</secondary-title></titles><periodical><full-title>Microvascular research</full-title></periodical><pages>304-313</pages><volume>77</volume><issue>3</issue><keywords><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: drug effects</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases: metabolis</keyword><keyword>Gene Silencing</keyword><keyword>Humans</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: pharmacology</keyword><keyword>Paxillin</keyword><keyword>Paxillin: metabolism</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: drug effects</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: pharmacology</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>alpha Catenin</keyword><keyword>alpha Catenin: metabolism</keyword><keyword>beta Catenin</keyword><keyword>beta Catenin: deficiency</keyword><keyword>beta Catenin: metabolism</keyword></keywords><dates><year>2009</year></dates><publisher>Elsevier Inc.</publisher><accession-num>19323978</accession-num><electronic-resource-num>10.1016/j.mvr.2008.12.004</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3136042&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Sphingosine 1-phosphate (S1P) is an important vascular barrier regulatory agonist which enhances the junctional integrity of human lung endothelial cell monolayers. We have now demonstrated that S1P induced cortical actin ring formation and redistribution of focal adhesion kinase (FAK) and paxillin to the cell periphery suggesting the critical role of cell-cell adhesion in endothelial barrier enhancement. Co-immunoprecipitation studies revealed increased association of VE-cadherin with FAK and paxillin in S1P-challenged human pulmonary artery endothelial cell (HPAEC) monolayers. Furthermore, S1P-induced enhancement of VE-cadherin interaction with alpha-catenin and beta-catenin was associated with the increased formation of FAK-beta-catenin protein complexes. Depletion of beta-catenin (siRNA) resulted in loss of S1P-mediated VE-cadherin association with FAK and paxillin rearrangement. Furthermore, transendothelial electrical resistance (an index of barrier function) demonstrated that beta-catenin siRNA significantly attenuated S1P-induced barrier enhancement. These results demonstrate a mechanism of S1P-induced endothelial barrier enhancement via beta-catenin-linked adherens junction and focal adhesion interaction.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tian, Jing</author><author>Smith, Anita</author><author>Nechtman, John</author><author>Podolsky, Robert</author><author>Aggarwal, Saurabh</author><author>Snead, Connie</author><author>Kumar, Sanjiv</author><author>Elgaish, Manal</author><author>Oishi, Peter</author><author>Göerlach, Agnes</author><author>Fratz, Sohrab</author><author>Hess, John</author><author>Catravas, John D</author><author>Verin, Alexander D</author><author>Fineman, Jeffrey R</author><author>She, Jin-Xiong</author><author>Black, Stephen M</author></authors></contributors><titles><title>Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.</title><secondary-title>Physiological genomics</secondary-title></titles><periodical><full-title>Physiological genomics</full-title></periodical><pages>48-60</pages><volume>40</volume><issue>1</issue><keywords><keyword>Anilides</keyword><keyword>Anilides: pharmacology</keyword><keyword>Animal</keyword><keyword>Animals</keyword><keyword>Arteries</keyword><keyword>Arteries: drug effects</keyword><keyword>Arteries: pathology</keyword><keyword>Blood-Air Barrier</keyword><keyword>Blood-Air Barrier: drug effects</keyword><keyword>Blood-Air Barrier: metabolism</keyword><keyword>Cattle</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: genetics</keyword><keyword>Cell Cycle</keyword><keyword>Cell Cycle: drug effects</keyword><keyword>Cell Cycle: genetics</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Disease Models</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: drug effects</keyword><keyword>Humans</keyword><keyword>Hypertension</keyword><keyword>Lung</keyword><keyword>Lung: pathology</keyword><keyword>Neovascularization</keyword><keyword>PPAR gamma</keyword><keyword>PPAR gamma: antagonists &amp; inhibitors</keyword><keyword>Physiologic</keyword><keyword>Physiologic: drug effects</keyword><keyword>Physiologic: genetics</keyword><keyword>Pulmonary</keyword><keyword>Pulmonary: genetics</keyword><keyword>Pulmonary: pathology</keyword><keyword>Reproducibility of Results</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Sheep</keyword><keyword>Ubiquitin</keyword><keyword>Ubiquitin: genetics</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: pharmacology</keyword><keyword>Zinc Fingers</keyword><keyword>Zinc Fingers: genetics</keyword></keywords><dates><year>2009</year></dates><accession-num>19825830</accession-num><electronic-resource-num>10.1152/physiolgenomics.00094.2009</electronic-resource-num><notes>From Duplicate 1 ( 

Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.

- Tian, Jing; Smith, Anita; Nechtman, John; Podolsky, Robert; Aggarwal, Saurabh; Snead, Connie; Kumar, Sanjiv; Elgaish, Manal; Oishi, Peter; Göerlach, Agnes; Fratz, Sohrab; Hess, John; Catravas, John D; Verin, Alexander D; Fineman, Jeffrey R; She, Jin-Xiong; Black, Stephen M )




From Duplicate 1 ( 


Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.


- Tian, Jing; Smith, Anita; Nechtman, John; Podolsky, Robert; Aggarwal, Saurabh; Snead, Connie; Kumar, Sanjiv; Elgaish, Manal; Oishi, Peter; Göerlach, Agnes; Fratz, Sohrab; Hess, John; Catravas, John D; Verin, Alexander D; Fineman, Jeffrey R; She, Jin-Xiong; Black, Stephen M )








From Duplicate 2 ( 


Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.


- Tian, Jing; Smith, Anita; Nechtman, John; Podolsky, Robert; Aggarwal, Saurabh; Snead, Connie; Kumar, Sanjiv; Elgaish, Manal; Oishi, Peter; Göerlach, Agnes; Fratz, Sohrab; Hess, John; Catravas, John D; Verin, Alexander D; Fineman, Jeffrey R; She, Jin-Xiong; Black, Stephen M )




From Duplicate 2 ( 


Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.


- Tian, Jing; Smith, Anita; Nechtman, John; Podolsky, Robert; Aggarwal, Saurabh; Snead, Connie; Kumar, Sanjiv; Elgaish, Manal; Oishi, Peter; Göerlach, Agnes; Fratz, Sohrab; Hess, John; Catravas, John D; Verin, Alexander D; Fineman, Jeffrey R; She, Jin-Xiong; Black, Stephen M )</notes><research-notes>From Duplicate 1 ( 

Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.

- Tian, Jing; Smith, Anita; Nechtman, John; Podolsky, Robert; Aggarwal, Saurabh; Snead, Connie; Kumar, Sanjiv; Elgaish, Manal; Oishi, Peter; Göerlach, Agnes; Fratz, Sohrab; Hess, John; Catravas, John D; Verin, Alexander D; Fineman, Jeffrey R; She, Jin-Xiong; Black, Stephen M )




From Duplicate 1 ( 


Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.


- Tian, Jing; Smith, Anita; Nechtman, John; Podolsky, Robert; Aggarwal, Saurabh; Snead, Connie; Kumar, Sanjiv; Elgaish, Manal; Oishi, Peter; Göerlach, Agnes; Fratz, Sohrab; Hess, John; Catravas, John D; Verin, Alexander D; Fineman, Jeffrey R; She, Jin-Xiong; Black, Stephen M )








From Duplicate 2 ( 


Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.


- Tian, Jing; Smith, Anita; Nechtman, John; Podolsky, Robert; Aggarwal, Saurabh; Snead, Connie; Kumar, Sanjiv; Elgaish, Manal; Oishi, Peter; Göerlach, Agnes; Fratz, Sohrab; Hess, John; Catravas, John D; Verin, Alexander D; Fineman, Jeffrey R; She, Jin-Xiong; Black, Stephen M )




From Duplicate 2 ( 


Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension.


- Tian, Jing; Smith, Anita; Nechtman, John; Podolsky, Robert; Aggarwal, Saurabh; Snead, Connie; Kumar, Sanjiv; Elgaish, Manal; Oishi, Peter; Göerlach, Agnes; Fratz, Sohrab; Hess, John; Catravas, John D; Verin, Alexander D; Fineman, Jeffrey R; She, Jin-Xiong; Black, Stephen M )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2807211&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Peroxisome proliferator-activated receptor type gamma (PPARgamma) is a subgroup of the PPAR transcription factor family. Recent studies indicate that loss of PPARgamma is associated with the development of pulmonary hypertension (PH). We hypothesized that the endothelial dysfunction associated with PPARgamma inhibition may play an important role in the disease process by altering cellular gene expression and signaling cascades. We utilized microarray analysis to determine if PPARgamma inhibition induced changes in gene expression in pulmonary arterial endothelial cells (PAEC). We identified 100 genes and expressed sequence tags (ESTs) that were upregulated by &gt;1.5-fold and 21 genes and ESTs that were downregulated by &gt;1.3-fold (P &lt; 0.05) by PPARgamma inhibition. The upregulated genes can be broadly classified into four functional groups: cell cycle, angiogenesis, ubiquitin system, and zinc finger proteins. The genes with the highest fold change in expression: hyaluronan-mediated motility receptor (HMMR), VEGF receptor 2 (Flk-1), endothelial PAS domain protein 1 (EPAS1), basic fibroblast growth factor (FGF-2), and caveolin-1 in PAEC were validated by real time RT-PCR. We further validated the upregulation of HMMR, Flk-1, FGF2, and caveolin-1 by Western blot analysis. In keeping with the microarray results, PPARgamma inhibition led to re-entry of cell cycle at G(1)/S phase and cyclin C upregulation. PPARgamma inhibition also exacerbated VEGF-induced endothelial barrier disruption. Finally we confirmed the downregulation of PPARgamma and the upregulation of HMMR, Flk-1, FGF2, and Cav-1 proteins in the peripheral lung tissues of an ovine model of PH. In conclusion, we have identified an array of endothelial genes modulated by attenuated PPARgamma signaling that may play important roles in the development of PH.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sarai, Kei</author><author>Shikata, Kenichi</author><author>Shikata, Yasushi</author><author>Omori, Kazuyoshi</author><author>Watanabe, Naomi</author><author>Sasaki, Motofumi</author><author>Nishishita, Shingo</author><author>Wada, Jun</author><author>Goda, Noriko</author><author>Kataoka, Noriyuki</author><author>Makino, Hirofumi</author></authors></contributors><titles><title>Endothelial barrier protection by FTY720 under hyperglycemic condition: involvement of focal adhesion kinase, small GTPases, and adherens junction proteins.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C945-54</pages><volume>297</volume><issue>4</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: drug effects</keyword><keyword>Adherens Junctions: physiology</keyword><keyword>Cadherins</keyword><keyword>Cadherins: physiology</keyword><keyword>Cell Adhesion Molecules</keyword><keyword>Cell Adhesion Molecules: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Endothelium</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases: physiolog</keyword><keyword>Humans</keyword><keyword>Hyperglycemia</keyword><keyword>Hyperglycemia: metabolism</keyword><keyword>Immunosuppressive Agents</keyword><keyword>Immunosuppressive Agents: pharmacology</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: metabolism</keyword><keyword>Lysosphingolipid</keyword><keyword>Lysosphingolipid: physiology</keyword><keyword>Microvessels</keyword><keyword>Microvessels: cytology</keyword><keyword>Monomeric GTP-Binding Proteins</keyword><keyword>Monomeric GTP-Binding Proteins: physiology</keyword><keyword>Phosphorylation</keyword><keyword>Propylene Glycols</keyword><keyword>Propylene Glycols: pharmacology</keyword><keyword>Receptors</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: metabolism</keyword><keyword>Sphingosine: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: physiology</keyword><keyword>rac GTP-Binding Proteins</keyword><keyword>rac GTP-Binding Proteins: physiology</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: physiology</keyword></keywords><dates><year>2009</year></dates><accession-num>19657053</accession-num><electronic-resource-num>10.1152/ajpcell.00606.2008</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19657053</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Recently, sphingosine 1-phosphate (S1P) has been highlighted as an endothelial barrier-stabilizing mediator. FTY720 is a S1P analog originally developed as a novel immunosuppressant. The phosphorylated form of FTY720 binds to S1P receptors to exert S1P-like biological effects, suggesting endothelial barrier promotion by FTY720. To elucidate whether FTY720 induces signaling events related to endothelial barrier enhancement under hyperglycemic conditions, human microvascular endothelial cells (HMVECs) preincubated with hyperglycemic (30 mM) medium were treated with 100 nM FTY720 for 3 h. Immunofluorescent microscopy and coprecipitation study revealed FTY720-induced focal adhesion kinase (FAK)-associated adherens junction (AJ) assembly at cell-cell contacts coincident with formation of a prominent cortical actin ring. FTY720 also induced transmonolayer electrical resistance (TER) augmentation in HMVEC monolayers in both normoglycemic and hyperglycemic conditions, implying endothelial barrier enhancement. Similar to S1P, site-specific FAK tyrosine phosphorylation analysis revealed FTY720-induced FAK [Y576] phosphorylation without phosphorylation of FAK [Y397/Y925]. Furthermore, FTY720 conditioned the phosphorylation profile of FAK [Y397/Y576/Y925] in hyperglycemic medium to the same pattern observed in normoglycemic medium. FTY720 challenge resulted in small GTPase Rac activation under hyperglycemic conditions, whereas increased Rho activity in hyperglycemic medium was restored to the basal level. Rac protein depletion by small interfering RNA (siRNA) technique completely abolished FTY720-induced FAK [Y576] phosphorylation. These findings strongly suggest the barrier protective effect of FTY720 on HMVEC monolayers in hyperglycemic medium via S1P signaling, further implying the possibility of FTY720 as a therapeutic agent of diabetic vascular disorder.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Shivanna, Mahesh</author><author>Srinivas, Sangly P</author></authors></contributors><titles><title>Microtubule stabilization opposes the (TNF-alpha)-induced loss in the barrier integrity of corneal endothelium.</title><secondary-title>Experimental eye research</secondary-title></titles><periodical><full-title>Experimental eye research</full-title></periodical><pages>950-959</pages><volume>89</volume><issue>6</issue><keywords><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cells</keyword><keyword>Corneal</keyword><keyword>Corneal: drug effects</keyword><keyword>Corneal: physiology</keyword><keyword>Corneal: ultrastructure</keyword><keyword>Cultured</keyword><keyword>Dextrans</keyword><keyword>Dextrans: pharmacokinetics</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Epothilones</keyword><keyword>Epothilones: pharmacology</keyword><keyword>Fluorescein-5-isothiocyanate</keyword><keyword>Fluorescein-5-isothiocyanate: analogs &amp; derivative</keyword><keyword>Fluorescein-5-isothiocyanate: pharmacokinetics</keyword><keyword>Humans</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Microtubules</keyword><keyword>Microtubules: drug effects</keyword><keyword>Microtubules: physiology</keyword><keyword>Paclitaxel</keyword><keyword>Paclitaxel: pharmacology</keyword><keyword>Permeability</keyword><keyword>Permeability: drug effects</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Tubulin Modulators</keyword><keyword>Tubulin Modulators: pharmacology</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: pharmacology</keyword></keywords><dates><year>2009</year></dates><publisher>Elsevier Ltd</publisher><accession-num>19695246</accession-num><electronic-resource-num>10.1016/j.exer.2009.08.004</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2784278&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Microtubule disassembly breaks down the barrier integrity in a number of epithelial and endothelial monolayers. This study has investigated effects of TNF-alpha, which is implicated in corneal allograft rejection, on microtubules and barrier integrity in cultured bovine corneal endothelial cells. Exposure to TNF-alpha led to disassembly of the microtubules, and also caused disruption of the perijunctional actomyosin ring (PAMR). As a measure of barrier integrity, trans-endothelial electrical resistance (TER) was determined based on electrical cell-substrate impedance sensing in realtime. Exposure to TNF-alpha caused a slow decline in TER for &gt; 20 h, and a similar exposure to cells grown on porous culture inserts led to a significant increase in permeability to FITC dextran. These changes, indicating a loss of barrier integrity, were also reflected by dislocation of ZO-1 at the cell border and disassembly of cadherins. These effects of TNF-alpha were inhibited upon stabilization of microtubules by pre-treatment with paclitaxel or epothilone B. Microtubule stabilization may be a useful strategy to overcome (TNF-alpha)-induced loss of the barrier integrity of corneal endothelium during inflammation associated with transplant rejection and uveitis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Oudhoff, Menno J</author><author>Kroeze, Kim L</author><author>Nazmi, Kamran</author><author>van den Keijbus, Petra a M</author><author>van 't Hof, Wim</author><author>Fernandez-borja, Mar</author><author>Hordijk, Peter L</author><author>Gibbs, Susan</author><author>Bolscher, Jan G M</author><author>Veerman, Enno C I</author><author>Keijbus, Petra A M Van Den</author><author>Hof, Wim Van</author></authors></contributors><titles><title>Structure-activity analysis of histatin, a potent wound healing peptide from human saliva: cyclization of histatin potentiates molar activity 1,000-fold.</title><secondary-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</secondary-title></titles><periodical><full-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</full-title></periodical><pages>3928-3935</pages><volume>23</volume><issue>11</issue><keywords><keyword>Amino Acid Sequence</keyword><keyword>Biological</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Proliferation</keyword><keyword>Cell Proliferation: drug effects</keyword><keyword>Cyclization</keyword><keyword>Drug Synergism</keyword><keyword>Histatins</keyword><keyword>Histatins: physiology</keyword><keyword>Humans</keyword><keyword>Infant</keyword><keyword>Keratinocytes</keyword><keyword>Keratinocytes: drug effects</keyword><keyword>Male</keyword><keyword>Models</keyword><keyword>Newborn</keyword><keyword>Saliva</keyword><keyword>Saliva: chemistry</keyword><keyword>Structure-Activity Relationship</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: drug effects</keyword><keyword>Wound Healing: physiology</keyword><keyword>and they have increased</keyword><keyword>antimicrobial peptides</keyword><keyword>cell migration</keyword><keyword>conditions such as mucositis</keyword><keyword>cyclic pep-</keyword><keyword>domain mapping</keyword><keyword>or xerostomia</keyword><keyword>reepithelialization</keyword><keyword>risk for oral</keyword><keyword>these patients suffer from</keyword><keyword>tide</keyword></keywords><dates><year>2009</year></dates><accession-num>19652025</accession-num><electronic-resource-num>10.1096/fj.09-137588</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19652025</url></web-urls></urls><label>ECIS Attachment;Wound Healing</label><abstract>Wounds in the mouth heal faster and with less scarification and inflammation than those in the skin. Saliva is thought to be essential for the superior oral wound healing, but the involved mechanism is still unclear. We have previously discovered that a human-specific peptide, histatin, might be implicated in the wound-healing properties of saliva. Here we report that histatin enhances reepithelialization in a human full-skin wound model closely resembling normal skin. The peptide does not stimulate proliferation but induces cell spreading and migration, two key initiating steps in reepithelialization. Activation of cells by histatin requires a G-protein-coupled receptor that activates the ERK1/2 pathway. Using a stepwise-truncation method, we determined the minimal domain (SHREFPFYGDYGS) of the 38-mer-parent peptide that is required for activity. Strikingly, N- to C-terminal cyclization of histatin-1 potentiates the molar activity approximately 1000-fold, indicating that the recognition of histatin by its cognate receptor requires a specific spatial conformation of the peptide. Our results emphasize the importance of histatin in human saliva for tissue protection and recovery and establish the experimental basis for the development of synthetic histatins as novel skin wound-healing agents.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Curtis, Theresa M</author><author>Tabb, Joel</author><author>Romeo, Lori</author><author>Schwager, Steven J</author><author>Widder, Mark W</author><author>van der Schalie, William H</author></authors></contributors><titles><title>Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.</title><secondary-title>Journal of applied toxicology : JAT</secondary-title></titles><periodical><full-title>Journal of applied toxicology : JAT</full-title></periodical><pages>374-380</pages><volume>29</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Cattle</keyword><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Chemical</keyword><keyword>Chemical: toxicity</keyword><keyword>Electric Impedance</keyword><keyword>Electrodes</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Humans</keyword><keyword>Iguanas</keyword><keyword>Toxicity Tests</keyword><keyword>Toxicity Tests: instrumentation</keyword><keyword>Toxicity Tests: methods</keyword><keyword>Water Pollutants</keyword></keywords><dates><year>2009</year></dates><accession-num>19267359</accession-num><electronic-resource-num>10.1002/jat.1421</electronic-resource-num><notes>From Duplicate 2 (Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor. - Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H)

From Duplicate 2 (Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor. - Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H)

From Duplicate 1 ( 

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.

- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )








From Duplicate 2 ( 

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.

- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )




From Duplicate 2 ( 


Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.


- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )





From Duplicate 1 ( 

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.

- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )








From Duplicate 2 ( 

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.

- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )




From Duplicate 2 ( 


Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.


- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )</notes><research-notes>From Duplicate 2 (Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor. - Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H)

From Duplicate 2 (Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor. - Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H)

From Duplicate 1 ( 

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.

- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )








From Duplicate 2 ( 

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.

- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )




From Duplicate 2 ( 


Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.


- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )





From Duplicate 1 ( 

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.

- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )








From Duplicate 2 ( 

Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.

- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )




From Duplicate 2 ( 


Improved cell sensitivity and longevity in a rapid impedance-based toxicity sensor.


- Curtis, Theresa M; Tabb, Joel; Romeo, Lori; Schwager, Steven J; Widder, Mark W; van der Schalie, William H )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19267359</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>A number of toxicity sensors for testing field water using a range of eukaryotic cell types have been proposed, but it has been difficult to identify sensors with both appropriate sensitivity to toxicants and the potential for long-term viability. Assessment of bovine pulmonary artery endothelial cell (BPAEC) monolayer electrical impedance with electric cell-substrate impedance sensing (ECIS) showed promise in a previous systematic evaluation of toxicity sensor technologies. The goal of the study reported here was to improve toxicant responsiveness and field portability of this cell-based toxicity sensor. A variety of human cells, non-human mammalian cells, and non-mammalian vertebrate cells were screened for sensitivity to 12 waterborne industrial chemicals. The results of this assessment show that bovine lung microvessel endothelial cell (BLMVEC) monolayers and iguana heart (IgH-2) cell monolayers could detect nine out of the 12 waterborne industrial chemicals, an improvement over the seven chemicals previously detected using BPAEC monolayers. Both the BLMVEC and IgH-2 cell monolayers were tested for their ability for long-term survival on the ECIS test chips in a laboratory environment. Both cell lines were able to maintain high impedance readings on the ECIS electrodes for 37 days, a key trait in developing a field-portable toxicity sensor for water. Cell line optimization has greatly contributed to the on-going development of a field-portable cell-based biosensor that detects with sensitivity a wide range of waterborne toxicants.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jalimarada, Supriya S</author><author>Shivanna, Mahesh</author><author>Kini, Vidisha</author><author>Mehta, Dolly</author><author>Srinivas, Sangly P</author></authors></contributors><titles><title>Microtubule disassembly breaks down the barrier integrity of corneal endothelium.</title><secondary-title>Experimental eye research</secondary-title></titles><periodical><full-title>Experimental eye research</full-title></periodical><pages>333-343</pages><volume>89</volume><issue>3</issue><keywords><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Corneal</keyword><keyword>Corneal: drug effects</keyword><keyword>Corneal: metabolism</keyword><keyword>Corneal: ultrastructure</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP: physiology</keyword><keyword>Endothelium</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Microtubules</keyword><keyword>Microtubules: drug effects</keyword><keyword>Microtubules: metabolism</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Nocodazole</keyword><keyword>Nocodazole: pharmacology</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Tubulin Modulators</keyword><keyword>Tubulin Modulators: pharmacology</keyword></keywords><dates><year>2009</year></dates><publisher>Elsevier Ltd</publisher><accession-num>19345211</accession-num><electronic-resource-num>10.1016/j.exer.2009.03.019</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2745835&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Increased contractility of the peri-junctional actomyosin ring (PAMR) breaks down the barrier integrity of corneal endothelium. This study has examined the effects of microtubule disassembly on Myosin Light Chain (MLC) phosphorylation, a biochemical marker of actomyosin contraction, and barrier integrity in monolayers of cultured bovine corneal endothelial cells (BCEC). Exposure to nocodazole, which readily induced microtubule disassembly, led to disruption of the characteristically dense assembly of cortical actin cytoskeleton at the apical junctional complex (i.e., PAMR) and dispersion of ZO-1 from its normal locus. Nocodazole also led to an increase in phosphorylation of MLC. Concomitant with these changes, nocodazole caused an increase in permeability to HRP and FITC dextran (10 kDa) and a decrease in trans-endothelial electrical resistance (TER). Y-27632 (a Rho kinase inhibitor) and forskolin (known to inhibit activation of RhoA through direct elevation of cAMP) opposed the nocodazole-induced MLC phosphorylation, decrease in TER, and dispersion of ZO-1. Thrombin, which breaks down the barrier integrity of BCEC monolayers, also induced microtubule disassembly and MLC phosphorylation. Pre-treatment with paclitaxel to stabilize microtubules opposed the thrombin effects. These results suggest that microtubule disassembly breaks down the barrier integrity of BCEC through activation of RhoA and subsequent disruption of the PAMR. The thrombin effect also highlights that signaling downstream of GPCRs can also influence the organization of microtubules.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Opp, Daniel</author><author>Wafula, Brian</author><author>Lim, Jennifer</author><author>Huang, Eric</author><author>Lo, Jun-Chih</author><author>Lo, Chun-Min</author></authors></contributors><titles><title>Use of electric cell-substrate impedance sensing to assess in vitro cytotoxicity.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>2625-2629</pages><volume>24</volume><issue>8</issue><keywords><keyword>Apoptosis</keyword><keyword>Apoptosis: drug effects</keyword><keyword>Biological Assay</keyword><keyword>Biological Assay: instrumentation</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytochalasin B</keyword><keyword>Cytochalasin B: toxicity</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Electrochemistry</keyword><keyword>Electrochemistry: instrumentation</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Humans</keyword><keyword>Impedance</keyword><keyword>Impedance: instrumentation</keyword><keyword>Impedance: methods</keyword><keyword>Plethysmography</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Toxicity Tests</keyword><keyword>Toxicity Tests: instrumentation</keyword></keywords><dates><year>2009</year></dates><accession-num>19230649</accession-num><electronic-resource-num>10.1016/j.bios.2009.01.015</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2668605&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Apoptosis;ECIS Cytotoxicity;ECIS Micromotion</label><abstract>In vitro assessment of cytotoxicity based on electrochemical impedance spectroscopy (EIS) needs more quantitative methods to analyze the alteration of cell morphology and motility, and hence the potential risk to human health. Here, we applied electric cell-substrate impedance sensing (ECIS) to evaluate dose-dependent responses of human umbilical vein endothelial cells exposed to cytochalasin B. To detect subtle changes in cell morphology, the frequency-dependent impedance data of the cell monolayer were measured and analyzed with a theoretical cell-electrode model. To detect the alternation of cell micromotion in response to cytochalasin B challenge, time-series impedance fluctuations of cell-covered electrodes were monitored and the values of power spectrum, variance, and variance of the increments were calculated to verify the difference. While a dose-dependent relationship was generally observed from the overall resistance of the cell monolayer, the analysis of frequency-dependent impedance and impedance fluctuations distinguished cytochalasin B levels as low as 0.1 microM. Our results show that cytochalasin B causes a decrease of junctional resistance between cells, an increase of membrane capacitance, and the reduction in micromotion.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Betzen, Christian</author><author>White, Robin</author><author>Zehendner, Christoph M</author><author>Pietrowski, Eweline</author><author>Bender, Bianca</author><author>Luhmann, Heiko J</author><author>Kuhlmann, Christoph R W</author></authors></contributors><titles><title>Oxidative stress upregulates the NMDA receptor on cerebrovascular endothelium.</title><secondary-title>Free radical biology &amp; medicine</secondary-title></titles><periodical><full-title>Free radical biology &amp; medicine</full-title></periodical><pages>1212-1220</pages><volume>47</volume><issue>8</issue><keywords><keyword>Animals</keyword><keyword>Apoptosis</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: metabolism</keyword><keyword>Blotting</keyword><keyword>Cells</keyword><keyword>Cerebrovascular Circulation</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Glutamic Acid</keyword><keyword>Glutamic Acid: pharmacology</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Messenger: metabolism</keyword><keyword>Mice</keyword><keyword>N-Methyl-D-Aspartate</keyword><keyword>N-Methyl-D-Aspartate: genetics</keyword><keyword>N-Methyl-D-Aspartate: metabolism</keyword><keyword>N-Methylaspartate</keyword><keyword>N-Methylaspartate: pharmacology</keyword><keyword>Oxidative Stress</keyword><keyword>RNA</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reactive Oxygen Species: metabolism</keyword><keyword>Receptors</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>Western</keyword></keywords><dates><year>2009</year></dates><publisher>Elsevier Inc.</publisher><accession-num>19660541</accession-num><electronic-resource-num>10.1016/j.freeradbiomed.2009.07.034</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19660541</url></web-urls></urls><label>Apoptosis;Blood Brain Barrier;ECIS Attachment;ECIS TEER</label><abstract>N-methyl-d-aspartate receptor (NMDA-R)-mediated oxidative stress has been implicated in blood-brain barrier (BBB) disruption in a variety of neuropathological diseases. Although some interactions between both phenomena have been elucidated, possible influences of reactive oxygen species (ROS) on the NMDA-R itself have so far been neglected. The objective of this study was to examine how the cerebroendothelial NMDA-R is affected by exposure to oxidative stress and to assess possible influences on BBB integrity. RT-PCR confirmed several NMDA-R subunits (NR1, NR2B-D) expressed in the bEnd3 cell line (murine cerebrovascular endothelial cells). NR1 protein expression after exposure to ROS was observed via in-cell Western. The functionality of the expressed NMDA-R was determined by measuring DiBAC fluorescence in ROS-preexposed cells upon stimulation with the specific agonist NMDA. Finally, the effects on barrier integrity were evaluated using the ECIS system to detect changes in monolayer impedance upon NMDA-R stimulation after exposure to ROS. The expression of NR1 significantly (p&lt;0.001) increased 72 h after 30 min exposure to superoxide (+33.8+/-7.5%), peroxynitrite (+84.9+/-10.7%), or hydrogen peroxide (+92.8+/-7.6%), resulting in increased cellular response to NMDA-R stimulation and diminished monolayer impedance. We conclude that oxidative stress upregulates NMDA-R on cerebrovascular endothelium and thus heightens susceptibility to glutamate-induced BBB disruption.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukova, Anna a</author><author>Cokic, Ivan</author><author>Moldobaeva, Nurgul</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>99-107</pages><volume>40</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: metabolism</keyword><keyword>Gene Knockdown Techniques</keyword><keyword>Hepatocyte Growth Factor</keyword><keyword>Hepatocyte Growth Factor: metabolism</keyword><keyword>Humans</keyword><keyword>Paxillin</keyword><keyword>Paxillin: genetics</keyword><keyword>Paxillin: metabolism</keyword><keyword>Permeability</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Small Interfering: metabolism</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: metabolism</keyword><keyword>rac GTP-Binding Proteins</keyword><keyword>rac GTP-Binding Proteins: genetics</keyword><keyword>rac GTP-Binding Proteins: metabolism</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: genetics</keyword><keyword>rho GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2009</year></dates><accession-num>18664639</accession-num><electronic-resource-num>10.1165/rcmb.2008-0099OC</electronic-resource-num><notes>From Duplicate 1 (Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. - Birukova, Anna a; Cokic, Ivan; Moldobaeva, Nurgul; Birukov, Konstantin G)

From Duplicate 2 ( Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. - Birukova, Anna a; Cokic, Ivan; Moldobaeva, Nurgul; Birukov, Konstantin G )</notes><research-notes>From Duplicate 1 (Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. - Birukova, Anna a; Cokic, Ivan; Moldobaeva, Nurgul; Birukov, Konstantin G)

From Duplicate 2 ( Paxillin is involved in the differential regulation of endothelial barrier by HGF and VEGF. - Birukova, Anna a; Cokic, Ivan; Moldobaeva, Nurgul; Birukov, Konstantin G )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2606951&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Circulating levels of hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) are increased during acute lung injury; however, combined effects of HGF and VEGF on pulmonary endothelial cell (EC) permeability remain to be elucidated. We have previously shown differential remodeling of focal adhesions (FA) caused by barrier-protective and barrier-disruptive mechanical and chemical stimuli. This study examined a role of FA protein paxillin in the pulmonary EC barrier responses induced by HGF and VEGF. VEGF increased, but HGF decreased, pulmonary EC permeability. These effects were accompanied by differential patterns of site-specific phosphorylation of focal adhesion kinase (FAK) and paxillin and FA redistribution. HGF antagonized random FA formation caused by VEGF challenge and promoted FA accumulation at the cell periphery. HGF attenuated VEGF-induced paxillin redistribution, FA remodeling, and endothelial permeability. SiRNA-based paxillin knockdown attenuated VEGF-induced EC permeability, myosin light chain phosphorylation, and stress fiber and paracellular gap formation. Paxillin knockdown also decreased HGF-induced EC barrier enhancement and suppressed activation of Rac and its effector PAK1. Expression of paxillin-S(273) deficient on PAK1 phosphorylation site prevented HGF-induced cytoskeletal remodeling. These data show a dual role of paxillin in the HGF- and VEGF-mediated endothelial barrier regulation and suggest essential paxillin role in the modulation of Rac-Rho crosstalk. Our results also support a model of pulmonary EC barrier recovery during resolution of ALI via switch from VEGF to HGF signaling.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jiang, Wen G</author><author>Ablin, Richard J</author><author>Kynaston, Howard G</author><author>Mason, Malcolm D</author></authors></contributors><titles><title>The prostate transglutaminase (TGase-4, TGaseP) regulates the interaction of prostate cancer and vascular endothelial cells, a potential role for the ROCK pathway.</title><secondary-title>Microvascular research</secondary-title></titles><periodical><full-title>Microvascular research</full-title></periodical><pages>150-157</pages><volume>77</volume><issue>2</issue><keywords><keyword>Base Sequence</keyword><keyword>Catalytic</keyword><keyword>Catalytic: genetics</keyword><keyword>Catalytic: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Communication</keyword><keyword>Cell Line</keyword><keyword>DNA Primers</keyword><keyword>DNA Primers: genetics</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Endothelial Cells: pathology</keyword><keyword>Gene Expression</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Prostatic Neoplasms</keyword><keyword>Prostatic Neoplasms: blood supply</keyword><keyword>Prostatic Neoplasms: enzymology</keyword><keyword>Prostatic Neoplasms: pathology</keyword><keyword>RNA</keyword><keyword>Transglutaminases</keyword><keyword>Transglutaminases: antagonists &amp; inhibitors</keyword><keyword>Transglutaminases: genetics</keyword><keyword>Transglutaminases: metabolism</keyword><keyword>Tumor</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2009</year></dates><publisher>Elsevier Inc.</publisher><accession-num>18983858</accession-num><electronic-resource-num>10.1016/j.mvr.2008.09.010</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18983858</url><url>http://www.sciencedirect.com/science/article/pii/S0026286208001465</url></web-urls></urls><label>ECIS Invasion</label><abstract>Prostate transglutaminase (TGase-4 or TGaseP) is an enzyme that is uniquely expressed in prostate tissues. The function of the TGase, implicated in the cell-matrix, is yet to be fully established. In the present study, we investigated the role of TGase-4 in tumor-endothelial cell interactions, by creating a panel of prostate cancer cell lines that have different expression profiles of human TGase-4. Here, we report that prostate cancer cells PC-3, when over-expressing TGase-4 (PC-3(TGase4exp)) increased their ability to adhere to quiescent and activated (by hepatocyte growth factor) endothelial cells. In contrast, the prostate cancer cell CAHPV-10, which expressed high levels of TGase-4, reduced the adhesiveness to the endothelial cells after TGase-4 expression was knocked down. By using frequency based electric cell impedance sensing, we found that TGase-4 mediated adhesion resulted in a change in impedance at low frequency (400 Hz), indicating a paracellular pathway disruption. The study further showed that expression of TGase-4 rendered the cells to exert regulation of endothelial interaction by bypassing the ROCK pathway. It is therefore concluded, that TGase-4 plays a pivotal role in the interaction between endothelial cells and prostate cancer cells, an action which is independent of the ROCK pathway.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Han, Jingyan</author><author>Liu, Guoquan</author><author>Profirovic, Jasmina</author><author>Niu, Jiaxin</author><author>Voyno-Yasenetskaya, Tatyana</author></authors></contributors><titles><title>Zyxin is involved in thrombin signaling via interaction with PAR-1 receptor.</title><secondary-title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</secondary-title></titles><periodical><full-title>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</full-title></periodical><pages>4193-4206</pages><volume>23</volume><issue>12</issue><keywords><keyword>Animals</keyword><keyword>COS Cells</keyword><keyword>Cell Adhesion Molecules</keyword><keyword>Cell Adhesion Molecules: metabolism</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: genetics</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: physiology</keyword><keyword>Glycoproteins</keyword><keyword>Glycoproteins: genetics</keyword><keyword>Glycoproteins: metabolism</keyword><keyword>Heterotrimeric GTP-Binding Proteins</keyword><keyword>Heterotrimeric GTP-Binding Proteins: metabolism</keyword><keyword>Humans</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>PAR-1</keyword><keyword>PAR-1: genetics</keyword><keyword>PAR-1: metabolism</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Protein Transport</keyword><keyword>Receptor</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: genetics</keyword><keyword>Thrombin: metabolism</keyword><keyword>Zyxin</keyword></keywords><dates><year>2009</year></dates><accession-num>19690217</accession-num><electronic-resource-num>10.1096/fj.09-131862</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2812041&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Protease-activated receptor 1 (PAR-1) mediates thrombin signaling in human endothelial cells. As a G-protein-coupled receptor, PAR-1 transmits thrombin signal through activation of the heterotrimeric G proteins, Gi, Gq, and G12/13. In this study, we demonstrated that zyxin, a LIM-domain-containing protein, is involved in thrombin-mediated actin cytoskeleton remodeling and serum response element (SRE)-dependent gene transcription. We determined that zyxin binds to the C-terminal domain of PAR-1, providing a possible mechanism of involvement of zyxin as a signal transducer in PAR-1 signaling. Data showing that disruption of PAR-1-zyxin interaction inhibited thrombin-induced stress fiber formation and SRE activation supports this hypothesis. Similarly, depletion of zyxin using siRNA inhibited thrombin-induced actin stress fiber formation and SRE-dependent gene transcription. In addition, depletion of zyxin resulted in delay of endothelial barrier restoration after thrombin treatment. Notably, down-regulation of zyxin did not affect thrombin-induced activation of RhoA or Gi, Gq, and G12/13 heterotrimeric G proteins, implicating a novel signaling pathway regulated by PAR-1 that is not mediated by G-proteins. The observation that zyxin targets VASP, a partner of zyxin in regulation of actin assembly and dynamics, to focal adhesions and along stress fibers on thrombin stimulation suggests that zyxin may participate in thrombin-induced cytoskeletal remodeling through recruitment of VASP. In summary, this study establishes a crucial role of zyxin in thrombin signaling in endothelial cells and provides evidence for a novel PAR-1 signaling pathway mediated by zyxin.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tarantola, Marco</author><author>Schneider, David</author><author>Sunnick, Eva</author><author>Adam, Holger</author><author>Pierrat, Sebastien</author><author>Rosman, Christina</author><author>Breus, Vladimir</author><author>Sönnichsen, Carsten</author><author>Basché, Thomas</author><author>Wegener, Joachim</author><author>Janshoff, Andreas</author></authors></contributors><titles><title>Cytotoxicity of metal and semiconductor nanoparticles indicated by cellular micromotility.</title><secondary-title>ACS nano</secondary-title></titles><periodical><full-title>ACS nano</full-title></periodical><pages>213-222</pages><volume>3</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Biodegradation</keyword><keyword>Contrast Media</keyword><keyword>Contrast Media: pharmacology</keyword><keyword>Drug Delivery Systems</keyword><keyword>Electric Impedance</keyword><keyword>Environmental</keyword><keyword>Fluorescent Dyes</keyword><keyword>Fluorescent Dyes: chemistry</keyword><keyword>Gold</keyword><keyword>Gold: chemistry</keyword><keyword>Humans</keyword><keyword>Metal Nanoparticles</keyword><keyword>Metal Nanoparticles: chemistry</keyword><keyword>Metals</keyword><keyword>Metals: chemistry</keyword><keyword>Nanoparticles</keyword><keyword>Nanoparticles: chemistry</keyword><keyword>Nanotechnology</keyword><keyword>Nanotechnology: methods</keyword><keyword>Quantum Dots</keyword><keyword>Semiconductors</keyword></keywords><dates><year>2009</year></dates><accession-num>19206269</accession-num><electronic-resource-num>10.1021/nn800721j</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19206269</url></web-urls></urls><label>ECIS Cytotoxicity;ECIS Micromotion;ECIS TEER</label><abstract>In the growing field of nanotechnology, there is an urgent need to sensitively determine the toxicity of nanoparticles since many technical and medical applications are based on controlled exposure to particles, that is, as contrast agents or for drug delivery. Before the in vivo implementation, in vitro cell experiments are required to achieve a detailed knowledge of toxicity and biodegradation as a function of the nanoparticles' physical and chemical properties. In this study, we show that the micromotility of animal cells as monitored by electrical cell-substrate impedance analysis (ECIS) is highly suitable to quantify in vitro cytotoxicity of semiconductor quantum dots and gold nanorods. The method is validated by conventional cytotoxicity testing and accompanied by fluorescence and dark-field microscopy to visualize changes in the cytoskeleton integrity and to determine the location of the particles within the cell.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Breslin, Jerome W</author><author>Kurtz, Kristine M</author></authors></contributors><titles><title>Lymphatic endothelial cells adapt their barrier function in response to changes in shear stress.</title><secondary-title>Lymphatic research and biology</secondary-title></titles><periodical><full-title>Lymphatic research and biology</full-title></periodical><pages>229-237</pages><volume>7</volume><issue>4</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Adult</keyword><keyword>Cells</keyword><keyword>Computer Simulation</keyword><keyword>Controlled</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: metabolism</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Dermis</keyword><keyword>Dermis: cytology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Environment</keyword><keyword>Humans</keyword><keyword>Lymphatic</keyword><keyword>Lymphatic: physiology</keyword><keyword>Mechanical</keyword><keyword>Stress</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2009</year></dates><accession-num>20143922</accession-num><electronic-resource-num>10.1089/lrb.2009.0015</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2883493&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Flow;ECIS TEER</label><abstract>Lymphatic endothelial cells form an important barrier necessary for normal lymph formation and propulsion. However, little is known about how physical forces within lymphatic vessels affect endothelial barrier function. The purpose of this study was to characterize how laminar flow affects lymphatic endothelial barrier function and to test whether endothelial cells respond to flow changes by activating the intracellular actin cytoskeleton to enhance barrier function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Goncalves, Juan Jose</author><author>Govind, Rakesh</author></authors></contributors><titles><title>Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device</title><secondary-title>Sensors and Actuators B: Chemical</secondary-title></titles><periodical><full-title>Sensors and Actuators B: Chemical</full-title></periodical><pages>341-348</pages><volume>143</volume><issue>1</issue><keywords><keyword>biofilm attachment</keyword><keyword>corresponding author</keyword><keyword>dr juan goncalves</keyword><keyword>electrical impedance spectroscopy</keyword><keyword>first author</keyword><keyword>juan goncalves</keyword><keyword>model</keyword><keyword>polyethyleneimine</keyword><keyword>s institution</keyword><keyword>university of cincinnati</keyword></keywords><dates><year>2009</year></dates><electronic-resource-num>10.1016/j.snb.2009.07.036</electronic-resource-num><notes>From Duplicate 2 (Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device - Goncalves, Juan Jose; Govind, Rakesh)

From Duplicate 1 (Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device - Goncalves, Juan Jose; Govind, Rakesh)

From Duplicate 1 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )




From Duplicate 4 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )












From Duplicate 2 ( 


Rapid Evaluation of Biofilm attachment protors and biofilm growth orientation using a mini-impedimetric device


- )
And Duplicate 3 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )












From Duplicate 1 ( 

Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device

- Goncalves, Juan Jose; Govind, Rakesh )




From Duplicate 1 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )




From Duplicate 4 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )












From Duplicate 2 ( 


Rapid Evaluation of Biofilm attachment protors and biofilm growth orientation using a mini-impedimetric device


- )
And Duplicate 3 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )





From Duplicate 4 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )</notes><research-notes>From Duplicate 2 (Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device - Goncalves, Juan Jose; Govind, Rakesh)

From Duplicate 1 (Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device - Goncalves, Juan Jose; Govind, Rakesh)

From Duplicate 1 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )




From Duplicate 4 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )












From Duplicate 2 ( 


Rapid Evaluation of Biofilm attachment protors and biofilm growth orientation using a mini-impedimetric device


- )
And Duplicate 3 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )












From Duplicate 1 ( 

Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device

- Goncalves, Juan Jose; Govind, Rakesh )




From Duplicate 1 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )




From Duplicate 4 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )












From Duplicate 2 ( 


Rapid Evaluation of Biofilm attachment protors and biofilm growth orientation using a mini-impedimetric device


- )
And Duplicate 3 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )





From Duplicate 4 ( 


Rapid evaluation of biofilm attachment promoters and biofilm growth orientation using a mini-impedimetric device


- Goncalves, Juan Jose; Govind, Rakesh )</research-notes><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0925400509005991</url></web-urls></urls><label>ECIS Attachment;ECIS Biofilms;ECIS Growth</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rahman, Abdur Rub Abdur</author><author>Lo, Chun-Min</author><author>Bhansali, Shekhar</author></authors></contributors><titles><title>A detailed model for high-frequency impedance characterization of ovarian cancer epithelial cell layer using ECIS electrodes.</title><secondary-title>IEEE transactions on bio-medical engineering</secondary-title></titles><periodical><full-title>IEEE transactions on bio-medical engineering</full-title></periodical><pages>485-492</pages><volume>56</volume><issue>2</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Electric Impedance</keyword><keyword>Electrodes</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: pathology</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Equipment Design</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Ovarian Neoplasms</keyword><keyword>Ovarian Neoplasms: pathology</keyword><keyword>Ovarian Neoplasms: physiopathology</keyword><keyword>Spectrum Analysis</keyword><keyword>Spectrum Analysis: instrumentation</keyword><keyword>Tumor</keyword></keywords><dates><year>2009</year></dates><accession-num>19272881</accession-num><electronic-resource-num>10.1109/TBME.2008.2008488</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19272881</url></web-urls></urls><label>ECIS Modeling;ECIS Theory</label><abstract>We report on the electrical impedance spectroscopy characterization of OVCA429 ovarian cancer cells. A commercially available eight-well cell culture impedance array (ECIS-8W1E), commonly used in electrical cell-substrate impedance sensing (ECIS), was used for OVCA429 characterization. Impedances of ECIS-8W1E array were recorded with cell culture medium (without cells) and with OVCA429 cell layer in the culture medium between 100 Hz and 10 MHz frequency. Physiological and interfacial components of experimental impedance data were modeled by equivalent circuit fitting, using a newly developed model. Impedance measurements with cell culture medium show only two semicircles in the admittance plane, which are identified as: 1) low-frequency semicircle due to impedance of gold electrode in contact with the electrolyte and 2) high-frequency semicircle due to impedance of polymer-coated region of the gold electrode in contact with the electrolyte. In the presence of OVCA429 cell layer, three convolved semicircles are observed in the Cole-Cole plane, which are identified as the interfacial impedance in series with the cell layer impedance. The average resistance and capacitance of the OVCA429 cell layer was found to be 152+/-59 ohm x cm(2) and 8.5+/-2.4 microF/cm(2), respectively.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Slaughter, Gymama E</author><author>Hobson, Rosalyn</author></authors></contributors><titles><title>An impedimetric biosensor based on PC 12 cells for the monitoring of exogenous agents.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>1153-1158</pages><volume>24</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Biological Assay</keyword><keyword>Biological Assay: instrumentation</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Drug Evaluation</keyword><keyword>Electric Impedance</keyword><keyword>Electrochemistry</keyword><keyword>Electrochemistry: instrumentation</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>PC12 Cells</keyword><keyword>Pharmaceutical Preparations</keyword><keyword>Pharmaceutical Preparations: administration &amp; dosa</keyword><keyword>Preclinical</keyword><keyword>Preclinical: instrumentation</keyword><keyword>Preclinical: methods</keyword><keyword>Rats</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Toxicity Tests</keyword><keyword>Toxicity Tests: instrumentation</keyword><keyword>Toxicity Tests: methods</keyword></keywords><dates><year>2009</year></dates><accession-num>18760912</accession-num><electronic-resource-num>10.1016/j.bios.2008.06.060</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18760912</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>The effect of exogenous agents on the complex impedance of PC 12 cells that were cultured to confluency on 250-mum gold microdot electrodes fabricated within 8-well cell culture biochips was studied. Surface attachment of PC 12 cells to gold microelectrodes was accomplished using cysteamine SAMs covalently derivatized with laminin. The impedimetric response of PC 12 cells that undergo calcium exocytosis in the presence of calcimycin, nifedipine, mannitol and carbachol were identified. Treatment with carbachol induces muscarinic receptor-dependent rises in free cytosolic Ca(2+). Experiments with calcimycin and nifedipine were carried out to clarify the relationship between these two receptor-triggered events. In particular, it is believed to mediate intracellularly the release of Ca(2+) from non-mitochondrial stores. We also examined cellular impedance responsiveness of PC 12 cells in response to phenotypic alteration especially with regard to modulation of ion fluxes using nerve growth factor (NGF), dexamethasone and forskolin. Our results demonstrate that a change in electrophysiological behavior, such as exocytosis of cytosolic Ca(2+) is detectable using impedance spectroscopy, and therefore support the results of impedance fluctuation to be attributed to ion-fluxes.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Apopa, Patrick L</author><author>Qian, Yong</author><author>Shao, Rong</author><author>Guo, Nancy Lan</author><author>Schwegler-Berry, Diane</author><author>Pacurari, Maricica</author><author>Porter, Dale</author><author>Shi, Xianglin</author><author>Vallyathan, Val</author><author>Castranova, Vincent</author><author>Flynn, Daniel C</author></authors></contributors><titles><title>Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.</title><secondary-title>Particle and fibre toxicology</secondary-title></titles><periodical><full-title>Particle and fibre toxicology</full-title></periodical><pages>1</pages><volume>6</volume><keywords/><dates><year>2009</year></dates><accession-num>19134195</accession-num><electronic-resource-num>10.1186/1743-8977-6-1</electronic-resource-num><notes>From Duplicate 1 (Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. - Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C)

From Duplicate 2 (Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. - Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C)

From Duplicate 2 ( 

Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.

- Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C )




From Duplicate 1 ( 


Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.


- Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C )








From Duplicate 2 ( 


Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.


- Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C )




From Duplicate 1 ( 


Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.


- Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C )</notes><research-notes>From Duplicate 1 (Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. - Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C)

From Duplicate 2 (Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling. - Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C)

From Duplicate 2 ( 

Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.

- Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C )




From Duplicate 1 ( 


Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.


- Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C )








From Duplicate 2 ( 


Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.


- Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C )




From Duplicate 1 ( 


Iron oxide nanoparticles induce human microvascular endothelial cell permeability through reactive oxygen species production and microtubule remodeling.


- Apopa, Patrick L; Qian, Yong; Shao, Rong; Guo, Nancy Lan; Schwegler-Berry, Diane; Pacurari, Maricica; Porter, Dale; Shi, Xianglin; Vallyathan, Val; Castranova, Vincent; Flynn, Daniel C )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2632982&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>Engineered iron nanoparticles are being explored for the development of biomedical applications and many other industry purposes. However, to date little is known concerning the precise mechanisms of translocation of iron nanoparticles into targeted tissues and organs from blood circulation, as well as the underlying implications of potential harmful health effects in human.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Grab, Dennis J</author><author>Nyarko, E</author><author>Nikolskaia, O V</author><author>Kim, Y V</author><author>Dumler, J S</author></authors></contributors><titles><title>Human brain microvascular endothelial cell traversal by Borrelia burgdorferi requires calcium signaling.</title><secondary-title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</secondary-title></titles><periodical><full-title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</full-title></periodical><pages>422-426</pages><volume>15</volume><issue>5</issue><keywords><keyword>Borrelia burgdorferi</keyword><keyword>Borrelia burgdorferi: pathogenicity</keyword><keyword>Brain</keyword><keyword>Brain: microbiology</keyword><keyword>Calcium Signaling</keyword><keyword>Cell Line</keyword><keyword>Egtazic Acid</keyword><keyword>Egtazic Acid: analogs &amp; derivatives</keyword><keyword>Egtazic Acid: pharmacology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: microbiology</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Estrenes</keyword><keyword>Estrenes: pharmacology</keyword><keyword>Humans</keyword><keyword>Pyrrolidinones</keyword><keyword>Pyrrolidinones: pharmacology</keyword></keywords><dates><year>2009</year></dates><accession-num>19489925</accession-num><electronic-resource-num>10.1111/j.1469-0691.2009.02869.x</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19489925</url></web-urls></urls><label>Calcium Signaling;ECIS Invasion;ECIS TEER</label><abstract>Neurological manifestations of Lyme disease (or neuroborreliosis) occur variably and while it is clear that Borrelia burgdorferi can invade the nervous system, how it does so is not well understood. Pathogen penetration through the blood brain barrier (BBB) is often influenced by calcium signaling in the endothelial cells triggered by extracellular host-pathogen interactions. We examined the traversal of B. burgdorferi across the human BBB using in vitro model systems constructed of human brain microvascular endothelial cells (HBMEC) grown on Costar Transwell inserts. Pretreatment of the cell monolayers with BAPTA-AM (an intracellular calcium chelator) or phospholipase C (PLC) inhibitor U73122 inhibited B. burgdorferi transmigration. By 5 h, BAPTA-AM significantly inhibited (82-99%; p &lt;0.017) spirochete traversal of HBMEC compared to DMSO controls. Spirochete traversal was almost totally blocked (&gt; or =99%; p &lt;0.017) after pretreatment with the PLC-beta inhibitor U73122 as a result of barrier tightening based on electric cell-substrate impedance sensing (ECIS). The data suggest a role for calcium signaling in CNS spirochete invasion through endothelial cell barriers.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Guo, Mingzhang</author><author>Daines, Dayle</author><author>Tang, Jing</author><author>Shen, Qiang</author><author>Perrin, Rachel M</author><author>Takada, Yoshikazu</author><author>Yuan, Sarah Y</author><author>Wu, Mack H</author></authors></contributors><titles><title>Fibrinogen-gamma C-terminal fragments induce endothelial barrier dysfunction and microvascular leak via integrin-mediated and RhoA-dependent mechanism.</title><secondary-title>Arteriosclerosis, thrombosis, and vascular biology</secondary-title></titles><periodical><full-title>Arteriosclerosis, thrombosis, and vascular biology</full-title></periodical><pages>394-400</pages><volume>29</volume><issue>3</issue><keywords><keyword>Albumins</keyword><keyword>Albumins: metabolism</keyword><keyword>Amides</keyword><keyword>Amides: pharmacology</keyword><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Fibrinogen</keyword><keyword>Fibrinogen: metabolism</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Integrin alphaVbeta3</keyword><keyword>Integrin alphaVbeta3: genetics</keyword><keyword>Integrin alphaVbeta3: metabolism</keyword><keyword>Integrin beta3</keyword><keyword>Integrin beta3: genetics</keyword><keyword>Integrin beta3: metabolism</keyword><keyword>Knockout</keyword><keyword>Mice</keyword><keyword>Microcirculation</keyword><keyword>Microcirculation: drug effects</keyword><keyword>Microscopy</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Peptide Fragments</keyword><keyword>Peptide Fragments: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Protein Binding</keyword><keyword>Protein Kinase Inhibitors</keyword><keyword>Protein Kinase Inhibitors: pharmacology</keyword><keyword>Pyridines</keyword><keyword>Pyridines: pharmacology</keyword><keyword>RNA</keyword><keyword>RNA Interference</keyword><keyword>Rats</keyword><keyword>Recombinant Proteins</keyword><keyword>Recombinant Proteins: metabolism</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: metabolism</keyword><keyword>Splanchnic Circulation</keyword><keyword>Sprague-Dawley</keyword><keyword>Stress Fibers</keyword><keyword>Stress Fibers: metabolism</keyword><keyword>Time Factors</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: physiopathology</keyword><keyword>Video</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: antagonists &amp; inhibitors</keyword><keyword>rhoA GTP-Binding Protein: genetics</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2009</year></dates><accession-num>19122172</accession-num><electronic-resource-num>10.1161/ATVBAHA.108.180950</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2737386&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>The purposes of this study were to characterize the direct effect of the C-terminal fragment of fibrinogen gamma chain (gammaC) on microvascular endothelial permeability and to examine its molecular mechanism of action.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chan, Chi-Ming</author><author>Fang, Jia-You</author><author>Lin, Hsin-Huang</author><author>Yang, Chi-Yea</author><author>Hung, Chi-Feng</author></authors></contributors><titles><title>Lycopene inhibits PDGF-BB-induced retinal pigment epithelial cell migration by suppression of PI3K/Akt and MAPK pathways.</title><secondary-title>Biochemical and biophysical research communications</secondary-title></titles><periodical><full-title>Biochemical and biophysical research communications</full-title></periodical><pages>172-176</pages><volume>388</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Antioxidants</keyword><keyword>Antioxidants: pharmacology</keyword><keyword>Carotenoids</keyword><keyword>Carotenoids: pharmacology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Humans</keyword><keyword>Mitogen-Activated Protein Kinase Kinases</keyword><keyword>Mitogen-Activated Protein Kinase Kinases: antagoni</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: antagonists &amp; inhi</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Platelet-Derived Growth Factor</keyword><keyword>Platelet-Derived Growth Factor: antagonists &amp; inhi</keyword><keyword>Platelet-Derived Growth Factor: pharmacology</keyword><keyword>Platelet-Derived Growth Factor: physiology</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>Proto-Oncogene Proteins c-akt: antagonists &amp; inhib</keyword><keyword>Retinal Pigment Epithelium</keyword><keyword>Retinal Pigment Epithelium: drug effects</keyword><keyword>Retinal Pigment Epithelium: physiology</keyword></keywords><dates><year>2009</year></dates><publisher>Elsevier Inc.</publisher><accession-num>19664603</accession-num><electronic-resource-num>10.1016/j.bbrc.2009.07.155</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19664603</url></web-urls></urls><label>ECIS Migration</label><abstract>Retinal pigment epithelial (RPE) cells play a dominant role in the development of proliferative vitreoretinopathy (PVR), which is the leading cause of failure in retinal reattachment surgery. Several studies have shown that platelet-derived growth factor (PDGF) exhibits chemotaxis and proliferation effects on RPE cells in PVR. In this study, the inhibitory effect of lycopene on PDGF-BB-induced ARPE19 cell migration is examined. In electric cell-substrate impedance sensing (ECIS) and Transwell migration assays, significant suppression of PDGF-BB-induced ARPE19 cell migration by lycopene is observed. Cell viability assays show no cytotoxicity of lycopene on RPE cells. Lycopene shows no effect on ARPE19 cell adhesion and is found to inhibit PDGF-BB-induced tyrosine phosphorylation and the underlying signaling pathways of PI3K, Akt, ERK and p38 activation. However, PDGF-BB and lycopene show no effects on JNK activation. Taken together, our results demonstrate that lycopene inhibits PDGF-BB-induced ARPE19 cell migration through inhibition of PI3K/Akt, ERK and p38 activation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Melnikova, Vladislava O</author><author>Balasubramanian, Krishnakumar</author><author>Villares, Gabriel J</author><author>Dobroff, Andrey S</author><author>Zigler, Maya</author><author>Wang, Hua</author><author>Petersson, Frederik</author><author>Price, Janet E</author><author>Schroit, Alan</author><author>Prieto, Victor G</author><author>Hung, Mien-Chie</author><author>Bar-Eli, Menashe</author></authors></contributors><titles><title>Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>28845-28855</pages><volume>284</volume><issue>42</issue><keywords><keyword>Antigens</keyword><keyword>CD146</keyword><keyword>CD146: metabolism</keyword><keyword>CREB-Binding Protein</keyword><keyword>CREB-Binding Protein: metabolism</keyword><keyword>Cell Line</keyword><keyword>G-Protein-Coupled</keyword><keyword>G-Protein-Coupled: metabolism</keyword><keyword>Gene Silencing</keyword><keyword>Genetic</keyword><keyword>Humans</keyword><keyword>Melanoma</keyword><keyword>Melanoma: metabolism</keyword><keyword>Melanoma: pathology</keyword><keyword>Neoplasm Metastasis</keyword><keyword>PAR-1</keyword><keyword>PAR-1: metabolism</keyword><keyword>Platelet Membrane Glycoproteins</keyword><keyword>Platelet Membrane Glycoproteins: metabolism</keyword><keyword>Promoter Regions</keyword><keyword>RNA</keyword><keyword>RNA Interference</keyword><keyword>Receptor</keyword><keyword>Receptors</keyword><keyword>Skin Neoplasms</keyword><keyword>Skin Neoplasms: metabolism</keyword><keyword>Skin Neoplasms: pathology</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: metabolism</keyword><keyword>Transcription Factors</keyword><keyword>Transcription Factors: metabolism</keyword><keyword>Tumor</keyword></keywords><dates><year>2009</year></dates><accession-num>19703903</accession-num><electronic-resource-num>10.1074/jbc.M109.042150</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2781430&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Invasion</label><abstract>The cellular and molecular pathways that regulate platelet activation, blood coagulation, and inflammation are emerging as critical players in cancer progression and metastasis. Here, we demonstrate a novel signaling mechanism whereby protease-activated receptor 1 (PAR1) mediates expression of melanoma cell adhesion molecule MCAM/MUC18 (MUC18), a critical marker of melanoma metastasis, via activation of platelet-activating factor receptor (PAFR) and cAMP-responsive element-binding protein (CREB). We found that PAR1 silencing with small hairpin RNA inhibits MUC18 expression in metastatic melanoma cells by inhibiting CREB phosphorylation, activity, and binding to the MUC18 promoter. We further demonstrate that the PAF/PAFR pathway mediates MUC18 expression downstream of PAR1. Indeed, PAR1 silencing down-regulates PAFR expression and PAF production, PAFR silencing blocks MUC18 expression, and re-expression of PAFR in PAR1-silenced cells rescues MUC18 expression. We further demonstrate that the PAR1-PAFR-MUC18 pathway mediates melanoma cell adhesion to microvascular endothelial cells, transendothelial migration, and metastatic retention in the lungs. Rescuing PAFR expression in PAR1-silenced cells fully restores metastatic phenotype of melanoma, indicating that PAFR plays critical role in the molecular mechanism of PAR1 action. Our results link the two pro-inflammatory G-protein-coupled receptors, PAR1 and PAFR, with the metastatic dissemination of melanoma and suggest that PAR1, PAFR, and MUC18 are attractive therapeutic targets for preventing melanoma metastasis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lovelady, Douglas C</author><author>Friedman, Jennifer</author><author>Patel, Sonali</author><author>Rabson, David a</author><author>Lo, Chun-Min</author></authors></contributors><titles><title>Detecting effects of low levels of cytochalasin B in 3T3 fibroblast cultures by analysis of electrical noise obtained from cellular micromotion.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>2250-2254</pages><volume>24</volume><issue>7</issue><keywords><keyword>3T3 Cells</keyword><keyword>Animals</keyword><keyword>Artifacts</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Cytochalasin B</keyword><keyword>Cytochalasin B: analysis</keyword><keyword>Electrochemistry</keyword><keyword>Electrochemistry: instrumentation</keyword><keyword>Electrochemistry: methods</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Mice</keyword><keyword>Motion</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword></keywords><dates><year>2009</year></dates><accession-num>19026529</accession-num><electronic-resource-num>10.1016/j.bios.2008.09.033</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2673106&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Cytotoxicity;ECIS Micromotion</label><abstract>We performed micromotion experiments using electric cell-substrate impedance sensing (ECIS) on a confluent layer of 3T3 fibroblasts exposed to different low levels of the toxin cytochalasin B. This toxin is know to affect actin polymerization and to disrupt cytoskeletal structure and function in cells, changing the morphology of confluent cell cultures and altering the nature of the cellular micromotion, which is measured by ECIS as changes in impedance. By looking at several measures to characterize the long- and short-term correlations in the noise of the impedance time series, we are able to detect the effects of the toxin at concentrations down to 1 microM; there are intriguing hints that the effects may be discernible at levels as low as 0.1 microM. These measures include the power spectrum, the Hurst and detrended-fluctuation-analysis exponents, and the first zero and first 1/e crossings of the autocorrelation function. While most published work with ECIS uses only average impedance values, we demonstrate that noise analysis provides a more sensitive probe.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Grab, Dennis J</author><author>Garcia-Garcia, Jose C</author><author>Nikolskaia, Olga V</author><author>Kim, Yuri V</author><author>Brown, Amanda</author><author>Pardo, Carlos a</author><author>Zhang, Yongqing</author><author>Becker, Kevin G</author><author>Wilson, Brenda a</author><author>de A Lima, Ana Paula C</author><author>Scharfstein, Julio</author><author>Dumler, J Stephen</author></authors></contributors><titles><title>Protease activated receptor signaling is required for African trypanosome traversal of human brain microvascular endothelial cells.</title><secondary-title>PLoS neglected tropical diseases</secondary-title></titles><periodical><full-title>PLoS neglected tropical diseases</full-title></periodical><pages>e479</pages><volume>3</volume><issue>7</issue><keywords><keyword>Animals</keyword><keyword>Bacterial Proteins</keyword><keyword>Bacterial Proteins: toxicity</keyword><keyword>Bacterial Toxins</keyword><keyword>Bacterial Toxins: toxicity</keyword><keyword>Cell Line</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: parasitology</keyword><keyword>Gene Silencing</keyword><keyword>Humans</keyword><keyword>PAR-2</keyword><keyword>PAR-2: antagonists &amp; inhibitors</keyword><keyword>PAR-2: genetics</keyword><keyword>PAR-2: physiology</keyword><keyword>RNA</keyword><keyword>Receptor</keyword><keyword>Signal Transduction</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Trypanosoma brucei rhodesiense</keyword><keyword>Trypanosoma brucei rhodesiense: pathogenicity</keyword></keywords><dates><year>2009</year></dates><accession-num>19621073</accession-num><electronic-resource-num>10.1371/journal.pntd.0000479</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2707606&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Invasion;ECIS TEER;Signal Transduction</label><abstract>Using human brain microvascular endothelial cells (HBMECs) as an in vitro model for how African trypanosomes cross the human blood-brain barrier (BBB) we recently reported that the parasites cross the BBB by generating calcium activation signals in HBMECs through the activity of parasite cysteine proteases, particularly cathepsin L (brucipain). In the current study, we examined the possible role of a class of protease stimulated HBMEC G protein coupled receptors (GPCRs) known as protease activated receptors (PARs) that might be implicated in calcium signaling by African trypanosomes.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van Gils, Janine M</author><author>Stutterheim, Janine</author><author>van Duijn, Trynette J</author><author>Zwaginga, Jaap Jan</author><author>Porcelijn, Leendert</author><author>de Haas, Masja</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity.</title><secondary-title>Molecular immunology</secondary-title></titles><periodical><full-title>Molecular immunology</full-title></periodical><pages>406-415</pages><volume>46</volume><issue>3</issue><keywords><keyword>Antibodies</keyword><keyword>Antibodies: pharmacology</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Female</keyword><keyword>Human Platelet</keyword><keyword>Human Platelet: immunology</keyword><keyword>Humans</keyword><keyword>Integrin beta3</keyword><keyword>Isoantibodies</keyword><keyword>Isoantibodies: immunology</keyword><keyword>Umbilical Cord</keyword><keyword>Umbilical Cord: cytology</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: drug effects</keyword></keywords><dates><year>2009</year></dates><accession-num>19038456</accession-num><electronic-resource-num>10.1016/j.molimm.2008.10.015</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/19038456</url></web-urls></urls><label>ECIS Attachment;ECIS Migration;ECIS TEER;Wound Healing</label><abstract>Maternal human platelet antigen (HPA)-1a alloantibodies causing neonatal alloimmune thrombocytopenia can bind also to endothelium, via the beta3-integrin (CD61). The aim of this study was to investigate the effect of HPA-1a Abs on endothelial cell function, with emphasis on monolayer integrity. We used a CD61 mAb as a model for the HPA-1a alloantibodies and confirmed the results with purified IgG fractions from HPA-1a alloimmunized women. The effect of these antibodies was examined by monitoring the adhesion, spreading, and monolayer integrity of primary HUVECs with conventional adhesion assays as well as electrical cell-substrate impedance sensing. We found that both the mAb CD61 and the HPA-1a antibodies caused a significant reduction in HUVEC spreading. Moreover, addition of the mAb CD61 and the HPA-1a antibodies prior to or following formation of a stable endothelial monolayer negatively affected endothelial monolayer integrity, which was accompanied by a redistribution of junctional proteins. Our data suggest that HPA-1a alloantibodies have a direct effect on endothelial cell spreading and monolayer integrity, which could contribute to the increased bleeding tendency in children with neonatal alloimmune thrombocytopenia.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>English, Anthony E</author><author>Moy, Alan B</author><author>Kruse, Kara L</author><author>Ward, Richard C</author><author>Kirkpatrick, Stacy S</author><author>Goldman, Mitchell H</author></authors></contributors><titles><title>Instrumental noise estimates stabilize and quantify endothelial cell micro-impedance barrier function parameter estimates</title><secondary-title>Biomedical Signal Processing and Control</secondary-title></titles><periodical><full-title>Biomedical Signal Processing and Control</full-title></periodical><pages>86-93</pages><volume>4</volume><issue>2</issue><keywords/><dates><year>2009</year></dates><electronic-resource-num>10.1016/j.bspc.2008.12.002</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S1746809408000827</url></web-urls></urls><label>ECIS Theory</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Fordjour, Akua K</author><author>Harrington, Elizabeth O</author></authors></contributors><titles><title>PKCdelta influences p190 phosphorylation and activity: events independent of PKCdelta-mediated regulation of endothelial cell stress fiber and focal adhesion formation and barrier function.</title><secondary-title>Biochimica et biophysica acta</secondary-title></titles><periodical><full-title>Biochimica et biophysica acta</full-title></periodical><pages>1179-1190</pages><volume>1790</volume><issue>10</issue><keywords><keyword>Acetophenones</keyword><keyword>Acetophenones: pharmacology</keyword><keyword>Animals</keyword><keyword>Benzopyrans</keyword><keyword>Benzopyrans: pharmacology</keyword><keyword>Binding Sites</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Fluorescence</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: drug effects</keyword><keyword>Focal Adhesions: metabolism</keyword><keyword>Green Fluorescent Proteins</keyword><keyword>Green Fluorescent Proteins: genetics</keyword><keyword>Green Fluorescent Proteins: metabolism</keyword><keyword>Immunoblotting</keyword><keyword>Microscopy</keyword><keyword>Phosphorylation</keyword><keyword>Protein Binding</keyword><keyword>Protein Kinase C-delta</keyword><keyword>Protein Kinase C-delta: antagonists &amp; inhibitors</keyword><keyword>Protein Kinase C-delta: genetics</keyword><keyword>Protein Kinase C-delta: metabolism</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>RNA</keyword><keyword>Rats</keyword><keyword>Repressor Proteins</keyword><keyword>Repressor Proteins: genetics</keyword><keyword>Repressor Proteins: metabolism</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Stress Fibers</keyword><keyword>Stress Fibers: metabolism</keyword><keyword>Transfection</keyword></keywords><dates><year>2009</year></dates><publisher>Elsevier B.V.</publisher><accession-num>19632305</accession-num><electronic-resource-num>10.1016/j.bbagen.2009.07.012</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2759355&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>We have shown that protein kinase Cdelta (PKCdelta) inhibition results in increased endothelial cell (EC) permeability and decreased RhoA activity; which correlated with diminished stress fibers (SF) and focal adhesions (FA). We have also shown co-precipitation of p190RhoGAP (p190) with PKCdelta. Here, we investigated if PKCdelta regulates p190 and whether PKCdelta-mediated changes in SF and FA or permeability were dependent upon p190.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Del Gaudio, Costantino</author><author>Bianco, Alessandra</author><author>Folin, Marcella</author><author>Baiguera, Silvia</author><author>Grigioni, Mauro</author></authors></contributors><titles><title>Structural characterization and cell response evaluation of electrospun PCL membranes: micrometric versus submicrometric fibers.</title><secondary-title>Journal of biomedical materials research. Part A</secondary-title></titles><periodical><full-title>Journal of biomedical materials research. Part A</full-title></periodical><pages>1028-1039</pages><volume>89</volume><issue>4</issue><keywords><keyword>Artificial</keyword><keyword>Cell Death</keyword><keyword>Cell Shape</keyword><keyword>Cell Survival</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Electron</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Humans</keyword><keyword>Materials Testing</keyword><keyword>Membranes</keyword><keyword>Microscopy</keyword><keyword>Polyesters</keyword><keyword>Polyesters: chemistry</keyword><keyword>Scanning</keyword><keyword>Tensile Strength</keyword><keyword>X-Ray Diffraction</keyword></keywords><dates><year>2009</year></dates><accession-num>18478554</accession-num><electronic-resource-num>10.1002/jbm.a.32048</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18478554</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>Electrospinning is a valuable technique to fabricate fibrous scaffolds for tissue engineering. The typical nonwoven architecture allows cell adhesion and proliferation, and supports diffusion of nutrients and waste products. Poly(epsilon-caprolactone) (PCL) electrospun membranes were produced starting from 14% w/v solutions in (a) mixture 1:1 tetrahydrofuran and N,N-dimethylformamide and (b) chloroform. Matrices made up of randomly arranged uniform fibers free of beads were obtained. The average fiber diameters were (a) 0.8 +/- 0.2 microm and (b) 3.6 +/- 0.8 microm. PCL matrices showed the following tensile mechanical properties: tensile modulus (a) 5.0 +/- 0.7 MPa (b) 6.4 +/- 0.2 MPa, yield stress (a) 0.55 +/- 0.06 MPa (b) 0.43 +/- 0.02 MPa, and ultimate tensile stress (a) 1.7 +/- 0.2 MPa and (b) 0.8 +/- 0.1 MPa. The ultimate strain ranged between 300% and 400%. Cytotoxicity of electrospun membranes was continuously evaluated by means of electric cell-substrate impedance sensing technique using human umbilical vein endothelial cells (HUVEC). PCL matrices resulted free of toxic amounts of contaminants and/or process by-products. In vitro studies performed by culturing HUVEC on micrometric and submicrometric fibrous mats showed that both structures supported cell adhesion and spreading. However, cells cultured on the micrometric network showed higher vitality and improved interaction with the polymeric fibers, suggesting an increased ability to promote cell colonization.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Balasubramanian, Lavanya</author><author>Yip, Kay-Pong</author><author>Hsu, Tai-Hsin</author><author>Lo, Chun-Min</author></authors></contributors><titles><title>Impedance analysis of renal vascular smooth muscle cells.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C954-65</pages><volume>295</volume><issue>4</issue><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Cell Adhesion</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Kidney</keyword><keyword>Kidney: blood supply</keyword><keyword>Male</keyword><keyword>Models</keyword><keyword>Muscle</keyword><keyword>Myocytes</keyword><keyword>Rats</keyword><keyword>Smooth</keyword><keyword>Smooth Muscle</keyword><keyword>Smooth Muscle: physiology</keyword><keyword>Smooth Muscle: ultrastructure</keyword><keyword>Sprague-Dawley</keyword><keyword>Time Factors</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword></keywords><dates><year>2008</year></dates><accession-num>18684988</accession-num><electronic-resource-num>10.1152/ajpcell.00009.2008</electronic-resource-num><notes>From Duplicate 2 (Impedance analysis of renal vascular smooth muscle cells. - Balasubramanian, Lavanya; Yip, Kay-Pong; Hsu, Tai-Hsin; Lo, Chun-Min)

From Duplicate 2 ( Impedance analysis of renal vascular smooth muscle cells. - Balasubramanian, Lavanya; Yip, Kay-Pong; Hsu, Tai-Hsin; Lo, Chun-Min )</notes><research-notes>From Duplicate 2 (Impedance analysis of renal vascular smooth muscle cells. - Balasubramanian, Lavanya; Yip, Kay-Pong; Hsu, Tai-Hsin; Lo, Chun-Min)

From Duplicate 2 ( Impedance analysis of renal vascular smooth muscle cells. - Balasubramanian, Lavanya; Yip, Kay-Pong; Hsu, Tai-Hsin; Lo, Chun-Min )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2575826&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Attachment;ECIS Modeling</label><abstract>Impedance of renal vascular smooth muscle cells (VSMCs) cultured on microelectrodes was measured by electric cell-substrate impedance sensing. Changes in measured impedance as a function of frequency were compared with the calculated values obtained from an extended cell-electrode model to estimate the junctional resistance, distance between the ventral cell surface and the substratum, and apical and basolateral membrane capacitances of renal VSMCs. This cell-electrode model was derived to accommodate the slender and rectangular shape of VSMCs. The calculated changes in impedance (Z(cal)) based on the model agreed well with the experimental measurement (Z(exp)), and the percentage error defined as |(Z(cal)-Z(exp))/Z(exp)| was 1.0%. To test the sensitivity of the new model for capturing changes in cell-cell and cell-substrate interactions induced by changes in cellular environment, we then applied this model to analyze impedance changes induced by an integrin binding peptide in renal VSMCs. Our result demonstrates that integrin binding peptide decreases junctional resistance between cells, increases the distance between the basolateral cell surface and substratum, and increases the apical membrane capacitance, whereas the basolateral membrane capacitance stays relatively stable. This model provides a generic approach for impedance analysis of cell layers composed of slender, rectangular cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jiang, Wen G</author><author>Martin, Tracey a</author><author>Lewis-Russell, Jonathan M</author><author>Douglas-Jones, Anthony</author><author>Ye, Lin</author><author>Mansel, Robert E</author></authors></contributors><titles><title>Eplin-alpha expression in human breast cancer, the impact on cellular migration and clinical outcome.</title><secondary-title>Molecular cancer</secondary-title></titles><periodical><full-title>Molecular cancer</full-title></periodical><pages>71</pages><volume>7</volume><keywords><keyword>Animals</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: genetics</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Cell Movement</keyword><keyword>Cohort Studies</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: genetics</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Down-Regulation</keyword><keyword>Female</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Mice</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplastic</keyword><keyword>Nude</keyword></keywords><dates><year>2008</year></dates><accession-num>18796137</accession-num><electronic-resource-num>10.1186/1476-4598-7-71</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2553413&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration;ECIS TEER</label><abstract>To investigate the expression of EPLIN-alpha, epithelial protein lost in neoplasm, in human breast cancer tissues/cells and investigate the cellular impact of EPLIN-alpha on breast cancer cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Dheilly, A.</author><author>Linossier, I.</author><author>Darchen, A.</author><author>Hadjiev, D.</author><author>Corbel, C.</author><author>Alonso, V.</author></authors></contributors><titles><title>Monitoring of microbial adhesion and biofilm growth using electrochemical impedancemetry</title><secondary-title>Applied Microbiology and Biotechnology</secondary-title></titles><periodical><full-title>Applied Microbiology and Biotechnology</full-title></periodical><pages>157-164</pages><volume>79</volume><issue>1</issue><keywords/><dates><year>2008</year></dates><electronic-resource-num>10.1007/s00253-008-1404-7</electronic-resource-num><urls><web-urls><url>http://link.springer.com/10.1007/s00253-008-1404-7</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Male, Keith B</author><author>Lachance, Bernard</author><author>Hrapovic, Sabahudin</author><author>Sunahara, Geoff</author><author>Luong, John H T</author></authors></contributors><titles><title>Assessment of cytotoxicity of quantum dots and gold nanoparticles using cell-based impedance spectroscopy.</title><secondary-title>Analytical chemistry</secondary-title></titles><periodical><full-title>Analytical chemistry</full-title></periodical><pages>5487-5493</pages><volume>80</volume><issue>14</issue><keywords><keyword>Animals</keyword><keyword>Cadmium</keyword><keyword>Cadmium: chemistry</keyword><keyword>Cadmium: pharmacology</keyword><keyword>Cell Line</keyword><keyword>Cell Size</keyword><keyword>Cell Size: drug effects</keyword><keyword>Cricetinae</keyword><keyword>Gold</keyword><keyword>Gold: chemistry</keyword><keyword>Gold: toxicity</keyword><keyword>Ions</keyword><keyword>Ions: chemistry</keyword><keyword>Metal Nanoparticles</keyword><keyword>Metal Nanoparticles: chemistry</keyword><keyword>Quantum Dots</keyword><keyword>Spectrum Analysis</keyword><keyword>Spectrum Analysis: methods</keyword></keywords><dates><year>2008</year></dates><accession-num>18553941</accession-num><electronic-resource-num>10.1021/ac8004555</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18553941</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>A continuous online technique based on electric cell-substrate impedance sensing (ECIS) was demonstrated for measuring the concentration and time response function of fibroblastic V79 cells exposed to nanomaterials such as quantum dots (QDs) and fluorescent gold nanoparticles. The half-inhibition concentration, (ECIS50), the required concentration to attain 50% inhibition of the cytotoxic response, was estimated from the response function to ascertain cytotoxicity during the course of measurement. The ECIS50 values agreed well with the results obtained using the standard neutral red assay. Cadmium selenide quantum dots showed direct cytotoxicity with the ECIS assay. For the cadmium telluride quantum dots, significant toxicity could be assigned to free cadmium, although additional toxicity could be attributed to the QDs per se. The QDs synthesized with indium gallium phosphide and the fluorescent gold nanoparticles were not cytotoxic.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Navdaev, Alexei</author><author>Heitmann, Vanessa</author><author>deSantana Evangelista, Karla</author><author>Mörgelin, Matthias</author><author>Wegener, Joachim</author><author>Eble, Johannes a.</author></authors></contributors><titles><title>The C-terminus of the γ2 chain but not of the β3 chain of laminin-332 is indirectly but indispensably necessary for integrin-mediated cell reactions</title><secondary-title>Experimental Cell Research</secondary-title></titles><periodical><full-title>Experimental Cell Research</full-title></periodical><pages>489-497</pages><volume>314</volume><issue>3</issue><keywords/><dates><year>2008</year></dates><electronic-resource-num>10.1016/j.yexcr.2007.10.027</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0014482707005216</url></web-urls></urls><label>ECIS Attachment</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rentsendorj, Otgonchimeg</author><author>Mirzapoiazova, Tamara</author><author>Adyshev, Djanybek</author><author>Servinsky, Laura E</author><author>Renné, Thomas</author><author>Verin, Alexander D</author><author>Pearse, David B</author></authors></contributors><titles><title>Role of vasodilator-stimulated phosphoprotein in cGMP-mediated protection of human pulmonary artery endothelial barrier function.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L686-97</pages><volume>294</volume><issue>4</issue><keywords><keyword>Cyclic GMP</keyword><keyword>Cyclic GMP: pharmacology</keyword><keyword>Cyclosporine</keyword><keyword>Cyclosporine: pharmacology</keyword><keyword>Endothelium</keyword><keyword>Forskolin</keyword><keyword>Forskolin: pharmacology</keyword><keyword>Humans</keyword><keyword>Hydrogen Peroxide</keyword><keyword>Hydrogen Peroxide: pharmacology</keyword><keyword>Kinetics</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Phosphoserine</keyword><keyword>Phosphoserine: metabolism</keyword><keyword>Plasmids</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Pulmonary Artery: drug effects</keyword><keyword>Pulmonary Artery: physiology</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Transfection</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: physiology</keyword><keyword>Vasodilator Agents</keyword><keyword>Vasodilator Agents: pharmacology</keyword></keywords><dates><year>2008</year></dates><accession-num>18281604</accession-num><electronic-resource-num>10.1152/ajplung.00417.2007</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18281604</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Increased pulmonary endothelial cGMP was shown to prevent endothelial barrier dysfunction through activation of protein kinase G (PKG(I)). Vasodilator-stimulated phosphoprotein (VASP) has been hypothesized to mediate PKG(I) barrier protection because VASP is a cytoskeletal phosphorylation target of PKG(I) expressed in cell-cell junctions. Unphosphorylated VASP was proposed to increase paracellular permeability through actin polymerization and stress fiber bundling, a process inhibited by PKG(I)-mediated phosphorylation of Ser(157) and Ser(239). To test this hypothesis, we examined the role of VASP in the transient barrier dysfunction caused by H(2)O(2) in human pulmonary artery endothelial cell (HPAEC) monolayers studied without and with PKG(I) expression introduced by adenoviral infection (Ad.PKG). In the absence of PKG(I) expression, H(2)O(2) (100-250 microM) caused a transient increased permeability and pSer(157)-VASP formation that were both attenuated by protein kinase C inhibition. Potentiation of VASP Ser(157) phosphorylation by either phosphatase 2B inhibition with cyclosporin or protein kinase A activation with forskolin prolonged, rather than inhibited, the increased permeability caused by H(2)O(2). With Ad.PKG infection, inhibition of VASP expression with small interfering RNA exacerbated H(2)O(2)-induced barrier dysfunction but had no effect on cGMP-mediated barrier protection. In addition, expression of a Ser-double phosphomimetic mutant VASP failed to reproduce the protective effects of activated PKG(I). Finally, expression of a Ser-double phosphorylation-resistant VASP failed to interfere with the ability of cGMP/PKG(I) to attenuate H(2)O(2)-induced disruption of VE-cadherin homotypic binding. Our results suggest that VASP phosphorylation does not explain the protective effect of cGMP/PKG(I) on H(2)O(2)-induced endothelial barrier dysfunction in HPAEC.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chen, Jinfeng</author><author>Ye, Lin</author><author>Zhang, Lijian</author><author>Jiang, Wen G</author></authors></contributors><titles><title>Placenta growth factor, PLGF, influences the motility of lung cancer cells, the role of Rho associated kinase, Rock1.</title><secondary-title>Journal of cellular biochemistry</secondary-title></titles><periodical><full-title>Journal of cellular biochemistry</full-title></periodical><pages>313-320</pages><volume>105</volume><issue>1</issue><keywords><keyword>Catalytic</keyword><keyword>Catalytic: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Lung Neoplasms</keyword><keyword>Lung Neoplasms: genetics</keyword><keyword>Lung Neoplasms: metabolism</keyword><keyword>Lung Neoplasms: pathology</keyword><keyword>Neoplastic</keyword><keyword>Pregnancy Proteins</keyword><keyword>Pregnancy Proteins: genetics</keyword><keyword>Pregnancy Proteins: metabolism</keyword><keyword>RNA</keyword><keyword>Transgenes</keyword><keyword>Transgenes: genetics</keyword><keyword>Tumor</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2008</year></dates><accession-num>18615591</accession-num><electronic-resource-num>10.1002/jcb.21831</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18615591</url></web-urls></urls><label>ECIS Attachment</label><abstract>Placenta growth factor (PlGF) is a member of the VEGF family and has been implicated in the aggressive capacity of solid tumours, partly via its impact on angiogenesis. The present study determined the direct biological function of endogenous PlGF in lung cancer cells. From the human non-small cell lung cancer cell line A549 which expressed good level of PlGF, we created sublines within which PlGF expression was knockdown by way of anti-PlGF ribozyme transgenes. Remarkable reductions of both PlGF mRNA and protein by the ribozyme transgenes were revealed in A549 transfectants (A549(DeltaPlGF)) using RT-PCR and Western blotting respectively. A549(DeltaPlGF) cells exhibited significantly reduced migration and adhesion compared with the wild-type (A549(WT)) and the empty plasmid control (A549(pEF/His)) cells. Immunocytochemistry and Western blotting further revealed that the expression of ROCK1, Rho associated kinase, was also reduced in A549(DeltaPlGF) cells, in comparison with wild-type and control cells. In addition, A549(DeltaPlGF) cells lost its response to a ROCK inhibitor, which otherwise strongly inhibited the motility of A549(WT) and A549(pEF/His) cells. These data indicate that PlGF directly regulates the motility of human lung cancer cells and that this regulation critically dependent on ROCK-1. The study further indicates that PlGF is a potential therapeutic target in lung cancer.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Male, Keith B</author><author>Rao, Yerra Koteswara</author><author>Tzeng, Yew-Min</author><author>Montes, Johnny</author><author>Kamen, Amine</author><author>Luong, John H T</author></authors></contributors><titles><title>Probing inhibitory effects of Antrodia camphorata isolates using insect cell-based impedance spectroscopy: inhibition vs chemical structure.</title><secondary-title>Chemical research in toxicology</secondary-title></titles><periodical><full-title>Chemical research in toxicology</full-title></periodical><pages>2127-2133</pages><volume>21</volume><issue>11</issue><keywords><keyword>Animals</keyword><keyword>Antrodia</keyword><keyword>Antrodia: chemistry</keyword><keyword>Cell Line</keyword><keyword>Electric Impedance</keyword><keyword>Ergosterol</keyword><keyword>Ergosterol: analogs &amp; derivatives</keyword><keyword>Ergosterol: chemistry</keyword><keyword>Ergosterol: pharmacology</keyword><keyword>Inhibitory Concentration 50</keyword><keyword>Spectrum Analysis</keyword><keyword>Spodoptera</keyword><keyword>Structure-Activity Relationship</keyword><keyword>Triterpenes</keyword><keyword>Triterpenes: chemistry</keyword><keyword>Triterpenes: pharmacology</keyword></keywords><dates><year>2008</year></dates><accession-num>18816072</accession-num><electronic-resource-num>10.1021/tx800202a</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18816072</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>A continuous online technique based on electric cell-substrate impedance sensing (ECIS) was used for probing inhibitory effects on Spodoptera frugiperda Sf9 insect cells exposed to structurally similar compounds isolated and purified from the fruiting bodies of the fungus Antrodia camphorata. Such chemicals consisted of three ergostane-related steroids and five lanosta-related triterpenes, which are known for their diverse properties and use in the formulation of nutraceuticals and functional foods. The half-inhibition concentration (ECIS(50)), the level at which 50% inhibition of the resistance response was obtained, was determined from the response function to establish inhibitory effects of the different isolates. A slight change in their chemical structures resulted in significant effects on inhibition as probed by impedance spectroscopy. The ergostane-related steroids were mostly inhibitory, but replacing their ketone groups with hydrogen or hydroxyl groups significantly reduced the inhibition. Similarly, the addition of methyl or carboxymethyl groups also lowered the inhibition. Removal of the double bond conjugation within the rings (sulfurenic acid) of the isolate drastically reduced the inhibition.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Guo, Mingzhang</author><author>Breslin, Jerome W</author><author>Wu, Mack H</author><author>Gottardi, Cara J</author><author>Yuan, Sarah Y</author></authors></contributors><titles><title>VE-cadherin and beta-catenin binding dynamics during histamine-induced endothelial hyperpermeability.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C977-84</pages><volume>294</volume><issue>4</issue><keywords><keyword>Albumins</keyword><keyword>Albumins: pharmacokinetics</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Cell Cycle Proteins</keyword><keyword>Cell Cycle Proteins: genetics</keyword><keyword>Cell Cycle Proteins: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelium</keyword><keyword>Gene Expression Regulation</keyword><keyword>Histamine</keyword><keyword>Histamine: pharmacology</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: drug effects</keyword><keyword>Intercellular Junctions: physiology</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Intracellular Signaling Peptides and Proteins: gen</keyword><keyword>Intracellular Signaling Peptides and Proteins: met</keyword><keyword>Permeability</keyword><keyword>Permeability: drug effects</keyword><keyword>Protein Binding</keyword><keyword>Transcription Factors</keyword><keyword>Transcription Factors: genetics</keyword><keyword>Transcription Factors: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: physiology</keyword><keyword>beta Catenin</keyword><keyword>beta Catenin: metabolism</keyword></keywords><dates><year>2008</year></dates><accession-num>18287330</accession-num><electronic-resource-num>10.1152/ajpcell.90607.2007</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18287330</url></web-urls></urls><label>ECIS TEER</label><abstract>Beta-catenin plays an important role in the regulation of vascular endothelial cell-cell adhesions and barrier function by linking the VE-cadherin junction complex to the cytoskeleton. The purpose of this study was to evaluate the effect of beta-catenin and VE-cadherin interactions on endothelial permeability during inflammatory stimulation by histamine. We first assessed the ability of a beta-catenin binding polypeptide known as inhibitor of beta-catenin and T cell factor (ICAT) to compete beta-catenin binding to VE-cadherin in vitro. We then overexpressed recombinant FLAG-ICAT in human umbilical vein endothelial cells (HUVECs) to study its impact on endothelial barrier function controlled by cell-cell adhesions. The binding of beta-catenin to VE-cadherin was quantified before and after stimulation with histamine along with measurements of transendothelial electrical resistance (TER) and apparent permeability to albumin (P(a)) under the same conditions. The results showed that ICAT bound to beta-catenin and competitively inhibited binding of the VE-cadherin cytoplasmic domain to beta-catenin in a concentration-dependent manner. Overexpression of FLAG-ICAT in endothelial cell monolayers did not affect their basal permeability properties, as indicated by unaltered TER and P(a); however, the magnitude and duration of histamine-induced decreases in TER were significantly augmented. Likewise, the increase in P(a) in the presence of histamine was exacerbated. Overexpression of FLAG-ICAT also significantly decreased the level of beta-catenin-associated VE-cadherin following histamine stimulation. Taken together, these data suggest that inflammatory agents like histamine cause a transient and reversible disruption of binding between beta-catenin and VE-cadherin, during which endothelial permeability is elevated.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Argraves, Kelley M</author><author>Gazzolo, Patrick J</author><author>Groh, Eric M</author><author>Wilkerson, Brent a</author><author>Matsuura, Bryan S</author><author>Twal, Waleed O</author><author>Hammad, Samar M</author><author>Argraves, W Scott</author></authors></contributors><titles><title>High density lipoprotein-associated sphingosine 1-phosphate promotes endothelial barrier function.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>25074-25081</pages><volume>283</volume><issue>36</issue><keywords><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Enzyme Activation: physiology</keyword><keyword>HDL</keyword><keyword>HDL: metabolism</keyword><keyword>HDL: pharmacology</keyword><keyword>Humans</keyword><keyword>Lipoproteins</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: metabolism</keyword><keyword>Lysophospholipids: pharmacology</keyword><keyword>Lysosphingolipid</keyword><keyword>Lysosphingolipid: metabolism</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>MAP Kinase Signaling System: drug effects</keyword><keyword>MAP Kinase Signaling System: physiology</keyword><keyword>Mitogen-Activated Protein Kinase 1</keyword><keyword>Mitogen-Activated Protein Kinase 1: metabolism</keyword><keyword>Mitogen-Activated Protein Kinase 3</keyword><keyword>Mitogen-Activated Protein Kinase 3: metabolism</keyword><keyword>Pertussis Toxin</keyword><keyword>Pertussis Toxin: pharmacology</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>Proto-Oncogene Proteins c-akt: metabolism</keyword><keyword>Receptors</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: metabolism</keyword><keyword>Sphingosine: pharmacology</keyword></keywords><dates><year>2008</year></dates><accession-num>18606817</accession-num><electronic-resource-num>10.1074/jbc.M801214200</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2529014&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Signal Transduction</label><abstract>High density lipoproteins (HDL) are major plasma carriers of sphingosine 1-phosphate (S1P). Here we show that HDL increases endothelial barrier integrity as measured by electric cell substrate impedance sensing. S1P was implicated as the mediator in this process through findings showing that pertussis toxin, an inhibitor of Gi-coupled S1P receptors, as well as antagonists of the S1P receptor, S1P1, inhibited barrier enhancement by HDL. Additional findings show that HDL stimulates endothelial cell activation of Erk1/2 and Akt, signaling pathway intermediates that have been implicated in S1P-dependent endothelial barrier activity. HDL was also found to promote endothelial cell motility, a process that may also relate to endothelial barrier function in the context of a vascular injury response. The effects of HDL on endothelial cell Erk1/2 and Akt activation and motility were suppressed by pertussis toxin and S1P1 antagonists. However, both HDL-induced barrier enhancement and HDL-induced motility showed a greater dependence on Akt activation as compared with Erk1/2 activation. Together, the findings indicate that HDL has endothelial barrier promoting activities, which are attributable to its S1P component and signaling through the S1P1/Akt pathway.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lorenowicz, Magdalena J</author><author>Fernandez-Borja, Mar</author><author>Kooistra, Matthijs R H</author><author>Bos, Johannes L</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>PKA and Epac1 regulate endothelial integrity and migration through parallel and independent pathways.</title><secondary-title>European journal of cell biology</secondary-title></titles><periodical><full-title>European journal of cell biology</full-title></periodical><pages>779-792</pages><volume>87</volume><issue>10</issue><keywords><keyword>Capillary Permeability</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: metabolism</keyword><keyword>Cyclic AMP: analogs &amp; derivatives</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Cyclic AMP: pharmacology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: metabolism</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: metabolism</keyword><keyword>Humans</keyword><keyword>Integrins</keyword><keyword>Integrins: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Telomere-Binding Proteins</keyword><keyword>Telomere-Binding Proteins: metabolism</keyword><keyword>Transfection</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2008</year></dates><accession-num>18635287</accession-num><electronic-resource-num>10.1016/j.ejcb.2008.05.004</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18635287</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>The vascular endothelium provides a semi-permeable barrier, which restricts the passage of fluid, macromolecules and cells to the surrounding tissues. Cyclic AMP promotes endothelial barrier function and protects the endothelium against pro-inflammatory mediators. This study analyzed the relative contribution of two cAMP targets, PKA and Epac1, to the control of endothelial barrier function and endothelial cell migration. Real-time recording of transendothelial electrical resistance showed that activation of either PKA or Epac1 with specific cAMP analogues increases endothelial barrier function and promotes endothelial cell migration. In addition, reduction of Epac1 expression showed that Epac1 and PKA control endothelial integrity and cell motility by two independent and complementary signaling pathways. We demonstrate that integrin-mediated adhesion is required for PKA, but not Epac1-Rap1-driven stimulation of endothelial barrier function. In contrast, both PKA- and Epac1-stimulated endothelial cell migration requires integrin function. These data show that activation of Epac1 and PKA by cAMP results in the stimulation of two parallel, independent signaling pathways that positively regulate endothelial integrity and cell migration, which is important for recovery after endothelial damage and for restoration of compromised endothelial barrier function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Okochi, Mina</author><author>Nomura, Shigeyuki</author><author>Kaga, Chiaki</author><author>Honda, Hiroyuki</author></authors></contributors><titles><title>Peptide array-based screening of human mesenchymal stem cell-adhesive peptides derived from fibronectin type III domain.</title><secondary-title>Biochemical and biophysical research communications</secondary-title></titles><periodical><full-title>Biochemical and biophysical research communications</full-title></periodical><pages>85-89</pages><volume>371</volume><issue>1</issue><keywords><keyword>Amino Acid Sequence</keyword><keyword>Biological Assay</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion Molecules</keyword><keyword>Cell Adhesion Molecules: chemistry</keyword><keyword>Cell Adhesion Molecules: isolation &amp; purification</keyword><keyword>Cell Adhesion Molecules: pharmacology</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Line</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: chemistry</keyword><keyword>Fibronectins: genetics</keyword><keyword>Humans</keyword><keyword>Mesenchymal Stem Cells</keyword><keyword>Mesenchymal Stem Cells: chemistry</keyword><keyword>Mesenchymal Stem Cells: metabolism</keyword><keyword>Molecular Sequence Data</keyword><keyword>Oligopeptides</keyword><keyword>Oligopeptides: isolation &amp; purification</keyword><keyword>Oligopeptides: pharmacology</keyword><keyword>Peptide Library</keyword><keyword>Peptides</keyword><keyword>Peptides: chemistry</keyword><keyword>Peptides: isolation &amp; purification</keyword><keyword>Peptides: pharmacology</keyword><keyword>Protein Array Analysis</keyword><keyword>Protein Array Analysis: methods</keyword><keyword>Protein Structure</keyword><keyword>Tertiary</keyword><keyword>Vinculin</keyword><keyword>Vinculin: metabolism</keyword></keywords><dates><year>2008</year></dates><accession-num>18413142</accession-num><electronic-resource-num>10.1016/j.bbrc.2008.04.019</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/18413142</url></web-urls></urls><label>ECIS Attachment</label><abstract>Human mesenchymal stem cell-adhesive peptides were screened based on the amino acid sequence of fibronectin type III domain 8-11 (FN-III(8-11)) using a peptide array synthesized by the Fmoc-chemistry. Using hexameric peptide library of FN-III(8-11) scan, we identified the ALNGR (Ala-Leu-Asn-Gly-Arg) peptide that induced cell adhesion as well as RGDS (Arg-Gly-Asp-Ser) peptide. After incubation for 2h, approximately 68% of inoculated cells adhere to the ALNGR peptide disk. Adhesion inhibition assay with integrin antibodies showed that the ALNGR peptide interacts with integrin beta1 but not with alphavbeta3, indicating that the receptors for ALNGR are different from RGDS. Additionally, the ALNGR peptide expressed cell specificities for adhesion: cell adhesion was promoted for fibroblasts but not for keratinocytes or endotherial cells. The ALNGR peptide induced cell adhesion and promoted cell proliferation without changing its property. It is therefore useful for the construction of functional biomaterials.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xu, Mei</author><author>Waters, Chris L</author><author>Hu, Chuan</author><author>Wysolmerski, Robert B</author><author>Vincent, Peter a</author><author>Minnear, Fred L</author></authors></contributors><titles><title>Sphingosine 1-phosphate rapidly increases endothelial barrier function independently of VE-cadherin but requires cell spreading and Rho kinase.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C1309-18</pages><volume>293</volume><issue>4</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Amides</keyword><keyword>Amides: pharmacology</keyword><keyword>Antibodies</keyword><keyword>Antibodies: immunology</keyword><keyword>Antibodies: pharmacology</keyword><keyword>Antigens</keyword><keyword>Bicyclo Compounds</keyword><keyword>CD</keyword><keyword>CD: genetics</keyword><keyword>CD: immunology</keyword><keyword>CD: metabolism</keyword><keyword>Cadherins</keyword><keyword>Cadherins: genetics</keyword><keyword>Cadherins: immunology</keyword><keyword>Cadherins: metabolism</keyword><keyword>Calcium</keyword><keyword>Calcium: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cell Shape</keyword><keyword>Cell Shape: drug effects</keyword><keyword>Cell Shape: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: drug effects</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Egtazic Acid</keyword><keyword>Egtazic Acid: pharmacology</keyword><keyword>Electric Impedance</keyword><keyword>Electrophysiology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Heterocyclic</keyword><keyword>Heterocyclic: pharmacology</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: drug effects</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: pharmacology</keyword><keyword>Pyridines</keyword><keyword>Pyridines: pharmacology</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: pharmacology</keyword><keyword>Thiazolidines</keyword><keyword>Thiazolidines: pharmacology</keyword><keyword>rho-Associated Kinases</keyword><keyword>rho-Associated Kinases: antagonists &amp; inhibitors</keyword><keyword>rho-Associated Kinases: metabolism</keyword></keywords><dates><year>2007</year></dates><accession-num>17670896</accession-num><electronic-resource-num>10.1152/ajpcell.00014.2007</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17670896</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Sphingosine 1-phosphate (S1P) rapidly increases endothelial barrier function and induces the assembly of the adherens junction proteins vascular endothelial (VE)-cadherin and catenins. Since VE-cadherin contributes to the stabilization of the endothelial barrier, we determined whether the rapid, barrier-enhancing activity of S1P requires VE-cadherin. Ca(2+)-dependent, homophilic VE-cadherin binding of endothelial cells, derived from human umbilical veins and grown as monolayers, was disrupted with EGTA, an antibody to the extracellular domain of VE-cadherin, or gene silencing of VE-cadherin with small interfering RNA. All three protocols caused a reduction in the immunofluorescent localization of VE-cadherin at intercellular junctions, the separation of adjacent cells, and a decrease in basal endothelial electrical resistance. In all three conditions, S1P rapidly increased endothelial electrical resistance. These findings demonstrate that S1P enhances the endothelial barrier independently of homophilic VE-cadherin binding. Junctional localization of VE-cadherin, however, was associated with the sustained activity of S1P. Imaging with phase-contrast and differential interference contrast optics revealed that S1P induced cell spreading and closure of intercellular gaps. Pretreatment with latrunculin B, an inhibitor of actin polymerization, or Y-27632, a Rho kinase inhibitor, attenuated cell spreading and the rapid increase in electrical resistance induced by S1P. We conclude that S1P rapidly closes intercellular gaps, resulting in an increased electrical resistance across endothelial cell monolayers, via cell spreading and Rho kinase and independently of VE-cadherin.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Saxena, Neeraj K</author><author>Sharma, Dipali</author><author>Ding, Xiaokun</author><author>Lin, Songbai</author><author>Marra, Fabio</author><author>Merlin, Didier</author><author>Anania, Frank a</author></authors></contributors><titles><title>Concomitant activation of the JAK/STAT, PI3K/AKT, and ERK signaling is involved in leptin-mediated promotion of invasion and migration of hepatocellular carcinoma cells.</title><secondary-title>Cancer research</secondary-title></titles><periodical><full-title>Cancer research</full-title></periodical><pages>2497-2507</pages><volume>67</volume><issue>6</issue><keywords><keyword>Carcinoma</keyword><keyword>Cell Cycle</keyword><keyword>Cell Cycle: drug effects</keyword><keyword>Cell Growth Processes</keyword><keyword>Cell Growth Processes: drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cell Surface</keyword><keyword>Cell Surface: biosynthesis</keyword><keyword>Enzyme Activation</keyword><keyword>Extracellular Signal-Regulated MAP Kinases</keyword><keyword>Extracellular Signal-Regulated MAP Kinases: metabo</keyword><keyword>Hepatocellular</keyword><keyword>Hepatocellular: enzymology</keyword><keyword>Hepatocellular: pathology</keyword><keyword>Humans</keyword><keyword>Janus Kinases</keyword><keyword>Janus Kinases: metabolism</keyword><keyword>Leptin</keyword><keyword>Leptin: pharmacology</keyword><keyword>Liver Neoplasms</keyword><keyword>Liver Neoplasms: enzymology</keyword><keyword>Liver Neoplasms: pathology</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>MAP Kinase Signaling System: drug effects</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>Proto-Oncogene Proteins c-akt: metabolism</keyword><keyword>Receptors</keyword><keyword>STAT3 Transcription Factor</keyword><keyword>STAT3 Transcription Factor: metabolism</keyword><keyword>Tumor</keyword></keywords><dates><year>2007</year></dates><accession-num>17363567</accession-num><electronic-resource-num>10.1158/0008-5472.CAN-06-3075</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2925446&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Invasion;ECIS Migration;Wound Healing</label><abstract>Various epidemiologic studies have shown that obesity is associated with hepatocellular carcinoma. Leptin, the key player in the regulation of energy balance and body weight control, also acts as a growth factor on certain organs in both normal and disease states. It is plausible that leptin acts to promote hepatocellular carcinogenesis directly affecting malignant properties of liver cancer cells. However, a direct role for leptin in hepatocellular carcinoma has not been shown. In this study, we analyzed the role of leptin and the mechanism(s) underlying its action in hepatocellular carcinoma cells, which express both short and long isoforms of leptin receptors. Treatment with leptin resulted in increased proliferation of both HepG2 and Huh7 cells and involves activation of signal transducers and activators of transcription 3 (STAT3), AKT, and extracellular signal-regulated kinase (ERK) signaling pathways. Leptin-induced phosphorylation of ERK and AKT was dependent on Janus-activated kinase (JAK)/STAT activation. Intriguingly, we also found that leptin potently induces invasion of hepatocellular carcinoma cells in Matrigel invasion and electric cell-substrate impedance-sensing assays. Leptin-stimulated invasion was effectively blocked by pharmacologic inhibitors of JAK/STAT and, to a lesser extent, by ERK and phosphatidylinositol 3-kinase (PI3K) inhibition. Importantly, leptin also induced the migration of both HepG2 and Huh7 cells on fibronectin matrix. Inhibition of JAK/STAT, ERK, and PI3K activation using pharmacologic inhibitors effectively blocked leptin-induced migration of HepG2 and Huh7 cells. Taken together, these data indicate that leptin promotes hepatocellular carcinoma growth, invasiveness, and migration and implicate the JAK/STAT pathway as a critical mediator of leptin action. Our findings have potential clinical implications for hepatocellular carcinoma progression in obese patients.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Litkouhi, Babak</author><author>Kwong, Joseph</author><author>Lo, Chun-Min</author><author>Smedley, James G</author><author>McClane, Bruce a.</author><author>Aponte, Margarita</author><author>Gao, Zhijian</author><author>Sarno, Jennifer L</author><author>Hinners, Jennifer</author><author>Welch, William R</author><author>Berkowitz, Ross S</author><author>Mok, Samuel C</author><author>Garner, Elizabeth I O</author></authors></contributors><titles><title>Claudin-4 Overexpression in Epithelial Ovarian Cancer Is Associated with Hypomethylation and Is a Potential Target for Modulation of Tight Junction Barrier Function Using a C-Terminal Fragment of Clostridium perfringens Enterotoxin</title><secondary-title>Neoplasia</secondary-title></titles><periodical><full-title>Neoplasia</full-title></periodical><pages>304-314</pages><volume>9</volume><issue>4</issue><keywords><keyword>claudin-4</keyword><keyword>gene expression</keyword><keyword>methylation</keyword><keyword>ovarian cancer</keyword><keyword>therapy</keyword></keywords><dates><year>2007</year></dates><electronic-resource-num>10.1593/neo.07118</electronic-resource-num><urls><web-urls><url>http://openurl.ingenta.com/content/xref?genre=article&amp;issn=1522-8002&amp;volume=9&amp;issue=4&amp;spage=304</url></web-urls></urls><label>ECIS Modeling;ECIS TEER</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hadjout, Nacima</author><author>Yin, Xiuyun</author><author>Knecht, David a</author><author>Lynes, Michael a</author></authors></contributors><titles><title>Automated real-time measurements of leukocyte chemotaxis.</title><secondary-title>Journal of immunological methods</secondary-title></titles><periodical><full-title>Journal of immunological methods</full-title></periodical><pages>70-80</pages><volume>320</volume><issue>1-2</issue><keywords><keyword>Animals</keyword><keyword>Bone Marrow Cells</keyword><keyword>Bone Marrow Cells: drug effects</keyword><keyword>Bone Marrow Cells: immunology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cells</keyword><keyword>Chemotaxis</keyword><keyword>Complement C5a</keyword><keyword>Complement C5a: immunology</keyword><keyword>Complement C5a: pharmacology</keyword><keyword>Computer Systems</keyword><keyword>Cultured</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electrodes</keyword><keyword>Humans</keyword><keyword>Inbred C57BL</keyword><keyword>Leukocyte</keyword><keyword>Mice</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: drug effects</keyword><keyword>Neutrophils: immunology</keyword><keyword>Time Factors</keyword></keywords><dates><year>2007</year></dates><accession-num>17275834</accession-num><electronic-resource-num>10.1016/j.jim.2006.12.005</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1934897&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><abstract>We have previously described an automated system (ECIS/taxis) for measuring chemotactic movement of Dictyostelium amoebae in a folic acid gradient [Hadjout, N., Laevsky, G., Knecht, D.A. and Lynes, M.A., 2001. Automated real-time measurement of chemotactic cell motility. Biotechniques 31, 1130-1138.]. In the ECIS/taxis system, cells migrate in an under-agarose environment, and their position is monitored by determining the impedance change caused by cells crawling onto the surface of an electrode. In this report, we show that chemotaxis of primary and immortalized leukocytes in response to complement (C5a) could be measured using the ECIS/taxis system. Several modifications to the design of the target electrode were tested, and a linear electrode perpendicular to the direction of movement was found to increase the sensitivity and reliability of the assay. Using the optimized ECIS/taxis assay, the dose response of neutrophils and WBC 265-9C cells was established and compared to the Boyden chamber assay. The ECIS/taxis assay system can be used to compare the movement of different cell types, to assess the effect of complex chemotactic gradients, or to determine the effects of pharmaceuticals on chemotactic motility.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Campbell, Carmen Elaine</author><author>Laane, Morten Motzfeldt</author><author>Haugarvoll, Erlend</author><author>Giaever, Ivar</author></authors></contributors><titles><title>Monitoring viral-induced cell death using electric cell-substrate impedance sensing.</title><secondary-title>Biosensors &amp; bioelectronics</secondary-title></titles><periodical><full-title>Biosensors &amp; bioelectronics</full-title></periodical><pages>536-542</pages><volume>23</volume><issue>4</issue><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Carps</keyword><keyword>Cell Death</keyword><keyword>Cell Death: physiology</keyword><keyword>Cell Line</keyword><keyword>Electric Impedance</keyword><keyword>Electrodes</keyword><keyword>Embryonic Stem Cells</keyword><keyword>Embryonic Stem Cells: cytology</keyword><keyword>Embryonic Stem Cells: virology</keyword><keyword>Infectious hematopoietic necrosis virus</keyword><keyword>Infectious hematopoietic necrosis virus: growth &amp;</keyword><keyword>Infectious pancreatic necrosis virus</keyword><keyword>Infectious pancreatic necrosis virus: growth &amp; dev</keyword><keyword>Salmonidae</keyword><keyword>Time Factors</keyword><keyword>Tumor</keyword></keywords><dates><year>2007</year></dates><accession-num>17826975</accession-num><electronic-resource-num>10.1016/j.bios.2007.06.015</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17826975</url></web-urls></urls><abstract>Using an electrical measurement known as electric cell-substrate impedance sensing (ECIS), we have recorded the dynamics of viral infections in cell culture. With this technique, cells are cultured on small gold electrodes where the measured impedance mirrors changes in attachment and morphology of cultured cells. As the cells attach and spread on the electrode, the measured impedance increases until the electrode is completely covered. Viral infection inducing cytopathic effect results in dramatic impedance changes, which are mainly due to cell death. In the current study, two different fish cell lines have been used: chinook salmonid embryonic (CHSE-214) cells infected with infectious pancreatic necrosis virus (IPNV) and epithelioma papulosum cyprini (EPC) carp cells infected with infectious hematopoeitic necrosis virus (IHNV). The impedance changes caused by cell response to virus are easily measured and converted to resistance and capacitance. An approximate linear correlation between log of viral titer and time of cell death was determined.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hartmann, Christoph</author><author>Zozulya, Alla</author><author>Wegener, Joachim</author><author>Galla, Hans-Joachim</author></authors></contributors><titles><title>The impact of glia-derived extracellular matrices on the barrier function of cerebral endothelial cells: an in vitro study.</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>1318-1325</pages><volume>313</volume><issue>7</issue><keywords><keyword>Animals</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: cytology</keyword><keyword>Blood-Brain Barrier: physiology</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cell Surface Extensions</keyword><keyword>Cell Surface Extensions: physiology</keyword><keyword>Cell-Matrix Junctions</keyword><keyword>Cell-Matrix Junctions: physiology</keyword><keyword>Cerebellum</keyword><keyword>Cerebellum: cytology</keyword><keyword>Cerebellum: physiology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Endothelium</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: physiology</keyword><keyword>Extracellular Matrix: secretion</keyword><keyword>Mice</keyword><keyword>Neuroglia</keyword><keyword>Neuroglia: physiology</keyword><keyword>Neuroglia: secretion</keyword><keyword>Swine</keyword><keyword>Tight Junctions</keyword><keyword>Tight Junctions: physiology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: physiology</keyword><keyword>Vascular: secretion</keyword></keywords><dates><year>2007</year></dates><accession-num>17346702</accession-num><electronic-resource-num>10.1016/j.yexcr.2007.01.024</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17346702</url></web-urls></urls><label>Blood Brain Barrier</label><abstract>The blood-brain barrier (BBB) is composed of the cerebral microvascular endothelium, which, together with astrocytes, pericytes, and the extracellular matrix (ECM), contributes to a &quot;neurovascular unit&quot;. It was our objective to clarify the impact of endogenous extracellular matrices on the barrier function of BBB microvascular endothelial cells cultured in vitro. The study was performed in two consecutive steps: (i) The ECM-donating cells (astrocytes, pericytes, endothelial cells) were grown to confluence and then removed from the growth substrate by a protocol that leaves the ECM behind. (ii) Suspensions of cerebral endothelial cells were seeded on the endogenous matrices and barrier formation was followed with time. In order to quantify the tightness of the cell junctions, all experiments were performed on planar gold-film electrodes that can be used to read the electrical resistance of the cell layers as a direct measure for endothelial barrier function (electric cell-substrate impedance sensing, ECIS). We observed that endogenously isolated ECM from both, astrocytes and pericytes, improved the tightness of cerebral endothelial cells significantly compared to ECM that was derived from the endothelial cells themselves as a control. Moreover, when cerebral endothelial cells were grown on extracellular matrices produced by non-brain endothelial cells (aorta), the electrical resistances were markedly reduced. Our observations indicate that glia-derived ECM - as an essential part of the BBB - is required to ensure proper barrier formation of cerebral endothelial cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Omori, Kazuyoshi</author><author>Shikata, Yasushi</author><author>Sarai, Kei</author><author>Watanabe, Naomi</author><author>Wada, Jun</author><author>Goda, Noriko</author><author>Kataoka, Noriyuki</author><author>Shikata, Kenichi</author><author>Makino, Hirofumi</author></authors></contributors><titles><title>Edaravone mimics sphingosine-1-phosphate-induced endothelial barrier enhancement in human microvascular endothelial cells.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C1523-31</pages><volume>293</volume><issue>5</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Adherens Junctions</keyword><keyword>Adherens Junctions: drug effects</keyword><keyword>Adherens Junctions: metabolism</keyword><keyword>Antipyrine</keyword><keyword>Antipyrine: analogs &amp; derivatives</keyword><keyword>Antipyrine: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cardiovascular Agents</keyword><keyword>Cardiovascular Agents: pharmacology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Kinase 1: metabolism</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: drug effects</keyword><keyword>Focal Adhesions: metabolism</keyword><keyword>Free Radical Scavengers</keyword><keyword>Free Radical Scavengers: pharmacology</keyword><keyword>Humans</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: metabolism</keyword><keyword>Lysosphingolipid</keyword><keyword>Lysosphingolipid: genetics</keyword><keyword>Lysosphingolipid: metabolism</keyword><keyword>Microcirculation</keyword><keyword>Microcirculation: cytology</keyword><keyword>Microcirculation: drug effects</keyword><keyword>Microcirculation: metabolism</keyword><keyword>Paxillin</keyword><keyword>Paxillin: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>RNA</keyword><keyword>RNA Interference</keyword><keyword>Receptors</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: metabolism</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: metabolism</keyword><keyword>Time Factors</keyword><keyword>rac GTP-Binding Proteins</keyword><keyword>rac GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2007</year></dates><accession-num>17686998</accession-num><electronic-resource-num>10.1152/ajpcell.00524.2006</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17686998</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Edaravone is a potent scavenger of hydroxyl radicals and is quite successful in patients with acute cerebral ischemia, and several organ-protective effects have been reported. Treatment of human microvascular endothelial cells with edaravone (1.5 microM) resulted in the enhancement of transmonolayer electrical resistance coincident with cortical actin enhancement and redistribution of focal adhesion proteins and adherens junction proteins to the cell periphery. Edaravone also induced small GTPase Rac activation and focal adhesion kinase (FAK; Tyr(576)) phosphorylation associated with sphingosine-1-phosphate receptor type 1 (S1P(1)) transactivation. S1P(1) protein depletion by the short interfering RNA technique completely abolished edaravone-induced FAK (Tyr(576)) phosphorylation and Rac activation. This is the first report of edaravone-induced endothelial barrier enhancement coincident with focal adhesion remodeling and cytoskeletal rearrangement associated with Rac activation via S1P(1) transactivation. Considering the well-established endothelial barrier-protective effect of S1P, endothelial barrier enhancement as a consequence of S1P(1) transactivation may at least partly be the potent mechanisms for the organ-protective effect of edaravone and is suggestive of edaravone as a therapeutic agent against systemic vascular barrier disorder.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Charrier, Laetitia</author><author>Yan, Yutao</author><author>Nguyen, Hang Thi Thu</author><author>Dalmasso, Guillaume</author><author>Laboisse, Christian L</author><author>Gewirtz, Andrew T</author><author>Sitaraman, Shanthi V</author><author>Merlin, Didier</author></authors></contributors><titles><title>ADAM-15/metargidin mediates homotypic aggregation of human T lymphocytes and heterotypic interactions of T lymphocytes with intestinal epithelial cells.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>16948-16958</pages><volume>282</volume><issue>23</issue><keywords><keyword>ADAM Proteins</keyword><keyword>ADAM Proteins: metabolism</keyword><keyword>ADAM Proteins: physiology</keyword><keyword>Base Sequence</keyword><keyword>Blotting</keyword><keyword>Caco-2 Cells</keyword><keyword>Cell Adhesion</keyword><keyword>Cytoplasm</keyword><keyword>Cytoplasm: metabolism</keyword><keyword>DNA Primers</keyword><keyword>Humans</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: cytology</keyword><keyword>Jurkat Cells</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Membrane Proteins: physiology</keyword><keyword>Oligopeptides</keyword><keyword>Oligopeptides: metabolism</keyword><keyword>T-Lymphocytes</keyword><keyword>T-Lymphocytes: cytology</keyword><keyword>Western</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2007</year></dates><accession-num>17416588</accession-num><electronic-resource-num>10.1074/jbc.M700158200</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17416588</url></web-urls></urls><label>ECIS Migration;Wound Healing</label><abstract>Intestinal epithelial cells (IEC) play an immunoregulatory role in the intestine. This role involves cell-cell interactions with intraepithelial lymphocytes that may also play a role in some enteropathies. The discovery of the RGD motif-containing Protein ADAM-15 (a disintegrin and metalloprotease-15) raises the question of its involvement in these cell-cell interactions. Cell adhesion assays were performed using the Jurkat E6.1 T cell line as a model of T lymphocytes and Caco2-BBE monolayers as a model of intestinal epithelia. Our results show that an anti-ADAM-15 ectodomain antibody inhibited the attachment of Jurkat cells on Caco2-BBE monolayers. Overexpression of ADAM-15 in Caco2-BBE cells enhanced Jurkat cell binding, and overexpression of ADAM-15 in Jurkat cells enhanced their aggregation. Mutagenesis experiments showed that both the mutation of ADAM-15 RGD domain or the deletion of its cytoplasmic tail decreased these cell-cell interactions. Moreover, wound-healing experiments showed that epithelial ADAM-15-mediated Jurkat cell adhesion to Caco2-BBE cells enhances the mechanisms of wound repair. We also found that ADAM-15-mediated aggregation of Jurkat cells increases the expression of tumor necrosis factor-alpha mRNA. These results demonstrate the following: 1) ADAM-15 is involved in heterotypic adhesion of intraepithelial lymphocytes to IEC as well as in homotypic aggregation of T cells; 2) both the RGD motif and the cytoplasmic tail of ADAM-15 are involved for these cell-cell interactions; and 3) ADAM-15-mediated cell-cell interactions are involved in mechanisms of epithelial restitution and production of pro-inflammatory mediators. Altogether these findings point to ADAM-15 as a possible therapeutic target for prevention of inappropriate T cell activation involved in some pathologies.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>ten Klooster, Jean Paul</author><author>Jaffer, Zahara M</author><author>Chernoff, Jonathan</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>Targeting and activation of Rac1 are mediated by the exchange factor beta-Pix.</title><secondary-title>The Journal of cell biology</secondary-title></titles><periodical><full-title>The Journal of cell biology</full-title></periodical><pages>759-769</pages><volume>172</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>COS Cells</keyword><keyword>Cell Cycle Proteins</keyword><keyword>Cell Cycle Proteins: metabolism</keyword><keyword>Cell Cycle Proteins: physiology</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: genetics</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: genetics</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Dogs</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Targeting</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: metabolism</keyword><keyword>Guanine Nucleotide Exchange Factors: physiology</keyword><keyword>Humans</keyword><keyword>Protein Structure</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: metabolism</keyword><keyword>Tertiary</keyword><keyword>p21-Activated Kinases</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: genetics</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2006</year></dates><accession-num>16492808</accession-num><electronic-resource-num>10.1083/jcb.200509096</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2063707&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Attachment;ECIS TEER</label><abstract>Rho guanosine triphosphatases (GTPases) are critical regulators of cytoskeletal dynamics and control complex functions such as cell adhesion, spreading, migration, and cell division. It is generally accepted that localized GTPase activation is required for the proper initiation of downstream signaling events, although the molecular mechanisms that control targeting of Rho GTPases are unknown. In this study, we show that the Rho GTPase Rac1, via a proline stretch in its COOH terminus, binds directly to the SH3 domain of the Cdc42/Rac activator beta-Pix (p21-activated kinase [Pak]-interacting exchange factor). The interaction with beta-Pix is nucleotide independent and is necessary and sufficient for Rac1 recruitment to membrane ruffles and to focal adhesions. In addition, the Rac1-beta-Pix interaction is required for Rac1 activation by beta-Pix as well as for Rac1-mediated spreading. Finally, using cells deficient for the beta-Pix-binding kinase Pak1, we show that Pak1 regulates the Rac1-beta-Pix interaction and controls cell spreading and adhesion-induced Rac1 activation. These data provide a model for the intracellular targeting and localized activation of Rac1 through its exchange factor beta-Pix.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Moldobaeva, Aigul</author><author>Welsh-Servinsky, Laura E</author><author>Shimoda, Larissa a</author><author>Stephens, R Scott</author><author>Verin, Alexander D</author><author>Tuder, Rubin M</author><author>Pearse, David B</author></authors></contributors><titles><title>Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L919-30</pages><volume>290</volume><issue>5</issue><keywords><keyword>Adenoviridae</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic GMP</keyword><keyword>Cyclic GMP-Dependent Protein Kinases</keyword><keyword>Cyclic GMP-Dependent Protein Kinases: genetics</keyword><keyword>Cyclic GMP-Dependent Protein Kinases: metabolism</keyword><keyword>Cyclic GMP: physiology</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: physiology</keyword><keyword>Recombinant Proteins</keyword><keyword>Recombinant Proteins: metabolism</keyword><keyword>Transfection</keyword><keyword>Vascular</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2006</year></dates><accession-num>16339778</accession-num><electronic-resource-num>10.1152/ajplung.00434.2005</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16339778</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Increases in endothelial cGMP prevent oxidant-mediated endothelial barrier dysfunction, but the downstream mechanisms remain unclear. To determine the role of cGMP-dependent protein kinase (PKG)(I), human pulmonary artery endothelial cells (HPAEC) lacking PKG(I) expression were infected with a recombinant adenovirus encoding PKG(Ibeta) (Ad.PKG) and compared with uninfected and control-infected (Ad.betagal) HPAEC. Transendothelial electrical resistance (TER), an index of permeability, was measured after H(2)O(2) (250 microM) exposure with or without pretreatment with 8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphate (CPT-cGMP). HPAEC infected with Ad.PKG, but not Ad.betagal, expressed PKG(I) protein and demonstrated Ser(239) and Ser(157) phosphorylation of vasodilator-stimulated phosphoprotein after treatment with CPT-cGMP. Adenoviral infection decreased basal permeability equally in Ad.PKG- and Ad.betagal-infected HPAEC compared with uninfected cells. Treatment with CPT-cGMP (100 microM) caused a PKG(I)-independent decrease in permeability (8.2 +/- 0.6%). In all three groups, H(2)O(2) (250 microM) caused a similar approximately 35% increase in permeability associated with increased actin stress fiber formation, intercellular gaps, loss of membrane VE-cadherin, and increased intracellular Ca(2+) concentration ([Ca(2+)](i)). In uninfected and Ad.betagal-infected HPAEC, pretreatment with CPT-cGMP (100 microM) partially blocked the increased permeability induced by H(2)O(2). In Ad.PKG-infected HPAEC, CPT-cGMP (50 microM) prevented the H(2)O(2)-induced TER decrease, cytoskeletal rearrangement, and loss of junctional VE-cadherin. CPT-cGMP attenuated the peak [Ca(2+)](i) caused by H(2)O(2) similarly (23%) in Ad.betagal- and Ad.PKG-infected HPAEC, indicating a PKG(I)-independent effect. These data suggest that cGMP decreased HPAEC basal permeability by a PKG(I)-independent process, whereas the ability of cGMP to prevent H(2)O(2)-induced barrier dysfunction was predominantly mediated by PKG(I) through a Ca(2+)-independent mechanism.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukova, Anna a</author><author>Adyshev, Djanybek</author><author>Gorshkov, Boris</author><author>Bokoch, Gary M</author><author>Birukov, Konstantin G</author><author>Verin, Alexander D</author></authors></contributors><titles><title>GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L540-8</pages><volume>290</volume><issue>3</issue><keywords><keyword>Actin Cytoskeleton</keyword><keyword>Actin Cytoskeleton: metabolism</keyword><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Antineoplastic Agents</keyword><keyword>Antineoplastic Agents: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Dominant</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Genes</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: physiology</keyword><keyword>Humans</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Myosin-Light-Chain Phosphatase</keyword><keyword>Myosin-Light-Chain Phosphatase: metabolism</keyword><keyword>Nocodazole</keyword><keyword>Nocodazole: pharmacology</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>RNA</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: pharmacology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2006</year></dates><accession-num>16257999</accession-num><electronic-resource-num>10.1152/ajplung.00259.2005</electronic-resource-num><notes>From Duplicate 2 (GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. - Birukova, Anna a; Adyshev, Djanybek; Gorshkov, Boris; Bokoch, Gary M; Birukov, Konstantin G; Verin, Alexander D)

From Duplicate 2 ( GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. - Birukova, Anna a; Adyshev, Djanybek; Gorshkov, Boris; Bokoch, Gary M; Birukov, Konstantin G; Verin, Alexander D )</notes><research-notes>From Duplicate 2 (GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. - Birukova, Anna a; Adyshev, Djanybek; Gorshkov, Boris; Bokoch, Gary M; Birukov, Konstantin G; Verin, Alexander D)

From Duplicate 2 ( GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction. - Birukova, Anna a; Adyshev, Djanybek; Gorshkov, Boris; Bokoch, Gary M; Birukov, Konstantin G; Verin, Alexander D )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16257999</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Endothelial cell (EC) permeability is precisely controlled by cytoskeletal elements [actin filaments, microtubules (MT), intermediate filaments] and cell contact protein complexes (focal adhesions, adherens junctions, tight junctions). We have recently shown that the edemagenic agonist thrombin caused partial MT disassembly, which was linked to activation of small GTPase Rho, Rho-mediated actin remodeling, cell contraction, and dysfunction of lung EC barrier. GEF-H1 is an MT-associated Rho-specific guanosine nucleotide (GDP/GTP) exchange factor, which in MT-unbound state stimulates Rho activity. In this study we tested hypothesis that GEF-H1 may be a key molecule involved in Rho activation, myosin light chain phosphorylation, actin remodeling, and EC barrier dysfunction associated with partial MT disassembly. Our results show that depletion of GEF-H1 or expression of dominant negative GEF-H1 mutant significantly attenuated permeability increase, actin stress fiber formation, and increased MLC and MYPT1 phosphorylation induced by thrombin or MT-depolymerizing agent nocodazole. In contrast, expression of wild-type or activated GEF-H1 mutants dramatically enhanced thrombin and nocodazole effects on stress fiber formation and cell retraction. These results show a critical role for the GEF-H1 in the Rho activation caused by MT disassembly and suggest GEF-H1 as a key molecule involved in cross talk between MT and actin cytoskeleton in agonist-induced Rho-dependent EC barrier regulation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chiang, Eddie T</author><author>Persaud-Sawin, Dixie-Ann</author><author>Kulkarni, Sandhya</author><author>Garcia, Joe G N</author><author>Imani, Farhad</author></authors></contributors><titles><title>Bluetongue virus and double-stranded RNA increase human vascular permeability: role of p38 MAPK.</title><secondary-title>Journal of clinical immunology</secondary-title></titles><periodical><full-title>Journal of clinical immunology</full-title></periodical><pages>406-416</pages><volume>26</volume><issue>4</issue><keywords><keyword>Bluetongue virus</keyword><keyword>Bluetongue virus: pathogenicity</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytokines</keyword><keyword>Cytokines: genetics</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Double-Stranded</keyword><keyword>Double-Stranded: pharmacology</keyword><keyword>Endothelium</keyword><keyword>Gene Expression Regulation</keyword><keyword>Hemorrhagic Fevers</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: pathology</keyword><keyword>Lung: virology</keyword><keyword>RNA</keyword><keyword>Vascular</keyword><keyword>Vascular: pathology</keyword><keyword>Vascular: virology</keyword><keyword>Viral</keyword><keyword>Viral: etiology</keyword><keyword>Viral: pathology</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>p38 Mitogen-Activated Protein Kinases: physiology</keyword></keywords><dates><year>2006</year></dates><isbn>1087500690244</isbn><accession-num>16786433</accession-num><electronic-resource-num>10.1007/s10875-006-9024-4</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16786433</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Endothelial cell (EC) involvement in viral hemorrhagic fevers has been clearly established. However, virally activated mechanisms leading to endothelial activation and dysfunction are not well understood. Several different potential mechanisms such as direct viral infection, alterations in procoagulant/anticoagulant balance, and increased cytokine production have been suggested. We utilized a model of EC barrier dysfunction and vascular endothelial leakage to explore the effect of bluetongue virus (BTV), a hemorrhagic fever virus of ruminants, on human lung endothelial cell barrier properties. Infection of human lung EC with BTV induced a significant and dose-dependent decrease in trans-endothelial electrical resistance (TER). Furthermore, decreases in TER occurred in conjunction with cytoskeletal rearrangement, suggesting a direct mechanism for viral infection-mediated endothelial barrier disruption. Interestingly, double-stranded RNA (dsRNA) mimicked the effects of BTV on endothelial barrier properties. Both BTV- and dsRNA-induced endothelial barrier dysfunction was blocked by treatment with a pharmacological inhibitor of p38 MAPK. The induction of vascular permeability by dsRNA treatment or BTV infection was concomitent with induction of inflammatory cytokines. Taken together, our data suggest that the presence of dsRNA during viral infections and subsequent activation of p38 MAPK is a potential molecular pathway for viral induction of hemorrhagic fevers. Collectively, our data suggest that inhibition of p38 MAPK may be a possible therapeutic approach to alter viral-induced acute hemorrhagic diseases.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Driss, Adel</author><author>Charrier, Laetitia</author><author>Yan, Yutao</author><author>Nduati, Vivienne</author><author>Sitaraman, Shanthi</author><author>Merlin, Didier</author></authors></contributors><titles><title>Dystroglycan receptor is involved in integrin activation in intestinal epithelia.</title><secondary-title>American journal of physiology. Gastrointestinal and liver physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Gastrointestinal and liver physiology</full-title></periodical><pages>G1228-42</pages><volume>290</volume><issue>6</issue><keywords><keyword>Antigens</keyword><keyword>CD29</keyword><keyword>CD29: metabolism</keyword><keyword>Caco-2 Cells</keyword><keyword>Dystroglycans</keyword><keyword>Dystroglycans: metabolism</keyword><keyword>Dystrophin-Associated Protein Complex</keyword><keyword>Dystrophin-Associated Protein Complex: metabolism</keyword><keyword>Humans</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: metabolism</keyword><keyword>Laminin</keyword><keyword>Laminin: metabolism</keyword></keywords><dates><year>2006</year></dates><accession-num>16357060</accession-num><electronic-resource-num>10.1152/ajpgi.00378.2005</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2738938&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Attachment</label><abstract>The dystroglycans (alpha-DG and beta-DG), which play important roles in the formation of basement membranes, have been well studied in skeletal muscle and nerve, but their expression and localization in intestinal epithelial cells has not been previously investigated. Here, we demonstrated that the DG complex, composed of alpha-DG, beta-DG, and utrophin, is specifically expressed in the basolateral membrane of the Caco-2-BBE monolayer. The DG complex coprecipitated with beta(1)-integrin, suggesting a possible interaction among these proteins. In addition, we observed that activation of DG receptors by laminin-1 enhanced the interaction between beta(1)-integrin and laminin-1, whereas activation of DG receptors by laminin-2 reduced the interaction between beta(1)-integrin and laminin-2. Finally, we demonstrated that the intracellular COOH-terminal tail of beta-DG and its binding to the DG binding domain of utrophin are crucial for the interactions between laminin-1/-2 and beta(1)-integrin. Collectively, these novel results indicate that dystroglycans play important roles in the regulation of interactions between intestinal epithelial cells and the extracellular matrix.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Berdyshev, Evgeny V</author><author>Gorshkova, Irina a</author><author>Usatyuk, Peter</author><author>Zhao, Yutong</author><author>Saatian, Bahman</author><author>Hubbard, Walter</author><author>Natarajan, Viswanathan</author></authors></contributors><titles><title>De novo biosynthesis of dihydrosphingosine-1-phosphate by sphingosine kinase 1 in mammalian cells.</title><secondary-title>Cellular signalling</secondary-title></titles><periodical><full-title>Cellular signalling</full-title></periodical><pages>1779-1792</pages><volume>18</volume><issue>10</issue><keywords><keyword>Avian Sarcoma Viruses</keyword><keyword>Avian Sarcoma Viruses: physiology</keyword><keyword>Calcium</keyword><keyword>Calcium: metabolism</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Gene Expression</keyword><keyword>Gene Expression: drug effects</keyword><keyword>Humans</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: analysis</keyword><keyword>Lysophospholipids: chemistry</keyword><keyword>Lysophospholipids: pharmacology</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Phosphotransferases (Alcohol Group Acceptor)</keyword><keyword>Phosphotransferases (Alcohol Group Acceptor): meta</keyword><keyword>RNA</keyword><keyword>Serine C-Palmitoyltransferase</keyword><keyword>Serine C-Palmitoyltransferase: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Small Interfering</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: analysis</keyword><keyword>Sphingosine: biosynthesis</keyword><keyword>Sphingosine: chemistry</keyword><keyword>Sphingosine: pharmacology</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: metabolism</keyword><keyword>Up-Regulation</keyword><keyword>Up-Regulation: drug effects</keyword><keyword>Up-Regulation: genetics</keyword></keywords><dates><year>2006</year></dates><accession-num>16529909</accession-num><electronic-resource-num>10.1016/j.cellsig.2006.01.018</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16529909</url></web-urls></urls><label>ECIS Migration;Signal Transduction</label><abstract>Sphingosine kinase 1 (SK1) is one of the two known kinases, which generates sphingosine-1-phosphate (S1P), a potent endogenous lipid mediator involved in cell survival, proliferation, and cell-cell interactions. Activation of SK1 and intracellular generation of S1P were suggested to be part of the growth and survival factor-induced signaling, and overexpression of SK1 provoked cell tumorigenic transformation. Using a highly selective and sensitive LC-MS/MS approach, here we show that SK1 overexpression, but not SK2, in different primary cells and cultured cell lines results in predominant upregulation of the synthesis of dihydrosphingosine-1-phosphate (DHS1P) compared to S1P. Stable isotope pulse-labeling experiments in conjunction with LC-MS/MS quantitation of different sphingolipids demonstrated strong interference of overexpressed SK1 with the de novo sphingolipid biosynthesis by deviating metabolic flow of newly formed sphingoid bases from ceramide formation toward the synthesis of DHS1P. On the contrary, S1P biosynthesis was not directly linked to the de novo sphingoid bases transformations and was dependent on catabolic generation of sphingosine from complex sphingolipids. As a result of SK1 overexpression, migration and Ca2+-response of human pulmonary artery endothelial cells (HPAEC) to stimulation with external S1P, but not thrombin, was strongly impaired. In contrast, selective increase in intracellular content of DHS1P or S1P through the uptake and phosphorylation of corresponding sphingoid bases had no effect on S1P-induced signaling or facilitation of wound healing. Furthermore, infection of human bronchial epithelial cells (HBEpC) with RSV A-2 virus increased SK1-mediated synthesis of DHS1P and S1P, whereas TNF-alpha enhanced only S1P production in HPAEC. These findings uncover a new functional role for SK1, which can control survival/death (DHS1P-S1P/ceramides) balance by targeting sphingolipid de novo biosynthesis and selectively generating DHS1P at a metabolic step preceding ceramide formation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sapper, Angelika</author><author>Reiss, Björn</author><author>Janshoff, Andreas</author><author>Wegener, Joachim</author></authors></contributors><titles><title>Adsorption and fluctuations of giant liposomes studied by electrochemical impedance measurements.</title><secondary-title>Langmuir : the ACS journal of surfaces and colloids</secondary-title></titles><periodical><full-title>Langmuir : the ACS journal of surfaces and colloids</full-title></periodical><pages>676-680</pages><volume>22</volume><issue>2</issue><keywords><keyword>Adsorption</keyword><keyword>Animals</keyword><keyword>Biocompatible</keyword><keyword>Biocompatible: chemistry</keyword><keyword>Cells</keyword><keyword>Cells: cytology</keyword><keyword>Coated Materials</keyword><keyword>Computer Simulation</keyword><keyword>Electric Impedance</keyword><keyword>Electrochemistry</keyword><keyword>Electrodes</keyword><keyword>Gold</keyword><keyword>Gold: chemistry</keyword><keyword>Liposomes</keyword><keyword>Liposomes: chemistry</keyword><keyword>Materials Testing</keyword><keyword>Monte Carlo Method</keyword><keyword>Proteins</keyword><keyword>Proteins: chemistry</keyword><keyword>Spectrum Analysis</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword></keywords><dates><year>2006</year></dates><accession-num>16401116</accession-num><electronic-resource-num>10.1021/la051344b</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16401116</url></web-urls></urls><label>ECIS Attachment;ECIS Micromotion</label><abstract>The present study describes a novel approach based on electrochemical impedance measurements to follow the adsorption of giant liposomes on protein-coated solid surfaces with a time resolution in the order of seconds. The technical key features are circular gold-film electrodes as small as a few hundred micrometers in diameter and measurements of the electrode capacitance using AC signals in the kilohertz regime. Using Monte Carlo simulations, we were able to support the experiments and extract the rate constant of liposome adsorption. Besides monitoring the adsorption of liposomes on protein-coated surfaces, we also applied this technique to study shape fluctuations of the adsorbed vesicles and compared the corresponding power spectra with those recorded for hard particles and living animal cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Riethmüller, C</author><author>Jungmann, P</author><author>Wegener, Joachim</author><author>Oberleithner, H</author></authors></contributors><titles><title>Bradykinin shifts endothelial fluid passage from para- to transcellular routes.</title><secondary-title>Pflügers Archiv : European journal of physiology</secondary-title></titles><periodical><full-title>Pflügers Archiv : European journal of physiology</full-title></periodical><pages>157-165</pages><volume>453</volume><issue>2</issue><keywords><keyword>Body Fluid Compartments</keyword><keyword>Body Fluid Compartments: physiology</keyword><keyword>Bradykinin</keyword><keyword>Bradykinin: physiology</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Dextrans</keyword><keyword>Dextrans: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endocytosis</keyword><keyword>Endocytosis: physiology</keyword><keyword>Endothelium</keyword><keyword>Exocytosis</keyword><keyword>Exocytosis: physiology</keyword><keyword>Humans</keyword><keyword>Vascular</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2006</year></dates><accession-num>17047985</accession-num><electronic-resource-num>10.1007/s00424-006-0121-2</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/17047985</url></web-urls></urls><label>ECIS Modeling;ECIS TEER</label><abstract>The signalling peptide bradykinin (BK) is implicated in inflammation and angiogenesis. It promotes fluid transport from blood vessels to interstitial space, and thus facilitates oedema formation. To clarify whether paracellular or transcellular pathways mediate this effect, we investigated the BK-stimulated fluid transport across endothelial monolayers in vitro by comparison of electrical and fluorescence methods. Electrical cell impedance sensing monitored a biphasic response of cell layers to BK with high time resolution: a short decrease (18%, 1 min) was followed by a more sustained increase in paracellular resistance (30%, 10 min). The two phases can be assigned to second messengers of the BK-signalling pathway: Ca(2+) for the decrease and cyclic adenosine monophosphate for the rise of resistance, respectively. Despite tightening of the intercellular clefts, BK increased the fluid permeability by 39%, indicating transcellular fluid transport. Additionally, BK stimulated both in- and outwardly directed membrane trafficking as assessed by vesicular fluid uptake (by 49%) and secretion of von Willebrandt factor (by 85%). In conclusion, the combination of electrical and fluorescence data suggests that BK induces a shift from para- to transcellular fluid transport across endothelium.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Urdapilleta, E</author><author>Bellotti, M</author><author>Bonetto, F J</author></authors></contributors><titles><title>Impedance analysis of cultured cells: A mean-field electrical response model for electric cell-substrate impedance sensing technique</title><secondary-title>Physical Review E</secondary-title></titles><periodical><full-title>Physical Review E</full-title></periodical><pages>41908</pages><volume>74</volume><issue>4</issue><keywords/><dates><year>2006</year></dates><electronic-resource-num>10.1103/PhysRevE.74.041908</electronic-resource-num><urls><web-urls><url>http://link.aps.org/doi/10.1103/PhysRevE.74.041908</url></web-urls></urls><label>ECIS Theory</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>AAS, VIGDIS</author><author>TORBLÅ, SIRI</author><author>ANDERSEN, MERETHE H</author><author>JENSEN, JØRGEN</author><author>RUSTAN, ARILD C H R</author></authors></contributors><titles><title>Electrical Stimulation Improves Insulin Responses in a Human Skeletal Muscle Cell Model of Hyperglycemia</title><secondary-title>Annals of the New York Academy of Sciences</secondary-title></titles><periodical><full-title>Annals of the New York Academy of Sciences</full-title></periodical><pages>506-515</pages><volume>967</volume><issue>1</issue><keywords><keyword>2-deoxyglucose uptake</keyword><keyword>electrical stimulation</keyword><keyword>hyperglycemia</keyword></keywords><dates><year>2006</year></dates><electronic-resource-num>10.1111/j.1749-6632.2002.tb04309.x</electronic-resource-num><urls><web-urls><url>http://doi.wiley.com/10.1111/j.1749-6632.2002.tb04309.x</url></web-urls></urls><label>ECIS Micromotion</label><abstract>Myoblasts from human skeletal muscle were isolated from needle biopsy samples of the vastus lateralis of young and healthy volunteers. Contaminating fibroblasts were removed, and myoblasts were fused into differentiated multinucleated myotubes. These myotubes manifested both basal and insulin-stimulated (1-100 nM) glucose transport and glycogen synthesis. Insulin increased 2-deoxyglucose uptake by 1.4-fold and glycogen synthesis by 2.1-fold. Measurements of impedance of cell-covered gold electrodes (ECIS system) showed increased micromotion of caffeine-stimulated cells, showing their ability to contract. Acute electrical stimulation of the myotubes increased 2-deoxyglucose uptake by about 30%. Treatment with high glucose concentrations (10-20 mM) for 2-8 days reduced both basal and insulin-stimulated glucose uptake. Maximal effect was seen after 2 days of treatment with 20 mM glucose. Baseline glucose uptake and glycogen synthesis were reduced by 35%, insulin-stimulated glucose uptake by 25%, and insulin-stimulated glycogen synthesis by 39%. Total cell content of glycogen was not changed by hyperglycemia. The insulin-stimulated glucose uptake in hyperglycemia-treated cells was improved by electrical stimulation of the cells. In conclusion, a model of hyperglycemia has been established, and electrical stimulation improved insulin responses.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Qiao, Jing</author><author>Huang, Fei</author><author>Naikawadi, Ram P</author><author>Kim, Kwang Sik</author><author>Said, Tamer</author><author>Lum, Hazel</author></authors></contributors><titles><title>Lysophosphatidylcholine impairs endothelial barrier function through the G protein-coupled receptor GPR4.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L91-101</pages><volume>291</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>COS Cells</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: immunology</keyword><keyword>Cells</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Cultured</keyword><keyword>Dermis</keyword><keyword>Dermis: blood supply</keyword><keyword>Electric Conductivity</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>G-Protein-Coupled</keyword><keyword>G-Protein-Coupled: genetics</keyword><keyword>G-Protein-Coupled: metabolism</keyword><keyword>Gene Expression</keyword><keyword>Humans</keyword><keyword>Inflammation</keyword><keyword>Inflammation: metabolism</keyword><keyword>Lysophosphatidylcholines</keyword><keyword>Lysophosphatidylcholines: pharmacology</keyword><keyword>Mutagenesis</keyword><keyword>Receptors</keyword></keywords><dates><year>2006</year></dates><accession-num>16461426</accession-num><electronic-resource-num>10.1152/ajplung.00508.2005</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16461426</url></web-urls></urls><label>ECIS TEER;Inflammation;Signal Transduction</label><abstract>Abundant evidence indicates that lysophosphatidylcholine (LPC) is proinflammatory and atherogenic. In the vascular endothelium, LPC increases permeability and expression of proinflammatory molecules such as adhesion molecules and cytokines. Yet, mechanisms by which LPC mediates these activities remain unclear and controversial. Recent evidence implicates involvement of a novel subfamily of G protein-coupled receptors (GPR4, G2A, OGR1, and TDAG8) that are sensitive to lysolipids and protons. We previously reported that one of these receptors, GPR4, is selectively expressed by a variety of endothelial cells and therefore hypothesize that the LPC-stimulated endothelial barrier dysfunction is mediated through GPR4. We developed a peptide Ab against GPR4 that detected GPR4 expression in transfected COS 7 cells and endogenous GPR4 expression in endothelial cells by Western blot. Endothelial cells infected with a retrovirus containing small interference RNA (siRNA) to GPR4 resulted in 40-50% decreased GPR4 expression, which corresponded with partial prevention of the LPC-induced 1) decrease in transendothelial resistance, 2) stress fiber formation, and 3) activation of RhoA. Furthermore, coexpression of the siRNA-GPR4 with a siRNA-resistant mutant GPR4 fully restored the LPC-induced resistance decrease. However, extracellular pH of &lt;7.4 did not alter baseline or LPC-stimulated resistances. The results provide strong evidence that the LPC-mediated endothelial barrier dysfunction is regulated by endogenous GPR4 in endothelial cells and suggest that GPR4 may play a critical role in the inflammatory responses activated by LPC.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ren, Juan</author><author>Xiao, Yi-jin</author><author>Singh, Lisam Shanjukumar</author><author>Zhao, Xiaoxian</author><author>Zhao, Zhenwen</author><author>Feng, Li</author><author>Rose, Tyler M</author><author>Prestwich, Glenn D</author><author>Xu, Yan</author></authors></contributors><titles><title>Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells.</title><secondary-title>Cancer research</secondary-title></titles><periodical><full-title>Cancer research</full-title></periodical><pages>3006-3014</pages><volume>66</volume><issue>6</issue><keywords><keyword>Arachidonic Acids</keyword><keyword>Arachidonic Acids: pharmacology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Collagen Type I</keyword><keyword>Conditioned</keyword><keyword>Culture Media</keyword><keyword>Cytosol</keyword><keyword>Cytosol: enzymology</keyword><keyword>Epithelium</keyword><keyword>Epithelium: enzymology</keyword><keyword>Epithelium: metabolism</keyword><keyword>Extracellular Signal-Regulated MAP Kinases</keyword><keyword>Extracellular Signal-Regulated MAP Kinases: metabo</keyword><keyword>Female</keyword><keyword>Group VI Phospholipases A2</keyword><keyword>Humans</keyword><keyword>Isoenzymes</keyword><keyword>Isoenzymes: antagonists &amp; inhibitors</keyword><keyword>Isoenzymes: metabolism</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: biosynthesis</keyword><keyword>Lysophospholipids: physiology</keyword><keyword>Naphthalenes</keyword><keyword>Naphthalenes: pharmacology</keyword><keyword>Ovarian Neoplasms</keyword><keyword>Ovarian Neoplasms: enzymology</keyword><keyword>Ovarian Neoplasms: metabolism</keyword><keyword>Ovarian Neoplasms: pathology</keyword><keyword>Peritoneal Cavity</keyword><keyword>Peritoneal Cavity: pathology</keyword><keyword>Peritoneum</keyword><keyword>Peritoneum: enzymology</keyword><keyword>Peritoneum: metabolism</keyword><keyword>Phosphodiesterase Inhibitors</keyword><keyword>Phosphodiesterase Inhibitors: pharmacology</keyword><keyword>Phospholipases A</keyword><keyword>Phospholipases A: antagonists &amp; inhibitors</keyword><keyword>Phospholipases A: metabolism</keyword><keyword>Proto-Oncogene Proteins c-akt</keyword><keyword>Proto-Oncogene Proteins c-akt: metabolism</keyword><keyword>Pyrones</keyword><keyword>Pyrones: pharmacology</keyword><keyword>Tumor</keyword></keywords><dates><year>2006</year></dates><accession-num>16540649</accession-num><electronic-resource-num>10.1158/0008-5472.CAN-05-1292</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16540649</url></web-urls></urls><label>ECIS Invasion</label><abstract>Lysophosphatidic acid (LPA) is both a potential marker and a therapeutic target for ovarian cancer. It is critical to identify the sources of elevated LPA levels in ascites and blood of patients with ovarian cancer. We show here that human peritoneal mesothelial cells constitutively produce LPA, which accounts for a significant portion of the chemotactic activity of the conditioned medium from peritoneal mesothelial cells to ovarian cancer cells. Both production of LPA by peritoneal mesothelial cells and the chemotactic activity in the conditioned medium can be blocked by HELSS [an inhibitor of the calcium-independent phospholipase A(2) (iPLA(2))] and AACOCF(3) [an inhibitor of both cytosolic PLA(2) (cPLA(2)) and iPLA(2)]. Moreover, cell-based enzymatic activity assays for PLA(2) indicate that peritoneal mesothelial cells have strong constitutive PLA(2) activity. Receptors for LPA, LPA(2), and LPA(3) are involved in the conditioned medium-induced chemotactic activity. Invasion of ovarian cancer cells into peritoneal mesothelial cells has also been analyzed and shown to require PLA(2), LPA receptors, and the mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase signaling pathway. Thus, we show here, for the first time, that human peritoneal mesothelial cells constitutively produce bioactive lipid signaling molecules, such as LPA, via iPLA(2) and/or cPLA(2) activities. Conditioned medium from peritoneal mesothelial cells stimulate migration, adhesion, and invasion of ovarian cancer cells, and may play similar roles in vivo.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yin, Fei</author><author>Watsky, Mitchell a</author></authors></contributors><titles><title>LPA and S1P increase corneal epithelial and endothelial cell transcellular resistance.</title><secondary-title>Investigative ophthalmology &amp; visual science</secondary-title></titles><periodical><full-title>Investigative ophthalmology &amp; visual science</full-title></periodical><pages>1927-1933</pages><volume>46</volume><issue>6</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Cell Culture Techniques</keyword><keyword>Corneal</keyword><keyword>Corneal: drug effects</keyword><keyword>Corneal: metabolism</keyword><keyword>Diphosphates</keyword><keyword>Diphosphates: pharmacology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Epithelium</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>GTP-Binding Protein alpha Subunits</keyword><keyword>Gi-Go</keyword><keyword>Gi-Go: metabol</keyword><keyword>Glycerol</keyword><keyword>Glycerol: analogs &amp; derivatives</keyword><keyword>Glycerol: pharmacology</keyword><keyword>Indirect</keyword><keyword>Lysophosphatidic Acid</keyword><keyword>Lysophosphatidic Acid: metabolism</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: pharmacology</keyword><keyword>Pertussis Toxin</keyword><keyword>Pertussis Toxin: pharmacology</keyword><keyword>Rabbits</keyword><keyword>Receptors</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: pharmacology</keyword><keyword>Tetradecanoylphorbol Acetate</keyword><keyword>Tetradecanoylphorbol Acetate: pharmacology</keyword></keywords><dates><year>2005</year></dates><accession-num>15914605</accession-num><electronic-resource-num>10.1167/iovs.04-1256</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15914605</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>To determine whether lysophosphatidic acid (LPA) or sphingosine-1-phosphate (S1P) affects transcellular resistance across cultured rabbit corneal epithelial and endothelial cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Barker, Thomas H</author><author>Baneyx, Gretchen</author><author>Cardó-Vila, Marina</author><author>Workman, Gail a</author><author>Weaver, Matt</author><author>Menon, Priya M</author><author>Dedhar, Shoukat</author><author>Rempel, Sandra a</author><author>Arap, Wadih</author><author>Pasqualini, Renata</author><author>Vogel, Viola</author><author>Sage, E Helene</author></authors></contributors><titles><title>SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>36483-36493</pages><volume>280</volume><issue>43</issue><keywords><keyword>Actins</keyword><keyword>Actins: chemistry</keyword><keyword>Adenoviridae</keyword><keyword>Adenoviridae: genetics</keyword><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Biological</keyword><keyword>Biotinylation</keyword><keyword>CD29</keyword><keyword>CD29: metabolism</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Cell Separation</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: metabolism</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: metabolism</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: chemistry</keyword><keyword>Fibronectins: metabolism</keyword><keyword>Flow Cytometry</keyword><keyword>Fluorescence</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Gene Expression Regulation</keyword><keyword>Glycoproteins</keyword><keyword>Glycoproteins: chemistry</keyword><keyword>Immunoblotting</keyword><keyword>Immunoprecipitation</keyword><keyword>Inbred C57BL</keyword><keyword>Integrin alpha5</keyword><keyword>Integrin alpha5: metabolism</keyword><keyword>Mice</keyword><keyword>Microscopy</keyword><keyword>Models</keyword><keyword>Molecular Sequence Data</keyword><keyword>Myosin-Light-Chain Phosphatase</keyword><keyword>Myosin-Light-Chain Phosphatase: chemistry</keyword><keyword>Osteonectin</keyword><keyword>Osteonectin: metabolism</keyword><keyword>Osteonectin: physiology</keyword><keyword>Peptide Library</keyword><keyword>Phosphorylation</keyword><keyword>Protein Denaturation</keyword><keyword>Protein Folding</keyword><keyword>Protein Structure</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Tertiary</keyword><keyword>Time Factors</keyword><keyword>Transgenic</keyword></keywords><dates><year>2005</year></dates><accession-num>16115889</accession-num><electronic-resource-num>10.1074/jbc.M504663200</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16115889</url></web-urls></urls><label>ECIS Attachment;Signal Transduction</label><abstract>SPARC, a 32-kDa matricellular glycoprotein, mediates interactions between cells and their extracellular matrix, and targeted deletion of Sparc results in compromised extracellular matrix in mice. Fibronectin matrix provides provisional tissue scaffolding during development and wound healing and is essential for the stabilization of mature extracellular matrix. Herein, we report that SPARC expression does not significantly affect fibronectin-induced cell spreading but enhances fibronectin-induced stress fiber formation and cell-mediated partial unfolding of fibronectin molecules, an essential process in fibronectin matrix assembly. By phage display, we identify integrin-linked kinase as a potential binding partner of SPARC and verify the interaction by co-immunoprecipitation and colocalization in vitro. Cells lacking SPARC exhibit diminished fibronectin-induced integrin-linked kinase activation and integrin-linked kinase-dependent cell-contractile signaling. Furthermore, induced expression of SPARC in SPARC-null fibroblasts restores fibronectin-induced integrin-linked kinase activation, downstream signaling, and fibronectin unfolding. These data further confirm the function of SPARC in extracellular matrix organization and identify a novel mechanism by which SPARC regulates extracellular matrix assembly.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>McCoy, Morgan H</author><author>Wang, Eugenia</author></authors></contributors><titles><title>Use of electric cell-substrate impedance sensing as a tool for quantifying cytopathic effect in influenza A virus infected MDCK cells in real-time.</title><secondary-title>Journal of virological methods</secondary-title></titles><periodical><full-title>Journal of virological methods</full-title></periodical><pages>157-161</pages><volume>130</volume><issue>1-2</issue><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cytopathogenic Effect</keyword><keyword>Electric Impedance</keyword><keyword>Influenza A virus</keyword><keyword>Influenza A virus: isolation &amp; purification</keyword><keyword>Influenza A virus: physiology</keyword><keyword>Viral</keyword><keyword>Virology</keyword><keyword>Virology: methods</keyword></keywords><dates><year>2005</year></dates><accession-num>16095727</accession-num><electronic-resource-num>10.1016/j.jviromet.2005.06.023</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16095727</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>Resulting from its subjective nature, cytopathic effect (CPE) due to virus infection in cell culture has long been difficult to quantify. This report illustrates the use of electric cell-substrate impedance sensing (ECIS) for monitoring the progression of CPE due to influenza A virus infection. ECIS monitors the impedance of a non-invasive ac current flowing through cell culture medium by gold film electrodes placed on the surface of the culture dish. As cultured cells attach and spread onto the electrodes, the current is impeded proportional to the number of attached cells, the number of tight junctions between cells and the shortness in distance between the cells and the substratum. In the case at hand, a healthy monolayer of cells was insulted with influenza A virus infection and exhibited a characteristic rounded cell morphology and cell detachment. These effects resulted in reduced impedance, which was monitored with ECIS. Since data obtained through ECIS are both quantitative and in real-time, it was possible to monitor continuously cell behavior during infection. This, in turn, allowed for a more detailed and comprehensive data set to analyze. More importantly, through ammonium chloride treatment of cells, it was also shown that ECIS may be exploited to examine a treatment's effect on the reduction of resistance because of its antiviral activity. Thus, ECIS may be a powerful approach for screening antiviral compounds quantitatively in a real-time fashion.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Treeratanapiboon, Lertyot</author><author>Psathaki, Katherina</author><author>Wegener, Joachim</author><author>Looareesuwan, Sornchai</author><author>Galla, Hans-Joachim</author><author>Udomsangpetch, Rachanee</author></authors></contributors><titles><title>In vitro study of malaria parasite induced disruption of blood-brain barrier.</title><secondary-title>Biochemical and biophysical research communications</secondary-title></titles><periodical><full-title>Biochemical and biophysical research communications</full-title></periodical><pages>810-818</pages><volume>335</volume><issue>3</issue><keywords><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Plasmodium falciparum</keyword><keyword>Plasmodium falciparum: immunology</keyword><keyword>Plasmodium falciparum: physiology</keyword><keyword>Protozoan</keyword><keyword>Protozoan: immunology</keyword><keyword>Swine</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: pharmacology</keyword></keywords><dates><year>2005</year></dates><accession-num>16105659</accession-num><electronic-resource-num>10.1016/j.bbrc.2005.07.151</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16105659</url></web-urls></urls><label>Blood Brain Barrier;ECIS Invasion;ECIS Modeling</label><abstract>The mechanism of blood-brain barrier breakdown in the complex pathogenesis of cerebral malaria is not well understood. In this study, primary cultures of porcine brain capillary endothelial cells (PBCEC) were used as in vitro model. Membrane-associated malaria antigens obtained from lysed Plasmodium falciparum schizont-infected erythrocytes stimulated human peripheral blood mononuclear cells (PBMC) to secrete tumor necrosis factor alpha. In co-cultivation with the brain endothelial cell model, the malaria-activated PBMC stimulated the expression of E-selectin and ICAM-1 on the PBCEC. Using electric cell-substrate impedance sensing, we detected a significant decrease of endothelial barrier function within 4h of incubation with the malaria-activated PBMC. Correspondingly, immunocytochemical studies showed the disruption of tight junctional complexes. Combination of biochemical and biophysical techniques provides a promising tool to study changes in the blood-brain barrier function associated with cerebral malaria. Moreover, it is shown that the porcine endothelial model is able to respond to human inflammatory cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wang, Hwai-Shi</author><author>Hung, Ying</author><author>Su, Cheng-Hsi</author><author>Peng, Shu-Ting</author><author>Guo, Yi-Jhih</author><author>Lai, Mei-Chun</author><author>Liu, Ching-Yi</author><author>Hsu, Jia-Wei</author></authors></contributors><titles><title>CD44 cross-linking induces integrin-mediated adhesion and transendothelial migration in breast cancer cell line by up-regulation of LFA-1 (alpha L beta2) and VLA-4 (alpha4beta1).</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>116-126</pages><volume>304</volume><issue>1</issue><keywords><keyword>Antigens</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: metabolism</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Breast Neoplasms: physiopathology</keyword><keyword>CD44</keyword><keyword>CD44: physiology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Exocytosis</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Integrin alpha4beta1</keyword><keyword>Integrin alpha4beta1: metabolism</keyword><keyword>Integrins</keyword><keyword>Integrins: metabolism</keyword><keyword>Lymphocyte Function-Associated Antigen-1</keyword><keyword>Lymphocyte Function-Associated Antigen-1: metaboli</keyword><keyword>Tumor</keyword><keyword>Up-Regulation</keyword></keywords><dates><year>2005</year></dates><accession-num>15707579</accession-num><electronic-resource-num>10.1016/j.yexcr.2004.10.015</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15707579</url></web-urls></urls><label>ECIS Invasion</label><abstract>CD44, a widely expressed cell surface glycoprotein, plays a major role in cell-cell adhesion, cell-substrate interaction, lymphocyte homing, and tumor metastasis. For tumor metastasis to occur through the blood vessel and lymphatic vessel pathway, the tumor cells must first adhere to endothelial cells. Recent studies have shown that high expression of CD44 in certain types of tumors is associated with the hematogenic spread of cancer cells. However, the functional relevance of CD44 to tumor cell metastasis remains unknown. In this study, we investigated the mechanisms of CD44 cross-linking-induced adhesion and transendothelial migration of tumor cells using MDA-MB-435S breast cancer cell line. Breast cancer cells were found to express high levels of CD44. Using flow cytometric analysis and immunofluorescence staining, we demonstrated that cross-linking of CD44 resulted in a marked induction of the expression of lymphocyte function-associated antigen-1 (LFA-1) and very late antigen-4 (VLA-4) by exocytosis. These results were also observed with the Hs578T breast cancer cell line. Furthermore, LFA-1- and VLA-4-mediated adhesion and transendothelial cancer cell migration were also studied. Anti-LFA-1 mAb or anti-VLA-4 mAb alone had no effect on adhesion or transendothelial cancer cell migration, but were able to inhibit both of these functions when added together. This shows that CD44 cross-linking induces LFA-1 and VLA-4 expression in MDA-MB-435S cells and increases integrin-mediated adhesion to endothelial cells, resulting in the transendothelial migration of breast cancer cells. These observations provide direct evidence of a new function for CD44 that is involved in the induction of LFA-1 and VLA-4 expression by exocytosis in MDA-MB-435S cells. Because these induced integrins promote tumor cell migration into the target tissue, it may be possible to suppress this by pharmacological means, and thus potentially cause a reduction in invasive capability and metastasis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yin, Xiuyun</author><author>Knecht, David a</author><author>Lynes, Michael a</author></authors></contributors><titles><title>Metallothionein mediates leukocyte chemotaxis.</title><secondary-title>BMC immunology</secondary-title></titles><periodical><full-title>BMC immunology</full-title></periodical><pages>21</pages><volume>6</volume><keywords><keyword>Actins</keyword><keyword>Actins: chemistry</keyword><keyword>Amino Acid</keyword><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Antibodies</keyword><keyword>CC</keyword><keyword>CC: chemistry</keyword><keyword>CXC</keyword><keyword>CXC: pharmacology</keyword><keyword>Chemokine CCL17</keyword><keyword>Chemokine CXCL12</keyword><keyword>Chemokines</keyword><keyword>Chemotaxis</keyword><keyword>Cysteine</keyword><keyword>Cysteine: chemistry</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Humans</keyword><keyword>Jurkat Cells</keyword><keyword>Jurkat Cells: drug effects</keyword><keyword>Leukocyte</keyword><keyword>Leukocyte: drug effects</keyword><keyword>Metallothionein</keyword><keyword>Metallothionein: antagonists &amp; inhibitors</keyword><keyword>Metallothionein: immunology</keyword><keyword>Metallothionein: isolation &amp; purification</keyword><keyword>Metallothionein: pharmacology</keyword><keyword>Microscopy</keyword><keyword>Molecular Sequence Data</keyword><keyword>Monoclonal</keyword><keyword>Monoclonal: pharmacology</keyword><keyword>Rabbits</keyword><keyword>Sequence Alignment</keyword><keyword>Sequence Homology</keyword><keyword>Video</keyword></keywords><dates><year>2005</year></dates><accession-num>16164753</accession-num><electronic-resource-num>10.1186/1471-2172-6-21</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1262721&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Chemotaxis</label><abstract>Metallothionein (MT) is a cysteine-rich, metal-binding protein that can be induced by a variety of agents. Modulation of MT levels has also been shown to alter specific immune functions. We have noticed that the MT genes map close to the chemokines Ccl17 and Cx3cl1. Cysteine motifs that characterize these chemokines are also found in the MT sequence suggesting that MT might also act as a chemotactic factor.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Woods, Michael E</author><author>Wen, Gary</author><author>Olano, Juan P</author></authors></contributors><titles><title>Nitric oxide as a mediator of increased microvascular permeability during acute rickettsioses.</title><secondary-title>Annals of the New York Academy of Sciences</secondary-title></titles><periodical><full-title>Annals of the New York Academy of Sciences</full-title></periodical><pages>239-245</pages><volume>1063</volume><issue>409</issue><keywords><keyword>Acute Disease</keyword><keyword>Animals</keyword><keyword>Anti-Bacterial Agents</keyword><keyword>Anti-Bacterial Agents: metabolism</keyword><keyword>Anti-Bacterial Agents: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cell Line</keyword><keyword>Cell-Free System</keyword><keyword>Cell-Free System: drug effects</keyword><keyword>Cell-Free System: metabolism</keyword><keyword>Cell-Free System: microbiology</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Endothelium</keyword><keyword>Gene Dosage</keyword><keyword>Gene Dosage: drug effects</keyword><keyword>Humans</keyword><keyword>Microcirculation</keyword><keyword>Microcirculation: cytology</keyword><keyword>Microcirculation: metabolism</keyword><keyword>Microcirculation: microbiology</keyword><keyword>Nitric Oxide</keyword><keyword>Nitric Oxide: pharmacology</keyword><keyword>Nitric Oxide: physiology</keyword><keyword>Rickettsia conorii</keyword><keyword>Rickettsia conorii: drug effects</keyword><keyword>Rickettsia conorii: genetics</keyword><keyword>Rickettsia conorii: physiology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: microbiology</keyword><keyword>Vero Cells</keyword></keywords><dates><year>2005</year></dates><accession-num>16481520</accession-num><electronic-resource-num>10.1196/annals.1355.037</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16481520</url></web-urls></urls><label>ECIS TEER</label><abstract>Rickettsiae primarily infect the microvascular endothelium, leading to changes in microvascular permeability that result in potentially severe pulmonary and cerebral edema. The mechanisms responsible for these changes are not well understood. One potential mechanism of increased vascular permeability is the anti-rickettsial nitric oxide response described by Walker and colleagues. We hypothesized that anti-rickettsial levels of nitric oxide adversely affects microvascular permeability in vitro. To this end we sought to describe the effects of exogenous nitric oxide on the proliferation of intracellular rickettsiae while monitoring the transendothelial electrical resistance as a measure of endothelial barrier integrity. It was determined that the addition of the NO-donor DETA NONOate at certain levels results in a dose-dependent change in electrical resistance across the monolayer while effectively limiting the number of intracellular rickettsiae in human microvascular endothelial cells. The data presented support the idea that nitric oxide produced by infected endothelial cells may be contributing to the changes in vascular permeability that occur during acute rickettsioses. Future experiments aim to elaborate on these results in a model that more clearly depicts the in vivo response as well as to describe the changes that occur with respect to interendothelial junctions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Charrier, Laetitia</author><author>Yan, Yutao</author><author>Driss, Adel</author><author>Laboisse, Christian L</author><author>Sitaraman, Shanthi V</author><author>Merlin, Didier</author></authors></contributors><titles><title>ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers.</title><secondary-title>American journal of physiology. Gastrointestinal and liver physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Gastrointestinal and liver physiology</full-title></periodical><pages>G346-53</pages><volume>288</volume><issue>2</issue><keywords><keyword>ADAM Proteins</keyword><keyword>Amino Acid Sequence</keyword><keyword>Amyloid Precursor Protein Secretases</keyword><keyword>Caco-2 Cells</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: physiology</keyword><keyword>Electric Impedance</keyword><keyword>Gene Expression</keyword><keyword>HT29 Cells</keyword><keyword>Humans</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: chemistry</keyword><keyword>Intestinal Mucosa: cytology</keyword><keyword>Intestinal Mucosa: physiology</keyword><keyword>Logistic Models</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: analysis</keyword><keyword>Membrane Proteins: chemistry</keyword><keyword>Membrane Proteins: physiology</keyword><keyword>Messenger</keyword><keyword>Metalloendopeptidases</keyword><keyword>Metalloendopeptidases: analysis</keyword><keyword>Metalloendopeptidases: chemistry</keyword><keyword>Metalloendopeptidases: physiology</keyword><keyword>Molecular Sequence Data</keyword><keyword>RNA</keyword><keyword>Wound Healing</keyword><keyword>Wound Healing: physiology</keyword></keywords><dates><year>2005</year></dates><accession-num>15358598</accession-num><electronic-resource-num>10.1152/ajpgi.00262.2004</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15358598</url><url>http://ajpgi.physiology.org/cgi/doi/10.1152/ajpgi.00262.2004</url></web-urls></urls><label>ECIS Migration;Wound Healing</label><abstract>The disintegrin metalloproteases (or ADAMs) are membrane-anchored glycoproteins that have been implicated in cell-cell or cell-matrix interactions and in proteolysis of molecules on the cell surface. The expression and/or the pathophysiological implications of ADAMs are not known in intestinal epithelial cells. Therefore, our aim was to investigate the expression and the role of ADAMs in intestinal epithelial cells. Expression of ADAMs was assessed by RT-PCR, Western blot analysis, and immunufluorescence experiments. Wound-healing experiments were performed by using the electric cell substrate impedence sensing technology. Our results showed that ADAMs-10, -12, and -15 mRNA are expressed in the colonic human cell lines Caco2-BBE and HT29-Cl.19A. An ADAM-15 complementary DNA cloned from Caco2-BBE poly(A)+ RNA, and encompassing the entire coding region, was found to be shorter and to present a different region encoding the cytoplasmic tail compared with ADAM-15 sequence deposited in the database. In Caco2-BBE cells and colonic epithelial cells, ADAM-15 protein was found in the apical, basolateral, and intracellular compartments. We also showed that the overexpression of ADAM-15 reduced cell migration in a wound-healing assay in Caco2-BBE monolayers. Our data show that 1) ADAM-15 is expressed in human intestinal epithelia, 2) a new variant of ADAM-15 is expressed in a human intestinal epithelial cell line, and 3) ADAM-15 is involved in intestinal epithelial cells wound-healing processes. Together, these results suggest that ADAM-15 may have important pathophysiological roles in intestinal cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Weidenfeller, Christian</author><author>Schrot, Sebastian</author><author>Zozulya, Alla</author><author>Galla, Hans-Joachim</author></authors></contributors><titles><title>Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone.</title><secondary-title>Brain research</secondary-title></titles><periodical><full-title>Brain research</full-title></periodical><pages>162-174</pages><volume>1053</volume><issue>1-2</issue><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Blotting</keyword><keyword>Brain</keyword><keyword>Brain: cytology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Culture Media</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Electron</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Endothelial Cells: ultrastructure</keyword><keyword>Factor VIII</keyword><keyword>Factor VIII: metabolism</keyword><keyword>Hydrocortisone</keyword><keyword>Hydrocortisone: pharmacology</keyword><keyword>Immunohistochemistry</keyword><keyword>Immunohistochemistry: methods</keyword><keyword>Inbred C57BL</keyword><keyword>Male</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Messenger</keyword><keyword>Messenger: metabolism</keyword><keyword>Mice</keyword><keyword>Microscopy</keyword><keyword>Models</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>RNA</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction: m</keyword><keyword>Serum-Free</keyword><keyword>Serum-Free: pharmacology</keyword><keyword>Transmission</keyword><keyword>Transmission: methods</keyword><keyword>Western</keyword><keyword>Western: methods</keyword></keywords><dates><year>2005</year></dates><accession-num>16040011</accession-num><electronic-resource-num>10.1016/j.brainres.2005.06.049</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16040011</url></web-urls></urls><label>ECIS Modeling</label><abstract>Hydrocortisone is known to induce barrier properties in porcine primary cultures of microvascular endothelial cells. Here we present similar effects of hydrocortisone on a serum-free in vitro model based on primary cultured mouse brain endothelial cells. These cells in culture express typical blood-brain barrier properties and the transendothelial electrical resistance is enhanced after the addition of hydrocortisone to the medium in physiological concentrations. The improvement of the barrier is accompanied by changes at the cell borders indicated by immunofluorescence staining of tight junction proteins. Transmission electron microscopy imaging indicates morphological changes at the cell-cell contact zones which correlates to the observed changes in the transendothelial electrical resistance after HC supplementation. Phalloidin staining of F-actin shows a rearrangement to &quot;fiber-like&quot; structures in the longitudinal direction of the cell. These findings together with additional electrical impedance analysis of the monolayer suggest that several changes including cell-cell contact alteration, cell-substrate attachment and cytoskeletal rearrangements cause enhanced barrier properties in this murine endothelial culture. The present data are consistent with earlier findings in a porcine serum-free in vitro model. Thus, evidence is given that the barrier enforcement induced by glucocorticoids is not a species-specific effect and that the barrier improvement is correlated with a change of the cell morphology rather than changes in tight junction protein expression.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Singleton, Patrick a</author><author>Dudek, Steven M</author><author>Chiang, Eddie T</author><author>Garcia, Joe G N</author></authors></contributors><titles><title>Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin.</title><secondary-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</secondary-title></titles><periodical><full-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</full-title></periodical><pages>1646-1656</pages><volume>19</volume><issue>12</issue><keywords><keyword>Actinin</keyword><keyword>Actinin: metabolism</keyword><keyword>Actinin: physiology</keyword><keyword>Biological</keyword><keyword>Catalytic Domain</keyword><keyword>Caveolin 1</keyword><keyword>Caveolin 1: chemistry</keyword><keyword>Cells</keyword><keyword>Cholesterol</keyword><keyword>Cholesterol: chemistry</keyword><keyword>Chromones</keyword><keyword>Chromones: pharmacology</keyword><keyword>Cultured</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Electrophoresis</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Enzymologic</keyword><keyword>Fluorescence</keyword><keyword>Gene Expression Regulation</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: metabolism</keyword><keyword>Guanine Nucleotide Exchange Factors: physiology</keyword><keyword>Humans</keyword><keyword>Immunoblotting</keyword><keyword>Immunoprecipitation</keyword><keyword>Inflammation</keyword><keyword>Lysosphingolipid</keyword><keyword>Lysosphingolipid: physiology</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Microscopy</keyword><keyword>Models</keyword><keyword>Morpholines</keyword><keyword>Morpholines: pharmacology</keyword><keyword>Neoplasm Proteins</keyword><keyword>Neoplasm Proteins: physiology</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Phosphatidylinositol 3-Kinases: physiology</keyword><keyword>Polyacrylamide Gel</keyword><keyword>Protein Isoforms</keyword><keyword>Protein Structure</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: pathology</keyword><keyword>RNA</keyword><keyword>Receptors</keyword><keyword>Signal Transduction</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: metabolism</keyword><keyword>Tertiary</keyword><keyword>Transfection</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: pathology</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: physiology</keyword></keywords><dates><year>2005</year></dates><accession-num>16195373</accession-num><electronic-resource-num>10.1096/fj.05-3928com</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16195373</url></web-urls></urls><label>ECIS TEER;Inflammation;Signal Transduction</label><abstract>Endothelial cell (EC) barrier dysfunction results in increased vascular permeability observed in inflammation, tumor angiogenesis, and atherosclerosis. The platelet-derived phospholipid sphingosine-1-phosphate (S1P) decreases EC permeability in vitro and in vivo and thus has obvious therapeutic potential. We examined S1P-mediated human pulmonary artery EC signaling and barrier regulation in caveolin-enriched microdomains (CEM). Immunoblotting from S1P-treated EC revealed S1P-mediated rapid recruitment (1 microM, 5 min) to CEMs of the S1P receptors S1P1 and S1P3, p110 PI3 kinase alpha and beta catalytic subunits, the Rac1 GEF, Tiam1, and alpha-actinin isoforms 1 and 4. Immunoprecipitated p110 PI3 kinase catalytic subunits from S1P-treated EC exhibited PIP3 production in CEMs. Immunoprecipitation of S1P receptors from CEM fractions revealed complexes containing Tiam1 and S1P1. PI3 kinase inhibition (LY294002) attenuated S1P-induced Tiam1 association with S1P1, Tiam1/Rac1 activation, alpha-actinin-1/4 recruitment, and EC barrier enhancement. Silencing of either S1P1 or Tiam1 expression resulted in the loss of S1P-mediated Rac1 activation and alpha-actinin-1/4 recruitment to CEM. Finally, silencing S1P1, Tiam1, or both alpha-actinin isoforms 1/4 inhibits S1P-induced cortical F-actin rearrangement and S1P-mediated barrier enhancement. Taken together, these results suggest that S1P-induced recruitment of S1P1 to CEM fractions promotes PI3 kinase-mediated Tiam1/Rac1 activation required for alpha-actinin-1/4-regulated cortical actin rearrangement and EC barrier enhancement.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Shikata, Yasushi</author><author>Rios, Alexander</author><author>Kawkitinarong, Kamon</author><author>DePaola, Natacha</author><author>Garcia, Joe G N</author><author>Birukov, Konstantin G</author></authors></contributors><titles><title>Differential effects of shear stress and cyclic stretch on focal adhesion remodeling, site-specific FAK phosphorylation, and small GTPases in human lung endothelial cells.</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>40-49</pages><volume>304</volume><issue>1</issue><keywords><keyword>Adaptor Proteins</keyword><keyword>Cell Cycle Proteins</keyword><keyword>Cell Cycle Proteins: analysis</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: analysis</keyword><keyword>Elasticity</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: chemistry</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Endothelial Cells: ultrastructure</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>Focal Adhesions</keyword><keyword>Focal Adhesions: enzymology</keyword><keyword>Focal Adhesions: ultrastructure</keyword><keyword>GTPase-Activating Proteins</keyword><keyword>GTPase-Activating Proteins: analysis</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Lung: enzymology</keyword><keyword>Mechanical</keyword><keyword>Paxillin</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: analysis</keyword><keyword>Phosphorylation</keyword><keyword>Protein-Tyrosine Kinases</keyword><keyword>Protein-Tyrosine Kinases: metabolism</keyword><keyword>Signal Transducing</keyword><keyword>Stress</keyword><keyword>rac GTP-Binding Proteins</keyword><keyword>rac GTP-Binding Proteins: metabolism</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2005</year></dates><accession-num>15707572</accession-num><electronic-resource-num>10.1016/j.yexcr.2004.11.001</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15707572</url></web-urls></urls><label>ECIS Flow;ECIS TEER</label><abstract>Regulation of endothelial cell (EC) permeability by bioactive molecules is associated with specific patterns of cytoskeletal and cell contact remodeling. A role for mechanical factors such as shear stress (SS) and cyclic stretch (CS) in cytoskeletal rearrangements and regulation of EC permeability becomes increasingly recognized. This paper examined redistribution of focal adhesion (FA) proteins, site-specific focal adhesion kinase (FAK) phosphorylation, small GTPase activation and barrier regulation in human pulmonary EC exposed to laminar shear stress (15 dyn/cm2) or cyclic stretch (18% elongation) in vitro. SS caused peripheral accumulation of FAs, whereas CS induced randomly distributed FAs attached to the ends of newly formed stress fibers. SS activated small GTPase Rac without effects on Rho, whereas 18% CS activated without effect on Rac. SS increased transendothelial electrical resistance (TER) in EC monolayers, which was further elevated by barrier-protective phospholipid sphingosine 1-phosphate. Finally, SS induced FAK phosphorylation at Y576, whereas CS induced FAK phosphorylation at Y397 and Y576. These results demonstrate for the first time differential effects of SS and CS on Rho and Rac activation, FA redistribution, site-specific FAK phosphorylation, and link them with SS-mediated barrier enhancement. Thus, our results suggest common signaling and cytoskeletal mechanisms shared by mechanical and chemical factors involved in EC barrier regulation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Huang, Fei</author><author>Subbaiah, Papasani V</author><author>Holian, Oksana</author><author>Zhang, Jihang</author><author>Johnson, Arnold</author><author>Gertzberg, Nancy</author><author>Lum, Hazel</author></authors></contributors><titles><title>Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L176-85</pages><volume>289</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cattle</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Guanosine Triphosphate</keyword><keyword>Guanosine Triphosphate: metabolism</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: blood supply</keyword><keyword>Lysophosphatidylcholines</keyword><keyword>Lysophosphatidylcholines: chemistry</keyword><keyword>Lysophosphatidylcholines: metabolism</keyword><keyword>Lysophosphatidylcholines: pharmacology</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C-alpha</keyword><keyword>Protein Kinase C: metabolism</keyword><keyword>Protein Transport</keyword><keyword>Signal Transduction</keyword><keyword>Skin</keyword><keyword>Skin: blood supply</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>cdc42 GTP-Binding Protein</keyword><keyword>cdc42 GTP-Binding Protein: metabolism</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: antagonists &amp; inhibitors</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2005</year></dates><accession-num>15764646</accession-num><electronic-resource-num>10.1152/ajplung.00003.2005</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15764646</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Lysophosphatidylcholine (LPC) is a bioactive proinflammatory lipid that can be generated by pathological activities. We investigated the hypothesis that LPC signals increase in endothelial permeability. Stimulation of human dermal microvascular endothelial cells and bovine pulmonary microvascular endothelial cells with LPC (10-50 microM) induced decreases (within minutes) in transendothelial electrical resistance and increase of endothelial permeability. LPC activated (within 5 min) membrane-associated PKC phosphotransferase activity in the absence of translocation. Affinity-binding analysis indicated that LPC induced increases (also by 5 min) of GTP-bound RhoA, but not Rac1 or Cdc42. By 60 min, both signaling pathways decreased toward baseline. Inhibition of RhoA with C3 transferase inhibited approximately 50% of LPC-induced resistance decrease. Pretreatment with PKC inhibitor Gö-6983 (concentrations selective for classic PKC), PMA-induced depletion of PKCalpha, and transfection of antisense PKCalpha oligonucleotide each prevented 40-50% of the LPC-induced resistance decrease. Furthermore, these three PKC inhibition strategies inhibited 60-80% of the LPC-induced GTP-bound RhoA. These results show that LPC directly impairs the endothelial barrier function that was dependent, at least in part, on cross talk of PKCalpha and RhoA signals. The evidence indicates that elevated LPC levels can contribute to the activation of a proinflammatory endothelial phenotype.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Castaneda, Florencia E</author><author>Walia, Baljit</author><author>Vijay-Kumar, Matam</author><author>Patel, Neal R</author><author>Roser, Susanne</author><author>Kolachala, Vasantha L</author><author>Rojas, Mauricio</author><author>Wang, Lixin</author><author>Oprea, Gabriela</author><author>Garg, Pallavi</author><author>Gewirtz, Andrew T</author><author>Roman, Jesse</author><author>Merlin, Didier</author><author>Sitaraman, Shanthi V</author></authors></contributors><titles><title>Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP.</title><secondary-title>Gastroenterology</secondary-title></titles><periodical><full-title>Gastroenterology</full-title></periodical><pages>1991-2008</pages><volume>129</volume><issue>6</issue><keywords><keyword>Animals</keyword><keyword>Cell Movement</keyword><keyword>Colitis</keyword><keyword>Colitis: chemically induced</keyword><keyword>Colitis: metabolism</keyword><keyword>Colitis: pathology</keyword><keyword>Dextran Sulfate</keyword><keyword>Dextran Sulfate: toxicity</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Female</keyword><keyword>Gene Deletion</keyword><keyword>Humans</keyword><keyword>Inflammatory Bowel Diseases</keyword><keyword>Inflammatory Bowel Diseases: metabolism</keyword><keyword>Inflammatory Bowel Diseases: pathology</keyword><keyword>Intestinal Mucosa</keyword><keyword>Intestinal Mucosa: cytology</keyword><keyword>Intestinal Mucosa: metabolism</keyword><keyword>Intestinal Mucosa: pathology</keyword><keyword>Knockout</keyword><keyword>Male</keyword><keyword>Matrix Metalloproteinase 9</keyword><keyword>Matrix Metalloproteinase 9: genetics</keyword><keyword>Matrix Metalloproteinase 9: metabolism</keyword><keyword>Mice</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: cytology</keyword><keyword>Neutrophils: metabolism</keyword><keyword>Random Allocation</keyword><keyword>Salmonella Infections</keyword><keyword>Salmonella Infections: immunology</keyword><keyword>Salmonella Infections: pathology</keyword><keyword>Sepsis</keyword><keyword>Sepsis: immunology</keyword><keyword>Sepsis: pathology</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2005</year></dates><accession-num>16344067</accession-num><electronic-resource-num>10.1053/j.gastro.2005.09.017</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16344067</url></web-urls></urls><label>ECIS Attachment;ECIS Migration;Wound Healing</label><abstract>There is mounting evidence that matrix metalloproteinases are the predominant proteinases expressed in the gut mucosa during active inflammatory bowel disease. We investigated the role of metalloproteinase 9 (MMP-9), a secreted gelatinase that is consistently up-regulated in both animal models and human inflammatory bowel disease and is associated with disease severity, in the pathogenesis of colitis by using mice containing a targeted deletion of the MMP-9 gene.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Goda, Noriko</author><author>Kataoka, Noriyuki</author><author>Shimizu, Juichiro</author><author>Mohri, Satoshi</author></authors></contributors><titles><title>Evaluation Of Micromotion Of Vascular Endothelial Cells In Electrical Cell-Substrate Impedance Sensing ( Ecis ) Method Using A Mathematical Model.</title><secondary-title>J. Mech. Med.</secondary-title></titles><periodical><full-title>J. Mech. Med.</full-title></periodical><pages>357-368</pages><volume>5</volume><issue>2</issue><keywords><keyword>bio-electrical impedance</keyword><keyword>ecis method</keyword><keyword>endothelial cells</keyword><keyword>mathematical</keyword></keywords><dates><year>2005</year></dates><electronic-resource-num>10.1142/S0219519405001497</electronic-resource-num><urls><web-urls><url>http://www.worldscinet.com/abstract?id=pii:S0219519405001497</url></web-urls></urls><label>ECIS Micromotion;ECIS Modeling</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wang, Qun</author><author>Turlington, Alicia</author><author>Heo, Stephan</author><author>Blanco, Andrea</author><author>Tian, Jian</author><author>Xie, Zijia</author><author>Yan, Bingfang</author><author>Wan, Yinsheng</author></authors></contributors><titles><title>Extracellular matrix activity and caveolae events contribute to cell surface receptor activation that leads to MAP kinase activation in response to UV irradiation in cultured human keratinocytes.</title><secondary-title>International journal of molecular medicine</secondary-title></titles><periodical><full-title>International journal of molecular medicine</full-title></periodical><pages>633-640</pages><volume>15</volume><issue>4</issue><keywords><keyword>Caveolae</keyword><keyword>Caveolae: metabolism</keyword><keyword>Caveolin 1</keyword><keyword>Caveolins</keyword><keyword>Caveolins: metabolism</keyword><keyword>Cell Surface</keyword><keyword>Cell Surface: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: metabolism</keyword><keyword>Filipin</keyword><keyword>Filipin: metabolism</keyword><keyword>Humans</keyword><keyword>Keratinocytes</keyword><keyword>Keratinocytes: enzymology</keyword><keyword>Keratinocytes: metabolism</keyword><keyword>Keratinocytes: radiation effects</keyword><keyword>Mitogen-Activated Protein Kinases</keyword><keyword>Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>Receptors</keyword><keyword>Ultraviolet Rays</keyword></keywords><dates><year>2005</year></dates><publisher>D.A. Spandidos</publisher><accession-num>15754025</accession-num><language>eng</language><urls><web-urls><url>http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=16658868</url><url>http://www.ncbi.nlm.nih.gov/pubmed/15754025</url></web-urls></urls><label>ECIS TEER</label><abstract>Activation of cell surface components has been implicated in the activation of downstream signaling cascade in response to UV irradiation, and yet the identity and the interaction of those components have been scantly documented. Accumulating evidence indicates that caveolae encapsulating caveolins is the location for those interactions. We found in cultured human keratinocytes that UV irradiation induced both caveolin-1 and EGFR phosphorylation. Filipin, a caveolae disruptive agent, inhibited UV-induced caveolin-1 activation. Na+-K+-ATPase catalyzes active transport of Na+ and K+ across plasma membrane of mammalian cells, inactivation of which has recently been shown to be involved in the activation of signal transduction pathways including MAP kinase cascade. We found in this study that UV inactivated Na+-K+-ATPase in time-dependent manner, Na+-K+-ATPase activity started to decrease 5 min post UV irradiation and reduced to 60% of its original activity within 1 h. Pretreatment with Flipin and MMP inhibitor recovered Na+-K+-ATPase activity lost by UV irradiation. ECIS analysis indicated that both EGF treatment and UV irradiation increased membrane electric activity which was inhibited by MMP inhibitor and Filipin. Further study showed that pretreatment of human keratinocytes with MMP inhibitor or Filipin inhibited UV-induced phosphorylation of p38 and JNK, which was however not observed in LnCap cells, a prostate cancer cell line lacking caveolin-1. UV irradiation also induced ectodomain shedding of HB-EGF in a time-dependent manner in keratinocytes. Collectively, we conclude that UV-induced MAP kinase activation is mediated by cell surface receptor activation due to the matrix activity and membrane caveolae function and inactivation of Na+-K+-ATPase.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Clements, Richard T</author><author>Minnear, Fred L</author><author>Singer, Harold a</author><author>Keller, Rebecca S</author><author>Vincent, Peter a</author></authors></contributors><titles><title>RhoA and Rho-kinase dependent and independent signals mediate TGF-beta-induced pulmonary endothelial cytoskeletal reorganization and permeability.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L294-306</pages><volume>288</volume><issue>2</issue><keywords><keyword>ADP Ribose Transferases</keyword><keyword>ADP Ribose Transferases: pharmacology</keyword><keyword>Amides</keyword><keyword>Amides: pharmacology</keyword><keyword>Animals</keyword><keyword>Botulinum Toxins</keyword><keyword>Botulinum Toxins: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: ultrastructure</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: antagonists &amp; in</keyword><keyword>Protein-Serine-Threonine Kinases: metabolism</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: drug effects</keyword><keyword>Pulmonary Artery: metabolism</keyword><keyword>Pulmonary Artery: ultrastructure</keyword><keyword>Pyridines</keyword><keyword>Pyridines: pharmacology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Transfection</keyword><keyword>Transforming Growth Factor beta</keyword><keyword>Transforming Growth Factor beta1</keyword><keyword>Transforming Growth Factor beta: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: ultrastructure</keyword><keyword>rho-Associated Kinases</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: antagonists &amp; inhibitors</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword><keyword>rhoA GTP-Binding Protein: pharmacology</keyword></keywords><dates><year>2005</year></dates><accession-num>15475381</accession-num><electronic-resource-num>10.1152/ajplung.00213.2004</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15475381</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Transforming growth factor (TGF)-beta is a potent inflammatory mediator involved in acute lung injury. TGF-beta directly increases pulmonary endothelial myosin light chain (MLC) phosphorylation, which is associated with increased endothelial stress fiber formation, gap formation, and protein permeability, all hallmarks of pulmonary endothelial responses during acute lung injury. We performed the following experiments in pulmonary endothelial monolayers to determine whether RhoA and Rho-kinase mediate these TGF-beta-induced responses. TGF-beta caused the sustained activation of RhoA 2 h posttreatment associated with increased MLC phosphorylation. Inhibition of either RhoA or Rho-kinase with either C3 exoenzyme or Y-27632 blocked MLC phosphorylation. In addition, both C3 and Y-27632 partially attenuated the maximal TGF-beta-induced increase in permeability but did not affect the initial phase of compromised barrier integrity. Inhibition of Rho-kinase completely blocked the TGF-beta-induced increase in the content of filamentous actin (F-actin) but only partially inhibited TGF-beta-induced changes in actin reorganization. To assess the contribution of Rho-kinase in RhoA-mediated responses independent of additional TGF-beta-induced signals, cells were infected with a constitutively active RhoA adenovirus (RhoAQ63L) with or without Y-27632. RhoAQ63L increased MLC phosphorylation, F-actin content, and permeability. Treatment with Y-27632 blocked these responses, suggesting that Rho-kinase mediates these RhoA-induced effects. Collectively, these data suggest the following: 1) the RhoA/Rho-kinase pathway is an important component of TGF-beta-induced effects on endothelial MLC phosphorylation, cytoskeletal reorganization, and barrier integrity; and 2) additional signaling mechanisms independent of the RhoA/Rho-kinase signaling cascade contribute to TGF-beta-induced changes in cytoskeletal organization and permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Becker, Patrice M</author><author>Waltenberger, Johannes</author><author>Yachechko, Robin</author><author>Mirzapoiazova, Tamara</author><author>Sham, James S K</author><author>Lee, Chun Geun</author><author>Elias, Jack a</author><author>Verin, Alexander D</author></authors></contributors><titles><title>Neuropilin-1 regulates vascular endothelial growth factor-mediated endothelial permeability.</title><secondary-title>Circulation research</secondary-title></titles><periodical><full-title>Circulation research</full-title></periodical><pages>1257-1265</pages><volume>96</volume><issue>12</issue><keywords><keyword>Adult</keyword><keyword>Adult: etiology</keyword><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Humans</keyword><keyword>Lung</keyword><keyword>Lung: blood supply</keyword><keyword>Lung: metabolism</keyword><keyword>Mice</keyword><keyword>Mitogen-Activated Protein Kinase 1</keyword><keyword>Mitogen-Activated Protein Kinase 1: physiology</keyword><keyword>Mitogen-Activated Protein Kinase 3</keyword><keyword>Mitogen-Activated Protein Kinase 3: physiology</keyword><keyword>Neuropilin-1</keyword><keyword>Neuropilin-1: physiology</keyword><keyword>Respiratory Distress Syndrome</keyword><keyword>Swine</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: physiology</keyword><keyword>Vascular Endothelial Growth Factor Receptor-2</keyword><keyword>Vascular Endothelial Growth Factor Receptor-2: phy</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>p38 Mitogen-Activated Protein Kinases: physiology</keyword></keywords><dates><year>2005</year></dates><accession-num>15920019</accession-num><electronic-resource-num>10.1161/01.RES.0000171756.13554.49</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15920019</url></web-urls></urls><label>ECIS TEER</label><abstract>Neuropilin-1 (Npn-1) is a cell surface receptor that binds vascular endothelial growth factor (VEGF), a potent mediator of endothelial permeability, chemotaxis, and proliferation. In vitro, Npn-1 can complex with VEGF receptor-2 (VEGFR2) to enhance VEGFR2-mediated endothelial cell chemotaxis and proliferation. To determine the role of Npn-1/VEGFR2 complexes in VEGF-induced endothelial barrier dysfunction, endothelial cells were stably transfected with Npn1 or VEGFR2 alone (PAE/Npn and PAE/KDR, respectively), or VEGFR2 and Npn-1 (PAE/KDR/Npn-1). Permeability, estimated by measurement of transendothelial electrical resistance (TER), of PAE/Npn and PAE/KDR cell lines was not altered by VEGF165. In contrast, TER of PAE/KDR/Npn-1 cells decreased in dose-dependent fashion following VEGF165 (10 to 200 ng/mL). Activation of VEGFR2, and 2 downstream signaling intermediates (p38 and ERK1/2 MAPK) involved in VEGF-mediated permeability, also increased in PAE/KDR/Npn-1. Consistent with these data, inhibition of Npn-1, but not VEGFR2, attenuated VEGF165-mediated permeability of human pulmonary artery endothelial cells (HPAE), and VEGF121 (which cannot ligate Npn-1) did not alter TER of HPAE. Npn-1 inhibition also attenuated both VEGF165-mediated pulmonary vascular leak and activation of VEGFR2, p38, and ERK1/2 MAPK, in inducible lung-specific VEGF transgenic mice. These data support a critical role for Npn-1 in regulating endothelial barrier dysfunction in response to VEGF and suggest that activation of distinct receptor complexes may determine specificity of cellular response to VEGF.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>McLaughlin, Joseph N</author><author>Shen, Lixin</author><author>Holinstat, Michael</author><author>Brooks, Joshua D</author><author>Dibenedetto, Emmanuele</author><author>Hamm, Heidi E</author></authors></contributors><titles><title>Functional selectivity of G protein signaling by agonist peptides and thrombin for the protease-activated receptor-1.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>25048-25059</pages><volume>280</volume><issue>26</issue><keywords><keyword>Actins</keyword><keyword>Actins: chemistry</keyword><keyword>Adenosine Diphosphate</keyword><keyword>Adenosine Diphosphate: chemistry</keyword><keyword>Amides</keyword><keyword>Amides: pharmacology</keyword><keyword>Biological</keyword><keyword>Calcium</keyword><keyword>Calcium: chemistry</keyword><keyword>Calcium: metabolism</keyword><keyword>Cells</keyword><keyword>Chelating Agents</keyword><keyword>Chelating Agents: pharmacology</keyword><keyword>Cultured</keyword><keyword>Dipeptides</keyword><keyword>Dipeptides: pharmacology</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Egtazic Acid</keyword><keyword>Egtazic Acid: analogs &amp; derivatives</keyword><keyword>Egtazic Acid: pharmacology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>G12-G13</keyword><keyword>G12-G13: metab</keyword><keyword>GTP-Binding Protein alpha Subunits</keyword><keyword>GTP-Binding Proteins</keyword><keyword>GTP-Binding Proteins: metabolism</keyword><keyword>Gq-G11</keyword><keyword>Gq-G11: metabo</keyword><keyword>Humans</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Kinetics</keyword><keyword>Ligands</keyword><keyword>Matrix Metalloproteinases</keyword><keyword>Matrix Metalloproteinases: antagonists &amp; inhibitor</keyword><keyword>Microcirculation</keyword><keyword>Models</keyword><keyword>PAR-1</keyword><keyword>PAR-1: chemistry</keyword><keyword>PAR-1: physiology</keyword><keyword>Peptides</keyword><keyword>Peptides: chemistry</keyword><keyword>Pertussis Toxin</keyword><keyword>Pertussis Toxin: pharmacology</keyword><keyword>Protease Inhibitors</keyword><keyword>Protease Inhibitors: pharmacology</keyword><keyword>Protein Binding</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: antagonists &amp; in</keyword><keyword>Pyridines</keyword><keyword>Pyridines: pharmacology</keyword><keyword>Receptor</keyword><keyword>Signal Transduction</keyword><keyword>Theoretical</keyword><keyword>Thrombin</keyword><keyword>Thrombin: chemistry</keyword><keyword>Time Factors</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>rho-Associated Kinases</keyword></keywords><dates><year>2005</year></dates><accession-num>15878870</accession-num><electronic-resource-num>10.1074/jbc.M414090200</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15878870</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Thrombin activates protease-activated receptor-1 (PAR-1) by cleavage of the amino terminus to unmask a tethered ligand. Although peptide analogs can activate PAR-1, we show that the functional responses mediated via PAR-1 differ between the agonists. Thrombin caused endothelial monolayer permeability and mobilized intracellular calcium with EC(50) values of 0.1 and 1.7 nm, respectively. The opposite order of activation was observed for agonist peptide (SFLLRN-CONH(2) or TFLLRNKPDK) activation. The addition of inactivated thrombin did not affect agonist peptide signaling, suggesting that the differences in activation mechanisms are intramolecular in origin. Although activation of PAR-1 or PAR-2 by agonist peptides induced calcium mobilization, only PAR-1 activation affected barrier function. Induced barrier permeability is likely to be Galpha(12/13)-mediated as chelation of Galpha(q)-mediated intracellular calcium with BAPTA-AM, pertussis toxin inhibition of Galpha(i/o), or GM6001 inhibition of matrix metalloproteinase had no effect, whereas Y-27632 inhibition of the Galpha(12/13)-mediated Rho kinase abrogated the response. Similarly, calcium mobilization is Galpha(q)-mediated and independent of Galpha(i/o) and Galpha(12/13) because pertussis toxin Y-27632 and had no effect, whereas U-73122 inhibition of phospholipase C-beta blocked the response. It is therefore likely that changes in permeability reflect Galpha(12/13) activation, and changes in calcium reflect Galpha(q) activation, implying that the pharmacological differences between agonists are likely caused by the ability of the receptor to activate Galpha(12/13) or Galpha(q). This functional selectivity was characterized quantitatively by a mathematical model describing each step leading to Rho activation and/or calcium mobilization. This model provides an estimate that peptide activation alters receptor/G protein binding to favor Galpha(q) activation over Galpha(12/13) by approximately 800-fold.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Finigan, James H</author><author>Dudek, Steven M</author><author>Singleton, Patrick a</author><author>Chiang, Eddie T</author><author>Jacobson, Jeffrey R</author><author>Camp, Sara M</author><author>Ye, Shiu Q</author><author>Garcia, Joe G N</author></authors></contributors><titles><title>Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>17286-17293</pages><volume>280</volume><issue>17</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Biological</keyword><keyword>Blood Coagulation Factors</keyword><keyword>Blood Coagulation Factors: chemistry</keyword><keyword>Blood Coagulation Factors: metabolism</keyword><keyword>Cell Surface</keyword><keyword>Cell Surface: chemistry</keyword><keyword>Cell Surface: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Dominant</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Endothelium: metabolism</keyword><keyword>Endothelium: pathology</keyword><keyword>Fluorescence</keyword><keyword>Genes</keyword><keyword>Humans</keyword><keyword>Immunoprecipitation</keyword><keyword>Lung</keyword><keyword>Lung: metabolism</keyword><keyword>Lung: pathology</keyword><keyword>Lysosphingolipid</keyword><keyword>Lysosphingolipid: metabolism</keyword><keyword>Microscopy</keyword><keyword>Models</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: chemistry</keyword><keyword>Phosphorylation</keyword><keyword>Protein Binding</keyword><keyword>Protein C</keyword><keyword>Protein C: metabolism</keyword><keyword>RNA</keyword><keyword>Receptors</keyword><keyword>Sepsis</keyword><keyword>Sepsis: metabolism</keyword><keyword>Serine</keyword><keyword>Serine: chemistry</keyword><keyword>Signal Transduction</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: metabolism</keyword><keyword>Threonine</keyword><keyword>Threonine: chemistry</keyword><keyword>Thrombin</keyword><keyword>Thrombin: metabolism</keyword><keyword>Time Factors</keyword><keyword>Transcriptional Activation</keyword><keyword>Transfection</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>rac GTP-Binding Proteins</keyword><keyword>rac GTP-Binding Proteins: metabolism</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2005</year></dates><isbn>7737021051</isbn><accession-num>15710622</accession-num><electronic-resource-num>10.1074/jbc.M412427200</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15710622</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Increased endothelial cell (EC) permeability is central to the pathophysiology of inflammatory syndromes such as sepsis and acute lung injury (ALI). Activated protein C (APC), a serine protease critically involved in the regulation of coagulation and inflammatory processes, improves sepsis survival through an unknown mechanism. We hypothesized a direct effect of APC to both prevent increased EC permeability and to restore vascular integrity after edemagenic agonists. We measured changes in transendothelial electrical resistance (TER) and observed that APC produced concentration-dependent attenuation of TER reductions evoked by thrombin. We next explored known EC barrier-protective signaling pathways and observed dose-dependent APC-mediated increases in cortical myosin light chain (MLC) phosphorylation in concert with cortically distributed actin polymerization, findings highly suggestive of Rac GTPase involvement. We next determined that APC directly increases Rac1 activity, with inhibition of Rac1 activity significantly attenuating APC-mediated barrier protection to thrombin challenge. Finally, as these signaling events were similar to those evoked by the potent EC barrier-enhancing agonist, sphingosine 1-phosphate (S1P), we explored potential cross-talk between endothelial protein C receptor (EPCR) and S1P1, the receptors for APC and S1P, respectively. EPCR-blocking antibody (RCR-252) significantly attenuated both APC-mediated barrier protection and increased MLC phosphorylation. We next observed rapid, EPCR and PI 3-kinase-dependent, APC-mediated phosphorylation of S1P1 on threonine residues consistent with S1P1 receptor activation. Co-immunoprecipitation studies demonstrate an interaction between EPCR and S1P1 upon APC treatment. Targeted silencing of S1P1 expression using siRNA significantly reduced APC-mediated barrier protection against thrombin. These data suggest that novel EPCR ligation and S1P1 transactivation results in EC cytoskeletal rearrangement and barrier protection, components potentially critical to the improved survival of APC-treated patients with severe sepsis.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>McLaughlin, Joseph N</author><author>Mazzoni, Maria R</author><author>Cleator, John H</author><author>Earls, Laurie</author><author>Perdigoto, Ana Luisa</author><author>Brooks, Joshua D</author><author>Muldowney, James a S</author><author>Vaughan, Douglas E</author><author>Hamm, Heidi E</author></authors></contributors><titles><title>Thrombin modulates the expression of a set of genes including thrombospondin-1 in human microvascular endothelial cells.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>22172-22180</pages><volume>280</volume><issue>23</issue><keywords><keyword>Adenosine Diphosphate</keyword><keyword>Adenosine Diphosphate: chemistry</keyword><keyword>Algorithms</keyword><keyword>Amides</keyword><keyword>Amides: pharmacology</keyword><keyword>Apoptosis</keyword><keyword>Biological</keyword><keyword>Cells</keyword><keyword>Cluster Analysis</keyword><keyword>Complementary</keyword><keyword>Complementary: metabolism</keyword><keyword>Culture Media</keyword><keyword>Cultured</keyword><keyword>DNA</keyword><keyword>DNA Primers</keyword><keyword>DNA Primers: chemistry</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: metabolism</keyword><keyword>GTP-Binding Protein alpha Subunits</keyword><keyword>Gene Expression Regulation</keyword><keyword>Genetic</keyword><keyword>Gi-Go</keyword><keyword>Gi-Go: metabolism</keyword><keyword>Gq-G11</keyword><keyword>Gq-G11: metabolism</keyword><keyword>Humans</keyword><keyword>Indoles</keyword><keyword>Indoles: pharmacology</keyword><keyword>Maleimides</keyword><keyword>Maleimides: pharmacology</keyword><keyword>Microcirculation</keyword><keyword>Microcirculation: metabolism</keyword><keyword>Models</keyword><keyword>Nucleic Acid Hybridization</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>PAR-1</keyword><keyword>PAR-1: metabolism</keyword><keyword>Peptides</keyword><keyword>Peptides: chemistry</keyword><keyword>Pertussis Toxin</keyword><keyword>Pertussis Toxin: pharmacology</keyword><keyword>Promoter Regions</keyword><keyword>Protein Binding</keyword><keyword>Pyridines</keyword><keyword>Pyridines: pharmacology</keyword><keyword>RNA</keyword><keyword>RNA: metabolism</keyword><keyword>Receptor</keyword><keyword>Reverse Transcriptase Polymerase Chain Reaction</keyword><keyword>Signal Transduction</keyword><keyword>Thrombin</keyword><keyword>Thrombin: chemistry</keyword><keyword>Thrombin: metabolism</keyword><keyword>Thrombospondin 1</keyword><keyword>Thrombospondin 1: biosynthesis</keyword><keyword>Time Factors</keyword><keyword>Umbilical Veins</keyword><keyword>Umbilical Veins: cytology</keyword><keyword>Up-Regulation</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2005</year></dates><accession-num>15817447</accession-num><electronic-resource-num>10.1074/jbc.M500721200</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15817447</url></web-urls></urls><label>Apoptosis;ECIS TEER;Signal Transduction</label><abstract>Thrombospondin-1 (THBS1) is a large extracellular matrix glycoprotein that affects vasculature systems such as platelet activation, angiogenesis, and wound healing. Increases in THBS1 expression have been liked to disease states including tumor progression, atherosclerosis, and arthritis. The present study focuses on the effects of thrombin activation of the G-protein-coupled, protease-activated receptor-1 (PAR-1) on THBS1 gene expression in the microvascular endothelium. Thrombin-induced changes in gene expression were characterized by microarray analysis of approximately 11,000 different human genes in human microvascular endothelial cells (HMEC-1). Thrombin induced the expression of a set of at least 65 genes including THBS1. Changes in THBS1 mRNA correlated with an increase in the extracellular THBS1 protein concentration. The PAR-1-specific agonist peptide (TFLLRNK-PDK) mimicked thrombin stimulation of THBS1 expression, suggesting that thrombin signaling is through PAR-1. Further studies showed THBS1 expression was sensitive to pertussis toxin and protein kinase C inhibition indicating G(i/o)- and G(q)-mediated pathways. THBS1 up-regulation was also confirmed in human umbilical vein endothelial cells stimulated with thrombin. Analysis of the promoter region of THBS1 and other genes of similar expression profile identified from the microarray predicted an EBOX/EGRF transcription model. Expression of members of each family, MYC and EGR1, respectively, correlated with THBS1 expression. These results suggest thrombin formed at sites of vascular injury increases THBS1 expression into the extracellular matrix via activation of a PAR-1, G(i/o), G(q), EBOX/EGRF-signaling cascade, elucidating regulatory points that may play a role in increased THBS1 expression in disease states.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lee, Chong-Chou</author><author>Putnam, Andrew J</author><author>Miranti, Cindy K</author><author>Gustafson, Margaret</author><author>Wang, Ling-Mei</author><author>Vande Woude, George F</author><author>Gao, Chong-Feng</author></authors></contributors><titles><title>Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis.</title><secondary-title>Oncogene</secondary-title></titles><periodical><full-title>Oncogene</full-title></periodical><pages>5193-5202</pages><volume>23</volume><issue>30</issue><keywords><keyword>Biosensing Techniques</keyword><keyword>Blotting</keyword><keyword>Carcinoma</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Division</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Collagen</keyword><keyword>Collagen: metabolism</keyword><keyword>Drug Combinations</keyword><keyword>Focal Adhesions</keyword><keyword>Gene Expression Regulation</keyword><keyword>Green Fluorescent Proteins</keyword><keyword>Hepatocyte Growth Factor</keyword><keyword>Hepatocyte Growth Factor: metabolism</keyword><keyword>Hepatocyte Growth Factor: pharmacology</keyword><keyword>Humans</keyword><keyword>Laminin</keyword><keyword>Laminin: metabolism</keyword><keyword>Leiomyosarcoma</keyword><keyword>Leiomyosarcoma: metabolism</keyword><keyword>Leiomyosarcoma: pathology</keyword><keyword>Luminescent Proteins</keyword><keyword>Luminescent Proteins: metabolism</keyword><keyword>Mitogens</keyword><keyword>Mitogens: metabolism</keyword><keyword>Mitogens: pharmacology</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplastic</keyword><keyword>Nerve Tissue Proteins</keyword><keyword>Nerve Tissue Proteins: metabolism</keyword><keyword>Polyploidy</keyword><keyword>Proteoglycans</keyword><keyword>Proteoglycans: metabolism</keyword><keyword>Proto-Oncogene Proteins c-met</keyword><keyword>Proto-Oncogene Proteins c-met: metabolism</keyword><keyword>Renal Cell</keyword><keyword>Renal Cell: metabolism</keyword><keyword>Renal Cell: pathology</keyword><keyword>Signal Transduction</keyword><keyword>Stress Fibers</keyword><keyword>Tumor</keyword><keyword>Western</keyword></keywords><dates><year>2004</year></dates><accession-num>15122328</accession-num><electronic-resource-num>10.1038/sj.onc.1207646</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15122328</url></web-urls></urls><label>ECIS Attachment;Signal Transduction</label><abstract>A strict regulation of hepatocyte growth factor/scatter factor (HGF/SF)-Met signaling is essential for its appropriate function. Several negative regulators of Met signaling have been identified. Here we report that human Spry2 is induced by HGF/SF and negatively regulates HGF/SF-Met signaling. We show that overexpression of Spry2 inhibits cell proliferation, anchorage-independent cell growth, and migration in wound-healing and in vitro invasion assays. Measured in an electric cell-substrate impedance sensing biosensor, cell movement is restricted, because Spry2 dramatically facilitates cell attachment and spreading by enhancing focal adhesions and increasing stress fibers. An analysis of cell cycle distribution shows, unexpectedly, that Spry2-GFP cells are polyploid. Thus, as with FGF and EGF receptors, Spry2-GFP tempers downstream Met signaling in addition to its pronounced effect on cell adhesion, and it has properties suitable to be considered a tumor-suppressor protein.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Grab, Dennis J</author><author>Nikolskaia, Olga</author><author>Kim, Yuri V</author><author>Lonsdale-Eccles, John D</author><author>Ito, Susumu</author><author>Hara, Tatsuru</author><author>Fukuma, Toshihide</author><author>Nyarko, Elvis</author><author>Kim, Kwang Sik Kee Jun</author><author>Stins, Monique F</author><author>Delannoy, Michael J</author><author>Rodgers, Jean</author><author>Kim, Kwang Sik Kee Jun</author></authors></contributors><titles><title>African trypanosome interactions with an in vitro model of the human blood-brain barrier.</title><secondary-title>The Journal of parasitology</secondary-title></titles><periodical><full-title>The Journal of parasitology</full-title></periodical><pages>970-979</pages><volume>90</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: cytology</keyword><keyword>Blood-Brain Barrier: parasitology</keyword><keyword>Blood-Brain Barrier: ultrastructure</keyword><keyword>Calcium</keyword><keyword>Calcium: metabolism</keyword><keyword>Cell Line</keyword><keyword>Electric Impedance</keyword><keyword>Electron</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: parasitology</keyword><keyword>Endothelial Cells: ultrastructure</keyword><keyword>Fluorescence</keyword><keyword>Humans</keyword><keyword>Microscopy</keyword><keyword>Scanning</keyword><keyword>Transfection</keyword><keyword>Transmission</keyword><keyword>Trypanosoma brucei brucei</keyword><keyword>Trypanosoma brucei brucei: physiology</keyword><keyword>Trypanosoma brucei gambiense</keyword><keyword>Trypanosoma brucei gambiense: physiology</keyword></keywords><dates><year>2004</year></dates><accession-num>15562595</accession-num><electronic-resource-num>10.1645/GE-287R</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15562595</url></web-urls></urls><label>Blood Brain Barrier;ECIS TEER</label><abstract>The neurological manifestations of sleeping sickness in man are attributed to the penetration of the blood-brain barrier (BBB) and invasion of the central nervous system by Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense. However, how African trypanosomes cross the BBB remains an unresolved issue. We have examined the traversal of African trypanosomes across the human BBB using an in vitro BBB model system constructed of human brain microvascular endothelial cells (BMECs) grown on Costar Transwell inserts. Human-infective T. b. gambiense strain IL 1852 was found to cross human BMECs far more readily than the animal-infective Trypanosoma brucei brucei strains 427 and TREU 927. Tsetse fly-infective procyclic trypomastigotes did not cross the human BMECs either alone or when coincubated with bloodstreamform T. b. gambiense. After overnight incubation, the integrity of the human BMEC monolayer measured by transendothelial electrical resistance was maintained on the inserts relative to the controls when the endothelial cells were incubated with T. b. brucei. However, decreases in electrical resistance were observed when the BMEC-coated inserts were incubated with T. b. gambiense. Light and electron microscopy studies revealed that T. b. gambiense initially bind at or near intercellular junctions before crossing the BBB paracellularly. This is the first demonstration of paracellular traversal of African trypanosomes across the BBB. Further studies are required to determine the mechanism of BBB traversal by these parasites at the cellular and molecular level.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Regard, Jean B</author><author>Scheek, Sigrid</author><author>Borbiev, Talaibek</author><author>Lanahan, Anthony a</author><author>Schneider, Armin</author><author>Demetriades, Anna-Maria</author><author>Hiemisch, Holger</author><author>Barnes, Carol a</author><author>Verin, Alexander D</author><author>Worley, Paul F</author></authors></contributors><titles><title>Verge: a novel vascular early response gene.</title><secondary-title>The Journal of neuroscience : the official journal of the Society for Neuroscience</secondary-title></titles><periodical><full-title>The Journal of neuroscience : the official journal of the Society for Neuroscience</full-title></periodical><pages>4092-4103</pages><volume>24</volume><issue>16</issue><keywords><keyword>Amino Acid</keyword><keyword>Amino Acid Sequence</keyword><keyword>Animal</keyword><keyword>Animals</keyword><keyword>Base Sequence</keyword><keyword>Brain Ischemia</keyword><keyword>Brain Ischemia: metabolism</keyword><keyword>Cell Hypoxia</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Developmental</keyword><keyword>Developmental: physiol</keyword><keyword>Disease Models</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activators</keyword><keyword>Enzyme Activators: pharmacology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Genes</keyword><keyword>Growth Substances</keyword><keyword>Growth Substances: pharmacology</keyword><keyword>Humans</keyword><keyword>Immediate-Early</keyword><keyword>Immediate-Early Proteins</keyword><keyword>Immediate-Early Proteins: biosynthesis</keyword><keyword>Immediate-Early Proteins: genetics</keyword><keyword>Immediate-Early: genetics</keyword><keyword>Messenger</keyword><keyword>Messenger: biosynthesis</keyword><keyword>Mice</keyword><keyword>Molecular Sequence Data</keyword><keyword>Myocardium</keyword><keyword>Myocardium: metabolism</keyword><keyword>Neovascularization</keyword><keyword>Organ Specificity</keyword><keyword>Physiologic</keyword><keyword>Physiologic: genetics</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C: metabolism</keyword><keyword>RNA</keyword><keyword>Rats</keyword><keyword>Seizures</keyword><keyword>Seizures: chemically induced</keyword><keyword>Seizures: metabolism</keyword><keyword>Sequence Homology</keyword><keyword>Transfection</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2004</year></dates><accession-num>15102925</accession-num><electronic-resource-num>10.1523/JNEUROSCI.4252-03.2004</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15102925</url></web-urls></urls><label>ECIS TEER</label><abstract>Vascular endothelium forms a continuous, semipermeable barrier that regulates the transvascular movement of hormones, macromolecules, and other solutes. Here, we describe a novel immediate early gene that is expressed selectively in vascular endothelial cells, verge (vascular early response gene). Verge protein includes an N-terminal region of approximately 70 amino acids with modest homology (approximately 30% identity) to Apolipoprotein L but is otherwise unique. Verge mRNA and protein are induced selectively in the endothelium of adult vasculature by electrical or chemical seizures. Verge expression appears to be responsive to local tissue conditions, because it is induced in the hemisphere ipsilateral to transient focal cerebral ischemia. In contrast to the transient expression in adult, Verge mRNA and protein are constitutively expressed at high levels in the endothelium of developing tissues (particularly heart) in association with angiogenesis. Verge mRNA is induced in cultured endothelial cells by defined growth factors and hypoxia. Verge protein is dramatically increased by cysteine proteinase inhibitors, suggesting rapid turnover, and is localized to focal regions near the periphery of the cells. Endothelial cell lines that stably express Verge form monolayers that show enhanced permeability in response to activation of protein kinase C by phorbol esters. This response is accompanied by reorganization of the actin cytoskeleton and the formation of paracellular gaps. These studies suggest that Verge functions as a dynamic regulator of endothelial cell signaling and vascular function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kilani, Muna M</author><author>Mohammed, Kamal a</author><author>Nasreen, Najmunnisa</author><author>Hardwick, Joyce a</author><author>Kaplan, Mark H</author><author>Tepper, Robert S</author><author>Antony, Veena B</author></authors></contributors><titles><title>Respiratory syncytial virus causes increased bronchial epithelial permeability.</title><secondary-title>Chest</secondary-title></titles><periodical><full-title>Chest</full-title></periodical><pages>186-191</pages><volume>126</volume><issue>1</issue><keywords><keyword>Bronchi</keyword><keyword>Bronchi: metabolism</keyword><keyword>Bronchi: virology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Enzyme-Linked Immunosorbent Assay</keyword><keyword>Humans</keyword><keyword>Permeability</keyword><keyword>Respiratory Syncytial Virus Infections</keyword><keyword>Respiratory Syncytial Virus Infections: metabolism</keyword><keyword>Respiratory Syncytial Viruses</keyword><keyword>Vascular Endothelial Growth Factors</keyword><keyword>Vascular Endothelial Growth Factors: biosynthesis</keyword></keywords><dates><year>2004</year></dates><accession-num>15249461</accession-num><electronic-resource-num>10.1378/chest.126.1.186</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15249461</url></web-urls></urls><label>ECIS TEER</label><abstract>Respiratory syncytial virus (RSV)-induced diseases are mediated through active cytokines released during infection. We hypothesized that RSV infection causes bronchial epithelial monolayer permeability in vitro via induction of vascular endothelial growth factor (VEGF).</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Keese, Charles R</author><author>Wegener, Joachim</author><author>Walker, Sarah R</author><author>Giaever, Ivar</author></authors></contributors><titles><title>Electrical wound-healing assay for cells in vitro.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>1554-1559</pages><volume>101</volume><issue>6</issue><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Dogs</keyword><keyword>Electroporation</keyword><keyword>Rats</keyword><keyword>Wound Healing</keyword></keywords><dates><year>2004</year></dates><accession-num>14747654</accession-num><electronic-resource-num>10.1073/pnas.0307588100</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=341773&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Migration;Wound Healing</label><abstract>Confluent cell monolayers in tissue culture are fragile and can easily be mechanically disrupted, often leaving an area devoid of cells. This opening in the cell sheet is then repopulated, because the cells on the fringe of the damage, which are no longer contact-inhibited, move into the available space. This mechanical disruption is often done deliberately in a &quot;wound-healing&quot; assay as a means to assess the migration of the cells. In such assays, a scrape is made in the cell layer followed by microscopy to monitor the advance of the cells into the wound. We have found that these types of assays can also be accomplished electrically. In this approach, cells growing on small electrodes and monitored by using electric cell-substrate impedance sensing are subjected to currents, resulting in severe electroporation and subsequent cell death. After this invasive treatment, the electrode's impedance is again monitored to chart the migration and ultimate healing of the wound. We report here that this procedure to study cell behavior is both highly reproducible, quantitative, and provides data similar to that acquired with traditional measurements.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kundranda, Madappa N</author><author>Ray, Sanhita</author><author>Saria, Margaret</author><author>Friedman, David</author><author>Matrisian, Lynn M</author><author>Lukyanov, Pavel</author><author>Ochieng, Josiah</author></authors></contributors><titles><title>Annexins expressed on the cell surface serve as receptors for adhesion to immobilized fetuin-A.</title><secondary-title>Biochimica et biophysica acta</secondary-title></titles><periodical><full-title>Biochimica et biophysica acta</full-title></periodical><pages>111-123</pages><volume>1693</volume><issue>2</issue><keywords><keyword>Annexin A2</keyword><keyword>Annexin A2: deficiency</keyword><keyword>Annexin A2: genetics</keyword><keyword>Annexin A2: metabolism</keyword><keyword>Annexin A4</keyword><keyword>Annexin A4: deficiency</keyword><keyword>Annexin A4: genetics</keyword><keyword>Annexin A4: metabolism</keyword><keyword>Antibodies</keyword><keyword>Antibodies: immunology</keyword><keyword>Antibodies: pharmacology</keyword><keyword>Antigens</keyword><keyword>CD29</keyword><keyword>CD29: immunology</keyword><keyword>CD29: metabolism</keyword><keyword>Calcium</keyword><keyword>Calcium: pharmacology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Division</keyword><keyword>Cell Division: drug effects</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Cell Surface</keyword><keyword>Cell Surface: metabolism</keyword><keyword>Collagen Type IV</keyword><keyword>Collagen Type IV: metabolism</keyword><keyword>Fluorescence Resonance Energy Transfer</keyword><keyword>Humans</keyword><keyword>Magnesium</keyword><keyword>Magnesium: pharmacology</keyword><keyword>Mass</keyword><keyword>Matrix-Assisted Laser Desorpti</keyword><keyword>Protein Binding</keyword><keyword>RNA</keyword><keyword>Receptors</keyword><keyword>Small Interfering</keyword><keyword>Small Interfering: genetics</keyword><keyword>Small Interfering: metabolism</keyword><keyword>Spectrometry</keyword><keyword>Tumor</keyword><keyword>alpha-Fetoproteins</keyword><keyword>alpha-Fetoproteins: metabolism</keyword></keywords><dates><year>2004</year></dates><accession-num>15313013</accession-num><electronic-resource-num>10.1016/j.bbamcr.2004.06.005</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15313013</url></web-urls></urls><label>ECIS Attachment</label><abstract>Fetuin-A is a major constituent of the fetal bovine serum used extensively in cell culture media. We hereby present data demonstrating that breast carcinoma cells can adhere to immobilized fetuin-A in a calcium-dependent fashion. Interestingly, the cells can also divide and attain confluency under these conditions. Using a proteomic approach, we have identified annexin-II and -VI as the putative cell surface receptors for fetuin-A in the presence of Ca2+ ions. Biotinylation of cell surface proteins followed by immunoprecipitation revealed that annexin-VI was expressed on the extracytoplasmic surface of the cell membranes. Finally, to demonstrate that annexin-II and -VI were the adhesive receptors for fetuin-A, siRNA knockdown of expression of the annexins significantly reduced the calcium-mediated adhesion. Interestingly, we demonstrated that the tumor cells could also adhere to immobilized fetuin-A in the presence of magnesium ions, and that this adhesion was most likely mediated by integrins because neutralizing antibodies against beta1 integrins substantially reduced the adhesion. Our studies suggest that the expression of annexin-II and -VI and possibly other members of the family mediate novel adhesion and signaling mechanisms in tumor cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Luong, John H T T</author><author>Xiao, Caide</author><author>LACHANCE, Bernard</author><author>Leabu, Š.Mircea</author><author>Li, Xiaolan</author><author>Uniyal, Shashi</author><author>CHAN, Bosco M C C</author><author>CAIDE, XIAO</author><author>LACHANCE, Bernard</author><author>LEABU, S Mircea</author><author>XIAOLAN, L I</author><author>Uniyal, Shashi</author><author>CHAN, Bosco M C C</author><author>Xiao, Caide</author><author>LACHANCE, Bernard</author><author>Leabu, Š.Mircea</author><author>Li, Xiaolan</author><author>Uniyal, Shashi</author><author>CHAN, Bosco M C C</author><author>CAIDE, XIAO</author><author>LEABU, S Mircea</author><author>XIAOLAN, L I</author></authors></contributors><titles><title>Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin</title><secondary-title>Analytica Chimica Acta</secondary-title></titles><periodical><full-title>Analytica Chimica Acta</full-title></periodical><pages>61-69</pages><volume>501</volume><issue>1</issue><keywords><keyword>Adherencia</keyword><keyword>Adhesion</keyword><keyword>Adhérence</keyword><keyword>Cell Adhesion</keyword><keyword>Cellule membrane</keyword><keyword>Collagen</keyword><keyword>Collagène</keyword><keyword>Colágeno</keyword><keyword>Célula membrana</keyword><keyword>Electroporación</keyword><keyword>Electroporation</keyword><keyword>Fibronectin</keyword><keyword>Fibronectina</keyword><keyword>Fibronectine</keyword><keyword>Human rhabdomyosarcoma cells</keyword><keyword>Impedance measurement</keyword><keyword>Impedancia</keyword><keyword>Impédance</keyword><keyword>Integrina β1</keyword><keyword>Intégrine β1</keyword><keyword>Laminin</keyword><keyword>Laminina</keyword><keyword>Laminine</keyword><keyword>Membrane cell</keyword><keyword>Monitorage</keyword><keyword>Monitoreo</keyword><keyword>Monitoring</keyword><keyword>Rabdomiosarcoma</keyword><keyword>Rhabdomyosarcoma</keyword><keyword>Rhabdomyosarcome</keyword><keyword>cell adhesion</keyword><keyword>collagen</keyword><keyword>fibronectin</keyword><keyword>human rhabdomyosarcoma cells</keyword><keyword>impedance measurement</keyword><keyword>laminin</keyword><keyword>β1 integrin</keyword></keywords><dates><year>2004</year></dates><publisher>Elsevier</publisher><electronic-resource-num>10.1016/j.aca.2003.09.016</electronic-resource-num><notes>From Duplicate 1 (Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin - Luong, John H.T T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; Uniyal, Shashi; CHAN, Bosco M.C C.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI)

From Duplicate 1 (Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin - Luong, John H.T T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; Uniyal, Shashi; CHAN, Bosco M.C C.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI)

From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T T.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI )




From Duplicate 1 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure-function of α2β1 integrin


- LUONG, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )








From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T; Xiao, Caide; Lachance, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; Chan, Bosco M.C )




From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )



From Duplicate 2 (Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin - Luong, John H.T T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; Uniyal, Shashi; CHAN, Bosco M.C C.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI)

From Duplicate 1 (Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin - Luong, John H.T T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; Uniyal, Shashi; CHAN, Bosco M.C C.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI)

From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T T.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI )




From Duplicate 1 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure-function of α2β1 integrin


- LUONG, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )








From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T; Xiao, Caide; Lachance, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; Chan, Bosco M.C )




From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )





From Duplicate 2 ( 

Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin

- Luong, John H.T T.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI )




From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T T.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI )




From Duplicate 1 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure-function of α2β1 integrin


- LUONG, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )








From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T; Xiao, Caide; Lachance, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; Chan, Bosco M.C )




From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )</notes><research-notes>From Duplicate 1 (Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin - Luong, John H.T T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; Uniyal, Shashi; CHAN, Bosco M.C C.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI)

From Duplicate 1 (Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin - Luong, John H.T T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; Uniyal, Shashi; CHAN, Bosco M.C C.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI)

From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T T.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI )




From Duplicate 1 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure-function of α2β1 integrin


- LUONG, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )








From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T; Xiao, Caide; Lachance, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; Chan, Bosco M.C )




From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )



From Duplicate 2 (Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin - Luong, John H.T T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; Uniyal, Shashi; CHAN, Bosco M.C C.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI)

From Duplicate 1 (Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin - Luong, John H.T T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; Uniyal, Shashi; CHAN, Bosco M.C C.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI)

From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T T.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI )




From Duplicate 1 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure-function of α2β1 integrin


- LUONG, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )








From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T; Xiao, Caide; Lachance, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; Chan, Bosco M.C )




From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )





From Duplicate 2 ( 

Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin

- Luong, John H.T T.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI )




From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T T.; Xiao, Caide; LACHANCE, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; CHAN, Bosco M.C C.; CAIDE, XIAO; LEABU, S. Mircea; XIAOLAN, LI )




From Duplicate 1 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure-function of α2β1 integrin


- LUONG, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )








From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H.T; Xiao, Caide; Lachance, Bernard; Leabu, Š.Mircea; Li, Xiaolan; Uniyal, Shashi; Chan, Bosco M.C )




From Duplicate 2 ( 


Extended applications of electric cell-substrate impedance sensing for assessment of the structure–function of α2β1 integrin


- Luong, John H. T.; CAIDE, XIAO; LACHANCE, Bernard; LEABU, S. Mircea; XIAOLAN, LI; UNIYAL, Shashi; CHAN, Bosco M. C. )</research-notes><language>eng</language><urls><web-urls><url>http://cat.inist.fr/?aModele=afficheN&amp;cpsidt=15348324</url><url>http://linkinghub.elsevier.com/retrieve/pii/S0003267003012121</url></web-urls></urls><label>ECIS Attachment;ECIS Electroporation;ECIS Migration</label><abstract>Electric cell-substrate impedance sensing (ECIS) was applied to assess the structure-function of α2β1 integrin, receptor for collagen and laminin. On collagen-coated gold electrodes, expression of this integrin on human rhabdomyosarcoma (RD) cells (RDX2C2) yielded a five-fold increase in resistance when compared with mock transfected RD (RDpF) cells (34.5 ± 5.2 versus 6.5 ± 0.8 Ω/cell). An intermediate level of 16 ± 2 Ω/cell was measured upon expression of an α2β1 mutant that lacked the α2 cytoplasmic domain (RDX2CO). On laminin, the resistance measured for RDX2C2 cells was also higher but only twice that of RDpF cells at 71 ± 4 and 37 ± 4 Ω/cell, respectively. In comparison, RDX2CO cells (38 ± 4 Ω/cell), exhibiting no enhanced adhesive function, yielded a similar result to that of RDpF cells. On fibronectin, RDX2C2 and RDpF cells, exhibiting comparable levels of adhesion, were similar in resistance measurements at 85 ± Sand 89 ± 7 Ω/cell, respectively. It has been shown that deletion of a2 cytoplasmic domain results in dysregulated recruitment of the α2β1 mutant to focal adhesion complexes that mediate binding of fibronectin. RDX2CO cells on fibronectin, exhibiting reduced adhesive function, was associated with noticeably lower resistance (60 ± 4 Ω/cell). Monitoring electroporation of the RD plasma membrane also indirectly validated cell attachment as reflected by the resistance measured. Results from this study demonstrated the potential of ECIS for study of the structure-function of β1 integrin adhesion receptors.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukova, Anna a</author><author>Birukov, Konstantin G</author><author>Smurova, Ksenya</author><author>Adyshev, Djanybek</author><author>Kaibuchi, Kozo</author><author>Alieva, Irina</author><author>Garcia, Joe G N</author><author>Verin, Alexander D</author></authors></contributors><titles><title>Novel role of microtubules in thrombin-induced endothelial barrier dysfunction.</title><secondary-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</secondary-title></titles><periodical><full-title>The FASEB journal : official publication of the Federation of American Societies for Experimental Biology</full-title></periodical><pages>1879-1890</pages><volume>18</volume><issue>15</issue><keywords><keyword>Cell Membrane Permeability</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>G12-G13</keyword><keyword>G12-G13: metabolism</keyword><keyword>GTP-Binding Protein alpha Subunits</keyword><keyword>Guanine Nucleotide Exchange Factors</keyword><keyword>Guanine Nucleotide Exchange Factors: physiology</keyword><keyword>Heterotrimeric GTP-Binding Proteins</keyword><keyword>Heterotrimeric GTP-Binding Proteins: physiology</keyword><keyword>Humans</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Lung</keyword><keyword>Lung: blood supply</keyword><keyword>Microtubules</keyword><keyword>Microtubules: physiology</keyword><keyword>Microtubules: ultrastructure</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: physiology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: physiology</keyword><keyword>Vascular: ultrastructure</keyword><keyword>rho-Associated Kinases</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: physiology</keyword><keyword>tau Proteins</keyword><keyword>tau Proteins: metabolism</keyword></keywords><dates><year>2004</year></dates><accession-num>15576491</accession-num><electronic-resource-num>10.1096/fj.04-2328com</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15576491</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Disturbances in endothelial cell (EC) barrier regulation are critically dependent upon rearrangements of EC actin cytoskeleton. However, the role of microtubule (MT) network in the regulation of EC permeability is not well understood. We examined involvement of MT remodeling in thrombin-induced EC permeability and explored MT regulation by heterotrimeric G12/13 proteins and by small GTPase Rho. Thrombin induced phosphorylation of MT regulatory protein tau at Ser409 and Ser262 and peripheral MT disassembly, which was linked to increased EC permeability. MT stabilization by taxol attenuated thrombin-induced permeability, actin remodeling, and paracellular gap formation and diminished thrombin-induced activation of Rho and Rho-kinase. Expression of activated Galpha12/13 subunits involved in thrombin-mediated signaling or their effector p115RhoGEF involved in Rho activation caused MT disassembly, whereas p115RhoGEF-specific negative regulator RGS preserved MT from thrombin-induced disassembly. Consistent with these results, expression of activated RhoA and Rho-kinase induced MT disassembly. Conversely, thrombin-induced disassembly of peripheral MT network was attenuated by expression of dominant negative RhoA and Rho-kinase mutants or by pharmacological inhibition of Rho-kinase. Collectively, our data demonstrate for the first time a critical involvement of MT disassembly in thrombin-induced EC barrier dysfunction and indicate G-protein-dependent mechanisms of thrombin-induced MT alteration.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Zeng, Wei</author><author>Matter, William F</author><author>Yan, S Betty</author><author>Um, Suzane L</author><author>Vlahos, Chris J</author><author>Liu, Ling</author></authors></contributors><titles><title>Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling.</title><secondary-title>Critical care medicine</secondary-title></titles><periodical><full-title>Critical care medicine</full-title></periodical><pages>S302-8</pages><volume>32</volume><issue>5 Suppl</issue><keywords><keyword>Anti-Infective Agents</keyword><keyword>Anti-Infective Agents: pharmacology</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Humans</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Protein C</keyword><keyword>Protein C: pharmacology</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: drug effects</keyword><keyword>Protein-Serine-Threonine Kinases: physiology</keyword><keyword>Recombinant Proteins</keyword><keyword>Recombinant Proteins: pharmacology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>rho-Associated Kinases</keyword></keywords><dates><year>2004</year></dates><accession-num>15118535</accession-num><electronic-resource-num>10.1097/01.CCM.0000128038.49201.8C</electronic-resource-num><urls><web-urls><url>http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&amp;an=00003246-200405001-00020</url><url>http://www.ncbi.nlm.nih.gov/pubmed/15118535</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>To explore whether the improvement in organ function and the vasoactive effect observed in the clinical studies of drotrecogin alfa (activated) (recombinant human activated protein C, rhAPC) in sepsis are a result of rhAPC's effect on endothelial cell (EC) permeability and modulation of the intracellular cytoskeleton via the Rho kinase signaling pathway.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Iyer, Seema</author><author>Ferreri, Deana M</author><author>DeCocco, Nina C</author><author>Minnear, Fred L</author><author>Vincent, Peter a</author></authors></contributors><titles><title>VE-cadherin-p120 interaction is required for maintenance of endothelial barrier function.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L1143-53</pages><volume>286</volume><issue>6</issue><keywords><keyword>Albumins</keyword><keyword>Albumins: metabolism</keyword><keyword>Animals</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>Cadherins</keyword><keyword>Cadherins: genetics</keyword><keyword>Cadherins: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Catenins</keyword><keyword>Cattle</keyword><keyword>Cell Adhesion Molecules</keyword><keyword>Cell Adhesion Molecules: genetics</keyword><keyword>Cell Adhesion Molecules: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Desmoplakins</keyword><keyword>Endothelium</keyword><keyword>Gene Expression</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: metabolism</keyword><keyword>Molecular Sequence Data</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: genetics</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Protein Binding</keyword><keyword>Protein Binding: physiology</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2004</year></dates><accession-num>14672921</accession-num><electronic-resource-num>10.1152/ajplung.00305.2003</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/14672921</url></web-urls></urls><label>ECIS TEER</label><abstract>Interaction of p120 with juxtamembrane domain (JMD) of VE-cadherin has been implicated in regulation of endothelial cell-cell adhesion. We used a number of approaches to alter the level of p120 available for binding to VE-cadherin as a means to investigate the role of p120-VE-cadherin interaction in regulation of barrier function in confluent endothelial monolayers. Expression of an epitope-tagged fragment corresponding to JMD of VE-cadherin resulted in a decrease in endothelial barrier function as assessed by changes in albumin clearance and electrical resistance. Binding of JMD-Flag to p120 resulted in a decreased level of p120. In addition to decreasing p120 level, expression of JMD also decreased level of VE-cadherin. Expression of JMD also caused an increase in MLC phosphorylation and rearrangement of actin cytoskeleton, which, coupled with decreased cadherin, can contribute to loss of barrier function. Reducing p120 by siRNA resulted in a decrease in VE-cadherin, whereas increasing the level of p120 increased the level of VE-cadherin, demonstrating that p120 regulates the level of VE-cadherin. Overexpression of p120 was, however, associated with decreased barrier function and rearrangement of the actin cytoskeleton. Interestingly, expression of p120 was able to inhibit thrombin-induced increases in MLC phosphorylation, suggesting that p120 inhibits activation of Rho/Rho kinase pathway in endothelial cells. Excess p120 also prevented JMD-induced increases in MLC phosphorylation, correlating this phosphorylation with Rho/Rho kinase pathway. These findings show p120 plays a major role in regulating endothelial barrier function, as either a decrease or increase of p120 resulted in disruption of permeability across cell monolayers.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Jacobson, Jeffrey R</author><author>Dudek, Steven M</author><author>Birukov, Konstantin G</author><author>Ye, Shui Q</author><author>Grigoryev, Dmitry N</author><author>Girgis, Reda E</author><author>Garcia, Joe G N</author></authors></contributors><titles><title>Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin.</title><secondary-title>American journal of respiratory cell and molecular biology</secondary-title></titles><periodical><full-title>American journal of respiratory cell and molecular biology</full-title></periodical><pages>662-670</pages><volume>30</volume><issue>5</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Cells</keyword><keyword>Cortactin</keyword><keyword>Cultured</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Electrophysiology</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: drug effects</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: drug effects</keyword><keyword>Hemostatics</keyword><keyword>Hemostatics: pharmacology</keyword><keyword>Humans</keyword><keyword>Hydroxymethylglutaryl-CoA Reductase Inhibitors</keyword><keyword>Hydroxymethylglutaryl-CoA Reductase Inhibitors: ph</keyword><keyword>Microfilament Proteins</keyword><keyword>Microfilament Proteins: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Simvastatin</keyword><keyword>Simvastatin: pharmacology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>rac GTP-Binding Proteins</keyword><keyword>rac GTP-Binding Proteins: metabolism</keyword><keyword>rho GTP-Binding Proteins</keyword><keyword>rho GTP-Binding Proteins: metabolism</keyword></keywords><dates><year>2004</year></dates><accession-num>14630613</accession-num><electronic-resource-num>10.1165/rcmb.2003-0267OC</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/14630613</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>The statins, a class of HMG-CoA reductase inhibitors, directly affect multiple vascular processes via inhibition of geranylgeranylation, a covalent modification essential for Rho GTPase interaction with cell membrane-bound activators. We explored simvastatin effects on endothelial cell actomyosin contraction, gap formation, and barrier dysfunction produced by the edemagenic agent, thrombin. Human pulmonary artery endothelial cells exposed to prolonged simvastatin treatment (5 microM, 16 h) demonstrated significant reductions in thrombin-induced (1 U/ml) barrier dysfunction ( approximately 70% inhibition) with accelerated barrier recovery, as measured by transendothelial resistance. Furthermore, simvastatin attenuated basal and thrombin-stimulated (1 U/ml, 5 min) myosin light chain diphosphorylation and stress fiber formation while dramatically increasing peripheral immunostaining of actin and cortactin, an actin-binding protein, in conjunction with increased Rac GTPase activity. As both simvastatin-induced Rac activation and barrier protection were delayed (maximal after 16 h), we assessed the role of gene expression and protein translation in the simvastatin response. Simultaneous treatment with cycloheximide (10 microg/ml, 16 h) abolished simvastatin-mediated barrier protection. Robust alterations were noted in the expression of cytoskeletal proteins (caldesmon, integrin beta4), thrombin regulatory elements (PAR-1, thrombomodulin), and signaling genes (guanine nucleotide exchange factors) in response to simvastatin by microarray analysis. These novel observations have broad clinical implications in numerous vascular pathobiologies characterized by alterations in vascular integrity including inflammation, angiogenesis, and acute lung injury.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Chang, Yun C</author><author>Stins, Monique F</author><author>McCaffery, Michael J</author><author>Miller, Georgina F</author><author>Pare, Dan R</author><author>Dam, Tapen</author><author>Paul-Satyaseela, Maneesh</author><author>Kim, Kwang Sik</author><author>Kwon-chung, Kyung J</author><author>Paul-Satyasee, Maneesh</author><author>Mmun, I Nfect I</author></authors></contributors><titles><title>Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier.</title><secondary-title>Society</secondary-title></titles><periodical><full-title>Society</full-title></periodical><pages>4985-4995</pages><volume>72</volume><issue>9</issue><keywords><keyword>Animals</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: microbiology</keyword><keyword>Brain</keyword><keyword>Brain: blood supply</keyword><keyword>Brain: microbiology</keyword><keyword>Cells</keyword><keyword>Central Nervous System</keyword><keyword>Central Nervous System: microbiology</keyword><keyword>Cerebrovascular Circulation</keyword><keyword>Cryptococcosis</keyword><keyword>Cryptococcosis: microbiology</keyword><keyword>Cryptococcus neoformans</keyword><keyword>Cryptococcus neoformans: pathogenicity</keyword><keyword>Cryptococcus neoformans: physiology</keyword><keyword>Cultured</keyword><keyword>Electron</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: microbiology</keyword><keyword>Endothelium</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Inbred BALB C</keyword><keyword>Mice</keyword><keyword>Microcirculation</keyword><keyword>Microcirculation: microbiology</keyword><keyword>Microscopy</keyword><keyword>Scanning</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: microbiology</keyword></keywords><dates><year>2004</year></dates><publisher>Am Soc Microbiol</publisher><accession-num>15321990</accession-num><electronic-resource-num>10.1128/IAI.72.9.4985-4995.2004</electronic-resource-num><notes>From Duplicate 2 ( 

Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier.

- Chang, Yun C; Stins, Monique F; McCaffery, Michael J; Miller, Georgina F; Pare, Dan R; Dam, Tapen; Paul-Satyaseela, Maneesh; Kim, Kwang Sik; Kwon-Chung, Kyung J; Paul-Satyasee, Maneesh )</notes><research-notes>From Duplicate 2 ( 

Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier.

- Chang, Yun C; Stins, Monique F; McCaffery, Michael J; Miller, Georgina F; Pare, Dan R; Dam, Tapen; Paul-Satyaseela, Maneesh; Kim, Kwang Sik; Kwon-Chung, Kyung J; Paul-Satyasee, Maneesh )</research-notes><urls><web-urls><url>http://iai.asm.org/cgi/content/abstract/72/9/4985</url><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=517459&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Blood Brain Barrier;ECIS Invasion;ECIS TEER</label><abstract>Cryptococcal meningoencephalitis develops as a result of hematogenous dissemination of inhaled Cryptococcus neoformans from the lung to the brain. The mechanism(s) by which C. neoformans crosses the blood-brain barrier (BBB) is a key unresolved issue in cryptococcosis. We used both an in vivo mouse model and an in vitro model of the human BBB to investigate the cryptococcal association with and traversal of the BBB. Exposure of human brain microvascular endothelial cells (HBMEC) to C. neoformans triggered the formation of microvillus-like membrane protrusions within 15 to 30 min. Yeast cells of C. neoformans adhered to and were internalized by the HBMEC, and they crossed the HBMEC monolayers via a transcellular pathway without affecting the monolayer integrity. The histopathology of mouse brains obtained after intravenous injection of C. neoformans showed that the yeast cells either were associated with endothelial cells or escaped from the brain capillary vessels into the neuropil by 3 h. C. neoformans was found in the brain parenchyma away from the vessels by 22 h. Association of C. neoformans with the choroid plexus, however, was not detected during up to 10 days of observation. Our findings indicate that C. neoformans cells invade the central nervous system by transcellular crossing of the endothelium of the BBB.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tar, Krisztina</author><author>Birukova, Anna a</author><author>Csortos, Csilla</author><author>Bakó, Eva</author><author>Garcia, Joe G N</author><author>Verin, Alexander D</author></authors></contributors><titles><title>Phosphatase 2A is involved in endothelial cell microtubule remodeling and barrier regulation.</title><secondary-title>Journal of cellular biochemistry</secondary-title></titles><periodical><full-title>Journal of cellular biochemistry</full-title></periodical><pages>534-546</pages><volume>92</volume><issue>3</issue><keywords><keyword>Actomyosin</keyword><keyword>Actomyosin: metabolism</keyword><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cattle</keyword><keyword>Cell Fractionation</keyword><keyword>Cell Line</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: cytology</keyword><keyword>Endothelial Cells: enzymology</keyword><keyword>Endothelial Cells: metabolism</keyword><keyword>Endothelium</keyword><keyword>Endothelium: cytology</keyword><keyword>Endothelium: enzymology</keyword><keyword>Endothelium: metabolism</keyword><keyword>Microtubules</keyword><keyword>Microtubules: metabolism</keyword><keyword>Nocodazole</keyword><keyword>Nocodazole: pharmacology</keyword><keyword>Okadaic Acid</keyword><keyword>Okadaic Acid: pharmacology</keyword><keyword>Phosphoprotein Phosphatases</keyword><keyword>Phosphoprotein Phosphatases: antagonists &amp; inhibit</keyword><keyword>Phosphoprotein Phosphatases: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Protein Phosphatase 2</keyword><keyword>Protein Transport</keyword><keyword>tau Proteins</keyword><keyword>tau Proteins: metabolism</keyword></keywords><dates><year>2004</year></dates><accession-num>15156565</accession-num><electronic-resource-num>10.1002/jcb.20036</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15156565</url></web-urls></urls><label>ECIS TEER</label><abstract>We have recently shown that microtubule (MT) inhibitor, nocodazole (2-5 microM) significantly increases endothelial cells (EC) actomyosin contraction and permeability indicating the importance of MT in maintaining the EC barrier (Verin et al. [2001]: Cell Mol Physiol 281:L565-L574). Okadaic acid (OA, 2-5 nM), a powerful inhibitor of protein phosphatase 2A (PP2A), significantly potentiates the effect of submaximal concentrations of nocodazole (50-200 nM) on transendothelial electrical resistance (TER) suggesting the involvement of PP2A activity in the MT-mediated EC barrier regulation. Immunofluorescent staining of EC revealed that in control cells PP2A distributes in a pattern similar to MT. Consistent with these results, we demonstrated that significant amounts of PP2A were present in MT-enriched EC fractions indicating tight association of PP2A with MT in endothelium. Treatment of EC with OA leads to disappearance of MT-like PP2A staining suggesting dissociation of PP2A from the MT network. Next, we examined the effect of PP2A inhibition on phosphorylation status of MT-associated protein tau, which in its unphosphorylated form promotes MT assembly. OA caused significant increases in tau phosphorylation confirming that tau is a substrate for PP2A in endothelium. Immunofluorescent experiments demonstrated that the OA-induced increases in tau phosphorylation strongly correlated with translocation of phospho-tau to cell periphery and disassembly of peripheral MT. These results suggest the involvement of PP2A-mediated tau dephosphorylation in alteration of EC MT structure and highlight the potential importance of PP2A in the regulation of EC the MT cytoskeleton and barrier function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ramirez-Icaza, Gail</author><author>Mohammed, Kamal a</author><author>Nasreen, Najmunnisa</author><author>Van Horn, Robert D</author><author>Hardwick, Joyce a</author><author>Sanders, Kerry L</author><author>Tian, Jun</author><author>Ramirez-Icaza, Carlos</author><author>Johnson, Mary T</author><author>Antony, Veena B</author></authors></contributors><titles><title>Th2 cytokines IL-4 and IL-13 downregulate paxillin expression in bronchial airway epithelial cells.</title><secondary-title>Journal of clinical immunology</secondary-title></titles><periodical><full-title>Journal of clinical immunology</full-title></periodical><pages>426-434</pages><volume>24</volume><issue>4</issue><keywords><keyword>Bronchi</keyword><keyword>Bronchi: cytology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: genetics</keyword><keyword>Down-Regulation</keyword><keyword>Down-Regulation: drug effects</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Humans</keyword><keyword>Interleukin-13</keyword><keyword>Interleukin-13: pharmacology</keyword><keyword>Interleukin-4</keyword><keyword>Interleukin-4: pharmacology</keyword><keyword>Paxillin</keyword><keyword>Permeability</keyword><keyword>Permeability: drug effects</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: genetics</keyword><keyword>Th2 Cells</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factor A: pharmacology</keyword></keywords><dates><year>2004</year></dates><accession-num>15163899</accession-num><electronic-resource-num>10.1023/B:JOCI.0000029111.27168.c6</electronic-resource-num><notes>From Duplicate 1 ( 

Th2 cytokines IL-4 and IL-13 downregulate paxillin expression in bronchial airway epithelial cells.

- Ramirez-Icaza, Gail; Mohammed, Kamal a; Nasreen, Najmunnisa; Van Horn, Robert D; Hardwick, Joyce a; Sanders, Kerry L; Tian, Jun; Ramirez-Icaza, Carlos; Johnson, Mary T; Antony, Veena B )</notes><research-notes>From Duplicate 1 ( 

Th2 cytokines IL-4 and IL-13 downregulate paxillin expression in bronchial airway epithelial cells.

- Ramirez-Icaza, Gail; Mohammed, Kamal a; Nasreen, Najmunnisa; Van Horn, Robert D; Hardwick, Joyce a; Sanders, Kerry L; Tian, Jun; Ramirez-Icaza, Carlos; Johnson, Mary T; Antony, Veena B )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15163899</url></web-urls></urls><label>ECIS TEER</label><abstract>Asthma is characterized by infiltration and shedding of the bronchial epithelium. The Th2 cytokines IL-4 and IL-13 are involved in the cellular recruitment and infiltration seen in asthma. The effects of IL-4 and IL-13 on cell-matrix interactions and epithelial shedding are unknown. We hypothesize that bronchial airway epithelial cells (BAEC) express paxillin, a structural focal adhesion protein, and downregulation of paxillin by Th2 cytokines lead to BAEC hyperpermeability. We showed by confocal microscopy the presence of paxillin in BAEC. We demonstrated by Western blot analysis that IL-4 and IL-13 stimulation results in downregulation of paxillin production. IL-4 and IL-13 stimulation decreased epithelial cell-matrix attachment as measured by electrical cell-substrate impedance sensing system (ECIS). Our results suggest that Th2 cytokines IL-4 and IL-13 downregulate paxillin production by BAEC, thereby disrupting the cell-matrix interactions. This may help explain the epithelial shedding and epithelial membrane hyperpermeability that occurs in asthma.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>De Blasio, Birgitte Freiesleben</author><author>Laane, Morten</author><author>Walmann, Thomas</author><author>Giaever, Ivar</author></authors></contributors><titles><title>Combining optical and electrical impedance techniques for quantitative measurement of confluence in MDCK-I cell cultures.</title><secondary-title>BioTechniques</secondary-title></titles><periodical><full-title>BioTechniques</full-title></periodical><pages>650-4, 656, 658 passim</pages><volume>36</volume><issue>4</issue><keywords><keyword>Animals</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Dogs</keyword><keyword>Electric Impedance</keyword><keyword>Electrodes</keyword><keyword>Optics and Photonics</keyword></keywords><dates><year>2004</year></dates><accession-num>15088383</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15088383</url></web-urls></urls><label>ECIS Attachment;ECIS Growth</label><abstract>A new method combining optical and electrical impedance measurements is described that enables submicroscopic cell movements to be monitored. The cells are grown on small gold electrodes that are transparent to light. This modified electrical cell-substrate impedance sensor (ECIS) allows simultaneous microscopic recording of both growth and motility, thus enabling cell confluence on the electrodes to be systematically correlated to the impedance in regular time intervals of seconds and for extended periods of time. Furthermore, the technique provides an independent measure of monolayer cell densities that we compare to calculated values from a theoretical model. We have followed the attachment and spreading behavior of epithelial Madin-Darby canine kidney strain I (MDCK-I) cell cultures on microelectrodes for up to 40 h. The studies reveal a high degree of correlation between the measured resistance at 4 kHz and the corresponding cell confluence in 4- to 6-h intervals with typical linear cross-correlation factors of r equaling approximately 0.9. In summary, the impedance measured with the ECIS technique provides a good quantitative measure of cell confluence.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kilani, Muna M</author><author>Mohammed, Kamal a</author><author>Nasreen, Najmunnisa</author><author>Tepper, Robert S</author><author>Antony, Veena B</author></authors></contributors><titles><title>RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.</title><secondary-title>Inflammation</secondary-title></titles><periodical><full-title>Inflammation</full-title></periodical><pages>245-251</pages><volume>28</volume><issue>5</issue><keywords><keyword>Benzoates</keyword><keyword>Benzoates: pharmacology</keyword><keyword>Bronchi</keyword><keyword>Bronchi: metabolism</keyword><keyword>Bronchi: pathology</keyword><keyword>Bronchi: virology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>DNA-Binding Proteins</keyword><keyword>DNA-Binding Proteins: analysis</keyword><keyword>DNA-Binding Proteins: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Epithelial Cells: virology</keyword><keyword>Free Radical Scavengers</keyword><keyword>Free Radical Scavengers: pharmacology</keyword><keyword>Humans</keyword><keyword>Hypoxia-Inducible Factor 1</keyword><keyword>Imidazoles</keyword><keyword>Imidazoles: pharmacology</keyword><keyword>Nitric Oxide</keyword><keyword>Nitric Oxide: antagonists &amp; inhibitors</keyword><keyword>Nitric Oxide: biosynthesis</keyword><keyword>Nitric Oxide: metabolism</keyword><keyword>Nuclear Proteins</keyword><keyword>Nuclear Proteins: analysis</keyword><keyword>Nuclear Proteins: metabolism</keyword><keyword>Permeability</keyword><keyword>Respiratory Syncytial Viruses</keyword><keyword>Respiratory Syncytial Viruses: pathogenicity</keyword><keyword>Time Factors</keyword><keyword>Transcription Factors</keyword><keyword>Transcription Factors: analysis</keyword><keyword>Transcription Factors: metabolism</keyword><keyword>Vascular Endothelial Growth Factors</keyword><keyword>Vascular Endothelial Growth Factors: antagonists &amp;</keyword><keyword>Vascular Endothelial Growth Factors: metabolism</keyword><keyword>alpha Subunit</keyword></keywords><dates><year>2004</year></dates><isbn>1075300460</isbn><accession-num>16133997</accession-num><electronic-resource-num>10.1007/s10753-004-6047-y</electronic-resource-num><notes>From Duplicate 1 (RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells. - Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B)

From Duplicate 1 (RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells. - Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B)

From Duplicate 2 ( 

RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.

- Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B )




From Duplicate 1 ( 


RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.


- Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B )








From Duplicate 2 ( 


RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.


- Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B )




From Duplicate 1 ( 


RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.


- Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B )</notes><research-notes>From Duplicate 1 (RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells. - Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B)

From Duplicate 1 (RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells. - Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B)

From Duplicate 2 ( 

RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.

- Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B )




From Duplicate 1 ( 


RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.


- Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B )








From Duplicate 2 ( 


RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.


- Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B )




From Duplicate 1 ( 


RSV causes HIF-1alpha stabilization via NO release in primary bronchial epithelial cells.


- Kilani, Muna M; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, Robert S; Antony, Veena B )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/16133997</url></web-urls></urls><label>ECIS TEER</label><abstract>RSV infection is characterized by airway edema. Stabilization of hypoxia inducible factor-1alpha (HIF-1alpha) is important in both inflammation and edema formation. In this study we evaluated whether RSV induced release of nitric oxide (NO) by bronchial airway epithelial cells leading to the stabilization of HIF-1alpha and subsequent transcription of VEGF(165). Primary human bronchial epithelial cells (HBEpC) were used; cell supernatants were analyzed. Western blot analysis was used for the detection of HIF-1alpha. Bronchial airway epithelial monolayer permeability was assessed using electric cell-substrate impedance sensing (ECIS) in real time. There was increased stabilization of HIF-1alpha in RSV infected cells. Addition of an NO inhibitor blocked RSV mediated HIF-1alpha expression. Antagonism of NO also inhibited VEGF production and HBEpC monolayer permeability. Our results demonstrate that in HBEpC, RSV induced NO causes stabilization of HIF-1alpha in vitro.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yanase, Mikio</author><author>Ikeda, Hitoshi</author><author>Matsui, Atsushi</author><author>Noiri, Eisei</author><author>Tomiya, Tomoaki</author><author>Arai, Masahiro</author><author>Inoue, Yukiko</author><author>Tejima, Kazuaki</author><author>Nagashima, Kayo</author><author>Nishikawa, Takako</author><author>Kimura, Satoshi</author><author>Fujiwara, Kenji</author><author>Rojkind, Marcos</author><author>Ogata, Itsuro</author></authors></contributors><titles><title>HMG-COA reductase inhibitor modulates collagen GEL-contraction by hepatic myofibroblast-like stellate cell line: involvement of geranylgeranylated proteins.</title><secondary-title>Comparative hepatology</secondary-title></titles><periodical><full-title>Comparative hepatology</full-title></periodical><pages>S21</pages><volume>3 Suppl 1</volume><keywords/><dates><year>2004</year></dates><accession-num>14960173</accession-num><electronic-resource-num>10.1186/1476-5926-2-S1-S21</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2410241&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Attachment</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Arndt, Silke</author><author>Seebach, Jochen</author><author>Psathaki, Katherina</author><author>Galla, Hans-Joachim</author><author>Wegener, Joachim</author></authors></contributors><titles><title>Bioelectrical impedance assay to monitor changes in cell shape during apoptosis</title><secondary-title>Biosensors and Bioelectronics</secondary-title></titles><periodical><full-title>Biosensors and Bioelectronics</full-title></periodical><pages>583-594</pages><volume>19</volume><issue>6</issue><keywords><keyword>apoptosis</keyword><keyword>cell</keyword><keyword>cell contacts</keyword><keyword>ecis</keyword><keyword>impedance analysis</keyword><keyword>substrate contacts</keyword><keyword>whole-cell biosensor</keyword></keywords><dates><year>2004</year></dates><isbn>4925183397</isbn><electronic-resource-num>10.1016/S0956-5663(03)00269-0</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0956566303002690</url></web-urls></urls><label>Apoptosis;ECIS Cytotoxicity</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Slaughter, Gymama E</author><author>Bieberich, Erhard</author><author>Wnek, Gary E</author><author>Wynne, Kenneth J</author><author>Guiseppi-Elie, Anthony</author></authors></contributors><titles><title>Improving neuron-to-electrode surface attachment via alkanethiol self-assembly: an alternating current impedance study.</title><secondary-title>Langmuir : the ACS journal of surfaces and colloids</secondary-title></titles><periodical><full-title>Langmuir : the ACS journal of surfaces and colloids</full-title></periodical><pages>7189-7200</pages><volume>20</volume><issue>17</issue><keywords><keyword>Adsorption</keyword><keyword>Alkanes</keyword><keyword>Alkanes: chemistry</keyword><keyword>Animals</keyword><keyword>Atomic Force</keyword><keyword>Atomic Force: methods</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Collagen</keyword><keyword>Collagen: chemistry</keyword><keyword>Cultured</keyword><keyword>Cysteamine</keyword><keyword>Cysteamine: chemistry</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: chemistry</keyword><keyword>Gold</keyword><keyword>Gold: chemistry</keyword><keyword>Laminin</keyword><keyword>Laminin: chemistry</keyword><keyword>Microelectrodes</keyword><keyword>Microscopy</keyword><keyword>Neurons</keyword><keyword>Neurons: chemistry</keyword><keyword>Neurons: physiology</keyword><keyword>PC12 Cells</keyword><keyword>Rats</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Sulfhydryl Compounds</keyword><keyword>Sulfhydryl Compounds: chemistry</keyword><keyword>Surface Properties</keyword><keyword>Time Factors</keyword><keyword>Tumor Cells</keyword></keywords><dates><year>2004</year></dates><accession-num>15301505</accession-num><electronic-resource-num>10.1021/la049192s</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15301505</url></web-urls></urls><label>ECIS Attachment</label><abstract>In this work, the omega-amine alkanethiols, cysteamine (CA) and 11-amino-1-undecanethiol (11-AUT), were chemisorbed as self-assembled monolayers (SAMs) onto 250-microm gold microelectrodes that were microlithographically fabricated within eight-well cell culture plates and investigated as a means to improve neuron-to-electrode surface attachment (NESA). Dynamic contact angle (DCA) measurements showed similar advancing, theta(a) (69 degrees and 65 degrees ), but contrasting receding contact angles, theta(r) (9 and 30 degrees ) for CA- and 11-AUT-SAMs, respectively. The corresponding hysteresis (Deltatheta(ar) = 60 and 35 degrees, respectively) indicates the CA-SAM displays greater amphiphilic character than the 11-AUT-SAM. A portion of the greater Deltatheta(ar) for CA-SAMs may arise from surface heterogeneity, as compared to sputter-deposited gold and 11-AUT-SAMs. Tapping mode atomic force microscopy (AFM) confirmed a 6% increase (CA-SAM) and a 22% decrease (11-AUT-SAM) in surface roughness when compared to clean but unmodified, sputter-deposited gold. The extracellular matrix cell adhesion proteins, collagen, fibronectin, and laminin, were covalently coupled to the aminoalkanethiol-decorated gold electrodes via acid-amine heterobifunctional cross-linking. Using fluorescein isothiocyanate-tagged laminin, confocal fluorescence microscopy of both CA- and 11-AUT-SAM-modified and unmodified gold microelectrodes confirmed coupling of the protein to the electrode and was readily distinguishable from nonspecifically adsorbed protein. DCA measurements of laminin physisorbed directly onto gold or covalently immobilized via CA- or 11-AUT-SAM had similar advancing (ca. 63-65 degrees ) and receding (ca. 7-9 degrees ) contact angles. Tapping mode AFM of these protein-bearing surfaces likewise showed dimerized protein aggregates of similar surface roughness. PC-12 cells cultured to confluence on both unmodified and SAM-modified, protein-derivatized gold microelectrodes were examined by alternating current impedance (50 mV p-t-p at 4 kHz). CA- and 11-AUT-SAM-modified surfaces when serving as a foundation or covalently immobilized adhesion proteins produced highly stable and reproducible temporal impedance responses. On the basis of the magnitude and the reproducibility of the impedance responses, the CA-SAM-modified surfaces were identified as being best suited for optimal neuron-to-electrode contact with laminin. Laminin performed best when compared to collagen and fibronectin. Covalent immobilization of the adhesion-promoting proteins results in enhanced NESA by tightly anchoring cells to the electrode.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kim, Yuri V</author><author>Di Cello, Francescopaolo</author><author>Hillaire, Coryse S</author><author>Kim, Kwang Sik</author></authors></contributors><titles><title>Differential Ca2+ signaling by thrombin and protease-activated receptor-1-activating peptide in human brain microvascular endothelial cells.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C31-42</pages><volume>286</volume><issue>1</issue><keywords><keyword>Calcium</keyword><keyword>Calcium Signaling</keyword><keyword>Calcium Signaling: drug effects</keyword><keyword>Calcium-Transporting ATPases</keyword><keyword>Calcium-Transporting ATPases: antagonists &amp; inhibi</keyword><keyword>Calcium: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Cerebrovascular Circulation</keyword><keyword>Cerebrovascular Circulation: drug effects</keyword><keyword>Cerebrovascular Circulation: physiology</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Extracellular Fluid</keyword><keyword>Extracellular Fluid: metabolism</keyword><keyword>Humans</keyword><keyword>Intracellular Membranes</keyword><keyword>Intracellular Membranes: metabolism</keyword><keyword>Microcirculation</keyword><keyword>Microcirculation: drug effects</keyword><keyword>Microcirculation: physiology</keyword><keyword>Oligopeptides</keyword><keyword>Oligopeptides: metabolism</keyword><keyword>Oligopeptides: pharmacology</keyword><keyword>Osmolar Concentration</keyword><keyword>Phospholipase D</keyword><keyword>Phospholipase D: antagonists &amp; inhibitors</keyword><keyword>Sarcoplasmic Reticulum Calcium-Transporting ATPase</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2004</year></dates><accession-num>12944324</accession-num><electronic-resource-num>10.1152/ajpcell.00157.2003</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12944324</url></web-urls></urls><label>Calcium Signaling;ECIS TEER</label><abstract>Thrombin and related protease-activated receptors 1, 2, 3, and 4 (PAR1-4) play a multifunctional role in many types of cells including endothelial cells. Here, using RT-PCR and immunofluorescence staining, we showed for the first time that PAR1-4 are expressed on primary human brain microvascular endothelial cells (HBMEC). Digital fluorescence microscopy and fura 2 were used to monitor intracellular Ca2+ concentration ([Ca2+]i) changes in response to thrombin and PAR1-activating peptide (PAR1-AP) SFFLRN. Both thrombin and PAR1-AP induced a dose-dependent [Ca2+]i rise that was inhibited by pretreatment of HBMEC with the phospholipase C inhibitor U-73122 and the sarco(endo)plasmic reticulum Ca2+-ATPase inhibitor thapsigargin. Thrombin induced transient [Ca2+]i increase, whereas PAR1-AP exhibited sustained [Ca2+]i rise. The PAR1-AP-induced sustained [Ca2+]i rise was significantly reduced in the absence of extracellular calcium or in the presence of an inhibitor of store-operated calcium channels, SKF-96365. Restoration of extracellular Ca2+ to the cells that were initially activated by PAR1-AP in the absence of extracellular Ca2+ resulted in significant [Ca2+]i rise; however, this effect was not observed after thrombin stimulation. Pretreatment of the cells with a low thrombin concentration (0.1 nM) prevented [Ca2+]i rise in response to high thrombin concentration (10 nM), but pretreatment with PAR1-AP did not prevent subsequent [Ca2+]i rise to high PAR1-AP concentration. Additionally, treatment with thrombin decreased transendothelial electrical resistance in HBMEC, whereas PAR1-AP was without significant effect. These findings suggest that, in contrast to thrombin, stimulation of PAR1 by untethered peptide SFFLRN results in stimulation of store-operated Ca2+ influx without significantly affecting brain endothelial barrier functions.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>De Blasio, B F</author><author>Røttingen, J-a</author><author>Sand, K L</author><author>Giaever, I</author><author>Iversen, J-G</author></authors></contributors><titles><title>Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.</title><secondary-title>Acta physiologica Scandinavica</secondary-title></titles><periodical><full-title>Acta physiologica Scandinavica</full-title></periodical><pages>335-346</pages><volume>180</volume><issue>4</issue><keywords><keyword>Animals</keyword><keyword>Bradykinin</keyword><keyword>Bradykinin: pharmacology</keyword><keyword>Calcium</keyword><keyword>Calcium Signaling</keyword><keyword>Calcium Signaling: physiology</keyword><keyword>Calcium: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: physiology</keyword><keyword>Cytosol</keyword><keyword>Cytosol: metabolism</keyword><keyword>Dogs</keyword><keyword>Electric Impedance</keyword><keyword>Gap Junctions</keyword><keyword>Gap Junctions: drug effects</keyword><keyword>Glycyrrhetinic Acid</keyword><keyword>Glycyrrhetinic Acid: analogs &amp; derivatives</keyword><keyword>Glycyrrhetinic Acid: pharmacology</keyword><keyword>Kidney</keyword><keyword>Kidney: cytology</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword></keywords><dates><year>2004</year></dates><accession-num>15030375</accession-num><electronic-resource-num>10.1111/j.1365-201X.2004.01261.x</electronic-resource-num><notes>From Duplicate 2 (Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells. - De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G)

From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )










From Duplicate 2 (Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells. - De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G)

From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )












From Duplicate 1 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )








From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )




From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )
















From Duplicate 2 ( 

Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.

- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )




From Duplicate 1 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )








From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )




From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )</notes><research-notes>From Duplicate 2 (Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells. - De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G)

From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )










From Duplicate 2 (Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells. - De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G)

From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )












From Duplicate 1 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )








From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )




From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )
















From Duplicate 2 ( 

Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.

- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )




From Duplicate 1 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )








From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )




From Duplicate 2 ( 


Global, synchronous oscillations in cytosolic calcium and adherence in bradykinin-stimulated Madin-Darby canine kidney cells.


- De Blasio, B F; Røttingen, J-a; Sand, K L; Giaever, I; Iversen, J-G )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15030375</url></web-urls></urls><label>Calcium Signaling;ECIS Micromotion;Signal Transduction</label><abstract>Intercellular Ca2+ oscillations are a universal mode of signalling in both excitable and non-excitable cells. Here, we study the relationship between Ca2+ signalling and coherent changes in adhesion properties by measuring the transepithelial impedance across bradykinin-stimulated Madin-Darby canine kidney (MDCK) cell layers grown on a microelectrode. During hormone stimulation, the impedance is found to oscillate, reflecting that the cells undergo morphological/adhesive alterations with high spatio-temporal organization. The experiments are supplemented with parallel, digital imaging fluorescence microscopy of bradykinin-induced single-cell Ca2+ oscillations.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tsikitis, Vassiliki L</author><author>Morin, Nicole a</author><author>Harrington, Elizabeth O</author><author>Albina, Jorge E</author><author>Reichner, Jonathan S</author></authors></contributors><titles><title>The lectin-like domain of complement receptor 3 protects endothelial barrier function from activated neutrophils.</title><secondary-title>Journal of immunology (Baltimore, Md. : 1950)</secondary-title></titles><periodical><full-title>Journal of immunology (Baltimore, Md. : 1950)</full-title></periodical><pages>1284-1291</pages><volume>173</volume><issue>2</issue><keywords><keyword>Chemotaxis</keyword><keyword>Endothelial Cells</keyword><keyword>Endothelial Cells: physiology</keyword><keyword>Glucans</keyword><keyword>Glucans: physiology</keyword><keyword>Humans</keyword><keyword>Lectins</keyword><keyword>Leukocyte</keyword><keyword>Macrophage-1 Antigen</keyword><keyword>Macrophage-1 Antigen: chemistry</keyword><keyword>Macrophage-1 Antigen: immunology</keyword><keyword>Macrophage-1 Antigen: physiology</keyword><keyword>Neutrophil Activation</keyword><keyword>Neutrophils</keyword><keyword>Neutrophils: physiology</keyword><keyword>Protein Structure</keyword><keyword>Tertiary</keyword><keyword>Tertiary: physiology</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: physiology</keyword></keywords><dates><year>2004</year></dates><accession-num>15240721</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/15240721</url></web-urls></urls><label>ECIS Invasion</label><abstract>The adhesion of neutrophils to endothelial cells is a central event leading to diapedesis and involves the binding of the I-domain of beta(2) integrins (CD11/CD18) to endothelial ICAMs. In addition to the I-domain, the beta(2) integrin complement receptor 3 (CR3) (CD11b/CD18) contains a lectin-like domain (LLD) that can alter leukocyte functions such as chemotaxis and cytotoxicity. The present study demonstrates that, in contrast to the CR3 I-domain, Ab blockade of the CR3 LLD has no role in mediating neutrophil-induced loss of endothelial barrier function. However, activation of CR3 with the LLD agonist beta-glucan protects the barrier function of endothelial cells in the presence of activated neutrophils and reduces transendothelial migration without affecting adhesion of the neutrophils to the endothelium. The LLD site-specific mAb VIM12 obviates beta-glucan protection while activation of the LLD by VIM12 cross-linking mimics the beta-glucan response by both preserving endothelial barrier function and reducing neutrophil transendothelial migration. beta-glucan has no direct effect on endothelial cell function in the absence of activated neutrophils. These findings demonstrate that signaling through the CR3 LLD prevents neutrophil-induced loss of endothelial barrier function and reduces diapedesis. This suggests that the LLD may be a suitable target for oligosaccharide-based anti-inflammatory therapeutics.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schmidt, Mirko H H</author><author>Chen, Baihua</author><author>Randazzo, Lisa M</author><author>Bogler, Oliver</author></authors></contributors><titles><title>SETA/CIN85/Ruk and its binding partner AIP1 associate with diverse cytoskeletal elements, including FAKs, and modulate cell adhesion.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>2845-2855</pages><volume>116</volume><issue>Pt 14</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Adaptor Proteins</keyword><keyword>Animals</keyword><keyword>Astrocytes</keyword><keyword>Astrocytes: metabolism</keyword><keyword>Astrocytes: pathology</keyword><keyword>Blotting</keyword><keyword>Calcium</keyword><keyword>Calcium: metabolism</keyword><keyword>Carrier Proteins</keyword><keyword>Carrier Proteins: chemistry</keyword><keyword>Carrier Proteins: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Confocal</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Dimerization</keyword><keyword>Electric Impedance</keyword><keyword>Electrophysiology</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Kinase 2</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>Glioma</keyword><keyword>Glioma: pathology</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Microscopy</keyword><keyword>Microtubules</keyword><keyword>Microtubules: metabolism</keyword><keyword>Mutation</keyword><keyword>Neoplasm Proteins</keyword><keyword>Neoplasm Proteins: chemistry</keyword><keyword>Neoplasm Proteins: metabolism</keyword><keyword>Nerve Tissue Proteins</keyword><keyword>Nerve Tissue Proteins: chemistry</keyword><keyword>Nerve Tissue Proteins: metabolism</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Precipitin Tests</keyword><keyword>Protein Binding</keyword><keyword>Protein Structure</keyword><keyword>Protein-Tyrosine Kinases</keyword><keyword>Protein-Tyrosine Kinases: metabolism</keyword><keyword>Rats</keyword><keyword>Signal Transducing</keyword><keyword>Signal Transduction</keyword><keyword>Tertiary</keyword><keyword>Time Factors</keyword><keyword>Transfection</keyword><keyword>Tubulin</keyword><keyword>Tubulin: metabolism</keyword><keyword>Ubiquitin</keyword><keyword>Ubiquitin: metabolism</keyword><keyword>Western</keyword></keywords><dates><year>2003</year></dates><accession-num>12771190</accession-num><electronic-resource-num>10.1242/jcs.00522</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12771190</url></web-urls></urls><label>ECIS Attachment;Signal Transduction</label><abstract>The adaptor protein SETA/CIN85/Ruk is involved in regulating diverse signal transduction pathways, including the internalization of tyrosine kinase receptors via the Cbl ubiquitin ligases, and attenuating PI3K activity by interaction with its regulatory subunit. Here we present evidence for a new aspect of SETA function, based on the initial observation that it co-localizes with actin in microfilaments and at focal adhesions, and with microtubules. Although there was no evidence for direct molecular interactions between SETA and cytoskeletal proteins, the SETA-interacting protein AIP1, which is a rat ortholog of the Xenopus src substrate Xp95, strongly interacted with structural proteins of the cytoskeleton, including actin and tubulins. Both SETA and AIP1 interacted with focal adhesion kinase (FAK) and proline rich tyrosine kinase 2 (PYK-2), and c-Cbl interacted with PYK-2. AIP1, which interacted more strongly than either SETA or c-Cbl, required an intact consensus tyrosine kinase phosphorylation sequence at Y319 to bind to focal adhesion kinases, which suggests that phosphorylation is an important mediator of this complex. SETA, which interacted as a dimer with focal adhesion kinases, promoted the interaction between PYK-2 and AIP1. Direct analysis of the impact of these proteins on cell adhesion, by use of an electrical cell-substrate impedance sensor (ECIS), showed that SETA promoted cell adhesion while AIP1 and c-Cbl reduced it. Furthermore, the ability of AIP1 and AIP1 mutants to decrease cell adhesion in ECIS analysis correlated with their presence in PYK-2 complexes, providing a direct link between AIP1-mediated molecular interactions and cellular behavior. Transfection of AIP1 also reduced the level of phosphorylation of endogenous PYK-2 and FAK, suggesting that this protein may directly regulate focal adhesion kinases, and thereby cell adhesion. These data are the first to implicate the adaptor protein SETA and its binding partner AIP1 as being involved with the cytoskeleton and in the regulation of cell adhesion, and suggest that they may be part of the focal adhesion kinase regulatory complex.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiao, Caide</author><author>Luong, John H T</author></authors></contributors><titles><title>On-line monitoring of cell growth and cytotoxicity using electric cell-substrate impedance sensing (ECIS).</title><secondary-title>Biotechnology progress</secondary-title></titles><periodical><full-title>Biotechnology progress</full-title></periodical><pages>1000-1005</pages><volume>19</volume><issue>3</issue><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Biosensing Techniques</keyword><keyword>Biosensing Techniques: instrumentation</keyword><keyword>Biosensing Techniques: methods</keyword><keyword>Cell Count</keyword><keyword>Cell Count: methods</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cell Culture Techniques: instrumentation</keyword><keyword>Cell Culture Techniques: methods</keyword><keyword>Cell Division</keyword><keyword>Cell Division: drug effects</keyword><keyword>Cell Division: physiology</keyword><keyword>Cells</keyword><keyword>Computer Simulation</keyword><keyword>Cricetinae</keyword><keyword>Cricetulus</keyword><keyword>Cultured</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Equipment Design</keyword><keyword>Equipment Failure Analysis</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: cytology</keyword><keyword>Fibroblasts: drug effects</keyword><keyword>Fibroblasts: physiology</keyword><keyword>Lethal Dose 50</keyword><keyword>Lung</keyword><keyword>Lung: cytology</keyword><keyword>Lung: drug effects</keyword><keyword>Lung: physiology</keyword><keyword>Mercuric Chloride</keyword><keyword>Mercuric Chloride: toxicity</keyword><keyword>Models</keyword><keyword>Reproducibility of Results</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Toxicity Tests</keyword><keyword>Toxicity Tests: instrumentation</keyword><keyword>Toxicity Tests: methods</keyword><keyword>Trinitrobenzenes</keyword><keyword>Trinitrobenzenes: toxicity</keyword></keywords><dates><year>2003</year></dates><accession-num>12790667</accession-num><electronic-resource-num>10.1021/bp025733x</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12790667</url></web-urls></urls><label>ECIS Cytotoxicity;ECIS Growth</label><abstract>An on-line and continuous technique based on electric cell-substrate impedance sensing (ECIS) was developed for measuring the concentration and time response function of fibroblastic V79 cells exposed to mercury chloride and 1,3,5-trinitrobenzene (TNB). Attachment, spreading and proliferation of V79 fibroblastic cells cultured on a microarray of small gold electrodes precoated with fibronectin were detected as resistance changes. The response function was derived to reflect the resistance change as a result of cell attachment, spreading, mitosis and cytotoxicity effect. Exposure of V79 cells to mercury chloride or TNB led to alterations in cell behavior, and therefore, chemical cytotoxicity was easily screened by measuring the response function of the attached and spread cells in the presence of inhibitor. The half inhibition concentration, the required concentration to achieve 50% inhibition, was obtained from the response function to provide information about cytotoxicity during the course of the assay. A simple mathematical model was developed to describe the responses of ECIS that were related to the attachment, spreading, and proliferation of V79 fibroblastic cells. The novel results of this paper are mainly characterized by the systematic study of several parameters including the cell number, detection limit, sensor sensitivity, and cytotoxicity, and they may motivate further research and study of ECIS sensors.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Birukov, Konstantin G</author><author>Jacobson, Jeffrey R</author><author>Flores, Alejandro a</author><author>Ye, Shui Q</author><author>Birukova, Anna a</author><author>Verin, Alexander D</author><author>Garcia, Joe G N</author></authors></contributors><titles><title>Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L785-97</pages><volume>285</volume><issue>4</issue><keywords><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: physiology</keyword><keyword>Cells</keyword><keyword>Conditioning (Psychology)</keyword><keyword>Conditioning (Psychology): physiology</keyword><keyword>Cultured</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: physiology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Gap Junctions</keyword><keyword>Gap Junctions: physiology</keyword><keyword>Gene Expression Profiling</keyword><keyword>Humans</keyword><keyword>Mechanical</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Oligonucleotide Array Sequence Analysis</keyword><keyword>Periodicity</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: drug effects</keyword><keyword>Pulmonary Artery: metabolism</keyword><keyword>Pulmonary Artery: physiology</keyword><keyword>Stress</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Time Factors</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2003</year></dates><accession-num>12639843</accession-num><electronic-resource-num>10.1152/ajplung.00336.2002</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12639843</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Ventilator-induced lung injury syndromes are characterized by profound increases in vascular leakiness and activation of inflammatory processes. To explore whether excessive cyclic stretch (CS) directly causes vascular barrier disruption or enhances endothelial cell sensitivity to edemagenic agents, human pulmonary artery endothelial cells (HPAEC) were exposed to physiologically (5% elongation) or pathologically (18% elongation) relevant levels of strain. CS produced rapid (10 min) increases in myosin light chain (MLC) phosphorylation, activation of p38 and extracellular signal-related kinase 1/2 MAP kinases, and actomyosin remodeling. Acute (15 min) and chronic (48 h) CS markedly enhanced thrombin-induced MLC phosphorylation (2.1-fold and 3.2-fold for 15-min CS at 5 and 18% elongation and 2.1-fold and 3.1-fold for 48-h CS at 5 and 18% elongation, respectively). HPAEC preconditioned at 18% CS, but not at 5% CS, exhibited significantly enhanced thrombin-induced reduction in transendothelial electrical resistance but did not affect barrier protective effect of sphingosine-1-phosphate (0.5 microM). Finally, expression profiling analysis revealed a number of genes, including small GTPase rho, apoptosis mediator ZIP kinase, and proteinase activated receptor-2, to be regulated by CS in an amplitude-dependent manner. Thus our study demonstrates a critical role for the magnitude of CS in regulation of agonist-mediated pulmonary endothelial cell permeability and strongly suggests phenotypic regulation of HPAEC barrier properties by CS.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Fox, Michael a.</author><author>Colello, Raymond J</author><author>Macklin, Wendy B</author><author>Fuss, Babette</author></authors></contributors><titles><title>Phosphodiesterase-Ialpha/autotaxin: a counteradhesive protein expressed by oligodendrocytes during onset of myelination.</title><secondary-title>Molecular and cellular neurosciences</secondary-title></titles><periodical><full-title>Molecular and cellular neurosciences</full-title></periodical><pages>507-519</pages><volume>23</volume><issue>3</issue><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Developmental</keyword><keyword>Enzymologic</keyword><keyword>Extracellular Space</keyword><keyword>Extracellular Space: enzymology</keyword><keyword>Female</keyword><keyword>Gene Expression Regulation</keyword><keyword>Glucose-6-Phosphate Isomerase</keyword><keyword>Glucose-6-Phosphate Isomerase: genetics</keyword><keyword>Glucose-6-Phosphate Isomerase: metabolism</keyword><keyword>Glycoproteins</keyword><keyword>Glycoproteins: genetics</keyword><keyword>Glycoproteins: metabolism</keyword><keyword>Inbred Lew</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Multienzyme Complexes</keyword><keyword>Myelin Sheath</keyword><keyword>Myelin Sheath: enzymology</keyword><keyword>Oligodendroglia</keyword><keyword>Oligodendroglia: cytology</keyword><keyword>Oligodendroglia: enzymology</keyword><keyword>Optic Nerve</keyword><keyword>Optic Nerve: cytology</keyword><keyword>Optic Nerve: embryology</keyword><keyword>Optic Nerve: physiology</keyword><keyword>Phosphodiesterase I</keyword><keyword>Phosphoric Diester Hydrolases</keyword><keyword>Phosphoric Diester Hydrolases: genetics</keyword><keyword>Phosphoric Diester Hydrolases: metabolism</keyword><keyword>Pregnancy</keyword><keyword>Pyrophosphatases</keyword><keyword>RNA</keyword><keyword>Rats</keyword><keyword>Solubility</keyword></keywords><dates><year>2003</year></dates><isbn>1804828947</isbn><accession-num>12837632</accession-num><electronic-resource-num>10.1016/S1044-7431</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S1044743103000733</url><url>http://www.ncbi.nlm.nih.gov/pubmed/12837632</url></web-urls></urls><label>ECIS Attachment</label><abstract>The initial stages of central nervous system (CNS) myelination require complex interactions of oligodendrocytes with their surrounding extracellular environment. In the present study, we demonstrate that commencing with active myelination oligodendrocytes express phosphodiesterase-Ialpha/autotaxin [PD-Ialpha/ATX (NPP-2)] as a non-membrane-associated extracellular factor. As such a component of the extracellular environment, PD-Ialpha/ATX has the ability to antagonize the adhesive interactions between oligodendroglial cells and known extracellular matrix (ECM) molecules present in the developing CNS. This counteradhesion requires intracellular signaling through heterotrimeric G proteins on fibronectin substrates and thus represents an active cellular response. Similar counteradhesive effects in other systems have been attributed to the activity of matricellular proteins, which support intermediate stages of cell adhesion thought to facilitate cellular locomotion and remodeling. Thus, the release of PD-Ialpha/ATX may be critically involved in the regulation of the initial stages of myelination, i.e., oligodendrocyte remodeling, via modulation of oligodendrocyte-ECM interactions in a matricellular fashion.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Luong, John H T</author></authors></contributors><titles><title>An Emerging Impedance Sensor Based on Cell-Protein Interactions: Applications in Cell Biology and Analytical Biochemistry</title><secondary-title>Analytical Letters</secondary-title></titles><periodical><full-title>Analytical Letters</full-title></periodical><pages>3147-3164</pages><volume>36</volume><issue>15</issue><keywords/><dates><year>2003</year></dates><electronic-resource-num>10.1081/AL-120026565</electronic-resource-num><urls><web-urls><url>http://www.tandfonline.com/doi/abs/10.1081/AL-120026565</url></web-urls></urls><label>ECIS Theory</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pearse, David B</author><author>Shimoda, Larissa A</author><author>Verin, Alexander D</author><author>Bogatcheva, Natalia</author><author>Moon, Cheil</author><author>Ronnett, Gabriele V</author><author>Welsh, Laura E</author><author>Becker, Patrice M</author></authors></contributors><titles><title>Effect of cGMP on lung microvascular endothelial barrier dysfunction following hydrogen peroxide.</title><secondary-title>Endothelium : journal of endothelial cell research</secondary-title></titles><periodical><full-title>Endothelium : journal of endothelial cell research</full-title></periodical><pages>309-317</pages><volume>10</volume><issue>6</issue><keywords><keyword>Actins</keyword><keyword>Actins: drug effects</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Calcium</keyword><keyword>Calcium: metabolism</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cattle</keyword><keyword>Cell Line</keyword><keyword>Cyclic GMP</keyword><keyword>Cyclic GMP: pharmacology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Gap Junctions</keyword><keyword>Gap Junctions: drug effects</keyword><keyword>Gap Junctions: metabolism</keyword><keyword>Hydrogen Peroxide</keyword><keyword>Hydrogen Peroxide: pharmacology</keyword><keyword>Lung</keyword><keyword>Lung: blood supply</keyword><keyword>Lung: cytology</keyword><keyword>Oxidants</keyword><keyword>Oxidants: pharmacology</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Pulmonary Artery: drug effects</keyword><keyword>Pulmonary Artery: metabolism</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2003</year></dates><accession-num>14741846</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/14741846</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>The authors determined the effect of cyclic guanosine 3',5'-monophosphate (cGMP) on hydrogen peroxide (H(2)O(2))-induced barrier dysfunction in bovine lung microvascular endothelial cell (BLMVEC) monolayers and compared the results to bovine pulmonary artery endothelial cells (BPAECs). In BLMVECs, H(2)O(2) (250 microM) caused a 31.9% +/- 4.8% decrease in transendothelial electrical resistance (TER) associated with increased actin stress fiber formation, intercellular gaps, and intracellular calcium concentration ([Ca(2+)](i)). The cGMP analogue 8-(p-chlorophenylthio)-cGMP (8p-CPT-cGMP; 30 or 50 microM) prevented the H(2)O(2)-induced decrease in TER (p &lt;.001) as well as the cytoskeletal rearrangement and intercellular gap formation. 8-pCPT-cGMP (50 microM) attenuated the peak (418.8 +/- 42.1 versus 665.2 +/- 38.0 nmol/L; p &lt;.001) and eliminated the sustained increase in [Ca(2+)](i) (193.5 +/- 21.3 versus 418.8 +/- 42.1 nmol/L; p &lt;.001) caused by H(2)O(2). 8-pCPT-cGMP also increased TER (14.2% +/- 2.2%; p &lt;.05) and decreased [Ca(2+)](i) (201.2 +/- 12.5 vs. 214.4 +/- 12.1 nmol/L; p &lt;.03) before H(2)O(2). In BPAECs, 8p-CPT-cGMP significantly attenuated H(2)O(2)-induced increases in permeability and [Ca(2+)](i) but less effectively than in BLMVECs. These results suggest that in BLMVECs, cGMP countered the adverse effects of H(2)O(2) on barrier function by preventing actin cytoskeletal rearrangement and attenuating the increase in [Ca(2+)](i).</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Schaphorst, Kane L</author><author>Chiang, Eddie</author><author>Jacobs, Keri N</author><author>Zaiman, Ari</author><author>Natarajan, Viswanathan</author><author>Wigley, Frederick</author><author>Garcia, Joe G N</author></authors></contributors><titles><title>Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L258-67</pages><volume>285</volume><issue>1</issue><keywords><keyword>Blood Platelets</keyword><keyword>Blood Platelets: metabolism</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cell Surface</keyword><keyword>Cell Surface: antagonists &amp; inhibitors</keyword><keyword>Cell Surface: metabolism</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>G-Protein-Coupled</keyword><keyword>GTP-Binding Protein alpha Subunits</keyword><keyword>Gap Junctions</keyword><keyword>Gap Junctions: drug effects</keyword><keyword>Gap Junctions: physiology</keyword><keyword>Gi-Go</keyword><keyword>Gi-Go: metabolism</keyword><keyword>Growth Substances</keyword><keyword>Growth Substances: metabolism</keyword><keyword>Hemostatics</keyword><keyword>Hemostatics: pharmacology</keyword><keyword>Humans</keyword><keyword>Immediate-Early Proteins</keyword><keyword>Immediate-Early Proteins: antagonists &amp; inhibitors</keyword><keyword>Immediate-Early Proteins: metabolism</keyword><keyword>Lung Diseases</keyword><keyword>Lung Diseases: metabolism</keyword><keyword>Lysophospholipid</keyword><keyword>Lysophospholipids</keyword><keyword>Microfilaments</keyword><keyword>Microfilaments: metabolism</keyword><keyword>Pertussis Toxin</keyword><keyword>Pertussis Toxin: pharmacology</keyword><keyword>Receptors</keyword><keyword>Respiratory Mucosa</keyword><keyword>Respiratory Mucosa: cytology</keyword><keyword>Respiratory Mucosa: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Sphingosine</keyword><keyword>Sphingosine: analogs &amp; derivatives</keyword><keyword>Sphingosine: metabolism</keyword><keyword>Sphingosine: pharmacology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2003</year></dates><accession-num>12626332</accession-num><electronic-resource-num>10.1152/ajplung.00311.2002</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12626332</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>In vitro and in vivo evidence indicates that circulating platelets affect both vascular integrity and hemostasis. How platelets enhance the permeability barrier of the vascular endothelium is not well understood. We measured the effect of isolated human platelets on human pulmonary artery endothelial cell (EC) barrier integrity by monitoring transmonolayer electrical resistance. EC barrier function was significantly increased by the addition of platelets ( approximately 40% maximum, 2.5 x 106 platelets/ml). Platelet supernatants, derived from 2.5 x 106 platelets/ml, reproduced the barrier enhancement and reversed the barrier dysfunction produced by the edemagenic agonist thrombin, which implicates a soluble barrier-promoting factor. The barrier-enhancing effect of platelet supernatants was heat stable but was attenuated by either charcoal delipidation (suggesting a vasoactive lipid mediator) or pertussis toxin, implying involvement of a Gialpha-coupled receptor signal transduction pathway. Sphingosine-1-phosphate (S1P), a sphingolipid that is released from activated platelets, is known to ligate G protein-coupled EC differentiation gene (EDG) receptors, increase EC electrical resistance, and reorganize the actin cytoskeleton (Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, and English D. J Clin Invest 108: 689-701, 2001). Infection of EC with an adenoviral vector expressing an antisense oligonucleotide directed against EDG-1 but not infection with control vector attenuated the barrier-enhancing effect of both platelet supernatants and S1P. These results indicate that a major physiologically relevant vascular barrier-protective mediator produced by human platelets is S1P.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Yanase, Mikio</author><author>Ikeda, Hitoshi</author><author>Ogata, Itsuro</author><author>Matsui, Atsushi</author><author>Noiri, Eisei</author><author>Tomiya, Tomoaki</author><author>Arai, Masahiro</author><author>Inoue, Yukiko</author><author>Tejima, Kazuaki</author><author>Nagashima, Kayo</author><author>Nishikawa, Takako</author><author>Shibata, Masao</author><author>Ikebe, Mitsuo</author><author>Rojkind, Marcos</author><author>Fujiwara, Kenji</author></authors></contributors><titles><title>Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line</title><secondary-title>Biochemical and Biophysical Research Communications</secondary-title></titles><periodical><full-title>Biochemical and Biophysical Research Communications</full-title></periodical><pages>223-228</pages><volume>305</volume><issue>2</issue><keywords><keyword>actomyosin-interaction</keyword><keyword>are located in the</keyword><keyword>cell</keyword><keyword>cell migration</keyword><keyword>cells</keyword><keyword>collagen gel-contraction</keyword><keyword>electric</keyword><keyword>hepatic stellate cells</keyword><keyword>hscs</keyword><keyword>lipocytes</keyword><keyword>myosin light chain kinase</keyword><keyword>or fat-storing cells</keyword><keyword>previously called ito</keyword><keyword>rho-kinase</keyword><keyword>substrate impedance sensor system</keyword></keywords><dates><year>2003</year></dates><electronic-resource-num>10.1016/S0006-291X(03)00726-5</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0006291X03007265</url></web-urls></urls><label>ECIS Attachment</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Qiao, Jing</author><author>Huang, Fei</author><author>Lum, Hazel</author></authors></contributors><titles><title>PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L972-80</pages><volume>284</volume><issue>6</issue><keywords><keyword>Adenoviridae</keyword><keyword>Adenoviridae: genetics</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Carrier Proteins</keyword><keyword>Carrier Proteins: genetics</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: metabolism</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Hemostatics</keyword><keyword>Hemostatics: pharmacology</keyword><keyword>Humans</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Skin</keyword><keyword>Skin: blood supply</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: enzymology</keyword><keyword>rac1 GTP-Binding Protein</keyword><keyword>rac1 GTP-Binding Protein: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2003</year></dates><isbn>3361433622</isbn><accession-num>12588708</accession-num><electronic-resource-num>10.1152/ajplung.00429.2002</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12588708</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Much evidence indicates that cAMP-dependent protein kinase (PKA) prevents increased endothelial permeability induced by inflammatory mediators. We investigated the hypothesis that PKA inhibits Rho GTPases, which are regulator proteins believed to mediate endothelial barrier dysfunction. Stimulation of human microvascular endothelial cells (HMEC) with thrombin (10 nM) increased activated RhoA (RhoA-GTP) within 1 min, which remained elevated approximately fourfold over control for 15 min. The activation was accompanied by RhoA translocation to the cell membrane. However, thrombin did not activate Cdc42 or Rac1 within similar time points, indicating selectivity of activation responses by Rho GTPases. Pretreatment of HMEC with 10 micro M forskolin plus 1 micro M IBMX (FI) to elevate intracellular cAMP levels inhibited both thrombin-induced RhoA activation and translocation responses. FI additionally inhibited thrombin-mediated dissociation of RhoA from guanine nucleotide dissociation inhibitor (GDI) and enhanced in vivo incorporation of (32)P by GDI. HMEC pretreated in parallel with FI showed &gt;50% reduction in time for the thrombin-mediated resistance drop to return to near baseline and inhibition of approximately 23% of the extent of resistance drop. Infection of HMEC with replication-deficient adenovirus containing the protein kinase A inhibitor gene (PKA inhibitor) blocked both the FI-mediated protective effects on RhoA activation and resistance changes. In conclusion, the results provide evidence that PKA inhibited RhoA activation in endothelial cells, supporting a signaling mechanism of protection against vascular endothelial barrier dysfunction.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sawhney, Rajinder S</author><author>Sharma, Bhavya</author><author>Humphrey, Lisa E</author><author>Brattain, Michael G</author></authors></contributors><titles><title>Integrin alpha2 and extracellular signal-regulated kinase are functionally linked in highly malignant autocrine transforming growth factor-alpha-driven colon cancer cells.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>19861-19869</pages><volume>278</volume><issue>22</issue><keywords><keyword>Butadienes</keyword><keyword>Butadienes: pharmacology</keyword><keyword>Chromones</keyword><keyword>Chromones: pharmacology</keyword><keyword>Colonic Neoplasms</keyword><keyword>Colonic Neoplasms: enzymology</keyword><keyword>Colonic Neoplasms: metabolism</keyword><keyword>Colonic Neoplasms: pathology</keyword><keyword>Cultured</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Flavonoids</keyword><keyword>Flavonoids: pharmacology</keyword><keyword>Humans</keyword><keyword>Integrin alpha2</keyword><keyword>Integrin alpha2: physiology</keyword><keyword>Mitogen-Activated Protein Kinases</keyword><keyword>Mitogen-Activated Protein Kinases: antagonists &amp; i</keyword><keyword>Mitogen-Activated Protein Kinases: physiology</keyword><keyword>Morpholines</keyword><keyword>Morpholines: pharmacology</keyword><keyword>Nitriles</keyword><keyword>Nitriles: pharmacology</keyword><keyword>Transforming Growth Factor alpha</keyword><keyword>Transforming Growth Factor alpha: physiology</keyword><keyword>Tumor Cells</keyword></keywords><dates><year>2003</year></dates><accession-num>12657625</accession-num><electronic-resource-num>10.1074/jbc.M213162200</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12657625</url></web-urls></urls><label>ECIS Micromotion</label><abstract>Recently, we have shown that autocrine transforming growth factor-alpha (TGF-alpha) controls the expression of integrin alpha2, cell adhesion to collagen IV and motility in highly progressed HCT116 colon cancer cells (Sawhney, R. S., Zhou, G-H. K., Humphrey, L. E., Ghosh, P., Kreisberg, J. I., and Brattain, M. G. (2002) J. Biol. Chem. 277, 75-86). We now report that expression of basal integrin alpha2 and its biological effects are controlled by constitutive activation of the extracellular signal-regulated/mitogen-activated protein kinase (ERK/MAPK) pathway. Treatment of cells with selective mitogen-activated protein kinase kinase (MEK) inhibitors PD098059 and U0126 showed that integrin alpha2 expression, cell adhesion, and activation of ERK are inhibited in a parallel concentration-dependent fashion. Moreover, autocrine TGF-alpha-mediated epidermal growth factor receptor activation was shown to control the constitutive activation of the ERK/MAPK pathway, since neutralizing antibody to the epidermal growth factor receptor was able to block basal ERK activity. TGF-alpha antisense-transfected cells also showed attenuated activation of ERK. Using a real time electric cell impedance sensing technique, it was shown that ERK-dependent integrin alpha2-mediated cell micromotion signaling is controlled by autocrine TGF-alpha. Thus, this study implicates ERK/MAPK signaling activated by endogenous TGF-alpha as one of the mechanistic features controlling metastatic spread.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>van Wetering, Sandra</author><author>van den Berk, Nadia</author><author>van Buul, Jaap D</author><author>Mul, Frederik P J</author><author>Lommerse, Ingrid</author><author>Mous, Rogier</author><author>ten Klooster, Jean-Paul</author><author>Zwaginga, Jaap-Jan</author><author>Hordijk, Peter L</author></authors></contributors><titles><title>VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C343-52</pages><volume>285</volume><issue>2</issue><keywords><keyword>ADP Ribose Transferases</keyword><keyword>ADP Ribose Transferases: pharmacology</keyword><keyword>Botulinum Toxins</keyword><keyword>Botulinum Toxins: pharmacology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Communication</keyword><keyword>Cell Communication: drug effects</keyword><keyword>Cell Communication: physiology</keyword><keyword>Cell Line</keyword><keyword>Chemotaxis</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Humans</keyword><keyword>Interleukin-1</keyword><keyword>Interleukin-1: pharmacology</keyword><keyword>Leukocyte</keyword><keyword>Leukocyte: drug effects</keyword><keyword>Leukocyte: physiology</keyword><keyword>Leukocytes</keyword><keyword>Leukocytes: cytology</keyword><keyword>Leukocytes: drug effects</keyword><keyword>Leukocytes: metabolism</keyword><keyword>Mitogen-Activated Protein Kinases</keyword><keyword>Mitogen-Activated Protein Kinases: drug effects</keyword><keyword>Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>Peptide Fragments</keyword><keyword>Peptide Fragments: pharmacology</keyword><keyword>Reactive Oxygen Species</keyword><keyword>Reactive Oxygen Species: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Vascular</keyword><keyword>Vascular Cell Adhesion Molecule-1</keyword><keyword>Vascular Cell Adhesion Molecule-1: drug effects</keyword><keyword>Vascular Cell Adhesion Molecule-1: metabolism</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>rac GTP-Binding Proteins</keyword><keyword>rac GTP-Binding Proteins: drug effects</keyword><keyword>rac GTP-Binding Proteins: metabolism</keyword><keyword>rhoA GTP-Binding Protein</keyword><keyword>rhoA GTP-Binding Protein: drug effects</keyword><keyword>rhoA GTP-Binding Protein: metabolism</keyword></keywords><dates><year>2003</year></dates><accession-num>12700137</accession-num><electronic-resource-num>10.1152/ajpcell.00048.2003</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12700137</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Leukocyte adhesion is mediated totally and transendothelial migration partially by heterotypic interactions between the beta1- and beta2-integrins on the leukocytes and their ligands, Ig-like cell adhesion molecules (Ig-CAM), VCAM-1, and ICAM-1, on the endothelium. Both integrins and Ig-CAMs are known to have signaling capacities. In this study we analyzed the role of VCAM-1-mediated signaling in the control of endothelial cell-cell adhesion and leukocyte transendothelial migration. Antibody-mediated cross-linking of VCAM-1 on IL-1beta-activated primary human umbilical vein endothelial cells (pHUVEC) induced actin stress fiber formation, contractility, and intercellular gaps. The effects induced by VCAM-1 cross-linking were inhibited by C3 toxin, indicating that the small GTPase p21Rho is involved. In addition, the effects of VCAM-1 were accompanied by activation of Rac, which we recently showed induce intercellular gaps in pHUVEC in a Rho-dependent fashion. With the use of a cell-permeable peptide inhibitor, it was shown that Rac signaling is required for VCAM-1-mediated loss of cell-cell adhesion. Furthermore, VCAM-1-mediated signaling toward cell-cell junctions was accompanied by, and dependent on, Rac-mediated production of reactive oxygen species and activation of p38 MAPK. In addition, it was found that inhibition of Rac-mediated signaling blocks transendothelial migration of monocytic U937 cells. Together, these data indicate that VCAM-1-induced, Rac-dependent signaling plays a key role in the modulation of vascular-endothelial cadherin-mediated endothelial cell-cell adhesion and leukocyte extravasation.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Usatyuk, Peter V</author><author>Fomin, Victor P</author><author>Shi, Shu</author><author>Garcia, Joe G N</author><author>Schaphorst, Kane</author><author>Natarajan, Viswanathan</author></authors></contributors><titles><title>Role of Ca2+ in diperoxovanadate-induced cytoskeletal remodeling and endothelial cell barrier function.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L1006-17</pages><volume>285</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Calcium</keyword><keyword>Calcium Channel Blockers</keyword><keyword>Calcium Channel Blockers: pharmacology</keyword><keyword>Calcium: physiology</keyword><keyword>Cattle</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: drug effects</keyword><keyword>Cytoskeleton: physiology</keyword><keyword>Cytoskeleton: ultrastructure</keyword><keyword>Egtazic Acid</keyword><keyword>Egtazic Acid: analogs &amp; derivatives</keyword><keyword>Egtazic Acid: pharmacology</keyword><keyword>Endothelium</keyword><keyword>Kinetics</keyword><keyword>Myosin-Light-Chain Kinase</keyword><keyword>Myosin-Light-Chain Kinase: antagonists &amp; inhibitor</keyword><keyword>Nifedipine</keyword><keyword>Nifedipine: pharmacology</keyword><keyword>Peroxides</keyword><keyword>Peroxides: pharmacology</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: physiology</keyword><keyword>Vanadates</keyword><keyword>Vanadates: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2003</year></dates><accession-num>12882766</accession-num><electronic-resource-num>10.1152/ajplung.00408.2002</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12882766</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Diperoxovanadate (DPV), a potent inhibitor of protein tyrosine phosphatases and activator of tyrosine kinases, alters endothelial barrier function via signaling pathways that are incompletely understood. One potential pathway is Src kinase-mediated tyrosine phosphorylation of proteins such as cortactin that regulate endothelial cell (EC) cytoskeleton assembly. As DPV modulates endothelial cell signaling via protein tyrosine phosphorylation, we determined the role of DPV-induced intracellular free calcium concentration ([Ca2+]i) in activation of Src kinase, cytoskeletal remodeling, and barrier function in bovine pulmonary artery endothelial cells (BPAECs). DPV in a dose- and time-dependent fashion increased [Ca2+]i, which was partially blocked by the calcium channel blockers nifedipine and Gd3+. Treatment of cells with thapsigargin released Ca2+ from the endoplasmic reticulum, and subsequent addition of DPV caused no further change in [Ca2+]i. These data suggest that DPV-induced [Ca2+]i includes Ca release from the endoplasmic reticulum and Ca influx through store-operated calcium entry. Furthermore, DPV induced an increase in protein tyrosine phosphorylation, phosphorylation of Src and cortactin, actin remodeling, and altered transendothelial electrical resistance in BPAECs. These DPV-mediated effects were significantly attenuated by BAPTA (25 microM), a chelator of [Ca2+]i. Immunofluorescence studies reveal that the DPV-mediated colocalization of cortactin with peripheral actin was also prevented by BAPTA. Chelation of extracellular Ca2+ by EGTA had marginal effects on DPV-induced phosphorylation of Src and cortactin; actin stress fibers formation, however, affected EC barrier function. These data suggest that DPV-induced changes in [Ca2+]i regulate endothelial barrier function using signaling pathways that involve Src and cytoskeleton remodeling.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Charboneau, Aubri L</author><author>Singh, Vinita</author><author>Yu, Tingxi</author><author>Newsham, Irene F</author></authors></contributors><titles><title>Suppression of growth and increased cellular attachment after expression of DAL-1 in MCF-7 breast cancer cells.</title><secondary-title>International journal of cancer. Journal international du cancer</secondary-title></titles><periodical><full-title>International journal of cancer. Journal international du cancer</full-title></periodical><pages>181-188</pages><volume>100</volume><issue>2</issue><keywords><keyword>Apoptosis</keyword><keyword>Blotting</keyword><keyword>Breast Neoplasms</keyword><keyword>Breast Neoplasms: genetics</keyword><keyword>Breast Neoplasms: metabolism</keyword><keyword>Breast Neoplasms: pathology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Division</keyword><keyword>Cultured</keyword><keyword>Cultured: pathology</keyword><keyword>Electric Impedance</keyword><keyword>Female</keyword><keyword>Gene Expression Regulation</keyword><keyword>Genes</keyword><keyword>Humans</keyword><keyword>Immunoenzyme Techniques</keyword><keyword>In Situ Nick-End Labeling</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: biosynthesis</keyword><keyword>Membrane Proteins: genetics</keyword><keyword>Microfilament Proteins</keyword><keyword>Neoplastic</keyword><keyword>Transfection</keyword><keyword>Tumor Cells</keyword><keyword>Tumor Suppressor</keyword><keyword>Tumor Suppressor Proteins</keyword><keyword>Tumor Suppressor Proteins: biosynthesis</keyword><keyword>Tumor Suppressor Proteins: genetics</keyword><keyword>Western</keyword></keywords><dates><year>2002</year></dates><accession-num>12115567</accession-num><electronic-resource-num>10.1002/ijc.10470</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12115567</url></web-urls></urls><label>Apoptosis;ECIS Attachment</label><abstract>The differentially expressed in adenocarcinoma of the lung (DAL-1) gene, which shares significant homology with members of the 4.1/ezrin/radixin/moesin/neurofibromatosis 2 (ERM/NF2) protein family, has previously been shown to suppress growth in lung cancer cell lines. This gene localizes to chromosome band 18p11.3, which undergoes loss of heterozygosity (LOH) in nonsmall cell lung carcinomas and a significant proportion of ductal carcinomas in situ (DCIS) of the breast. This finding suggests that alteration of gene(s) (possibly DAL-1) within this chromosomal region may be important early in the progression of breast disease. We generated MCF-7 cell lines expressing DAL-1 constitutively or under the control of an inducible promoter and analyzed the effect of DAL-1 expression on growth. These investigations revealed that the DAL-1 protein suppresses the growth of MCF-7 cells and may do so in part through the induction of apoptosis. In addition, expression of DAL-1 increased attachment of these cells to a variety of extracellular matrices. This is the first evidence that the DAL-1 protein functions at the interface between cell adhesion and apoptosis in controlling cell growth.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sriram, P S</author><author>Mohammed, Kamal A</author><author>Nasreen, Najmunnisa</author><author>Hardwick, Joyce</author><author>Van Horn, Robert</author><author>Sanders, Kerry</author><author>Antony, Veena B</author></authors></contributors><titles><title>Adherence of ovarian cancer cells induces pleural mesothelial cell (PMC) permeability.</title><secondary-title>Oncology research</secondary-title></titles><periodical><full-title>Oncology research</full-title></periodical><pages>79-85</pages><volume>13</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Coculture Techniques</keyword><keyword>Endothelial Growth Factors</keyword><keyword>Endothelial Growth Factors: biosynthesis</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Intercellular Signaling Peptides and Proteins</keyword><keyword>Intercellular Signaling Peptides and Proteins: bio</keyword><keyword>Lymphokines</keyword><keyword>Lymphokines: biosynthesis</keyword><keyword>Mice</keyword><keyword>Ovarian Neoplasms</keyword><keyword>Ovarian Neoplasms: pathology</keyword><keyword>Permeability</keyword><keyword>Pleura</keyword><keyword>Pleura: cytology</keyword><keyword>Proteins</keyword><keyword>Proteins: metabolism</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factors</keyword></keywords><dates><year>2002</year></dates><accession-num>12392155</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12392155</url></web-urls></urls><label>ECIS TEER</label><abstract>Malignant pleural effusion (MPE) carries a grave prognosis with median survival after diagnosis being 5 months. The major causes of MPE are lung, breast, ovary,and gastric cancer. It is still unclear how cancer cells penetrate the pleural mesothelial monolayer and reach the pleural space. In this study we examined the effect of ovarian epithelial cancer cells on a confluent pleural mesothelial cell (PMC) monolayer. We demonstrate that ovarian cancer cells adhere to the mesothelial monolayer in a time-dependent manner and induce PMC barrier dysfunction as evidenced by a drop in electrical resistance on electrical cell substrate impedance-sensing system (ECIS) and increased protein permeability. Barrier dysfunction is attenuated by addition of vascular endothelial growth factor (VEGF) antibody. Significant release of VEOF was noted when ovarian cancer cells were cocultured with PMC. Electron microscopy demonstrated gap formation in PMC monolayer only at the site of cancer cell attachment with surrounding areas remaining confluent.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Goldberg, Peter L</author><author>MacNaughton, Darren E</author><author>Clements, Richard T</author><author>Minnear, Fred L</author><author>Vincent, Peter A</author></authors></contributors><titles><title>p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L146-54</pages><volume>282</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cycloheximide</keyword><keyword>Cycloheximide: pharmacology</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Mitogen-Activated Protein Kinases</keyword><keyword>Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Protein Biosynthesis</keyword><keyword>Protein Synthesis Inhibitors</keyword><keyword>Protein Synthesis Inhibitors: pharmacology</keyword><keyword>Time Factors</keyword><keyword>Transforming Growth Factor beta</keyword><keyword>Transforming Growth Factor beta1</keyword><keyword>Transforming Growth Factor beta: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword></keywords><dates><year>2002</year></dates><publisher>Am Physiological Soc</publisher><accession-num>11741826</accession-num><urls><web-urls><url>http://ajplung.physiology.org/content/282/1/L146.short</url><url>http://www.ncbi.nlm.nih.gov/pubmed/11741826</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Transforming growth factor (TGF)-beta1 increases endothelial monolayer permeability and myosin light chain phosphorylation (MLC-P) beginning 1-2 h posttreatment, suggesting that changes in gene expression may be required for these responses. The role of extracellular signal-regulated kinase (ERK) 1/2 and p38 mitogen-activated protein kinase (p38 MAPK) was investigated because both kinases have been implicated in regulating gene expression after TGF-beta1. ERK1/2 phosphorylation increased threefold above the control level, and the increase was temporally associated with the increase in MLC-P. Inhibition of ERK1/2 phosphorylation with the MAPK kinase inhibitor U-0126 did not prevent the increase in either monolayer permeability or MLC-P. p38 MAPK phosphorylation increased fourfold above the control level, but unlike ERK1/2, this increase peaked 30 min and 1 h post-TGF-beta1 treatment. Inhibition of p38 MAPK activity with SB-203580 prevented the increases in both monolayer permeability and MLC-P. Treatment of the monolayers with cycloheximide in conjunction with TGF-beta1-inhibited MLC-P, showing a requirement for protein synthesis. These studies demonstrate that p38 MAPK activation and subsequent protein synthesis are part of the signal transduction pathway leading to the TGF-beta1-induced increases in monolayer permeability and MLC-P.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wegener, Joachim</author><author>Keese, Charles R</author><author>Giaever, Ivar</author></authors></contributors><titles><title>Recovery of adherent cells after in situ electroporation monitored electrically.</title><secondary-title>BioTechniques</secondary-title></titles><periodical><full-title>BioTechniques</full-title></periodical><pages>348-357</pages><volume>33</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cercopithecus aethiops</keyword><keyword>Dogs</keyword><keyword>Electrodes</keyword><keyword>Electroporation</keyword><keyword>Electroporation: instrumentation</keyword><keyword>Electroporation: methods</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Fluorescence</keyword><keyword>Gold</keyword><keyword>Isoquinolines</keyword><keyword>Isoquinolines: pharmacokinetics</keyword><keyword>Kidney</keyword><keyword>Kidney: cytology</keyword><keyword>Kidney: metabolism</keyword><keyword>Kidney: physiology</keyword><keyword>Microscopy</keyword><keyword>Rats</keyword><keyword>Sensitivity and Specificity</keyword><keyword>Species Specificity</keyword></keywords><dates><year>2002</year></dates><accession-num>12188187</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12188187</url></web-urls></urls><label>ECIS Electroporation</label><abstract>Here we describe various experiments that address the efficiency of loading extracellular probes into the cytoplasm of adherent mammalian cells (normal rat kidney, Madin-Darby canine kidney, and African green monkey) by means of in situ electroporation. Subsequent cell recovery from the electroporation pulse was monitored electrically in real time for each condition. In this study, small, gold-film electrodes (5 x 10(-4) cm2) are used as culture substrates and at the same time as an electrode for both the application of the electroporating voltage pulse and the noninvasive electrical monitoring of cell recovery, using a technique referred to as ECIS. Electroporation has been performed by using ac sinusoidal voltage pulses of varying frequency, amplitude, and duration. Permeabilization and re-closure of the plasma membrane were evaluated by the uptake of the fluorescence probe, Lucifer Yellow, from the extracellularfluid. With the experimental setup described here, efficient electroporation was achieved with voltages less than 5 V. Using ECIS, we followed the morphological response of the cells to the electricfield-induced membrane permeabilization. For optimized electroporation conditions, cell recovery was completed in less than 1 h. The introduction of membrane-impermeable substances by electroporation and in situ monitoring of the cellular response mayfind many applications in cell biology.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Keese, Charles R</author><author>Bhawe, Kaumudi</author><author>Wegener, Joachim</author><author>Giaever, Ivar</author></authors></contributors><titles><title>Real-time impedance assay to follow the invasive activities of metastatic cells in culture.</title><secondary-title>BioTechniques</secondary-title></titles><periodical><full-title>BioTechniques</full-title></periodical><pages>842-844,846,848-850</pages><volume>33</volume><issue>4</issue><keywords><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Endothelium: cytology</keyword><keyword>Humans</keyword><keyword>Male</keyword><keyword>Neoplasm Invasiveness</keyword><keyword>Neoplasm Invasiveness: physiopathology</keyword><keyword>Neoplasm Metastasis</keyword><keyword>Neoplasm Metastasis: physiopathology</keyword><keyword>Prostatic Neoplasms</keyword><keyword>Tumor Cells</keyword><keyword>Umbilical Veins</keyword><keyword>Umbilical Veins: cytology</keyword></keywords><dates><year>2002</year></dates><accession-num>12398193</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12398193</url></web-urls></urls><label>ECIS Invasion</label><abstract>Here we present research detecting the invasive activities of metastatic cells in vitro using electric cell-substrate impedance sensing (ECIS). The assay is based on previous microscopic observations, where metastatic cells added over established endothelial cell layers were observed to attach to and invade the cell layer. Human umbilical vein endothelial cells (HUVECs) werefirst grown to confluence on small gold electrodes. The impedance of these electrodes was followed after the addition of suspensions of different sublines of the Dunning murine prostatic adenocarcinoma series (G, AT1, AT2, AT3, ML, and MLL). For highly metastatic sublines, within an hour after being challenged, the impedance of the confluent HUVEC layer was substantially reduced. The effect of the weakly metastatic sublines was less pronounced, and the extent and the rate of this drop in impedance could be correlated with the metastatic potential of each of six sublines tested. The real-time assay is effective in both normal and low (1%) serum concentrations, and the detected activity requires the presence of viable transformed cells. In addition to the murine cell lines, similar behavior was observed using four established human prostatic cancer lines (DU145, PC3, TSU, and PPC1). These results suggest that this ECIS-based assay might be used with primary human cultures to establish the metastatic abilities of cells isolated from biopsies.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiao, Caide</author><author>Lachance, Bernard</author><author>Sunahara, Geoffrey</author><author>Luong, John H T</author></authors></contributors><titles><title>An in-depth analysis of electric cell-substrate impedance sensing to study the attachment and spreading of mammalian cells.</title><secondary-title>Analytical chemistry</secondary-title></titles><periodical><full-title>Analytical chemistry</full-title></periodical><pages>1333-1339</pages><volume>74</volume><issue>6</issue><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Cricetinae</keyword><keyword>Cricetulus</keyword><keyword>Electricity</keyword><keyword>Electrodes</keyword></keywords><dates><year>2002</year></dates><accession-num>11924593</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11924593</url></web-urls></urls><label>ECIS Attachment</label><abstract>The attachment and spreading of fibroblast cells on a gold surface coated with fibronectin or ovalbumin were studied by a modified electric cell-substrate impedance sensor. In this system, cells were cultured in a well, equipped with a detecting gold electrode (surface area of 0.057 mm2) and a gold counter electrode (18 mm2). Based on a comprehensive theoretical framework, the impedance of the electrode-electrolyte interface and a cell layer was precisely obtained for frequencies ranging from 1 to 10 kHz. Surface concentrations of the protein adsorbed on the gold surface were determined by a surface plasmon resonance biosensor. The resistance change of the electrode-electrolyte interface at 4 kHz increased linearly with the number of fibroblast cells attached on the detecting electrode. The slope of the linear relationship appeared to depend on the type of coating protein. As the surface area occupied by the cells was also proportional to the cell number, the resistance change was in turn proportional to the area covered by the cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lum, Hazel</author><author>Hao, Zengping</author><author>Gayle, Dave</author><author>Kumar, Priyadarsini</author><author>Patterson, Carolyn E</author><author>Uhler, Michael D</author></authors></contributors><titles><title>Vascular endothelial cells express isoforms of protein kinase A inhibitor.</title><secondary-title>American journal of physiology. Cell physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Cell physiology</full-title></periodical><pages>C59-66</pages><volume>282</volume><issue>1</issue><keywords><keyword>Adaptor Proteins</keyword><keyword>Animals</keyword><keyword>Brain</keyword><keyword>Brain: blood supply</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Carrier Proteins</keyword><keyword>Carrier Proteins: genetics</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: antagonists</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Dermis</keyword><keyword>Dermis: blood supply</keyword><keyword>Endothelium</keyword><keyword>Enzymologic</keyword><keyword>Enzymologic: physiology</keyword><keyword>Gene Expression</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression: physiology</keyword><keyword>Humans</keyword><keyword>Intracellular Signaling Peptides and Proteins</keyword><keyword>Isoenzymes</keyword><keyword>Isoenzymes: genetics</keyword><keyword>Messenger</keyword><keyword>Messenger: analysis</keyword><keyword>Muscle</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>RNA</keyword><keyword>Rabbits</keyword><keyword>Signal Transducing</keyword><keyword>Skeletal</keyword><keyword>Skeletal: enzymology</keyword><keyword>Vascular</keyword><keyword>Vascular Resistance</keyword><keyword>Vascular Resistance: physiology</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: enzymology</keyword></keywords><dates><year>2002</year></dates><accession-num>11742798</accession-num><electronic-resource-num>10.1152/ajpcell.00256.2001</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11742798</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>The expression and function of the endogenous inhibitor of cAMP-dependent protein kinase (PKI) in endothelial cells are unknown. In this study, overexpression of rabbit muscle PKI gene into endothelial cells inhibited the cAMP-mediated increase and exacerbated thrombin-induced decrease in endothelial barrier function. We investigated PKI expression in human pulmonary artery (HPAECs), foreskin microvessel (HMECs), and brain microvessel endothelial cells (HBMECs). RT-PCR using specific primers for human PKI alpha, human PKI gamma, and mouse PKI beta sequences detected PKI alpha and PKI gamma mRNA in all three cell types. Sequencing and BLAST analysis indicated that forward and reverse DNA strands for PKI alpha and PKI gamma were of &gt;96% identity with database sequences. RNase protection assays showed protection of the 542 nucleotides in HBMEC and HPAEC PKI alpha mRNA and 240 nucleotides in HBMEC, HPAEC, and HMEC PKI gamma mRNA. Western blot analysis indicated that PKI gamma protein was detected in all three cell types, whereas PKI alpha was found in HBMECs. In summary, endothelial cells from three different vascular beds express PKI alpha and PKI gamma, which may be physiologically important in endothelial barrier function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tiruppathi, Chinnaswamy</author><author>Freichel, Marc</author><author>Vogel, Stephen M</author><author>Paria, Biman C</author><author>Mehta, Dolly</author><author>Flockerzi, Veit</author><author>Malik, Asrar B</author></authors></contributors><titles><title>Impairment of store-operated Ca2+ entry in TRPC4(-/-) mice interferes with increase in lung microvascular permeability.</title><secondary-title>Circulation research</secondary-title></titles><periodical><full-title>Circulation research</full-title></periodical><pages>70-76</pages><volume>91</volume><issue>1</issue><keywords><keyword>Amino Acid Sequence</keyword><keyword>Animals</keyword><keyword>Calcium</keyword><keyword>Calcium Channels</keyword><keyword>Calcium Channels: genetics</keyword><keyword>Calcium Channels: physiology</keyword><keyword>Calcium: metabolism</keyword><keyword>Calcium: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cell Size</keyword><keyword>Cell Size: drug effects</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Genotype</keyword><keyword>Humans</keyword><keyword>Knockout</keyword><keyword>Lanthanum</keyword><keyword>Lanthanum: pharmacology</keyword><keyword>Lung</keyword><keyword>Lung: blood supply</keyword><keyword>Lung: cytology</keyword><keyword>Lung: drug effects</keyword><keyword>Mice</keyword><keyword>Oligopeptides</keyword><keyword>Oligopeptides: pharmacology</keyword><keyword>PAR-1</keyword><keyword>Pulmonary Circulation</keyword><keyword>Pulmonary Circulation: drug effects</keyword><keyword>Pulmonary Circulation: physiology</keyword><keyword>Receptor</keyword><keyword>Receptors</keyword><keyword>TRPC Cation Channels</keyword><keyword>Thrombin</keyword><keyword>Thrombin: agonists</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2002</year></dates><accession-num>12114324</accession-num><electronic-resource-num>10.1161/01.RES.0000023391.40106.A8</electronic-resource-num><urls><web-urls><url>http://circres.ahajournals.org/cgi/doi/10.1161/01.RES.0000023391.40106.A8</url><url>http://www.ncbi.nlm.nih.gov/pubmed/12114324</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>We investigated the possibility that the TRPC gene family of putative store-operated Ca2+ entry channels contributes to the increase in microvascular endothelial permeability by prolonging the rise in intracellular Ca2+ signaling. Studies were made in wild-type (wt) and TRPC4 knockout (TRPC4(-/-) mice and lung vascular endothelial cells (LECs) isolated from these animals. RT-PCR showed expression of TRPC1, TRPC3, TRPC4, and TRPC6 mRNA in wt LECs, but TRPC4 mRNA expression was not detected in TRPC4(-/-) LECs. We studied the response to thrombin because it is known to increase endothelial permeability by the activation of G protein-coupled proteinase-activated receptor-1 (PAR-1). In wt LECs, thrombin or PAR-1 agonist peptide (TFLLRNPNDK-NH2) resulted in a prolonged Ca2+ transient secondary to influx of Ca2+. Ca2+ influx activated by thrombin was blocked by La3+ (1 micromol/L). In TRPC4(-/-) LECs, thrombin or TFLLRNPNDK-NH2 produced a similar initial increase of intracellular Ca2+ secondary to Ca2+ store depletion, but Ca2+ influx induced by these agonists was drastically reduced. The defect in Ca2+ influx in TRPC4(-/-) endothelial cells was associated with lack of thrombin-induced actin-stress fiber formation and a reduced endothelial cell retraction response. In isolated-perfused mouse lungs, the PAR-1 agonist peptide increased microvessel filtration coefficient (K(f,c)), a measure of vascular permeability, by a factor of 2.8 in wt and 1.4 in TRPC4(-/-); La3+ (1 micromol/L) addition to wt lung perfusate reduced the agonist effect to that observed in TRPC4(-/-). These results show that TRPC4-dependent Ca2+ entry in mouse LECs is a key determinant of increased microvascular permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Rotundo, Robert F</author><author>Curtis, Theresa M</author><author>Shah, Melissa D</author><author>Gao, Baochong</author><author>Mastrangelo, Anthony</author><author>LaFlamme, Susan E</author><author>Saba, Thomas M</author></authors></contributors><titles><title>TNF-alpha disruption of lung endothelial integrity: reduced integrin mediated adhesion to fibronectin.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L316-29</pages><volume>282</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Antibodies</keyword><keyword>Antigens</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cattle</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Epitopes</keyword><keyword>Epitopes: analysis</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: metabolism</keyword><keyword>Fibronectin</keyword><keyword>Fibronectin: analysis</keyword><keyword>Fibronectin: immunology</keyword><keyword>Fibronectin: metabolism</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: metabolism</keyword><keyword>Flow Cytometry</keyword><keyword>Interference</keyword><keyword>Iodine Radioisotopes</keyword><keyword>Iodine Radioisotopes: diagnostic use</keyword><keyword>Manganese</keyword><keyword>Manganese: pharmacology</keyword><keyword>Microscopy</keyword><keyword>Monoclonal</keyword><keyword>Monoclonal: pharmacology</keyword><keyword>Oligopeptides</keyword><keyword>Oligopeptides: metabolism</keyword><keyword>Oligopeptides: pharmacology</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Receptors</keyword><keyword>Surface</keyword><keyword>Surface: analysis</keyword><keyword>Tumor Necrosis Factor-alpha</keyword><keyword>Tumor Necrosis Factor-alpha: metabolism</keyword><keyword>Tumor Necrosis Factor-alpha: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: chemistry</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2002</year></dates><accession-num>11792637</accession-num><electronic-resource-num>10.1152/ajplung.00145.2000</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11792637</url></web-urls></urls><label>ECIS Attachment</label><abstract>Tumor necrosis factor-alpha (TNF-alpha) causes an increase in transendothelial protein permeability of confluent monolayers of calf pulmonary artery endothelial (CPAE) cells, and the addition of plasma fibronectin (pFn) to the culture medium can attenuate this increase in permeability. We determined if reduced integrin function had a role in decreased endothelial cell adhesion to immobilized Fn after exposure of the endothelial monolayers to TNF-alpha. TNF-alpha also causes a reorganization of the subendothelial Fn rich matrix and a significant loss in RGD-dependent adhesion of TNF-alpha treated CPAE cells to pFn coated surfaces. However, flow cytometry revealed no decrease in alpha(5)beta(1) or total beta(1) integrin expression on the surface of the CPAE cells after TNF-alpha. Reduced CPAE adhesion to immobilized Fn was, in part, due to a loss of beta(1)-integrin function since the beta(1)-integrin blocking antibody mAb 13 significantly (P &lt; 0.05) prevented the adhesion of normal control CPAE cells but did not further reduce the adhesion of TNF-alpha-treated cells. In addition, antibodies which activate beta(1) integrins restored (P &lt; 0.05) adhesion of TNF-alpha-treated cells to immobilized pFn but did not alter the adhesion of control cells. Despite reduced ability to adhere to immobilized Fn, TNF-alpha-treated CPAE monolayers demonstrated increased binding and incorporation of fluid-phase pFn into the subendothelial extracellular matrix (ECM) as measured by the analysis of the deoxycholate (DOC) detergent insoluble pool of (125)I-Fn in the cell layer. In contrast to the RGD-mediated adhesion of CPAE cells to matrix Fn, the increased binding of soluble pFn after TNF-alpha was not inhibited by RGD peptides or mAb 13. Thus reduced integrin-dependent adhesion of the CPAE cells to matrix Fn as well as disruption of the Fn matrix may contribute to the increased protein permeability of previously confluent endothelial monolayer after TNF-alpha. In addition, increased ability for the monolayer to incorporate fluid-phase Fn into the ECM after TNF-alpha via a non-beta(1)- integrin dependent mechanism may be a compensatory response to stabilize the Fn matrix and the endothelial barrier.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Antony, Ajay B</author><author>Tepper, Robert S</author><author>Mohammed, Kamal a.</author></authors></contributors><titles><title>Cockroach extract antigen increases bronchial airway epithelial permeability</title><secondary-title>Journal of Allergy and Clinical Immunology</secondary-title></titles><periodical><full-title>Journal of Allergy and Clinical Immunology</full-title></periodical><pages>589-595</pages><volume>110</volume><issue>4</issue><keywords><keyword>antigen</keyword><keyword>bronchial airway epithelial cells</keyword><keyword>bronchial epithelial</keyword><keyword>cockroach extract</keyword><keyword>vascular endothelial growth factor</keyword></keywords><dates><year>2002</year></dates><electronic-resource-num>10.1067/mai.2002.127798</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0091674902001550</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lundien, Matthew C</author><author>Mohammed, Kamal a</author><author>Nasreen, Najmunnisa</author><author>Tepper, R S</author><author>Hardwick, Joyce a</author><author>Sanders, Kerry L</author><author>Van Horn, Robert D</author><author>Antony, Veena B</author></authors></contributors><titles><title>Induction of MCP-1 expression in airway epithelial cells: role of CCR2 receptor in airway epithelial injury.</title><secondary-title>Journal of clinical immunology</secondary-title></titles><periodical><full-title>Journal of clinical immunology</full-title></periodical><pages>144-152</pages><volume>22</volume><issue>3</issue><keywords><keyword>Bronchi</keyword><keyword>Bronchi: cytology</keyword><keyword>CCR2</keyword><keyword>Cell Division</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Chemokine</keyword><keyword>Chemokine CCL2</keyword><keyword>Chemokine CCL2: biosynthesis</keyword><keyword>Chemokine CCL2: physiology</keyword><keyword>Chemokine: drug effects</keyword><keyword>Chemokine: physiology</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Epithelial Cells: pathology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Humans</keyword><keyword>Interleukin-2</keyword><keyword>Interleukin-2: pharmacology</keyword><keyword>Lipopolysaccharides</keyword><keyword>Lipopolysaccharides: pharmacology</keyword><keyword>Receptors</keyword><keyword>Transformed</keyword></keywords><dates><year>2002</year></dates><accession-num>12078856</accession-num><notes>From Duplicate 1 ( 

Induction of MCP-1 expression in airway epithelial cells: role of CCR2 receptor in airway epithelial injury.

- Lundien, Matthew C; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, R S; Hardwick, Joyce a; Sanders, Kerry L; Van Horn, Robert D; Antony, Veena B )</notes><research-notes>From Duplicate 1 ( 

Induction of MCP-1 expression in airway epithelial cells: role of CCR2 receptor in airway epithelial injury.

- Lundien, Matthew C; Mohammed, Kamal a; Nasreen, Najmunnisa; Tepper, R S; Hardwick, Joyce a; Sanders, Kerry L; Van Horn, Robert D; Antony, Veena B )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12078856</url></web-urls></urls><label>ECIS Growth</label><abstract>The repair of an injured bronchial epithelial cell (BEC) monolayer requires proliferation and migration of BECs into the injured area. We hypothesized that BEC monolayer injury results in monocyte chemoattractant protein-1 (MCP-1) production, which initiates the repair process. BECs (BEAS-2B from ATCC) were utilized in this study. MCP-1 interacts with CCR2B receptor (CCR2B), resulting in cell proliferation, haptotaxis, and healing of the monolayer. Reverse transcriptase-polymerase chain reaction (RT-PCR) was employed to verify the presence of CCR2B. CCR2B was not merely present but also inducible by interleukin-2 (IL-2) and lipopolysaccharide (LPS). We demonstrated by immunohistochemistry that BECs express MCP-1 after injury and that receptor expression can be regulated by exposure to IL-2 and LPS. Haptotactic migration of cells was enhanced in the presence of MCP-1 and reduced in the presence of CCR2B antibody. This enhanced or depressed ability of the BECs to perform haptotactic migration was shown to be statistically significant (P &lt; 0.05) when compared to controls. Finally, BECs proliferate in response to MCP-1 as proven by electric cell-substrate impedance sensing (ECIS) technology. MCP-1-specific antibodies were shown to neutralize the MCP-1-mediated BEC proliferation. This cascade of events following injury to the bronchial epithelium may provide insight into the mechanism of the repair process.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Kataoka, Noriyuki</author><author>Iwaki, Kanso</author><author>Hashimoto, Ken</author><author>Mochizuki, Seiichi</author><author>Ogasawara, Yasuo</author><author>Sato, Masaaki</author><author>Tsujioka, Katsuhiko</author><author>Kajiya, Fumihiko</author></authors></contributors><titles><title>Measurements of endothelial cell-to-cell and cell-to-substrate gaps and micromechanical properties of endothelial cells during monocyte adhesion.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>15638-15643</pages><volume>99</volume><issue>24</issue><keywords><keyword>Actins</keyword><keyword>Actins: analysis</keyword><keyword>Arteriosclerosis</keyword><keyword>Arteriosclerosis: pathology</keyword><keyword>Atomic Force</keyword><keyword>Biomechanics</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Movement</keyword><keyword>Cells</keyword><keyword>Computer Systems</keyword><keyword>Computer-Assisted</keyword><keyword>Cultured</keyword><keyword>Elasticity</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Fluorescent Dyes</keyword><keyword>Fluorescent Dyes: analysis</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>Focal Adhesions</keyword><keyword>Green Fluorescent Proteins</keyword><keyword>Humans</keyword><keyword>Image Processing</keyword><keyword>Imaging</keyword><keyword>Interleukin-1</keyword><keyword>Interleukin-1: pharmacology</keyword><keyword>Luminescent Proteins</keyword><keyword>Luminescent Proteins: analysis</keyword><keyword>Microscopy</keyword><keyword>Monocytes</keyword><keyword>Monocytes: cytology</keyword><keyword>Nanotechnology</keyword><keyword>Protein-Tyrosine Kinases</keyword><keyword>Protein-Tyrosine Kinases: analysis</keyword><keyword>Three-Dimensional</keyword><keyword>Vascular</keyword><keyword>Vascular: chemistry</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword></keywords><dates><year>2002</year></dates><accession-num>12434019</accession-num><electronic-resource-num>10.1073/pnas.242590799</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=137769&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Modeling</label><abstract>The interaction between monocytes and endothelial cells is considered to play a major role in the early stage of atherosclerosis, and the involved endothelial cell micromechanics may provide us with important aspects of atherogenesis. In the present study, we evaluated (i) the endothelial cell-to-cell and cell-to-substrate gaps with the electric cell-substrate impedance sensing system, which can detect the nanometer order changes of cell-to-cell and cell-to-substrate distances separately, and (ii) the endothelial cell micromechanical properties with an atomic force microscope after application of monocytes to endothelial cells. Application of monocytic THP-1 cells to IL-1beta-stimulated human umbilical vein endothelial cells immediately decreased the electrical resistance of the endothelial cell-to-substrate (increase of the cell-to-substrate gap), whereas the endothelial cell-to-cell resistance (cell-to-cell gap) did not change. The elastic modulus of the endothelial cells decreased after 2-h monocyte application, indicating an increase of endothelial cell deformability. In conclusion, the interaction of the monocytes to the endothelial cells reduced the adhesiveness to the substrate and increased the deformability of endothelial cells. These changes in the adhesiveness and the deformability may facilitate migration of monocytes, a key process of atherogenesis in the later stage.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sawhney, Rajinder S</author><author>Zhou, Guo-Hao K</author><author>Humphrey, Lisa E</author><author>Ghosh, Paramita</author><author>Kreisberg, Jeffrey I</author><author>Brattain, Michael G</author></authors></contributors><titles><title>Differences in sensitivity of biological functions mediated by epidermal growth factor receptor activation with respect to endogenous and exogenous ligands.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>75-86</pages><volume>277</volume><issue>1</issue><keywords><keyword>Antigens</keyword><keyword>CD</keyword><keyword>CD: genetics</keyword><keyword>CD: physiology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Cultured</keyword><keyword>Epidermal Growth Factor</keyword><keyword>Epidermal Growth Factor: pharmacology</keyword><keyword>Epidermal Growth Factor: physiology</keyword><keyword>Extracellular Matrix Proteins</keyword><keyword>Extracellular Matrix Proteins: physiology</keyword><keyword>Humans</keyword><keyword>Integrin alpha2</keyword><keyword>Ligands</keyword><keyword>Messenger</keyword><keyword>Messenger: analysis</keyword><keyword>RNA</keyword><keyword>Receptor</keyword><keyword>Transfection</keyword><keyword>Transforming Growth Factor alpha</keyword><keyword>Transforming Growth Factor alpha: physiology</keyword><keyword>Tumor Cells</keyword><keyword>Tyrphostins</keyword><keyword>Tyrphostins: pharmacology</keyword></keywords><dates><year>2002</year></dates><accession-num>11684674</accession-num><electronic-resource-num>10.1074/jbc.M103268200</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11684674</url></web-urls></urls><label>ECIS Attachment;ECIS Micromotion</label><abstract>Despite constitutive expression of autocrine transforming growth factor-alpha (TGF-alpha) in growth factor-independent colon carcinoma cells, the epidermal growth factor receptor (EGFr) is not saturated and can be further activated by exogenous EGFr ligand. Given that the activation of EGFr by exogenous growth factor has no further effect on DNA synthesis, the question arises as to what function this additional EGFr activation might have. We report that EGF induces integrin alpha2 expression, integrin-mediated adhesion, and micromotility of HCT116 cells. The stimulatory effect of ligand on these biological functions is abrogated by treatment with AG1478- and EGFr-blocking monoclonal antibody. This provides evidence that the biological responses are EGFr-mediated and EGFr is located upstream of integrin alpha2 expression. Therefore, although exogenous EGF has no effect on DNA synthesis beyond that induced by autocrine TGF-alpha (at subsaturating levels of EGFr occupation) exogenous growth factor does induce integrin alpha2 expression, cell adhesion, and micromotion. An important finding revealed by this study is the documentation of biological responses of EGFr-mediated functions, including DNA synthesis, cell adhesion, and micromotion, which differ in sensitivity with respect to different degrees of EGFr activation at the basal state and in response to exogenous ligand.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Negash, Sewite</author><author>Wang, Hwai-Shi</author><author>Gao, Chun</author><author>Ledee, Dolena</author><author>Zelenka, Peggy</author></authors></contributors><titles><title>Cdk5 regulates cell-matrix and cell-cell adhesion in lens epithelial cells.</title><secondary-title>Journal of cell science</secondary-title></titles><periodical><full-title>Journal of cell science</full-title></periodical><pages>2109-2117</pages><volume>115</volume><issue>Pt 10</issue><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Differentiation</keyword><keyword>Cell-Matrix Junctions</keyword><keyword>Cell-Matrix Junctions: metabolism</keyword><keyword>Cells</keyword><keyword>Crystalline</keyword><keyword>Crystalline: cytology</keyword><keyword>Cultured</keyword><keyword>Cyclin-Dependent Kinase 5</keyword><keyword>Cyclin-Dependent Kinases</keyword><keyword>Cyclin-Dependent Kinases: genetics</keyword><keyword>Cyclin-Dependent Kinases: metabolism</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Lens</keyword><keyword>Messenger</keyword><keyword>Messenger: genetics</keyword><keyword>Messenger: metabolism</keyword><keyword>Mice</keyword><keyword>Nerve Tissue Proteins</keyword><keyword>Nerve Tissue Proteins: genetics</keyword><keyword>Nerve Tissue Proteins: metabolism</keyword><keyword>RNA</keyword><keyword>Rabbits</keyword><keyword>Transfection</keyword></keywords><dates><year>2002</year></dates><accession-num>11973352</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11973352</url></web-urls></urls><label>ECIS Attachment</label><abstract>Cdk5 is a member of the cyclin-dependent kinase family, which is expressed predominantly in terminally differentiated neurons. Lower levels of Cdk5 are also found in a wide variety of cell types, including the lens. Although Cdk5 has been shown to play an important role in neuronal migration and neurite outgrowth, its function in non-neuronal cells is not known. Therefore, this study was undertaken to explore the role of Cdk5 in the lens. Results showed that, within the adult mouse lens, Cdk5 was localized to the cytoplasm, especially along the lateral membranes of differentiating primary fiber cells, which suggests a role in cell-cell adhesion. Staining at the tips of elongating fiber cells was also particularly strong, suggesting a role in cell-matrix adhesion. To examine the possible role of Cdk5 in lens epithelial cell adhesion, we stably transfected N/N1003A rabbit lens epithelial cells with cDNAs for Cdk5 or a dominant-negative mutation, Cdk5-T33. Attachment to a fibronectin matrix, as measured with substrate-coated cell adhesion strips, was increased by Cdk5 overexpression, while an equivalent overexpression of Cdk5-T33 had no effect. Cdk5 also increased the rate of cell attachment and spreading as measured by electric cell-substrate impedance sensing (ECIS). In addition, Cdk5 overexpression decreased cell-cell adhesion as measured by a cell aggregation assay. These findings suggest that Cdk5 plays a role in regulating both cell-matrix and cell-cell interactions in the lens.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Xiao, Caide</author><author>Lachance, Bernard</author><author>Sunahara, Geoffrey</author><author>Luong, John H T</author></authors></contributors><titles><title>Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.</title><secondary-title>Analytical chemistry</secondary-title></titles><periodical><full-title>Analytical chemistry</full-title></periodical><pages>5748-5753</pages><volume>74</volume><issue>22</issue><keywords><keyword>Animals</keyword><keyword>Antitumor</keyword><keyword>Cell Line</keyword><keyword>Cell Survival</keyword><keyword>Cell Survival: drug effects</keyword><keyword>Cells</keyword><keyword>Cells: drug effects</keyword><keyword>Cells: ultrastructure</keyword><keyword>Cricetinae</keyword><keyword>Cytotoxins</keyword><keyword>Cytotoxins: toxicity</keyword><keyword>Drug Screening Assays</keyword><keyword>Electric Impedance</keyword><keyword>Electrodes</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: drug effects</keyword><keyword>Kinetics</keyword><keyword>Neutral Red</keyword></keywords><dates><year>2002</year></dates><accession-num>12463358</accession-num><notes>From Duplicate 1 (Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T)

From Duplicate 1 (Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T)

From Duplicate 2 ( 

Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.

- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )




From Duplicate 1 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )








From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )




From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )


















From Duplicate 3 (Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T)

From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )





From Duplicate 2 ( 

Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.

- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )




From Duplicate 1 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )








From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )




From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )



From Duplicate 2 (Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T)

From Duplicate 1 ( Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )</notes><research-notes>From Duplicate 1 (Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T)

From Duplicate 1 (Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T)

From Duplicate 2 ( 

Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.

- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )




From Duplicate 1 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )








From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )




From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )


















From Duplicate 3 (Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T)

From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )





From Duplicate 2 ( 

Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.

- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )




From Duplicate 1 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )








From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )




From Duplicate 2 ( 


Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach.


- Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )



From Duplicate 2 (Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T)

From Duplicate 1 ( Assessment of cytotoxicity using electric cell-substrate impedance sensing: concentration and time response function approach. - Xiao, Caide; Lachance, Bernard; Sunahara, Geoffrey; Luong, John H T )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/12463358</url></web-urls></urls><label>ECIS Cytotoxicity</label><abstract>This paper describes a simple and convenient method to measure the concentration and time response function f (C,t) of cells exposed to a toxicant by electric cell-substrate impedance sensing. Attachment and spreading of fibroblastic V79 cells cultured on small gold electrodes precoated with fibronectin were detected as electrical resistance changes. With this method, chemical cytotoxicity was easily screened by observing the response function of attached cells in the presence of inhibitor. The cytotoxicities of three test models, cadmium chloride, sodium arsenate, and benzalkonium chloride, were quantified by measuring the percentage inhibition as a function of the inhibitor concentration. The half-inhibition concentration, the required concentration to achieve 50% inhibition, derived from the response function agreed well with the results obtained using the standard neutral red assay.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sandoval, Raudel</author><author>Malik, Asrar B</author><author>Naqvi, Tabassum</author><author>Mehta, Dolly</author><author>Tiruppathi, Chinnaswamy</author></authors></contributors><titles><title>Requirement for Ca2+ signaling in the mechanism of thrombin-induced increase in endothelial permeability.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L239-47</pages><volume>280</volume><issue>2</issue><keywords><keyword>4</keyword><keyword>5-Trisphosphate</keyword><keyword>5-Trisphosphate: metabolism</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>Cadherins</keyword><keyword>Cadherins: biosynthesis</keyword><keyword>Calcium</keyword><keyword>Calcium Signaling</keyword><keyword>Calcium Signaling: drug effects</keyword><keyword>Calcium Signaling: physiology</keyword><keyword>Calcium: metabolism</keyword><keyword>Calcium: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: drug effects</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Inositol 1</keyword><keyword>Intracellular Fluid</keyword><keyword>Intracellular Fluid: metabolism</keyword><keyword>Lanthanum</keyword><keyword>Lanthanum: pharmacology</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Phosphatidylinositols</keyword><keyword>Phosphatidylinositols: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Radio-Iodinated</keyword><keyword>Radio-Iodinated: metabolism</keyword><keyword>Receptors</keyword><keyword>Serum Albumin</keyword><keyword>Thapsigargin</keyword><keyword>Thapsigargin: pharmacology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: metabolism</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2001</year></dates><accession-num>11159002</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11159002</url></web-urls></urls><label>Calcium Signaling;ECIS TEER;Signal Transduction</label><abstract>We compared the thrombin-activated responses in human umbilical vein endothelial cells (HUVECs) and a HUVEC-derived cell line, ECV304. Thrombin induced a 40-50% decrease in transendothelial monolayer electrical resistance and a twofold increase in 125I-albumin permeability in HUVECs, whereas it failed to alter the endothelial barrier function in ECV304 cells. Thrombin produced a brisk intracellular Ca2+ concentration transient and phosphorylation of 20-kDa myosin light chain in HUVECs but not in ECV304 cells. Thrombin-induced phosphoinositide hydrolysis was comparable in ECV304 cells and HUVECs, indicating the activation of thrombin receptors in both cell types. La3+ reduced both the thrombin-induced decrease in endothelial monolayer electrical resistance and the increase in 125I-albumin permeability in HUVECs. Because the absence of Ca2+ signaling could explain the impairment in the permeability response in ECV304 cells, we studied the effect of increasing intracellular Ca2+ concentration in ECV304 cells with thapsigargin. Exposure of ECV304 cells to thapsigargin caused decreased endothelial monolayer electrical resistance and increased 125I-albumin permeability. These results indicate that Ca2+ influx and activation of Ca2+-dependent signaling pathways are important determinants of the thrombin-induced increase in endothelial permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Becker, Patrice M</author><author>Verin, Alexander D</author><author>Booth, M A</author><author>Liu, Feng</author><author>Birukova, Anna</author><author>Garcia, J G</author></authors></contributors><titles><title>Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L1500-11</pages><volume>281</volume><issue>6</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Butadienes</keyword><keyword>Butadienes: pharmacology</keyword><keyword>Cattle</keyword><keyword>Cell Division</keyword><keyword>Cell Division: drug effects</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Chemotaxis</keyword><keyword>Chemotaxis: drug effects</keyword><keyword>Cultured</keyword><keyword>Cytoskeleton</keyword><keyword>Cytoskeleton: drug effects</keyword><keyword>Cytoskeleton: metabolism</keyword><keyword>Endothelial Growth Factors</keyword><keyword>Endothelial Growth Factors: pharmacology</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: physiology</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Growth Factor</keyword><keyword>Growth Factor: antagonists &amp; inhibitors</keyword><keyword>Growth Factor: metabolism</keyword><keyword>Imidazoles</keyword><keyword>Imidazoles: pharmacology</keyword><keyword>Lymphokines</keyword><keyword>Lymphokines: pharmacology</keyword><keyword>Mitogen-Activated Protein Kinase 1</keyword><keyword>Mitogen-Activated Protein Kinase 1: antagonists &amp;</keyword><keyword>Mitogen-Activated Protein Kinase 1: metabolism</keyword><keyword>Mitogen-Activated Protein Kinase 3</keyword><keyword>Mitogen-Activated Protein Kinases</keyword><keyword>Mitogen-Activated Protein Kinases: antagonists &amp; i</keyword><keyword>Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>Nitriles</keyword><keyword>Nitriles: pharmacology</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Pyridines</keyword><keyword>Pyridines: pharmacology</keyword><keyword>Pyrimidines</keyword><keyword>Pyrimidines: pharmacology</keyword><keyword>Receptor Protein-Tyrosine Kinases</keyword><keyword>Receptor Protein-Tyrosine Kinases: antagonists &amp; i</keyword><keyword>Receptor Protein-Tyrosine Kinases: metabolism</keyword><keyword>Receptors</keyword><keyword>Vascular</keyword><keyword>Vascular Endothelial Growth Factor</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factors</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: physiology</keyword><keyword>p38 Mitogen-Activated Protein Kinases</keyword><keyword>src-Family Kinases</keyword><keyword>src-Family Kinases: antagonists &amp; inhibitors</keyword><keyword>src-Family Kinases: metabolism</keyword></keywords><dates><year>2001</year></dates><accession-num>11704547</accession-num><notes>From Duplicate 1 (Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. - Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G)

From Duplicate 1 ( Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. - Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )


From Duplicate 2 (Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. - Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G)

From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )










From Duplicate 2 (Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. - Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G)

From Duplicate 1 ( 

Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.

- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 2 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )
















From Duplicate 2 ( 

Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.

- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 2 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )
















From Duplicate 2 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




















From Duplicate 2 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )
















From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )</notes><research-notes>From Duplicate 1 (Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. - Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G)

From Duplicate 1 ( Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. - Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )


From Duplicate 2 (Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. - Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G)

From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )










From Duplicate 2 (Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells. - Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G)

From Duplicate 1 ( 

Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.

- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 2 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )
















From Duplicate 2 ( 

Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.

- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 2 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )
















From Duplicate 2 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




















From Duplicate 2 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )




From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )
















From Duplicate 1 ( 


Differential regulation of diverse physiological responses to VEGF in pulmonary endothelial cells.


- Becker, Patrice M; Verin, Alexander D; Booth, M A; Liu, Feng; Birukova, Anna; Garcia, J G )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11704547</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>The mechanisms responsible for the divergent physiological responses of endothelial cells to vascular endothelial growth factor (VEGF) are incompletely understood. We hypothesized that VEGF elicits increased endothelial permeability and cell migration via differential activation of intracellular signal transduction pathways. To test this hypothesis, we established a model of VEGF-induced endothelial barrier dysfunction and chemotaxis with bovine pulmonary endothelial cells. We compared the effects of VEGF on transendothelial electrical resistance (TER), actin cytoskeletal remodeling, and chemotaxis of lung endothelial cells and then evaluated the role of the mitogen-activated protein kinases (MAPKs) p38 and extracellular signal-regulated kinase (ERK)1/2 in VEGF-mediated endothelial responses. The dose response of pulmonary arterial and lung microvascular endothelial cells to VEGF differed when barrier regulation and chemotaxis were evaluated. Inhibition of tyrosine kinase, phosphoinositol 3-kinase, or p38 MAPK significantly attenuated VEGF-mediated TER, F-actin remodeling, and chemotaxis. VEGF-mediated decreased TER was also significantly attenuated by inhibition of ERK1/2 MAPK but not by inhibition of fetal liver kinase-1 (flk-1) or Src kinase. In contrast, VEGF-mediated endothelial migration was not attenuated by ERK1/2 inhibition but was abolished by inhibition of either flk-1 or Src kinase. These data suggest potential mechanisms by which VEGF may differentially mediate physiological responses in vivo.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sandoval, R</author><author>Malik, a B</author><author>Minshall, R D</author><author>Kouklis, P</author><author>Ellis, C a</author><author>Tiruppathi, Chinnaswamy</author></authors></contributors><titles><title>Ca(2+) signalling and PKCalpha activate increased endothelial permeability by disassembly of VE-cadherin junctions.</title><secondary-title>The Journal of physiology</secondary-title></titles><periodical><full-title>The Journal of physiology</full-title></periodical><pages>433-445</pages><volume>533</volume><issue>Pt 2</issue><keywords><keyword>Albumins</keyword><keyword>Albumins: pharmacokinetics</keyword><keyword>Antigens</keyword><keyword>CD</keyword><keyword>Cadherins</keyword><keyword>Cadherins: metabolism</keyword><keyword>Calcium</keyword><keyword>Calcium Signaling</keyword><keyword>Calcium Signaling: drug effects</keyword><keyword>Calcium Signaling: physiology</keyword><keyword>Calcium: metabolism</keyword><keyword>Carcinogens</keyword><keyword>Carcinogens: pharmacology</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Desmoplakins</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Hemostatics</keyword><keyword>Hemostatics: pharmacology</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: enzymology</keyword><keyword>Iodine Radioisotopes</keyword><keyword>Iodine Radioisotopes: diagnostic use</keyword><keyword>Isoenzymes</keyword><keyword>Isoenzymes: metabolism</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Naphthalenes</keyword><keyword>Naphthalenes: pharmacology</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C-alpha</keyword><keyword>Protein Kinase C: metabolism</keyword><keyword>Stress Fibers</keyword><keyword>Stress Fibers: physiology</keyword><keyword>Tetradecanoylphorbol Acetate</keyword><keyword>Tetradecanoylphorbol Acetate: pharmacology</keyword><keyword>Thapsigargin</keyword><keyword>Thapsigargin: pharmacology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Umbilical Veins</keyword><keyword>Umbilical Veins: cytology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword></keywords><dates><year>2001</year></dates><accession-num>11389203</accession-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2278647&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>Calcium Signaling;ECIS TEER;Signal Transduction</label><abstract>1. The role of intracellular Ca(2+) mobilization in the mechanism of increased endothelial permeability was studied. Human umbilical vein endothelial cells (HUVECs) were exposed to thapsigargin or thrombin at concentrations that resulted in similar increases in intracellular Ca(2+) concentration ([Ca(2+)](i)). The rise in [Ca(2+)](i) in both cases was due to release of Ca(2+) from intracellular stores and influx of extracellular Ca(2+). 2. Both agents decreased endothelial cell monolayer electrical resistance (a measure of endothelial cell shape change) and increased transendothelial (125)I-albumin permeability. Thapsigargin induced activation of PKCalpha and discontinuities in VE-cadherin junctions without formation of actin stress fibres. Thrombin also induced PKCalpha activation and similar alterations in VE-cadherin junctions, but in association with actin stress fibre formation. 3. Thapsigargin failed to promote phosphorylation of the 20 kDa myosin light chain (MLC(20)), whereas thrombin induced MLC(20) phosphorylation consistent with formation of actin stress fibres. 4. Calphostin C pretreatment prevented the disruption of VE-cadherin junctions and the decrease in transendothelial electrical resistance caused by both agents. Thus, the increased [Ca(2+)](i) elicited by thapsigargin and thrombin may activate a calphostin C-sensitive PKC pathway that signals VE-cadherin junctional disassembly and increased endothelial permeability. 5. Results suggest a critical role for Ca(2+) signalling and activation of PKCalpha in mediating the disruption of VE-cadherin junctions, and thereby in the mechanism of increased endothelial permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Sharma, K V</author><author>Koenigsberger, C</author><author>Brimijoin, S</author><author>Bigbee, J W</author></authors></contributors><titles><title>Direct evidence for an adhesive function in the noncholinergic role of acetylcholinesterase in neurite outgrowth.</title><secondary-title>Journal of neuroscience research</secondary-title></titles><periodical><full-title>Journal of neuroscience research</full-title></periodical><pages>165-175</pages><volume>63</volume><issue>2</issue><keywords><keyword>Acetylcholine</keyword><keyword>Acetylcholine: metabolism</keyword><keyword>Acetylcholinesterase</keyword><keyword>Acetylcholinesterase: drug effects</keyword><keyword>Acetylcholinesterase: genetics</keyword><keyword>Acetylcholinesterase: metabolism</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Differentiation</keyword><keyword>Cell Differentiation: drug effects</keyword><keyword>Cell Differentiation: physiology</keyword><keyword>Central Nervous System</keyword><keyword>Central Nervous System: cytology</keyword><keyword>Central Nervous System: enzymology</keyword><keyword>Cholinesterase Inhibitors</keyword><keyword>Cholinesterase Inhibitors: pharmacology</keyword><keyword>Cultured</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: drug effects</keyword><keyword>Gene Expression Regulation: physiology</keyword><keyword>Humans</keyword><keyword>Neurites</keyword><keyword>Neurites: drug effects</keyword><keyword>Neurites: enzymology</keyword><keyword>Neurites: ultrastructure</keyword><keyword>Neuroblastoma</keyword><keyword>Tumor Cells</keyword></keywords><dates><year>2001</year></dates><accession-num>11169626</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11169626</url></web-urls></urls><label>ECIS Attachment</label><abstract>Acetylcholinesterase (AChE) can promote neurite outgrowth through a mechanism that is independent of its role in hydrolyzing the neurotransmitter acetylcholine. It has been proposed that this neuritogenic capacity of AChE may result from its intrinsic capacity to function in adhesion. In this study we directly tested this hypothesis using neuroblastoma cell lines that have been engineered for altered cell-surface expression of AChE. Using a microtiter-plate adhesion assay and the electrical cell-substrate impedance-sensing (ECIS) method, we demonstrate that the level of cell-substratum adhesion of these cells directly correlates with their level of AChE expression. Furthermore, this adhesion is blocked by either an anti-AChE antibody or a highly specific AChE inhibitor (BW284c51), both of which have also been shown to block neurite outgrowth. In addition, cells that overexpress AChE showed enhanced neurite initiation. By employing cell lines with different levels of AChE expression in two types of cell-substratum adhesion assays, our current studies provide evidence for an adhesive function for AChE. These results, together with the fact that AChE shares sequence homology and structural similarities with several known cell adhesion molecules, support the hypothesis that AChE promotes neurite outgrowth, at least in part, through an adhesive function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Garcia, Joe G N</author><author>Liu, Feng</author><author>Verin, Alexander D</author><author>Birukova, Anna</author><author>Dechert, Melissa A</author><author>Gerthoffer, William T</author><author>Bamberg, James R</author><author>English, Denis</author></authors></contributors><titles><title>Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement</title><secondary-title>Journal of Clinical Investigation</secondary-title></titles><periodical><full-title>Journal of Clinical Investigation</full-title></periodical><pages>689-701</pages><volume>108</volume><issue>5</issue><keywords/><dates><year>2001</year></dates><electronic-resource-num>10.1172/JCI12450</electronic-resource-num><notes>From Duplicate 1 ( 

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

- Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D; Birukova, Anna; Dechert, Melissa A; Gerthoffer, William T; Bamberg, James R.; English, Denis )




From Duplicate 2 ( 


Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement


- Garcia, J. G.N. )












From Duplicate 2 ( 

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

- Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D; Birukova, Anna; Dechert, Melissa A; Gerthoffer, William T; Bamberg, James R.; English, Denis )




From Duplicate 1 ( 

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

- Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D; Birukova, Anna; Dechert, Melissa A; Gerthoffer, William T; Bamberg, James R.; English, Denis )




From Duplicate 2 ( 


Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement


- Garcia, J. G.N. )


















From Duplicate 2 (Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement - Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D.; Birukova, Anna; Dechert, Melissa A.; Gerthoffer, William T.; Bamberg, James R.; English, Denis)

From Duplicate 1 ( 

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

- Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D; Birukova, Anna; Dechert, Melissa A; Gerthoffer, William T; Bamberg, James R.; English, Denis )




From Duplicate 2 ( 


Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement


- Garcia, J. G.N. )</notes><research-notes>From Duplicate 1 ( 

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

- Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D; Birukova, Anna; Dechert, Melissa A; Gerthoffer, William T; Bamberg, James R.; English, Denis )




From Duplicate 2 ( 


Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement


- Garcia, J. G.N. )












From Duplicate 2 ( 

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

- Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D; Birukova, Anna; Dechert, Melissa A; Gerthoffer, William T; Bamberg, James R.; English, Denis )




From Duplicate 1 ( 

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

- Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D; Birukova, Anna; Dechert, Melissa A; Gerthoffer, William T; Bamberg, James R.; English, Denis )




From Duplicate 2 ( 


Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement


- Garcia, J. G.N. )


















From Duplicate 2 (Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement - Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D.; Birukova, Anna; Dechert, Melissa A.; Gerthoffer, William T.; Bamberg, James R.; English, Denis)

From Duplicate 1 ( 

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement

- Garcia, Joe G.N.; Liu, Feng; Verin, Alexander D; Birukova, Anna; Dechert, Melissa A; Gerthoffer, William T; Bamberg, James R.; English, Denis )




From Duplicate 2 ( 


Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement


- Garcia, J. G.N. )</research-notes><urls><web-urls><url>http://www.jci.org/cgi/content/abstract/108/5/689</url><url>www.jci.org/cgi/doi/10.1172/JCI200112450</url><url>http://www.jci.org/articles/view/12450</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Gainor, Jonathan P</author><author>Morton, Christine A</author><author>Roberts, Jared T</author><author>Vincent, Peter A</author><author>Minnear, Fred L</author></authors></contributors><titles><title>Platelet-conditioned medium increases endothelial electrical resistance independently of cAMP/PKA and cGMP/PKG.</title><secondary-title>American journal of physiology. Heart and circulatory physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Heart and circulatory physiology</full-title></periodical><pages>H1992-2001</pages><volume>281</volume><issue>5</issue><keywords><keyword>Alkaloids</keyword><keyword>Alkaloids: pharmacology</keyword><keyword>Androstadienes</keyword><keyword>Androstadienes: pharmacology</keyword><keyword>Animals</keyword><keyword>Blood Platelets</keyword><keyword>Blood Platelets: metabolism</keyword><keyword>Carbazoles</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Chromones</keyword><keyword>Chromones: pharmacology</keyword><keyword>Conditioned</keyword><keyword>Conditioned: pharmacology</keyword><keyword>Culture Media</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: metabolism</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Cyclic GMP</keyword><keyword>Cyclic GMP-Dependent Protein Kinases</keyword><keyword>Cyclic GMP-Dependent Protein Kinases: metabolism</keyword><keyword>Cyclic GMP: metabolism</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>GTP-Binding Protein alpha Subunits</keyword><keyword>Gi-Go</keyword><keyword>Gi-Go: metabolism</keyword><keyword>Indoles</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: metabolism</keyword><keyword>MAP Kinase Signaling System</keyword><keyword>MAP Kinase Signaling System: drug effects</keyword><keyword>MAP Kinase Signaling System: physiology</keyword><keyword>Mitogen-Activated Protein Kinases</keyword><keyword>Mitogen-Activated Protein Kinases: metabolism</keyword><keyword>Morpholines</keyword><keyword>Morpholines: pharmacology</keyword><keyword>Phosphatidylinositol 3-Kinases</keyword><keyword>Phosphatidylinositol 3-Kinases: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: enzymology</keyword></keywords><dates><year>2001</year></dates><accession-num>11668060</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11668060</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Platelets release a soluble factor into blood and conditioned medium (PCM) that decreases vascular endothelial permeability. The objective of this study was to determine the signal-transduction pathway that elicits this decrease in permeability. Permeability-decreasing activity of PCM was assessed by the real-time measurement of electrical resistance across cell monolayers derived from bovine pulmonary arteries and microvessels. Using a desensitization protocol with cAMP/protein kinase A (PKA)-enhancing agents and pharmacological inhibitors, we determined that the activity of PCM is independent of PKA and PKG. Genistein, an inhibitor of tyrosine kinases, prevented the increase in endothelial electrical resistance. Because lysophosphatidic acid (LPA) has been proposed to be responsible for this activity of PCM and is known to activate the G(i) protein, inhibitors of the G protein pertussis toxin and of the associated phosphatidylinositol 3-kinase (PI3K) wortmannin were used. Pertussis toxin and wortmannin caused a 10- to 15-min delay in the characteristic rise in electrical resistance induced by PCM. Inhibition of phosphorylation of extracellular signal-regulated kinase with the mitogen-activated kinase kinase inhibitors PD-98059 and U-0126 did not prevent the activity of PCM. Similar findings with regard to the cAMP protocols and inhibition of G(i) and PI3K were obtained for 1-oleoyl-LPA. These results demonstrate that PCM increases endothelial electrical resistance in vitro via a novel, signal transduction pathway independent of cAMP/PKA and cGMP/PKG. Furthermore, PCM rapidly activates a signaling pathway involving tyrosine phosphorylation, the G(i) protein, and PI3K.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lo, Chun-Min</author><author>Linton, Michael</author><author>Keese, Charles R</author><author>Giaever, Ivar</author></authors></contributors><titles><title>Correlated Motion and Oscillation of Neighboring Cells in Vitro</title><secondary-title>Cell Communication and Adhesion</secondary-title></titles><periodical><full-title>Cell Communication and Adhesion</full-title></periodical><pages>139-145</pages><volume>8</volume><issue>3</issue><keywords/><dates><year>2001</year></dates><electronic-resource-num>10.3109/15419060109080713</electronic-resource-num><urls><web-urls><url>http://informahealthcare.com/doi/abs/10.3109/15419060109080713</url></web-urls></urls></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Minnear, Fred L</author><author>Patil, Sandeep</author><author>Bell, Donald</author><author>Gainor, Jonathan P</author><author>Morton, C A</author></authors></contributors><titles><title>Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L1337-44</pages><volume>281</volume><issue>6</issue><keywords><keyword>Albumins</keyword><keyword>Albumins: analysis</keyword><keyword>Albumins: metabolism</keyword><keyword>Animals</keyword><keyword>Blood Platelets</keyword><keyword>Blood Platelets: metabolism</keyword><keyword>Capillaries</keyword><keyword>Capillaries: chemistry</keyword><keyword>Capillaries: cytology</keyword><keyword>Capillaries: metabolism</keyword><keyword>Cattle</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Chromatography</keyword><keyword>Coloring Agents</keyword><keyword>Conditioned</keyword><keyword>Conditioned: chemistry</keyword><keyword>Conditioned: pharmacology</keyword><keyword>Culture Media</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Electrophoresis</keyword><keyword>Electrospray Ionization</keyword><keyword>Endothelium</keyword><keyword>Fatty Acids</keyword><keyword>Fatty Acids: analysis</keyword><keyword>Fatty Acids: metabolism</keyword><keyword>Gel</keyword><keyword>Humans</keyword><keyword>Lysophospholipids</keyword><keyword>Lysophospholipids: analysis</keyword><keyword>Lysophospholipids: pharmacokinetics</keyword><keyword>Mass</keyword><keyword>Methanol</keyword><keyword>Polyacrylamide Gel</keyword><keyword>Precipitin Tests</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: chemistry</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Pulmonary Artery: metabolism</keyword><keyword>Sepharose</keyword><keyword>Sepharose: analogs &amp; derivatives</keyword><keyword>Spectrometry</keyword><keyword>Vascular</keyword><keyword>Vascular: chemistry</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword></keywords><dates><year>2001</year></dates><accession-num>11704528</accession-num><notes>From Duplicate 2 ( 

Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA.

- Minnear, Fred L; Patil, Sandeep; Bell, Donald; Gainor, Jonathan P; Morton, C A )</notes><research-notes>From Duplicate 2 ( 

Platelet lipid(s) bound to albumin increases endothelial electrical resistance: mimicked by LPA.

- Minnear, Fred L; Patil, Sandeep; Bell, Donald; Gainor, Jonathan P; Morton, C A )</research-notes><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11704528</url></web-urls></urls><label>ECIS TEER</label><abstract>The objectives were to determine whether the permeability-decreasing activity of platelet-conditioned medium (PCM) is associated with a lipid bound to albumin and whether lysophosphatidic acid (LPA) is present in the PCM. A decrease in permeability was assessed by an increase in electrical resistance across endothelial cell monolayers derived from bovine pulmonary arteries and microvessels. The Sephacryl S-200 fraction of PCM that contained albumin, the albumin immunoprecipitate from the PCM, and the methanol extract from the albumin immunoprecipitate all increased endothelial electrical resistance. Increased electrical resistance induced by PCM was not abolished by boiling and was mimicked by 1-oleoyl-LPA and 1-palmitoyl-LPA. Analysis of a methanol-chloroform extract of one sample of PCM by electrospray mass spectrometry revealed many fatty acids, ceramide, diacylglycerol, phosphatidic acid, and palmitoyl-LPA, but analysis of a second sample of PCM and the methanol extract of its albumin immunoprecipitate revealed no LPA, only lipids. These findings indicate that a bioactive lipid(s), possibly LPA, released from platelets and subsequently bound to albumin forms an active complex that decreases endothelial permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Luong, J H</author><author>Habibi-Rezaei, M</author><author>Meghrous, J</author><author>Xiao, C</author><author>Male, K B</author><author>Kamen, A</author></authors></contributors><titles><title>Monitoring motility, spreading, and mortality of adherent insect cells using an impedance sensor.</title><secondary-title>Analytical chemistry</secondary-title></titles><periodical><full-title>Analytical chemistry</full-title></periodical><pages>1844-1848</pages><volume>73</volume><issue>8</issue><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Death</keyword><keyword>Cell Movement</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Spodoptera</keyword><keyword>Spodoptera: cytology</keyword></keywords><dates><year>2001</year></dates><accession-num>11338600</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11338600</url></web-urls></urls><label>ECIS Attachment;ECIS Cytotoxicity</label><abstract>An emerging sensor technology referred to as electric cell-substrate impedance sensing (ECIS) has been extended for monitoring the behavior of insect cells including attachment, motility, and mortality. In ECIS, adherent cells were cultured on an array of eight small gold electrodes deposited on the bottom of tissue culture wells and immersed in a culture medium. Upon the attachment and spreading of cells on the gold electrode, the impedance increased because the cells acted as insulating particles to restrict the current flow. Experimental data revealed that insect cells interacted differently with various proteins used to precoat the gold electrode with concanavalin A as the best promoter to accelerate the rate of cell attachment. After the cells were fully spread, the measured impedance continued to fluctuate to reflect the constant motion and metabolic activity of the cells. As the cell behavior was sensitive to external chemicals, the applicability of ECIS for inhibition assays was demonstrated with HgCl2, trinitrotoluene, trinitrobenzene (TNB), and 2-amino-4,6-dinitrotoluene as model systems. Unlike conventional assays, the quantitative data obtained in this study are taken in real time and in a continuous fashion to depict cell motility and mortality.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lum, H</author><author>Podolski, J L</author><author>Gurnack, M E</author><author>Schulz, I T</author><author>Huang, F</author><author>Holian, O</author></authors></contributors><titles><title>Protein phosphatase 2B inhibitor potentiates endothelial PKC activity and barrier dysfunction.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L546-55</pages><volume>281</volume><issue>3</issue><keywords><keyword>Animals</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Isoenzymes</keyword><keyword>Isoenzymes: antagonists &amp; inhibitors</keyword><keyword>Isoenzymes: metabolism</keyword><keyword>Isoenzymes: physiology</keyword><keyword>Phosphoprotein Phosphatases</keyword><keyword>Phosphoprotein Phosphatases: antagonists &amp; inhibit</keyword><keyword>Phosphoprotein Phosphatases: physiology</keyword><keyword>Phosphorylation</keyword><keyword>Phosphorylation: drug effects</keyword><keyword>Protein Kinase C</keyword><keyword>Protein Kinase C-alpha</keyword><keyword>Protein Kinase C: metabolism</keyword><keyword>Tacrolimus</keyword><keyword>Tacrolimus: pharmacology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: physiology</keyword><keyword>Vascular: physiopathology</keyword></keywords><dates><year>2001</year></dates><accession-num>11504680</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11504680</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Serine/threonine (Ser/Thr) protein phosphatases (PPs) are implicated in the recovery from endothelial barrier dysfunction caused by inflammatory mediators. We hypothesized that Ser/Thr PPs may regulate protein kinase C (PKC), a critical signaling molecule in barrier dysfunction, in the promotion of barrier recovery. Western analysis indicated that bovine pulmonary microvascular endothelial cells (BPMECs) expressed the three major Ser/Thr PPs, PP1, PP2A, and PP2B. Pretreatment with 100 ng/ml of FK506 (a PP2B inhibitor) but not with the PP1 and PP2A inhibitors calyculin A or okadaic acid potentiated the thrombin-induced increase in PKC phosphotransferase activity. FK506 also potentiated thrombin-induced PKC-alpha but not PKC-beta phosphorylation. FK506 but not calyculin A or okadaic acid inhibited recovery from the thrombin-induced decrease in transendothelial resistance. Neither FK506 nor okadaic acid altered the thrombin-induced resistance decrease, whereas calyculin A potentiated the decrease. Downregulation of PKC with phorbol 12-myristate 13-acetate rescued the FK506-mediated inhibition of recovery, which was consistent with the finding that the thrombin-induced phosphorylation of PKC-alpha was reduced during the recovery phase. These results indicated that PP2B may play a physiologically important role in returning endothelial barrier dysfunction to normal through the regulation of PKC.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>DePaola, Natacha</author><author>Phelps, Jeffrey E</author><author>Florez, Lucio</author><author>Keese, Charles R</author><author>Minnear, Fred L</author><author>Giaever, Ivar</author><author>Vincent, Peter</author></authors></contributors><titles><title>Electrical Impedance of Cultured Endothelium Under Fluid Flow</title><secondary-title>Annals of Biomedical Engineering</secondary-title></titles><periodical><full-title>Annals of Biomedical Engineering</full-title></periodical><pages>648-656</pages><volume>29</volume><issue>8</issue><keywords><keyword>electrical impedance</keyword><keyword>endothelial cells</keyword><keyword>shear</keyword></keywords><dates><year>2001</year></dates><electronic-resource-num>10.1114/1.1385811</electronic-resource-num><urls><web-urls><url>http://www.springerlink.com/openurl.asp?id=doi:10.1114/1.1385811</url></web-urls></urls><label>ECIS Flow</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Hadjout, Nacima</author><author>Laevsky, G</author><author>Knecht, David A</author><author>Lynes, Michael A</author></authors></contributors><titles><title>Automated real-time measurement of chemotactic cell motility.</title><secondary-title>BioTechniques</secondary-title></titles><periodical><full-title>BioTechniques</full-title></periodical><pages>1130-1138</pages><volume>31</volume><issue>5</issue><keywords><keyword>Animals</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Chemotaxis</keyword><keyword>Cisplatin</keyword><keyword>Cisplatin: pharmacology</keyword><keyword>Dictyostelium</keyword><keyword>Dictyostelium: physiology</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Folic Acid</keyword><keyword>Folic Acid: pharmacology</keyword></keywords><dates><year>2001</year></dates><accession-num>11730019</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11730019</url></web-urls></urls><label>ECIS Migration</label><abstract>We have developed a novel method, (ECIS/taxis), for monitoring cell movement in response to chemotactic and chemokinetic factors. In this system, cells migrate in an under-agarose environment, and their positions are monitored using the electric cell-substrate impedance sensor technology to measure the impedance change at a target electrode, that is lithographed onto the substrate, as the cells arrive at the target. In the studies reported here, Dictyostelium discoideum was used as a prototypical, motile eukaryotic cell. Using the ECIS/taxis system, the arrival of cells at the target electrode was proportional to the dose offolate used to stimulate the cells and could be assessed by changes in resistance at the electrode. ECIS/taxis was readily able to distinguish between wild-type cells and a mutant that is deficient in its chemotactic response. Finally, we have shown that an agent that interferes with chemotactic motility leads to the delayed arrival of cells at the target electrode. The multi-well assay configuration allows for simultaneous automated screening of many samples for chemotactic or anti-chemotactic activity. This assay system is compatible with measurements of mammalian cell movement and should be valuable in the assessment of both agonists and antagonists of cell movement.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wegener, Joachim</author><author>Keese, C R</author><author>Giaever, I</author></authors></contributors><titles><title>Electric cell-substrate impedance sensing (ECIS) as a noninvasive means to monitor the kinetics of cell spreading to artificial surfaces.</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>158-166</pages><volume>259</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Computer Systems</keyword><keyword>Electric Conductivity</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: chemistry</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Extracellular Matrix Proteins</keyword><keyword>Extracellular Matrix Proteins: pharmacology</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: cytology</keyword><keyword>Fibroblasts: physiology</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: pharmacology</keyword><keyword>Integrins</keyword><keyword>Integrins: physiology</keyword><keyword>Kidney</keyword><keyword>Kidney: cytology</keyword><keyword>Kinetics</keyword><keyword>Oligopeptides</keyword><keyword>Oligopeptides: pharmacology</keyword><keyword>Platelet Aggregation Inhibitors</keyword><keyword>Platelet Aggregation Inhibitors: pharmacology</keyword></keywords><dates><year>2000</year></dates><accession-num>10942588</accession-num><electronic-resource-num>10.1006/excr.2000.4919</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10942588</url></web-urls></urls><label>ECIS Attachment</label><abstract>This article describes the optimization of an experimental technique referred to as electric cell-substrate impedance sensing (ECIS) to monitor attachment and spreading of mammalian cells quantitatively and in real time. The method is based on measuring changes in AC impedance of small gold-film electrodes deposited on a culture dish and used as growth substrate. Based on experimental data and theoretical considerations we demonstrate that high-frequency capacitance measurements (f = 40 kHz) are most suited to follow the increasing surface coverage of the electrode due to cell spreading. The excellent time resolution of the method allowed an in-depth analysis of cell spreading kinetics under various experimental conditions. Using ECIS we studied the attachment and spreading of epithelial MDCK cells (strain II) on different protein coatings, and investigated the influence of divalent cations on spreading kinetics. We quantified the inhibitory effect of soluble peptides that mimic the recognition sequence of fibronectin and other extracellular matrix proteins (RGDS). We also applied the ECIS technique to monitor the detachment of confluent fibroblastic cell layers (WI38/VA-13) by means of these peptides.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tiruppathi, Chinnaswamy</author><author>Yan, Weihong</author><author>Sandoval, Raudel</author><author>Naqvi, Tabassum</author><author>Pronin, Alexey N A N</author><author>Benovic, J L Jeffery L J L</author><author>Malik, Asrar B A B</author></authors></contributors><titles><title>G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells</title><secondary-title>Proceedings of the National Academy of Sciences</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences</full-title></periodical><pages>7440</pages><volume>97</volume><issue>13</issue><keywords><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: metabolism</keyword><keyword>Endothelium</keyword><keyword>G-Protein-Coupled Receptor Kinase 2</keyword><keyword>G-Protein-Coupled Receptor Kinase 5</keyword><keyword>G-Protein-Coupled Receptor Kinases</keyword><keyword>Humans</keyword><keyword>Protein-Serine-Threonine Kinases</keyword><keyword>Protein-Serine-Threonine Kinases: metabolism</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Thrombin</keyword><keyword>Thrombin: metabolism</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: metabolism</keyword><keyword>beta-Adrenergic Receptor Kinases</keyword></keywords><dates><year>2000</year></dates><publisher>National Acad Sciences</publisher><accession-num>10861009</accession-num><electronic-resource-num>10.1073/pnas.97.13.7440</electronic-resource-num><notes>From Duplicate 1 (G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells - Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B.)

From Duplicate 1 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B. )




From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, C.; Yan, W.; Sandoval, R.; Naqvi, T.; Pronin, A.N.; Benovic, J.L.; Malik, A.B. )












From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N; Benovic, Jeffery L; Malik, Asrar B )










From Duplicate 2 (G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells - Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B.)

From Duplicate 1 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B. )




From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, C.; Yan, W.; Sandoval, R.; Naqvi, T.; Pronin, A.N.; Benovic, J.L.; Malik, A.B. )












From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N; Benovic, Jeffery L; Malik, Asrar B )












From Duplicate 2 ( 

G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells

- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B. )




From Duplicate 1 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B. )




From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, C.; Yan, W.; Sandoval, R.; Naqvi, T.; Pronin, A.N.; Benovic, J.L.; Malik, A.B. )












From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N; Benovic, Jeffery L; Malik, Asrar B )</notes><research-notes>From Duplicate 1 (G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells - Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B.)

From Duplicate 1 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B. )




From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, C.; Yan, W.; Sandoval, R.; Naqvi, T.; Pronin, A.N.; Benovic, J.L.; Malik, A.B. )












From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N; Benovic, Jeffery L; Malik, Asrar B )










From Duplicate 2 (G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells - Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B.)

From Duplicate 1 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B. )




From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, C.; Yan, W.; Sandoval, R.; Naqvi, T.; Pronin, A.N.; Benovic, J.L.; Malik, A.B. )












From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N; Benovic, Jeffery L; Malik, Asrar B )












From Duplicate 2 ( 

G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells

- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B. )




From Duplicate 1 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N A.N.; Benovic, Jeffery L J.L.; Malik, Asrar B A.B. )




From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells


- Tiruppathi, C.; Yan, W.; Sandoval, R.; Naqvi, T.; Pronin, A.N.; Benovic, J.L.; Malik, A.B. )












From Duplicate 2 ( 


G protein-coupled receptor kinase-5 regulates thrombin-activated signaling in endothelial cells.


- Tiruppathi, Chinnaswamy; Yan, Weihong; Sandoval, Raudel; Naqvi, Tabassum; Pronin, Alexey N; Benovic, Jeffery L; Malik, Asrar B )</research-notes><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=16564&amp;tool=pmcentrez&amp;rendertype=abstract</url><url>http://www.pnas.org/cgi/doi/10.1073/pnas.97.13.7440</url><url>http://www.pnas.org/content/97/13/7440.short</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>We studied the function of G protein-coupled receptor kinases (GRKs) in the regulation of thrombin-activated signaling in endothelial cells. GRK2, GRK5, and GRK6 isoforms were expressed predominantly in endothelial cells. The function of these isoforms was studied by expressing wild-type and dominant negative (dn) mutants in endothelial cells. We determined the responses to thrombin, which activates intracellular signaling in endothelial cells by cleaving the NH(2) terminus of the G protein-coupled proteinase-activated receptor-1 (PAR-1). We measured changes in phosphoinositide hydrolysis and intracellular Ca(2+) concentration ([Ca(2+)](i)) in response to thrombin as well as the state of endothelial activation. In the latter studies, the transendothelial monolayer electrical resistance, a measure of the loss of endothelial barrier function, was measured in real time. Of the three isoforms, GRK5 overexpression was selective in markedly reducing the thrombin-activated phosphoinositide hydrolysis and increased [Ca(2+)](i). GRK5 overexpression also inhibited the thrombin-induced decrease in endothelial monolayer resistance by 75%. These effects of GRK5 overexpression occurred in association with the specific increase in the thrombin-induced phosphorylation of PAR-1. In contrast to the effects of GRK5 overexpression, the expression of the dn-GRK5 mutant produced a long-lived increase in [Ca(2+)](i) in response to thrombin, whereas dn-GRK2 had no effect. These results indicate the crucial role of the GRK5 isoform in the mechanism of thrombin-induced desensitization of PAR-1 in endothelial cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wegener, Joachim</author><author>Hakvoort, Ansgar</author><author>Galla, Hans Joachim</author></authors></contributors><titles><title>Barrier function of porcine choroid plexus epithelial cells is modulated by cAMP-dependent pathways in vitro.</title><secondary-title>Brain research</secondary-title></titles><periodical><full-title>Brain research</full-title></periodical><pages>115-124</pages><volume>853</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Blood-Brain Barrier</keyword><keyword>Blood-Brain Barrier: drug effects</keyword><keyword>Blood-Brain Barrier: physiology</keyword><keyword>Blood-cerebrospinal-fluid barrier</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cells</keyword><keyword>Choroid Plexus</keyword><keyword>Choroid Plexus: cytology</keyword><keyword>Choroid Plexus: drug effects</keyword><keyword>Choroid Plexus: metabolism</keyword><keyword>Choroid plexus epithelium</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP: analogs &amp; derivatives</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Cyclic AMP: pharmacology</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Electrodes</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Epithelial Cells: metabolism</keyword><keyword>Forskolin</keyword><keyword>Forskolin: pharmacology</keyword><keyword>Gold</keyword><keyword>Impedance analysis</keyword><keyword>Models</keyword><keyword>Permeability</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Swine</keyword><keyword>Thionucleotides</keyword><keyword>Thionucleotides: pharmacology</keyword><keyword>Transepithelial electrical resistance</keyword><keyword>cAMP</keyword></keywords><dates><year>2000</year></dates><isbn>0006-8993 (Print)\r0006-8993 (Linking)</isbn><accession-num>10627315</accession-num><electronic-resource-num>10.1016/S0006-8993(99)02317-3</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10627315</url></web-urls></urls><label>Blood Brain Barrier;ECIS Modeling;ECIS TEER;ECIS Theory;Signal Transduction</label><abstract>In the present paper, we demonstrate that the barrier properties of primary cultured epithelial cells isolated from porcine choroid plexus are regulated by cAMP-dependent signal transduction pathways in vitro. Triggering cAMP-connected cascades in cell layers grown on permeable filters with cAMP-analogues or forskolin led to a significant increase of transepithelial electrical resistances and a pronounced reduction in the permeation rate of a 4 kDa-dextran probe. In dose-response experiments using the cAMP-analogue 8-(4-chlorophenylthio)-cAMP transepithelial electrical resistances were observed to increase above a threshold concentration ranging between 10(-5.5) and 10(-5) M. Additional impedance studies performed with confluent cell layers grown on gold-film electrodes revealed that the observed changes in transepithelial resistances and presumably also in macromolecular permeation rates were not entirely caused by a reinforcement of intercellular junctions but also contained contributions from changes in the cell-substrate adhesion pattern. These inherent contributions to the electrical resistance and macromolecular permeability are caused by a restricted diffusion pathway between basal plasma membrane and culture substrate that have to be considered in data analysis, especially when leaky cell layers on filter substrates with low pore densities are used.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Phelps, Jeffrey E</author><author>DePaola, N</author></authors></contributors><titles><title>Spatial variations in endothelial barrier function in disturbed flows in vitro.</title><secondary-title>American journal of physiology. Heart and circulatory physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Heart and circulatory physiology</full-title></periodical><pages>H469-76</pages><volume>278</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Aorta</keyword><keyword>Aorta: cytology</keyword><keyword>Aorta: physiology</keyword><keyword>Biological Transport</keyword><keyword>Biological Transport: physiology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cardiovascular</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Dextrans</keyword><keyword>Dextrans: pharmacokinetics</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Macromolecular Substances</keyword><keyword>Mechanical</keyword><keyword>Models</keyword><keyword>Regional Blood Flow</keyword><keyword>Regional Blood Flow: physiology</keyword><keyword>Stress</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2000</year></dates><accession-num>10666077</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10666077</url><url>http://ajpheart.physiology.org/content/278/2/H469.short</url></web-urls></urls><label>ECIS Flow;ECIS TEER</label><abstract>Hindered barrier function has been implicated in the initiation and progression of atherosclerosis, a disease of focal nature associated with altered hemodynamics. In this study, endothelial permeability to macromolecules and endothelial electrical resistance were investigated in vitro in monolayers exposed to disturbed flow fields that model spatial variations in fluid shear stress found at arterial bifurcations. After 5 h of flow, areas of high shear stress gradients showed a 5.5-fold increase in transendothelial transport of dextran (molecular weight 70,000) compared with no-flow controls. Areas of undisturbed fully developed flow, within the same monolayer, showed a 2.9-fold increase. Monolayer electrical resistance decreased with exposure to flow. The resistance measured during flow and the rate of change in monolayer resistance after removal of flow were lowest in the vicinity of flow reattachment (highest shear stress gradients). These results demonstrate that endothelial barrier function and permeability to macromolecules are regulated by spatial variations in shear stress forces in vitro.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ellen, R P</author><author>Ko, K S</author><author>Lo, Chun-Min M</author><author>Grove, D a</author><author>Ishihara, K</author></authors></contributors><titles><title>Insertional inactivation of the prtP gene of Treponema denticola confirms dentilisin's disruption of epithelial junctions.</title><secondary-title>Journal of molecular microbiology and biotechnology</secondary-title></titles><periodical><full-title>Journal of molecular microbiology and biotechnology</full-title></periodical><pages>581-586</pages><volume>2</volume><issue>4</issue><keywords><keyword>Bacterial Adhesion</keyword><keyword>Bacterial Adhesion: genetics</keyword><keyword>Cell Division</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: genetics</keyword><keyword>Cell Membrane: ultrastructure</keyword><keyword>Chymotrypsin</keyword><keyword>Chymotrypsin: genetics</keyword><keyword>Chymotrypsin: metabolism</keyword><keyword>Cultured</keyword><keyword>Drug Resistance</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: microbiology</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: microbiology</keyword><keyword>Fibroblasts: physiology</keyword><keyword>Fibroblasts: ultrastructure</keyword><keyword>Gingiva</keyword><keyword>Gingiva: microbiology</keyword><keyword>Gingiva: physiology</keyword><keyword>Gingiva: ultrastructure</keyword><keyword>Humans</keyword><keyword>Insertional</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: microbiology</keyword><keyword>Intercellular Junctions: physiology</keyword><keyword>Kinetics</keyword><keyword>Microbial</keyword><keyword>Microbial: genetics</keyword><keyword>Mutagenesis</keyword><keyword>Periodontal Diseases</keyword><keyword>Periodontal Diseases: microbiology</keyword><keyword>Treponema</keyword><keyword>Treponema: cytology</keyword><keyword>Treponema: genetics</keyword><keyword>Treponema: physiology</keyword><keyword>Tumor Cells</keyword></keywords><dates><year>2000</year></dates><accession-num>11075935</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11075935</url></web-urls></urls><label>ECIS Attachment;ECIS TEER</label><abstract>The purified chymotrypsin-like protease of Treponema denticola, designated dentilisin or PrtP (DDBJ accession no. D83264), can disrupt cell-cell junctions and impair the barrier function of epithelial monolayers in vitro. Serine protease inhibitors block these effects. Yet, the protease is apparently less significant in perturbing intracellular signaling pathways and cytoskeletal rearrangement in fibroblasts. The purpose of this study was to use a PrtP-deficient mutant of T. denticola to confirm that the cytopathic effects of whole bacteria and its outer membrane on epithelial cell junctions were primarily accounted for by the activity of this protease. The prtP gene of ATCC 35405 was inactivated by insertion of an erythromycin-resistance cassette, yielding mutant K1. In contrast to wildtype ATCC 35405, mutant K1 grew in tight cell aggregates; the cells had a disrupted outer sheath, as determined by electron microscopy. When compared by silver stained SDS-PAGE of sonicated extracts of whole cells, the extract of mutant K1 was missing a band at approximately 90 kDa that was present in the wildtype ATCC 35405 strain. Whole cells and Triton X-100 outer membrane (OM) extracts of K1 and the wildtype strains were compared 1) for SAAPNA degrading activity by a colorimetric assay, 2) for stress fiber disruption in human gingival fibroblasts (HGF) by fluorescence microscopy of TRITC-phalloidin stained cells, and 3) the OM extracts only for perturbation of HEp-2 epithelial monolayers by electrical cell-substrate impedance sensing (ECIS). Mutant K-1 cells and OM had no SAPPNA degrading activity that is characteristic of dentilisin. K1 cells had HGF stress fiber disrupting activity (86 +/- 4.5% of HGFs affected) equivalent to both 35405 wildtype strains (84 +/- 3.9% and 71 +/- 14.1% of HGF, respectively). Yet, mutant K1 OM had diminished stress fiber disrupting activity (12.9 +/- 4.6% of HGF) compared with its parent 35405's OM (94.6 +/- 2.9%). The major cytopathogenic difference between the K1 mutant and wildtype strains was in their OM's effect on epithelial cell junctions. ATCC 35405 OM completely disrupted epithelial resistance in a concentration - dependent manner; mutant K1 OM had negligible effects. These data confirm that inactivation of the prtP gene completely reverses T. denticola's disruption of epithelial junctions, but there are pleiotropic effects of the mutation that may account for its apparently diminished effects on the cytoskeleton of HGF when the cells were challenged with OM extracts.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Moy, A B B</author><author>Winter, Michael</author><author>Kamath, Anant</author><author>Blackwell, K</author><author>Reyes, Gina</author><author>Giaever, Ivar</author><author>Keese, Charles</author><author>Shasby, D Michael</author></authors></contributors><titles><title>Histamine alters endothelial barrier function at cell-cell and cell-matrix sites.</title><secondary-title>American journal of physiology. Lung cellular and molecular physiology</secondary-title></titles><periodical><full-title>American journal of physiology. Lung cellular and molecular physiology</full-title></periodical><pages>L888-98</pages><volume>278</volume><issue>5</issue><keywords><keyword>Biological</keyword><keyword>Cadherins</keyword><keyword>Cadherins: analysis</keyword><keyword>Cadherins: genetics</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Communication</keyword><keyword>Cell Communication: drug effects</keyword><keyword>Cell Communication: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Electron</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: chemistry</keyword><keyword>Epithelial Cells: drug effects</keyword><keyword>Epithelial Cells: ultrastructure</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: drug effects</keyword><keyword>Extracellular Matrix: physiology</keyword><keyword>Gene Expression Regulation</keyword><keyword>Gene Expression Regulation: physiology</keyword><keyword>Genetic</keyword><keyword>Genetic: physiology</keyword><keyword>Histamine</keyword><keyword>Histamine: pharmacology</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: chemistry</keyword><keyword>Intercellular Junctions: drug effects</keyword><keyword>Intercellular Junctions: ultrastructure</keyword><keyword>Microelectrodes</keyword><keyword>Microscopy</keyword><keyword>Models</keyword><keyword>Promoter Regions</keyword><keyword>Transfection</keyword><keyword>Umbilical Veins</keyword><keyword>Umbilical Veins: cytology</keyword></keywords><dates><year>2000</year></dates><accession-num>10781418</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10781418</url><url>http://ajplung.physiology.org/content/278/5/L888.short</url></web-urls></urls><label>ECIS Modeling;ECIS TEER</label><abstract>To determine how histamine regulates endothelial barrier function through an integrative cytoskeletal network, we mathematically modeled the resistance across an endothelial cell-covered electrode as a function of cell-cell, cell-matrix, and transcellular resistances. Based on this approach, histamine initiated a rapid decrease in transendothelial resistance predominantly through decreases in cell-cell resistance in confluent cultured human umbilical vein endothelial cells (HUVECs). Restoration of resistance was characterized by initially increasing cell-matrix resistance, with later increases in cell-cell resistance. Thus histamine disrupts barrier function by specifically disrupting cell-cell adhesion and restores barrier function in part through direct effects on cell-matrix adhesion. To validate the precision of our technique, histamine increased the resistance in subconfluent HUVECs in which there was no cell-cell contact. Exposure of confluent monolayers to an antibody against cadherin-5 caused a predominant decrease in cell-cell resistance, whereas the resistance was unaffected by the antibody to cadherin-5 in subconfluent cells. Furthermore, we observed an increase predominantly in cell-cell resistance in ECV304 cells that were transfected with a plasmid containing a glucocorticoid-inducible promoter controlling expression of E-cadherin. Transmission electron microscopy confirmed tens of nanometer displacements between adjacent cells at a time point in which histamine maximally decreased cell-cell resistance.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tsukahara, H</author><author>Noiri, E</author><author>Jiang, M Z</author><author>Hiraoka, M</author><author>Mayumi, M</author></authors></contributors><titles><title>Role of nitric oxide in human pulmonary microvascular endothelial cell adhesion.</title><secondary-title>Life sciences</secondary-title></titles><periodical><full-title>Life sciences</full-title></periodical><pages>1-11</pages><volume>67</volume><issue>1</issue><keywords><keyword>Antisense</keyword><keyword>Antisense: pharmacology</keyword><keyword>Capillary Permeability</keyword><keyword>Capillary Permeability: physiology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: drug effects</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cells</keyword><keyword>Chelating Agents</keyword><keyword>Chelating Agents: pharmacology</keyword><keyword>Cultured</keyword><keyword>Cyclic GMP</keyword><keyword>Cyclic GMP: analogs &amp; derivatives</keyword><keyword>Cyclic GMP: pharmacology</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Fibronectins</keyword><keyword>Fibronectins: metabolism</keyword><keyword>Humans</keyword><keyword>Immunohistochemistry</keyword><keyword>Lung</keyword><keyword>Lung: blood supply</keyword><keyword>Nitric Oxide</keyword><keyword>Nitric Oxide Donors</keyword><keyword>Nitric Oxide Donors: pharmacology</keyword><keyword>Nitric Oxide Synthase</keyword><keyword>Nitric Oxide Synthase Type III</keyword><keyword>Nitric Oxide Synthase: metabolism</keyword><keyword>Nitric Oxide: physiology</keyword><keyword>Oligonucleotides</keyword><keyword>Pulmonary Circulation</keyword><keyword>Pulmonary Circulation: physiology</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2000</year></dates><accession-num>10896023</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10896023</url></web-urls></urls><label>ECIS Attachment;ECIS TEER</label><abstract>We examined the effect of nitric oxide (NO) on cell adhesion using cultured human pulmonary microvascular endothelial cells (PMVEC). Attachment of these cells to fibronectin was significantly inhibited by NO donors, spermine NONOate and S-nitroso-N-acetyl-penicillamine or L-arginine, but not 8-bromoguanosine-3',5'-cyclic-monophosphate. Similar results were obtained with the electrical cell-substrate impedance sensor (ECIS) technique. Addition of NO donors or L-arginine, but not 8-bromoguanosine-3',5'-cyclic-monophosphate or N2,2'-O-dibutyrylguanosine-3',5'-cyclic-monophosphate, to confluent PMVEC monolayers resulted in a transient decrease in cell adhesion, which was quantitated by the ECIS. Exposure to 1 U/ml alpha-thrombin reduced the monolayer electrical resistance by approximately 50%. The observed response was significantly suppressed by pretreatment of cells with intracellular calcium chelator, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid or NO synthase inhibitor, N(G)-nitro-L-arginine methyl ester, but not guanylate cyclase inhibitor, 6-anilino-5,8-quinoline-quinone. Selective knockout of endothelial NO synthase with antisense oligodeoxynucleotides also significantly reduced thrombin-induced decrease in monolayer resistance. Our findings indicate that thrombin stimulates calcium-dependent release of NO from PMVEC, which mediates the retraction of endothelial cells via a cGMP-independent pathway. Our results suggest that NO modulates cell-matrix and/or cell-cell adhesion in PMVEC and that this molecule might modify microvascular permeability in the human lung.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Patterson, C E</author><author>Lum, H</author><author>Schaphorst, K L</author><author>Verin, A D</author><author>Garcia, J G</author></authors></contributors><titles><title>Regulation of endothelial barrier function by the cAMP-dependent protein kinase.</title><secondary-title>Endothelium : journal of endothelial cell research</secondary-title></titles><periodical><full-title>Endothelium : journal of endothelial cell research</full-title></periodical><pages>287-308</pages><volume>7</volume><issue>4</issue><keywords><keyword>Actins</keyword><keyword>Actins: metabolism</keyword><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP-Dependent Protein Kinases</keyword><keyword>Cyclic AMP-Dependent Protein Kinases: metabolism</keyword><keyword>Endothelium</keyword><keyword>Enzyme Activation</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>Humans</keyword><keyword>Myosin Light Chains</keyword><keyword>Myosin Light Chains: metabolism</keyword><keyword>Protein-Tyrosine Kinases</keyword><keyword>Protein-Tyrosine Kinases: metabolism</keyword><keyword>Pulmonary Artery</keyword><keyword>Pulmonary Artery: cytology</keyword><keyword>Vascular</keyword><keyword>Vascular: enzymology</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>2000</year></dates><accession-num>11201526</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/11201526</url></web-urls></urls><abstract>Elevation of cAMP promotes the endothelial cell (EC) barrier and protects the lung from edema development. Thus, we tested the hypothesis that both increases and decreases in PKA modulate EC function and coordinate distribution of regulatory, adherence, and cytoskeletal proteins. Inhibition of PKA activity by RpcAMPS and activation by cholera toxin was verified by assay of kemptide phosphorylation in digitonin permeabilized EC. Inhibition of PKA by RpcAMPS or overexpression of the endogenous inhibitor, PKI, decreased monolayer electrical impedance and exacerbated the decreases produced by agonists (thrombin and PMA). RpcAMPS directly increased F-actin content and organization into stress fibers, increased co-staining of actin with both phosphatase 2B and myosin light chain kinase (MLCK), caused reorganization of focal adhesions, and decreased catenin at cell borders. These findings are similar to those evoked by thrombin. In contrast, cholera toxin prevented the agonist-induced resistance decrease and protein redistribution. Although PKA activation attenuated thrombin-induced myosin light chain (MLC) phosphorylation, PKA inhibition per se did not cause MLC phosphorylation or affect [Ca2+]i. These studies indicate that a decrease in PKA activity alone can produce disruption of barrier function via mechanisms not involving MLCK and support a central role for cAMP/PKA in regulation of cytoskeletal and adhesive protein function in EC which correlates with altered barrier function.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Huang, C N</author><author>Lo, Chun-Min</author><author>Hsu, T C</author><author>Tsay, G J</author></authors></contributors><titles><title>Sera from patients with scleroderma inhibit fibroblast micromotions monitored electrically.</title><secondary-title>The Journal of rheumatology</secondary-title></titles><periodical><full-title>The Journal of rheumatology</full-title></periodical><pages>1312-1317</pages><volume>26</volume><issue>6</issue><keywords><keyword>Aged</keyword><keyword>Blood Proteins</keyword><keyword>Blood Proteins: pharmacology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Division</keyword><keyword>Cell Division: physiology</keyword><keyword>Cell Movement</keyword><keyword>Cell Movement: drug effects</keyword><keyword>Cell Movement: physiology</keyword><keyword>Cell Size</keyword><keyword>Cell Size: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Female</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: cytology</keyword><keyword>Fibroblasts: drug effects</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: physiology</keyword><keyword>Male</keyword><keyword>Middle Aged</keyword><keyword>Scleroderma</keyword><keyword>Systemic</keyword><keyword>Systemic: blood</keyword><keyword>Systemic: pathology</keyword></keywords><dates><year>1999</year></dates><accession-num>10381049</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10381049</url></web-urls></urls><abstract>To investigate scleroderma fibroblast behavior, and the effect of different human sera on fibroblast behavior, we established a model using the newly developed electrical biosensor, electrical cell-substrate impedance sensing (ECIS).</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lo, Chun-Min</author><author>Ferrier, J</author></authors></contributors><titles><title>Electrically measuring viscoelastic parameters of adherent cell layers under controlled magnetic forces.</title><secondary-title>European biophysics journal : EBJ</secondary-title></titles><periodical><full-title>European biophysics journal : EBJ</full-title></periodical><pages>112-118</pages><volume>28</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Electrophysiology</keyword><keyword>Electrophysiology: methods</keyword><keyword>Magnetics</keyword><keyword>Mathematical Computing</keyword><keyword>Models</keyword><keyword>Osteoblasts</keyword><keyword>Osteoblasts: cytology</keyword><keyword>Osteosarcoma</keyword><keyword>Rats</keyword><keyword>Tumor Cells</keyword><keyword>Viscosity</keyword></keywords><dates><year>1999</year></dates><accession-num>10028236</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10028236</url></web-urls></urls><label>ECIS Modeling</label><abstract>Electrical cell-substrate impedance sensing (ECIS) was used to measure the time-dependence and frequency-dependence of impedance for current flowing underneath and between cells. Osteosarcoma cells with a topology similar to a short cylinder (coin-like) surmounted by a dome were used in this study. Application of a small step increase in net vertical stress to the cells (4 and 7 dyn/cm2), via magnetic beads bound to the dorsal (upper) surface, causes an increase in cell body height and an increase in cell-cell separation, as well as stretching of the cell-substrate adhesion bonds. This results in a fast drop in measured resistance (less than 2 s), followed by a slower change with a time constant of 60-150 s. This time constant is about 1.5 times longer at 22 degrees C than that at 37 degrees C; it also increases with applied stress. Our frequency scan data, as well as our data for the time course of resistance and capacitance, show that the fast change is associated with both the under-the-cells and between-the-cells resistance. The slower change in resistance mainly reflects the between-the-cells resistance. To obtain viscoelastic parameters from our data we use a simple viscoelastic model comprising viscous and elastic elements (i.e., dashpot and two springs) for the cell body, and an elastic element (a spring) for the cell-substrate adhesion system. Our results show that the spring constants and the viscosity of the cell body components of this viscoelastic model decrease as the temperature increases, whereas the elastic modulus of cell-substrate adhesion increases with temperature. At 37 degrees C, for the cell body we obtain a value of about 10(5) P for the viscous element of the viscoelastic model, and a spring constant expressed in units of an elastic modulus of about 10(4) dyn/cm2 for the spring in series with the viscous element, with another spring with a modulus of about 2 x 10(3) dyn/cm2 in parallel with these. In comparable units, we have a modulus for the cell-substrate adhesion system of about 3 x 10(3) dyn/cm2.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lo, Chun-Min M</author><author>Keese, C R</author><author>Giaever, I</author></authors></contributors><titles><title>Cell-substrate contact: another factor may influence transepithelial electrical resistance of cell layers cultured on permeable filters.</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>576-580</pages><volume>250</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cell Culture Techniques</keyword><keyword>Cell Line</keyword><keyword>Dogs</keyword><keyword>Electric Impedance</keyword><keyword>Epithelial Cells</keyword><keyword>Epithelial Cells: cytology</keyword><keyword>Epithelial Cells: physiology</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: cytology</keyword><keyword>Fibroblasts: physiology</keyword><keyword>Humans</keyword><keyword>Intercellular Junctions</keyword><keyword>Intercellular Junctions: physiology</keyword><keyword>Micropore Filters</keyword><keyword>Models</keyword><keyword>Polycarboxylate Cement</keyword></keywords><dates><year>1999</year></dates><accession-num>10413610</accession-num><electronic-resource-num>10.1006/excr.1999.4538</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10413610</url></web-urls></urls><label>ECIS Modeling;ECIS TEER</label><abstract>Transepithelial resistance (TER) measurement has often been used to study the paracellular transport properties of epithelia grown on permeable filters, especially the barrier function of tight junctions. However, the TER value includes another source, the resistance caused by cell-substrate contact, that may give rise to a high TER value if cell-substrate separation is small. In this study we use electric cell-substrate impedance sensing (ECIS) to measure both paracellular resistance and the average cell-substrate distance of MDCK (II), HEp-2, and WI-38 VA13 cells. Comparing ECIS data with those from TER measurements of cell layers cultured on polycarbonate filters, we can obtain the approximate extra resistance resulting from cell-substrate contact for each cell type. The value of cell-substrate resistance was also estimated by two theoretical calculations that bracket the true values. Our results demonstrate that cell-substrate contact substantially influences the TER data measured using polycarbonate filters and that the extra resistance due to cell-substrate spaces depends on both cell type and filter property.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Wegener, J</author><author>Zink, S</author><author>Rösen, P</author><author>Galla, H</author></authors></contributors><titles><title>Use of electrochemical impedance measurements to monitor beta-adrenergic stimulation of bovine aortic endothelial cells.</title><secondary-title>Pflügers Archiv : European journal of physiology</secondary-title></titles><periodical><full-title>Pflügers Archiv : European journal of physiology</full-title></periodical><pages>925-934</pages><volume>437</volume><issue>6</issue><keywords><keyword>Adenylate Cyclase</keyword><keyword>Adenylate Cyclase: metabolism</keyword><keyword>Adrenergic</keyword><keyword>Adrenergic beta-Agonists</keyword><keyword>Adrenergic beta-Agonists: pharmacology</keyword><keyword>Animals</keyword><keyword>Aorta</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP: pharmacology</keyword><keyword>Electric Impedance</keyword><keyword>Electrochemistry</keyword><keyword>Electrodes</keyword><keyword>Endothelium</keyword><keyword>Isoproterenol</keyword><keyword>Isoproterenol: pharmacology</keyword><keyword>Kinetics</keyword><keyword>Receptors</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: drug effects</keyword><keyword>Vascular</keyword><keyword>Vascular: physiology</keyword><keyword>beta</keyword><keyword>beta: physiology</keyword></keywords><dates><year>1999</year></dates><accession-num>10370072</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10370072</url></web-urls></urls><label>Signal Transduction</label><abstract>Due to the high permeability of endothelial cell layers derived from macrovascular vessels, precise determination of their barrier function towards ion movement requires refined experimental techniques. We thus cultured bovine aortic endothelial cells (BAEC) directly on thin gold-film electrodes and measured the electrochemical impedance to study their passive electrical properties in general and during beta-adrenergic stimulation. Impedance spectra (10-2.10(6) Hz) of confluent cell monolayers revealed that the electrical characteristics of the cells can be modelled by a simple resistor-capacitor parallel network. Under control conditions the overall resistance of confluent BAEC monolayers was 3.6+/-0.6 Omega.cm2 (n=30) and the capacitance was 0. 6+/-0.1 microF/cm2. Both quantities are discussed with respect to morphological characteristics of these cells. Stimulation of BAECs with the synthetic beta-adrenoceptor agonist isoproterenol leads to a concentration-dependent, highly specific increase of the cell layer resistance characterized by a concentration for half-maximal response (EC50) of 0.3+/-0.1 microM. The cell layer capacitance, however, remained unaffected. Using impedance measurements at a single frequency, we analysed the response of BAECs to treatment with isoproterenol in comparison with several chemically unrelated compounds known to stimulate the adenosine 3',5'-cyclic monophosphate (cAMP)-dependent signal transduction cascade. These studies confirmed that the enhancement of the cell layer resistance after beta-adrenergic stimulation is mediated by an increase in intracellular cAMP.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ellis, Chad A</author><author>Tiruppathi, Chinnaswamy</author><author>Sandoval, Raudel</author><author>Niles, Walter D</author><author>Malik, Asrar B</author></authors></contributors><titles><title>Time course of recovery of endothelial cell surface thrombin receptor (PAR-1) expression.</title><secondary-title>The American journal of physiology</secondary-title></titles><periodical><full-title>The American journal of physiology</full-title></periodical><pages>C38-45</pages><volume>276</volume><issue>1 Pt 1</issue><keywords><keyword>Calcium</keyword><keyword>Calcium: metabolism</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: metabolism</keyword><keyword>Cell Size</keyword><keyword>Cell Size: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cycloheximide</keyword><keyword>Cycloheximide: pharmacology</keyword><keyword>Cytosol</keyword><keyword>Cytosol: metabolism</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Electric Impedance</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Osmolar Concentration</keyword><keyword>Protein Synthesis Inhibitors</keyword><keyword>Protein Synthesis Inhibitors: pharmacology</keyword><keyword>Receptors</keyword><keyword>Thrombin</keyword><keyword>Thrombin: drug effects</keyword><keyword>Thrombin: metabolism</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Time Factors</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: metabolism</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>1999</year></dates><accession-num>9886918</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/9886918</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>We studied dynamics of cell surface expression of proteolytically activated thrombin receptor (PAR-1) in human pulmonary artery endothelial cells (HPAEC). PAR-1 activation was measured by changes in cytosolic calcium concentration ([Ca2+]i) and HPAEC retraction response (determined by real-time transendothelial monolayer electrical resistance). [Ca2+]i increase in response to thrombin was abolished by preexposure to 25 nM thrombin for &gt;60 min, indicating PAR-1 desensitization, but preexposure to 25 nM thrombin for only 30 min or to 10 nM thrombin for up to 2 h did not desensitize PAR-1. Exposure to 10 or 25 nM thrombin decreased monolayer electrical resistance 40-60%. Cells preexposed to 10 nM thrombin, but not those preexposed to 25 nM thrombin, remained responsive to thrombin 3 h later. Loss of cell retractility was coupled to decreased cell surface PAR-1 expression as determined by immunofluorescence. Cell surface PAR-1 disappeared upon short-term (30 min) thrombin exposure but reappeared within 90 min after incubation in thrombin-free medium. Exposure to 25 nM thrombin for &gt;60 min prevented rapid cycloheximide-insensitive PAR-1 reappearance. Cycloheximide-sensitive recovery of cell surface PAR-1 expression required 18 h. Therefore, both duration and concentration of thrombin exposure regulate the time course of recovery of HPAEC surface PAR-1 expression. The results support the hypothesis that initial recovery of PAR-1 surface expression in endothelial cells results from a rapidly mobilizable PAR-1 pool, whereas delayed recovery results from de novo PAR-1 synthesis. We conclude that thrombin itself regulates endothelial cell surface PAR-1 expression and that decreased surface expression interferes with thrombin-induced endothelial cell activation responses.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Takahashi, N</author><author>Seko, Y</author><author>Noiri, E</author><author>Tobe, K</author><author>Kadowaki, T</author><author>Sabe, H</author><author>Yazaki, Y</author></authors></contributors><titles><title>Vascular endothelial growth factor induces activation and subcellular translocation of focal adhesion kinase (p125FAK) in cultured rat cardiac myocytes</title><secondary-title>Circulation …</secondary-title></titles><periodical><full-title>Circulation …</full-title></periodical><pages>1194-1202</pages><volume>84</volume><issue>10</issue><keywords><keyword>Adaptor Proteins</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Adhesion Molecules</keyword><keyword>Cell Adhesion Molecules: analysis</keyword><keyword>Cell Adhesion Molecules: metabolism</keyword><keyword>Cell Adhesion: physiology</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cytoskeletal Proteins</keyword><keyword>Cytoskeletal Proteins: analysis</keyword><keyword>Cytoskeletal Proteins: metabolism</keyword><keyword>Endothelial Growth Factors</keyword><keyword>Endothelial Growth Factors: analysis</keyword><keyword>Endothelial Growth Factors: metabolism</keyword><keyword>Enzyme Activation</keyword><keyword>Enzyme Activation: drug effects</keyword><keyword>Enzyme Activation: physiology</keyword><keyword>Enzyme Inhibitors</keyword><keyword>Enzyme Inhibitors: pharmacology</keyword><keyword>Extracellular Matrix</keyword><keyword>Extracellular Matrix: chemistry</keyword><keyword>Extracellular Matrix: metabolism</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: chemistry</keyword><keyword>Fibroblasts: cytology</keyword><keyword>Fibroblasts: metabolism</keyword><keyword>Focal Adhesion Kinase 1</keyword><keyword>Focal Adhesion Protein-Tyrosine Kinases</keyword><keyword>GRB2 Adaptor Protein</keyword><keyword>Genistein</keyword><keyword>Genistein: pharmacology</keyword><keyword>Growth Factor</keyword><keyword>Growth Factor: analysis</keyword><keyword>Growth Factor: metabolism</keyword><keyword>Lymphokines</keyword><keyword>Lymphokines: analysis</keyword><keyword>Lymphokines: metabolism</keyword><keyword>Muscle Fibers</keyword><keyword>Myocardium</keyword><keyword>Myocardium: chemistry</keyword><keyword>Myocardium: cytology</keyword><keyword>Myocardium: enzymology</keyword><keyword>Paxillin</keyword><keyword>Phosphoproteins</keyword><keyword>Phosphoproteins: analysis</keyword><keyword>Phosphoproteins: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Protein-Tyrosine Kinases</keyword><keyword>Protein-Tyrosine Kinases: analysis</keyword><keyword>Protein-Tyrosine Kinases: metabolism</keyword><keyword>Proteins</keyword><keyword>Proteins: analysis</keyword><keyword>Proteins: metabolism</keyword><keyword>Proto-Oncogene Proteins pp60(c-src)</keyword><keyword>Proto-Oncogene Proteins pp60(c-src): analysis</keyword><keyword>Proto-Oncogene Proteins pp60(c-src): metabolism</keyword><keyword>Rats</keyword><keyword>Receptor Protein-Tyrosine Kinases</keyword><keyword>Receptor Protein-Tyrosine Kinases: analysis</keyword><keyword>Receptor Protein-Tyrosine Kinases: metabolism</keyword><keyword>Receptors</keyword><keyword>Shc Signaling Adaptor Proteins</keyword><keyword>Signal Transducing</keyword><keyword>Signal Transduction</keyword><keyword>Signal Transduction: physiology</keyword><keyword>Skeletal</keyword><keyword>Skeletal: chemistry</keyword><keyword>Skeletal: enzymology</keyword><keyword>Tyrphostins</keyword><keyword>Tyrphostins: pharmacology</keyword><keyword>Vascular Endothelial Growth Factor</keyword><keyword>Vascular Endothelial Growth Factor A</keyword><keyword>Vascular Endothelial Growth Factors</keyword><keyword>Vesicular Transport</keyword><keyword>also known</keyword><keyword>and permeability</keyword><keyword>as vascular permeability factor</keyword><keyword>ascular endothelial growth factor</keyword><keyword>is an important regulator</keyword><keyword>migration</keyword><keyword>of endothelial cell proliferation</keyword><keyword>signal transduction ⅲ growth</keyword><keyword>substance ⅲ cardiac myocyte</keyword><keyword>vegf</keyword><keyword>ⅲ cell adhesion</keyword></keywords><dates><year>1999</year></dates><accession-num>10347094</accession-num><electronic-resource-num>10.1161/01.RES.84.10.1194</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/10347094</url><url>http://circres.ahajournals.org/content/84/10/1194.short</url><url>http://circres.ahajournals.org/cgi/doi/10.1161/01.RES.84.10.1194</url></web-urls></urls><label>ECIS TEER;Signal Transduction</label><abstract>Vascular endothelial growth factor (VEGF) has been proposed to be among the candidate factors with the most potential to play a role in ischemia-induced collateral vessel formation. Recently, we found that VEGF activated the mitogen-activated protein kinase cascade in cultured rat cardiac myocytes. To elucidate how VEGF affects adhesive interaction of cardiac myocytes with the extracellular matrix (ECM), one of the important cell functions, we investigated the molecular mechanism of activation of focal adhesion-related proteins, especially focal adhesion kinase (p125(FAK)), in cultured rat cardiac myocytes. We found that the 2 VEGF receptors, KDR/Flk-1 and Flt-1, were expressed in cardiac myocytes and that KDR/Flk-1 was significantly tyrosine phosphorylated on VEGF stimulation. VEGF induced tyrosine phosphorylation and activation of p125(FAK) as well as tyrosine phosphorylation of paxillin; this was accompanied by subcellular translocation of p125(FAK) from perinuclear sites to the focal adhesions. This VEGF-induced activation of p125(FAK) was inhibited partially by the tyrosine kinase inhibitors genistein and tyrphostin. Activation of p125(FAK) was accompanied by its increased association with adapter proteins GRB2, Shc, and nonreceptor type tyrosine kinase p60(c-src). Furthermore, we confirmed that VEGF induced a significant increase in adhesive interaction between cardiac myocytes and ECM using an electric cell-substrate impedance sensor. These results strongly suggest that p125(FAK) is one of the most important components in VEGF-induced signaling in cardiac myocytes, playing a critical role in adhesive interaction between cardiac myocytes and ECM.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lo, Chun-Min</author><author>Ferrier, J</author></authors></contributors><titles><title>Impedance analysis of fibroblastic cell layers measured by electric cell-substrate impedance sensing</title><secondary-title>Physical Review E</secondary-title></titles><periodical><full-title>Physical Review E</full-title></periodical><pages>6982</pages><volume>57</volume><issue>6</issue><keywords/><dates><year>1998</year></dates><publisher>APS</publisher><urls><web-urls><url>http://pre.aps.org/abstract/PRE/v57/i6/p6982_1</url></web-urls></urls><label>ECIS Modeling;ECIS Theory</label><abstract>Impedance measurements of cell layers cultured on gold electrode surfaces obtained by electric cellsubstrate impedance sensing provide morphological information such as junctional resistance and cell-substrate separation. Previously, a model that assumes that cells have a disklike shape and that electric currents flow radially underneath the ventral cell surface and then through the paracellular space has been used to theoretically calculate the impedance of the cell-covered electrode. In this paper we propose an extended model of impedance analysis for cell layers where cellular shape is rectangular. This is especially appropriate for normal fibroblasts in culture. To verify the model, we analyze impedance data obtained from four different kinds of fibroblasts that display a long rectangular shape. In addition, we measure the average cell-substrate separation of human gingival fibroblasts at different temperatures. At temperatures of 37, 22, and 4 °C, the average separation between ventral cell surface and substratum are 46, 55, and 89 nm, respectively.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Reddy, L</author><author>Wang, H S</author><author>Keese, C R</author><author>Giaever, I</author><author>Smith, T J</author></authors></contributors><titles><title>Assessment of rapid morphological changes associated with elevated cAMP levels in human orbital fibroblasts.</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>360-367</pages><volume>245</volume><issue>2</issue><keywords><keyword>8-Bromo Cyclic Adenosine Monophosphate</keyword><keyword>8-Bromo Cyclic Adenosine Monophosphate: pharmacolo</keyword><keyword>Abdomen</keyword><keyword>Bucladesine</keyword><keyword>Bucladesine: pharmacology</keyword><keyword>Cell Size</keyword><keyword>Cell Size: drug effects</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cyclic AMP</keyword><keyword>Cyclic AMP: metabolism</keyword><keyword>Cyclooxygenase 2</keyword><keyword>Dermis</keyword><keyword>Dinoprostone</keyword><keyword>Dinoprostone: pharmacology</keyword><keyword>Dose-Response Relationship</keyword><keyword>Drug</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: cytology</keyword><keyword>Fibroblasts: drug effects</keyword><keyword>Fibroblasts: metabolism</keyword><keyword>Forskolin</keyword><keyword>Forskolin: pharmacology</keyword><keyword>Graves Disease</keyword><keyword>Graves Disease: metabolism</keyword><keyword>Graves Disease: pathology</keyword><keyword>Humans</keyword><keyword>Isoenzymes</keyword><keyword>Isoenzymes: physiology</keyword><keyword>Lymphokines</keyword><keyword>Lymphokines: pharmacology</keyword><keyword>Membrane Proteins</keyword><keyword>Orbit</keyword><keyword>Orbit: cytology</keyword><keyword>Orbit: drug effects</keyword><keyword>Orbit: metabolism</keyword><keyword>Prostaglandin-Endoperoxide Synthases</keyword><keyword>Prostaglandin-Endoperoxide Synthases: physiology</keyword><keyword>Time Factors</keyword></keywords><dates><year>1998</year></dates><accession-num>9851877</accession-num><electronic-resource-num>10.1006/excr.1998.4273</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/9851877</url></web-urls></urls><label>Signal Transduction</label><abstract>Orbital fibroblasts exhibit a phenotype distinct from that of other types of fibroblasts. Addition of prostaglandin E2 (PGE2) to culture medium elicits a dramatic change in orbital fibroblast morphology. That response is mediated through the generation of cAMP. Orbital fibroblasts can generate high levels of PGE2 through induction by proinflammatory cytokines of prostaglandin endoperoxide H synthase-2 (PGHS-2). Here we compare the influence on fibroblast morphology of exogenous PGE2, forskolin, and 8-br-cAMP to that mediated through PGHS-2 induction by a lymphocyte-derived cytokine. Within a few hours, orbital fibroblasts treated with any of these test compounds appear under phase-contrast microscopy to exhibit a stellate morphology. When these changes were assessed quantitatively by electric cell-substrate impedance sensing (ECIS), it became evident that 8-br-cAMP, forskolin, and PGE2 initiated shape changes within 30 min of addition to the culture medium, while effects of the cytokine were first evident after approximately 3.5 h. Dermal fibroblasts failed to respond to any of these compounds with regard to changes in cellular morphology. Analysis of micromotion, manifested as small impedance fluctuations, revealed that orbital fibroblasts treated with 8-br-cAMP exhibit less motion than did untreated cells. These results suggest that orbital fibroblast shape can be altered by several compounds known to alter intracellular cAMP levels. They demonstrate the utility of ECIS in the assessment of very rapid and dynamic cellular events associated with changes in cell morphology.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ko, Kevin S.-C</author><author>Lo, Chun-min</author><author>Ferrier, Jack</author><author>Hannam, Pauline</author><author>Tamura, Muneaki</author><author>McBride, Barry C</author><author>Ellen, Richard P</author></authors></contributors><titles><title>Cell–substrate impedance analysis of epithelial cell shape and micromotion upon challenge with bacterial proteins that perturb extracellular matrix and cytoskeleton</title><secondary-title>Journal of Microbiological Methods</secondary-title></titles><periodical><full-title>Journal of Microbiological Methods</full-title></periodical><pages>125-132</pages><volume>34</volume><issue>2</issue><keywords><keyword>ecis</keyword><keyword>electrical cell</keyword><keyword>epithelial monolayer</keyword><keyword>major surface protein</keyword><keyword>micromotion</keyword><keyword>msp</keyword><keyword>proteinase</keyword><keyword>substrate impedance sensing</keyword><keyword>treponema denticola</keyword></keywords><dates><year>1998</year></dates><electronic-resource-num>10.1016/S0167-7012(98)00083-9</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/S0167701298000839</url></web-urls></urls><label>ECIS Micromotion</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lo, Chun-Min</author><author>Glogauer, M</author><author>Rossi, M</author><author>Ferrier, J</author></authors></contributors><titles><title>Cell-substrate separation: effect of applied force and temperature.</title><secondary-title>European biophysics journal : EBJ</secondary-title></titles><periodical><full-title>European biophysics journal : EBJ</full-title></periodical><pages>9-17</pages><volume>27</volume><issue>1</issue><keywords><keyword>Animals</keyword><keyword>Bone Neoplasms</keyword><keyword>Bone Neoplasms: pathology</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Separation</keyword><keyword>Cell Separation: methods</keyword><keyword>Collagen</keyword><keyword>Cultured</keyword><keyword>Electric Impedance</keyword><keyword>Fluorescence</keyword><keyword>Integrins</keyword><keyword>Integrins: physiology</keyword><keyword>Magnetics</keyword><keyword>Mathematical Computing</keyword><keyword>Microscopy</keyword><keyword>Osteosarcoma</keyword><keyword>Osteosarcoma: pathology</keyword><keyword>Rats</keyword><keyword>Temperature</keyword><keyword>Tumor Cells</keyword></keywords><dates><year>1998</year></dates><accession-num>9463886</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/9463886</url></web-urls></urls><label>ECIS Modeling;ECIS Theory</label><abstract>We measure the change in cell-substrate separation in response to an upward force by combining two relatively new techniques, Electric Cell-substrate Impedance Sensing (ECIS) to measure average cell-substrate separation, and collagen-coated magnetic beads to apply force to the top (dorsal) surface of cells. The collagen-coated ferric oxide beads attach to integrin receptors in the dorsal surfaces of osteoblastlike ROS 17/2.8 cells. Magnetic force is controlled by the position and the number of permanent magnets, applying an average 320 or 560 pN per cell. Comparing model calculations with experimental impedance data, the junctional resistivity of the cell layer and the average distance between the lower (ventral) cell surface and substrate can be determined. The ECIS analysis shows that these forces produce an increase in the distance between the ventral cell surface and the substrate that is in the range of 10 to 25%. At temperatures of 4 degrees, 22 degrees and 37 degrees C, the measured cell surface-substrate distances without magnetic beads are 84 +/- 4, 45 +/- 2 and 38 +/- 2 nm. The force-induced changes at 22 degrees are 11 +/- 3 and 21 +/- 3 nm for 320 and 560 pN, and at 37 degrees they are 5 +/- 2 and 9 +/- 2 nm. The resulting cell-substrate spring constants at 22 degrees and 37 degrees are thus about 28 and 63 pN nm-1 (dyne cm-1). Using a reasonable range for the number for individual integrin-ligand adhesion bonds gives a range for the spring constant of the individual adhesion bond of from about 10(-3) to 10(-1) pN nm-1. These data also provide evidence that the number of adhesion bonds per cell increases with temperature.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Keese, C R</author><author>Karra, N</author><author>Dillon, B</author><author>Goldberg, A M</author><author>Giaever, I</author></authors></contributors><titles><title>Cell-substratum interactions as a predictor of cytotoxicity</title><secondary-title>In Vitro &amp; Molecular Toxicology</secondary-title></titles><periodical><full-title>In Vitro &amp; Molecular Toxicology</full-title></periodical><pages>183-192</pages><volume>11</volume><issue>2</issue><keywords/><dates><year>1998</year></dates><urls><web-urls><url>http://www.csa.com/partners/viewrecord.php?requester=gs&amp;amp;collection=ENV&amp;amp;recid=4392799</url></web-urls></urls><label>ECIS Cytotoxicity;ECIS Micromotion</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Patil, Sandeep</author><author>Kaplan, John E</author><author>Minnear, Fred L</author></authors></contributors><titles><title>Protein, not adenosine or adenine nucleotides, mediates platelet decrease in endothelial permeability.</title><secondary-title>The American journal of physiology</secondary-title></titles><periodical><full-title>The American journal of physiology</full-title></periodical><pages>H2304-11</pages><volume>273</volume><issue>5 Pt 2</issue><keywords><keyword>Adenine Nucleotides</keyword><keyword>Adenine Nucleotides: pharmacology</keyword><keyword>Adenosine</keyword><keyword>Adenosine Deaminase</keyword><keyword>Adenosine Deaminase Inhibitors</keyword><keyword>Adenosine Deaminase: pharmacology</keyword><keyword>Adenosine Diphosphate</keyword><keyword>Adenosine Diphosphate: pharmacology</keyword><keyword>Adenosine Monophosphate</keyword><keyword>Adenosine Monophosphate: pharmacology</keyword><keyword>Adenosine Triphosphate</keyword><keyword>Adenosine Triphosphate: pharmacology</keyword><keyword>Adenosine: pharmacology</keyword><keyword>Animals</keyword><keyword>Blood Platelets</keyword><keyword>Blood Platelets: physiology</keyword><keyword>Blood Proteins</keyword><keyword>Blood Proteins: pharmacology</keyword><keyword>Blood Proteins: physiology</keyword><keyword>Cattle</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: drug effects</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Cells</keyword><keyword>Conditioned</keyword><keyword>Culture Media</keyword><keyword>Cultured</keyword><keyword>Endothelium</keyword><keyword>Humans</keyword><keyword>Pulmonary Artery</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: drug effects</keyword><keyword>Vascular: physiology</keyword><keyword>Xanthines</keyword><keyword>Xanthines: pharmacology</keyword></keywords><dates><year>1997</year></dates><accession-num>9374767</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/9374767</url></web-urls></urls><label>ECIS TEER</label><abstract>Platelets and platelet-conditioned medium (PCM) decrease endothelial protein permeability in vitro. Adenosine and a &gt; 100-kDa protein have previously been implicated as the soluble factors released from platelets that decrease endothelial permeability. The objective of this study was to further investigate the role of adenosine in this platelet response. Measurements of adenosine and its precursor adenine nucleotides by high-performance liquid chromatography were correlated with the assessment of permeability by 125I-labeled albumin clearance and electrical resistance across endothelial cell monolayers derived from the bovine pulmonary artery. PCM contained micromolar concentrations of AMP, ADP, and ATP, but adenosine was below detectable levels (&lt; or = 0.1 microM). Adenosine deaminase, an enzyme that converts adenosine to inactive inosine, or an adenosine-receptor antagonist did not block the platelet- or PCM-mediated decrease in endothelial permeability. A &lt; 3-kDa fraction of PCM that contained micromolar concentrations of AMP and ADP did not affect endothelial permeability, whereas a &gt; 3-kDa fraction that contained much reduced levels of AMP and ADP significantly decreased permeability. This activity of PCM was sensitive to insoluble trypsin. This study rules out adenosine and adenine nucleotides as primary factors in the platelet-induced decrease in endothelial permeability and suggests that the active factor is a protein.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tiruppathi, Chinnaswamy</author><author>Song, W</author><author>Bergenfeldt, M</author><author>Sass, P</author><author>Malik, a B</author></authors></contributors><titles><title>Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway.</title><secondary-title>The Journal of biological chemistry</secondary-title></titles><periodical><full-title>The Journal of biological chemistry</full-title></periodical><pages>25968-25975</pages><volume>272</volume><issue>41</issue><keywords><keyword>Animals</keyword><keyword>Biological Transport</keyword><keyword>Cattle</keyword><keyword>Caveolin 1</keyword><keyword>Caveolins</keyword><keyword>Endocytosis</keyword><keyword>Endothelium</keyword><keyword>Fluorescent Antibody Technique</keyword><keyword>Indirect</keyword><keyword>Membrane Proteins</keyword><keyword>Membrane Proteins: metabolism</keyword><keyword>Phosphorylation</keyword><keyword>Protein-Tyrosine Kinases</keyword><keyword>Protein-Tyrosine Kinases: metabolism</keyword><keyword>Proto-Oncogene Proteins pp60(c-src)</keyword><keyword>Proto-Oncogene Proteins pp60(c-src): metabolism</keyword><keyword>Serum Albumin</keyword><keyword>Serum Albumin: metabolism</keyword><keyword>Sialoglycoproteins</keyword><keyword>Sialoglycoproteins: metabolism</keyword><keyword>Surface Properties</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: metabolism</keyword><keyword>src Homology Domains</keyword></keywords><dates><year>1997</year></dates><isbn>3123550249</isbn><accession-num>9325331</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/9325331</url></web-urls></urls><label>ECIS TEER</label><abstract>We investigated the function of gp60, an endothelial cell membrane 60-kDa albumin-binding protein localized in caveolae, and the mechanism of its activation in regulating endothelial permeability of albumin. Gp60 organization on the bovine pulmonary microvessel endothelial cell (BPMVEC) surface was punctate as shown by immunofluorescence using an anti-gp60 antibody (Ab) conjugated with bisfunctional, N-hydroxysuccinimidyl fluorophore (Cy3). Addition of a secondary Ab to anti-gp60 Ab-treated BPMVEC induced cross-linking of gp60 as evident by increased size of fluorescent particles and cell surface gp60 clustering. Gp60 cross-linking also produced 2-3-fold increases in the endothelial cell uptake and the luminal to abluminal permeability of 125I-albumin as well as the fluid-phase tracer, horseradish peroxidase. The increased transendothelial permeability of macromolecules was the result of transcytosis as it was not associated with an increase in the paracellular pathway. Incubation of anti-gp60 Ab with BPMVEC at 37 degrees C caused internalization of gp60, and thereby reduced the uptake of the macromolecules. Activation of gp60 by either albumin (the gp60 ligand) or gp60 cross-linking induced the phosphorylation of both gp60 and caveolin-1 (the major structural caveolar protein) on tyrosine residues. Gp60 activation also phosphorylated the Src family tyrosine kinases pp60(c-Src) and Fyn. The activated pp60(c-Src) and Fyn co-immunoprecipitated with caveolin-1 in BPMVEC membrane. Protein tyrosine kinase (PTK) inhibitors, herbimycin A and genistein, prevented gp60-activated macromolecule uptake and transcytosis in a concentration-dependent manner, indicating the functional significance of the PTK pathway in activating albumin transcytosis. These findings indicate that activation of gp60 stimulates the Src PTK signaling pathway, and thus regulates the transcytosis of albumin across the endothelial cell monolayer.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lo, Chun-Min</author><author>Keese, C R</author><author>Giaever, I</author></authors></contributors><titles><title>Impedance analysis of MDCK cells measured by electric cell-substrate impedance sensing.</title><secondary-title>Biophysical journal</secondary-title></titles><periodical><full-title>Biophysical journal</full-title></periodical><pages>2800-2807</pages><volume>69</volume><issue>6</issue><keywords><keyword>Animals</keyword><keyword>Biological</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane</keyword><keyword>Cell Membrane: physiology</keyword><keyword>Dogs</keyword><keyword>Electrophysiology</keyword><keyword>Electrophysiology: instrumentation</keyword><keyword>Electrophysiology: methods</keyword><keyword>Epithelium</keyword><keyword>Epithelium: physiology</keyword><keyword>Gold</keyword><keyword>Kidney</keyword><keyword>Mathematics</keyword><keyword>Microelectrodes</keyword><keyword>Models</keyword></keywords><dates><year>1995</year></dates><accession-num>8599686</accession-num><electronic-resource-num>10.1016/S0006-3495(95)80153-0</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1236517&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Modeling;ECIS Theory</label><abstract>Transepithelial impedance of Madin-Darby canine kidney cell layers is measured by a new instrumental method, referred to as electric cell-substrate impedance sensing. In this method, cells are cultured on small evaporated gold electrodes, and the impedance is measured in the frequency range 20-50,000 Hz by a small probing current. A model for impedance analysis of epithelial cells measured by this method is developed. The model considers three different pathways for the current flowing from the electrode through the cell layer: (1) in through the basal and out through the apical membrane, (2) in through the lateral and out through the apical membrane, and (3) between the cells through the paracellular space. By comparing model calculation with experimental impedance data, several morphological and cellular parameters can be determined: (1) the resistivity of the cell layer, (2) the average distance between the basal cell surface and substratum, and (3) the capacitance of apical, basal, and lateral cell membranes. This model is used to analyze impedance changes on removal of Ca2+ from confluent Mardin-Darby canine kidney cell layers. The method shows that reduction of Ca2+ concentration causes junction resistance between cells to drop and the distance between the basal cell surface and substratum to increase.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lo, Chun-Min</author><author>Keese, C R</author><author>Giaever, I</author></authors></contributors><titles><title>pH changes in pulsed CO2 incubators cause periodic changes in cell morphology.</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>391-397</pages><volume>213</volume><issue>2</issue><keywords><keyword>Animals</keyword><keyword>Carbon Dioxide</keyword><keyword>Carbon Dioxide: metabolism</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Culture Media</keyword><keyword>Cultured</keyword><keyword>Cultured: cytology</keyword><keyword>Cultured: metabolism</keyword><keyword>Fourier Analysis</keyword><keyword>Hydrogen-Ion Concentration</keyword></keywords><dates><year>1994</year></dates><accession-num>8050495</accession-num><electronic-resource-num>10.1006/excr.1994.1214</electronic-resource-num><urls><web-urls><url>http://www.sciencedirect.com/science/article/pii/S0014482784712146</url><url>http://www.ncbi.nlm.nih.gov/pubmed/8050495</url></web-urls></urls><label>ECIS Micromotion</label><abstract>It is common in animal cell culture to utilize media that are buffered with bicarbonate ions and elevated CO2 concentrations in the incubator gas. Many modern incubators maintain these concentrations by monitoring the level of CO2 and injecting the gas when the value drops below a certain set point. This feedback system results in small oscillations in the incubator CO2 concentration of about 0.5%, resulting in oscillating pH values in the medium bathing the cells. These oscillations are very small and cannot be detected using a standard pH combination electrode, and until now no one has noticed any effect on the cells. In this study, however, we demonstrate that these periodic changes can result in detectable changes in cell morphology and therefore do affect cell behavior. Using electric cell-substrate impedance sensing (ECIS) to detect subtle alterations in cell morphology, we have measured cellular changes that when analyzed with the Fast Fourier Transform have a periodicity that matches those of the CO2 addition. This effect becomes particularly prominent when the culture medium has been acidified by cell metabolism reducing the liquid's buffer capacity. We have further analyzed the cyclical morphological changes employing a model of cell-electrode interactions in the ECIS measurement. We conclude that: (1) the periodic changes in cell morphology are most apparent if the medium is partially spent and if the surface to volume ratio of the culture vessel is high and (2) for confluent WI-38/VA13 fibroblasts and bovine pulmonary endothelial cells (B3B3), the main periodic morphological changes manifest themselves primarily as alterations in paracellular resistance.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Pei, Z</author><author>Keese, C R</author><author>Giaever, I</author><author>Kurzawa, H</author><author>Wilson, D E</author></authors></contributors><titles><title>Effect of the pSV2-neo plasmid on NIH 3T3 cell motion detected electrically.</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>225-229</pages><volume>212</volume><issue>2</issue><keywords><keyword>3T3 Cells</keyword><keyword>3T3 Cells: cytology</keyword><keyword>3T3 Cells: physiology</keyword><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Electrophysiology</keyword><keyword>Genetic Vectors</keyword><keyword>Mice</keyword><keyword>Restriction Mapping</keyword><keyword>Structure-Activity Relationship</keyword></keywords><dates><year>1994</year></dates><accession-num>8187817</accession-num><electronic-resource-num>10.1006/excr.1994.1138</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/8187817</url></web-urls></urls><abstract>Advantage was taken of DNA transfection techniques to investigate the effect of the pSV2-neo plasmid and its derivatives on recipient NIH 3T3 cell motion. Cell spreading and motion were followed by a newly developed electrical method to monitor cell morphology, referred to as electric cell-substrate impedance sensing. Using this method, we found that the eukaryotic-prokaryotic shuttle vector pSV2-neo had a strong effect on the recipient NIH 3T3 cell spreading and cell motion. However, two new neo plasmids, pSK-neo and pSP-neo, which were constructed by modifying the pSV2-neo plasmid, did not have a significant effect on the recipient cell activities. The results suggest that there may be some sequences in pSV2-neo which affect recipient cell behavior.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Keese, C R</author><author>Giaever, Ivar</author></authors></contributors><titles><title>A biosensor that monitors cell morphology with electrical fields</title><secondary-title>IEEE Engineering in Medicine and Biology Magazine</secondary-title></titles><periodical><full-title>IEEE Engineering in Medicine and Biology Magazine</full-title></periodical><pages>402-408</pages><volume>13</volume><issue>3</issue><keywords/><dates><year>1994</year></dates><publisher>IEEE</publisher><electronic-resource-num>10.1109/51.294012</electronic-resource-num><notes>From Duplicate 1 ( 

A biosensor that monitors cell morphology with electrical fields

- Keese, C.R.; Giaever, Ivar )</notes><research-notes>From Duplicate 1 ( 

A biosensor that monitors cell morphology with electrical fields

- Keese, C.R.; Giaever, Ivar )</research-notes><urls><web-urls><url>http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=294012</url><url>http://ieeexplore.ieee.org/lpdocs/epic03/wrapper.htm?arnumber=294012</url></web-urls></urls><label>ECIS Attachment;ECIS Cytotoxicity;ECIS Micromotion;ECIS TEER;ECIS Theory</label><abstract>Describes a “whole cell” biosensor that is very useful in the field of animal cell tissue culture and in many ways is akin to the canary in a coal mine. The heart of this method, called ECIS for electric cell-substrate impedance sensing, is a small gold electrode immersed in tissue culture medium. When cells attach and spread on this electrode, the measured electrical impedance changes because the cells constrain the current flow. This changing impedance can be interpreted to reveal useful information about cell behaviors. Since these behaviors, such as spreading and locomotion, involve the coordination of many biochemical reactions, they are extremely sensitive to most external parameters such as temperature, pH, and a myriad of chemical compounds. This broad response to changes in the environment allows this method to serve as a general biosensor. The measurements are easily automated, and the general conditions of the cells can be monitored by a personal computer controlling the necessary instrumentation</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Giaever, I</author><author>Keese, C R</author></authors></contributors><titles><title>A morphological biosensor for mammalian cells.</title><secondary-title>Nature</secondary-title></titles><periodical><full-title>Nature</full-title></periodical><pages>591-592</pages><volume>366</volume><issue>6455</issue><keywords><keyword>Adenocarcinoma</keyword><keyword>Animals</keyword><keyword>Biosensing Techniques</keyword><keyword>Cattle</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Movement</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Cultured: cytology</keyword><keyword>Cultured: physiology</keyword><keyword>Electrophysiology</keyword><keyword>Electrophysiology: instrumentation</keyword><keyword>Electrophysiology: methods</keyword><keyword>Endothelium</keyword><keyword>Macrophages</keyword><keyword>Macrophages: cytology</keyword><keyword>Macrophages: physiology</keyword><keyword>Male</keyword><keyword>Mammals</keyword><keyword>Mice</keyword><keyword>Prostatic Neoplasms</keyword><keyword>Rats</keyword><keyword>Tumor Cells</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>1993</year></dates><accession-num>8255299</accession-num><electronic-resource-num>10.1038/366591a0</electronic-resource-num><urls><web-urls><url>http://ukpmc.ac.uk/abstract/MED/8255299</url><url>http://www.ncbi.nlm.nih.gov/pubmed/8255299</url></web-urls></urls><label>ECIS Attachment;ECIS Cytotoxicity;ECIS Micromotion</label><abstract>An electrical biosensor is described that can continuously track morphological changes of adherent cells providing quantitative data from both sparse and confluent cultures. The method is capable of detecting vertical motion of cells of the order of 1 nm, much below the resolution of an optical microscope.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Ghosh, P M</author><author>Keese, C R</author><author>Giaever, I</author></authors></contributors><titles><title>Monitoring electropermeabilization in the plasma membrane of adherent mammalian cells.</title><secondary-title>Biophysical journal</secondary-title></titles><periodical><full-title>Biophysical journal</full-title></periodical><pages>1602-1609</pages><volume>64</volume><issue>5</issue><keywords><keyword>Biological</keyword><keyword>Biophysical Phenomena</keyword><keyword>Biophysics</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Line</keyword><keyword>Cell Membrane Permeability</keyword><keyword>Cell Membrane Permeability: physiology</keyword><keyword>Electric Impedance</keyword><keyword>Electric Stimulation</keyword><keyword>Electrophysiology</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: physiology</keyword><keyword>Humans</keyword><keyword>Membrane Potentials</keyword><keyword>Models</keyword></keywords><dates><year>1993</year></dates><publisher>Elsevier</publisher><accession-num>8324195</accession-num><electronic-resource-num>10.1016/S0006-3495(93)81531-5</electronic-resource-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1262488&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Electroporation</label><abstract>When an electrical potential of order one volt is induced across a cell membrane for a fraction of a second, temporary breakdown of ordinary membrane functions may occur. One result of such a breakdown is that molecules normally excluded by the membrane can now enter the cells. This phenomenon, generally referred to as electropermeabilization, is known as electroporation when actual pores form in the membrane. This paper presents a unique approach to the measurement of pore formation and closure in anchored mammalian cells. The cells are cultured on small gold electrodes, and by constantly monitoring the impedance of the electrode with a low-amplitude AC signal, small changes in cell morphology, cell motion, and membrane resistance can be detected. Because the active electrode is small, the application of a few volts across the cell-covered electrode causes pore formation in the cell membrane. In addition, the heat transfer is very efficient, and the cells can be porated in their regular growth medium. By this method, the formation and resealing of pores due to applied electric fields can be followed in real time for anchorage-dependent cells.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Lo, C M</author><author>Keese, C R</author><author>Giaever, I</author></authors></contributors><titles><title>Monitoring motion of confluent cells in tissue culture.</title><secondary-title>Experimental cell research</secondary-title></titles><periodical><full-title>Experimental cell research</full-title></periodical><pages>102-109</pages><volume>204</volume><issue>1</issue><keywords><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Culture Techniques</keyword><keyword>Cytochalasin D</keyword><keyword>Cytochalasin D: pharmacology</keyword><keyword>Fibroblasts</keyword><keyword>Glucose</keyword><keyword>Glucose: pharmacology</keyword><keyword>Humans</keyword><keyword>Methods</keyword><keyword>Temperature</keyword><keyword>Time Factors</keyword></keywords><dates><year>1993</year></dates><accession-num>8416788</accession-num><electronic-resource-num>10.1006/excr.1993.1014</electronic-resource-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/8416788</url></web-urls></urls><label>ECIS Micromotion</label><abstract>Cell movements in confluent fibroblastic cell layers have been followed with a new instrumental method. Using the electric cell-substrate impedance sensor (ECIS), cell motions on the scale of nanometers are manifested as fluctuations in the impedance of small gold film electrodes that serve as cell substrata. These fluctuations have been recorded and numerically processed for cells at 27 and 37 degrees C, for cells deprived of all external nutrients over extended periods of time, and for cells exposed to different levels of cytochalasin D. Results suggest that the movements in confluent layers detected via ECIS can be correlated with cell metabolic activity.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Tiruppathi, Chinnaswamy</author><author>Malik, a B</author><author>Del Vecchio, P J</author><author>Keese, C R</author><author>Giaever, I</author></authors></contributors><titles><title>Electrical method for detection of endothelial cell shape change in real time: assessment of endothelial barrier function.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>7919-7923</pages><volume>89</volume><issue>17</issue><keywords><keyword>Animals</keyword><keyword>Cattle</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electrophysiology</keyword><keyword>Endothelium</keyword><keyword>Membrane Potentials</keyword><keyword>Permeability</keyword><keyword>Thrombin</keyword><keyword>Thrombin: pharmacology</keyword><keyword>Vascular</keyword><keyword>Vascular: cytology</keyword><keyword>Vascular: physiology</keyword></keywords><dates><year>1992</year></dates><accession-num>1518814</accession-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=49826&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS TEER</label><abstract>We have developed an electrical method to study endothelial cell shape changes in real time in order to examine the mechanisms of alterations in the endothelial barrier function. Endothelial shape changes were quantified by using a monolayer of endothelial cells grown on a small (10(-3) cm2) evaporated gold electrode and measuring the changes in electrical impedance. Bovine pulmonary microvessel endothelial cells and bovine pulmonary artery endothelial cells were used to study the effects of alpha-thrombin on cell-shape dynamics by the impedance measurement. alpha-Thrombin produced a dose-dependent decrease in impedance that occurred within 0.5 min in both cell types, indicative of retraction of endothelial cells and widening of interendothelial junctions because of &quot;rounding up&quot; of the cells. The alpha-thrombin-induced decrease in impedance persisted for approximately 2 hr, after which the value recovered to basal levels. Pretreatment of endothelial cells with the protein kinase C inhibitor, calphostin C, or with 8-bromoadenosine 3',5'-cyclic monophosphate prevented the decreased impedance, suggesting that the endothelial cell change is modulated by activation of second-messenger pathways. The alpha-thrombin-induced decrease in impedance was in agreement with the previously observed increases in transendothelial albumin permeability and evidence of formation of intercellular gaps after alpha-thrombin challenge. The impedance measurement may be a valuable in vitro method for the assessment of mechanisms of decreased endothelial barrier function occurring with inflammatory mediators. Since the rapidly occurring changes in endothelial cell shape in response to mediators such as thrombin are mediated activation of second-messenger pathways, the ability to monitor endothelial cell dynamics in real time may provide insights into the signal-transduction events mediating the increased endothelial permeability.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Giaever, I</author><author>Keese, C R</author></authors></contributors><titles><title>Micromotion of mammalian cells measured electrically.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>7896-7900</pages><volume>88</volume><issue>17</issue><keywords><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Culture Techniques</keyword><keyword>Culture Techniques: instrumentation</keyword><keyword>Culture Techniques: methods</keyword><keyword>Electrophysiology</keyword><keyword>Electrophysiology: instrumentation</keyword><keyword>Electrophysiology: methods</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: physiology</keyword><keyword>Humans</keyword><keyword>Mathematics</keyword><keyword>Models</keyword><keyword>Theoretical</keyword></keywords><dates><year>1991</year></dates><accession-num>1881923</accession-num><urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=52411&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Micromotion</label><abstract>Motility is a fundamental property of mammalian cells that normally is observed in tissue culture by time lapse microscopy where resolution is limited by the wavelength of light. This paper examines a powerful electrical technique by which cell motion is quantitatively measured at the nanometer level. In this method, the cells are cultured on small evaporated gold electrodes carrying weak ac currents. A large change in the measured electrical impedance of the electrodes is observed when cells attach and spread on these electrodes. When the impedance is tracked as a function of time, fluctuations are observed that are a direct measure of cell motion. Surprisingly, these fluctuations continue even when the cell layer becomes confluent. By comparing the measured impedance with a theoretical model, it is clear that under these circumstances the average motions of the cell layer of 1 nm can be inferred from the measurements. We refer to this aspect of cell motility as micromotion.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Mitra, P</author><author>Keese, C R</author><author>Giaever, I</author></authors></contributors><titles><title>Electric measurements can be used to monitor the attachment and spreading of cells in tissue culture.</title><secondary-title>BioTechniques</secondary-title></titles><periodical><full-title>BioTechniques</full-title></periodical><pages>504-510</pages><volume>11</volume><issue>4</issue><keywords><keyword>Animals</keyword><keyword>Cell Adhesion</keyword><keyword>Cell Division</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cytological Techniques</keyword><keyword>Electrodes</keyword><keyword>Gold</keyword><keyword>Kinetics</keyword><keyword>Methods</keyword><keyword>Polystyrenes</keyword><keyword>Transformed</keyword></keywords><dates><year>1991</year></dates><accession-num>1793585</accession-num><urls><web-urls><url>http://www.ncbi.nlm.nih.gov/pubmed/1793585</url></web-urls></urls><abstract>A new electrical assay to measure the attachment and spreading of cells in tissue culture has been developed and substantiated by comparison with a more conventional assay. Small gold electrodes are vacuum deposited on the bottom of standard polystyrene culture dishes and coated with various proteins. As mammalian fibroblasts attach and spread on these surfaces, the measured impedance of the electrodes changes. These impedance changes reflect the amount of area blocked by the spreading cells. Since the weak electrical signals used have no noticeable effects on the cells, this is a very convenient method that is both quantitative and sensitive for measuring cell attachment and spreading.</abstract></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Giaever, Ivar</author><author>Keese, C R</author></authors></contributors><titles><title>Fractal motion of mammalian cells</title><secondary-title>Physica D: Nonlinear Phenomena</secondary-title></titles><periodical><full-title>Physica D: Nonlinear Phenomena</full-title></periodical><pages>128-133</pages><volume>38</volume><issue>1-3</issue><keywords/><dates><year>1989</year></dates><electronic-resource-num>10.1016/0167-2789(89)90182-6</electronic-resource-num><urls><web-urls><url>http://linkinghub.elsevier.com/retrieve/pii/0167278989901826</url></web-urls></urls><label>ECIS Micromotion</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Giaever, I</author><author>Keese, C R</author></authors></contributors><titles><title>Use of electric fields to monitor the dynamical aspect of cell behavior in tissue culture.</title><secondary-title>IEEE transactions on bio-medical engineering</secondary-title></titles><periodical><full-title>IEEE transactions on bio-medical engineering</full-title></periodical><pages>242-247</pages><volume>33</volume><issue>2</issue><keywords><keyword>Cell Adhesion</keyword><keyword>Cell Communication</keyword><keyword>Cell Line</keyword><keyword>Cell Movement</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electrochemistry</keyword><keyword>Electrochemistry: instrumentation</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: cytology</keyword><keyword>Humans</keyword><keyword>Microelectrodes</keyword></keywords><dates><year>1986</year></dates><publisher>IEEE</publisher><accession-num>3957373</accession-num><electronic-resource-num>10.1109/TBME.1986.325896</electronic-resource-num><urls><web-urls><url>http://ieeexplore.ieee.org/xpls/abs_all.jsp?arnumber=4122265</url><url>http://www.ncbi.nlm.nih.gov/pubmed/3957373</url></web-urls></urls><label>ECIS Attachment</label></record><record><database name="My Collection.enl" path="My Collection.enl">My Collection.enl</database><ref-type name="Journal Article">0</ref-type><contributors><authors><author>Giaever, I</author><author>Keese, C R</author></authors></contributors><titles><title>Monitoring fibroblast behavior in tissue culture with an applied electric field.</title><secondary-title>Proceedings of the National Academy of Sciences of the United States of America</secondary-title></titles><periodical><full-title>Proceedings of the National Academy of Sciences of the United States of America</full-title></periodical><pages>3761-3764</pages><volume>81</volume><issue>12</issue><keywords><keyword>Animals</keyword><keyword>Cell Movement</keyword><keyword>Cells</keyword><keyword>Cultured</keyword><keyword>Electricity</keyword><keyword>Fibroblasts</keyword><keyword>Fibroblasts: physiology</keyword></keywords><dates><year>1984</year></dates><accession-num>6587391</accession-num><urls><pdf-urls><url>internal-pdf://ECIS 1st Paper.pdf</url></pdf-urls><web-urls><url>http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=345299&amp;tool=pmcentrez&amp;rendertype=abstract</url></web-urls></urls><label>ECIS Theory</label><abstract>Mammalian fibroblasts have been cultured on evaporated gold electrodes subjected to an alternating electric field at 4000 Hz. The system consists of a large (approximately equal to 2 cm2) and a small (approximately equal to 3 X 10(-4) cm2) electrode bathed in tissue culture medium. The applied electric field produces a voltage drop at the boundary between the solution and the small electrode of a few mV at a current density of a few mA/cm2. The small population of cells that attach and spread on this electrode have a marked effect on the measured impedance and also cause it to fluctuate with time. The amplitude of these fluctuations is greatly reduced by cytochalasin B (10 microM), suggesting they are a consequence of cell movement.</abstract></record></records></xml>
